Citrus Sinensis ID: 003846
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 791 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.944 | 0.878 | 0.458 | 0.0 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.964 | 0.898 | 0.435 | 1e-178 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.949 | 0.886 | 0.452 | 1e-177 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.941 | 0.883 | 0.448 | 1e-175 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.932 | 0.885 | 0.433 | 1e-175 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.892 | 0.901 | 0.433 | 1e-170 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.916 | 0.861 | 0.430 | 1e-169 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.981 | 0.921 | 0.415 | 1e-167 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.949 | 0.876 | 0.421 | 1e-166 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.944 | 0.910 | 0.418 | 1e-165 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 642 bits (1656), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/804 (45%), Positives = 502/804 (62%), Gaps = 57/804 (7%)
Query: 18 FSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTV 77
+S+ + +S ++SL+ I+ + T+VS G FELGFF+PG +Y+GIWYK I +RT
Sbjct: 25 YSISANTLSASESLT----ISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTY 80
Query: 78 VWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTT---ATLLDSGNFV 134
VWVANRD PL+SS L IS + NLV+ D T S N++ + A LLD+GNFV
Sbjct: 81 VWVANRDTPLSSSIGTLKIS-DSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFV 139
Query: 135 LRNEKL----GLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKM 190
LR+ K G+LWQSFD+P+ T LP MKLG+ KTG + SWKS DDPS GD K+
Sbjct: 140 LRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKL 199
Query: 191 EPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMT-LNY-IFNYSLYTDENETYFIYSIK 248
E L R ++ SG W+G FS VPEM Y +FN++ + E TY K
Sbjct: 200 ETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTT-SKEEVTYSFRITK 258
Query: 249 DSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICNTATGS-CQC 304
+ SR + SG +++ +W+ Q W FW P+ C CG + C++ T C C
Sbjct: 259 SDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNC 318
Query: 305 LQGF------FIGSDKNLSECVRRTALQCGDNSADREDRFLRMHNVKLP--SPDKVLKLP 356
++GF G CVR+T L CG D F+R+ +KLP + V +
Sbjct: 319 IKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGG-----DGFVRLKKMKLPDTTTASVDRGI 373
Query: 357 GIEECKSACLNNCACTAYA----YNSSGVCSSWDGKLYDLEQLSKNEGENIFIKLAASEL 412
G++EC+ CL +C CTA+A S C +W G+L+D+ +K G++++++LAA++L
Sbjct: 374 GVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKG-GQDLYVRLAATDL 432
Query: 413 P-KPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYR--------EEREPSQDMLLFDI 463
K + +++ ++ V LLL + IF W+RK K + + S+D+L+
Sbjct: 433 EDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLM--- 489
Query: 464 NSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGEL 523
N +S+ +S ++ + D LPL F V+ +TNNFS NKLG+GGFG VYKG+L
Sbjct: 490 NEVVISSRRHISR----ENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKL 545
Query: 524 LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583
L+GQE+AVKRLSK S QG +E KNE LIA+LQH NLVRLL CC+D EK+LIYEYL N
Sbjct: 546 LDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENL 605
Query: 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP 643
SLDS LFD+++ L W+ R II GIA+GLLYLHQ SR RIIHRDLKASNILLD M P
Sbjct: 606 SLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTP 665
Query: 644 KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
KISDFGMAR+FG DE +ANT ++VGTYGYMSPEYA++G+FS+KSDVFSFGVLLLEI+S K
Sbjct: 666 KISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSK 725
Query: 704 KNTGFYHTG-SLNLLGHAWDLWKDNRALDLMDPILENEAS---YPMLARYVNVALLCVHE 759
+N GFY++ LNLLG W WK+ + L+++DPI+ + +S + R + + LLCV E
Sbjct: 726 RNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQE 785
Query: 760 NATDRPTMSEVVSMLTNEHLVLPR 783
A DRPTMS V+ ML +E +P+
Sbjct: 786 RAEDRPTMSLVILMLGSESTTIPQ 809
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 625 bits (1612), Expect = e-178, Method: Compositional matrix adjust.
Identities = 354/812 (43%), Positives = 504/812 (62%), Gaps = 49/812 (6%)
Query: 9 LIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIW 68
L + F + S+ + + +SL G + LVS K FELGFF PG S + ++GIW
Sbjct: 13 LFLYFFLYESSMAANTIRRGESLRDG---INHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69
Query: 69 YKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSS----QNTT 124
Y NI ++ VVWVANR P++ S VL IS++GNLV+ DG+ S N+ SS N
Sbjct: 70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRV 129
Query: 125 ATLLDSGNFVLRNEKLGL-LWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSV 183
++ D+GNFVL +W+SF++P+ TFLP M++ + +TG + SW+S DPS
Sbjct: 130 VSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189
Query: 184 GDAELKMEPGKSNAFSLMKRSQI-VWTSGVWDGYIFSLVPEMTL--NYIFNYSLYTDENE 240
G+ L ++P + L + ++ W SG W+ IF+ +P M+L NY++ + L + +E
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDE 249
Query: 241 T---YFIYSIKD-SIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSCVA---CGPFS 293
T YF Y D S++ R + +G E++ W + W F S+P + C CG F
Sbjct: 250 TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFG 309
Query: 294 ICNT--ATGSCQCLQGFFIGSDKNLSE-CVRRTALQCGDNSADREDRFLRMHNVKLPS-- 348
IC+ + G C C+ G+ S N S C RRT L+C N + ED FL + +VKLP
Sbjct: 310 ICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDFE 369
Query: 349 -PDKVLKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNEGENIFIKL 407
P+ L P E+C+ CL NC+C AY+ C W+ L DL+Q G ++ I+L
Sbjct: 370 IPEHNLVDP--EDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQQFEAG-GSSLHIRL 426
Query: 408 AASELPKPGGNKE--LLWITVIVVPLLLTASYIFLRWRRKLKYREE-----REPSQDMLL 460
A SE+ G N++ + I ++V ++L + L WR K K + +++
Sbjct: 427 ADSEV---GENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVV 483
Query: 461 FDINSSTET------SKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGG 514
D+ S ET S + + +G+A + LP+FS +++ +TN+F EN+LG GG
Sbjct: 484 ADLTKSKETTSAFSGSVDIMIEGKAVNTSE----LPVFSLNAIAIATNDFCKENELGRGG 539
Query: 515 FGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574
FGPVYKG L +G+E+AVKRLS KSGQG++E KNE +LIAKLQHRNLVRLLGCC + +EK+
Sbjct: 540 FGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKM 599
Query: 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634
L+YEY+PNKSLD FLFD K+ L+ W+ R IIEGIA+GLLYLH+ SRLRIIHRDLK SN
Sbjct: 600 LVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSN 659
Query: 635 ILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGV 694
+LLD +M PKISDFGMAR+FGG++ +ANT R+VGTYGYMSPEYA+EGLFS+KSDV+SFGV
Sbjct: 660 VLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGV 719
Query: 695 LLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVAL 754
LLLEI+SGK+NT + +L+G+AW L+ R+ +L+DP + S R ++VA+
Sbjct: 720 LLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAM 779
Query: 755 LCVHENATDRPTMSEVVSMLTNE--HLVLPRR 784
LCV ++A +RP M+ V+ ML ++ L PR+
Sbjct: 780 LCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 624 bits (1608), Expect = e-177, Method: Compositional matrix adjust.
Identities = 362/800 (45%), Positives = 492/800 (61%), Gaps = 49/800 (6%)
Query: 18 FSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTV 77
FS+ S T+SL+ I+ ++T++S + FELGFF P S +Y+GIWYK IP RT
Sbjct: 23 FSVYASNFSATESLT----ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTY 78
Query: 78 VWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQ---NTTATLLDSGNFV 134
VWVANRD PL+SS+ L IS + NLVI D S N++ A LLD GNFV
Sbjct: 79 VWVANRDNPLSSSNGTLKIS-DNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFV 137
Query: 135 LRNEK----LGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWS-LTSWKSRDDPSVGDAELK 189
LR+ K G LWQSFD+P+ T L MK+G+ K+G L SWK+ DDPS GD K
Sbjct: 138 LRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTK 197
Query: 190 MEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMT-LNYIFNYSLYTDENETYFIYSIK 248
+ F + + I + SG W G FS VP M ++YI N ++ Y K
Sbjct: 198 LRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNK 257
Query: 249 DSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICNTATGS-CQC 304
+I S L +G +++++W+ A Q+W W P+ C CG + C+ T C C
Sbjct: 258 TNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNC 317
Query: 305 LQGFFIGSDK-----NLSECVRRTALQCGDNSADREDRFLRMHNVKLP--SPDKVLKLPG 357
++GF +++ + CVR+T L C D D F+R+ ++LP + V K G
Sbjct: 318 IKGFEPMNEQAALRDDSVGCVRKTKLSC-----DGRDGFVRLKKMRLPDTTETSVDKGIG 372
Query: 358 IEECKSACLNNCACTAYA----YNSSGVCSSWDGKLYDLEQLSKNEGENIFIKLAASELP 413
++EC+ CL C CTA+A N C W G L+D+ +K G+++++++AA +L
Sbjct: 373 LKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKG-GQDLYVRVAAGDLE 431
Query: 414 -KPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLLFDINSSTETSKN 472
K +K+++ ++ V LLL + IF W+RK ++R + + D+ S ++ N
Sbjct: 432 DKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRK----QKRSITIQTPIVDLVRSQDSLMN 487
Query: 473 EL---SDGRAGKSKSTDAW-LPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQE 528
EL S K TD LPL + +++ +TNNFS +NKLG+GGFG VYKG LL+G+E
Sbjct: 488 ELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKE 547
Query: 529 VAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSF 588
+AVKRLSK S QG +E NE LIAKLQH NLVRLLGCC+D+ EK+LIYEYL N SLDS
Sbjct: 548 IAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSH 607
Query: 589 LFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648
LFD+ + L W+ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDF
Sbjct: 608 LFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDF 667
Query: 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGF 708
GMAR+FG +E +ANT R+VGTYGYMSPEYA++G+FS+KSDVFSFGVLLLEI+SGK+N GF
Sbjct: 668 GMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGF 727
Query: 709 YHTG-SLNLLGHAWDLWKDNRALDLMDPI----LENEASYPMLARYVNVALLCVHENATD 763
Y++ LNLLG W WK+ + L+++DPI L +E + R + + LLCV E A D
Sbjct: 728 YNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAED 787
Query: 764 RPTMSEVVSMLTNEHLVLPR 783
RP MS V+ ML +E +P+
Sbjct: 788 RPVMSSVMVMLGSETTAIPQ 807
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 616 bits (1589), Expect = e-175, Method: Compositional matrix adjust.
Identities = 360/802 (44%), Positives = 499/802 (62%), Gaps = 57/802 (7%)
Query: 18 FSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTV 77
FS+ + +S T+SL+ I+ ++T++S + FELGFF P S +Y+GIWYK IP RT
Sbjct: 23 FSVSPNTLSATESLT----ISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTY 78
Query: 78 VWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQ---NTTATLLDSGNFV 134
VWVANRD PL+SS+ L IS NLVI D S N++ A LLD+GNF+
Sbjct: 79 VWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFL 137
Query: 135 LRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGK 194
LR+ LLWQSFD+P+ T L MKLG+ +KTG L SWK+ DDPS G+ K+E +
Sbjct: 138 LRDSNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSE 197
Query: 195 SNAFSLMKRSQIVWTSGVWDGYIFSLVP-EMTLNYIFNYSLYTDENETYFIYSI-KDSII 252
F + + I++ SG W+G FS VP + ++Y+ Y+ + E + Y I K ++
Sbjct: 198 FPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMV-YNFTASKEEVTYSYRINKTNLY 256
Query: 253 SRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICNTAT-GSCQCLQGF 308
SR L+ +G +++++W Q+W W P+ C CG F C++ + +C C++GF
Sbjct: 257 SRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGF 316
Query: 309 FIGSDK------NLSECVRRTALQCGDNSADREDRFLRMHNVKLPSPDKVL--KLPGIEE 360
+++ + C+R+T L C D D F R+ +KLP + + G++
Sbjct: 317 KPVNEQAWDLRDGSAGCMRKTRLSC-----DGRDGFTRLKRMKLPDTTATIVDREIGLKV 371
Query: 361 CKSACLNNCACTAYA----YNSSGVCSSWDGKLYDLEQLSKNEGENIFIKLAASELP-KP 415
CK CL +C CTA+A N C W ++ D+ +K G++++++LAA+EL K
Sbjct: 372 CKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG-GQDLYVRLAAAELEDKR 430
Query: 416 GGNKELLWITVIVVPLLLTASYIFLRWRRKLKY-------REEREPSQDMLLFDINSSTE 468
N++++ ++ V LLL + IF W+RK K ++ SQD L+ D+ S
Sbjct: 431 IKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRR 490
Query: 469 --TSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNG 526
TSK + KS LPL +++ +TNNFS +NKLG+GGFG VYKG LL+G
Sbjct: 491 GYTSK---------EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDG 541
Query: 527 QEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLD 586
+E+AVKRLSK S QG +E NE LIAKLQH NLVRLLGCC+D+ EK+LIYEYL N SLD
Sbjct: 542 KEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLD 601
Query: 587 SFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646
S LFD+ + L W+ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKIS
Sbjct: 602 SHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKIS 661
Query: 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNT 706
DFGMAR+FG +E +ANT R+VGTYGYMSPEYA++G+FS+KSDVFSFGVLLLEI+SGK+N
Sbjct: 662 DFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNK 721
Query: 707 GFYHTG-SLNLLGHAWDLWKDNRALDLMDPI----LENEASYPMLARYVNVALLCVHENA 761
GFY++ LNLLG W WK+ L+++DPI L ++ + R + + LLCV E A
Sbjct: 722 GFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERA 781
Query: 762 TDRPTMSEVVSMLTNEHLVLPR 783
DRP MS V+ ML +E +P+
Sbjct: 782 EDRPVMSSVMVMLGSETTAIPQ 803
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 616 bits (1589), Expect = e-175, Method: Compositional matrix adjust.
Identities = 343/792 (43%), Positives = 481/792 (60%), Gaps = 54/792 (6%)
Query: 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPL 87
D++ Q + E ++S+GK F GFF G S YVGIWY I ++T+VWVANRD P+
Sbjct: 19 VDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPI 78
Query: 88 TSSSPVLTISSEGNLVI--EDGRITYRVSENVSSSQ---NTTATLLDSGNFVLRNEKLGL 142
+S ++ S+ GNL + D S NVS S ATL D GN VL + G
Sbjct: 79 NDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGR 138
Query: 143 -LWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLM 201
W+SFD+P+ TFLP M+LG++RK G SLTSWKS DP GD L+ME L
Sbjct: 139 SFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILY 198
Query: 202 KRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD-SIISRCILDVS 260
K W G W G+ +S VPEM + YIFN S +E+E F Y + D S+I+R +++ +
Sbjct: 199 KGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNET 258
Query: 261 GQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICNTA---TGSCQCLQGF------ 308
G + + +W+ + W FWS P+ C CGP C++ T C CL GF
Sbjct: 259 GTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPR 318
Query: 309 -FIGSDKNLSECVRRTALQCGDNSADREDRFLRMHNVKLP-SPDKVLKLP-GIEECKSAC 365
+ D + ++ A C + +D F+++ +K+P + D + + ++ECK C
Sbjct: 319 HWFLRDSSGGCTKKKRASICSE-----KDGFVKLKRMKIPDTSDASVDMNITLKECKQRC 373
Query: 366 LNNCACTAYA--YNSSGV----CSSWDGKLYDLEQLSKNEGENIFIKLAASELPK----- 414
L NC+C AYA Y+ S C W G + D + N G++ +I++ EL +
Sbjct: 374 LKNCSCVAYASAYHESKRGAIGCLKWHGGMLD-ARTYLNSGQDFYIRVDKEELARWNRNG 432
Query: 415 -PGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDM--LLFDINSSTETSK 471
G + LL + ++ ++L +F R + K R S + + FD + S
Sbjct: 433 LSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESF---- 488
Query: 472 NELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAV 531
R + K+ + LPLF ++ A+TNNFS++NKLG GGFGPVYKG L N E+AV
Sbjct: 489 ------RFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAV 542
Query: 532 KRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFD 591
KRLS+ SGQG+EE KNE LI+KLQHRNLVR+LGCC++ +EK+L+YEYLPNKSLD F+F
Sbjct: 543 KRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFH 602
Query: 592 RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651
++ L W R++I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLD++M PKISDFGMA
Sbjct: 603 EEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMA 662
Query: 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHT 711
R+FGG++++ T+R+VGT+GYM+PEYA+EG FSIKSDV+SFGVL+LEI++GKKN+ F H
Sbjct: 663 RIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAF-HE 721
Query: 712 GSLNLLGHAWDLWKDNRALDLMDPILENEA-SYPMLARYVNVALLCVHENATDRPTMSEV 770
S NL+GH WDLW++ A +++D +++ E + + + + LLCV ENA+DR MS V
Sbjct: 722 ESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSV 781
Query: 771 VSMLTNEHLVLP 782
V ML + LP
Sbjct: 782 VIMLGHNATNLP 793
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 598 bits (1541), Expect = e-170, Method: Compositional matrix adjust.
Identities = 345/796 (43%), Positives = 471/796 (59%), Gaps = 90/796 (11%)
Query: 2 ASFSICLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSR 61
A+ + LLIIS FS + TD L Q + +T+VS G FE+GFF PG SR
Sbjct: 3 ATNVLHLLIISLFS-----TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSR 57
Query: 62 NYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGR------ITYRVSE 115
N Y+GIWYK I +TVVWVANRD PL S L +S G+L + + R + S
Sbjct: 58 NRYLGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSS 117
Query: 116 NVSSSQNTTATLLDSGNFVLRN--EKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLT 173
+S +N +LD+GN V+RN + +WQS DYP FLPGMK G + TG LT
Sbjct: 118 QKASLRNPIVQILDTGNLVVRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLT 177
Query: 174 SWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYS 233
SW++ DDPS G+ KM+P F L K S +V+ +G W+G F+ +P + N I+ Y
Sbjct: 178 SWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYE 237
Query: 234 LYTDENETYFIYSIKD-SIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VAC 289
E E Y+ Y +++ S+++R L+ +G +++ +W+ Q+W + S SC C
Sbjct: 238 YVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLC 297
Query: 290 GPFSICN-TATGSCQCLQGFFIGSDK-----NLSE-CVRRTALQCGDNSADREDRFLRMH 342
G + CN + +C+CL+GF + + + SE CVRR L CG ED FL++
Sbjct: 298 GSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKG----EDGFLKIS 353
Query: 343 NVKLPSP-----DKVLKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSK 397
+KLP DK + L ECK CL NC C+AY+ +D+
Sbjct: 354 KLKLPDTRTSWYDKNMDL---NECKKVCLRNCTCSAYS-------------PFDI----- 392
Query: 398 NEGENIFIKLAASELPKPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQD 457
+ GG +LW ++ RE E QD
Sbjct: 393 ----------------RDGGKGCILWFGDLI------------------DIREYNENGQD 418
Query: 458 MLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGP 517
+ + +S ET + E S + K + D LP +VS +T+ FSA NKLG+GGFGP
Sbjct: 419 LYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGP 478
Query: 518 VYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577
VYKG L GQEVAVKRLS+ S QG+EE KNE LIAKLQHRNLV++LG C+D++E++LIY
Sbjct: 479 VYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIY 538
Query: 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637
EY PNKSLDSF+FD+ ++R L W RV+II+GIA+G+LYLH+ SRLRIIHRDLKASN+LL
Sbjct: 539 EYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLL 598
Query: 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLL 697
D+DM KISDFG+AR GGDE +ANT R+VGTYGYMSPEY ++G FS+KSDVFSFGVL+L
Sbjct: 599 DSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVL 658
Query: 698 EILSGKKNTGFYH-TGSLNLLGHAWDLWKDNRALDLMDPIL-ENEASYPMLARYVNVALL 755
EI+SG++N GF + LNLLGHAW + +++A +++D + E+ + R +++ LL
Sbjct: 659 EIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLL 718
Query: 756 CVHENATDRPTMSEVV 771
CV ++ DRP MS VV
Sbjct: 719 CVQQDPKDRPNMSVVV 734
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 595 bits (1535), Expect = e-169, Method: Compositional matrix adjust.
Identities = 336/780 (43%), Positives = 473/780 (60%), Gaps = 55/780 (7%)
Query: 38 TRSETLVSSGKFFELGFFRPGQS--RNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLT 95
+ SETL+ F GFF P S R YVGIWY+ IP +TVVWVAN+D P+ +S V++
Sbjct: 42 SESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKDSPINDTSGVIS 101
Query: 96 ISSEGNLVIEDGRITYRVSENVSSSQNTTAT---LLDSGNFVLRNEKLG--LLWQSFDYP 150
I +GNL + DGR S NVS AT L+DSGN +L++ + +LW+SF +P
Sbjct: 102 IYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNRNNGEILWESFKHP 161
Query: 151 SHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTS 210
+F+P M LG +TG LTSW S DDPS G+ + P + K + W S
Sbjct: 162 YDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPELLIWKNNVPTWRS 221
Query: 211 GVWDGYIFSLVPEM-TLNYIFNYSLYTDENETYFIYSIKDSIISRCILDVSGQVEQMSWL 269
G W+G +F +P M +L ++ ++L +D T + DS + LD G + Q W
Sbjct: 222 GPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISMSYANDSFMYHFNLDPEGIIYQKDWS 281
Query: 270 GARQAWFIFWSQPRTSCVA---CGPFSICNTATGS-CQCLQGFFIGSDKNLSE------- 318
+ + W I P T C A CG F C+ C+C++GF KN +E
Sbjct: 282 TSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKGFV---PKNNTEWNGGNWS 338
Query: 319 --CVRRTALQC-------GDNSADREDRFLRMHNVKLPSPDKVLKLPGIEECKSACLNNC 369
C+R+ LQC + D FL++ +K+P + + + C CL+NC
Sbjct: 339 NGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAERSE-ASEQVCPKVCLDNC 397
Query: 370 ACTAYAYNSSGVCSSWDGKLYDLEQLSKNEGENIFIKLAASELPKPGGNKELLWITVIVV 429
+CTAYAY+ C W G L D++ G ++FI++A SEL K N ++ ++
Sbjct: 398 SCTAYAYDRGIGCMLWSGDLVDMQSF-LGSGIDLFIRVAHSEL-KTHSNLAVMIAAPVIG 455
Query: 430 PLLLTASYIFLRWRRKLKYREEREPSQDM---LLFD----INSSTETSKNELSDGRAGKS 482
+L+ A + L R KY++ P++D L+F + S E++ N++ K
Sbjct: 456 VMLIAAVCVLLACR---KYKKRPAPAKDRSAELMFKRMEALTSDNESASNQI------KL 506
Query: 483 KSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGL 542
K LPLF F ++ ST++FS NKLG+GGFGPVYKG+L GQE+AVKRLS+KSGQGL
Sbjct: 507 KE----LPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGL 562
Query: 543 EELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWET 602
EEL NE ++I+KLQHRNLV+LLGCC++ +E++L+YEY+P KSLD++LFD K+++L W+T
Sbjct: 563 EELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKT 622
Query: 603 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662
R I+EGI +GLLYLH+ SRL+IIHRDLKASNILLD ++ PKISDFG+AR+F +E +AN
Sbjct: 623 RFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEAN 682
Query: 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFY-HTGSLNLLGHAW 721
T R+VGTYGYMSPEYA+EG FS KSDVFS GV+ LEI+SG++N+ + +LNLL +AW
Sbjct: 683 TRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAW 742
Query: 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781
LW D A L DP + ++ + + V++ LLCV E A DRP +S V+ MLT E++ L
Sbjct: 743 KLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSL 802
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 587 bits (1514), Expect = e-167, Method: Compositional matrix adjust.
Identities = 336/809 (41%), Positives = 475/809 (58%), Gaps = 33/809 (4%)
Query: 1 MASFSICLLIISAFSMQFSLVVD-AVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQ 59
MA F+ L +++ + L + + S ++S + I ++L+S + FELGFF P
Sbjct: 1 MAGFNRNLTLVTTLLIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKN 60
Query: 60 SRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVS- 118
S YVGIWYKNI +TVVWVANR++PL L I+ +GNLVI +G+ S NV
Sbjct: 61 STLRYVGIWYKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEP 120
Query: 119 SSQNTTATLLDSGNFVL--RNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWK 176
S NT A L +G+ VL +++ W+SF+ P+ TFLPGM++ + G+ + WK
Sbjct: 121 ESNNTVAVLFKTGDLVLCSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWK 180
Query: 177 SRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMT--LNYIFNYSL 234
S DPS G + ++P + + + + W SG W+ IF+ +P+M NYI+ + L
Sbjct: 181 SESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKL 240
Query: 235 YTD---ENETYFIYSIKDSI-ISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSCVA-- 288
+ + YF Y DS R + G EQ W + W + +P T C
Sbjct: 241 SSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYN 300
Query: 289 -CGPFSICNTA----TGSCQCLQGFFIGSDKNLSE------CVRRTALQCGDN-SADRED 336
CG +S+C+ + +G C C+ GF + C RR L C + A +ED
Sbjct: 301 RCGNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQED 360
Query: 337 RFLRMHNVKLPSPDKVLKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLS 396
F + +K+P V+ E CK C +C+C AYA C W L D+E
Sbjct: 361 GFTVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKAYALVVGIGCMIWTRDLIDMEHFE 420
Query: 397 KNEGENIFIKLAASELPKPGGNKE--LLWITVI-VVPLLLTASYIFLRWRRKLKYREERE 453
+ G +I I+LA S+L GG KE LWI V V+ L I++ W+ K +
Sbjct: 421 RG-GNSINIRLAGSKL---GGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLW 476
Query: 454 PSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEG 513
+D+ + DI + + S + + + + D LP+FSF SV+++T +F+ ENKLG+G
Sbjct: 477 KKKDITVSDIIENRDYSSSPIKVLVGDQVDTPD--LPIFSFDSVASATGDFAEENKLGQG 534
Query: 514 GFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573
GFG VYKG G+E+AVKRLS KS QGLEE KNE +LIAKLQHRNLVRLLGCC++ +EK
Sbjct: 535 GFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEK 594
Query: 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 633
+L+YEY+PNKSLD FLFD +K+ L W R ++I GIA+GLLYLH+ SRL+IIHRDLKAS
Sbjct: 595 MLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKAS 654
Query: 634 NILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFG 693
NILLDT+M PKISDFGMAR+F + ANT R+VGTYGYM+PEYA+EG+FS KSDV+SFG
Sbjct: 655 NILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFG 714
Query: 694 VLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVA 753
VL+LEI+SG+KN F T +L+G+AW LW + +++DPI+++ R ++V
Sbjct: 715 VLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVG 774
Query: 754 LLCVHENATDRPTMSEVVSMLTNEHLVLP 782
+LC ++ RP M V+ ML ++ LP
Sbjct: 775 MLCTQDSVIHRPNMGSVLLMLESQTSQLP 803
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 585 bits (1509), Expect = e-166, Method: Compositional matrix adjust.
Identities = 351/832 (42%), Positives = 493/832 (59%), Gaps = 81/832 (9%)
Query: 3 SFSICLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRN 62
SF + +++ S+ ++ +S T+SL+ I+ ++TLVS G FE+GFFR +
Sbjct: 14 SFLLVFVVMILIHPALSIYINTLSSTESLT----ISSNKTLVSPGSIFEVGFFR--TNSR 67
Query: 63 YYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQN 122
+Y+G+WYK + +RT VWVANRD PL+++ L IS NLV+ D N++
Sbjct: 68 WYLGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNE 126
Query: 123 ---TTATLLDSGNFVLR----NEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSW 175
A LL +GNFV+R N+ LWQSFDYP+ T LP MKLGY+ KTG LTSW
Sbjct: 127 RSPVVAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSW 186
Query: 176 KSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPE-MTLNYIFNYSL 234
+S DDPS G+ K+E F L + + + SG W+G FS +PE L+Y+ +
Sbjct: 187 RSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFI 246
Query: 235 YTDENETYFIYSIKDSIISRCILDVSGQVEQMSWLGARQAWFIFWSQP-RTSC---VACG 290
+E Y +S SR L G ++++W + + W FWS P C + CG
Sbjct: 247 ENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCG 306
Query: 291 PFSICNTATGS-CQCLQGFFIGSDKNLSE---------CVRRTALQCGDNSADREDRFLR 340
P++ C+ T C C+QGF + +N+ + C+RRT L C D F R
Sbjct: 307 PYAYCDVNTSPVCNCIQGF---NPRNIQQWDQRVWAGGCIRRTQLSCSG------DGFTR 357
Query: 341 MHNVKLPSPD--KVLKLPGIEECKSACLNNCACTAYA----YNSSGVCSSWDGKLYDLEQ 394
M +KLP V + G++ECK C+++C CTA+A N C W +L D+
Sbjct: 358 MKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRN 417
Query: 395 LSKN--EGENIFIKLAASELPKP-GGNKELLWITVIVVPLLLTASYIFLRWRRKLK---- 447
+ + +G++++++LAA+++ K + +++ +TV V LLL +F W+RK K
Sbjct: 418 YATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLI--MFCLWKRKQKRAKA 475
Query: 448 --------YREEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSA 499
R + P +M+L +SK E S G+ K + LPL +V
Sbjct: 476 SAISIANTQRNQNLPMNEMVL--------SSKREFS----GEYKFEELELPLIEMETVVK 523
Query: 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN 559
+T NFS+ NKLG+GGFG VYKG LL+G+E+AVKRLSK S QG +E NE LIA+LQH N
Sbjct: 524 ATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHIN 583
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
LV++LGCC++ DEK+LIYEYL N SLDS+LF + ++ L W R I G+A+GLLYLHQ
Sbjct: 584 LVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQ 643
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
SR RIIHRDLK SNILLD +M PKISDFGMAR+F DE +ANT ++VGTYGYMSPEYA+
Sbjct: 644 DSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAM 703
Query: 680 EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN-LLGHAWDLWKDNRALDLMDP-IL 737
G+FS KSDVFSFGV++LEI+SGKKN GFY+ N LL + W WK+ RAL+++DP I+
Sbjct: 704 YGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIV 763
Query: 738 ENEASYPML------ARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPR 783
++ +S P + + + + LLCV E A RP MS VV M +E +P+
Sbjct: 764 DSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQ 815
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 583 bits (1504), Expect = e-165, Method: Compositional matrix adjust.
Identities = 335/801 (41%), Positives = 480/801 (59%), Gaps = 54/801 (6%)
Query: 6 ICLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYV 65
+C+L++S F + SL + + L+ SET+VSS + F GFF P S + Y
Sbjct: 11 VCILVLSCFFLSVSLAQERAFFSGKLN------DSETIVSSFRTFRFGFFSPVNSTSRYA 64
Query: 66 GIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVS---SSQN 122
GIWY ++ +TV+WVAN+D+P+ SS V+++S +GNLV+ DG+ S NVS S+ +
Sbjct: 65 GIWYNSVSVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANS 124
Query: 123 TTATLLDSGNFVLRNEKL-GLLWQSFDYPSHTFLPGMKLGY-SRKTGKVWSLTSWKSRDD 180
T A LLDSGN VL+ LW+SF YP+ ++LP M +G +R G ++TSWKS D
Sbjct: 125 TVAELLDSGNLVLKEASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSD 184
Query: 181 PSVGDAELKMEPGKSNAFSLMKRS---QIVWTSGVWDGYIFSLVPEMTLN-YIFNYSLYT 236
PS G + +M + VW SG W+G +F+ +P++ +++ + +
Sbjct: 185 PSPGSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVND 244
Query: 237 DENETYFIYSIKDSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFS 293
D N + + DS + +D G V + W R+ W + P T C CG F+
Sbjct: 245 DTNGSVTMSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFA 304
Query: 294 ICNTATGS-CQCLQGFFIGSDKNLSE---------CVRRTALQCG-DNSADREDRFLRMH 342
CN C C++GF +NL E C RR LQC N+ D FLR+
Sbjct: 305 TCNPRKNPLCSCIRGF---RPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSADGFLRLR 361
Query: 343 NVKLPSPDKVLKLPGIE-ECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNEGE 401
+KLP D + E EC CL C+C A A+ C W+G L D ++LS + G
Sbjct: 362 RMKLP--DFARRSEASEPECLRTCLQTCSCIAAAHGLGYGCMIWNGSLVDSQELSAS-GL 418
Query: 402 NIFIKLAASELPKPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLLF 461
+++I+LA SE+ K + +L T++ + + A+ + L R +K R +++ +F
Sbjct: 419 DLYIRLAHSEI-KTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIF 477
Query: 462 DINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKG 521
+ L+ G GK K LPLF F ++A+TNNFS NKLG+GGFGPVYKG
Sbjct: 478 E-------RVEALAGGNKGKLKE----LPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKG 526
Query: 522 ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581
+L GQE+AVKRLS+ SGQGLEEL NE ++I+KLQHRNLV+LLGCC+ +E++L+YE++P
Sbjct: 527 KLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMP 586
Query: 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641
KSLD +LFD + +LL W+TR II GI +GLLYLH+ SRLRIIHRDLKASNILLD ++
Sbjct: 587 KKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENL 646
Query: 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
PKISDFG+AR+F G+E +ANT R+VGTYGYM+PEYA+ GLFS KSDVFS GV+LLEI+S
Sbjct: 647 IPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIIS 706
Query: 702 GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENA 761
G++N+ + LL + W +W + L+DP + + + + +++ LLCV E A
Sbjct: 707 GRRNS------NSTLLAYVWSIWNEGEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAA 760
Query: 762 TDRPTMSEVVSMLTNEHLVLP 782
DRP++S V SML++E +P
Sbjct: 761 NDRPSVSTVCSMLSSEIADIP 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 791 | ||||||
| 359493713 | 1988 | PREDICTED: uncharacterized protein LOC10 | 0.958 | 0.381 | 0.614 | 0.0 | |
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.954 | 0.872 | 0.569 | 0.0 | |
| 359493705 | 830 | PREDICTED: receptor-like serine/threonin | 0.962 | 0.916 | 0.572 | 0.0 | |
| 359493709 | 894 | PREDICTED: receptor-like serine/threonin | 0.963 | 0.852 | 0.568 | 0.0 | |
| 359493701 | 958 | PREDICTED: G-type lectin S-receptor-like | 0.958 | 0.791 | 0.556 | 0.0 | |
| 147768020 | 2026 | hypothetical protein VITISV_021034 [Viti | 0.958 | 0.374 | 0.558 | 0.0 | |
| 359493703 | 1658 | PREDICTED: uncharacterized protein LOC10 | 0.955 | 0.455 | 0.550 | 0.0 | |
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.786 | 0.898 | 0.616 | 0.0 | |
| 224138268 | 818 | predicted protein [Populus trichocarpa] | 0.927 | 0.897 | 0.514 | 0.0 | |
| 224106539 | 846 | predicted protein [Populus trichocarpa] | 0.950 | 0.888 | 0.520 | 0.0 |
| >gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 939 bits (2427), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/785 (61%), Positives = 599/785 (76%), Gaps = 27/785 (3%)
Query: 18 FSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTV 77
FS+ VDA DT + GQ++ +++T++S+G FELGFF PG S +Y+VGIWYK I E+TV
Sbjct: 293 FSISVDAAPDT--IFSGQMLRQTDTIISAGGNFELGFFSPGNSPSYFVGIWYKKISEQTV 350
Query: 78 VWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGNFVLRN 137
VWVANRD +T SSP LTI+ +GNLVI DGR+TY V+ N+S QN +ATLLDSGN +LRN
Sbjct: 351 VWVANRDYTITGSSPSLTINDDGNLVILDGRVTYMVA-NISLGQNVSATLLDSGNLILRN 409
Query: 138 EKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNA 197
+LWQSFDYPS+ FLPGMK+GY+RKTG+VWS TSWK+ +DP +G LKM+P +++
Sbjct: 410 GNSNILWQSFDYPSNHFLPGMKIGYNRKTGEVWSFTSWKNAEDPGLGPVSLKMDP-ETHQ 468
Query: 198 FSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD-SIISRCI 256
F +M SQ+VW+SGVW+G+ FS VPEM L+YIFNYS + D +E YF YS+ D SIISR +
Sbjct: 469 FVIMWNSQMVWSSGVWNGHAFSSVPEMRLDYIFNYSYFEDMSEAYFTYSLYDNSIISRLL 528
Query: 257 LDVSGQVEQMSWLGARQAWFIFWSQPRT-SC---VACGPFSICNTATGS-CQCLQGFFIG 311
+DVSG ++Q++WL R W +FWSQP+ C CG FS CN T CQCL GF
Sbjct: 529 IDVSGNIKQLTWLD-RSGWNLFWSQPQNFECDYYSYCGSFSSCNNQTTPICQCLYGFRPN 587
Query: 312 S------DKNLSECVRRTALQCGDNSA--DREDRFLRMHNVKLPSPDKVLKLPGIEECKS 363
S ++ CVR+T+LQC D ++ +D+FL+M NVK P ++L+ IE CK
Sbjct: 588 SAGDWMMNQFRDGCVRKTSLQCDDLTSVNSEKDKFLKMANVKFPQSPQILETQSIETCKM 647
Query: 364 ACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNE--GENIFIKLAASELPKPGGNKEL 421
CLN C+C AYA+N G C WD L +L+QLSK + G +++KLAASEL +K
Sbjct: 648 TCLNKCSCNAYAHN--GSCLMWDQILLNLQQLSKKDPDGRTLYLKLAASELQNSRESKMP 705
Query: 422 LWITVIVVPLLLTA---SYIFLRWRRKLKYREEREPSQDMLLFDINSSTETSKNELSDG- 477
W+ +VV +L SYI R ++++ REE SQD+LL++ ++ ++NEL++G
Sbjct: 706 RWVIGMVVVAVLVLLLASYICYRQMKRVQDREEMTTSQDILLYEFGMGSKATENELNEGN 765
Query: 478 RAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK 537
R GK K+ DAWLPLFSFASVSA+T +FS ENKLG+GGFGPVYKGEL NGQE+AVKRLS+
Sbjct: 766 RVGKDKNKDAWLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNGQEIAVKRLSRS 825
Query: 538 SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL 597
SGQGLEELKNET+L+A+LQHRNLVRLLGCC++Q EKILIYEY+PNKSLDSFLFD K+
Sbjct: 826 SGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPNKRGQ 885
Query: 598 LYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657
L W RV IIEGIAQGLLYLH+YSRLRIIHRDLKASNILLD DM PKISDFGMARMFGG+
Sbjct: 886 LDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARMFGGN 945
Query: 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLL 717
E ANTNRIVGTYGYMSPEYALEGLFS KSDVFSFGVL+LEILSGKKNTGFY++ +LNL+
Sbjct: 946 ESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDTLNLI 1005
Query: 718 GHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777
G+AW+LWK + A++LMDP+LE ++S ML RY+NV LLCV E A DRPT+SEVVSMLTNE
Sbjct: 1006 GYAWELWKSDMAINLMDPMLEGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVSMLTNE 1065
Query: 778 HLVLP 782
VLP
Sbjct: 1066 LAVLP 1070
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 862 bits (2226), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/793 (56%), Positives = 574/793 (72%), Gaps = 38/793 (4%)
Query: 12 SAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKN 71
+ F ++F+ DA +DT +S GQ IT S+T++S+G FELGFF PG S YYVGIWYK
Sbjct: 50 ACFHLEFA---DAFTDT--ISQGQSITTSQTIISAGGEFELGFFSPGNSTKYYVGIWYKK 104
Query: 72 IPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSG 131
+ E T+VWVANRD T S VLT+ ++GNL + +G+I+YRV+ ++SS+ T+ATLLDSG
Sbjct: 105 VSEPTIVWVANRDYSFTDPSVVLTVRTDGNLEVWEGKISYRVT-SISSNSKTSATLLDSG 163
Query: 132 NFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKME 191
N VLRN +LWQSFDYPS TFLPGMKLGY ++ GK WSL SWKS +DPS G +K +
Sbjct: 164 NLVLRNNNSSILWQSFDYPSDTFLPGMKLGYDKRAGKTWSLVSWKSTEDPSPGVFSMKYD 223
Query: 192 PGKSNAFSLMKRSQIVWTSGVWD--GYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD 249
P S +++ S + W SG WD G FSL+ EM LN +FN+S + E+Y YSI +
Sbjct: 224 PKGSGQIFILQGSTMYWASGTWDRDGQAFSLISEMRLNEVFNFSYSFSKEESYINYSIYN 283
Query: 250 SI-ISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICNTATGS--CQ 303
S I R +LDVSGQ++QMSWL A W +FW QP+T C CGPF IC+ C+
Sbjct: 284 SSKICRFVLDVSGQIKQMSWLEASHQWHMFWFQPKTQCEVYAYCGPFGICHDHAVDRFCE 343
Query: 304 CLQGFFIG--SDKNLSE----CVRRTALQCGDNSAD--REDRFLRMHNVKLPSPDKVLKL 355
CL GF G ++ NL++ CVR+ LQCG+++ D D+F R+ NV+LP L
Sbjct: 344 CLPGFEPGFPNNWNLNDTSGGCVRKADLQCGNSTHDNGERDQFYRVSNVRLPDYPLTLPT 403
Query: 356 PGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNE--GENIFIKLAASELP 413
G +C+S CLNNC+C+AY+Y C+ W G L +L+QLS + G++ ++KLAASEL
Sbjct: 404 SGAMQCESDCLNNCSCSAYSYYMEK-CTVWGGDLLNLQQLSDDNSNGQDFYLKLAASELS 462
Query: 414 -KPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLLFDINSSTETSKN 472
K +K +W+ ++ + + +T++++ RR+L R +++LLFD+++S+ +
Sbjct: 463 GKVSSSKWKVWL-IVTLAISVTSAFVIWGIRRRL-----RRKGENLLLFDLSNSSVDTNY 516
Query: 473 ELSDGR---AGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEV 529
ELS+ +G+ K D LP+FSFASVSA+TNNFS ENKLGEGGFGPVYKG+ G EV
Sbjct: 517 ELSETSKLWSGEKKEVD--LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEV 574
Query: 530 AVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFL 589
AVKRLSK+SGQG EELKNE MLIAKLQH+NLV+L G C+++DEKILIYEY+PNKSLD FL
Sbjct: 575 AVKRLSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFL 634
Query: 590 FDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649
FD K +L W+TRV II+G+AQGLLYLHQYSRLRIIHRDLKASNILLD DM P+ISDFG
Sbjct: 635 FDPTKHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFG 694
Query: 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFY 709
MAR+FGG+E +A TN IVGTYGYMSPEYALEGLFS KSDVFSFGVLLLEILSGKKNTGFY
Sbjct: 695 MARIFGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFY 753
Query: 710 HTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSE 769
T SLNLLG+AWDLWKD+R +LMDP LE +L RY+N+ LLCV E+A DRPTMS+
Sbjct: 754 QTDSLNLLGYAWDLWKDSRGQELMDPGLEETLPTHILLRYINIGLLCVQESADDRPTMSD 813
Query: 770 VVSMLTNEHLVLP 782
VVSML NE + LP
Sbjct: 814 VVSMLGNESVRLP 826
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 839 bits (2167), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/795 (57%), Positives = 563/795 (70%), Gaps = 34/795 (4%)
Query: 6 ICLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYV 65
+ LLI S F QF VDA TD++ GQ +T S+T+VS+G FELGFF PG+S YYV
Sbjct: 13 VFLLISSGFHWQF---VDAF--TDAILQGQSLTTSQTIVSAGGNFELGFFSPGKSTKYYV 67
Query: 66 GIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTA 125
GIWYK I E+T+VWVANRD T+ S VLT+S++GNL I +G+I+Y+V+ S+S T+A
Sbjct: 68 GIWYKKISEQTIVWVANRDYSFTNPSVVLTVSTDGNLEILEGKISYKVTSISSNSN-TSA 126
Query: 126 TLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGD 185
TLLDSGN VLRN+K +LW+SFDYPSHT+LPGMKLGY ++ GK WSL SWKS +DPS GD
Sbjct: 127 TLLDSGNLVLRNKKSDVLWESFDYPSHTYLPGMKLGYDKRAGKTWSLVSWKSAEDPSPGD 186
Query: 186 AELKMEP-GKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFI 244
L+++P G S FSL ++ WT+GVWDG IF+ VPEM L ++ ++ +ENE Y
Sbjct: 187 FSLQVDPNGTSQIFSLQGPNR-YWTTGVWDGQIFTQVPEMRLPDMYKCNISFNENEIYLT 245
Query: 245 YSIKD-SIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICN-TAT 299
YS+ + SI+SR +LDVSGQ+ ++W + W +FW QP+T C CGPF C +
Sbjct: 246 YSLHNPSILSRLVLDVSGQIRSLNWHEGTREWDLFWLQPKTQCEVYAYCGPFGTCTRDSV 305
Query: 300 GSCQCLQGF--FIGSDKNLSE----CVRRTALQCGDNSA--DREDRFLRMHNVKLPSPDK 351
C+CL GF D NL + CVR+ LQC + S D+FL + NV+LP
Sbjct: 306 EFCECLPGFEPRFPEDWNLQDRSGGCVRKADLQCVNESHANGERDQFLLVSNVRLPKYPV 365
Query: 352 VLKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNE--GENIFIKLAA 409
L+ EC+S CLN C+C+AYAY C W G L ++EQL + G + +IKLAA
Sbjct: 366 TLQARSAMECESICLNRCSCSAYAYKRE--CRIWAGDLVNVEQLPDGDSNGRSFYIKLAA 423
Query: 410 SELPKP-GGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLLFDINSSTE 468
SEL K +K +W+ + + L +A I+ W R R +D+L+FD +S+E
Sbjct: 424 SELNKRVSSSKWKVWLIITLAISLTSAFVIYGIWGRF------RRKGEDLLVFDFGNSSE 477
Query: 469 TSKNELSD-GRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQ 527
+ EL + R + + + LP+FSFASVSASTNNFS ENKLGEGGFG VYKG+
Sbjct: 478 DTSYELDETNRLWRGEKREVDLPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKSQRRY 537
Query: 528 EVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDS 587
EVAVKRLSK+S QG EELKNE MLIAKLQH+NLV++LG C+++DEKILIYEY+ NKSLD
Sbjct: 538 EVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDF 597
Query: 588 FLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISD 647
FLFD K +L W+TRV IIEG+AQGLLYLHQYSRLRIIHRDLKASNILLD DM PKISD
Sbjct: 598 FLFDPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISD 657
Query: 648 FGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTG 707
FGMAR+FGG+E + TN IVGTYGYMSPEYALEGLFS KSDVFSFGVLLLEILSGKKNTG
Sbjct: 658 FGMARIFGGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTG 716
Query: 708 FYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTM 767
FY T SLNLLG+AWDLWKD+R L+LMDP LE +L RY+NV LLCV E+A DRPTM
Sbjct: 717 FYQTDSLNLLGYAWDLWKDSRGLELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTM 776
Query: 768 SEVVSMLTNEHLVLP 782
S+VVSML NE + LP
Sbjct: 777 SDVVSMLGNESVRLP 791
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493709|ref|XP_002281056.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2156), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/795 (56%), Positives = 565/795 (71%), Gaps = 33/795 (4%)
Query: 6 ICLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYV 65
+ LLI S F +QF VDA +DT + GQ +T S+T++S+G FELGFF PG+S YYV
Sbjct: 16 VFLLISSGFHLQF---VDAFTDT--ILQGQSLTTSQTIISAGGNFELGFFSPGKSTKYYV 70
Query: 66 GIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTA 125
GIWYK E+T+VWVANRD T+ S VLT+S++GNL I +G+I+Y+V+ S+S T+A
Sbjct: 71 GIWYKKFSEQTIVWVANRDYSFTNPSVVLTVSTDGNLEILEGKISYKVTSISSNSN-TSA 129
Query: 126 TLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGD 185
TLLDSGN VLRN+K +LW+SFDYPS T LPGMKLGY ++ GK WSL SWKSRDDPS G
Sbjct: 130 TLLDSGNLVLRNKKSDVLWESFDYPSDTLLPGMKLGYDKRAGKTWSLVSWKSRDDPSPGA 189
Query: 186 AELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIY 245
++ + +S+ ++ ++ WTSGVW+G IFS VPEM L+ ++ Y+ +ENE+Y Y
Sbjct: 190 FSIEHDANESSQIFNLQGPKMYWTSGVWNGQIFSQVPEMRLSDMYKYNASFNENESYLTY 249
Query: 246 SIK-DSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICN-TATG 300
S++ SI+SR +LDVSGQV +++W W +FW QP+T C CGPF C +
Sbjct: 250 SLRYPSILSRVVLDVSGQVRKLNWHEGTHEWDLFWLQPKTQCEVYAYCGPFGTCTRDSVE 309
Query: 301 SCQCLQGF--FIGSDKNLSE----CVRRTALQCGDNSA--DREDRFLRMHNVKLPSPDKV 352
C+CL GF D NL + CVR+ L+C + S D+FL + NV+LP
Sbjct: 310 FCECLPGFEPRFPEDWNLQDRSGGCVRKADLECVNESHANGERDQFLLVSNVRLPKYPVT 369
Query: 353 LKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNE--GENIFIKLAAS 410
L+ EC+S CLN C+C+AYAY G C W G L ++EQL + + +IKLAAS
Sbjct: 370 LQARSAMECESICLNRCSCSAYAYE--GECRIWGGDLVNVEQLPDGDSNARSFYIKLAAS 427
Query: 411 ELPKP-GGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLLFDI-NSSTE 468
EL K +K +W+ + + L +A I+ W K+R + E D+L+FD NSS +
Sbjct: 428 ELNKRVSSSKWKVWLIITLAISLTSAFVIYGIWG---KFRRKGE---DLLVFDFGNSSED 481
Query: 469 TSKNELSD-GRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQ 527
TS EL + R + + + LP+FSF SVSASTNNF ENKLGEGGFG VYKG+ G
Sbjct: 482 TSCYELGETNRLWRGEKKEVDLPMFSFVSVSASTNNFCIENKLGEGGFGSVYKGKSQRGY 541
Query: 528 EVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDS 587
EVAVKRLSK+S QG EELKNE MLIAKLQH+NLV++LG C+++DEKILIYEY+ NKSLD
Sbjct: 542 EVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDF 601
Query: 588 FLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISD 647
FLFD AK+ +L WETRV+IIEG+AQGLLYLHQYSRLR+IHRDLKASNILLD DM PKISD
Sbjct: 602 FLFDPAKRGILNWETRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 661
Query: 648 FGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTG 707
FGMAR+FGG+E +A T IVGTYGYMSPEYALEGLFS KSDVFSFGVLLLEILSGKKNTG
Sbjct: 662 FGMARIFGGNESKA-TKHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTG 720
Query: 708 FYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTM 767
FY T SLNLLG+AWDLWKD+R +LMDP LE +L RY+NV LLCV E+A DRPTM
Sbjct: 721 FYQTDSLNLLGYAWDLWKDSRGQELMDPGLEETLPTHILLRYINVGLLCVQESADDRPTM 780
Query: 768 SEVVSMLTNEHLVLP 782
S+VVSML NE + LP
Sbjct: 781 SDVVSMLGNESVRLP 795
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493701|ref|XP_002281280.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2122), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/790 (55%), Positives = 559/790 (70%), Gaps = 32/790 (4%)
Query: 13 AFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNI 72
F QF VDA +DT + GQ +T S+T+VS+G FELGFF PG+S YYVGIWYK I
Sbjct: 8 GFHWQF---VDAFTDT--ILQGQSLTTSQTIVSAGGNFELGFFSPGKSTKYYVGIWYKKI 62
Query: 73 PERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGN 132
E+T+VWVANRD T+ S VLT+S++GNL I +G+I+Y+V+ S+S T+ATLLDSGN
Sbjct: 63 SEQTIVWVANRDYSFTNPSVVLTVSTDGNLEILEGKISYKVTSISSNSN-TSATLLDSGN 121
Query: 133 FVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEP 192
VLRN+K +LW+SFDYPS T LPGMKLGY ++ GK WSL SWKSR+DPS G ++ +
Sbjct: 122 LVLRNKKSDVLWESFDYPSDTLLPGMKLGYDKRAGKRWSLVSWKSREDPSPGAFSIEHDA 181
Query: 193 GKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD-SI 251
+S+ ++ ++ WT+GVWDG IFS VPEM Y++ ++ +ENE+YF YS+ + SI
Sbjct: 182 NESSQIFNLQGPKMYWTTGVWDGQIFSQVPEMRFFYMYKQNVSFNENESYFSYSLHNPSI 241
Query: 252 ISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICN-TATGSCQCLQG 307
+SR +LDVSGQV++++ W +FW QP+T C CGPF C + C+CL G
Sbjct: 242 LSRVVLDVSGQVKRLNCHEGAHEWDLFWLQPKTQCEVYAYCGPFGTCTGDSVEFCECLPG 301
Query: 308 F--FIGSDKNLSE----CVRRTALQCGDNSA--DREDRFLRMHNVKLPSPDKVLKLPGIE 359
F D NL + CVR+ LQC + S D+FL + NV+LP L+
Sbjct: 302 FEPLFPEDWNLQDRSGGCVRKADLQCVNESHANGERDQFLLVSNVRLPKYPVTLQARSAM 361
Query: 360 ECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNE--GENIFIKLAASELPKP-G 416
EC+S CLN C+C+AYAY G C W G L ++EQL E + +IKLAASEL K
Sbjct: 362 ECESICLNRCSCSAYAY--EGECRIWGGDLVNVEQLPDGESNARSFYIKLAASELNKRVS 419
Query: 417 GNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLLFDINSSTETSKNELSD 476
+K +W+ + + L +A I+ W R R +D+L+FD +S+E + EL +
Sbjct: 420 SSKWKVWLIITLAISLTSAFVIYGIWGRF------RRKGEDLLVFDFGNSSEDTSYELGE 473
Query: 477 -GRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLS 535
R + + + LP+FSFASVSASTNNFS ENKLGEGGFG VYKG+L G EVAVKRLS
Sbjct: 474 TNRLWRGEKKEVDLPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKLQRGYEVAVKRLS 533
Query: 536 KKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKK 595
K+S QG EELKNE MLIAKLQH+NLV++LG C+++DEKILIYEY+ NKSLD FLFD AK+
Sbjct: 534 KRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKR 593
Query: 596 RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655
+L WE RV+IIEG+AQGLLYLHQYSRLR+IHRDLKASNILLD DM PKISDFGMAR+FG
Sbjct: 594 GILNWEMRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFG 653
Query: 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN 715
G+E +A T IVGTYGYMSPEY L GLFS KSDVFSFGVLLLEILSGKK T FYH+GSLN
Sbjct: 654 GNESKA-TKHIVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSGSLN 712
Query: 716 LLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775
LLG+AWDLWK+N+ +L+DP+L + ++ RY+NVALLCV E+A DRPTM +VVSML
Sbjct: 713 LLGYAWDLWKNNKGQELIDPVLNEISLRHIMLRYINVALLCVQESADDRPTMFDVVSMLV 772
Query: 776 NEHLVLPRRN 785
E+++L N
Sbjct: 773 KENVLLSSPN 782
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147768020|emb|CAN69396.1| hypothetical protein VITISV_021034 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2109), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/791 (55%), Positives = 560/791 (70%), Gaps = 33/791 (4%)
Query: 13 AFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNI 72
F QF VDA +DT + GQ +T S+T+VS+G FELGFF PG+S YYVGIWYK I
Sbjct: 1216 GFHWQF---VDAFTDT--ILQGQSLTTSQTIVSAGGNFELGFFSPGKSTKYYVGIWYKKI 1270
Query: 73 PERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGN 132
E+T+VWVANRD T+ S VLT+S++GNL I +G+I+Y+V+ ++SS+ NT+ATLLDSGN
Sbjct: 1271 SEQTIVWVANRDYSFTNPSVVLTVSTDGNLEILEGKISYKVT-SISSNSNTSATLLDSGN 1329
Query: 133 FVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEP 192
VLRN+K +LW+SFDYPS T LPGMKLGY ++ GK WSL SWKSR+DPS G ++ +
Sbjct: 1330 LVLRNKKSDVLWESFDYPSDTLLPGMKLGYDKRAGKRWSLVSWKSREDPSPGAFSIEHDA 1389
Query: 193 GKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD-SI 251
+S+ ++ ++ WT+GVWDG IFS VPEM Y++ ++ +ENE+YF YS+ + SI
Sbjct: 1390 NESSQIFNLQGPKMYWTTGVWDGQIFSQVPEMRFFYMYKQNVSFNENESYFSYSLHNPSI 1449
Query: 252 ISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICN-TATGSCQCLQG 307
+SR +LDVSGQV++++ W +FW QP+T C CGPF C + C+CL G
Sbjct: 1450 LSRVVLDVSGQVKRLNCHEGAHEWDLFWLQPKTQCEVYAYCGPFGTCTGDSVEFCECLPG 1509
Query: 308 F--FIGSDKNLSE----CVRRTALQCGDNSA--DREDRFLRMHNVKLPSPDKVLKLPGIE 359
F D NL + CVR+ LQC + S D+FL + NV+LP L+
Sbjct: 1510 FEPLFPEDWNLQDRSGGCVRKADLQCVNESHANGERDQFLLVSNVRLPKYPVTLQARSAM 1569
Query: 360 ECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQL--SKNEGENIFIKLAASELPKP-G 416
EC+S CLN C+C AYAY G C W G L ++EQL + + +IKLAASEL K
Sbjct: 1570 ECESICLNRCSCXAYAY--EGECRIWGGDLVNVEQLPDGXSNXRSFYIKLAASELNKRVS 1627
Query: 417 GNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLLFDI-NSSTETSKNELS 475
+K +W+ + + L +A I+ W R R +D+L+FD NSS +TS EL
Sbjct: 1628 SSKWKVWLIITLAISLTSAFVIYGIWGRF------RRKGEDLLVFDFGNSSEDTSCYELG 1681
Query: 476 D-GRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRL 534
+ R + + + LP+FSFASVSASTNNFS ENKLGEGGFG VYKG+L G EVAVKRL
Sbjct: 1682 ETNRLWRGEKKEVDLPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKLQRGYEVAVKRL 1741
Query: 535 SKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAK 594
SK+S QG EELKNE MLIAKLQH+NLV++LG C+++DEKILIYEY+ NKSLD FLFD AK
Sbjct: 1742 SKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAK 1801
Query: 595 KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654
+L WE RV+IIEG+AQGLLYLHQYSRLR+IHRDLKASNILLD DM PKISDFGMAR+F
Sbjct: 1802 XGILNWEXRVRIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIF 1861
Query: 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL 714
GG+E +A T IVGTYGYMSPEY L GLFS KSDVFSFGVLLLEILSGKK T FYH+ SL
Sbjct: 1862 GGNESKA-TKHIVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSXSL 1920
Query: 715 NLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
NLLG+AWDLWK+N+ +L+DP+L + ++ RY+NVALLCV E+A DRPTM +VVSML
Sbjct: 1921 NLLGYAWDLWKNNKGQELIDPVLNEISLRHIMLRYINVALLCVQESADDRPTMFDVVSML 1980
Query: 775 TNEHLVLPRRN 785
E+++L N
Sbjct: 1981 VKENVLLSSPN 1991
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493703|ref|XP_002281224.2| PREDICTED: uncharacterized protein LOC100245158 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2086), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/795 (55%), Positives = 553/795 (69%), Gaps = 39/795 (4%)
Query: 12 SAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKN 71
+ F QF VDA +DT + GQ IT S+T++S+G FELGFF PG+S YYVGIWYK
Sbjct: 847 TCFHWQF---VDAFTDT--ILQGQSITTSQTIISAGGNFELGFFSPGKSTKYYVGIWYKK 901
Query: 72 IPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSG 131
I E+T+VWVANRD T+ S +LT+S++GNL I +G+ +Y+V+ S+S T+ATLLDSG
Sbjct: 902 ILEQTIVWVANRDYSFTNPSVILTVSTDGNLEILEGKFSYKVTSISSNSN-TSATLLDSG 960
Query: 132 NFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKME 191
N VLRN +LW+SFDYP+ T LPGMK+G+ +++GK WSL SWKS +DP GD ++++
Sbjct: 961 NLVLRNGNSDILWESFDYPTDTLLPGMKIGHDKRSGKTWSLVSWKSAEDPGPGDFSVQVD 1020
Query: 192 P-GKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD- 249
P G FSL ++ WT+GVWDG IFS +PE+ Y + Y+ +ENE+YF YS D
Sbjct: 1021 PNGTRQIFSLQGPNR-YWTTGVWDGQIFSQIPELRFYYFYKYNTSFNENESYFTYSFHDP 1079
Query: 250 SIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICN-TATGSCQCL 305
SI+SR ++DVSGQV ++ W W +FW QP+ C CGPF C + C+CL
Sbjct: 1080 SILSRVVVDVSGQVRKLKWHEGTHEWHLFWLQPKIQCEIYAYCGPFGTCTRDSVEFCECL 1139
Query: 306 QGF--FIGSDKNLSE----CVRRTALQCGDNSA--DREDRFLRMHNVKLPSPDKVLKLPG 357
GF D NL + CVR+ LQC + S D+FL + NV+LP L+
Sbjct: 1140 PGFEPRFPEDWNLQDRSGGCVRKEDLQCVNESHANGERDQFLLVSNVRLPKYPVTLQART 1199
Query: 358 IEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNE--GENIFIKLAASELPKP 415
EC+S CLN C+C+AYAY G C W G L ++EQL + + +IKLAASEL K
Sbjct: 1200 AMECESICLNRCSCSAYAY--EGECRIWGGDLVNVEQLPDGDSNARSFYIKLAASELNKR 1257
Query: 416 GGNKELLWITVIVVPLLLTASYIFLR---WRRKLKYREEREPSQDMLLFDI-NSSTETSK 471
+ W ++V L ++ + +F+ WRR R +D+L+FD NSS +T+
Sbjct: 1258 VSTSK--WKVWLIVTLAISLTSVFVNYGIWRRF------RRKGEDLLVFDFGNSSEDTNC 1309
Query: 472 NELSD-GRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVA 530
EL + R + + + LP+FSFASVSASTNNF ENKLGEGGFG VYKG+ G EVA
Sbjct: 1310 YELGETNRLWRDEKKEVDLPMFSFASVSASTNNFCIENKLGEGGFGSVYKGKSQRGYEVA 1369
Query: 531 VKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLF 590
VKRLSK+S QG EELKNE MLIAKLQH+NLV++LG C+++DEKILIYEY+ NKSLD FLF
Sbjct: 1370 VKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLF 1429
Query: 591 DRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650
D AK+ +L WETRV IIEG+AQGLLYLHQYSRLR+IHRDLKASNILLD DM PKISDFGM
Sbjct: 1430 DPAKRGILNWETRVHIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 1489
Query: 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYH 710
AR+FGG+E +A T IVGTYGYMSPEY L GLFS KSDVFSFGVLLLEILSGKK T FYH
Sbjct: 1490 ARIFGGNESKA-TKHIVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYH 1548
Query: 711 TGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
+ SLNLLG+AWDLWK NR +L+DP+L + +L RY+NVALLCV E+A DRPTMS+V
Sbjct: 1549 SDSLNLLGYAWDLWKSNRGQELIDPVLNEISLRHILLRYINVALLCVQESADDRPTMSDV 1608
Query: 771 VSMLTNEHLVLPRRN 785
VSML E+++L N
Sbjct: 1609 VSMLVKENVLLSSPN 1623
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/646 (61%), Positives = 492/646 (76%), Gaps = 24/646 (3%)
Query: 157 GMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGY 216
GMK+GY+RKTG+VWS TSWK+ +DP +G LKM+P +++ F +M SQ+VW+SGVW+G+
Sbjct: 12 GMKIGYNRKTGEVWSFTSWKNAEDPGLGPVSLKMDP-ETHQFVIMWNSQMVWSSGVWNGH 70
Query: 217 IFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD-SIISRCILDVSGQVEQMSWLGARQAW 275
FS VPEM L+YIFNYS + D +E YF YS+ D SIISR ++DVSG ++Q++WL R W
Sbjct: 71 AFSSVPEMRLDYIFNYSYFEDMSEAYFTYSLYDNSIISRLLIDVSGNIKQLTWLD-RSGW 129
Query: 276 FIFWSQPRT-SC---VACGPFSICNTATGS-CQCLQGFFIGS------DKNLSECVRRTA 324
+FWSQP+ C CG FS CN T CQCL GF S ++ CVR+T+
Sbjct: 130 NLFWSQPQNFECDYYSYCGSFSSCNNQTTPICQCLYGFRPNSAGDWMMNQFRDGCVRKTS 189
Query: 325 LQCGDNSA--DREDRFLRMHNVKLPSPDKVLKLPGIEECKSACLNNCACTAYAYNSSGVC 382
LQC D ++ +D+FL+M NVK P ++L+ IE CK CLN C+C AYA+N G C
Sbjct: 190 LQCDDLTSVNSEKDKFLKMANVKFPQSPQILETQSIETCKMTCLNKCSCNAYAHN--GSC 247
Query: 383 SSWDGKLYDLEQLSKNE--GENIFIKLAASELPKPGGNKELLWITVIVVPLLLTA---SY 437
WD L +L+QLSK + G +++KLAASEL +K W+ +VV +L SY
Sbjct: 248 LMWDQILLNLQQLSKKDPDGRTLYLKLAASELQNSRESKMPRWVIGMVVVAVLVLLLASY 307
Query: 438 IFLRWRRKLKYREEREPSQDMLLFDINSSTETSKNELSDG-RAGKSKSTDAWLPLFSFAS 496
I R ++++ REE SQD+LL++ ++ ++NEL++G R GK K+ DAWLPLFSFAS
Sbjct: 308 ICYRQMKRVQDREEMTTSQDILLYEFGMGSKATENELNEGNRVGKDKNKDAWLPLFSFAS 367
Query: 497 VSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ 556
VSA+T +FS ENKLG+GGFGPVYKGEL NGQE+AVKRLS+ SGQGLEELKNET+L+A+LQ
Sbjct: 368 VSAATEHFSTENKLGQGGFGPVYKGELFNGQEIAVKRLSRSSGQGLEELKNETVLLAELQ 427
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
HRNLVRLLGCC++Q EKILIYEY+PNKSLDSFLFD K+ L W RV IIEGIAQGLLY
Sbjct: 428 HRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPNKRGQLDWAKRVSIIEGIAQGLLY 487
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
LH+YSRLRIIHRDLKASNILLD DM PKISDFGMARMFGG+E ANTNRIVGTYGYMSPE
Sbjct: 488 LHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARMFGGNESYANTNRIVGTYGYMSPE 547
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
YALEGLFS KSDVFSFGVL+LEILSGKKNTGFY++ +LNL+G+AW+LWK + A++LMDP+
Sbjct: 548 YALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDTLNLIGYAWELWKSDMAINLMDPM 607
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782
LE ++S ML RY+NV LLCV E A DRPT+SEVVSMLTNE VLP
Sbjct: 608 LEGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVSMLTNELAVLP 653
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138268|ref|XP_002326560.1| predicted protein [Populus trichocarpa] gi|222833882|gb|EEE72359.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/776 (51%), Positives = 540/776 (69%), Gaps = 42/776 (5%)
Query: 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPL 87
+D+LSVGQ ++ +++L+S G+ FELGFFRPG S+N Y+GIWYKN ++ +VWVANR+ PL
Sbjct: 25 SDTLSVGQSLSVTQSLISEGRTFELGFFRPGASQNIYLGIWYKNFADKIIVWVANRESPL 84
Query: 88 TSSSPVLTISSEGNLVIEDGRITYRVSENVSSS-------QNTTATLLDSGNFVLRNEKL 140
+S L +S +GNLV+ +E V S+ +T A LLD+GNFV+R+
Sbjct: 85 NPASLKLELSPDGNLVL-----LTNFTETVWSTALISPILNSTEAILLDNGNFVIRDVSN 139
Query: 141 GLL--WQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEP-GKSNA 197
+ WQSFD P+ T+LPG KLG +++TG+V L SWK+ +DP+ G + ++P G
Sbjct: 140 TSITYWQSFDNPTDTWLPGGKLGINKQTGQVQRLISWKNSEDPAPGMFSVGIDPNGSIQY 199
Query: 198 FSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD-SIISRCI 256
F RS W+SGVW+G F+ +PEM +N I+N+S+ ++ENE+YF YS+ + SI+SR +
Sbjct: 200 FIEWNRSHRYWSSGVWNGQGFTAIPEMRVN-IYNFSVISNENESYFTYSLSNTSILSRFV 258
Query: 257 LDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICNTATGS-CQCLQGFF-IG 311
+D SG++ Q WL WF++WSQP ACG F + +T S C+C++GF G
Sbjct: 259 MDSSGKMMQWLWLAGSSQWFLYWSQPADQADVYAACGAFGVFGGSTTSPCKCIKGFKPFG 318
Query: 312 SDKNLSECVRRTALQCGDNSADRE-DRFLRMHNVKLPSPDKVLKLPGIEECKSACLNNCA 370
+ S CVR + LQC + +R+ D FL+M N+ LP+ K + C+ CL +C+
Sbjct: 319 QNDWSSGCVRESPLQCQNKEGNRKKDEFLKMSNLTLPTNSKAHEAANATRCELDCLGSCS 378
Query: 371 CTAYAYNSSGVCSSWDGKLYDLEQLSKNEGENIFIKLAASELPKPGGNKELLWITVIVVP 430
CT +AYN+SG C W+G L +L+Q EG ++I++ G + I +V+P
Sbjct: 379 CTVFAYNNSG-CFVWEGDLVNLQQ-QAGEGYFLYIQI--------GNKRRTRAILAVVIP 428
Query: 431 LLLTASYIFLRW----RRKLKYREEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTD 486
+ L +F+ + KL ++ E + S+++L FD ++ ++ N S + ++ +
Sbjct: 429 VTLITFGLFIYCCYLRKSKLHHKGEEDTSENLLFFDFDTCPNSTNNVPS---SVDNRRKN 485
Query: 487 AWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELK 546
LPLFS+ SVSA T FS +KLGEGGFGPVYKG+L NG EVAVKRLSK+SGQGLEE +
Sbjct: 486 VELPLFSYESVSAVTEQFS--HKLGEGGFGPVYKGKLSNGVEVAVKRLSKRSGQGLEEFR 543
Query: 547 NETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI 606
NETM+IA+LQHRNLVRLLGCC+++DEKILIYEY+PNKSLD FLFD K+++L W +RV+I
Sbjct: 544 NETMVIARLQHRNLVRLLGCCIERDEKILIYEYMPNKSLDFFLFDANKRQILDWGSRVRI 603
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI 666
IEGIAQGLLYLH+YSRLRIIHRDLK SNILLD++M PKISDFGMAR+FG E +ANT +I
Sbjct: 604 IEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGDSETEANTKKI 663
Query: 667 VGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD 726
GTYGYMSPEYA++GLFSIKSDVFSFGVLLLEI+SG+KNTGFYH SLNLLGHAW W
Sbjct: 664 AGTYGYMSPEYAMDGLFSIKSDVFSFGVLLLEIVSGRKNTGFYHRDSLNLLGHAWKSWNS 723
Query: 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782
+RALDLMDP+L + S +L R++N+ LLCV E+ DRPTMS+V SM+ NEH LP
Sbjct: 724 SRALDLMDPVLGDPPSTSVLLRHINIGLLCVQESPADRPTMSDVFSMIVNEHAPLP 779
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106539|ref|XP_002333669.1| predicted protein [Populus trichocarpa] gi|222837960|gb|EEE76325.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/787 (52%), Positives = 548/787 (69%), Gaps = 35/787 (4%)
Query: 27 DTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQP 86
+ D+L +GQ ++ ++TL+S FELGFF+P S + Y+GIWYKN ++ +VWVANR+ P
Sbjct: 27 EGDTLLIGQSLSANQTLISQNGIFELGFFKPAASFSIYLGIWYKNFADKMIVWVANRESP 86
Query: 87 LTS-SSPVLTISSEGNLVIEDGRITYRVSENVSSS--QNTTA--TLLDSGNFVLRN--EK 139
L + +S L +S +G LV+ S ++SS N+TA LLD+GNFV+++
Sbjct: 87 LNNPASSKLELSPDGILVLLTNFTKTVWSTALASSMPNNSTAQAALLDNGNFVIKDGSNP 146
Query: 140 LGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEP-GKSNAF 198
+ WQSFD P+ T LPG KLG ++ TGKV L SWK+ +DP+ G + M+P G S F
Sbjct: 147 SAIYWQSFDNPTDTLLPGGKLGINKHTGKVQKLISWKNPEDPAPGMFSITMDPNGSSQIF 206
Query: 199 SLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKDS-IISRCIL 257
RS + W+SGVW+G FS+VPEM LNY FNYS ++ENE+YF +S+ ++ ++SR ++
Sbjct: 207 IEWNRSHMYWSSGVWNGQRFSMVPEMNLNYYFNYSYISNENESYFTFSVYNAEMLSRYVI 266
Query: 258 DVSGQVEQMSWLGARQAWFIFWSQPRTSCVA---CGPFSICN-TATGSCQCLQGF--FIG 311
DVSGQ++Q++WL + W FWSQP CG F + + ++ SC+CL+GF +
Sbjct: 267 DVSGQIKQLNWLAGVRNWSEFWSQPSDQAGVYGLCGVFGVFHGNSSSSCECLKGFEPLVQ 326
Query: 312 SDKNLSECVRRTALQCGDN-SADREDRFLRMHNVKLPSPDKVLKLPGIEECKSACLNNCA 370
+D + S CVR++ LQC + S ++D FL+M + LP K + + C+ C+ NC
Sbjct: 327 NDWS-SGCVRKSPLQCQNKKSTGKKDGFLKMSILTLPENSKAYQKVSVARCRLYCMKNCY 385
Query: 371 CTAYAYNSSGVCSSWDGKLYDLEQ---LSKNEGENIFIKLAASEL-PKPGGNKELLWITV 426
C AYAYNSSG C W+G L +L+Q + G I+I+LAASEL P+ G K + T+
Sbjct: 386 CVAYAYNSSG-CFLWEGDLINLKQSEIAAGRAGAEIYIRLAASELEPQIGNIKWKIRTTL 444
Query: 427 IV-VPLLLTASYIFLRW----RRKLKYR---EEREPSQDMLLFDINSSTETSKNELS--D 476
V VP+ L +F + + KL ++ + ++L FD ++ ++ NE S D
Sbjct: 445 AVAVPVTLITLGLFTYFSCLRKGKLIHKGTSSKERTGHNLLRFDFDADPNSTTNESSSVD 504
Query: 477 GRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSK 536
R K S + PLFS+ SVS +T FS +KLGEGGFGPVYKG+L G E+AVKRLS+
Sbjct: 505 NRK-KRWSKNIEFPLFSYESVSVATGQFS--DKLGEGGFGPVYKGKLPTGLEIAVKRLSE 561
Query: 537 KSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKR 596
+SGQGLEE +NET LIAKLQHRNLVRLLG C+++DEK+LIYEY+PNKSLD FLFD + +
Sbjct: 562 RSGQGLEEFRNETTLIAKLQHRNLVRLLGSCIERDEKMLIYEYMPNKSLDFFLFDANRGQ 621
Query: 597 LLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656
+L W TR++IIEGIAQGLLYLH+YSRLRIIHRDLK SNILLD++M PKISDFGMAR+FGG
Sbjct: 622 ILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGG 681
Query: 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNL 716
+E QA+TNRIVGTYGYMSPEYA+EGLFSIKSDVFSFGVL+LEI+SGKKNT FYH+ +L+L
Sbjct: 682 NETQAHTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSDTLHL 741
Query: 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
LGHAW LW N+ALDLMDPIL + S L RY+N+ LLCV E+ DRPTMS+V+SM+ N
Sbjct: 742 LGHAWKLWNSNKALDLMDPILGDPPSTATLLRYINIGLLCVQESPADRPTMSDVISMIAN 801
Query: 777 EHLVLPR 783
EH+ LP
Sbjct: 802 EHVALPE 808
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 791 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.423 | 0.427 | 0.576 | 6.1e-170 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.963 | 0.903 | 0.447 | 5.8e-169 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.898 | 0.839 | 0.461 | 2.8e-160 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.964 | 0.919 | 0.418 | 6.3e-156 | |
| TAIR|locus:2137010 | 849 | AT4G11900 [Arabidopsis thalian | 0.835 | 0.778 | 0.429 | 1.7e-150 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.951 | 0.906 | 0.420 | 2.7e-148 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.386 | 0.36 | 0.624 | 4.1e-147 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.798 | 0.743 | 0.469 | 1e-146 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.936 | 0.902 | 0.417 | 6.6e-145 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.936 | 0.921 | 0.419 | 9.6e-144 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 6.1e-170, Sum P(2) = 6.1e-170
Identities = 196/340 (57%), Positives = 257/340 (75%)
Query: 449 REEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAEN 508
RE E QD+ + +S ET + E S + K + D LP +VS +T+ FSA N
Sbjct: 410 REYNENGQDLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGN 469
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
KLG+GGFGPVYKG L GQEVAVKRLS+ S QG+EE KNE LIAKLQHRNLV++LG C+
Sbjct: 470 KLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCV 529
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHR 628
D++E++LIYEY PNKSLDSF+FD+ ++R L W RV+II+GIA+G+LYLH+ SRLRIIHR
Sbjct: 530 DEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHR 589
Query: 629 DLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSD 688
DLKASN+LLD+DM KISDFG+AR GGDE +ANT R+VGTYGYMSPEY ++G FS+KSD
Sbjct: 590 DLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSD 649
Query: 689 VFSFGVLLLEILSGKKNTGFYHTG-SLNLLGHAWDLWKDNRALDLMDPILENEASYPM-- 745
VFSFGVL+LEI+SG++N GF + LNLLGHAW + +++A +++D + NE+ +
Sbjct: 650 VFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAV-NESCTDISE 708
Query: 746 LARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL-PRR 784
+ R +++ LLCV ++ DRP MS VV ML++E L+L PR+
Sbjct: 709 VLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQ 748
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1643 (583.4 bits), Expect = 5.8e-169, P = 5.8e-169
Identities = 364/813 (44%), Positives = 514/813 (63%)
Query: 3 SFSICLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRN 62
SF I L++I + FS+ + +S T+SL+ I+ ++T++S + FELGFF P S
Sbjct: 10 SFFIFLILI--LFLAFSVSPNTLSATESLT----ISSNKTIISPSQIFELGFFNPASSSR 63
Query: 63 YYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQ- 121
+Y+GIWYK IP RT VWVANRD PL+SS+ L IS NLVI D S N++
Sbjct: 64 WYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDV 122
Query: 122 --NTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRD 179
A LLD+GNF+LR+ LLWQSFD+P+ T L MKLG+ +KTG L SWK+ D
Sbjct: 123 RSPVAAELLDNGNFLLRDSNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTD 182
Query: 180 DPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVP-EMTLNYIFNYSLYTDE 238
DPS G+ K+E + F + + I++ SG W+G FS VP + ++Y+ Y+ +
Sbjct: 183 DPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMV-YNFTASK 241
Query: 239 NETYFIYSI-KDSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSI 294
E + Y I K ++ SR L+ +G +++++W Q+W W P+ C CG F
Sbjct: 242 EEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGY 301
Query: 295 CNT-ATGSCQCLQGFFIGSDK--NLSE----CVRRTALQCGDNSADREDRFLRMHNVKLP 347
C++ + +C C++GF +++ +L + C+R+T L C D D F R+ +KLP
Sbjct: 302 CDSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSC-----DGRDGFTRLKRMKLP 356
Query: 348 SPDKVL--KLPGIEECKSACLNNCACTAYAY----NSSGVCSSWDGKLYDLEQLSKNEGE 401
+ + G++ CK CL +C CTA+A N C W ++ D+ +K G+
Sbjct: 357 DTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG-GQ 415
Query: 402 NIFIKLAASELP-KPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREE-REPSQDML 459
+++++LAA+EL K N++++ ++ V LLL + IF W+RK K + P+ D +
Sbjct: 416 DLYVRLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQV 475
Query: 460 LFDINSSTETSKNELSDGRAG---KSKSTDAW-LPLFSFASVSASTNNFSAENKLGEGGF 515
S ++ N++ R G K K ++ LPL +++ +TNNFS +NKLG+GGF
Sbjct: 476 -----RSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGF 530
Query: 516 GPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575
G VYKG LL+G+E+AVKRLSK S QG +E NE LIAKLQH NLVRLLGCC+D+ EK+L
Sbjct: 531 GIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKML 590
Query: 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 635
IYEYL N SLDS LFD+ + L W+ R II GIA+GLLYLHQ SR RIIHRDLKASN+
Sbjct: 591 IYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNV 650
Query: 636 LLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVL 695
LLD +M PKISDFGMAR+FG +E +ANT R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL
Sbjct: 651 LLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVL 710
Query: 696 LLEILSGKKNTGFYHTG-SLNLLGHAWDLWKDNRALDLMDPI-LENEAS-YPM--LARYV 750
LLEI+SGK+N GFY++ LNLLG W WK+ L+++DPI +++ +S +P + R +
Sbjct: 711 LLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCI 770
Query: 751 NVALLCVHENATDRPTMSEVVSMLTNEHLVLPR 783
+ LLCV E A DRP MS V+ ML +E +P+
Sbjct: 771 QIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQ 803
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1561 (554.6 bits), Expect = 2.8e-160, P = 2.8e-160
Identities = 351/761 (46%), Positives = 473/761 (62%)
Query: 8 LLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGI 67
L II F + FS+ S T+SL+ I+ ++T++S + FELGFF P S +Y+GI
Sbjct: 14 LFIIILF-LAFSVYASNFSATESLT----ISSNKTIISPSQIFELGFFNPDSSSRWYLGI 68
Query: 68 WYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQ---NTT 124
WYK IP RT VWVANRD PL+SS+ L IS + NLVI D S N++
Sbjct: 69 WYKIIPIRTYVWVANRDNPLSSSNGTLKIS-DNNLVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 125 ATLLDSGNFVLRNEK----LGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWS-LTSWKSRD 179
A LLD GNFVLR+ K G LWQSFD+P+ T L MK+G+ K+G L SWK+ D
Sbjct: 128 AELLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTD 187
Query: 180 DPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMT-LNYIFNYSLYTDE 238
DPS GD K+ F + + I + SG W G FS VP M ++YI N +T+
Sbjct: 188 DPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNS--FTEN 245
Query: 239 NE-TYFIYSI-KDSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFS 293
N+ + Y + K +I S L +G +++++W+ A Q+W W P+ C CG +
Sbjct: 246 NQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYG 305
Query: 294 ICNTATGS-CQCLQGFF-IGSDKNLSE----CVRRTALQCGDNSADREDRFLRMHNVKLP 347
C+ T C C++GF + L + CVR+T L C D D F+R+ ++LP
Sbjct: 306 YCDANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSC-----DGRDGFVRLKKMRLP 360
Query: 348 SPDK--VLKLPGIEECKSACLNNCACTAYAY----NSSGVCSSWDGKLYDLEQLSKNEGE 401
+ V K G++EC+ CL C CTA+A N C W G L+D+ +K G+
Sbjct: 361 DTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKG-GQ 419
Query: 402 NIFIKLAASELP-KPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLL 460
++++++AA +L K +K+++ ++ V LLL + IF W+RK K R + +
Sbjct: 420 DLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQK----RSITIQTPI 475
Query: 461 FDINSSTETSKNEL---SDGRAGKSKSTDAW-LPLFSFASVSASTNNFSAENKLGEGGFG 516
D+ S ++ NEL S K TD LPL + +++ +TNNFS +NKLG+GGFG
Sbjct: 476 VDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFG 535
Query: 517 PVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576
VYKG LL+G+E+AVKRLSK S QG +E NE LIAKLQH NLVRLLGCC+D+ EK+LI
Sbjct: 536 IVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLI 595
Query: 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636
YEYL N SLDS LFD+ + L W+ R II GIA+GLLYLHQ SR RIIHRDLKASN+L
Sbjct: 596 YEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVL 655
Query: 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLL 696
LD +M PKISDFGMAR+FG +E +ANT R+VGTYGYMSPEYA++G+FS+KSDVFSFGVLL
Sbjct: 656 LDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLL 715
Query: 697 LEILSGKKNTGFYHTG-SLNLLGHAWDLWKDNRALDLMDPI 736
LEI+SGK+N GFY++ LNLLG W WK+ + L+++DPI
Sbjct: 716 LEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPI 756
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1520 (540.1 bits), Expect = 6.3e-156, P = 6.3e-156
Identities = 336/802 (41%), Positives = 483/802 (60%)
Query: 7 CLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVG 66
CLLI+ + FSL + TD ++ SET+VS+ F GFF P S Y G
Sbjct: 3 CLLILLLTLICFSLRLCLA--TDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAG 60
Query: 67 IWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENV--SSSQNTT 124
IW+ NIP +TVVWVAN + P+ SS +++IS EGNLV+ DGR S NV + NT
Sbjct: 61 IWFNNIPVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTF 120
Query: 125 -ATLLDSGNFVL---RNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDD 180
A LL++GN VL N +LW+SF++P + +LP M L KTG+ L SWKS D
Sbjct: 121 YARLLNTGNLVLLGTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFD 180
Query: 181 PSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNY-IFNYSLYTDEN 239
PS G + P + K ++W SG W+G F +P M +F +L +D
Sbjct: 181 PSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNR 240
Query: 240 ETYFIYSIKDSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICN 296
+ + ++++ +LD G V Q W A Q W + P T C CG F+ C
Sbjct: 241 GSVSMSYAGNTLLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCR 300
Query: 297 TATGS---CQCLQGFFIGS-----DKNLSE-CVRRTALQCG--DNS--ADREDRFLRMHN 343
GS C C++GF S + N ++ CVR+ LQC DN+ + + D F+R+
Sbjct: 301 FNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQK 360
Query: 344 VKLP-SPDKVLKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNEGEN 402
+K+P +P + ++C +CL NC+CTAY+++ C W G L D+++ S G
Sbjct: 361 MKVPHNPQR--SGANEQDCPESCLKNCSCTAYSFDRGIGCLLWSGNLMDMQEFS-GTGVV 417
Query: 403 IFIKLAASELPKPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDMLLFD 462
+I+LA SE K ++ +T++V L + + W K + RE +++ L
Sbjct: 418 FYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALW----KIAKHREKNRNTRL-- 471
Query: 463 INSSTET-SKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKG 521
+N E S N++ + K + LPLF F ++ +TNNFS NKLG+GGFG VYKG
Sbjct: 472 LNERMEALSSNDVGAILVNQYKLKE--LPLFEFQVLAVATNNFSITNKLGQGGFGAVYKG 529
Query: 522 ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581
L G ++AVKRLS+ SGQG+EE NE ++I+KLQHRNLVRLLG C++ +E++L+YE++P
Sbjct: 530 RLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMP 589
Query: 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641
LD++LFD K+RLL W+TR II+GI +GL+YLH+ SRL+IIHRDLKASNILLD ++
Sbjct: 590 ENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENL 649
Query: 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
PKISDFG+AR+F G+E + +T R+VGTYGYM+PEYA+ GLFS KSDVFS GV+LLEI+S
Sbjct: 650 NPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVS 709
Query: 702 GKKNTGFYHTG-SLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHEN 760
G++N+ FY+ G + NL +AW LW + L+DP++ E + R V+V LLCV ++
Sbjct: 710 GRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDH 769
Query: 761 ATDRPTMSEVVSMLTNEHLVLP 782
A DRP+++ V+ ML++E+ LP
Sbjct: 770 ANDRPSVATVIWMLSSENSNLP 791
|
|
| TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1284 (457.0 bits), Expect = 1.7e-150, Sum P(2) = 1.7e-150
Identities = 307/714 (42%), Positives = 420/714 (58%)
Query: 98 SEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGNFVLR---NEKLGLLWQSFDYPSHTF 154
SEGNL+ + + N S S++ A L DSGN VLR N +LWQSFD+PS T+
Sbjct: 132 SEGNLLFHE--TVWSTGVNSSMSKDVQAVLFDSGNLVLRDGPNSSAAVLWQSFDHPSDTW 189
Query: 155 LPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSG-VW 213
LPG K+ R +++ TSW+S DPS G L+ +P + ++ RS+ W+SG ++
Sbjct: 190 LPGGKI---RLGSQLF--TSWESLIDPSPGRYSLEFDPKLHSLVTVWNRSKSYWSSGPLY 244
Query: 214 DGY-IFSLVPEMTLNYIFNYSLYTDENETYFIYSIKDSIISRCILDVSGQVEQMSWLGAR 272
D F PE+ + +++L DE+ Y +S+ R ++ VSGQ W
Sbjct: 245 DWLQSFKGFPELQGTKL-SFTLNMDES--YITFSVDPQSRYRLVMGVSGQFMLQVWHVDL 301
Query: 273 QAWFIFWSQPRTSCV---ACGPFSICNT--ATGSCQCLQGF---FI-GSDKN---LSECV 320
Q+W + SQP C +CG F ICN C+C+ GF F GSD + C
Sbjct: 302 QSWRVILSQPDNRCDVYNSCGSFGICNENREPPPCRCVPGFKREFSQGSDDSNDYSGGCK 361
Query: 321 RRTALQCGDNSADREDRFLRMHNVKL---PSPDKVLKLPGIEECKSACLNNCACTAYAYN 377
R T L C R D FL + N+KL P+ VL C S C+ +C+C AYA N
Sbjct: 362 RETYLHC----YKRNDEFLPIENMKLATDPTTASVLTSGTFRTCASRCVADCSCQAYA-N 416
Query: 378 SSGVCSSWDGKLYDLEQLSKNEGENIFIKLAASELPKPGGNK-ELLWITVIVVPLLLTA- 435
C W ++L+QL N+G F++LA+S + K E IV+PL+L +
Sbjct: 417 DGNKCLVWTKDAFNLQQLDANKGHTFFLRLASSNISTANNRKTEHSKGKSIVLPLVLASL 476
Query: 436 ---SYIFLRWRRKLKYREEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLF 492
+ F+ + R R+ Q D S E + L D AG++ +L L
Sbjct: 477 VATAACFVGLYCCISSRIRRKKKQR----DEKHSRELLEGGLIDD-AGENM---CYLNLH 528
Query: 493 SFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLI 552
+ +TN+FS + KLGEGGFGPVYKG+L NG EVA+KRLSKKS QGL E KNE +LI
Sbjct: 529 D---IMVATNSFSRKKKLGEGGFGPVYKGKLPNGMEVAIKRLSKKSSQGLTEFKNEVVLI 585
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ 612
KLQH+NLVRLLG C++ DEK+LIYEY+ NKSLD LFD K R L WETR+KI+ G +
Sbjct: 586 IKLQHKNLVRLLGYCVEGDEKLLIYEYMSNKSLDGLLFDSLKSRELDWETRMKIVNGTTR 645
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
GL YLH+YSRLRIIHRDLKASNILLD +M PKISDFG AR+FG ++ +T RIVGT+GY
Sbjct: 646 GLQYLHEYSRLRIIHRDLKASNILLDDEMNPKISDFGTARIFGCKQIDDSTQRIVGTFGY 705
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN-LLGHAWDLWKDNRALD 731
MSPEYAL G+ S KSD++SFGVLLLEI+SGKK T F H + L+ + W+ W + + +
Sbjct: 706 MSPEYALGGVISEKSDIYSFGVLLLEIISGKKATRFVHNDQKHSLIAYEWESWCETKGVS 765
Query: 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH-LVLPRR 784
++D + S R +++ALLCV ++ DRP +S++V ML+N++ L +P++
Sbjct: 766 IIDEPMCCSYSLEEAMRCIHIALLCVQDHPKDRPMISQIVYMLSNDNTLPIPKQ 819
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
Identities = 340/808 (42%), Positives = 476/808 (58%)
Query: 1 MASFSICLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQS 60
M F+ CLL++ F F D ++ + LS+GQ TL S +ELGFF P S
Sbjct: 24 MVIFA-CLLLLIIFPT-FGYA-D-INTSSPLSIGQ------TLSSPDGVYELGFFSPNNS 73
Query: 61 RNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGR--ITYRVSENVS 118
R YVGIW+KNI + VVWVANRD+P+T ++ LTISS G+L++ DG + + E +
Sbjct: 74 RKQYVGIWFKNIAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEAFT 133
Query: 119 SSQNTTATLLDSGNFVLRNEKLG-LLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKS 177
S++ A LLD+GN V+ ++ G LW+SF+ +T LP + Y GK LTSW+S
Sbjct: 134 SNK-CHAELLDTGNLVVIDDVSGKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRS 192
Query: 178 RDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTD 237
DPS G+ L+ P + + S W SG W FS +P + +Y+ +++ D
Sbjct: 193 NSDPSPGEFTLEFTPQVPPQGLIRRGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQD 252
Query: 238 --ENETYFIYS-IKDSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSCV---ACGP 291
+ F YS +++ +S L G+++ + W + +W + + P +SC ACGP
Sbjct: 253 VAKGTASFSYSMLRNYKLSYVTLTSEGKMKIL-WNDGK-SWKLHFEAPTSSCDLYRACGP 310
Query: 292 FSIC-NTATGSCQCLQGFFIGSDKN------LSECVRRTALQCGDNSADRE-----DRFL 339
F +C + C CL+GF SD S CVRRT L C NS+ + D F
Sbjct: 311 FGLCVRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFY 370
Query: 340 RMHNVKLPSPDKVLKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNE 399
M VK P ++ E+C CL NC+CTA+AY S C W+ +L D Q ++
Sbjct: 371 HMTRVKTPDLYQLAGFLNAEQCYQDCLGNCSCTAFAYISGIGCLVWNRELVDTVQFL-SD 429
Query: 400 GENIFIKLAASELPKPGGNKELLWITVIVVPLLLTASYIFLRWRRKLKYREEREPSQDML 459
GE++ ++LA+SEL K +L TV + ++ + WR + K + EP+
Sbjct: 430 GESLSLRLASSELAGSNRTKIILGTTVSLSIFVILVFAAYKSWRYRTK---QNEPNP--- 483
Query: 460 LFDINSSTETSKNELSDGRAGKSKSTD-AWLPLFSFASVSASTNNFSAENKLGEGGFGPV 518
+F I+SS D A + D + + LF ++ +TNNFS+ NKLG+GGFGPV
Sbjct: 484 MF-IHSS--------QDAWAKDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPV 534
Query: 519 YKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578
YKG+L++G+E+AVKRLS SGQG +E NE LI+KLQH+NLVRLLGCC+ +EK+LIYE
Sbjct: 535 YKGKLVDGKEIAVKRLSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYE 594
Query: 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 638
YL NKSLD FLFD K + W+ R II+G+A+GLLYLH+ SRLR+IHRDLK SNILLD
Sbjct: 595 YLVNKSLDVFLFDSTLKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLD 654
Query: 639 TDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLE 698
M PKISDFG+ARM G + Q NT R+VGT GYM+PEYA G+FS KSD++SFGVLLLE
Sbjct: 655 EKMIPKISDFGLARMSQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLE 714
Query: 699 ILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM-LARYVNVALLCV 757
I+ G+K + F G LL +AW+ W + + +DL+D L ++S+P + R V + LLCV
Sbjct: 715 IIIGEKISRFSEEGK-TLLAYAWESWCETKGVDLLDQALA-DSSHPAEVGRCVQIGLLCV 772
Query: 758 HENATDRPTMSEVVSMLTN-EHLVLPRR 784
DRP E++SMLT L P++
Sbjct: 773 QHQPADRPNTLELMSMLTTISELPSPKQ 800
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 997 (356.0 bits), Expect = 4.1e-147, Sum P(2) = 4.1e-147
Identities = 196/314 (62%), Positives = 245/314 (78%)
Query: 478 RAGK--SKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLS 535
R GK +++ + L +FSF SV+ +T+ FS NKLGEGGFGPVYKG L++G+EVA+KRLS
Sbjct: 499 RRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLS 558
Query: 536 KKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKK 595
SGQGL E KNE MLIAKLQH NLV+LLGCC+++DEK+LIYEY+PNKSLD FLFD +K
Sbjct: 559 LASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRK 618
Query: 596 RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655
+L W+ R +I+EGI QGLLYLH+YSRL++IHRD+KA NILLD DM PKISDFGMAR+FG
Sbjct: 619 IVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFG 678
Query: 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHT--GS 713
E +ANT R+ GT+GYMSPEY EGLFS KSDVFSFGVL+LEI+ G+KN F+H G
Sbjct: 679 AQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGP 738
Query: 714 LNLLGHAWDLWKDNRALDLMDPILENEA-SYPMLARYVNVALLCVHENATDRPTMSEVVS 772
LNL+ H W+L+K+NR +++DP L + A P + R V VALLCV +NA DRP+M +VVS
Sbjct: 739 LNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVS 798
Query: 773 MLT---NEHLVLPR 783
M+ N L LP+
Sbjct: 799 MIYGDGNNALSLPK 812
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1433 (509.5 bits), Expect = 1.0e-146, P = 1.0e-146
Identities = 315/671 (46%), Positives = 420/671 (62%)
Query: 141 GLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSL 200
G+LWQSFD+P+ T LP MKLG+ KTG + SWKS DDPS GD K+E L
Sbjct: 150 GVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFL 209
Query: 201 MKRSQIVWTSGVWDGYIFSLVPEMT-LNY-IFNYSLYTDENETYFIYSIKDSIISRCILD 258
R ++ SG W+G FS VPEM Y +FN++ + E TY K + SR +
Sbjct: 210 WNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTT-SKEEVTYSFRITKSDVYSRLSIS 268
Query: 259 VSGQVEQMSWLGARQAWFIFWSQPRTSC---VACGPFSICNTATGS-CQCLQGF------ 308
SG +++ +W+ Q W FW P+ C CG + C++ T C C++GF
Sbjct: 269 SSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQ 328
Query: 309 FIGSDKNLSECVRRTALQCGDNSADREDRFLRMHNVKLPSPD--KVLKLPGIEECKSACL 366
G CVR+T L CG D F+R+ +KLP V + G++EC+ CL
Sbjct: 329 VWGLRDGSDGCVRKTLLSCGGG-----DGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 367 NNCACTAYA---YNSSGV-CSSWDGKLYDLEQLSKNEGENIFIKLAASELP-KPGGNKEL 421
+C CTA+A SG C +W G+L+D+ +K G++++++LAA++L K + ++
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKG-GQDLYVRLAATDLEDKRNRSAKI 442
Query: 422 LWITVIVVPLLLTASYIFLRWRRKLKYREERE-PSQDMLLFDINSSTETSKNE--LSDGR 478
+ ++ V LLL + IF W+RK K E P D L S + NE +S R
Sbjct: 443 IGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQL----RSRDLLMNEVVISSRR 498
Query: 479 --AGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSK 536
+ ++ + D LPL F V+ +TNNFS NKLG+GGFG VYKG+LL+GQE+AVKRLSK
Sbjct: 499 HISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSK 558
Query: 537 KSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKR 596
S QG +E KNE LIA+LQH NLVRLL CC+D EK+LIYEYL N SLDS LFD+++
Sbjct: 559 TSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNS 618
Query: 597 LLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656
L W+ R II GIA+GLLYLHQ SR RIIHRDLKASNILLD M PKISDFGMAR+FG
Sbjct: 619 KLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGR 678
Query: 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTG-SLN 715
DE +ANT ++VGTYGYMSPEYA++G+FS+KSDVFSFGVLLLEI+S K+N GFY++ LN
Sbjct: 679 DETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLN 738
Query: 716 LLGHAWDLWKDNRALDLMDPILENEAS---YPMLARYVNVALLCVHENATDRPTMSEVVS 772
LLG W WK+ + L+++DPI+ + +S + R + + LLCV E A DRPTMS V+
Sbjct: 739 LLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVIL 798
Query: 773 MLTNEHLVLPR 783
ML +E +P+
Sbjct: 799 MLGSESTTIPQ 809
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1416 (503.5 bits), Expect = 6.6e-145, P = 6.6e-145
Identities = 333/797 (41%), Positives = 460/797 (57%)
Query: 7 CLLIISAFSMQFSLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVG 66
CLL+I+A + A++ + LS+G TL S G +ELGFF S N YVG
Sbjct: 6 CLLLITALFSSYGYA--AITTSSPLSIGV------TLSSPGGSYELGFFSSNNSGNQYVG 57
Query: 67 IWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTT-A 125
IW+K + R +VWVANR++P++S+ LTISS G+L++ D + S + N A
Sbjct: 58 IWFKKVTPRVIVWVANREKPVSSTMANLTISSNGSLILLDSKKDLVWSSGGDPTSNKCRA 117
Query: 126 TLLDSGNFVLRNEKLG-LLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVG 184
LLD+GN V+ + G LWQSF++ T LP L Y K LTSWKS DPS G
Sbjct: 118 ELLDTGNLVVVDNVTGNYLWQSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKSETDPSPG 177
Query: 185 DAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDE-NET-Y 242
+ ++ P + + K S W SG W G F+ +PEM +Y+ + DE N T
Sbjct: 178 EFVAEITPQVPSQGLIRKGSSPYWRSGPWAGTRFTGIPEMDASYVNPLGMVQDEVNGTGV 237
Query: 243 FIYSI-KDSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSCVA---CGPFSIC-NT 297
F + + ++ +S L G + G W + P TSC CGPF +C +
Sbjct: 238 FAFCVLRNFNLSYIKLTPEGSLRITRNNGTD--WIKHFEGPLTSCDLYGRCGPFGLCVRS 295
Query: 298 ATGSCQCLQGFFIGSDK-----NLSE-CVRRTALQC-GDNSADRE--DR--FLRMHNVKL 346
T CQCL+GF SD+ N S CVRRT L C G++S + + DR F + N+K
Sbjct: 296 GTPMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNSSVETQGKDRDVFYHVSNIKP 355
Query: 347 PSPDKVLKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNEGENIFIK 406
P ++ E+C CL NC+CTA++Y S C W+ +L D + GE + ++
Sbjct: 356 PDSYELASFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQELLDTVKFIGG-GETLSLR 414
Query: 407 LAASELPKPGGNKELLWITVIVVPLLLTASYIFLR---WRRKLKYREEREPSQDMLLFDI 463
LA SEL G K + ITV + L + + + WR ++K
Sbjct: 415 LAHSELT---GRKRIKIITVATLSLSVCLILVLVACGCWRYRVKQ--------------- 456
Query: 464 NSSTETSKNELSDGRAGKSKSTD-AWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGE 522
N S+ SK+ + +S D + L F + +TNNFS NKLG+GGFG VYKG+
Sbjct: 457 NGSSLVSKDNVEGAWKSDLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGK 516
Query: 523 LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582
L +G+E+AVKRL+ S QG EE NE LI+KLQHRNL+RLLGCC+D +EK+L+YEY+ N
Sbjct: 517 LQDGKEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVN 576
Query: 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642
KSLD F+FD KK + W TR II+GIA+GLLYLH+ S LR++HRDLK SNILLD M
Sbjct: 577 KSLDIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMN 636
Query: 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
PKISDFG+AR+F G++ Q +T +VGT GYMSPEYA G FS KSD++SFGVL+LEI++G
Sbjct: 637 PKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITG 696
Query: 703 KKNTGF-YHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPML--ARYVNVALLCVHE 759
K+ + F Y + NLL +AWD W +N ++L+D L++ S + R V++ LLCV
Sbjct: 697 KEISSFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQH 756
Query: 760 NATDRPTMSEVVSMLTN 776
A DRP + +V+SMLT+
Sbjct: 757 QAIDRPNIKQVMSMLTS 773
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1405 (499.6 bits), Expect = 9.6e-144, P = 9.6e-144
Identities = 334/796 (41%), Positives = 461/796 (57%)
Query: 1 MASFSICLLIISAFSMQF-SLVVDAVSDTDS-LSVGQVITRSETLVSSGKFFELGFFRPG 58
M F+ CL + + F S AV T+S LS+GQ TL S+ + +ELGFF P
Sbjct: 2 MTRFA-CLHLFTMFLFTLLSGSSSAVITTESPLSMGQ------TLSSANEVYELGFFSPN 54
Query: 59 QSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVS 118
+++ YVGIW+K+ R VVWVANR++P+T S+ L ISS G+L++ +G+ S V+
Sbjct: 55 NTQDQYVGIWFKDTIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVT 114
Query: 119 -SSQNTTATLLDSGNF-VLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWK 176
SS A L DSGN V+ N LWQSFD+ T L L Y+ T + LTSWK
Sbjct: 115 FSSSGCRAELSDSGNLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWK 174
Query: 177 SRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYT 236
S DPS GD ++ P + +M+ S W SG W F+ +P M +Y ++L+
Sbjct: 175 SYTDPSPGDFLGQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLHQ 234
Query: 237 DENET-YFIYSIKDSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSCV---ACGPF 292
D N + Y Y +D +SR L G ++ G W +++ P+ C ACGPF
Sbjct: 235 DVNGSGYLTYFQRDYKLSRITLTSEGSIKMFRDNG--MGWELYYEAPKKLCDFYGACGPF 292
Query: 293 SIC-NTATGSCQCLQGFFIGSDKNLSE------CVRRTALQC-GDNSADREDRFLRMHNV 344
+C + + C+C +GF S + CVR T L C G+++ + D F ++ N+
Sbjct: 293 GLCVMSPSPMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIANI 352
Query: 345 KLPSPDKVLKLPGIEECKSACLNNCACTAYAYNSSGVCSSWDGKLYDLEQLSKNEGENIF 404
K P + EEC C++NC+C A+AY C W+ L D Q S GE +
Sbjct: 353 KPPDFYEFASSVNAEECHQRCVHNCSCLAFAYIKGIGCLVWNQDLMDAVQFSAT-GELLS 411
Query: 405 IKLAASELPKPGGNKELLWITVIVVPLLLTASYIFLR---WRRKLKYREEREPSQDMLLF 461
I+LA SEL GNK I +V L L F WR ++++ +
Sbjct: 412 IRLARSELD---GNKRKKTIVASIVSLTLFMILGFTAFGVWRCRVEH-----------IA 457
Query: 462 DINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKG 521
I S + KN+L K + L F ++ +TNNFS NKLG+GGFG VYKG
Sbjct: 458 HI--SKDAWKNDL------KPQDVPG-LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKG 508
Query: 522 ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581
+L +G+E+AVKRLS SGQG EE NE +LI+KLQHRNLVR+LGCC++++EK+LIYE++
Sbjct: 509 KLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMV 568
Query: 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641
NKSLD+FLFD K+ + W R II+GIA+GLLYLH SRLR+IHRDLK SNILLD M
Sbjct: 569 NKSLDTFLFDSRKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKM 628
Query: 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
PKISDFG+ARM+ G E Q NT R+VGT GYMSPEYA G+FS KSD++SFGVL+LEI+S
Sbjct: 629 NPKISDFGLARMYQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIIS 688
Query: 702 GKKNTGF-YHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM-LARYVNVALLCVHE 759
G+K + F Y L+ +AW+ W + R +DL+D L ++ +P+ + R + + LLCV
Sbjct: 689 GEKISRFSYGVEGKTLIAYAWESWSEYRGIDLLDQDLA-DSCHPLEVGRCIQIGLLCVQH 747
Query: 760 NATDRPTMSEVVSMLT 775
DRP E+++MLT
Sbjct: 748 QPADRPNTLELLAMLT 763
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4589 | 0.9443 | 0.8788 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 791 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-58 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-56 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-36 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-35 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-33 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-30 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-29 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-28 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-27 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 5e-27 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-25 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 7e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 6e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 9e-58
Identities = 95/281 (33%), Positives = 131/281 (46%), Gaps = 40/281 (14%)
Query: 507 ENKLGEGGFGPVYKGELL-----NGQEVAVKRLSK-KSGQGLEELKNETMLIAKLQHRNL 560
KLGEG FG VYKG+L EVAVK L + S Q +EE E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
V+LLG C +++ ++ EY+ L S+L R + L + IA+G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
IHRDL A N L+ ++ KISDFG++R D+ + +M+PE E
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKE 177
Query: 681 GLFSIKSDVFSFGVLLLEILS-------GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
G F+ KSDV+SFGVLL EI + G N L R
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE-----------YLKNGYR----- 221
Query: 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
L + P ++ L C E+ DRPT SE+V +L
Sbjct: 222 ---LPQPPNCP--PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-56
Identities = 96/281 (34%), Positives = 130/281 (46%), Gaps = 39/281 (13%)
Query: 507 ENKLGEGGFGPVYKGELLNG-----QEVAVKRLSK-KSGQGLEELKNETMLIAKLQHRNL 560
KLGEG FG VYKG L EVAVK L + S Q +EE E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
V+LLG C +++ +++ EY+P L +L K L + IA+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS-LSDLLSFALQIARGMEYLE-- 120
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
IHRDL A N L+ ++ KISDFG++R D+ + +M+PE E
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKE 178
Query: 681 GLFSIKSDVFSFGVLLLEILS-------GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
G F+ KSDV+SFGVLL EI + G N L K R
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE-----------YLKKGYR----- 222
Query: 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
L + P + L C E+ DRPT SE+V +L
Sbjct: 223 ---LPKPPNCP--PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 6e-55
Identities = 95/287 (33%), Positives = 135/287 (47%), Gaps = 44/287 (15%)
Query: 508 NKLGEGGFGPVYKGELLNGQ----EVAVKRLSK-KSGQGLEELKNETMLIAKLQHRNLVR 562
KLGEG FG VYKG+L EVAVK L + S + ++ E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFL------FDRAKKRLLYWETRVKIIEGIAQGLLY 616
LLG C +++ L+ EY+ L +L F +K L + + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTNRIVGTYGYMSP 675
L + +HRDL A N L+ D+ KISDFG++R ++ D + T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILS-------GKKNTGFYHTGSLNLLGHAWDLWKDNR 728
E +G+F+ KSDV+SFGVLL EI + G N L K R
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-----------YLRKGYR 225
Query: 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775
L P + Y + L C + DRPT SE+V L
Sbjct: 226 ---LPKPEYCPDELY-------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 81/194 (41%), Positives = 114/194 (58%), Gaps = 11/194 (5%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
LGEGGFG VY G++VA+K + K+ S LEEL E ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627
D++ L+ EY SL L + K L + ++I+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 628 RDLKASNILLD-TDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-EGLFSI 685
RDLK NILLD + K K++DFG++++ D+ T IVGT YM+PE L +G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 686 KSDVFSFGVLLLEI 699
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-52
Identities = 91/280 (32%), Positives = 132/280 (47%), Gaps = 41/280 (14%)
Query: 509 KLGEGGFGPVYKGELL-----NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVR 562
KLGEG FG VYKG L +VAVK L + + + EE E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
LLG C + ++ EY+P L FL R L + +++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTNRIVGTYGYMSPEYALEG 681
+HRDL A N L+ ++ KISDFG++R ++ D + + +M+PE +G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA-WDLWKDNRALDLMDPILENE 740
F+ KSDV+SFGVLL EI + LG + + L+L+ E
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLELL------E 218
Query: 741 ASYPMLA------RYVNVALLCVHENATDRPTMSEVVSML 774
Y + + L C + DRPT SE+V L
Sbjct: 219 DGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 6e-48
Identities = 76/198 (38%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 508 NKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEE-LKNETMLIAKLQHRNLVRLLG 565
KLGEG FG VY G+ VA+K + KK + E + E ++ KL+H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D+D+ L+ EY L L + + RL E R + I L YLH I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHS---KGI 118
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
+HRDLK NILLD D K++DFG+AR E VGT YM+PE L +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGYGK 175
Query: 686 KSDVFSFGVLLLEILSGK 703
D++S GV+L E+L+GK
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 89/267 (33%), Positives = 128/267 (47%), Gaps = 21/267 (7%)
Query: 509 KLGEGGFGPVYKGELLN-GQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLG 565
KLG G FG VYK + G+ VAVK L K+S + + + E ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D+D L+ EY L +L L E + KI I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAK-KIALQILRGLEYLH---SNGI 119
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL-FS 684
IHRDLK NILLD + KI+DFG+A+ ++ VGT YM+PE L G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 685 IKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYP 744
K DV+S GV+L E+L+GK F L+ L R L +
Sbjct: 178 PKVDVWSLGVILYELLTGK--PPFSGENILD------QLQLIRRILG-PPLEFDEPKWSS 228
Query: 745 MLARYVNVALLCVHENATDRPTMSEVV 771
++ C++++ + RPT E++
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 11/201 (5%)
Query: 508 NKLGEGGFGPVYKGELL-NGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRNLVRLL 564
LG G FG VY G+ +AVK LS S + LE L+ E +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 565 GCCLDQDEK-ILIY-EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
G D+++ + I+ EY+ SL S L + +L R + I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQ-ILEGLAYLH---S 119
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
I+HRD+K +NIL+D+D K++DFG A+ G E T + GT +M+PE
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
+ +D++S G ++E+ +GK
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 9/201 (4%)
Query: 504 FSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVR 562
F K+G+GGFG VYK G+EVA+K + +S + E++ NE ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
G L +DE ++ E+ SL L ++ + L + + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
IIHRD+KA+NILL +D + K+ DFG++ N +VGT +M+PE
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
+ K+D++S G+ +E+ GK
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 70/205 (34%), Positives = 107/205 (52%), Gaps = 13/205 (6%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLS--KKSGQGLEELKNETMLIAKLQHRN 559
N+ + +G G FG VYKG L G VA+K++S K + L+ + E L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLH 618
+V+ +G D +I EY N SL KK + E+ V + + + QGL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL----RQIIKKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+ +IHRD+KA+NIL D K++DFG+A + +VGT +M+PE
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVI 171
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK 703
S SD++S G ++E+L+G
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 52/110 (47%), Positives = 60/110 (54%), Gaps = 2/110 (1%)
Query: 74 ERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRIT-YRVSENVSSSQNTTATLLDSGN 132
+TVVWVANR PLT SS L + S+GNLV+ DG S A L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 133 FVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPS 182
VL + +LWQSFD+P+ T LPG K G G LTSWKS DPS
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQKDGN-VVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 76/213 (35%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 510 LGEGGFGPVYKGEL--LNGQE----VAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVR 562
LGEG FG VYKGEL N + VA+K L + + +E + E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLF-------------DRAKKRLLYWETRVKIIEG 609
LLG C + +++EYL + L FL D K L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTNRIVG 668
IA G+ YL S +HRDL A N L+ + KISDFG++R ++ D + + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M PE L G F+ +SD++SFGV+L EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 75/201 (37%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+ E KLG G FG V+ G +VAVK L K E E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+L C +++ ++ EY+ SL FL K+L V + IA+G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLE--- 120
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYA 678
IHRDL A NIL+ ++ KI+DFG+AR+ DE A G + +PE A
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAA 176
Query: 679 LEGLFSIKSDVFSFGVLLLEI 699
G F+IKSDV+SFG+LL EI
Sbjct: 177 NYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 71/208 (34%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 508 NKLGEGGFGPVYKGELLN-----GQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLV 561
+LGEG FG V G++VAVK L+ Q + + E ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 562 RLLGCCLDQDEKI--LIYEYLPNKSLDSFL-FDRAK---KRLLYWETRVKIIEGIAQGLL 615
+ G C + LI EYLP+ SL +L R + KRLL I +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL------LFSSQICKGMD 123
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIVGTYGYM 673
YL R IHRDL A NIL++++ KISDFG+A++ D + Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILS 701
+PE FS SDV+SFGV L E+ +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 29/226 (12%)
Query: 510 LGEGGFGPVYKGELLNGQE------VAVKRLSKKSGQGLEE-LKNETMLIAKLQHRNLVR 562
LGEG FG V+ GE + + VAVK L + + + + E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFL-----------FDRAKKRLLYWETRVKIIEGIA 611
G C + D I+++EY+ + L+ FL + L ++I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT-- 669
G++YL + +HRDL N L+ D+ KI DFGM+R D + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 670 --YGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713
+M PE + F+ +SDV+SFGV+L EI + K + +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 67/198 (33%), Positives = 109/198 (55%), Gaps = 6/198 (3%)
Query: 504 FSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
F+ E KLG G FG V++G N VA+K L ++ + E + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
C + +I E + SL +FL + ++L + + + +A+G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
IHRDL A NIL+ D+ K++DFG+AR+ D ++ +I Y + +PE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 684 SIKSDVFSFGVLLLEILS 701
S KSDV+SFG+LL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 11/207 (5%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKR--LSKKSGQGLEELKNETMLIAKLQHRN 559
+ ++G+G FG VY +G+ +K LS S + E+ NE ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLLYLH 618
+++ ++ + ++ EY L + + K+ + E ++ + L YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
SR +I+HRD+K NI L ++ K+ DFG++++ A T +VGT Y+SPE
Sbjct: 121 --SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE-L 174
Query: 679 LEGL-FSIKSDVFSFGVLLLEILSGKK 704
+ ++ KSD++S G +L E+ + K
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 56/117 (47%), Positives = 64/117 (54%), Gaps = 3/117 (2%)
Query: 35 QVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVL 94
++ +TLVSSG FELGFF+ Y I YK RTVVWVANRD P SS L
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSC-TL 59
Query: 95 TISSEGNLVIEDGR-ITYRVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQSFDYP 150
T+ S+GNLVI DG S + N LLD GN VL + LWQSFDYP
Sbjct: 60 TLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD 569
+G+G FG V G+ GQ+VAVK L K + E ++ L+H NLV+LLG L
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 570 QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRD 629
+ ++ EY+ SL +L R + ++ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 630 LKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY--GYMSPEYALEGLFSIKS 687
L A N+L+ D+ K+SDFG+A+ +A+ + G + +PE E FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 688 DVFSFGVLLLEILS 701
DV+SFG+LL EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 80/282 (28%), Positives = 140/282 (49%), Gaps = 46/282 (16%)
Query: 510 LGEGGFGPVYKG----ELLNGQ-EVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRL 563
LG G FG VYKG E + VA+K L +++ + +E+ +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRA----KKRLLYWETRVKIIEGIAQGLLYLHQ 619
LG CL + LI + +P L ++ + + LL W + IA+G+ YL +
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
R++HRDL A N+L+ T KI+DFG+A++ DE + + +M+ E L
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 680 EGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
+++ KSDV+S+GV + E+++ G K ++ A+++ D +LE
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP------------------YEGIPAVEIPD-LLE 225
Query: 739 NEASYPM-----LARYVNVALLCVHENATDRPTMSEVVSMLT 775
P + Y+ V + C +A RPT E+++ +
Sbjct: 226 KGERLPQPPICTIDVYM-VLVKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (315), Expect = 4e-31
Identities = 82/300 (27%), Positives = 128/300 (42%), Gaps = 20/300 (6%)
Query: 503 NFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQH-R 558
++ KLGEG FG VY + + VA+K L+KK + +E E ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N+V+L D+ L+ EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 619 QYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARMFGGD----ELQANTNRIVGTYGYM 673
IIHRD+K NILLD D K+ DFG+A++ + A + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 674 SPEYALEGLF---SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730
+PE L S SD++S G+ L E+L+G F + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIIL-ELPT 232
Query: 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNNQLSR 790
+ L + ++ + ++ +R + S +S HL L +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 76/241 (31%), Positives = 114/241 (47%), Gaps = 34/241 (14%)
Query: 510 LGEGGFGPVYK-GELLNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLG 565
LG+G FG V + G+ A+K L KK + +E E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 566 CCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRL 623
+EK+ L+ EY P L S L K + E R + I L YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLALEYLH---SL 112
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
II+RDLK NILLD D K++DFG+A+ + + NT GT Y++PE L +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170
Query: 684 SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743
D +S GVLL E+L+GK FY ++R + + IL++ +
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK--PPFYA---------------EDRKE-IYEKILKDPLRF 212
Query: 744 P 744
P
Sbjct: 213 P 213
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 25/203 (12%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
K+GEG G VYK + G+EVA+K++ + Q E + NE +++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IA-------QGLLYLHQ 619
L DE ++ EY+ SL ++ V++ E IA QGL YLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTD---------IITQ-NFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+IHRD+K+ NILL D K++DFG A + ++ N +VGT +M+PE
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIK 189
Query: 680 EGLFSIKSDVFSFGVLLLEILSG 702
+ K D++S G++ +E+ G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 91/284 (32%), Positives = 124/284 (43%), Gaps = 45/284 (15%)
Query: 508 NKLGEGGFGPVYKGELL--NGQE--VAVKRLSK-KSGQGLEELKNETMLIAKLQHRNLVR 562
+LG G FG V KG L +G+E VAVK L + G +E E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDR---AKKRLLYWETRVKIIEGIAQGLLYLHQ 619
L+G C + +L+ E P L +L R L +V A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARM--FGGDELQANTNRIVGTY--GYMSP 675
+HRDL A N+LL + KISDFGM+R G D +A T G + + +P
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAP 167
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGS--LNLLGHAWDLWKDNRALDL 732
E G FS KSDV+S+GV L E S G K G G+ + +L L +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG-EMKGAEVIAMLESGERLPRPEECPQE 226
Query: 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ I+ L C DRPT SE+ S
Sbjct: 227 IYSIM----------------LSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 69/227 (30%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL----- 555
++F +GEG F V E +E A+K L K+ Q ++E K + + I K
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 556 -QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGL 614
H +++L D++ + EY PN L ++ R L TR E I L
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAE-ILLAL 115
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL--------------- 659
YLH IIHRDLK NILLD DM KI+DFG A++ +
Sbjct: 116 EYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 660 ---QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+ VGT Y+SPE E SD+++ G ++ ++L+GK
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 76/210 (36%), Positives = 111/210 (52%), Gaps = 22/210 (10%)
Query: 510 LGEGGFGPVYKGELLN-------GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLV 561
LG G FG VY+G + VAVK L K + Q +E E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKR----LLYWETRVKIIEGIAQGLLYL 617
+LLG CL + + +I E + L S+L D +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 618 HQYSRLRIIHRDLKASNILL-----DTDMKPKISDFGMAR-MFGGDELQANTNRIVGTYG 671
Q + IHRDL A N L+ D D KI DFG+AR ++ D + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE L+G F+ +SDV+SFGVL+ EIL+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 75/278 (26%), Positives = 120/278 (43%), Gaps = 50/278 (17%)
Query: 509 KLGEGGFGPVYKGEL-LNGQEVAVKRL-SKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
LG+G G VYK G+ A+K++ + ++L E + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII-EGIAQGLLYLHQYSRLRI 625
+ E ++ EY+ SL L KK E + I I +GL YLH + I
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHT--KRHI 121
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
IHRD+K SN+L+++ + KI+DFG++++ Q NT VGT YMSPE +S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESYSY 179
Query: 686 KSDVFSFGVLLLEILSGK------KNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL-- 737
+D++S G+ LLE GK F+ +LM I
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFF---------------------ELMQAICDG 218
Query: 738 ------ENEASYPMLARYVNVALLCVHENATDRPTMSE 769
E S P +++ C+ ++ RP+ +E
Sbjct: 219 PPPSLPAEEFS-PEFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 68/196 (34%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
KLG G FG V++G N VAVK L K ++ E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHR 628
++ ++ E + SL +L A R L + + +A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 629 DLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLFSI 685
DL A N+L+ + K++DFG+AR+ D +A G + +PE AL FSI
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183
Query: 686 KSDVFSFGVLLLEILS 701
KSDV+SFG+LL EI++
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 78/271 (28%), Positives = 122/271 (45%), Gaps = 31/271 (11%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD 569
LG G FG V+ G+ +VA+K + ++ ++ E ++ KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 570 QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRD 629
Q ++ EY+ N L ++L R +K L E + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 630 LKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLFSIK 686
L A N L+ D K+SDFG+AR D+ ++ GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 687 SDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD--LMDPILENEASYP 744
SDV+SFGVL+ E+ S K ++ + ++ ++ L P
Sbjct: 182 SDVWSFGVLMWEVFSEGKM--------------PYERFSNSEVVESVSAGYRLYRPKLAP 227
Query: 745 MLARYVNVALLCVHENATDRPTMSEVVSMLT 775
+ C HE DRP +++S LT
Sbjct: 228 T--EVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 51/116 (43%), Positives = 65/116 (56%), Gaps = 4/116 (3%)
Query: 35 QVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVL 94
++ +TLVS FELGFF +N Y I YK+ RTVVWVANRD P++ S L
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSS-RTVVWVANRDNPVSDSC-TL 58
Query: 95 TISSEGNLVIEDGR-ITYRVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQSFDY 149
T+ S+GNLV+ DG S ++ N LLD GN V+ + LWQSFDY
Sbjct: 59 TLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 66/199 (33%), Positives = 107/199 (53%), Gaps = 13/199 (6%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
++G G FG V+ G L ++VA+K + ++ E+ E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHR 628
++ L++E++ + L +L RA++ ET + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 629 DLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLFSI 685
DL A N L+ + K+SDFGM R D+ ++T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 686 KSDVFSFGVLLLEILSGKK 704
KSDV+SFGVL+ E+ S K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 508 NKLGEGGFGPVYKGEL--LNG----QEVAVKRL-SKKSGQGLEELKNETMLIAKLQHRNL 560
LG G FG VY+G +G +VAVK L S Q + E ++++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKR----LLYWETRVKIIEGIAQGLLY 616
VRL+G ++ + ++ E + L SFL + + L + + +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 617 LHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
L + IHRD+ A N LL KI+DFGMAR R + +M
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILS 701
PE L+G+F+ K+DV+SFGVLL EI S
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 84/284 (29%), Positives = 112/284 (39%), Gaps = 48/284 (16%)
Query: 509 KLGEGGFGPVYKGELLNGQ----EVAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLVRL 563
KLG+G FG V +GE VAVK L +++ E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLL---YWETRVKIIEGIAQGLLYLHQY 620
G L ++ E P SL L A L + V+I A G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIVGTYGYMSPEYA 678
R IHRDL A NILL +D K KI DFG+ R D + V + + +PE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
FS SDV+ FGV L E+ + + + W IL+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT-----------------YGEEPWAGLSGSQ----ILK 211
Query: 739 N-EASYPMLAR-------YVNVALLCVHENATDRPTMSEVVSML 774
+ L R NV L C N DRPT + + L
Sbjct: 212 KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 503 NFSAENKLGEGGFGPVYKG-ELLNGQEVAVKR--LSKKSGQGLEELKNETMLIAKLQHRN 559
+F NK+G+G FG V+K + + A+K+ LSK + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL---LYWETRVKIIEGIAQGLLY 616
++R LD+ + ++ EY N L L + + L W ++I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
LH +I+HRD+K+ N+ LD KI D G+A++ + ANT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGK 703
+ ++ KSDV++ GV+L E +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 86/284 (30%), Positives = 128/284 (45%), Gaps = 38/284 (13%)
Query: 510 LGEGGFGPVYKGELLNGQE------VAVKRLSKKSGQGLE-ELKNETMLIAKLQHRNLVR 562
LG G FG V+ + +E V VK L K + L+ E + E + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFL------FDRAKKRLLYWETRVKIIEGIAQGLLY 616
LLG C + + +I EY L FL ++ K L + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
L S R +HRDL A N L+ + + K+S +++ E N ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGKK--NTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
E FS KSDV+SFGVL+ E+ + + G LN L A L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ----------AGKLEL 238
Query: 735 PILEN--EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
P+ E Y ++ R C N DRP+ SE+VS L
Sbjct: 239 PVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 81/274 (29%), Positives = 136/274 (49%), Gaps = 44/274 (16%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLS-----KKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG G FG VY+G L +G AVK +S + + +++L+ E L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 564 LGCCLDQDEKILIY-EYLPNKSLDSFL--FDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
LG + ++ + I+ E +P SL L + + ++ TR I GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL- 679
R +HRD+K +NIL+DT+ K++DFGMA+ + G+ +M+PE
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 680 EGLFSIKSDVFSFGVLLLEILSGKKNTG-FYHTGSLNLLGHAWDLWKDNRALDLMDPI-- 736
+G + + +D++S G +LE+ +GK + ++K R+ +L PI
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA---------VFKIGRSKEL-PPIPD 225
Query: 737 -LENEASYPMLARYVNVALLCVHENATDRPTMSE 769
L +EA + L C+ + + RPT +E
Sbjct: 226 HLSDEAK--------DFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 74/203 (36%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
KLG G FG V+ G +VA+K L K+ E E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIE---GIAQGLLYLH 618
RL + Q+ +I EY+ N SL FL +L T K+I+ IA+G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKL----TINKLIDMAAQIAEGMAFIE 119
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
R IHRDL+A+NIL+ + KI+DFG+AR+ +E A + +PE
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAI 175
Query: 679 LEGLFSIKSDVFSFGVLLLEILS 701
G F+IKSDV+SFG+LL EI++
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 70/202 (34%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVK--------RLSKKSGQGLEELKNETMLIAKLQHRNL 560
K+G+G FG VYKG L EVAVK L +K Q E LK H N+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQ-------YDHPNI 54
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
V+L+G C+ + ++ E +P SL +FL R KK L + +++ A G+ YL
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
+ IHRDL A N L+ + KISDFGM+R G + + +PE
Sbjct: 113 N---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 681 GLFSIKSDVFSFGVLLLEILSG 702
G ++ +SDV+S+G+LL E S
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 22/209 (10%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKR--LSKKSGQG-------LEELKNETMLIAKLQHRN 559
+G G FG VY G +G+ +AVK+ L S L+ L E L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGLLYLH 618
+V+ LG LD D + EY+P S+ + L + + ET V+ + I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYLH 123
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA--NTNR--IVGTYGYMS 674
+R IIHRD+K +NIL+D KISDFG+++ + L N R + G+ +M+
Sbjct: 124 --NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGK 703
PE + ++ K+D++S G L++E+L+GK
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVR 562
F KLGEG +G VYK GQ VA+K + + L+E+ E ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
G + ++ EY S+ + + + L E I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
+ IHRD+KA NILL+ + + K++DFG++ + NT ++GT +M+PE E
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIG 175
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
++ K+D++S G+ +E+ GK
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 88/288 (30%), Positives = 142/288 (49%), Gaps = 44/288 (15%)
Query: 502 NNFSAENKLGEGGFGPVYKGEL-LNGQE---VAVKRL-SKKSGQGLEELKNETMLIAKLQ 556
+ + E +G G FG V +G L L G++ VA+K L + S + + E ++ +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
H N++RL G ++I EY+ N SLD FL R V ++ GIA G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN--RIVGTYGYMS 674
L S + +HRDL A NIL+++++ K+SDFG++R E T +I + +
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTA 176
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
PE F+ SDV+SFG+++ E++S G++ Y WD+ N+ D++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERP---Y-----------WDM--SNQ--DVI 218
Query: 734 DPILENEASY----PM---LARYVNVALLCVHENATDRPTMSEVVSML 774
+ E Y PM A Y + L C ++ +RPT S++VS L
Sbjct: 219 KAV---EDGYRLPPPMDCPSALY-QLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 40/107 (37%), Positives = 59/107 (55%), Gaps = 7/107 (6%)
Query: 208 WTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENET-YFIYSI-KDSIISRCILDVSGQVEQ 265
W SG W+G FS +PEM + Y+ +T+ NE Y+ Y + +SI SR L G +E+
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYN-FTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER 59
Query: 266 MSWLGARQAWFIFWSQPRTSC---VACGPFSICNTAT-GSCQCLQGF 308
+W+ Q W +FWS P+ C CGP+ C+ T C C++GF
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGF 106
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 78/226 (34%), Positives = 114/226 (50%), Gaps = 27/226 (11%)
Query: 497 VSASTNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQGL-EELKNET 549
++ ST F E LGE FG VYKG L Q VA+K L K+ L EE K+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 550 MLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLF-------------DRAKKR 596
M+ ++LQH N+V LLG + +I+ Y + L FL D+ K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 597 LLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFG 655
L V I+ IA G+ +L S ++H+DL N+L+ + KISD G+ R ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
D + N ++ +MSPE + G FSI SD++S+GV+L E+ S
Sbjct: 177 ADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKGE---LLNGQE---VAVKRLSKK-SGQGLEELKNETMLIAK 554
NN +G+G FG V++ LL + VAVK L ++ S + + E L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL----------------- 597
H N+V+LLG C L++EY+ L+ FL R+ +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 598 --LYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MF 654
L ++ I + +A G+ YL S + +HRDL N L+ +M KI+DFG++R ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
D +A+ N + +M PE ++ +SDV+++GV+L EI S
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 40/284 (14%)
Query: 508 NKLGEGGFGPVYKGELL-NGQEVAVKRL-----SKKSGQGLEELKNETMLIAKLQHRNLV 561
+LG G G V K G+ +AVK + Q L EL ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD----ILHKCNSPYIV 62
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV--KIIEGIAQGLLYLHQ 619
G + + + EY+ SLD L + R+ R+ KI + +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKIL-KEVQGRI---PERILGKIAVAVLKGLTYLH- 117
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+ +IIHRD+K SNIL+++ + K+ DFG++ A T VGT YM+PE
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--LAKTF--VGTSSYMAPERIQ 172
Query: 680 EGLFSIKSDVFSFGVLLLEILSGK---KNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
+S+KSD++S G+ L+E+ +G+ G LL ++ P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL---------QYIVNEPPPR 223
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780
L + P +VN LC+ ++ +RP+ E +L + +
Sbjct: 224 LPSGKFSPDFQDFVN---LCLIKDPRERPSYKE---LLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 23/207 (11%)
Query: 508 NKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSG------QGLEELKNETMLIAKLQHRNL 560
++GEG +G VYK G+ VA+K++ ++ + E+K L+ KL+H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60
Query: 561 VRLLGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGLLYL 617
VRL + + +++EY+ + L L + + E+++K ++ + +GL YL
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL---DSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H I+HRD+K SNIL++ D K++DFG+AR + TNR++ T Y PE
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPEL 172
Query: 678 AL-EGLFSIKSDVFSFGVLLLEILSGK 703
L + + D++S G +L E+ GK
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 73/199 (36%), Positives = 109/199 (54%), Gaps = 25/199 (12%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
+GEG FG V +GE GQ+VAVK + K + ET ++ KL H+NLVRLLG L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIE------GIAQGLLYLHQYSR 622
I++ E + +L +FL R + R L V +I+ +A+G+ YL
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFL--RTRGRAL-----VSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
+++HRDL A NIL+ D K+SDFG+AR+ + + +++ + +PE
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKK 173
Query: 683 FSIKSDVFSFGVLLLEILS 701
FS KSDV+S+GVLL E+ S
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 30/281 (10%)
Query: 501 TNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRL-------SKKSGQGLEELKNETMLI 552
NF E K+G+G F VYK LL+G+ VA+K++ +K L+E+ L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIA 611
+L H N+++ L ++ +E ++ E L + K++ L E + K +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
L ++H RI+HRD+K +N+ + K+ D G+ R F A++ +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731
YMSPE E ++ KSD++S G LL E+ + + + FY +NL + L K D
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK-MNL----YSLCKKIEKCD 224
Query: 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772
P L + L V+ C++ + RP +S V+
Sbjct: 225 Y--PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 84/268 (31%), Positives = 128/268 (47%), Gaps = 24/268 (8%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
KLG G FG V+ G N +VAVK L K ++ E L+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHR 628
++ +I EY+ SL FL ++L + + IA+G+ Y+ R IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIE---RKNYIHR 127
Query: 629 DLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSD 688
DL+A+N+L+ + KI+DFG+AR+ +E A + +PE G F+IKSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSD 186
Query: 689 VFSFGVLLLEILSGKK--NTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPML 746
V+SFG+LL EI++ K G ++ ++ L + + P +EN
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-----------PRMEN-----CP 230
Query: 747 ARYVNVALLCVHENATDRPTMSEVVSML 774
++ C E A +RPT + S+L
Sbjct: 231 DELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 83/270 (30%), Positives = 130/270 (48%), Gaps = 33/270 (12%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
+LG G FG V G+ +VA+K + K+ +E E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL--HQYSRLRII 626
Q ++ EY+ N L ++L R + +++ + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLESKQF-----I 122
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLF 683
HRDL A N L+D K+SDFG++R DE ++ VG+ + PE L F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 684 SIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742
S KSDV++FGVL+ E+ S GK ++ K ++ L L P L +E
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE--------KVSQGLRLYRPHLASEKV 230
Query: 743 YPMLARYVNVALLCVHENATDRPTMSEVVS 772
Y ++ C HE A +RPT +++S
Sbjct: 231 YAIMYS-------CWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 76/204 (37%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 510 LGEGGFGPV--YKGELLN---GQEVAVKRLSKKSGQGLEE-LKNETMLIAKLQHRNLVRL 563
LGEG FG V Y + N G+ VAVK L ++ GQ K E ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 564 LGCCLDQDEKI--LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
GCC +Q K LI EY+P SL +L K L + + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL----QANTNRIVGTYGYMSPEY 677
IHRDL A N+LLD D KI DFG+A+ + + + V Y + E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---AVEC 181
Query: 678 ALEGLFSIKSDVFSFGVLLLEILS 701
E FS SDV+SFGV L E+L+
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 49/288 (17%)
Query: 510 LGEGGFGPVYKGELLN------GQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLV 561
LG+G FG VY+G VA+K +++ + +E L NE ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFL-NEASVMKEFNCHHVV 72
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKK------RLLYWETRVKIIE---GIAQ 612
RLLG +++ E + L S+L R+++ L T K I+ IA
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT--- 669
G+ YL + +HRDL A N ++ D+ KI DFGM R D + + R G
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 670 -YGYMSPEYALEGLFSIKSDVFSFGVLLLEI--LSGKKNTGFYHTGSLNLLGHAWDLWKD 726
+M+PE +G+F+ KSDV+SFGV+L E+ L+ + G + L + D
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-------D 236
Query: 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
LDL + +L + +C N RPT E+VS L
Sbjct: 237 GGHLDLPE-----NCPDKLL----ELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 505 SAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
+ ++KLG G +G VY+G VAVK L K+ +EE E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKR-----LLYWETRVKIIEGIAQGLLYLH 618
LG C + +I E++ +L +L + ++ LLY T+ I+ + YL
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ------ISSAMEYLE 121
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+ + IHRDL A N L+ + K++DFG++R+ GD A+ + +PE
Sbjct: 122 KKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESL 177
Query: 679 LEGLFSIKSDVFSFGVLLLEI 699
FSIKSDV++FGVLL EI
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 508 NKLGEGGFGPVYK------GELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+G+G FG V K G++L +E+ +++K Q +L +E ++ +L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIV 62
Query: 562 RLLGCCLD-QDEKILIY-EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH- 618
R +D ++ + I EY L + + KK Y E I + Q LL L+
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEF-IWRILTQLLLALYE 120
Query: 619 ----QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
++HRDLK +NI LD + K+ DFG+A++ G D A T VGT YMS
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMS 178
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGK 703
PE + KSD++S G L+ E+ +
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 72/212 (33%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEV-AVKRLSKKSG-----QGLEELKNETMLIAKL 555
++LGEG G V K L N + A+K ++ Q L EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 556 QHRNLVRLLGCCLD-QDEKILI-YEYLPNKSLDSFLFDRAKKRLLYWETRV--KIIEGIA 611
+ +V+ G LD I I EY SLDS ++ + KKR +V KI E +
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+GL YLH +IIHRD+K SNILL + K+ DFG++ A T GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSF 168
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
YM+PE +SI SDV+S G+ LLE+ +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 86/295 (29%), Positives = 140/295 (47%), Gaps = 39/295 (13%)
Query: 509 KLGEGGFGPVYKGELLNGQE-----------------VAVKRLSKKSGQGLE-ELKNETM 550
KLGEG FG V+ E ++ VAVK L + + + + E
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 551 LIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFL--------FDRAKKRLLYWET 602
++++L+ N++RLL C+ D +I EY+ N L+ FL ++A + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 603 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQA 661
+ + IA G+ YL S L +HRDL N L+ + KI+DFGM+R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW 721
R V +MS E L G F+ SDV++FGV L EIL+ K + ++ +
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247
Query: 722 DLWKD-NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775
+ ++D R + L P L ++ Y ++ L C NA +RP+ E+ + L
Sbjct: 248 EFFRDQGRQVYLPKPALCPDSLYKLM-------LSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 70/195 (35%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
KLG G FG V+ G +VAVK L K E E ++ KL+H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
+ ++ ++ EY+ SL FL D + R L V + +A G+ Y+ R+ I
Sbjct: 70 -VSEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIK 686
HRDL+++NIL+ + KI+DFG+AR+ +E A + +PE AL G F+IK
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 687 SDVFSFGVLLLEILS 701
SDV+SFG+LL E+++
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 69/208 (33%), Positives = 114/208 (54%), Gaps = 20/208 (9%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETM----LIAKLQHR 558
+ KLGEG +G VYK + G+ VA+K++ + E + + + L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 559 NLVRLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGLLY 616
N+V+LL + K+ L++EY + L +L D+ L +K I+ + +GL Y
Sbjct: 59 NIVKLLDVIH-TERKLYLVFEYC-DMDLKKYL-DKRPGPLS--PNLIKSIMYQLLRGLAY 113
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
H + RI+HRDLK NIL++ D K++DFG+AR F G L+ T+ +V T Y +PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
Query: 677 YAL-EGLFSIKSDVFSFGVLLLEILSGK 703
L +S D++S G + E+++GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 510 LGEGGFGPVYKGELLNGQ-EVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
LG+G +G VY L+ Q +A+K + ++ + ++ L E L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG--IAQGLLYLHQYSRLRII 626
+ + E +P SL + L R+K L + I I +GL YLH +I+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 627 HRDLKASNILLDT-DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL--F 683
HRD+K N+L++T KISDFG ++ G + T GT YM+PE +G +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 684 SIKSDVFSFGVLLLEILSGK 703
+D++S G ++E+ +GK
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 509 KLGEGGFGPVYKGE---LLNGQE---VAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVR 562
+LGEG FG V+ E LL Q+ VAVK L + S ++ + E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR------------VKIIEGI 610
G C + ++++EY+ + L+ FL + + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY 670
A G++YL + L +HRDL N L+ + KI DFGM+R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 671 GYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKK 704
+M PE L F+ +SD++SFGV+L EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/193 (35%), Positives = 103/193 (53%), Gaps = 7/193 (3%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
E KLG+G FG V+ G VA+K L K E E ++ KL+H LV+L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
+ ++ ++ EY+ SL FL K L V + IA G+ Y+ R+ +
Sbjct: 70 -VSEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIK 686
HRDL+A+NIL+ ++ K++DFG+AR+ +E A + +PE AL G F+IK
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 687 SDVFSFGVLLLEI 699
SDV+SFG+LL E+
Sbjct: 184 SDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 85/295 (28%), Positives = 126/295 (42%), Gaps = 37/295 (12%)
Query: 509 KLGEGGFGPVYKGELLNGQE-----------------VAVKRLSK-KSGQGLEELKNETM 550
KLGEG FG V+ E Q+ VAVK L S E+ E
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 551 LIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFL--------FDRAKKRLLYWET 602
++++L N+ RLLG C +I EY+ N L+ FL + L + T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 603 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQA 661
+ + IA G+ YL L +HRDL N L+ + KI+DFGM+R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW 721
R +M+ E L G F+ KSDV++FGV L EIL+ + + H ++ +A
Sbjct: 189 Q-GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG 247
Query: 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
++D D L + P + L C + DRPT E+ L
Sbjct: 248 HFFRD----DGRQIYLPRPPNCP--KDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/202 (34%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKR-----LSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+G FG VY ++ G+E+AVK+ S ++ + + L+ E L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 564 LGCCLDQDEKILIY-EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
GC L DE + I+ EY+P S+ L +A L TR K I +G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLH---S 122
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIV-GTYGYMSPEYALEG 681
I+HRD+K +NIL D+ K+ DFG ++ + V GT +MSPE
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 682 LFSIKSDVFSFGVLLLEILSGK 703
+ K+DV+S G ++E+L+ K
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 62/200 (31%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN--ETMLIAKLQHRNLVRLLG 565
K+GEG +G VYK + L G+ VA+K++ + E L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGLLYLHQYSRLR 624
+ + L++E++ + L + DR + E+ +K + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-EGLF 683
I+HRDLK N+L++T+ K++DFG+AR FG + T+ +V T Y +PE L + +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 684 SIKSDVFSFGVLLLEILSGK 703
S D++S G + E+LS +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 85/292 (29%), Positives = 132/292 (45%), Gaps = 50/292 (17%)
Query: 510 LGEGGFGPVYKGELL------NGQEVAVKRL-SKKSGQGLEELKNETMLIAKL--QHRNL 560
LGEG FG V K E + VAVK L + + L +L +E M + K+ +H+N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE-MEMMKMIGKHKNI 78
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG----------- 609
+ LLG C + ++ EY + +L FL R + E
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 610 --IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTN-R 665
+A+G+ +L + IHRDL A N+L+ D KI+DFG+AR + D + TN R
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEI--LSGKKNTGFYHTGSLNLLGHAWDL 723
+ +M+PE + +++ +SDV+SFGVLL EI L G G +L
Sbjct: 196 L--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI----------PVEEL 243
Query: 724 WKDNRALDLMD-PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+K + M+ P + Y ++ C HE + RPT ++V L
Sbjct: 244 FKLLKEGYRMEKPQNCTQELYHLMRD-------CWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 88/307 (28%), Positives = 145/307 (47%), Gaps = 55/307 (17%)
Query: 509 KLGEGGFGPVYKGELLNGQE-----------------VAVKRLSKKSGQG-----LEELK 546
KLGEG FG V+ E++N Q+ VAVK L + + L+E+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 547 NETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR-------------- 592
++++L+ N++RLLG C+D+D +I EY+ N L+ FL
Sbjct: 72 ----ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 593 --AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650
+ + + + + IA G+ YL S L +HRDL N L+ ++ KI+DFGM
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 651 AR-MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFY 709
+R ++ GD + R V +M+ E L G F+ SDV++FGV L EIL K +
Sbjct: 185 SRNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 710 HTGSLNLLGHAWDLWKDN-RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMS 768
++ +A + ++D R + L P + Y ++ L C + +RP+ S
Sbjct: 244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM-------LQCWSRDCRERPSFS 296
Query: 769 EVVSMLT 775
++ + LT
Sbjct: 297 DIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 8/201 (3%)
Query: 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLS-KKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
+G G VY L N ++VA+KR+ +K ++EL+ E +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
+ DE L+ YL SL + + L +++ + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIVGTYGYMSPEYALEGL- 682
IHRD+KA NILL D KI+DFG++ GGD + VGT +M+PE +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
+ K+D++SFG+ +E+ +G
Sbjct: 184 YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 69/221 (31%), Positives = 113/221 (51%), Gaps = 22/221 (9%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLN---GQE---VAVKRLSKKSGQGLEELKNETMLIAKL 555
+N + +LGEG FG V+ E N Q+ VAVK L S ++ E L+ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR----------VK 605
QH ++V+ G C++ D I+++EY+ + L+ FL +L E +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTN 664
I + IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + +
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 665 RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKK 704
++ +M PE + F+ +SDV+S GV+L EI + GK+
Sbjct: 182 TMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS---KKSGQGLEELKNETMLIAKLQHRN 559
F+ ++G G FG VY ++ + VA+K++S K+S + +++ E + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ GC L + L+ EY + D + + KK L E I G QGL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEI-AAICHGALQGLAYLHS 133
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+ R IHRD+KA NILL K++DFG A L + N VGT +M+PE L
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVIL 184
Query: 680 ---EGLFSIKSDVFSFGVLLLEI 699
EG + K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 69/222 (31%), Positives = 108/222 (48%), Gaps = 24/222 (10%)
Query: 507 ENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
+ +LGEG FG V+ E N VAVK L + ++ + E L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLF-------------DRAKKRLLYWETRVKII 607
V+ G C D D I+++EY+ + L+ FL R K L + I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTNRI 666
IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + + +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 667 VGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGF 708
+ +M PE + F+ +SDV+SFGV+L EI + K F
Sbjct: 187 LPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 80/275 (29%), Positives = 133/275 (48%), Gaps = 33/275 (12%)
Query: 504 FSAENKLGEGGFGPVYKGELLNGQEV-AVKRLS---KKSGQGLEELKNETMLIAKLQHRN 559
F+ ++G G FG VY + EV A+K++S K+S + +++ E + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ GC L + L+ EY + D L + KK L E I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 143
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
++ +IHRD+KA NILL + K++DFG A + + N VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 680 ---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
EG + K DV+S G+ +E+ ++ ++ +++ L H N + P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PT 243
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVV 771
L++ +V+ C+ + DRPT E++
Sbjct: 244 LQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 33/270 (12%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS---KKSGQGLEELKNETMLIAKLQHRN 559
FS ++G G FG VY ++ N + VA+K++S K+S + +++ E + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
++ GC L + L+ EY + D L + KK L E + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHS 133
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
++ +IHRD+KA NILL K+ DFG A + A N VGT +M+PE L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 680 ---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
EG + K DV+S G+ +E+ ++ ++ +++ L H N + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PA 233
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPT 766
L++ +V+ C+ + DRPT
Sbjct: 234 LQSGHWSEYFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
+LG G FG V+ G+ +VA+K + + E+ E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHR 628
Q ++ E++ N L ++L R ++ L + + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 629 DLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSD 688
DL A N L+ + K+SDFGM R DE +++ + PE +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKSD 183
Query: 689 VFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY-PMLA 747
V+SFGVL+ E+ + K ++ ++++ I Y P LA
Sbjct: 184 VWSFGVLMWEVFTEGKMP-----------------FEKKSNYEVVEMISRGFRLYRPKLA 226
Query: 748 RYV--NVALLCVHENATDRPTMSEVVSMLT 775
V C HE RPT +E++ +T
Sbjct: 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 6e-23
Identities = 67/202 (33%), Positives = 113/202 (55%), Gaps = 20/202 (9%)
Query: 510 LGEGGFGPVYKGELLNGQE-----VAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRL 563
LG G FG VYKG + E VA+K L++ +G + E +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDR----AKKRLLYWETRVKIIEGIAQGLLYLHQ 619
LG CL + L+ + +P+ L ++ + + LL W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
R++HRDL A N+L+ + KI+DFG+AR+ GDE + N + +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 680 EGLFSIKSDVFSFGVLLLEILS 701
F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 69/195 (35%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+ KLG+G FG V+ G +VA+K L K E E ++ KL+H LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
+ ++ ++ E++ SL FL + K L + V + IA G+ Y+ R+ I
Sbjct: 70 -VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE---RMNYI 124
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIK 686
HRDL+A+NIL+ ++ KI+DFG+AR+ +E A + +PE AL G F+IK
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 687 SDVFSFGVLLLEILS 701
SDV+SFG+LL E+++
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 25/211 (11%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVK----------RLSKKSGQGLEELKNETMLIAKLQHR 558
+G+G +G VY + G+ +AVK R + ++ L++E + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGLLYL 617
N+V+ LG ++ + EY+P S+ S L + + E V+ E + +GL YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR----FEEQLVRFFTEQVLEGLAYL 124
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN--TNRIVGTYGYMSP 675
H I+HRDLKA N+L+D D KISDFG+++ D++ N + G+ +M+P
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGSVFWMAP 179
Query: 676 E--YALEGLFSIKSDVFSFGVLLLEILSGKK 704
E ++ +S K D++S G ++LE+ +G++
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 69/209 (33%), Positives = 109/209 (52%), Gaps = 31/209 (14%)
Query: 510 LGEGGFGPVYKGELL--------NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
LG+G FG V EL G+ VAVK+L + + L + + E ++ LQH N+V
Sbjct: 12 LGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 562 RLLGCCLD--QDEKILIYEYLPNKSLDSFLF-DRAK---KRLLYWETRVKIIEGIAQGLL 615
+ G C + L+ EYLP SL +L R + ++LL + ++ I +G+
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ------ICKGME 122
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG---TYGY 672
YL R +HRDL NIL++++ + KI DFG+ ++ D+ + R G + Y
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY 178
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+PE E FS+ SDV+SFGV+L E+ +
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 56/294 (19%)
Query: 510 LGEGGFGPVYKGEL----LNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LGEG FG V +G+L + +VAVK +L + +EE +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 564 LGCCLDQDEK------ILIYEYLPNKSLDSFLFDRAKKRL------LYWETRVKIIEGIA 611
+G C + ++I ++ + L SFL RL L +T +K + IA
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDEL-QANTNRIVGT 669
G+ YL S IHRDL A N +L DM ++DFG+++ ++ GD Q ++
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--P 178
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-------GKKNTGFYHTGSLNLLGHAWD 722
+++ E + +++ KSDV++FGV + EI + G +N Y + L H
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY-----DYLRHGNR 233
Query: 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
L + LD + Y ++ C + DRPT +++ +L N
Sbjct: 234 LKQPEDCLDEL---------YDLMYS-------CWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-22
Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 50/295 (16%)
Query: 509 KLGEGGFGPVYKGELLNGQE---------------VAVKRL-SKKSGQGLEELKNETMLI 552
KLGEG FG V+ E E VAVK L + + + E ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR---------------AKKRL 597
++L++ N++RLLG C+ D +I EY+ N L+ FL R + L
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 598 LYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGG 656
LY + IA G+ YL + L +HRDL N L+ KI+DFGM+R ++ G
Sbjct: 132 LYMAVQ------IASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNL 716
D + R V +M+ E L G F+ SDV++FGV L E+ + K + +
Sbjct: 183 DYYRIQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241
Query: 717 LGHAWDLWKDN-RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
+ + + +++ R + L L + ++ R C + DRPT +++
Sbjct: 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR-------CWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKR--LSKKSGQGLEELKNETMLIAKLQHRN 559
+F KLG+G +G VYK + L + Q A+K L S + E+ NE ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLLYLH 618
++ LD ++ ++ EY P L + R KKR L E + +I + +GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+ +I+HRDLK++NILL + KI D G++++ + A T +GT YM+PE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQ--IGTPHYMAPEVW 173
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK 703
+S KSD++S G LL E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 71/214 (33%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 509 KLGEGGFGPVYKGELL-----NGQEVAVKRLSK-KSGQGLEELKNETMLIAKLQHRNLVR 562
+LGE FG +YKG L + Q VA+K L + Q E + E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAK--------------KRLLYWETRVKIIE 608
LLG + +++EYL L FL R+ K L + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTNRIV 667
IA G+ YL + +H+DL A NIL+ + KISD G++R ++ D + ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M PE + G FS SD++SFGV+L EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 26/209 (12%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLS----KKSGQG--LEELKNETMLIAKLQHRNLVR 562
LG G F Y+ ++ G +AVK+++ S Q +E L+ E L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRA--KKRLLYWETRVKIIEGIAQGLLYLHQY 620
+LG + L E++ S+ L K+ ++ + E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 621 SRLRIIHRDLKASNILLD-TDMKPKISDFGMA-----RMFGGDELQANTNRIVGTYGYMS 674
+IIHRD+K +N+L+D T + +I+DFG A + G E Q +++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGK 703
PE + DV+S G +++E+ + K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 73/271 (26%), Positives = 130/271 (47%), Gaps = 30/271 (11%)
Query: 510 LGEGGFGP--VYK----GELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+G FG +Y+ L+ +EV + RLS+K + NE ++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
+D + ++ EY +L + R K +L E + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
I+HRD+K NI L K+ DFG++++ G + A T +VGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 684 SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743
+ KSD+++ G +L E+L+ K+ F T LNL+ + + N P++
Sbjct: 179 NFKSDIWALGCVLYELLTLKRT--FDATNPLNLV---VKIVQGNYT-----PVVS----- 223
Query: 744 PMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ +++ + ++ RPT EV+
Sbjct: 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 510 LGEGGFGPVYKGEL--LNGQ----EVAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLVR 562
LGEG FG V K L G+ VAVK L + + L +L +E L+ ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFL---------------------FDRAKKRLLYWE 601
L G C +LI EY SL SFL D +R L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 602 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661
+ I++G+ YL + ++++HRDL A N+L+ K KISDFG++R ++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
++ +M+ E + +++ +SDV+SFGVLL EI++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 67/193 (34%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLE-ELKNETMLIAKLQHRNLVRLLGCCL 568
LG+G FG V+KG L + VAVK + Q L+ + +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHR 628
+ ++ E +P SFL R KK L + VK A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 629 DLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSD 688
DL A N L+ + KISDFGM+R D + +++ + +PE G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 689 VFSFGVLLLEILS 701
V+S+G+LL E S
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 20/208 (9%)
Query: 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGL------EELKNETMLIAKLQHRNLV 561
LG+G +G VY G GQ +AVK++ + L E+L+ E L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFL--FDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ LG CLD + + E++P S+ S L F + + T+ +I++G+A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMAR---MFGGDELQANTNRIV-GTYGYMSP 675
++HRD+K +N++L + K+ DFG AR G +N + + GT +M+P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGK 703
E E + KSD++S G + E+ +GK
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS-KKSGQGLEELKNETMLIAKLQHRNLV 561
F+ +G+G FG VYK + Q VA+K + +++ +E+++ E +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+ G L + +I EY S D K L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR---IVGTYGYMSPEYA 678
IHRD+KA+NILL + K++DFG++ +L + ++ VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK 703
+ + K+D++S G+ +E+ G+
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 510 LGEGGFGPVYKGELLNGQE-----VAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRL 563
LG G FG V+KG + + VA+K + +SG Q +E+ + + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDR----AKKRLLYWETRVKIIEGIAQGLLYLHQ 619
LG C + L+ + P SL + +RLL W + IA+G+ YL +
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+ R++HR+L A NILL +D +I+DFG+A + D+ + + +M+ E L
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 680 EGLFSIKSDVFSFGVLLLEILS 701
G ++ +SDV+S+GV + E++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKRL------SKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG G G V K + + V K++ S Q L EL+ ++ + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
G L+++ + E++ SLD + E KI + +GL YL Y+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV---EILGKIAVAVVEGLTYL--YNVH 123
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
RI+HRD+K SNIL+++ + K+ DFG++ G+ + + + VGT YMSPE G +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKY 179
Query: 684 SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743
++KSDV+S G+ ++E+ GK F + LDL+ I++
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM-------GILDLLQQIVQEPPPR 232
Query: 744 -------PMLARYVNVALLCVHENATDRPTMSEVVSM 773
L +V+ C+ ++ T+RPT ++ +M
Sbjct: 233 LPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 68/208 (32%), Positives = 115/208 (55%), Gaps = 29/208 (13%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRL---SKKSGQGLEELKNETMLIAKLQHRNLVRLL 564
K+GEG +G VYK + L G+ VA+K++ ++ G ++ E L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLL 64
Query: 565 GCCLDQDEKI-LIYEYLP---NKSLDS---FLFDRAK-KRLLYWETRVKIIEGIAQGLLY 616
+ + K+ L++E+L K +DS D K LY ++++GIA Y
Sbjct: 65 DV-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY-----QLLQGIA----Y 114
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
H + R++HRDLK N+L+D + K++DFG+AR F G ++ T+ +V T Y +PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 169
Query: 677 YALEG-LFSIKSDVFSFGVLLLEILSGK 703
L +S D++S G + E+++ +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 11/208 (5%)
Query: 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQ-EVAVKRLSKKSG---QGLEELKNETMLIAK 554
++ + + +G G FG V++G L + G+ EVAV + K G + ++ +E ++ +
Sbjct: 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ 62
Query: 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGL 614
H N++RL G ++I EY+ N +LD +L D + Y V ++ GIA G+
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY--QLVGMLRGIAAGM 120
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD-ELQANTNRIVGTYGYM 673
YL S + +HRDL A NIL++++++ K+SDFG++R+ D E T+ +
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILS 701
+PE F+ SDV+SFG+++ E++S
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 507 ENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKN--------ETMLIAKLQH 557
KLGEG + VYK G+ VA+K++ K G+ +E K+ E L+ +L+H
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKI--KLGE-RKEAKDGINFTALREIKLLQELKH 61
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGLLY 616
N++ LL + L++E++ L+ + D K ++ +K + +GL Y
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKD---KSIVLTPADIKSYMLMTLRGLEY 117
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
LH I+HRDLK +N+L+ +D K++DFG+AR FG + V T Y +PE
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--VVTRWYRAPE 172
Query: 677 YALEGLFSIKS-----DVFSFGVLLLEILSGK 703
LF + D++S G + E+L
Sbjct: 173 L----LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-21
Identities = 88/362 (24%), Positives = 156/362 (43%), Gaps = 52/362 (14%)
Query: 422 LWITVIVVPLLLTA----SYIFLRWRR--KLKYREEREPSQDMLLFDINSSTETSKNELS 475
+IT + L+ A ++F+R R +LK E + + ++ FD
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD------------- 676
Query: 476 DGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRL 534
+ KS + + +S EN + G G YKG+ + NG + VK +
Sbjct: 677 -SKVSKS---------ITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 535 SKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAK 594
+ + +E + KLQH N+V+L+G C + LI+EY+ K+L L
Sbjct: 724 NDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----- 774
Query: 595 KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654
R L WE R KI GIA+ L +LH ++ +L I++D +P + + +
Sbjct: 775 -RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832
Query: 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL 714
D + + Y++PE + KSD++ FG++L+E+L+GK
Sbjct: 833 CTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 715 NLLGHAWDLWKDNRALDLMDPILENEASYPM--LARYVNVALLCVHENATDRPTMSEVVS 772
+++ A + D +DP + + S + +N+AL C + T RP ++V+
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 773 ML 774
L
Sbjct: 947 TL 948
|
Length = 968 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 68/196 (34%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
E KLG G FG V+ +VAVK + K +E E ++ LQH LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 567 CLDQDEKILIYEYLPNKSLDSFL-FDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
+ ++ +I E++ SL FL D K+ L + IA+G+ ++ Q +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---Y 123
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
IHRDL+A+NIL+ + KI+DFG+AR+ +E A + +PE G F+I
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTI 182
Query: 686 KSDVFSFGVLLLEILS 701
KSDV+SFG+LL+EI++
Sbjct: 183 KSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 76/282 (26%), Positives = 136/282 (48%), Gaps = 24/282 (8%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLS---KKSGQGLEELKNETMLIAKLQHR 558
NF E K+G G F VY+ LL+G VA+K++ + + E L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFD-RAKKRLLYWETRVKIIEGIAQGLLYL 617
N+++ ++ +E ++ E L + + +KRL+ +T K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H SR R++HRD+K +N+ + K+ D G+ R F A++ +VGT YMSPE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD-PI 736
E ++ KSD++S G LL E+ + + + FY G +L+ + ++ D P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--------GDKMNLYSLCKKIEQCDYPP 227
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778
L ++ L + VN +C++ + RP ++ V + H
Sbjct: 228 LPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 82/291 (28%), Positives = 138/291 (47%), Gaps = 49/291 (16%)
Query: 502 NNFSAENKLGEGGFGPVYKGEL-LNGQ-EVAVKRLSKKSGQGLEELKN---ETMLIAKLQ 556
+ E +G G FG V G L L G+ E+ V + K+G ++ ++ E ++ +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
H N++ L G +++ EY+ N SLD+FL R V ++ GIA G+ Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG----- 671
L S + +HRDL A NIL+++++ K+SDFG++R+ D A T R G
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPI 173
Query: 672 -YMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRA 729
+ +PE F+ SDV+S+G+++ E++S G++ W++ N+
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--------------WEM--SNQ- 216
Query: 730 LDLMDPILENEASY----PM--LARYVNVALLCVHENATDRPTMSEVVSML 774
D I E Y PM A + L C ++ +RP ++VS+L
Sbjct: 217 ----DVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLS---KKSGQGLEELKNETMLIAKLQHR 558
NF E K+G G F VY+ LL+ + VA+K++ + ++ E L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFL-FDRAKKRLL----YWETRVKIIEGIAQG 613
N+++ L ++ +E ++ E L + + + +KRL+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
H +SR R++HRD+K +N+ + K+ D G+ R F A++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEI 699
SPE E ++ KSD++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 68/217 (31%), Positives = 109/217 (50%), Gaps = 34/217 (15%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKS-GQGLEELK-NETMLIAKLQHRN 559
+++ K+GEG +G VYKG GQ VA+K++ +S +G+ E L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 560 LVRLLGCCLDQDEKILIYEYL------------PNKSLDSFLFDRAKKRLLYWETRVKII 607
+V L + + LI+E+L + +D+ L K LY
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELV----KSYLY-------- 108
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIV 667
I QG+L+ H R++HRDLK N+L+D K++DFG+AR F G ++ T+ +V
Sbjct: 109 -QILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV 163
Query: 668 GTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGK 703
T Y +PE L +S D++S G + E+ + K
Sbjct: 164 -TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD 569
+G+G FG V G+ G +VAVK + K+ + E ++ +L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 570 QDEKILIY-EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHR 628
+ + I EY+ SL +L R + +L + +K + + + YL + +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 629 DLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSD 688
DL A N+L+ D K+SDFG+ + E + + + +PE E FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 689 VFSFGVLLLEILS 701
V+SFG+LL EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 503 NFSAENKLGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNETMLIAKLQHR 558
+F +G+G FG V + + +++ A+K ++K+ + + NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYL 617
LV L D++ L+ + L L + + K + E +VK I I L YL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVK---FSEEQVKFWICEIVLALEYL 116
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H IIHRD+K NILLD I+DF +A D T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGKK 704
+S+ D +S GV E L GK+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 513 GGFGPVYKGE-LLNGQEVAVKRLSKKSGQG---LEELKNETMLIAKLQHRNLVRLLGCCL 568
G +G V+ + G A+K + K ++++ E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 569 DQDEKI-LIYEYLPNKSLDSFL-----FDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYS 621
+ + L+ EYLP L S L D E +I I I L YLH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLD---------EDVARIYIAEIVLALEYLHSNG 113
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFG------MARMFGGDELQANTNRIVGTYGYMSP 675
IIHRDLK NIL+D++ K++DFG + R ++ + RIVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSG 702
E L S D +S G +L E L G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 74/206 (35%), Positives = 112/206 (54%), Gaps = 24/206 (11%)
Query: 510 LGEGGFGPV----YKGELLN-GQEVAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLVRL 563
LGEG FG V Y E N G++VAVK L +SG + +LK E ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 564 LGCCLDQ-DEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL--HQ 619
G C + I LI E+LP+ SL +L K L + ++K I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSRQ 129
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE----LQANTNRIVGTYGYMSP 675
Y +HRDL A N+L++++ + KI DFG+ + D+ ++ + + V Y +P
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---AP 181
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILS 701
E ++ F I SDV+SFGV L E+L+
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 64/227 (28%), Positives = 124/227 (54%), Gaps = 22/227 (9%)
Query: 509 KLGEGGFGPVYKGELLN--GQEVAVKRL---SKKSGQGLEELKNETML--IAKLQHRNLV 561
++GEG +G V+K L G+ VA+KR+ + + G L ++ +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 562 RLLGCCL----DQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
RL C D++ K+ L++E++ ++ L ++L D+ + + ET ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
LH + R++HRDLK NIL+ + + K++DFG+AR++ Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723
L+ ++ D++S G + E+ ++ F + ++ LG D+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQLGKILDV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 33/275 (12%)
Query: 504 FSAENKLGEGGFGPVYKGELLNGQE-VAVKRLS---KKSGQGLEELKNETMLIAKLQHRN 559
F +++G G FG VY + E VAVK++S K++ + +++ E + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ GC L + L+ EY + D L + KK L E I G QGL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 139
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
++ +IHRD+KA NILL + K++DFG A + N VGT +M+PE L
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVIL 190
Query: 680 ---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
EG + K DV+S G+ +E+ ++ ++ +++ L H N + P
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNDS-----PT 239
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVV 771
L++ +V+ C+ + +RP +E++
Sbjct: 240 LQSNEWTDSFRGFVD---YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 84/278 (30%), Positives = 139/278 (50%), Gaps = 41/278 (14%)
Query: 510 LGEGGFGPVYKGELL--NGQEV--AVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLL 564
+G+G FG VY G L+ +GQ++ AVK L++ + + +E+ E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 565 GCCLDQD-EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG----IAQGLLYLHQ 619
G CL + +++ Y+ + L +F+ R++ VK + G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI--RSETH----NPTVKDLIGFGLQVAKGMEYLAS 116
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY-A 678
+ +HRDL A N +LD K++DFG+AR E + N T + ++ A
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH---TGAKLPVKWMA 170
Query: 679 LEGL----FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
LE L F+ KSDV+SFGVLL E+++ + + S ++ + L + R L+
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVY---LLQGRR---LLQ 223
Query: 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772
P + Y V L C H RPT SE+VS
Sbjct: 224 PEYCPDPLY-------EVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 32/214 (14%)
Query: 508 NKLGEGGFGPVYK------GELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
NK+G G FG VY GEL+ +E+ ++ K+ ++E+ +E ++ L+H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLKHPNLV 62
Query: 562 RLLGCCLDQDEKILIY-EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
+ G + EK+ I+ EY +L+ L + L RV ++ + +GL YLH +
Sbjct: 63 KYYGVEV-HREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQ-LLEGLAYLHSH 118
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI-------VGTYGYM 673
I+HRD+K +NI LD + K+ DFG A L+ NT + GT YM
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQSLAGTPAYM 170
Query: 674 SPEYALEGLFSIK---SDVFSFGVLLLEILSGKK 704
+PE G +D++S G ++LE+ +GK+
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRN 559
NF K+GEG +G VYK L G+ VA+K RL ++ E L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+V+LL +++ L++E+L ++ L F+ D + + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+ R++HRDLK N+L++T+ K++DFG+AR F G ++ T+ +V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 680 -EGLFSIKSDVFSFGVLLLEILSGK 703
+S D++S G + E+++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 509 KLGEGGFGPV-YKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
K+GEG G V E +G++VAVK + + Q E L NE +++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627
L +E ++ E+L +L D + L E + E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 628 RDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKS 687
RD+K+ +ILL D + K+SDFG D + + +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198
Query: 688 DVFSFGVLLLEILSGK 703
D++S G++++E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 26/222 (11%)
Query: 491 LFSFASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNET 549
L + SV ++ K+G+G G VY ++ GQEVA+K+++ + E + NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 550 MLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG 609
+++ + +H N+V L L DE ++ EYL SL + T + EG
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------------TETCMDEG 115
Query: 610 -IA-------QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661
IA Q L +LH ++IHRD+K+ NILL D K++DFG ++ +
Sbjct: 116 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+T +VGT +M+PE + K D++S G++ +E++ G+
Sbjct: 173 ST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 507 ENKLGEGGFGPVYKGEL-LNGQE---VAVKRLSKKSG---QGLEELKNETMLIAKLQHRN 559
E +G G FG V +G L L G+ VA+K L KSG + + +E ++ + H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
++ L G ++I E++ N +LDSFL R V ++ GIA G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL-- 122
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG---TYGYMSPE 676
S + +HRDL A NIL+++++ K+SDFG++R D +G + +PE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 677 YALEGLFSIKSDVFSFGVLLLEILS 701
F+ SDV+S+G+++ E++S
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 510 LGEGGFGPVYKGELLN-GQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG+GGFG V ++ G+ A K+L KK +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRLR 624
+D+ L+ + L +++ + + E R I GL +LHQ R
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP--GFPEARAIFYAAQIICGLEHLHQ---RR 115
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
I++RDLK N+LLD +ISD G+A G GT GYM+PE ++
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 685 IKSDVFSFGVLLLEILSGK 703
D F+ G L E+++G+
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 502 NNFSAENKLGEGGFGPVYKGE---LLNGQ---EVAVKRL-SKKSGQGLEELKNETMLIAK 554
NN S LG G FG V + L +VAVK L E L +E +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 555 L-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQG 613
L H N+V LLG C ++I EY L +FL + + L + + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKG 153
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG----- 668
+ +L + IHRDL A N+LL KI DFG+AR ++ ++N +V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARL 205
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE +++ +SDV+S+G+LL EI S
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 24/178 (13%)
Query: 509 KLGEGGFGPVYK-GELLNGQEVAVKR--LSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
++GEG G V+K + G+ VA+K+ L + G + E + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAK-------KRLLYWETRVKIIEGIAQGLLYLH 618
+L+ EY+P+ L L D + K + +++G+A Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM-----RMLLKGVA----YMH 116
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
I+HRDLK +N+L+ D KI+DFG+AR+F +E + +++ V T Y +PE
Sbjct: 117 A---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 508 NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
++G G +G VYK ++ G+ VA+K + + G E ++ E ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IA-------QGLLYLH 618
L +D+ ++ EY SL +Y TR + E IA +GL YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD----------IYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+ IHRD+K +NILL D K++DFG++ A +GT +M+PE A
Sbjct: 119 E---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMAPEVA 173
Query: 679 LE---GLFSIKSDVFSFGVLLLE 698
G + K D+++ G+ +E
Sbjct: 174 AVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKS--GQGLEE-LKNETMLIAKLQHRNLVRLLG 565
LG GGFG V ++ + A+K + K+ G +E + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D+ ++ EY L + L DR + R I + YLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARF-YIACVVLAFEYLH---NRGI 114
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
I+RDLK N+LLD++ K+ DFG A+ + T GT Y++PE L +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDF 171
Query: 686 KSDVFSFGVLLLEILSGK 703
D +S G+LL E+L+G+
Sbjct: 172 SVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 510 LGEGGFGPVYKGELLNGQ---EVAVK--RLSKKSGQGLEELKNETMLIAKLQHRNLVRLL 564
LGEG FG V +G+L +VAVK +++ + +E+ +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 565 GCCLDQDEK------ILIYEYLPNKSLDSFL-FDRAKKRLLYWETR--VKIIEGIAQGLL 615
G CL E ++I ++ + L SFL + R Y T+ VK + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVGT-YGYM 673
YL S IHRDL A N +L+ +M ++DFG++ +++ GD + RI ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR--QGRIAKMPVKWI 181
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEI 699
+ E + +++ KSDV+SFGV + EI
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 510 LGEGGFGPVYKGELLNGQ------EVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
+G G FG V+ Q ++ V++++K + NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
L+ +++ EY P +L ++ R LL +T I+ Q LL LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDT---ILHFFVQILLALHHVHTK 120
Query: 624 RIIHRDLKASNILLDT-DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
I+HRDLK NILLD M KI DFG++++ +A T +VGT Y+SPE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYT--VVGTPCYISPELCEGKP 177
Query: 683 FSIKSDVFSFGVLLLEILSGKK 704
++ KSD+++ G +L E+ S K+
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCC 567
+GEG +G VYK GQ VA+K + EE+K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 568 L------DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK------IIEGIAQGLL 615
+ + D+ L+ E S+ + K L R+K I+ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
YLH+ ++IHRD+K NILL + + K+ DFG++ D N +GT +M+P
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAP 182
Query: 676 E-----YALEGLFSIKSDVFSFGVLLLEILSGK 703
E + + +SDV+S G+ +E+ GK
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELK-NETMLIAKLQHRNL 560
NF KLGEG + VYKG G+ VA+K + + +G E L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
VRL +++ +L++EY+ +K L ++ + L T + +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT--NRIVGTYGYMSPEYA 678
R++HRDLK N+L++ + K++DFG+AR FG + NT N +V T Y +P+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVL 172
Query: 679 LEG-LFSIKSDVFSFGVLLLEILSGK 703
L +S D++S G ++ E+++G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 510 LGEGGFGPV----YKGELLNGQEVAVKRLSK----KSGQGLEELKNETMLIAKLQHRNLV 561
LG G FG V +KG +G+ A+K LSK K Q +E + NE ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64
Query: 562 RLLGCCLDQDEKIL--IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
L G QD+ L + EY+P L S L R R R + + L YLH
Sbjct: 65 NLYGS--FQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQ-VVLALEYLHS 119
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
L I++RDLK N+LLD+D KI+DFG A+ ++ T + GT Y++PE L
Sbjct: 120 ---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIIL 171
Query: 680 EGLFSIKSDVFSFGVLLLEILSG 702
+ D ++ G+L+ E+L+G
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN--ETMLIAKLQ-HRNLVRLL 564
+LG+G FG VY G+ VA+K++ KK EE N E + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGLLYLHQYSRL 623
+ DE ++EY+ +L + DR K E+ ++ II I QGL ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS--ESVIRSIIYQILQGLAHIH---KH 118
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN---TNRIVGTYGYMSPEYALE 680
HRDLK N+L+ KI+DFG+AR E+++ T+ V T Y +PE L
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAPEILLR 172
Query: 681 -GLFSIKSDVFSFGVLLLEILSGK 703
+S D+++ G ++ E+ + +
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 510 LGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
LG+G FG VYK + G A K + +S + LE+ E ++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHR 628
+++ ++ E+ +LDS + ++ L + R + + + L +LH + ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHR 127
Query: 629 DLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS---- 684
DLKA NILL D K++DFG++ LQ + +GT +M+PE F
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKR-DTFIGTPYWMAPEVVACETFKDNPY 185
Query: 685 -IKSDVFSFGVLLLEI 699
K+D++S G+ L+E+
Sbjct: 186 DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 491 LFSFASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNET 549
L S SV ++ K+G+G G VY ++ GQEVA+K+++ + E + NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 550 MLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG 609
+++ + ++ N+V L L DE ++ EYL SL D + + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
Q L +LH ++IHRD+K+ NILL D K++DFG + Q+ + +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 178
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+M+PE + K D++S G++ +E++ G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 20/208 (9%)
Query: 504 FSAENKLGEGGFGPVYKGELLNGQE-----VAVKRLSK-KSGQGLEELKNETMLIAKLQH 557
F LG G FG VYKG + E VA+K L + S + +E+ +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR----AKKRLLYWETRVKIIEGIAQG 613
++ RLLG CL + LI + +P L ++ + + LL W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
+ YL + R++HRDL A N+L+ T KI+DFG+A++ G DE + + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILS 701
+ E L +++ +SDV+S+GV + E+++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 491 LFSFASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNET 549
L S SV ++ K+G+G G VY ++ GQEVA+++++ + E + NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 550 MLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG 609
+++ + ++ N+V L L DE ++ EYL SL D + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
Q L +LH ++IHRD+K+ NILL D K++DFG + Q+ + +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+M+PE + K D++S G++ +E++ G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 74/270 (27%), Positives = 129/270 (47%), Gaps = 26/270 (9%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLV 561
F+ ++G+G FG VYKG + + VA+K + + + +E+++ E ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
R G L + +I EYL S D K L I+ I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
R IHRD+KA+N+LL K++DFG+A +++ NT VGT +M+PE +
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
+ K+D++S G+ +E+ G+ H + L + K++ P LE +
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-----IPKNS------PPTLEGQY 225
Query: 742 SYPMLARYVNVALLCVHENATDRPTMSEVV 771
S P + C++++ RPT E++
Sbjct: 226 SKP----FKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 58/188 (30%), Positives = 96/188 (51%), Gaps = 19/188 (10%)
Query: 504 FSAENKLGEGGFGPVYKGELLN---GQEVAVKRL--SKKSGQGLEELK-NETMLIAKLQH 557
+ E +G G +G VYK + N G+E A+K+ K+ G+ + E L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 558 RNLVRLLGCCLDQDEKI--LIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGL 614
N+V L+ L+ +K L+++Y + F R KR+ + VK ++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKP----KISDFGMARMFGGDELQ--ANTNRIVG 668
YLH ++HRDLK +NIL+ + KI D G+AR+F L+ A+ + +V
Sbjct: 122 HYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVV 177
Query: 669 TYGYMSPE 676
T Y +PE
Sbjct: 178 TIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 512 EGGFGPVYKGELLNG-----QEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLG 565
EG FG ++ G L++ +EV VK + + + + L E+ L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 566 CCLDQDEKILIYEYLPNKS-LDSFL-----FDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
C++ E + N L FL + + L + V + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDE--LQANTNRIVGTYGYMSPE 676
+ +IH+D+ A N ++D +++ KI+D ++R +F D L N NR V +M+ E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALE 189
Query: 677 YALEGLFSIKSDVFSFGVLLLEILS 701
+ +S SDV+SFGVLL E+++
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELK---------NETM------- 550
+ +LG+G FG VY VK + + L+ LK NET+
Sbjct: 5 QQRLGKGSFGTVY----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ 54
Query: 551 LIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI 610
L++KL H +V+ L++D +I EY + LD L + E +V E
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV--CEWF 112
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY 670
Q LL +H + RI+HRDLKA NI L ++ KI DFG++R+ G A T GT
Sbjct: 113 IQLLLGVHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT--FTGTP 169
Query: 671 GYMSPEYALEGLFSIKSDVFSFGVLLLEI 699
YMSPE + KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 10/214 (4%)
Query: 491 LFSFASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNET 549
L + S+ ++ K+G+G G V+ ++ GQEVA+K+++ + E + NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 550 MLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG 609
+++ +L++ N+V L L DE ++ EYL SL D + + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
Q L +LH ++IHRD+K+ N+LL D K++DFG + Q+ + +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 178
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+M+PE + K D++S G++ +E++ G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 72/221 (32%), Positives = 117/221 (52%), Gaps = 36/221 (16%)
Query: 500 STNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRL---SKKSGQGLEELKNETMLIAKL 555
S + + N++ EG +G VY+ + G+ VA+K+L +K G + L+ E ++ KL
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKL 61
Query: 556 QHRNLVRL----LGCCLDQDEKILIY---EYLPN--KSLDSFLFDRAKKRLLYWETR--- 603
QH N+V + +G LD+ IY EY+ + KSL + K+ L E +
Sbjct: 62 QHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSL----METMKQPFLQSEVKCLM 112
Query: 604 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT 663
++++ G+A +LH I+HRDLK SN+LL+ KI DFG+AR + G L+ T
Sbjct: 113 LQLLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT 164
Query: 664 NRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
++V T Y +PE L +S D++S G + E+L+ K
Sbjct: 165 -QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 68/203 (33%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRL-----SKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+G FG VY ++ G+E+A K++ S ++ + + L+ E L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 564 LGCCLDQDEKIL--IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
GC D+ EK L EY+P S+ L +A L TR K I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHSN- 125
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR-IVGTYGYMSPEYALE 680
I+HRD+K +NIL D+ K+ DFG ++ + R + GT +MSPE
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 681 GLFSIKSDVFSFGVLLLEILSGK 703
+ K+DV+S G ++E+L+ K
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 69/213 (32%), Positives = 115/213 (53%), Gaps = 18/213 (8%)
Query: 499 ASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRL---SKKSGQGLEELKNETMLIAK 554
S F N++GEG +G VY+ + +G+ VA+K++ +++ G + L+ E L+
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLN 62
Query: 555 LQHRNLVRLLGCCLDQ--DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIA 611
L+H N+V L + + D L+ EY + L S L + + E++VK ++ +
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTP---FSESQVKCLMLQLL 118
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+GL YLH+ IIHRDLK SN+LL KI+DFG+AR + G + T ++V T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLW 173
Query: 672 YMSPEYALEGLFSIKS-DVFSFGVLLLEILSGK 703
Y +PE L + D+++ G +L E+L+ K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 509 KLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
+LG+G FG VYK + G A K + KS + LE+ E ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 568 LDQDEKILIYEYLPNKSLDSFLF--DRAKKRLLYWETRVKII-EGIAQGLLYLHQYSRLR 624
+ ++ E+ P ++D+ + DR E ++++I + + L YLH ++
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLT-----EPQIQVICRQMLEALQYLHS---MK 130
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL----- 679
IIHRDLKA N+LL D K++DFG++ LQ + +GT +M+PE +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQ-RRDSFIGTPYWMAPEVVMCETMK 188
Query: 680 EGLFSIKSDVFSFGVLLLEI 699
+ + K+D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 9e-19
Identities = 91/293 (31%), Positives = 130/293 (44%), Gaps = 50/293 (17%)
Query: 510 LGEGGFGPVYKGELLNGQE--------VAVKRLSKK-SGQGLEELKNETMLIAKL--QHR 558
LGEG FG V + E + VAVK L + + L +L +E M + KL +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE-MELMKLIGKHK 78
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFL-----------FD--RAKKRLLYWETRVK 605
N++ LLG C + +I EY +L FL FD + + L ++ V
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665
+A+G+ YL SR R IHRDL A N+L+ D KI+DFG+AR + T+
Sbjct: 139 CAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEI--LSGKKNTGFYHTGSLNLL--GHAW 721
+M+PE + +++ +SDV+SFG+L+ EI L G G LL GH
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR- 254
Query: 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
MD ML R C H T RPT ++V L
Sbjct: 255 -----------MDKPSNCTHELYMLMRE------CWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 66/227 (29%), Positives = 115/227 (50%), Gaps = 27/227 (11%)
Query: 498 SASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRL---SKKSGQGLEELKNETMLIA 553
+ ++ KLGEG FG VYK ++ G+ VA+K++ ++K G + L+ E ++
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62
Query: 554 KLQHRNLVRLLGCCLDQDEKIL-----IYEYLPNKSLD-SFLFDRAKKRLLYWETRVK-I 606
KL+H N+V L+ +++ +K +Y P D S L + +L E+++K
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT--ESQIKCY 120
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF---------GGD 657
+ + +G+ YLH+ I+HRD+KA+NIL+D KI+DFG+AR + GG
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 658 ELQANTNRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
+V T Y PE L E ++ D++ G + E+ + +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 67/274 (24%), Positives = 126/274 (45%), Gaps = 37/274 (13%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG-LEELKNETMLIAKLQH---RNLVRLL 564
+G G +G VY+G + G+ VA+K ++ + + +++ E L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
G L +I EY S+ + + +A + + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM--KAGP--IAEKYISVIIREVLVALKYIHKVG--- 121
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-LF 683
+IHRD+KA+NIL+ K+ DFG+A + + + +T VGT +M+PE EG +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYY 179
Query: 684 SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH----AWDLWKDNRALDLMDPILEN 739
K+D++S G+ + E+ TG+ A L ++ P LE+
Sbjct: 180 DTKADIWSLGITIYEMA----------TGNPPYSDVDAFRAMMLIPKSKP-----PRLED 224
Query: 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773
+L +V C+ E +R + E++
Sbjct: 225 NGYSKLLREFV---AACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 508 NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
K+GEG G V + G++VAVK++ + Q E L NE +++ QH N+V +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
L DE ++ E+L +L D + E + + + L +LH +I
Sbjct: 85 YLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIK 686
HRD+K+ +ILL +D + K+SDFG + + + +VGT +M+PE + +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYGTE 195
Query: 687 SDVFSFGVLLLEILSGK 703
D++S G++++E++ G+
Sbjct: 196 VDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETM----LIAKLQ 556
N + +GEG +G V K G+ VA+K+ K + E++K + ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
H N+V L + L++EY+ L+ L + + L R I + Q + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVR-SYIWQLLQAIAY 115
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR----IVGTYGY 672
H IIHRD+K NIL+ K+ DFG AR L+A V T Y
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWY 167
Query: 673 MSPEYALEGLFSIKS-DVFSFGVLLLEILSG 702
+PE + K DV++ G ++ E+L G
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 74/290 (25%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 503 NFSAENKLGEGGFGPVYK-------GELLNGQEVAVKRLS-----KKSGQGLEELKNETM 550
++ LG G FG VYK LL +E+ V + ++ + + ++ +E
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 551 LIAK-LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIE 608
+I + L+H N+VR L+ D ++ + + L +K+ + E R+ I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG 668
+ L YLH+ R I+HRDL +NI+L D K I+DFG+A+ + +VG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVG 175
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728
T Y PE + K+DV++FG +L ++ + FY T L+L
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNMLSL------------ 221
Query: 729 ALDLMDPILE--NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
A +++ + E E Y V + C+ +A RP + +V +M+++
Sbjct: 222 ATKIVEAVYEPLPEGMYSEDVTDVITS--CLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 63/203 (31%), Positives = 113/203 (55%), Gaps = 19/203 (9%)
Query: 508 NKLGEGGFGPVYKG-ELLNGQEVAVKRLS---KKSGQGLEELKNETML--IAKLQHRNLV 561
++GEG +G VYK +L G+ VA+K++ + G L L+ +L + +H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 562 RLLGCCL--DQDEKI---LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
RLL C D ++ L++E++ ++ L ++L + K L ET ++ + +G+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
LH + RI+HRDLK NIL+ +D + KI+DFG+AR++ + +V T Y +PE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPE 176
Query: 677 YALEGLFSIKSDVFSFGVLLLEI 699
L+ ++ D++S G + E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 29/218 (13%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRL---SKKSGQGLEELKNETMLIAKLQHRN 559
F ++GEG +G VYK + G+ VA+K++ ++K G + ++ E ++ +L HRN
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 560 LVRLLGCCLDQDEKI----------LIYEYLPNK---SLDSFLFDRAKKRLLYWETRVKI 606
+V L D+ + + L++EY+ + L+S L ++ +
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KSF 121
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI 666
++ + +GL Y H+ + L HRD+K SNILL+ + K++DFG+AR++ +E + TN++
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 667 VGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
+ T Y PE L E + DV+S G +L E+ + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 76/271 (28%), Positives = 131/271 (48%), Gaps = 28/271 (10%)
Query: 504 FSAENKLGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQG-LEELKNETMLIAKLQHRNLV 561
F+ K+G+G FG V+KG Q+V A+K + + + +E+++ E ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLLYLHQY 620
+ G L + +I EYL S L ET++ I+ I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-----ETQIATILREILKGLDYLHSE 120
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
+ IHRD+KA+N+LL + K++DFG+A + Q N VGT +M+PE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 681 GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740
+ K+D++S G+ +E+ G+ H + L + K+N P LE
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----IPKNN------PPTLEGN 224
Query: 741 ASYPMLARYVNVALLCVHENATDRPTMSEVV 771
S P L +V C+++ + RPT E++
Sbjct: 225 YSKP-LKEFVEA---CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 67/206 (32%), Positives = 108/206 (52%), Gaps = 20/206 (9%)
Query: 509 KLGEGGFGPVYKG--ELLNGQE-VAVKRLSKKSGQGL--EELKNETMLIAKLQHRNLVRL 563
+LG G FG V KG ++ ++ VAVK L + +EL E ++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
+G C + + +L+ E L+ FL K + + + +++ ++ G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL- 682
+HRDL A N+LL T KISDFG+++ G DE N + + YA E +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMN 171
Query: 683 ---FSIKSDVFSFGVLLLEILS-GKK 704
FS KSDV+SFGVL+ E S G+K
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLL 564
LG+G FG V EL E+ AVK L K +E E ++A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 565 GCCLDQDEKILIYEYLPNKSL-----DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
C +D + EY+ L S FD + R E I GL +LH+
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--------IVLGLQFLHE 114
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEY 677
II+RDLK N+LLD++ KI+DFGM + + GG T+ GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEI 167
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
+ D ++ GVLL E+L+G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 19/206 (9%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQ-GLE-ELKNETMLIAKLQ---HRNLVR 562
++G G +G VYK + +G VA+K + ++ + GL E L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 563 LLGCC----LDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL 617
L+ C D++ K+ L++E++ ++ L ++L D+ L ET ++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H I+HRDLK NIL+ + + K++DFG+AR++ Q +V T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
L+ ++ D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 509 KLGEGGFGPVYKG--ELLNGQ-EVAVKRLSKKSGQGL-EELKNETMLIAKLQHRNLVRLL 564
+LG G FG V KG ++ Q +VA+K L ++ + + +E+ E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
G C + + +L+ E L+ FL KK + V+++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY--GYMSPEYALEGL 682
+HRDL A N+LL KISDFG+++ G D+ R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174
Query: 683 FSIKSDVFSFGVLLLEILS-GKK 704
FS +SDV+S+G+ + E S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQE-VAVKRLSKKSGQGLEE---LKNETMLIAKLQH 557
+F ++G+GG+G V+ + + E VA+KR+ K L E + E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL 617
LV+LL D + L EY+P + L L R + E + L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDAL 117
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H L IHRDLK N L+D K++DFG+++ + N +VG+ YM+PE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEV 169
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSG 702
+ D +S G +L E L G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 20/202 (9%)
Query: 510 LGEGGFGPVYKGELLNGQE-----VAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRL 563
LG G FG VYKG + E VA+K L + S + +E+ +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLF---DRAKKR-LLYWETRVKIIEGIAQGLLYLHQ 619
LG CL + L+ + +P L ++ DR + LL W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+R++HRDL A N+L+ + KI+DFG+AR+ DE + + + +M+ E L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 680 EGLFSIKSDVFSFGVLLLEILS 701
F+ +SDV+S+GV + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCL 568
+G G +G VYKG + ++A ++ +G EE+K E ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 569 DQ------DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
+ D+ L+ E+ S+ L K L E I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL--- 679
++IHRD+K N+LL + + K+ DFG++ D N +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 680 --EGLFSIKSDVFSFGVLLLEILSG 702
+ + KSD++S G+ +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRL-----SKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG G FG VY + G+E+AVK++ S+++ + + L+ E L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 564 LGCCLDQDEKIL--IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
GC D +EK L EY+P S+ L +A L TR + I QG+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTR-RYTRQILQGVSYLHSN- 125
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN-TNRIVGTYGYMSPEYALE 680
I+HRD+K +NIL D+ K+ DFG ++ + + GT +MSPE
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 681 GLFSIKSDVFSFGVLLLEILSGK 703
+ K+DV+S ++E+L+ K
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRL-----SKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+G FG VY + G+E+AVK++ S ++ + + L+ E L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 564 LGCCLDQDEKIL--IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
GC D E+ L E++P S+ L ++ L TR K I +G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGVSYLHSN- 125
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN-TNRIVGTYGYMSPEYALE 680
I+HRD+K +NIL D+ K+ DFG ++ L + GT +MSPE
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 681 GLFSIKSDVFSFGVLLLEILSGK 703
+ K+D++S G ++E+L+ K
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 510 LGEGGFGPVYKGELLNGQE--------VAVKRL-SKKSGQGLEELKNETMLIAKL-QHRN 559
LGEG FG V E + + VAVK L S + + L +L +E ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKK---------------RLLYWETRV 604
++ LLG C +I EY +L +L RA++ L ++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN 664
+A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR + T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 665 RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE + +++ +SDV+SFGVLL EI +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 509 KLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLE-ELKNETMLIAKLQHRNLVRLLGC 566
++G G FG V+ G L + VAVK + L+ + E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
C + ++ E + +FL R + L + ++++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT-YGYMSPEYALEGLFSI 685
HRDL A N L+ KISDFGM+R D + A+T + + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 686 KSDVFSFGVLLLEILS 701
+SDV+SFG+LL E S
Sbjct: 176 ESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 509 KLGEGGFGPV-YKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
K+GEG G V E G++VAVK++ + Q E L NE +++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627
L DE ++ E+L +L D + E + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 628 RDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKS 687
RD+K+ +ILL +D + K+SDFG + + + +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEV 199
Query: 688 DVFSFGVLLLEILSGK 703
D++S G++++E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 509 KLGEGGFGPVYKG--ELLNGQE--VAVKRLSKKSGQGLEEL-KNETMLIAKLQHRNLVRL 563
+GEG FG VY+G ++ VAVK + + E E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
+G + I + E P L S+L + K L + + ++ L YL
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL-QANTNRIVGTYGYMSPEYALEGL 682
R +HRD+ A N+L+ + K+ DFG++R + +A+ ++ +M+PE
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184
Query: 683 FSIKSDVFSFGVLLLEILS-GKK 704
F+ SDV+ FGV + EIL G K
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-17
Identities = 38/87 (43%), Positives = 55/87 (63%), Gaps = 4/87 (4%)
Query: 323 TALQCGDNSADREDRFLRMHNVKLPSPDKVLKLPGIEECKSACLNNCACTAYAY-NSSGV 381
T L CG + + D FL++ +VKLP + +EEC+ ACL+NC+CTAYAY N SG
Sbjct: 1 TPLNCGGDGST--DGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGG 58
Query: 382 CSSWDGKLYDLEQLSKNEGENIFIKLA 408
C W+G L +L LS + G ++++LA
Sbjct: 59 CLLWNGLLNNLRSLS-SGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 510 LGEGGFGPVYKGEL-LNGQEVAVKRLSK---KSGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG+GGFG V ++ G+ A K+L+K K +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQGLLYLHQYSRLR 624
+ + L+ + L +++ ++ + E R I GL +LHQ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
II+RDLK N+LLD D +ISD G+A + Q+ T GT G+M+PE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 685 IKSDVFSFGVLLLEILSGK 703
D F+ GV L E+++ +
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 35/285 (12%)
Query: 509 KLGEGGFGPVYKG---ELLNGQ---EVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLV 561
+LG+G FG VY+G +++ G+ VAVK +++ S + E NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLF-------DRAKKRLLYWETRVKIIEGIAQGL 614
RLLG +++ E + + L S+L + + + +++ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
YL+ + +HRDL A N ++ D KI DFGM R + + + +M+
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEI--LSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732
PE +G+F+ SD++SFGV+L EI L+ + G + L + D LD
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-------MDGGYLDQ 242
Query: 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777
D E R ++ +C N RPT E+V++L ++
Sbjct: 243 PDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 510 LGEGGFGPVYKGELL--------NGQEVAVKRLSKKSGQ-GLEELKNETMLIAKL-QHRN 559
LGEG FG V E L VAVK L + + L +L +E ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFL-----------FD--RAKKRLLYWETRVKI 606
++ LLG C +I EY +L +L +D R + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI 666
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 667 VGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 510 LGEGGFGPVYKGELLNGQE--------VAVKRLSKK-SGQGLEELKNETMLIAKL-QHRN 559
LGEG FG V E + + VAVK L + + L +L +E ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFL-----------FDRAK--KRLLYWETRVKI 606
++ LLG C ++ EY +L +L FD K + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTNR 665
+A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR + D + TN
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+ +M+PE + +++ +SDV+SFGVLL EI +
Sbjct: 197 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 58/206 (28%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLV 561
F+ ++G+G FG V+KG + Q VA+K + + + +E+++ E ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFL----FDRAKKRLLYWETRVKIIEGIAQGLLYL 617
+ G L + +I EYL S L FD + +++ I +GL YL
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI--------ATMLKEILKGLDYL 117
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H + IHRD+KA+N+LL K++DFG+A +++ NT VGT +M+PE
Sbjct: 118 HSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEV 172
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
+ + K+D++S G+ +E+ G+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 67/212 (31%), Positives = 112/212 (52%), Gaps = 26/212 (12%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS-KKSGQGLEELK-NETMLIAKLQHRNL 560
+ K+GEG +G VYK + + + +A+K++ ++ +G+ E L+ ++QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 561 VRLLGCCLDQDEKILIYEYLP---NKSLDS---FLFD-RAKKRLLYWETRVKIIEGIAQG 613
VRL + L++EYL K +DS F + R K LY +I+ GIA
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY-----QILRGIA-- 116
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKP-KISDFGMARMFGGDELQANTNRIVGTYGY 672
Y H + R++HRDLK N+L+D K++DFG+AR F G ++ T+ +V T Y
Sbjct: 117 --YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWY 169
Query: 673 MSPEYALEGL-FSIKSDVFSFGVLLLEILSGK 703
+PE L +S D++S G + E+++ K
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 503 NFSAENKLGEGGFGPVY--KGELLNGQEVAVK-RLSKKSGQGLEELKNETMLIAKLQHRN 559
+ K+GEG FG +Y K + + V + L+K + E K E +L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSL-------DSFLFDRAKKRLLYWETRVKIIEGIAQ 612
+V + ++ EY L LF ++ ++L W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARMFGGDELQANTNRIVGTYG 671
GL ++H +I+HRD+K+ NI L + M K+ DFG+AR A T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
Y+SPE ++ K+D++S G +L E+ + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 27/204 (13%)
Query: 509 KLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
+LG+G FG VYK + G A K + KS + LE+ E ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII-EGIAQGLLYLHQYSRLRII 626
++ ++ E+ ++D+ + + + E +++++ + + L YLH+ +II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI------VGTYGYMSPEYAL- 679
HRDLKA NIL D K++DFG++ NT I +GT +M+PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 680 ----EGLFSIKSDVFSFGVLLLEI 699
+ + K+DV+S G+ L+E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 510 LGEGGFGPVYKGELLN----GQEVAVKRLSKKSGQGLEEL--KNETMLIAKLQHRNLVRL 563
LG+G FG V+ + GQ A+K L K + + + + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYSR 622
+ + LI ++L L F R K +++ E VK + +A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
L II+RDLK NILLD + K++DFG+++ E +A + GT YM+PE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRG 174
Query: 683 FSIKSDVFSFGVLLLEILSG 702
+ +D +SFGVL+ E+L+G
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 508 NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN--ETMLIAKLQ-HRNLVRL 563
K+GEG F V K G+ A+K + KK + LE++ N E + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 564 LGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYW-ETRVK-IIEGIAQGLLYLHQ 619
+ D+ L++E + D L++ K R E RVK + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
R I HRD+K NIL+ D+ K++DFG R G T I T Y +PE L
Sbjct: 118 --RNGIFHRDIKPENILIKDDIL-KLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLL 171
Query: 680 -EGLFSIKSDVFSFGVLLLEILS 701
+G + K D+++ G + EILS
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNG---QEVAVKRLSKKSGQG-LEELKNETMLIAKL-Q 556
N+ ++ +GEG FG V K + + A+KR+ + + + + E ++ KL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG------- 609
H N++ LLG C + L EY P+ +L FL K R+L + I
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSS 123
Query: 610 ---------IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660
+A+G+ YL Q + IHRDL A NIL+ + KI+DFG++R G E+
Sbjct: 124 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY 177
Query: 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+ E +++ SDV+S+GVLL EI+S
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 507 ENKLGEGGFGPVYKGELL---NGQEVAVKRLSK-KSGQGLEELKNETMLIAKL-QHRNLV 561
E+ +GEG FG V + + A+K L + S + E ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY----- 616
LLG C ++ + EY P +L FL K R+L + G A L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 617 --------LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG 668
+ S + IHRDL A N+L+ ++ KI+DFG++R G+E+
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+ E +++ KSDV+SFGVLL EI+S
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 509 KLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
K+GEG G V + +G+ VAVK++ + Q E L NE +++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627
L DE ++ E+L +L D + E + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 628 RDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKS 687
RD+K+ +ILL D + K+SDFG E+ + +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKS-LVGTPYWMAPELISRLPYGPEV 197
Query: 688 DVFSFGVLLLEILSGK 703
D++S G++++E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 509 KLGEGGFGPVY----KGELLNGQE--VAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLV 561
+LG+G FG VY KG + + E VA+K +++ S + E NE ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLF----DRAKKRLLYWETRVKIIE---GIAQGL 614
RLLG ++I E + L S+L + + + K+I+ IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
YL+ + +HRDL A N ++ D KI DFGM R + + + +MS
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEI 699
PE +G+F+ SDV+SFGV+L EI
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 39/195 (20%)
Query: 508 NKLGEGGFGPVYKG-ELLNGQEVAVKRL---SKKSGQGLEELKNETMLIAKLQHRNLVRL 563
K+G+G FG V+K Q VA+K++ ++K G + L+ E ++ L+H N+V L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76
Query: 564 LGCCLDQDEK--------ILIYEY--------LPNKSLDSFLFDRAKKRLLYWETRVKII 607
+ C + L++E+ L NK++ F ++ + K++
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK--------KVM 125
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG---GDELQANTN 664
+ + GL Y+H R +I+HRD+KA+NIL+ D K++DFG+AR F + TN
Sbjct: 126 KMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 665 RIVGTYGYMSPEYAL 679
R+V T Y PE L
Sbjct: 183 RVV-TLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 72/208 (34%), Positives = 98/208 (47%), Gaps = 31/208 (14%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEELKNETMLIAK------LQHRNLVR 562
LG+G FG V EL E A+K L K LE+ E ++ + +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 563 LLGCCLDQDEKILIY--EYLPNKSL-----DSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
L C Q ++ L + EYL L S FD A+ R E I GL
Sbjct: 61 LF--CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICGLQ 110
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
+LH+ II+RDLK N+LLD D KI+DFGM + E +A+T GT Y++P
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAP 165
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGK 703
E ++ D +SFGVLL E+L G+
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 62/218 (28%), Positives = 111/218 (50%), Gaps = 28/218 (12%)
Query: 504 FSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQH 557
F+ LG+G FG V + +L + Q+VAVK L S +EE E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 558 RNLVRLLGCCLDQDEK------ILIYEYLPNKSLDSFLFDRAKKRL------LYWETRVK 605
N+++L+G L K ++I ++ + L +FL R+ L +T V+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---MSRIGEEPFTLPLQTLVR 117
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDEL-QANT 663
+ IA G+ YL S IHRDL A N +L+ +M ++DFG+++ ++ GD Q
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 664 NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+++ +++ E + +++ SDV++FGV + EI++
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-15
Identities = 27/64 (42%), Positives = 38/64 (59%), Gaps = 5/64 (7%)
Query: 334 REDRFLRMHNVKLP--SPDKVLKLPGIEECKSACLNNCACTAYAYN---SSGVCSSWDGK 388
D FLR+ N+KLP + V + G++EC+ CL+NC+CTAYAY C W G+
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTGE 62
Query: 389 LYDL 392
L D+
Sbjct: 63 LVDM 66
|
Length = 66 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 68/225 (30%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 494 FASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK------SGQGLEELK 546
F +V TN + +G G FG V + L GQ VA+K++ K + + ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 547 NETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRV 604
L+ L+H N++ L + E I L L L R K+ + Y+ +
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ- 116
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-----MFGGDEL 659
I +GL Y+H ++HRDLK SNIL++ + KI DFG+AR M G
Sbjct: 117 -----ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG---- 164
Query: 660 QANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGK 703
V T Y +PE L + ++ D++S G + E+L GK
Sbjct: 165 ------YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 29/205 (14%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLG 565
+G G FG V+ + ++ A+K ++ + + + NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
DQ ++ EY+P L S+L R R E I L YLH I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASE-IVCALEYLHS---KEI 122
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
++RDLK NILLD + K++DFG A+ +L+ T + GT Y++PE I
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE-------VI 170
Query: 686 KS-------DVFSFGVLLLEILSGK 703
+S D ++ G+L+ E+L G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 45/229 (19%)
Query: 508 NKLGEGGFGPVYKGE-LLNGQEVAVKRL--------SKKSGQ----------GLEELKNE 548
LGEG +G V K L G+ VA+K++ K Q L ELK
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-- 72
Query: 549 TMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-II 607
++ +++H N++ L+ ++ D L+ + + S L +++ E++VK I+
Sbjct: 73 --IMNEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCIL 125
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI- 666
I GL LH++ +HRDL +NI +++ KI+DFG+AR +G ++
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 667 -----------VGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
V T Y +PE + + D++S G + E+L+GK
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 510 LGEGGFGPVYKGELLNG---QEVAVKRLSKKSGQG-LEELKNETMLIAKL-QHRNLVRLL 564
+GEG FG V K + + A+KR+ + + + + E ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFL-----------FDRAKKRLLYWETR--VKIIEGIA 611
G C + L EY P+ +L FL F A ++ + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R G E+
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+ E +++ SDV+S+GVLL EI+S
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 510 LGEGGFGPV------YKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+GGFG V G++ +++ KR+ K+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRA-----KKRLLYWETRVKIIEGIAQGLLYLH 618
+D L+ + L ++ + R +++ I GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE------ICCGLEDLH 119
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
Q RI++RDLK NILLD +ISD G+A E Q R VGT GYM+PE
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQTIKGR-VGTVGYMAPEVV 173
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK 703
++ D ++ G LL E+++G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 71/208 (34%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKL-----QHRNLVRL 563
LG+G FG V+ EL Q A+K L KK +++ TM+ ++ +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 564 LGCCLDQDEKIL-IYEYLPNKSLDSFL-----FDRAKKRLLYWETRVKIIEGIAQGLLYL 617
C E + + EYL L + FD + E I GL +L
Sbjct: 62 Y-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGLQFL 112
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSP 675
H I++RDLK NILLDTD KI+DFGM + M G A T GT Y++P
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAP 165
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGK 703
E L ++ D +SFGVLL E+L G+
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 503 NFSAENKLGEGGFGPVYKGELLNGQE----VAVKRLSK----KSGQGLEELKNETMLIAK 554
NF LG G +G V+ + G + A+K L K + + E + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 555 LQHRNLVRLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQG 613
++ + L D K+ LI +Y+ L + L+ R + E+ V++ IA+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESEVRVY--IAEI 114
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
+L L +L II+RD+K NILLD++ ++DFG+++ F +E + GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 674 SPEYAL--EGLFSIKSDVFSFGVLLLEILSG 702
+PE G D +S GVL E+L+G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 510 LGEGGFGPV------YKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+GGFG V G++ + + KR+ K+ G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRA-----KKRLLYWETRVKIIEGIAQGLLYLH 618
+D L+ + L +++ ++R L++ I GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVGTYGYMSPEY 677
+ + ++RDLK NILLD +ISD G+A ++ G+ ++ VGT GYM+PE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEV 172
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
+++ D + G L+ E++ G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 510 LGEGGFGPV------YKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+GGFG V G++ +++ KRL KKSG+ + L+ E ++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKK-----RLLYWETRVKIIEGIAQGLLYLH 618
+ L+ + L +++ ++ R++++ + I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVGTYGYMSPEY 677
+ I++RD+K N+LLD ++SD G+A + G + T R GT GYM+PE
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AGTNGYMAPEI 165
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
E +S D F+ G + E+++G+
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIV 667
IA GL +LH II+RDLK N++LD + KI+DFGM + +FGG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
GT Y++PE + D ++FGVLL E+L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLE-ELKNETMLIAKLQHRNLVRLLGCC 567
LG G G VYK LL + +AVK + L+ ++ +E ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIA----QGLLYLHQYSRL 623
++ + E++ SLD +Y + ++ IA +GL YL L
Sbjct: 69 FVENRISICTEFMDGGSLD-----------VYRKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
+I+HRD+K SN+L++T + K+ DFG++ + + VGT YM+PE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQY 170
Query: 684 SIKSDVFSFGVLLLEILSGK-------KNTGF 708
I SDV+S G+ +E+ G+ KN G
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 38/100 (38%), Positives = 65/100 (65%), Gaps = 8/100 (8%)
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN 664
KI + +GL YL + + +I+HRD+K SNIL+++ + K+ DFG++ G + + N
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMAN 156
Query: 665 RIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGK 703
VGT YMSPE L+G ++++SD++S G+ L+E+ G+
Sbjct: 157 SFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 510 LGEGGFGPVYKGELLN-GQEVAVKRLSKK---SGQGLEELKNET---MLIAKLQHRNLVR 562
LG G FG V E G+ A+K L K + +E L E +H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 563 LLGCCLDQDEKILIYEYLPNKSL------DSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
L C +D + EY L D F RA ++ V + GL Y
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV----FYAACVVL------GLQY 116
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMS 674
LH+ +I++RDLK N+LLDT+ KI+DFG+ + M GD T+ GT +++
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPEFLA 169
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSG 702
PE E ++ D + GVL+ E+L G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 509 KLGEGGFGPVYKGELL----NGQEVAVKRL--SKKSGQGLEELKNETMLIAKLQHRNLVR 562
K+GEG FG K L+ +G++ +K + SK S + EE + E +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
+ ++ +Y L + A++ +L+ E +I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL--YKKINAQRGVLFPED--QILDWFVQICLALKHVHD 119
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
+I+HRD+K+ NI L D K+ DFG+AR+ A T +GT Y+SPE
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRP 177
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
++ KSD+++ G +L E+ + K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKS---GQGLEELKNETMLIA-KLQHRNLVRLL 564
LG+G FG V EL EV A+K L K ++ E ++A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRL 623
C +D + EY+ L F R++K + E R + + L++LH++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL-MFQIQRSRK---FDEPRSRFYAAEVTLALMFLHRHG-- 116
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEYALEG 681
+I+RDLK NILLD + K++DFGM + + G T GT Y++PE E
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPDYIAPEILQEL 171
Query: 682 LFSIKSDVFSFGVLLLEILSGK 703
+ D ++ GVL+ E+++G+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 507 ENKLGEGGFGPVYKG--ELLNGQE--VAVK--RLSKKSGQGLEELKNETMLIAKLQHRNL 560
E LG G FG + +G +L + +E VA+ R Q L E + + + H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNI 68
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
VRL G + +++ EY+ N +LDSFL R + L + ++ G+A G+ YL
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA--NTNRIVGTYGYMSPEYA 678
S + +H+ L A +L+++D+ KIS F + D+ +A T + +PE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 679 LEGLFSIKSDVFSFGVLLLEILS 701
FS SDV+SFG+++ E++S
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 503 NFSAENKLGEGGFGPVYKGELLNGQEV----AVKRLSK----KSGQGLEELKNETMLIAK 554
NF LG G +G V+ ++G + A+K L K + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 555 LQHRNLVRLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQ 612
++ + L D K+ LI +Y+ L F +R + E V+I G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVL 116
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
L +LH +L II+RD+K NILLD++ ++DFG+++ F DE++ GT Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172
Query: 673 MSPEYAL--EGLFSIKSDVFSFGVLLLEILSG 702
M+P+ +G D +S GVL+ E+L+G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 84/284 (29%), Positives = 116/284 (40%), Gaps = 47/284 (16%)
Query: 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNET-MLIAKLQHRNLVRLL 564
LG+G FG V L +G+ AVK L K +E E +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 565 GCCLDQDEKILIYEYLPNKSL-----DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
C D + E++ L S FD A+ R E I L++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLHD 114
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEY 677
II+RDLK N+LLD + K++DFGM + +F G T+ GT Y++PE
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEI 167
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737
E L+ D ++ GVLL E+L GHA ++ DL + IL
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLC----------------GHA--PFEAENEDDLFEAIL 209
Query: 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781
+E YP V +L T PTM L E +L
Sbjct: 210 NDEVVYPTWLSQDAVDIL--KAFMTKNPTMRLGSLTLGGEEAIL 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCL 568
+G G +G VYKG + ++A ++ + EE+K E ++ K HRN+ G +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 569 DQ------DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
+ D+ L+ E+ S+ L K L + I I +GL +LH +
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHAH-- 140
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL--- 679
++IHRD+K N+LL + + K+ DFG++ D N +GT +M+PE
Sbjct: 141 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 680 --EGLFSIKSDVFSFGVLLLEILSG 702
+ + +SD++S G+ +E+ G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 509 KLGEGGFGPVYKGELLNGQE-VAVKRLS-KKSGQGLEELK-NETMLIAKLQHRNLVRLLG 565
K+GEG +G V+K + E VA+KR+ +G+ E L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 566 CCLDQDEKILIYEYLPN---KSLDSF--LFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
+ L++EY K DS D + ++ + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
++HRDLK N+L++ + + K++DFG+AR F G ++ + +V T Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 173
Query: 681 G-LFSIKSDVFSFGVLLLEILSG 702
L+S D++S G + E+ +
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 508 NKLGEGGFGPVYKGEL-LNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRNLVRLL 564
+KLGEG + VYKG L VA+K RL + G ++ E L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYSRL 623
+ L++EYL +K L +L D ++ VK+ + + +GL Y H R
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCH---RR 123
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL- 682
+++HRDLK N+L++ + K++DFG+AR + +N +V T Y P+ L
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDILLGSTD 181
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
+S + D++ G + E+ +G+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 503 NFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+F ++G G +G VYK +N G+ A+K + + G+ ++ E +++ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLF---DRAKKRLLYWETRVKIIEGIAQGLLYLH 618
G L +D+ + E+ SL ++ ++ Y + QGL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY------VSRETLQGLYYLH 123
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+ +HRD+K +NILL + K++DFG++ A +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 679 L---EGLFSIKSDVFSFGVLLLEI 699
+G ++ D+++ G+ +E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-13
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 20/191 (10%)
Query: 526 GQEVAVKRLSKKSGQGLEE---LKNETMLIAKLQHRNLVRLL--GCCLDQDEKILIYEYL 580
G EVA+K L + + + + ET L A+L H N+V LL G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61
Query: 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-T 639
P ++L L A L +++ + L H I+HRDLK NI++ T
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 640 DMKP--KISDFGMARMFGG----DELQAN-TNRIVGTYGYMSPEYALEGLFSIKSDVFSF 692
++P K+ DFG+ + G D T ++GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 693 GVLLLEILSGK 703
G++ LE L+G+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 39/212 (18%)
Query: 510 LGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQHRNLVRLLG 565
+G G +G V G++VA+K+LS+ Q K E L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 566 CCLDQDEKILIYEYLPNKSLDSF--------LFDR-----AKKRLLYWETRVKIIEGIAQ 612
+ P SL+ F L K + L + ++ I +
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
GL Y+H IIHRDLK SNI ++ D + KI DFG+AR DE+ V T Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWY 181
Query: 673 MSPEYALEGLFSIKS-DVFSFGVLLLEILSGK 703
+PE L + ++ D++S G ++ E+L+GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 508 NKLGEGGFGPVYKGEL-LNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRNLVRLL 564
KLGEG + V+KG L VA+K RL + G ++ E L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYSRL 623
L++EYL +K L ++ D ++ VKI + I +GL Y H R
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCH---RR 123
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-EGL 682
+++HRDLK N+L++ + K++DFG+AR + +N +V T Y P+ L
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
+S + D++ G + E+ SG+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 510 LGEGGFGPV------YKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+GGFG V G++ +++ KR+ K+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRA-----KKRLLYWETRVKIIEGIAQGLLYLH 618
+D L+ + L +++ ++R +++ I GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE------ITCGLEDLH 119
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVGTYGYMSPEY 677
R RI++RDLK NILLD +ISD G+A + G+ ++ VGT GYM+PE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV 172
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
++ D + G L+ E++ GK
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 71/246 (28%), Positives = 108/246 (43%), Gaps = 66/246 (26%)
Query: 493 SFASVSASTNNFSAE---------NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGL 542
S +S SAS + SA N++G G G VYK G+ A+K + +
Sbjct: 56 SSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV 115
Query: 543 E-ELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDS-------FLFDRAK 594
++ E ++ + H N+V+ E ++ E++ SL+ FL D A+
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR 175
Query: 595 KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654
+ I+ GIA YLH R I+HRD+K SN+L+++ KI+DFG++R+
Sbjct: 176 Q----------ILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
Query: 655 GGDELQANT----NRIVGTYGYMSPE-------------YALEGLFSIKSDVFSFGVLLL 697
A T N VGT YMSPE YA D++S GV +L
Sbjct: 219 ------AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSIL 264
Query: 698 EILSGK 703
E G+
Sbjct: 265 EFYLGR 270
|
Length = 353 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRL---SKKSGQGLEELKNETMLIAKLQHRNLVRLL 564
K+GEG +G VYK + G+ VA+K+ + G L+ ++L + +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 565 GCCLDQDEKI------LIYEYLPNKSLDSFL--FDRAKKRLLYWETRVKIIEGIAQGLLY 616
+EK L++EYL + L F+ R R L +T + + +G+ +
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 617 LHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
H++ ++HRDLK N+L+D KI+D G+ R F +++ T+ IV T Y +P
Sbjct: 126 CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYRAP 180
Query: 676 EYALEGL-FSIKSDVFSFGVLLLEILSG 702
E L +S D++S G + E+
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETM--LIAKL 555
A N+ ++G G G VYK G +AVK++ + + EE K M +
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK 69
Query: 556 QHR--NLVRLLGCCL-DQDEKILIYEYLPNKSLDSFLFDRAKKRLL-YWETRV--KIIEG 609
H +V+ G + D D I + L S D+ KR+ + K+
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICM-------ELMSTCLDKLLKRIQGPIPEDILGKMTVA 122
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVG 668
I + L YL + + +IHRD+K SNILLD K+ DFG++ R+ + +A T R G
Sbjct: 123 IVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAG 176
Query: 669 TYGYMSPEY----ALEGLFSIKSDVFSFGVLLLEILSGK 703
YM+PE + I++DV+S G+ L+E+ +G+
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 4e-13
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 57/224 (25%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSK--------KSGQGLEELKNETMLIAKLQHRNL 560
+G G +G V G++VA+K++S K + L E+K L+ L+H N+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK--RILREIK----LLRHLRHENI 61
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSF--------LFDRAKKRLLYWETRVKIIEGIAQ 612
+ LL + L S + F L + +++ + + + Q
Sbjct: 62 IGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIK--SPQPLTDDHIQ 106
Query: 613 --------GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN-- 662
GL YLH +IHRDLK SNIL++++ KI DFG+AR DE +
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 663 TNRIVGTYGYMSPEYALEGL---FSIKSDVFSFGVLLLEILSGK 703
T +V T Y +PE L +I D++S G + E+L+ K
Sbjct: 164 TEYVV-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
+++ ++G G +G VYK L G+ AVK + + G ++ E ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLF---DRAKKRLLYWETRVKIIEGIAQGLLYL 617
V G L +++ + EY SL ++ ++ Y + QGL YL
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY------VCRETLQGLAYL 122
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H ++ HRD+K +NILL + K++DFG+A A +GT +M+PE
Sbjct: 123 HSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEV 177
Query: 678 AL---EGLFSIKSDVFSFGVLLLEI 699
A G ++ D+++ G+ +E+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 68/251 (27%), Positives = 120/251 (47%), Gaps = 32/251 (12%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLE-ELKNETMLIAKLQHRNLVRLLGCC 567
K+G G +G VYK + +G++ L + G G+ E L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 568 LDQ-DEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY-----LHQY 620
L D K+ L+++Y + F RA K + V++ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 621 SRLRIIHRDLKASNILLDTD----MKPKISDFGMARMFGGD-ELQANTNRIVGTYGYMSP 675
++HRDLK +NIL+ + + KI+D G AR+F + A+ + +V T+ Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 676 EYALEGLFSIKS-DVFSFGVLLLEILSGK----------KNTGFYHTGSL----NLLGHA 720
E L K+ D+++ G + E+L+ + K + YH L N++G
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 721 WDL-WKDNRAL 730
D W+D + +
Sbjct: 245 ADKDWEDIKKM 255
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 8/196 (4%)
Query: 510 LGEGGFG-PVYKGELLNGQEVAVKRLS-KKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
+GEG FG + + + Q+ A+K + KS +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627
++ EY L + + + +L +T ++ + G+ ++H+ R++H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLH 123
Query: 628 RDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKS 687
RD+K+ NI L + K K+ DFG AR+ A T VGT Y+ PE ++ KS
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKS 181
Query: 688 DVFSFGVLLLEILSGK 703
D++S G +L E+ + K
Sbjct: 182 DIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 45/144 (31%), Positives = 78/144 (54%), Gaps = 9/144 (6%)
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+V G E + E++ SLD L + + + E K+ + +GL YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+ +I+HRD+K SNIL+++ + K+ DFG++ G + + N VGT YMSPE
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 680 EGLFSIKSDVFSFGVLLLEILSGK 703
+S++SD++S G+ L+E+ G+
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 27/200 (13%)
Query: 513 GGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKN----ETMLIAKLQHRNLVRLLGCC 567
G FG VY + G A+K L K ++ N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLY----WETRVKIIEGIAQGLLYLHQYSRL 623
+D L+ EYL S + K L W + I + G+ LHQ
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAK--QYIAEVVLGVEDLHQRG-- 117
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
IIHRD+K N+L+D K++DFG++R G E + VGT Y++PE + G+
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGVG 169
Query: 684 SIK-SDVFSFGVLLLEILSG 702
K SD +S G ++ E L G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 509 KLGEGGFGPVYK-GELLNGQEVAVKR--------LSKKSGQGLEELKNETMLIAKLQHRN 559
K+GEG +G V+K GQ VA+K+ + KK L E++ ML +L+H N
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIR---ML-KQLKHPN 61
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
LV L+ + + L++EY + L+ ++ + + + KII Q + + H+
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHK 118
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
++ IHRD+K NIL+ + K+ DFG AR+ G + V T Y +PE L
Sbjct: 119 HN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPEL-L 172
Query: 680 EG--LFSIKSDVFSFGVLLLEILSG 702
G + DV++ G + E+L+G
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 35/286 (12%)
Query: 509 KLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKN----ETMLIAKLQHRNLVRL 563
+GEG +G V K + GQ VA+K+ + + +K E ++ +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
+ + L++E++ + LD ++ L R K + I +G+ + H ++
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVR-KYLFQILRGIEFCHSHN-- 120
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-EGL 682
IIHRD+K NIL+ K+ DFG AR + T+ V T Y +PE + +
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTK 177
Query: 683 FSIKSDVFSFGVLLLEILSGKKNTGF---------YHTGSL--NLLGHAWDLWKDNR--- 728
+ D+++ G L+ E+L+G F YH NL+ ++++ N
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG--EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 729 --ALDLMDPILENEASYPMLARYV-NVALLCVHENATDRPTMSEVV 771
L + I E +P L+ V ++A C+ + DRP+ S+++
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 42/218 (19%)
Query: 508 NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNET---------MLIAKL-Q 556
KLG+G +G V+K + + VA+K++ + +N T M + +L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 557 HRNLVRLLGCC-LDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGL 614
H N+V+LL + D+ I L++EY+ ++ L + +L + I+ + + L
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKAL 120
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI----VGTY 670
Y+H S +IHRDLK SNILL++D + K++DFG+AR E + N + V T
Sbjct: 121 KYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE-ENPENPVLTDYVATR 176
Query: 671 GYMSPEYALEGLFSIKS-----DVFSFGVLLLEILSGK 703
Y +PE L D++S G +L E+L GK
Sbjct: 177 WYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 43/225 (19%)
Query: 504 FSAEN-----KLGEGGFGPVYKGELLN---GQEVAVKRL-SKKSGQGLEELKNETMLIAK 554
F+AE+ ++G G FG V K +L+ G +AVKR+ S + + L + ++ +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR 58
Query: 555 LQH-RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI--- 610
+V+ G + + + E L + SLD F + +Y + I E I
Sbjct: 59 SSDCPYIVKFYGALFREGDCWICME-LMDISLDKFY------KYVYEVLKSVIPEEILGK 111
Query: 611 -----AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ---AN 662
+ L YL + L+IIHRD+K SNILLD + K+ DFG++ +L A
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAK 164
Query: 663 TNRIVGTYGYMSPE----YALEGLFSIKSDVFSFGVLLLEILSGK 703
T R G YM+PE A +G + ++SDV+S G+ L E+ +GK
Sbjct: 165 T-RDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 59/288 (20%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC- 567
LG G +G V K + G +AVKR+ ++ +E K M + ++ C
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDL------DISMRSVDCP 60
Query: 568 --------LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV--KIIEGIAQGLLYL 617
L ++ + I + + SLD F + + + L + KI I + L YL
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTSLDKF-YKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG---DELQANTNRIVGTYGYMS 674
H S+L +IHRD+K SN+L++ + + K+ DFG++ G D + A T G YM+
Sbjct: 120 H--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSV-AKTIDA-GCKPYMA 171
Query: 675 PEYALEGL----FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD---- 726
PE L + +KSDV+S G+ ++E+ +G+ +D WK
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGR---------------FPYDSWKTPFQQ 216
Query: 727 -NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773
+ ++ P L E P +VN C+ +N +RP E++
Sbjct: 217 LKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLE-ELKNETMLIAKLQHRNLVRLLGC 566
KLGEG + VYKG +NGQ VA+K +S K+ +G+ E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
++ ++EY+ + L ++ L + R+ + + + +GL Y+H I+
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGG-LHPYNVRLFMFQ-LLRGLAYIH---GQHIL 125
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL-FSI 685
HRDLK N+L+ + K++DFG+AR Q ++ +V T Y P+ L +S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATDYSS 183
Query: 686 KSDVFSFGVLLLEILSGK 703
D++ G + +E+L G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 49/226 (21%)
Query: 503 NFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQ-----GLEELKNETMLIAKLQ 556
+ + +GEG +G V G +VA+K++S Q L E+K ++ + +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSF--------LFDRAKKRLLYWETRV---- 604
H N+ I I + + S +SF L + +L+ T+
Sbjct: 62 HENI-------------IGILDIIRPPSFESFNDVYIVQELMETDLYKLIK--TQHLSND 106
Query: 605 ---KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661
+ I +GL Y+H + ++HRDLK SN+LL+T+ KI DFG+AR+ D
Sbjct: 107 HIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHD 161
Query: 662 NTNRI---VGTYGYMSPEYALEGLFSIKS-DVFSFGVLLLEILSGK 703
+T + V T Y +PE L K+ D++S G +L E+LS +
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 61/207 (29%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHR 558
+++ KLGEG + VYKG+ +NG+ VA+K RL ++ G ++ E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N+V L ++ L++EY+ + L ++ D+ L ++ + + + +GL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYIH 120
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT--NRIVGTYGYMSPE 676
Q I+HRDLK N+L+ + K++DFG+AR + ++T N +V T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVV-TLWYRPPD 173
Query: 677 YALEGL-FSIKSDVFSFGVLLLEILSG 702
L +S D++ G + +E++ G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 67/230 (29%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 491 LFSFASVSASTNNFSAENKLGEGGFGPVYK-GELLNGQEVAVKRLSKKSGQGLEELKNET 549
+ S+ T+ + +G+G +G VYK +G AVK L S EE++ E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 550 MLIAKL-QHRNLVRLLGCCLDQDEKI-----LIYEYLPNKSLDSFLFDRAKKRLLYWETR 603
++ L H N+V+ G D+ + L+ E S+ + K LL R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 604 VK------IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657
+ I+ G GL +LH RIIHRD+K +NILL T+ K+ DFG++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 658 ELQANTNRIVGTYGYMSPEY-----ALEGLFSIKSDVFSFGVLLLEILSG 702
L+ NT+ VGT +M+PE + + + DV+S G+ +E+ G
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN----ETMLIAKLQHRNLVRL 563
+G+GG G VY + + + VA+K++ ++ LK E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWE----TRVK----IIEGIAQGLL 615
C D D Y+ +L S L +K L E T V I I +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE-----LQANTN------ 664
Y+H S+ ++HRDLK NILL + I D+G A +E + +
Sbjct: 128 YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 665 -----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+IVGT YM+PE L S +D+++ GV+L ++L+
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 548 ETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII 607
E ML+ + H +++R+ + ++ LP+ S D + + + R L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR------MFGGDELQA 661
+ I +GL YLH RIIHRD+K NI ++ + I D G A+ F G
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG----- 215
Query: 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+ GT +PE ++ K+D++S G++L E+L+
Sbjct: 216 ----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 510 LGEGGFGPV------YKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563
LG+GGFG V G++ +++ KR+ K+ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRA-----KKRLLYWETRVKIIEGIAQGLLYLH 618
+D L+ + L +++ ++R +++ + GL L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE------LCCGLEDLQ 119
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVGTYGYMSPEY 677
R RI++RDLK NILLD +ISD G+A ++ G+ ++ VGT GYM+PE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEV 172
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
++ D + G L+ E++ G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 509 KLGEGGFGPVYKGEL---LNGQEVAVKRLSKKSGQGLEELK--NETMLIAKLQHRNLVRL 563
++G G FG V GE+ +V VK L + S E++K E LQH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV--KIIEGIAQGLLYLHQYS 621
LG C + +L+ E+ P L +L K L+ + ++ IA GLL+LH+ +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE- 680
IH DL N LL D+ KI D+G++ ++ +++ +++PE E
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 681 --GLF----SIKSDVFSFGVLLLEIL 700
L + +S+V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 503 NFSAENKLGEGGFGPVYKGELLNGQEV----AVKRLSK----KSGQGLEELKNETMLIAK 554
NF LG G +G V+ + G + A+K L K + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 555 LQHRNLVRLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQ 612
++ + L + K+ LI +Y+ + + L+ R + E V+ G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIIL 116
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
L +LH +L I++RD+K NILLD++ ++DFG+++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 673 MSPEYAL-EGLFSIKSDVFSFGVLLLEILSG 702
M+PE +G D +S G+L+ E+L+G
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 36/99 (36%), Positives = 62/99 (62%), Gaps = 6/99 (6%)
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN 664
K+ + +GL YL + + +I+HRD+K SNIL+++ + K+ DFG++ G + + N
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMAN 160
Query: 665 RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
VGT YMSPE +S++SD++S G+ L+E+ G+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 34/197 (17%)
Query: 522 ELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578
+ + GQ VA+K+LS+ Q + K E +L+ + H+N++ LL
Sbjct: 37 DTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------ 83
Query: 579 YLPNKSLDSF--------LFD----RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
+ P KSL+ F L D + + L E ++ + G+ +LH II
Sbjct: 84 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---II 140
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIK 686
HRDLK SNI++ +D KI DFG+AR G + T +V Y Y +PE L +
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKEN 197
Query: 687 SDVFSFGVLLLEILSGK 703
D++S G ++ E++ G
Sbjct: 198 VDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLG 565
LG+G FG V EL G+ AVK L K +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 566 CCLDQDEKIL-IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
C E + + E+L L + D K R + E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAE-IVCGLQFLHSKG--- 116
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEYALEGL 682
II+RDLK N++LD D KI+DFGM + +FG + +A+T GT Y++PE L+GL
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST--FCGTPDYIAPE-ILQGL 171
Query: 683 -FSIKSDVFSFGVLLLEILSGK 703
++ D +SFGVLL E+L G+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 508 NKLGEGGFGPVYKGEL-LNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRNLVRLL 564
+KLGEG + V+KG L VA+K RL + G ++ E L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
+ L++EYL + L +L D + ++ + + + +GL Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRK 123
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL-F 683
I+HRDLK N+L++ + K++DFG+AR + +N +V T Y P+ L +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 684 SIKSDVFSFGVLLLEILSGK 703
S D++ G +L E+ +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 48/292 (16%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLE-ELKNETMLIAKLQHRNLVRLLGCC 567
K+G G +G VYK + +G++ L + G G+ E L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 568 LDQ-DEKI-LIYEYLPNKSLDSFLFDRA----KKRLLYWETRVK-IIEGIAQGLLYLHQY 620
L D K+ L+++Y + F RA KK + + VK ++ I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 621 SRLRIIHRDLKASNILLDTD----MKPKISDFGMARMFGGD-ELQANTNRIVGTYGYMSP 675
++HRDLK +NIL+ + + KI+D G AR+F + A+ + +V T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 676 EYALEGLFSIKS-DVFSFGVLLLEILSGK----------KNTGFYHTGSLN----LLGHA 720
E L K+ D+++ G + E+L+ + K + +H L+ ++G
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 721 WDL-WKDNRALDLMDPILENEASYPMLAR------YVNVALLCVHENATDRP 765
D W+D R + YP L + Y N +L+ E +P
Sbjct: 245 ADKDWEDIRKM----------PEYPTLQKDFRRTTYANSSLIKYMEKHKVKP 286
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 71/282 (25%), Positives = 115/282 (40%), Gaps = 28/282 (9%)
Query: 508 NKLGEGGFGPVYKGELLNGQEVA---VKRLSKKSGQGLEELK--NETMLIAKLQHRNLVR 562
+++G G FG V GE G A VK L + S E+L E +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV--KIIEGIAQGLLYLHQY 620
LG C++ +L+ E+ P L ++L + V ++ +A GLL+LHQ
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
IH DL N L D+ KI D+G+A ++ + +++PE
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 681 GLFSI-------KSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
+ KS+++S GV + E L + + +L + + L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWE-LFTAADQPYPDLSDEQVLKQV----VREQDIKLP 231
Query: 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775
P L+ R+ V C + T RPT EV +LT
Sbjct: 232 KPQLD----LKYSDRWYEVMQFCWLDPET-RPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 498 SASTNNFSAENK-----------LGEGGFGPVYKGELLNGQ--EVAVKRLSKKS---GQG 541
S ST +NK LG G FG V N VA+KR K +
Sbjct: 15 SDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74
Query: 542 LEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWE 601
++ + +E ++ + H V L G D+ L+ E++ +FL R KR +
Sbjct: 75 VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKR---FP 129
Query: 602 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661
V AQ +L L I++RDLK N+LLD D K++DFG A++ +
Sbjct: 130 NDVGCFYA-AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDT 183
Query: 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
T + GT Y++PE L +D ++ G+ + EIL G
Sbjct: 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQE-VAVKRLSKKSGQGLEELKNETM----LIAKLQ 556
N F +GEG +G V K +E VA+K+ K + EE+K T+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
N+V L + + L++EY+ L+ L + + + R I + I
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKA---- 112
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
+H + I+HRD+K N+L+ + K+ DFG AR + AN V T Y SPE
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPE 171
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGK 703
L + D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 30/207 (14%)
Query: 510 LGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC-- 566
+G GGFG VY + G+ A+K L KK ++ + ET+ + + +LV C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 567 --CLD-----QDEKILIYEYLPNKSLDSFLFDR---AKKRLLYWETRVKIIEGIAQGLLY 616
C+ D+ I + + L L ++K + ++ T +II G+
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT--EIILGLE----- 111
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
H ++R +++RDLK +NILLD +ISD G+A F + A+ VGT+GYM+PE
Sbjct: 112 -HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 165
Query: 677 YALEGL-FSIKSDVFSFGVLLLEILSG 702
+G + +D FS G +L ++L G
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLL---- 564
LG G G V+ + + VAVK++ Q ++ E +I +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 565 --GCCLDQDEKILIY---EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
G L +D L Y+ + +++ L + ++ L E + + +GL Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 620 YSRLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGGD-ELQANTNRIVGTYGYMSPEY 677
+ ++HRDLK +N+ ++T D+ KI DFG+AR+ + + + T Y SP
Sbjct: 133 AN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL 189
Query: 678 ALEGLFSIKS-DVFSFGVLLLEILSGK 703
L K+ D+++ G + E+L+GK
Sbjct: 190 LLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 56/172 (32%), Positives = 82/172 (47%), Gaps = 26/172 (15%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIV 667
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR D ++ R+
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD---LW 724
+M+PE + +++ +SDV+SFGVLL EI S G+ G D
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LGASPYPGVQIDEEFCR 287
Query: 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ + P Y ++ L C H N DRPT SE+V +L +
Sbjct: 288 RLKEGTRMRAPEYATPEIYSIM-------LDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 37/211 (17%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSK--KSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G G +G V + G VAVK+LS+ +S + E L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 567 CLDQDEKILIYEYLPNKSLDSF-------------LFDRAKKRLLYWETRVKIIEGIAQG 613
+ P +SL+ F L + K + L + +I I +G
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
L Y+H IIHRDLK SN+ ++ D + KI DFG+AR DE+ V T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 184
Query: 674 SPEYALEGL-FSIKSDVFSFGVLLLEILSGK 703
+PE L + ++ D++S G ++ E+L+G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 54/168 (32%), Positives = 88/168 (52%), Gaps = 23/168 (13%)
Query: 544 ELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE---YLPNKSLD----SFLFDRA--- 593
+L+NE + + +L H N++++ E+IL E Y+ + D SF++D A
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 594 KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653
K R L +TR I++ + + Y+H ++IHRD+K NI L+ D K + DFG A
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
F E +A VGT SPE + +D++S G++LL++LS
Sbjct: 317 F-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 35/93 (37%), Positives = 54/93 (58%)
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
Q LL +H +IHRD+K++NILL ++ K+ DFG ++M+ GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKK 704
Y++PE +S K+D+FS GVLL E+L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 494 FASVSASTNNFSAENKLGEGGFGPVYK-GELLNGQEVAVKRLSKKSGQGLEELKNETMLI 552
F S ++ + +G+G +G V+K NG + AVK L EE++ E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 553 AKLQ-HRNLVRLLGCCLDQDEKI-----LIYEYLPNKSLDSFLFDRAKKRLLYWETRVK- 605
L H N+V+ G +D K L+ E S+ + K+ E +
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665
I+ GL +LH + IHRD+K +NILL T+ K+ DFG++ L+ NT+
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184
Query: 666 IVGTYGYMSPEY-----ALEGLFSIKSDVFSFGVLLLEILSG 702
VGT +M+PE L+ + + DV+S G+ +E+ G
Sbjct: 185 -VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
I +GL YLH I+HRD+K N+L++++ KI DFG+AR+ DE + T +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 670 YGYMSPEYALEGL--FSIKSDVFSFGVLLLEILSGK 703
Y Y +PE L G ++ D++S G + E+L +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 38/211 (18%)
Query: 510 LGEGGFGPVY---KGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G GGFG VY K + G+ A+K L KK ++ + ET+ + + +LV C
Sbjct: 2 IGRGGFGEVYGCRKAD--TGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLVSTGDC 56
Query: 567 ----CLD-----QDEKILIYEYLPNKSLDSFL-----FDRAKKRLLYWETRVKIIEGIAQ 612
C+ D+ I + + L L F A+ R E II G+
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE----IILGLE- 111
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
H ++R +++RDLK +NILLD +ISD G+A F + A+ VGT+GY
Sbjct: 112 -----HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161
Query: 673 MSPEYALEGL-FSIKSDVFSFGVLLLEILSG 702
M+PE +G+ + +D FS G +L ++L G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKN----ETMLIAKLQHRNLVRLL 564
+G+G FG V + +G+ AVK L KK+ +E K+ +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRL 623
D+ + +Y+ L F ++ + E R + IA L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL----FFHLQRERSFPEPRARFYAAEIASALGYLHS---L 115
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
II+RDLK NILLD+ ++DFG+ + G E T+ GT Y++PE + +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 684 SIKSDVFSFGVLLLEILSG 702
D + G +L E+L G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 510 LGEGGFGPVYKGELLNGQE----VAVKRLSK----KSGQGLEELKNETMLIAKLQHRNLV 561
LG+GG+G V++ + G + A+K L K ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQY 620
L+ + LI EYL L F ++ ++ E + I+ L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQ- 118
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEYA 678
II+RDLK NILLD K++DFG+ + + G T+ GT YM+PE
Sbjct: 119 --QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEIL 172
Query: 679 LEGLFSIKSDVFSFGVLLLEILSG 702
+ D +S G L+ ++L+G
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 62/270 (22%), Positives = 119/270 (44%), Gaps = 42/270 (15%)
Query: 518 VYKGELLNGQEVAVKRL---SKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK- 573
+YKG N +EV ++ K ++ +NE + ++ N++++ G +D +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 574 ---ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDL 630
LI EY L L K++ L ++T++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 631 KASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS---IKS 687
+ + L+ + K KI G+ ++ + N N +V Y S + L +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKM-LNDIFSEYTIKD 203
Query: 688 DVFSFGVLLLEILSGK---KNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYP 744
D++S GV+L EI +GK +N +L + N +L L P
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTT--KEIYDL------IINKNNSLKL-------PLDCP 248
Query: 745 MLARYVNVALLCVHENATDRPTMSEVVSML 774
+ + + A C ++ RP + E++ L
Sbjct: 249 LEIKCIVEA--CTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIV 667
I+ GL +LH R II+RDLK N++LD++ KI+DFGM + M G T
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
GT Y++PE + D +++GVLL E+L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSK--KSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G G +G V + G++VA+K+LS+ +S + E L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 567 CLDQ---DEKILIYEYLPNKSLD-----SFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
DE Y +P D K + L ++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYIH 134
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
IIHRDLK N+ ++ D + KI DFG+AR A V T Y +PE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVI 186
Query: 679 LEGLFSIKS-DVFSFGVLLLEILSGK 703
L + ++ D++S G ++ E+L+GK
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSK--KSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G G +G V + Q+VAVK+LS+ +S E L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 567 CLDQDEKILIYEYLPNKSLDSF-------------LFDRAKKRLLYWETRVKIIEGIAQG 613
+ P S+++F L + K + L E +I + +G
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
L Y+H IIHRDLK SN+ ++ D + +I DFG+AR DE+ V T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYR 182
Query: 674 SPEYALEGL-FSIKSDVFSFGVLLLEILSGK 703
+PE L + ++ D++S G ++ E+L GK
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 39/92 (42%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE + +++I+SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 510 LGEGGFGPV-YKGELLNGQEVAVKRLSKKSGQGLEE--LKNETMLIAKLQHRNLVR---- 562
+G+G +G V +G++ +K+L+ ++ E + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 563 ----------LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ 612
++G C D +Y L + K +LL V+ IA
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYHKLKEQ----------KGKLLPENQVVEWFVQIAM 113
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
L YLH+ I+HRDLK N+ L K+ D G+AR+ A+T ++GT Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
MSPE ++ KSDV++ G + E+ + K
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-10
Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 2/156 (1%)
Query: 546 KNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK 605
++E +A H +V+ D+ +LI EY L+ + R K+ L + E V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665
++ Q +L L + +++HRDLK++NI L K+ DFG ++ + +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
GT Y++PE +S K+D++S GV+L E+L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 510 LGEGGFGPVYKG---ELLNGQ-----EVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
LG+G F ++KG E+ + EV +K L K E ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
G C+ DE I++ EY+ SLD++L + W ++++ + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 622 RLRIIHRDLKASNILL--DTDMKP------KISDFGMARMFGGDELQANTNRIVGTYGYM 673
+ H ++ A N+LL + D K K+SD G++ E+ RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171
Query: 674 SPEYALEGL-FSIKSDVFSFGVLLLEILSG 702
PE S+ +D +SFG L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/147 (35%), Positives = 79/147 (53%), Gaps = 10/147 (6%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
KLGEG + VYKG L GQ VA+K RL + G ++ E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
+ L++EYL + L ++ D L R+ + + + +GL Y HQ R+
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRLFLFQ-LLRGLAYCHQR---RV 124
Query: 626 IHRDLKASNILLDTDMKPKISDFGMAR 652
+HRDLK N+L+ + K++DFG+AR
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 38/96 (39%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIV 667
IA GL +LH II+RDLK N++LD++ KI+DFGM + M+ G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
GT Y++PE + D ++FGVLL E+L+G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 13/101 (12%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+AQG+ +L + IHRD+ A N+LL KI DFG+AR ++ ++N +V
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272
Query: 670 YG-----YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN 705
+M+PE + +++++SDV+S+G+LL EI S K+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 43/232 (18%)
Query: 494 FASVSASTNNFSAENK------LGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELK 546
F SV + + F+ + +G G G V + + G VAVK+LS+ +
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQ 59
Query: 547 NETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSF--------LFDRAKKRLL 598
N+T AK +R LV LL C ++ L+ + P KSL+ F L D +++
Sbjct: 60 NQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI 116
Query: 599 YW----ETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654
+ E ++ + G+ +LH IIHRDLK SNI++ +D KI DFG+AR
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART- 172
Query: 655 GGDELQANTNRIVGTY----GYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
A TN ++ Y Y +PE L + D++S G ++ E++ G
Sbjct: 173 ------ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 52/170 (30%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR D
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN-- 727
+M+PE + +++ +SDV+SFGVLL EI S G + + KD
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQINEEFCQRLKDGTR 295
Query: 728 -RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
RA + P + + L C + +RPT S +V +L +
Sbjct: 296 MRAPENATPEIY------------RIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 73/287 (25%), Positives = 131/287 (45%), Gaps = 41/287 (14%)
Query: 509 KLGEGGFGPVYKGELLNGQEVA---VKRLSKKSGQGLEE----LKN-ETMLIAKLQHRNL 560
++G G FG V E+ VA VK L K+ +E L+ + I LQH N+
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKEL--KANASSKEQNEFLQQGDPYRI--LQHPNI 57
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG----IAQGLLY 616
++ LG C++ +L++EY L S+L ++++ +++ +++ IA G+ +
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVTH 114
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVGTYGYMSP 675
+H + +H DL N L +D+ K+ D+G+ + D ++ ++ V +++P
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAP 170
Query: 676 EYALE---GLFSIK----SDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728
E E GL + + S+V++ GV L E+ + H +L H + KD +
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP-YSHLSDREVLNH---VIKD-Q 225
Query: 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775
+ L P LE P R+ V C + R T EV +LT
Sbjct: 226 QVKLFKPQLE----LPYSERWYEVLQFC-WLSPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 510 LGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKN----ETMLIAKLQHRNLVRLL 564
+G+G FG V + +G AVK L KK+ +E + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
++ + +Y+ L F + ++ L R E +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---LN 116
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
II+RDLK NILLD+ ++DFG+ + G E + T+ GT Y++PE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 685 IKSDVFSFGVLLLEILSG 702
D + G +L E+L G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 72/252 (28%), Positives = 111/252 (44%), Gaps = 43/252 (17%)
Query: 481 KSKSTDAWLPLFSFASVSASTNNFSAEN-----KLGEGGFGPVYKGELLNGQEV-AVKRL 534
K+K+ D +L + A+ + AE+ +G G FG V + ++V A+K L
Sbjct: 17 KNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL 76
Query: 535 SKKSGQGLEELK--------NETMLIAKLQHRNLVRLLGCCLDQDEKIL--IYEYLPNKS 584
SK E +K E ++A +V+L QD+K L + EY+P
Sbjct: 77 SK-----FEMIKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGD 129
Query: 585 LDSFL--FDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642
L + + +D +K W R E + L +H IHRD+K N+LLD
Sbjct: 130 LVNLMSNYDIPEK----W-ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 180
Query: 643 PKISDFGMA-RMFGGDELQANTNRIVGTYGYMSPEYAL----EGLFSIKSDVFSFGVLLL 697
K++DFG +M + VGT Y+SPE +G + + D +S GV L
Sbjct: 181 LKLADFGTCMKM--DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 698 EILSGKKNTGFY 709
E+L G +T FY
Sbjct: 239 EMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 509 KLGEGGFGPVYKG---ELLNGQEVAVKRL----SKK--SGQGLEELKNETMLIAKLQHRN 559
+LG+G +G V E + VA+K++ SKK + + L ELK +L H+N
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRHFRGHKN 63
Query: 560 LVRLLGCCLDQD-------EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ 612
+ C D D ++ +YE L L + R+ + L T I Q
Sbjct: 64 IT----CLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPL----TDAHFQSFIYQ 113
Query: 613 ---GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIV 667
GL Y+H + ++HRDLK N+L++ D + KI DFG+AR F E V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 668 GTYGYMSPEYALEGLFSIKS-DVFSFGVLLLEILSGK 703
T Y +PE L K+ DV+S G +L E+L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 503 NFSAENKLGEGGFGPV----YKGELLNGQEVAVKRLSKKS---GQGLEELKNETMLIAKL 555
+F LG G FG V +KG G+ A+K L K+ + ++ + E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDS-------FLFDRAKKRLLYWETRVKIIE 608
H +V ++ D++ + E++ L + F D AK Y V E
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK---FYHAELVLAFE 132
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG 668
YLH II+RDLK N+LLD K++DFG A+ ++ T + G
Sbjct: 133 -------YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCG 177
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
T Y++PE D ++ GVLL E ++G
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 13/97 (13%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+A+G+ +L + IHRDL A NILL KI DFG+AR +++ ++N +V
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274
Query: 670 YG-----YMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE +++ +SDV+S+G+LL EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 510 LGEGGFGPV-YKGELLNGQEVAVKRLSK--KSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G G +G V + G +VA+K+L + +S + E L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 567 CLDQDEKILIYEYLPNKSLDSFL------------FDRAKKRLLYWETRVK-IIEGIAQG 613
+ P+ SLD F + K E R++ ++ + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
L Y+H IIHRDLK N+ ++ D + KI DFG+AR + + V T Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYR 182
Query: 674 SPEYALEGL-FSIKSDVFSFGVLLLEILSGK 703
+PE L + ++ D++S G ++ E+L+GK
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 510 LGEGGFGPV-YKGELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQHRNLVRLLG 565
LG+G FG V E +G+ A+K L K+ +E+ + E+ ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRLR 624
+D + EY+ L F +++R+ + E R + I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERV-FSEDRTRFYGAEIVSALDYLHSG---K 115
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
I++RDLK N++LD D KI+DFG+ + G A GT Y++PE + +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 685 IKSDVFSFGVLLLEILSGK 703
D + GV++ E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 63/227 (27%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSK----KSGQGLEELKNETMLIAKLQHRNLVRLL 564
+G G FG V+ + GQ A+K L K K Q ++ E ++A +V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKLY 67
Query: 565 GCCLDQDEKIL--IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
QDE+ L + EY+P L + L K R I E + L +H+
Sbjct: 68 --YSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAE-LVLALDSVHK--- 119
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMA-------------------------RMFGGD 657
L IHRD+K NIL+D D K++DFG+ + D
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 658 ELQANTNR--IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
Q VGT Y++PE + ++ D +S GV+L E+L G
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 510 LGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKN----ETMLIAKLQHRNLVRLL 564
+G+G FG V + L+G+ AVK L KK +E K+ +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYSRL 623
++ + +++ L F ++ + E R + IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
I++RDLK NILLD+ ++DFG+ + G T GT Y++PE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 684 SIKSDVFSFGVLLLEILSG 702
D + G +L E+L G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 54/245 (22%)
Query: 502 NNFSAENKLGEGGFGPV-YKGELLNGQEVAVKRLSK----KSGQGLEELKNETMLIAKLQ 556
++F + +G G FG V + G A+K+L K + Q + ++ E ++A+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 557 HRNLVRLLGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYWE-TRVKIIEGIAQG 613
+ +V+L QDE LI EYLP + + L KK E TR I E I
Sbjct: 60 NPWVVKLY--YSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETI--- 111
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM------------ARMFGGDELQA 661
L + +L IHRD+K N+LLD K+SDFG+ R+
Sbjct: 112 -LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 662 NT------------------NRI------VGTYGYMSPEYALEGLFSIKSDVFSFGVLLL 697
NR VGT Y++PE L+ ++ + D +S GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 698 EILSG 702
E+L G
Sbjct: 231 EMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
H LV L C + + EY+ L +F ++R L E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMS 674
LH+ II+RDLK N+LLD++ K++D+GM + + GD T+ GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIA 164
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGK 703
PE + D ++ GVL+ E+++G+
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEELKN----ETMLIAKLQHRNLVRLL 564
+G+G FG V ++ AVK L KK+ +E K+ +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRL 623
D+ + +Y+ L F ++ + E R + IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 115
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
I++RDLK NILLD+ ++DFG+ + E T+ GT Y++PE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 684 SIKSDVFSFGVLLLEILSG-----KKNTGFYHTGSLN 715
D + G +L E+L G +NT + LN
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 510 LGEGGFGPVYKGELLN---------GQEVAVKRLSKKSGQGLEELKNETM-LIAKLQHRN 559
LG+G F +YKG L GQEV+V S ET L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL-LYWETRVKIIEGIAQGLLYLH 618
LV+L G C+ +DE I++ EY+ LD FL R K + L+W ++ + + +A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 619 QYSRLRIIHRDLKASNILL-----DTDMKP--KISDFGMARMFGG-DELQANTNRIVGTY 670
+++H ++ NIL+ + P K+SD G+ +E RI
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERI---- 168
Query: 671 GYMSPEYALEGLFS---IKSDVFSFGVLLLEILSGKK 704
+++PE + + I +D +SFG LLEI S +
Sbjct: 169 PWIAPEC-IRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 28/189 (14%)
Query: 527 QEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLD 586
+ VA+K+LS+ +N+T AK +R LV L+ C ++ L+ + P KSL+
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 587 SF--------LFD----RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634
F L D + + L E ++ + G+ +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 635 ILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGV 694
I++ +D KI DFG+AR G + T +V Y Y +PE L + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 695 LLLEILSGK 703
++ E++ G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
+G+G FG VY+ + + + A+K LSKK E+ + + + RN+ L L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK------EIVAKKEVAHTIGERNI---LVRTL 51
Query: 569 DQDEKILI---YEYLPNKSLDSFLFDRAKKRLLYW---------ETRVKI-IEGIAQGLL 615
+ ++ + + + L + D L+W E R K I + L
Sbjct: 52 LDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE 110
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN--TNRIVGTYGYM 673
+LH+Y I++RDLK NILLD + DFG+++ L N TN GT Y+
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKA----NLTDNKTTNTFCGTTEYL 163
Query: 674 SPEYAL-EGLFSIKSDVFSFGVLLLEILSG 702
+PE L E ++ D +S GVL+ E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 508 NKLGEGGFGPVYK------GELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
++LG+G +G VYK G + +E+ ++ K Q + EL ++ K +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIV 62
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
G + + EY+ SLD + + +I + +GL +L +
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-- 120
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ--ANTNRIVGTYGYMSPEYAL 679
IIHRD+K +N+L++ + + K+ DFG++ G+ + A TN +G YM+PE
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN--IGCQSYMAPERIK 174
Query: 680 EG------LFSIKSDVFSFGVLLLEILSGK 703
G ++++SDV+S G+ +LE+ G+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 503 NFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+ +G G +G V + +G++VA+K++ + +AK R L
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLREL- 55
Query: 562 RLLGCCLDQDEKILIYEYL-PNKSL--DSFL-FDRAKKRLLYWETRVKIIEG-------- 609
++L D I I + L P + D ++ D + L II
Sbjct: 56 KILRH-FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLH------HIIHSDQPLTEEH 108
Query: 610 -------IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQ 660
+ +GL Y+H + +IHRDLK SN+L++ D + +I DFGMAR E +
Sbjct: 109 IRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 661 ANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEIL 700
V T Y +PE L ++ D++S G + E+L
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 45/146 (30%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
LV L C L+ EY+ L +F ++R L E I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEY 677
II+RDLK N+LLD D K++D+GM + + GD T+ GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEI 167
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
+ D ++ GVL+ E+++G+
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 22/206 (10%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKR--LSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
+ + K + VAVK+ L S + L+ L+ E + +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 568 LDQDEKILIYEYLPNKSLDSFL---FDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
+ E ++ + S + L F L I++ + L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI----AFILKDVLNALDYIHS---KG 121
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQAN----TNRIVGTYGYMSPEY-- 677
IHR +KAS+ILL D K +S + M + Q V ++SPE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 678 -ALEGLFSIKSDVFSFGVLLLEILSG 702
L+G ++ KSD++S G+ E+ +G
Sbjct: 182 QNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 510 LGEGGFGPV-YKGELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQHRNLVRLLG 565
LG+G FG V E G+ A+K L K+ +E+ + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRLR 624
D + EY L F +++R+ + E R + I L YLH S
Sbjct: 63 SFQTHDRLCFVMEYANGGEL---FFHLSRERV-FSEDRARFYGAEIVSALDYLH--SEKN 116
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
+++RDLK N++LD D KI+DFG+ + G + A GT Y++PE + +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 685 IKSDVFSFGVLLLEILSGK 703
D + GV++ E++ G+
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-09
Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 5/79 (6%)
Query: 333 DREDRFLRMHNVKLP-SPDKVLKLPGIEECKSACLN-NCACTAYAYN-SSGVCSSWD-GK 388
+D F+R+ N KLP V+ + +EEC S CLN NC+C ++ YN + C W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESS 60
Query: 389 LYDLEQLSKNEGENIFIKL 407
L D + G +++ K+
Sbjct: 61 LGDARLF-PSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 510 LGEGGFGPV-YKGELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQHRNLVRLLG 565
LG+G FG V E G+ A+K L K+ +E+ + E+ ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRLR 624
D + EY L F +++R+ + E R + I L YLH
Sbjct: 63 AFQTHDRLCFVMEYANGGEL---FFHLSRERV-FTEERARFYGAEIVSALEYLHSRD--- 115
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
+++RD+K N++LD D KI+DFG+ + D A GT Y++PE + +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 685 IKSDVFSFGVLLLEILSGK 703
D + GV++ E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 7e-09
Identities = 66/247 (26%), Positives = 110/247 (44%), Gaps = 38/247 (15%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIA-----KLQ 556
N + K+G G FG V+ + QE + S +GL+E + ++I +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 557 HRNLVRLLGCCLDQ-DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR--VKIIEGIAQG 613
H+N+VR + L++ ++K+ I + S + K E V I +
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 614 LLYLHQY----SRLRIIHRDLKASNILLDTDMK-----------------PKISDFGMAR 652
L Y H + R++HRDLK NI L T ++ KI DFG+++
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSI--KSDVFSFGVLLLEILSGKKNTGFYH 710
G +++ + VGT Y SPE L S KSD+++ G ++ E+ SGK T F+
Sbjct: 191 NIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHK 245
Query: 711 TGSLNLL 717
+ + L
Sbjct: 246 ANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+A+G+ +L + +HRDL A N+LL KI DFG+AR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE + L++ SDV+S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 510 LGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-----------HR 558
+G G + V EL + + ++ KK EL N+ I +Q H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKK------ELVNDDEDIDWVQTEKHVFETASNHP 56
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
LV L C + + E++ L +F ++R L E I+ L +LH
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLH 113
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPE 676
+ II+RDLK N+LLD + K++D+GM + + GD T+ GT Y++PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPE 166
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGK 703
+ D ++ GVL+ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEELK--------NETMLIAKLQHRNL 560
+G G FG V + Q+V A+K LSK E +K E ++A +
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSK-----FEMIKRSDSAFFWEERDIMAFANSPWV 105
Query: 561 VRLLGCCLDQDEKIL--IYEYLPNKSLDSFL--FDRAKKRLLYWETRVKIIEGIAQGLLY 616
V+L C QD+K L + EY+P L + + +D +K ++ V +L
Sbjct: 106 VQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV---------VLA 154
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
L + +IHRD+K N+LLD K++DFG M + + VGT Y+SPE
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPE 213
Query: 677 Y----ALEGLFSIKSDVFSFGVLLLEILSGKKNTGFY 709
+G + + D +S GV L E+L G +T FY
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 28/189 (14%)
Query: 527 QEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLD 586
+ VA+K+LS+ +N+T AK +R LV L+ C ++ L+ + P KSL+
Sbjct: 43 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92
Query: 587 SF--------LFD----RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634
F L D + + L E ++ + G+ +LH IIHRDLK SN
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149
Query: 635 ILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGV 694
I++ +D KI DFG+AR G + T +V Y Y +PE L + D++S G
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 206
Query: 695 LLLEILSGK 703
++ E++ K
Sbjct: 207 IMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 4/114 (3%)
Query: 589 LFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648
LF ++ + +R + A+ L L + +I+RDLK NILLD + DF
Sbjct: 80 LFHHLQREGRFDLSRARFY--TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDF 137
Query: 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
G+ ++ D+ + NT GT Y++PE L ++ D ++ GVLL E+L+G
Sbjct: 138 GLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 37/106 (34%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVG 668
+A+ +L + +L +HRD+K N+LLD + +++DFG R+ +Q+N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 669 TYGYMSPEY--ALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFY 709
T Y+SPE A+E G + + D +S GV + E+L G+ T FY
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 37/97 (38%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTNRIVGTY 670
+ L Y+H + + HRDLK NIL + D K KI DFG+AR F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 671 GYMSPEYALEGLFSIKS----DVFSFGVLLLEILSGK 703
Y +PE L G F K D++S G + E+L+GK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 38/106 (35%), Positives = 61/106 (57%), Gaps = 10/106 (9%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQANTNRIVG 668
IA+ +L +H +L +HRD+K N+LLD + +++DFG +M +Q++ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV--AVG 165
Query: 669 TYGYMSPEY--ALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFY 709
T Y+SPE A+E G + + D +S GV + E+L G+ T FY
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 55/243 (22%)
Query: 510 LGEGGFGPV-YKGELLNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG G FG V ++ A+K L KK + + +K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D+D + +Y+P + S L R+ + + IA+ L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMEVFPEVLARFY-IAELTLAIESVHKMGF 122
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFG------------------------------ 655
IHRD+K NIL+D D K++DFG+ F
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 656 ---GDELQANTNR------------IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEIL 700
GD L+ R +VGT Y++PE L ++ D +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 701 SGK 703
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFD--RAKKRLLYWETRVKIIEGIAQGL 614
+ N ++L +LI +Y+ D LFD + + +L E + KII + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVK-KIIRQLVEAL 122
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKP-KISDFGMARMFGGDELQANTNRIVGTYGYM 673
LH++ IIH D+K N+L D + D+G+ ++ G GT Y
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYF 173
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
SPE + + D ++ GVL E+L+GK
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 502 NNFSAENKLGEGGFGPVY-KGELLNGQEVAVKRLSKKSGQGLEEL---KNETMLIAKLQH 557
+F ++ +G G FG V E G A+K + K E + + E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFL------FDRAKKRLLYWETRVKIIEGIA 611
+ +L D+D L+ EY P L S L FD + +A
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------LA 109
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+ +L +H ++ +HRD+K N+L+D K++DFG A ++ N+ VGT
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPD 168
Query: 672 YMSPEY------ALEGLFSIKSDVFSFGVLLLEILSGK 703
Y++PE +G + ++ D +S GV+ E++ G+
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 10/97 (10%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+ +GL Y+H + ++HRDLK SN+LL+ + KI DFG+AR ++ T +V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-T 171
Query: 670 YGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGK 703
Y +PE L E +I DV+S G + E+L K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 55/243 (22%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLG 565
LG G FG V ++ + + A+K L KK + +K E ++A+ + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D+D + +Y+P + S L ++ E + IA+ + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFY--IAELTCAVESVHKMGF 122
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMF----------GGDELQANT------------ 663
IHRD+K NIL+D D K++DFG+ F GD ++ ++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 664 -----------------------NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEIL 700
+ +VGT Y++PE L ++ D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 701 SGK 703
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 55/239 (23%), Positives = 95/239 (39%), Gaps = 51/239 (21%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLG 565
+G G FG V ++ + A+K L K +K E ++A+ + +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D+D + +Y+P + S L + ++ E + IA+ + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI----RLGIFEEDLARFY--IAELTCAIESVHKMGF 122
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMF-----------GG----------DELQANTN 664
IHRD+K NIL+D D K++DFG+ F G +E
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 665 R--------------------IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+VGT Y++PE L ++ D +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 510 LGEGGFGPV-YKGELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQHRNLVRLLG 565
LG+G FG V E G+ A+K L K+ +E+ + E+ ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRLR 624
D + EY L F + ++ E R + I L YLH
Sbjct: 63 SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALGYLH---SCD 115
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
+++RDLK N++LD D KI+DFG+ + G A GT Y++PE + +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 685 IKSDVFSFGVLLLEILSGK 703
D + GV++ E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+A G+ +L + +HRDL A N+L+ KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE L++ SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 33/147 (22%), Positives = 55/147 (37%), Gaps = 15/147 (10%)
Query: 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV--RLLGC 566
L G VY ++ +K S + + + E ++ L + L ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
L+ E++ ++LD E + I E +A+ L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSE----------EEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 627 HRDLKASNILLDTDMKPKISDFGMARM 653
H DL NIL+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 60/232 (25%), Positives = 85/232 (36%), Gaps = 49/232 (21%)
Query: 509 KLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQHRNLVRLL 564
LG+G G V+ L G+ A+K L KK ++K E ++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
+ L+ +Y P L L + K L R E + L YLH L
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHL---LG 123
Query: 625 IIHRDLKASNILL---------DTDMKPKISDFGMARMFGG------------------D 657
I++RDLK NILL D D+ + +
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKS-------DVFSFGVLLLEILSG 702
E +N VGT Y++PE I D ++ G+LL E+L G
Sbjct: 184 EPSFRSNSFVGTEEYIAPEV-------ISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 63/253 (24%), Positives = 99/253 (39%), Gaps = 61/253 (24%)
Query: 502 NNFSAENKLGEGGFGPV-YKGELLNGQEVAVKRLSK----KSGQGLEELKNETMLIAKLQ 556
+F +G+G FG V + G+ A+K L K K Q L +K E ++A+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQ-LAHVKAERDVLAESD 59
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWE--TRVKIIEGIAQGL 614
+V L D LI E+LP L + L K + E TR + E +
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECV---- 111
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-------------RMFGGDELQA 661
L + +L IHRD+K NIL+D K+SDFG++ ++ G +
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 662 NTN---------------------------RI-----VGTYGYMSPEYALEGLFSIKSDV 689
+ R+ VGT Y++PE L+ + + D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231
Query: 690 FSFGVLLLEILSG 702
+S G ++ E L G
Sbjct: 232 WSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 20/148 (13%)
Query: 570 QDEKIL--IYEYLPNKSLDSFL--FDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
QD++ L + EY+P L + + +D +K ++ V +L L +
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV---------VLALDAIHSMGF 163
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY----ALEG 681
IHRD+K N+LLD K++DFG + + + VGT Y+SPE +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFY 709
+ + D +S GV L E+L G +T FY
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 30/168 (17%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN 559
S F + G FG VY G N ++ ++ KK+ ++ N+ M+ R+
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA-----DMINKNMVHQVQAERD 56
Query: 560 LVRL--------LGCCLDQDEKI-LIYEYLPNKSLDSFL-----FDRAKKRLLYWETRVK 605
+ L L L + L+ EYL + S L FD E VK
Sbjct: 57 ALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVK 108
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653
I +A L YLH++ IIHRDLK N+L+ + K++DFG++++
Sbjct: 109 YISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQE-VAVKRLSKKSGQGLEELKNETMLIAK-LQ 556
+ ++ N +G G FG VY+ ++ E VA+K++ + + KN +LI K L
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117
Query: 557 HRNLVRLLGC----CLDQDEKIL----IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIE 608
H N++ L C ++EK + + E++P +++ ++ A+ VK+
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 609 -GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP-KISDFGMAR-MFGGDELQANTNR 665
+ + L Y+H S+ I HRDLK N+L+D + K+ DFG A+ + G Q + +
Sbjct: 177 YQLCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSY 230
Query: 666 IVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSG 702
I + Y +PE L ++ D++S G ++ E++ G
Sbjct: 231 ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 8/156 (5%)
Query: 548 ETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII 607
E ++ + H ++++L G LI LP D + + AK+ + + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIV 667
+ + + YLH+ RIIHRD+KA NI ++ + DFG A F D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
GT +PE + D++S G++L E+ +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 47/178 (26%), Positives = 72/178 (40%), Gaps = 15/178 (8%)
Query: 537 KSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLF-DRAKK 595
K+ G + E ++ + HR ++ L+ K + +P D F + DR+
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 596 RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655
L E + I + + L YLH IIHRD+K NI LD + DFG A
Sbjct: 182 LPL--EQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEI------LSGKKNTG 707
GT SPE + K+D++S G++L E+ L GK+
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 503 NFSAENKLGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEE---LKNETMLIAKLQHR 558
+F +G G FG V +L N +V A+K L+K E + E ++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
+ L D++ L+ +Y L + L + + RL R + A+ ++ +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYL----AEMVIAID 116
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY- 677
+L +HRD+K NIL+D + +++DFG D ++ VGT Y+SPE
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEIL 175
Query: 678 -ALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFY 709
A+E G + + D +S GV + E+L G+ T FY
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM---------FGG----DELQ 660
L YLH Y I+HRDLK N+L+ + K++DFG++++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
++ GT Y++PE L + D ++ G++L E L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 503 NFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEE----LKNETMLIAKLQHR 558
+F + +G G FG V + + V ++ +K+ +E ++ E ++ +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
+V++ D+ LI E+LP + + L K L ET+ I A+ +L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYI----AETVLAID 115
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMA---RMFGGDELQANTNR---------- 665
+L IHRD+K N+LLD+ K+SDFG+ + E N N
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 666 --------------------IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
VGT Y++PE ++ ++ D +S GV++ E+L G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 54/238 (22%), Positives = 99/238 (41%), Gaps = 43/238 (18%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSG----QGLEELKNETMLIAKLQH 557
++F + +G G FG V + + + ++ +K+ + + ++ E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL 617
+V++ D+ LI E+LP + + L K L T+ I E + L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETV----LAI 114
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG---------------------- 655
+L IHRD+K N+LLD K+SDFG+
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 656 --GDELQANT---NR------IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
+ +A T NR VGT Y++PE ++ ++ D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 551 LIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI 610
++ ++ H+++V L G C+ E I++ E++ LD LF K +L + K+ + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL 114
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILL-----DTDMKP--KISDFG-----MARMFGGDE 658
A L YL ++H ++ NILL D + P K+SD G ++R
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------ 165
Query: 659 LQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEI 699
Q RI +++PE + SI +D +SFG L EI
Sbjct: 166 -QECVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 30/175 (17%)
Query: 503 NFSAENKLGEGGFGPVYKGELLN-----GQEVAVKRLSKKSGQGLEELKNETML------ 551
+F KLGEG FG VYK L+N + +K+ + + G +E NE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPNS 190
Query: 552 IAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR-----AKKRLLY------- 599
A + L + +DE L++ Y +L + + + LL
Sbjct: 191 CADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248
Query: 600 -WETRVKIIEGIAQGLLY-LHQYSRLRIIHRDLKASNILLDTDMKP-KISDFGMA 651
E KII+ I + +L+ L I+HRD+K NI+ KI D G A
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/115 (31%), Positives = 52/115 (45%), Gaps = 23/115 (20%)
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DTDMKP-------------KISDF 648
+II L Y H + L ++H DLK NIL+ DT + P +I D
Sbjct: 235 QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
G DE + T IV T Y SPE L + +D++S G ++ E+ +GK
Sbjct: 293 GGC----CDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 19/157 (12%)
Query: 551 LIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI 610
L++++ H +L + G C+ E I++ E++ + LD L R +K + ++ + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAWKITVAQQL 126
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILL-------DTDMKPKISDFGMARMFGGDELQANT 663
A L YL + ++H ++ A NILL T K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 664 NRIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEI 699
RI +++PE G S +D +SFG LLEI
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 20/110 (18%)
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665
I+ G +GL YLHQ IHR++KAS+IL+ D +S G++ ++ L N +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYS---LVRNGQK 157
Query: 666 IVGTYGY----------MSPEYALEGL--FSIKSDVFSFGVLLLEILSGK 703
Y + +SPE + L +++KSD++S G+ E+ +G+
Sbjct: 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 9/77 (11%)
Query: 604 VKIIEGIA-QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA-RMFGGDELQA 661
+ +I+G+ Q L L + R+ I+HRD+K N+L+ D + KI DFG A M G
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG----I 363
Query: 662 NTNRIVGTYGYMSPEYA 678
N N + YG + P Y+
Sbjct: 364 NFNPL---YGMLDPRYS 377
|
Length = 507 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 41/178 (23%), Positives = 77/178 (43%), Gaps = 48/178 (26%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+ +G GGFG VY+ + + + + ++K +E L+NET+++ L + N+
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAK-----IENLENETIVMETLVYNNIY----- 66
Query: 567 CLDQDEKILIYEYLPNKSLD-----------SFLFDRAKKRLLYWE----------TRV- 604
+ I + ++D SF R R + E R+
Sbjct: 67 -----DIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK 121
Query: 605 ----KIIEGIAQGLL----YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654
K+I+ I + +L Y+H++ I H D+K NI++D + + I D+G+A F
Sbjct: 122 CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 791 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.53 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.16 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.08 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.8 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.77 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.68 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.64 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.4 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.33 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.33 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.21 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.05 | |
| PLN02236 | 344 | choline kinase | 97.0 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.85 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.8 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.67 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.66 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.43 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.2 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.05 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.64 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=437.98 Aligned_cols=288 Identities=45% Similarity=0.754 Sum_probs=252.8
Q ss_pred CCCceehhhhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEE
Q 003846 488 WLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567 (791)
Q Consensus 488 ~l~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 567 (791)
....|++.++..+|++|...++||+|+||.||+|.+.+|+.||||++.....+...+|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765543145699999999999999999999999
Q ss_pred EcCC-cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 568 LDQD-EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 568 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
.+.+ +.+||||||++|+|+++|+..... .++|..+++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999765444 88999999999999999999999888889999999999999999999999
Q ss_pred eeccccccCCCccccccccc-cccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCC-CCccchhhhhhHHh
Q 003846 647 DFGMARMFGGDELQANTNRI-VGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYH-TGSLNLLGHAWDLW 724 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~ 724 (791)
|||+|+..+.. ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+... .+...+..|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999765431 1111112 79999999999999999999999999999999999998877544 33455888888889
Q ss_pred hcCCcccccccccc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 725 KDNRALDLMDPILE-NEASY-PMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 725 ~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
......+++|+.+. +.... .....+..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 88899999999987 55443 57888999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=387.67 Aligned_cols=258 Identities=32% Similarity=0.494 Sum_probs=210.2
Q ss_pred CCCccceecccCceeEEEeEeeCCcEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-cceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ--GLEELKNETMLIAKLQHRNLVRLLGCCLDQD-EKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey 579 (791)
.+.+.+.||+|+||+||+|.......||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34445679999999999998854444999999764322 2569999999999999999999999999988 79999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~~~ 658 (791)
+++|+|.++|+.. ....+++..+++++.|||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999664 56789999999999999999999999873 99999999999999998 99999999998765332
Q ss_pred cccccccccccCcccCchhcc--cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYAL--EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||...... .. +.... ...
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~---~~~v~---------~~~ 262 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QV---ASAVV---------VGG 262 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HH---HHHHH---------hcC
Confidence 2223368999999999999 569999999999999999999999998765431 11 11111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
.+...+...+..+..++.+||+.||.+||++.|++..|+.+..
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1222222255788899999999999999999999999986433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=366.15 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=207.9
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc-ceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE-KILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~E 578 (791)
.+++..+.||+|..|+|||+.++ +++.+|+|.+... ++...+++.+|++++++.+||+||+++|.|..+.. ..|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35566789999999999999765 6888999999543 45567889999999999999999999999999985 999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||.+|+|++++.. .+.+++....+|+.+|++||.|||+ ++ ||||||||+|||++..|++||+|||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999843 3568889999999999999999996 55 999999999999999999999999999877544
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
..+..+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+........ ...++++.+.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-------------~~~~Ll~~Iv 295 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-------------DIFELLCAIV 295 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-------------CHHHHHHHHh
Confidence 33457999999999999999999999999999999999999998765421111 1122222222
Q ss_pred cC---CCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 EN---EASY-PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~---~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+ ..+. ..++++++++..||+.||.+|||++|++++
T Consensus 296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 21 1222 256789999999999999999999999865
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=388.96 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=213.4
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.+|...+.||+|||..||+++. .+|+.||+|++.+. .....+.+.+||+|.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999976 78999999999764 3455778899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
|+|++++|.+++. ..+.+.+.+++.+++||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 5567999999999999999999999998 999999999999999999999999999987644
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
. ......+|||.|+|||++.....+..+||||+|||||-||+|++||+... ..+.++.+.
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------------vkety~~Ik 231 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------------VKETYNKIK 231 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------------HHHHHHHHH
Confidence 3 22345799999999999999999999999999999999999999976432 122222222
Q ss_pred cCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENE--ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+ .+...+....+||.++|+.||.+|||+++|+.+
T Consensus 232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222 233466788999999999999999999999865
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=370.54 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=201.6
Q ss_pred ccCCCccceecccCceeEEEe-EeeCCcEEEEEEecccCcc-------cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQ-------GLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
.+.|.+.+.||+|+||.|-+| +.++|+.||||++++.... ....+++|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 456778899999999999999 4567999999999764211 12335799999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC---CCeEEeeec
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD---MKPKISDFG 649 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFg 649 (791)
.||||||++||+|.+.+-. .+.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999998843 445667777889999999999999999 9999999999999765 789999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCC---CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGL---FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
+|+..+.. ..+...+||+.|.|||++.+.. +..++|+||+|||||-+++|.+||.....+. .
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-s----------- 389 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-S----------- 389 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-c-----------
Confidence 99987632 3455679999999999998654 3458899999999999999999986433221 1
Q ss_pred CCccccccccccCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 NRALDLMDPILENEA------SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.+.+..+.+ -...+++..++|.+||..||++|||+.|++++
T Consensus 390 -----l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 -----LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -----HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111222211 12367889999999999999999999999865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=364.13 Aligned_cols=199 Identities=35% Similarity=0.572 Sum_probs=179.6
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..+|.+.++||+|+|++||+|+++ ++..||||.+.+. ..+..+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888999999999999999764 5899999999876 5666788899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC------CCeEEeeeccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD------MKPKISDFGMA 651 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DFgla 651 (791)
|||.||+|..||+. .+.+++.+++.++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 347899999999999999999999998 9999999999999764 45899999999
Q ss_pred cccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCC
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGF 708 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~ 708 (791)
+.+..... ....+|++.|||||++...+|+.|+|+||+|+|||+|++|+.||..
T Consensus 163 R~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98874433 3346999999999999999999999999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=348.35 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=207.3
Q ss_pred ccCCCccceecccCceeEEEe-EeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeee-EEEcCCc-ceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLG-CCLDQDE-KIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~l 575 (791)
..+|++.++||+|.||+||++ .+.+|..+|.|.++-. +.+.......|+.+|++|+|||||++++ .+.++.+ .+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 356889999999999999999 5678999999998743 4455677889999999999999999998 4555555 799
Q ss_pred EEeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccC-CCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 576 IYEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYS-RLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
||||+.+|+|...+... ..++.+++..+++++.|++.||.++|+.- +..|+||||||.||+|+.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999999764 44567889999999999999999999832 12399999999999999999999999999998
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
+..... .....+|||.||+||.+.+..|+.|+||||+||++|||+.-++||... ++ .++-
T Consensus 178 l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~-------------~~L~ 237 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NL-------------LSLC 237 (375)
T ss_pred hcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cH-------------HHHH
Confidence 875542 234579999999999999999999999999999999999999996532 11 1111
Q ss_pred cccccCCC---C-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 734 DPILENEA---S-YPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 734 ~~~l~~~~---~-~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
..+-.++. + ..++..+..||..|+..||+.||+...+++.+
T Consensus 238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 22222222 2 45788999999999999999999854444443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=373.37 Aligned_cols=255 Identities=33% Similarity=0.503 Sum_probs=212.8
Q ss_pred CCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 503 NFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
.+...+.||+|.||.||.|.+.....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++..+||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 34567899999999999999977779999999754 34457889999999999999999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++.+...
T Consensus 286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 999999965 35667888999999999999999999998 99999999999999999999999999996655554333
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
. ...-+..|.|||.+..+.++.|+|||||||+|+||+| |+.|++..... +..+.++.--+-..
T Consensus 362 ~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 362 E-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------EVLELLERGYRLPR 425 (468)
T ss_pred C-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------HHHHHHhccCcCCC
Confidence 2 2344679999999999999999999999999999999 66665433221 11222222223334
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
+...++.+.+|+..||+.+|++|||++.+...|++..
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 4446788999999999999999999999999988754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=356.26 Aligned_cols=246 Identities=27% Similarity=0.369 Sum_probs=205.5
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|++.+.||+|+||.||.++. .+++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+.++|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 357899999999999999999965 458899999998752 3356778899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
|+||+.||.|..+|. +.+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||.+|+++|+||||++..-
T Consensus 103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999983 4566888889999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.. ...+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||.... ..+..+.
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------------------~~~~~~~ 236 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------------------VKKMYDK 236 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------------------HHHHHHH
Confidence 32 233445799999999999999999999999999999999999999965322 1222222
Q ss_pred cccCC---CCHHHHHHHHHHHHHccccCCCCCC----CHHHHH
Q 003846 736 ILENE---ASYPMLARYVNVALLCVHENATDRP----TMSEVV 771 (791)
Q Consensus 736 ~l~~~---~~~~~~~~l~~li~~cl~~dp~~RP----t~~evl 771 (791)
++... .+...+.+.++++..+|+.||++|. ++.++.
T Consensus 237 I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 237 ILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred HhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 22222 2222567889999999999999996 455543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=381.29 Aligned_cols=261 Identities=32% Similarity=0.480 Sum_probs=218.6
Q ss_pred hccCCCccceecccCceeEEEeEeeC------CcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
...+....+.||+|+||+||+|+..+ ...||||.++..... ...+|++|++++..++|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 34455667899999999999997533 457999999877655 78899999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc-----------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK-----------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
.++|+|||..|+|.+||..+.. ...++..+.+.||.|||.||+||-++. ++||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999965321 233788899999999999999999987 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 003846 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHA 720 (791)
Q Consensus 642 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 720 (791)
.+||+||||++.....++........-...|||||.+..+.|++++|||||||+|||+++ |+.|+....+++ .
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--V---- 714 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--V---- 714 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--H----
Confidence 999999999999888887776655567889999999999999999999999999999998 777755443321 1
Q ss_pred hHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 721 WDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.+....++. -+.+...+.++++|+..||+.+|.+||+++||-..|+...
T Consensus 715 Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 715 IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 111111111 2344456789999999999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=336.20 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=203.2
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|+...++|+|+||.||+++.+ +|+.||||++.... +...+-..+|+++|++++|+|+|.++++|.......||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788899999999999999765 59999999996543 2334556799999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|++..-|+++= .....++.+.+.++++|+++|+.|+|+++ +|||||||+|||++.+|.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 99987666652 23345788999999999999999999998 999999999999999999999999999987632
Q ss_pred cccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccc---------hhhhhhHHhhcCC
Q 003846 659 LQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN---------LLGHAWDLWKDNR 728 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~ 728 (791)
....+..+.|..|+|||.+.+ .+|...+||||+||++.||++|.+-|...++-+.- +.......+....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 223344688999999999987 68999999999999999999999877655432211 1111111111111
Q ss_pred cc-ccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 AL-DLMDPILENE-----ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~~-~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. -+.-|..... .-+..+.-+.+++..||+.||.+|++-+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 10 0101111110 111234577899999999999999999998753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=348.20 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=205.0
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC--cceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD--EKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~E 578 (791)
.++...+.||+|+||+||++... +|+..|||.+...+....+.+.+|+++|.+++|||||+++|.....+ ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677889999999999999765 49999999987664434677999999999999999999999865555 5899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeEEeeeccccccCC-
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGG- 656 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~- 656 (791)
|+++|+|.+++..... .+++..++.+++||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999954332 6899999999999999999999998 999999999999999 79999999999987764
Q ss_pred CccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
...........||+.|||||++..+ ....++|||||||++.||+||++|+.... .............
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----~~~~~~~~ig~~~-------- 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----EEAEALLLIGRED-------- 239 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----chHHHHHHHhccC--------
Confidence 1222333457899999999999964 34469999999999999999999976430 0011111100000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
.....+...+....+++..|++.||++||||+|++++.-
T Consensus 240 -~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 -SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111334446678999999999999999999999998863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=354.19 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=209.6
Q ss_pred hhccCCCccceecccCceeEEEeE-eeCCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcc
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 573 (791)
....+|...+.||+|+|++|++|+ ..+++.+|||++.+. .+...+-+..|-.+|.+| .||.|++|+.-|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 445789999999999999999995 456999999999764 233345566788889999 899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
|+|+||+++|+|.++|.+ -+.+++..++.++.+|+.||+|||++| ||||||||+|||||.|+++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999954 466888999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccc---------ccc--ccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 654 FGGDELQ---------ANT--NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 654 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
++..... ... ...+||..|.+||++..+..+..+|||+||||||+|+.|++||....+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---------- 293 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---------- 293 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----------
Confidence 7543222 111 3479999999999999999999999999999999999999997643211
Q ss_pred HhhcCCcccccccc--ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 723 LWKDNRALDLMDPI--LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 723 ~~~~~~~~~~~~~~--l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
-.+..+ +.-+++...++.+.+|+.+.|..||.+|+|..|+.++.
T Consensus 294 --------liFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 --------LIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred --------HHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 011111 11223334557889999999999999999999998874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.06 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=206.5
Q ss_pred hccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 574 (791)
..+.|+.+++||+|+||.||+|+ ..+|+.||+|++.... +.......+||.||++|.||||++|.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34678888999999999999994 5679999999998664 44566778999999999999999999999876 6789
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||+|||++ +|.-++ ....-.++..++..++.||+.||.|+|+++ |+|||||.+|||||.+|.+||+|||||+.+
T Consensus 195 lVFeYMdh-DL~GLl--~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLL--SSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhh--cCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999987 777777 234456888999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH--------hh
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL--------WK 725 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~ 725 (791)
....... .+..+-|..|+|||.+.+. .|+.++|+||.||||.||+.|++.++...+ .......+++ |.
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCChhccc
Confidence 6554333 3455789999999999876 799999999999999999999988654321 1111111111 11
Q ss_pred cCCcc--ccccc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 DNRAL--DLMDP------ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 ~~~~~--~~~~~------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+.. ..+.+ .+.+. ....+....+|+..+|..||.+|.|+.++++.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00110 11111 11111 12245677899999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.61 Aligned_cols=265 Identities=28% Similarity=0.382 Sum_probs=206.7
Q ss_pred hccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHH--HHHHHHHHhcC-CCceeeeeeEEEcCC-cce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEEL--KNETMLIAKLQ-HRNLVRLLGCCLDQD-EKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~ 574 (791)
..++|.++++||.|.||.||+|+ ..+|+.||||+++++-.. +++. .+|++.|++|+ |||||++.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45789999999999999999995 457999999999766433 4443 47999999998 999999999999988 899
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+|||||+. +|.+++.++ ++.++++.+..|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+..
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 899998654 778999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCccccccccccccCcccCchhcc-cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-c----hhhh-hhHHhhcC
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-N----LLGH-AWDLWKDN 727 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-~----~~~~-~~~~~~~~ 727 (791)
.+.... +..+.|..|+|||++. .+-|+.+.|+|++|||++|+.+-++-|....+-+. . +.+. .++.|.++
T Consensus 161 ~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 655432 3458899999999886 56799999999999999999999887665432111 0 0000 00011110
Q ss_pred -Ccccccc---ccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 728 -RALDLMD---PILENE----ASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 728 -~~~~~~~---~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.....+. +...+. .....+.++.+++.+|++.||.+|||++|++++-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0000111 111111 1112567889999999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=317.97 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=206.3
Q ss_pred cCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQ--GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.+|...++||+|.||.||+|+ ..+|+.||||+++..... ......+|++.|+.++|+||+.++++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999994 567999999999755322 24567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
||+- +|+..+.+ +...+...++..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9964 89998843 5567889999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc---c----
Q 003846 659 LQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA---L---- 730 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---- 730 (791)
..... .+-|..|+|||.+.+. .|+..+|+||.|||+.||+-|.+-+....+ .+.............. .
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHHcCCCCcccCccccc
Confidence 33322 2779999999998875 699999999999999999998875543222 1111111111111100 0
Q ss_pred --ccc----ccc-ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 731 --DLM----DPI-LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 731 --~~~----~~~-l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
+.. -+. .........+.++.+++..|+..||.+|+|+.|++++=-
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 000 000 011122334567799999999999999999999998753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=350.92 Aligned_cols=271 Identities=28% Similarity=0.447 Sum_probs=212.2
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
+..+.+.+.++||+|.||+||+|++. -.||||++.... .+..+.|++|+.++++-+|.||+=+.|+|..+.. .||
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 34455667789999999999999873 379999997653 4467889999999999999999999999998887 999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
.-+|+|.+|+.+|+. .+..++..+.+.||+||++|+.|||.++ |||||||..||+|.+++++||+||||+..-..
T Consensus 466 TqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred ehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 999999999999954 4466888899999999999999999998 99999999999999999999999999865332
Q ss_pred CccccccccccccCcccCchhccc---CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
-..........|...|||||++.. .+|++.+||||||+|+|||++|..|+.....+.. + |..++..-..
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--i------fmVGrG~l~p 612 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--I------FMVGRGYLMP 612 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--E------EEecccccCc
Confidence 211122223457789999999974 4799999999999999999999999762211111 0 1111111001
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCCCCcC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNNQL 788 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~ 788 (791)
|... .....+.++.+|+..||..++++||.+.+|+.+|+.....+|+-++.+
T Consensus 613 d~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~ 664 (678)
T KOG0193|consen 613 DLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSA 664 (678)
T ss_pred cchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCc
Confidence 1000 111234688999999999999999999999999988776666655533
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.01 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=212.4
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..+.|++.+.||.|..++||+|+. ..++.||||++..+. ....+.+++|+..|+.++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999964 468999999997653 334689999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
.||.+|++.++++..-.. .+++..+..|++++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999765443 3888889999999999999999998 999999999999999999999999987655432
Q ss_pred c-ccc-ccccccccCcccCchhccc--CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 658 E-LQA-NTNRIVGTYGYMSPEYALE--GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 658 ~-~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
. ... .....+||+.|||||++.. ..|+.|+||||||+...||.+|..||..+.....-+. .. .+......
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-----tL-qn~pp~~~ 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-----TL-QNDPPTLL 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-----Hh-cCCCCCcc
Confidence 2 111 1145789999999999654 3699999999999999999999999886654322111 11 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
-..+..+........+++++..||+.||.+|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1222222333455689999999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=350.41 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=211.5
Q ss_pred ccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
...|...++||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.+...+++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4567778999999999999994 456889999999877766777889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
|+||+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999987 3445889999999999999999999998 99999999999999999999999999987765443
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.....+|||.|||||++....|.+|.||||||++.+||+-|++|+-... .....+....++ ...-
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAlyLIa~ng--------~P~l 489 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRALYLIATNG--------TPKL 489 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHHHHHhhcC--------CCCc
Confidence 3345799999999999999999999999999999999999999964311 111111111111 1112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+++++.+||+.|+.+||++.|+|++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2334467889999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.04 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=205.9
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc----Cc-ccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCC
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK----SG-QGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQD 571 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 571 (791)
...++|.+.+.||+|.||.|++|.. .+++.||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999954 56899999977653 22 34567778999999998 999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeeecc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGM 650 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgl 650 (791)
..++||||+.+|+|.+++.+ ...+.+..+..+++||+.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999843 456778999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCC-CC-cccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGL-FS-IKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.....
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----------------- 228 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----------------- 228 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----------------
Confidence 99874 1123344569999999999999977 85 889999999999999999999875211
Q ss_pred ccccccccccCC--CCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ALDLMDPILENE--ASYPM-LARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~~~~~~~~l~~~--~~~~~-~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+. .+... +..+.+++.+|+..||.+|+|+.|++++
T Consensus 229 -~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 229 -PNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred -HHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 11111111111 11122 6789999999999999999999999943
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.60 Aligned_cols=262 Identities=29% Similarity=0.415 Sum_probs=204.4
Q ss_pred hccCCCccceecccCceeEEEeEe------eCCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCC
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQD 571 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 571 (791)
..++|++.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 357899999999999999999963 235689999987543 23346788999999999 8999999999987654
Q ss_pred -cceEEEeecCCCChhHHHhhhcc--------------------------------------------------------
Q 003846 572 -EKILIYEYLPNKSLDSFLFDRAK-------------------------------------------------------- 594 (791)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 594 (791)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred ---ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCc
Q 003846 595 ---KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671 (791)
Q Consensus 595 ---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 671 (791)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134777888999999999999999988 99999999999999999999999999986543322222223456788
Q ss_pred ccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHH
Q 003846 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYV 750 (791)
Q Consensus 672 y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 750 (791)
|+|||++.+..++.++||||||++||||++ |..|+....... . .......... ...+...++.+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~----~~~~~~~~~~---------~~~~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-E----FCQRLKDGTR---------MRAPENATPEIY 307 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-H----HHHHHhcCCC---------CCCCCCCCHHHH
Confidence 999999999999999999999999999997 999976432211 0 1111111110 011122346789
Q ss_pred HHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 751 NVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 751 ~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
+++.+||+.||.+|||+.|+++.|+...
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=322.88 Aligned_cols=235 Identities=29% Similarity=0.389 Sum_probs=202.8
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG---QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|+..+.||.|+||+|.+++.+ +|..+|+|++.+..- ...+...+|..+|+.+.||+++++++.+.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467888999999999999999764 588999999987542 3355677899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||++||.|..+|. +.+.+++..++.+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999984 3456888999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. +-..+|||.|+|||++....+..++|.|+|||++|||+.|.+||-.. ...+..+.+
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~------------------~~~~iY~KI 253 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD------------------NPIQIYEKI 253 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC------------------ChHHHHHHH
Confidence 3 44579999999999999999999999999999999999999996421 223334444
Q ss_pred ccCC--CCHHHHHHHHHHHHHccccCCCCC
Q 003846 737 LENE--ASYPMLARYVNVALLCVHENATDR 764 (791)
Q Consensus 737 l~~~--~~~~~~~~l~~li~~cl~~dp~~R 764 (791)
+.++ ++......+.+|+...|+.|-.+|
T Consensus 254 ~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 4443 444467889999999999999999
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.93 Aligned_cols=265 Identities=28% Similarity=0.440 Sum_probs=219.1
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.....+.++||+|-||.|.++....+..||||+++..... ...+|.+|+++|.+++|||||+++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4567788999999999999999988899999999876544 458999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
|++|+|.+||.++... .+..+...+|+.||+.||+||.+.+ ++||||.++|+|++.++++||+|||+++.+...++
T Consensus 617 mEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999665322 2455666789999999999999987 99999999999999999999999999998888877
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh--CCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS--GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.....+.+-+..|||||.+..++++.++|||+||++|||+++ .+.|+.... +.+.++..-..+..+....++
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~~~~~l---- 766 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQGRQVVL---- 766 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCCcceec----
Confidence 777777788899999999999999999999999999999865 556654433 233333333333333222211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
..+...+..+.+++..||..|.++||+++++...|.+.
T Consensus 767 --~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 --SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11223456788999999999999999999999988653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=348.65 Aligned_cols=245 Identities=29% Similarity=0.431 Sum_probs=209.3
Q ss_pred cCCCccceecccCceeEEEeE-eeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|.+.+.||+|.||.||||+ ..+.+.||+|.+.+. ..+..+.+++|++|+++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999995 456889999998764 34457789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+.| +|..+|. ....++++.+..++.+++.||.|||+.. |+|||+||+|||++..+.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999984 4456899999999999999999999987 9999999999999999999999999999776533
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
...+.+.|||.|||||++.+.+|+..+|.||+|||||||.+|++||- .....+++..++.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------------------a~si~~Lv~~I~~ 214 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------------------ARSITQLVKSILK 214 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------------------HHHHHHHHHHHhc
Confidence 33446789999999999999999999999999999999999999952 1122233333333
Q ss_pred CC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NE--ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
++ .+...+..+..++...|+.||.+|.|-.+++.+
T Consensus 215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 32 223467789999999999999999999998765
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.93 Aligned_cols=267 Identities=29% Similarity=0.453 Sum_probs=204.0
Q ss_pred ccCCCccceecccCceeEEEeEeeC-----------------CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-----------------GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVR 562 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 562 (791)
.++|++.++||+|+||.||++...+ +..||+|.+.... .....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999996532 3469999987543 334567899999999999999999
Q ss_pred eeeEEEcCCcceEEEeecCCCChhHHHhhhc----------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCee
Q 003846 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRA----------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626 (791)
Q Consensus 563 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ii 626 (791)
+++++.+.+..++||||+++++|.+++.... ....+++..+.+++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999985421 1134677888999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCC
Q 003846 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNT 706 (791)
Q Consensus 627 H~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~ 706 (791)
||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+++..+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998664433322333445678999999999889999999999999999999754332
Q ss_pred CCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 707 GFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.+....................... ....+...+..+.+++.+||+.||++|||+.||.+.|++
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 2222222222222111111110000 001112234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.15 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=208.9
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
+-|++.+-||.|+.|.|-+|+. .+|+.+|||++.+.. ......+.+|+.+|+.+.||||+++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999965 579999999997763 223566889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|.|.++| ..++.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998 34567888999999999999999999988 999999999999999999999999999875443
Q ss_pred ccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. ....+|.|.|.|||++.+.+| ..++||||.|||||.||+|+.||+ ++....++.+.
T Consensus 166 kl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------------------DdNir~LLlKV 224 (786)
T KOG0588|consen 166 KL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------------------DDNIRVLLLKV 224 (786)
T ss_pred cc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------------------CccHHHHHHHH
Confidence 32 234599999999999999998 579999999999999999999976 12222233333
Q ss_pred ccCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 737 LENEAS--YPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 737 l~~~~~--~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
-.+.+. ...+.++++|+.+|+..||++|.|++||+++-
T Consensus 225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 333332 23567899999999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=332.17 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=210.5
Q ss_pred ccCCCccceecccCceeEEEeE-eeCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..+|++.+.||+|.||.|-+|. ...|+.||||.+++. ++++.-.+++|++||+.|+||||+.++++|++.+..+||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4689999999999999999995 478999999998764 456677789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||..+|.|.+|+. ..+.+++.+++.+++||..|+.|+|.+. ++|||||.+|||||.++++||+||||+..+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999994 4566899999999999999999999987 99999999999999999999999999988765
Q ss_pred CccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... ....+|++.|.+||++.+.+| .+.+|-|||||+||.|+.|..||+...- ..++.+
T Consensus 206 ~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------------------k~lvrQ 264 (668)
T KOG0611|consen 206 KKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------------------KRLVRQ 264 (668)
T ss_pred ccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------------------HHHHHH
Confidence 433 335699999999999999988 5889999999999999999999764321 111122
Q ss_pred cccCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 736 ILENEAS-YPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 736 ~l~~~~~-~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
+-.+.+. ++.+....-||+|||..+|++|.|+.+|..+.-
T Consensus 265 Is~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 265 ISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred hhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 2222211 223456778999999999999999999998863
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=374.52 Aligned_cols=259 Identities=31% Similarity=0.496 Sum_probs=213.2
Q ss_pred cCCCccceecccCceeEEEeEeeC--Cc----EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN--GQ----EVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.+.+..+.||+|+||.||+|...+ |. .||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445566889999999999997643 43 4899998765 5667889999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhc----cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 575 LIYEYLPNKSLDSFLFDRA----KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
|++|||++|+|..||.+.. ....+...+.+.++.|||+|+.|||+++ +|||||..+|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999996542 2567889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
|+.+...++........-...|||||.+..+.|+.|+|||||||+|||++| |..|+....+.+. ... ....+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~~~---~~~gg-- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--LLD---VLEGG-- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--HHH---HHhCC--
Confidence 997776666555544455679999999999999999999999999999999 6777654332211 100 00111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
+-..+...++.+.+|+.+||+.+|++||++..+++.+..+.
T Consensus 922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 11223345678899999999999999999999999887643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.87 Aligned_cols=257 Identities=23% Similarity=0.315 Sum_probs=205.3
Q ss_pred hhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
....++|++++.||+|+||.||+++. .+|..+|+|++++.. ....+.++.|-.+|....+|.||+++..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44678999999999999999999965 469999999998764 33466788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
||||||++||++..+| .+...|+++.+..++.+++-|+..||++| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999999 45678999999999999999999999998 99999999999999999999999999853
Q ss_pred cCC----------------------Ccccc-----cc------------------ccccccCcccCchhcccCCCCcccc
Q 003846 654 FGG----------------------DELQA-----NT------------------NRIVGTYGYMSPEYALEGLFSIKSD 688 (791)
Q Consensus 654 ~~~----------------------~~~~~-----~~------------------~~~~gt~~y~aPE~~~~~~~~~~~D 688 (791)
+.. .+... .. ...+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 00000 00 1247999999999999999999999
Q ss_pred eeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC--
Q 003846 689 VFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPT-- 766 (791)
Q Consensus 689 vwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-- 766 (791)
.||||||+||||.|.+||........ +.... -.+..+.-........+..+||.+|+. ||++|.-
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T------~rkI~------nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQET------YRKIV------NWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH------HHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 99999999999999999754322211 11000 001112222222334788999999999 9999974
Q ss_pred -HHHHHHH
Q 003846 767 -MSEVVSM 773 (791)
Q Consensus 767 -~~evl~~ 773 (791)
++||.++
T Consensus 438 G~~EIK~H 445 (550)
T KOG0605|consen 438 GAEEIKKH 445 (550)
T ss_pred cHHHHhcC
Confidence 6676554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.08 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=209.4
Q ss_pred cCCCccceecccCceeEEEeE-eeCCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..|+..++||+|.||.||+|. ...++.||+|++... .....++++.|+.++..++|+||.++++.+..+..+.++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456777899999999999994 456899999999765 344578899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+.||++.++| .....+.+....-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 33444577778889999999999999998 99999999999999999999999999988776554
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.. ...+||+.|||||++....|+.|+||||||++.+||++|.+|+...+.. +...++-+....
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------rvlflIpk~~PP 229 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------RVLFLIPKSAPP 229 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------eEEEeccCCCCC
Confidence 43 4579999999999999889999999999999999999999997655442 111122211122
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+..+++++..||..||+.||+|.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2222456779999999999999999999999865
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=310.10 Aligned_cols=269 Identities=24% Similarity=0.271 Sum_probs=216.6
Q ss_pred hhhhhccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC---
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD--- 571 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 571 (791)
.+....++|++.++||+|||.-||+++ +.+++.+|+|++...+.++.+..++|++.-++++||||++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 344567899999999999999999995 5678899999998888788899999999999999999999999886544
Q ss_pred --cceEEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 572 --EKILIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 572 --~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
..+|+++|...|+|.+.+.... ++..+++.+.++|+.+|.+||++||+.. .+.+||||||.|||+.+++.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 3799999999999999987644 4458999999999999999999999986 47999999999999999999999999
Q ss_pred ccccccCCCccccc-------cccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhh
Q 003846 649 GMARMFGGDELQAN-------TNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLG 718 (791)
Q Consensus 649 gla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~ 718 (791)
|.++...-...... -.....|..|+|||.+. +...++++|||||||+||+|+.|..||+........+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl-- 251 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL-- 251 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE--
Confidence 99876532111000 01235688999999886 4568999999999999999999999987533222111
Q ss_pred hhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 719 HAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...+....+.-....++++.+.+++.+|++.||.+||++.|++..+.+.
T Consensus 252 ----------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 ----------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1112222222222223778999999999999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.32 Aligned_cols=244 Identities=28% Similarity=0.420 Sum_probs=202.4
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
.++-||.|+.|.||+|++ .++.||||+++.-. ..+|+-|++|+||||+.+.|+|.....+|||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 357899999999999998 67899999985332 3578889999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
.++|. .++.+.......|..+||.||.|||.+. |||||||.-||||..+..+||+|||-++...... ..-.
T Consensus 200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMS 270 (904)
T KOG4721|consen 200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMS 270 (904)
T ss_pred HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhh
Confidence 99993 4566888889999999999999999987 9999999999999999999999999998765442 2234
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
+.||..|||||++.+.+.++|+|||||||||||||||..|+........ . |.. -...+.-..+...
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----I---wGV------GsNsL~LpvPstc 336 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----I---WGV------GSNSLHLPVPSTC 336 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----E---Eec------cCCcccccCcccC
Confidence 6899999999999999999999999999999999999999654322111 0 000 0111222233345
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCC
Q 003846 746 LARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 780 (791)
++.+.-|+++||+-.|..||++++++.+|.=..++
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 67888999999999999999999999999765443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.62 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=203.6
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--------------cccHHHHHHHHHHHHhcCCCceeee
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--------------GQGLEELKNETMLIAKLQHRNLVRL 563 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l 563 (791)
...++|++.+.||+|.||.|-+|+. .+++.||||++.+.. ....+..++||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3458899999999999999999965 468999999997642 1135688999999999999999999
Q ss_pred eeEEEcC--CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 564 LGCCLDQ--DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 564 ~~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
+++..+. +..|||+|||..|.+...- .....+...++++++++++.||+|||.++ ||||||||+|+||+.+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9998764 5789999999998885442 23333899999999999999999999999 99999999999999999
Q ss_pred CeEEeeeccccccCCC---ccccccccccccCcccCchhcccCC----CCcccceeehhHHHHHHHhCCCCCCCCCCCcc
Q 003846 642 KPKISDFGMARMFGGD---ELQANTNRIVGTYGYMSPEYALEGL----FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL 714 (791)
Q Consensus 642 ~~kl~DFgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvvl~elltg~~p~~~~~~~~~ 714 (791)
++||+|||.+..+... .........+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~------ 321 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD------ 321 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc------
Confidence 9999999999876332 1222334478999999999998742 36789999999999999999999632
Q ss_pred chhhhhhHHhhcCCccccccccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 715 NLLGHAWDLWKDNRALDLMDPILENE----ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
+...++.+++.... ....+.+.+.+||.++|+.||+.|.+..+|..+.-
T Consensus 322 ------------~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 322 ------------DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ------------chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 12222223322222 12235678999999999999999999999988774
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=347.81 Aligned_cols=259 Identities=29% Similarity=0.397 Sum_probs=203.6
Q ss_pred ccCCCccceecccCceeEEEeEe------eCCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 572 (791)
.++|++.++||+|+||.||+|.. .++..||||+++... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45789999999999999999953 235689999986543 33456788999999999 89999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc----------------------------------------------------------
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK---------------------------------------------------------- 594 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 594 (791)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999854211
Q ss_pred --------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 595 --------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 595 --------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
...++++.+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124778889999999999999999988 999999999999999999999999999876443222
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.......++..|+|||++.+..++.++||||||+++|||++ |..|+....... .......... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-----~~~~~~~~~~---------~~ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-----KFYKMIKEGY---------RM 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-----HHHHHHHhCc---------cC
Confidence 22222345678999999999999999999999999999998 788865432211 0111111110 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..+...+.++.+++.+||+.||++||++.|++++|++
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0111124578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.98 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=210.1
Q ss_pred hhhhccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCC
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQD 571 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 571 (791)
.....++|.+.+.||+|.||.|+++..+ +++.+|||.+++. .....+..+.|.+|+.... ||.++.++.++++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3455688999999999999999999765 5789999999876 3556788889999998884 999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
+.+.||||+.||++..+ .....+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+|||++
T Consensus 443 ~l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred eEEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 99999999999995333 45567889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
+.--. ....++..+|||.|||||++.+..|+.++|.|||||+|||||.|+.||. .++..+
T Consensus 516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~------------------gddEee 575 (694)
T KOG0694|consen 516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP------------------GDDEEE 575 (694)
T ss_pred cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC------------------CCCHHH
Confidence 86432 2235567899999999999999999999999999999999999999965 334445
Q ss_pred cccccccCCCCHH--HHHHHHHHHHHccccCCCCCCCH
Q 003846 732 LMDPILENEASYP--MLARYVNVALLCVHENATDRPTM 767 (791)
Q Consensus 732 ~~~~~l~~~~~~~--~~~~l~~li~~cl~~dp~~RPt~ 767 (791)
+++.++..+..++ .+.+...+++++|+.+|++|.-+
T Consensus 576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 6666666554444 67889999999999999999866
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=346.92 Aligned_cols=260 Identities=29% Similarity=0.444 Sum_probs=203.7
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||++... ++..||||++.... ....+.+.+|+++++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457899999999999999998632 34579999997543 33356788999999999 89999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc----------------------------------------------------------
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK---------------------------------------------------------- 594 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 594 (791)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854211
Q ss_pred ---------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 595 ---------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 595 ---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
...+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124677888999999999999999988 99999999999999999999999999986543322112222
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYP 744 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 744 (791)
..++..|+|||++.+..++.++||||||+++|||++ |+.||....... . ........ .....+..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~----~~~~~~~~---------~~~~~~~~ 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K----FYKMVKRG---------YQMSRPDF 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H----HHHHHHcc---------cCccCCCC
Confidence 345678999999999999999999999999999997 999976432211 0 01111100 01111112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 745 MLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.+..+.+++.+||+.||.+|||+.|++++|++.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 346789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.97 Aligned_cols=244 Identities=21% Similarity=0.328 Sum_probs=197.1
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCccc---HHHHHHHHHHHHhcCCCceeeeeeEEEc----CCcceEEEeec
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQG---LEELKNETMLIAKLQHRNLVRLLGCCLD----QDEKILIYEYL 580 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~ 580 (791)
..||+|++|.||+|.. +|+.||||+++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999987 79999999997654333 5678899999999999999999999876 34678999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999843 34678899999999999999999984 5 8899999999999999999999999998654322
Q ss_pred ccccccccccCcccCchhccc--CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALE--GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...... .... .
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i---~~~~---------~ 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLI---INKN---------N 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHH---HhcC---------C
Confidence 12367899999999976 68999999999999999999999998643211 111100 0000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...+..+.+++.+||+.||++|||++|+++.|+..
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111223456799999999999999999999999999763
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=354.01 Aligned_cols=269 Identities=25% Similarity=0.334 Sum_probs=216.9
Q ss_pred hhhhccCCCccceecccCceeEEEeEeeCC-cEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeE-EEcC---
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELLNG-QEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGC-CLDQ--- 570 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~~--- 570 (791)
+.....+.++.+.|.+|||+.||+|....+ .++|+|++...++...+.+.+|+.+|++|+ |+|||.+++. ....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 345567888999999999999999977665 999999998888889999999999999997 9999999993 3221
Q ss_pred ---CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEee
Q 003846 571 ---DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISD 647 (791)
Q Consensus 571 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 647 (791)
-+.+|.||||.+|.|-+++..+...+ +.+.++++|+.++++|+++||... .+|||||||-+||||..+|+.||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 25689999999999999997766655 999999999999999999999985 7899999999999999999999999
Q ss_pred eccccccCCCcccc-------ccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchh
Q 003846 648 FGMARMFGGDELQA-------NTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLL 717 (791)
Q Consensus 648 Fgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~ 717 (791)
||.|...-...... ..-....|+-|+|||++. +..+++|+|||+|||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99987432221110 011235799999999874 67899999999999999999999999764321
Q ss_pred hhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc-CcCCCCCCC
Q 003846 718 GHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN-EHLVLPRRN 785 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~-~~~~~~~~~ 785 (791)
..++.....-...+.++..+.+||+.||+.+|.+||++-||++.+-. ...+.|.++
T Consensus 264 ------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~ 320 (738)
T KOG1989|consen 264 ------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD 320 (738)
T ss_pred ------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence 12222222222335688999999999999999999999999988854 333344443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.21 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=200.7
Q ss_pred CCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 504 FSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
|+..+.||+|+||.||++.. .+|+.||||++.+.. ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999965 578999999986532 22345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999887543 2345788999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ .......... ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~----------~~~ 222 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKE----------DQE 222 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhc----------ccc
Confidence 1234789999999999999999999999999999999999999764322110 0000000000 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
..+...+..+.+|+.+||+.||.+||+ ++|++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 122234567889999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=339.75 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=200.6
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367888999999999999999764 58899999986532 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++.. ...++.+.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999843 345788888999999999999999988 99999999999999999999999999986543
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .........
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~----~~~~i~~~~-------- 231 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FR----IYEKILAGR-------- 231 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HH----HHHHHhcCC--------
Confidence 22 234789999999999999999999999999999999999999753211 00 111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
. ..+...+..+.+++.+||+.||.+||+ ++|++++
T Consensus 232 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 L--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred c--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 011123457889999999999999996 6888765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=335.57 Aligned_cols=246 Identities=23% Similarity=0.269 Sum_probs=200.8
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999764 68999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999843 345788889999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+...... .. ........
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~----~~~i~~~~--------- 214 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GI----YEKILAGK--------- 214 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH----HHHHHhCC---------
Confidence 22346899999999999989999999999999999999999997532211 00 01111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHh
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSML 774 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~L 774 (791)
...+......+.+++.+||+.||.+||+ ++|++++-
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 0111223467889999999999999995 88888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.91 Aligned_cols=258 Identities=30% Similarity=0.414 Sum_probs=205.2
Q ss_pred cCCCccceecccCceeEEEeEeeC--C---cEEEEEEecc---cCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN--G---QEVAVKRLSK---KSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~--g---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.+..+.++||+|+||.||+|++.. + ..||||..+. .......+|.+|+++|++++|||||+++|++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445556899999999999997653 2 2289999875 3456678999999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++|||+|.||+|+++|.... ..++..++..++.+.|.||+|||+++ +|||||..+|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999995432 36889999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
... +........-+..|+|||.+....|+.++|||||||++||+.+ |..|+...... .+. .. +
T Consensus 312 ~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~----~k--------I 375 (474)
T KOG0194|consen 312 GSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVK----AK--------I 375 (474)
T ss_pred Ccc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHH----HH--------H
Confidence 431 1111112245679999999999999999999999999999999 77775533221 100 00 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 780 (791)
......-..+...+..+..++.+|+..+|++||||.++.+.|+.....
T Consensus 376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 011111122224456788899999999999999999999999875443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.01 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=203.4
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999765 58999999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 345788889999999999999999988 99999999999999999999999999976543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .... ...+....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~----i~~~--~~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWEN----LKYW--KETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHH----HHhc--cccccCCC
Confidence 2234578999999999999999999999999999999999999975432111 0000 0000 00011000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+++.+||+.+|.+||+++|++++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 011112345678999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.93 Aligned_cols=249 Identities=28% Similarity=0.379 Sum_probs=208.0
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
-++|++.+.||+|-||.||.|+. +++-.||+|++.+.. .+...++++|++|.+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46899999999999999999965 467889999997652 34567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
+||.++|+|...|.+. ....+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+...+.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999998542 3455778888999999999999999987 99999999999999999999999999876442
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. .....+||..|.+||...+..++.++|+|++|++.||++.|.+||+....+ .. +... ...+.
T Consensus 177 ~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--et----YkrI---~k~~~---- 239 (281)
T KOG0580|consen 177 N----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--ET----YKRI---RKVDL---- 239 (281)
T ss_pred C----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--HH----HHHH---HHccc----
Confidence 1 223469999999999999999999999999999999999999998754411 11 1111 00111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.++|.+|+..+|.+|.+..|++++
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1223455788999999999999999999999876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.05 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=195.7
Q ss_pred ceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 508 NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.||+|+||.||+++. .+|+.||||++.+.. ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 468999999987542 233456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccc
Q 003846 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT 663 (791)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 663 (791)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99988843 346788999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCH
Q 003846 664 NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743 (791)
Q Consensus 664 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 743 (791)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ ...+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~----~~~~~~~~----------~~~p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KL----FELILMEE----------IRFPR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HH----HHHHHcCC----------CCCCC
Confidence 3457999999999999999999999999999999999999997532110 00 00000000 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 744 PMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 744 ~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
..+..+.+++.+||+.||++|| ++.|++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3456789999999999999999 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=328.10 Aligned_cols=257 Identities=31% Similarity=0.499 Sum_probs=206.2
Q ss_pred cCCCccceecccCceeEEEeEeeC------CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....++.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478889999999999999997543 2579999986543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhcc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 575 LIYEYLPNKSLDSFLFDRAK-------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
++|||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145788889999999999999999988 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 003846 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHA 720 (791)
Q Consensus 642 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 720 (791)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...... +.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~---- 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EV---- 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH----
Confidence 999999999986544333222334466889999999998899999999999999999998 98886532211 11
Q ss_pred hHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 721 WDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
........ ....+...+.++.+|+.+||+.||.+||++.||++.|+.
T Consensus 236 ~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 111223345789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=334.82 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=204.0
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999664 58889999987542 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++.. ...+++..+..++.|+++||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999843 345788889999999999999999853 39999999999999999999999999997653321
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh-h--cC--------
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW-K--DN-------- 727 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~--~~-------- 727 (791)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+....... +........ . ..
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcc
Confidence 223468999999999999999999999999999999999999985432110 000000000 0 00
Q ss_pred -------------------CccccccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 728 -------------------RALDLMDPILEN----EASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 728 -------------------~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
...+..+..... ......+.++.+++.+||+.||++|||++|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000000 01112456789999999999999999999998774
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.25 Aligned_cols=265 Identities=25% Similarity=0.305 Sum_probs=202.9
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQ--GLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 574 (791)
..+.|+.+++|++|+||.||+|+. .+++.||+|+++...+. ..-.-.+||.+|.+++|||||.+..+... -+..+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 346788999999999999999955 56889999999754322 23345789999999999999999988764 45689
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
|||||+++ +|..++... ...+...++.-++.|+++|++|||.+. |+||||||+|+|+...|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999987 888888433 356788889999999999999999988 999999999999999999999999999988
Q ss_pred CCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh--------
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK-------- 725 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 725 (791)
+... ...+..+-|..|+|||.+.+. .|+++.|+||+|||+.||+++++-|.....- +..........
T Consensus 228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~--dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI--DQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH--HHHHHHHHHhCCCccccCC
Confidence 7652 334456889999999999876 6999999999999999999999876543321 11111111111
Q ss_pred cCCccccc---------cccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 726 DNRALDLM---------DPILENEASYP-MLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 726 ~~~~~~~~---------~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.-...... ...+...+... ..+.-.+|+..+|.+||.+|.|++|.+++=
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 00000000 01111111111 446778999999999999999999998763
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=318.23 Aligned_cols=269 Identities=23% Similarity=0.322 Sum_probs=205.3
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecc--cCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc-----C
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSK--KSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD-----Q 570 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~ 570 (791)
.....|...+.||+|+||.|..+.. .+|+.||||++.. ......++..+|+++|+.++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3456677788999999999999954 5799999999973 445567788899999999999999999999875 3
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
...|+|+|+| +.+|...+. .+..+..+.+..+++||++||+|+|+.+ |+||||||.|+|++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 4679999999 668888883 3444888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCC-ccchhhh--------h
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTG-SLNLLGH--------A 720 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~-~~~~~~~--------~ 720 (791)
|+...........+..+.|..|+|||++.. ..|+.+.||||+||||.||++|++-|.....- +..++.. .
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998765433334456788999999998865 57999999999999999999999877653221 1111100 0
Q ss_pred hHHhhcCCccccccccccC-CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 721 WDLWKDNRALDLMDPILEN-EAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~-~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
............+...... ..+ +...+...+|+.+||..||.+|+|++|.+++-
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 1111111111111111100 011 12346788999999999999999999998764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=352.03 Aligned_cols=252 Identities=19% Similarity=0.232 Sum_probs=203.7
Q ss_pred CCCccceecccCceeEEEeEee-C-CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-N-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+++|+.+++.++|||||++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999543 3 6789999876655555667889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 581 PNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 581 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
++|+|.++|.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999886532 3345788889999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .... .... .... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~---~~~~-~~~~---------~ 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIM---QQVL-YGKY---------D 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHH-hCCC---------C
Confidence 2233445799999999999999999999999999999999999999753211 0000 0000 0000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
..+...+..+.+++.+||+.||++||++.|+++
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111234467899999999999999999999865
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.02 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=206.7
Q ss_pred ccCCCccceecccCceeEEEeEeeC------CcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|.+.+.||+|+||.||+|...+ ++.||||.+...... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999997533 478999999765443 457899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhc-----------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 574 ILIYEYLPNKSLDSFLFDRA-----------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
++||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996432 2345778889999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 721 (791)
+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..|+...... .....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~-- 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIEC-- 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH--
Confidence 99999999986543332222223356788999999999999999999999999999998 99886432211 11110
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..... ....+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus 237 --~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 --ITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11110 011112345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=324.84 Aligned_cols=265 Identities=23% Similarity=0.284 Sum_probs=201.7
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999765 58899999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|++++++..+.. ....++++.+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2345888899999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccch-hh--------hhhHHh-hcCC
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNL-LG--------HAWDLW-KDNR 728 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~-~~--------~~~~~~-~~~~ 728 (791)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .. .....+ ....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12223568999999999999899999999999999999999999986432211000 00 000000 0000
Q ss_pred ccccccccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ALDLMDPILEN------EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~~~~~~~~l~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+.... ......+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000011100 0111245679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=324.76 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=202.3
Q ss_pred ccCCCccceecccCceeEEEeEee----CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+|... .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999653 36689999987653 2334678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998542 346889999999999999999999988 9999999999999999999999999876543
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .... .....
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~----~~~~~------- 224 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIK----AVEDG------- 224 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH----HHHCC-------
Confidence 2211 11112345678999999999999999999999999999775 99987533211 1110 01111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.....+...+..+.+++.+||+.+|.+||+++|+++.|++
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0011122245678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=332.69 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=210.9
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc-ceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE-KILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV 576 (791)
.++|..+++||+|+||.++..+.+ +++.+|+|++.... ........+|+.++++++|||||.+.+.+.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999998554 57899999887543 3334567899999999999999999999999998 8999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|+|++||+|.+.+.+.. +..++++.+..++.|++.|+.|||++. |+|||||+.||+++.++.+||+|||+|+.++.
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999996543 567888889999999999999999776 99999999999999999999999999999876
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. ......+||+.||.||++.+.+|..|+|||||||++|||++-+++|.... ...++.++
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------------------m~~Li~ki 218 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------------------MSELILKI 218 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------------------hHHHHHHH
Confidence 65 22335689999999999999999999999999999999999999865322 22222222
Q ss_pred c---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 L---ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ....+..++.++..++..|++.+|..||++.+++.+
T Consensus 219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2 223444577899999999999999999999999876
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=328.94 Aligned_cols=263 Identities=28% Similarity=0.452 Sum_probs=210.8
Q ss_pred cCCCccceecccCceeEEEeEee------CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.+|.+.+.||+|+||.||++... ++..+++|++........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999642 355699999876665556789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 576 IYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1235788999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 721 (791)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~----~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--E----VI 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H----HH
Confidence 99999999986554332222333456788999999999999999999999999999999 89886432211 1 11
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCC
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (791)
.......... .+...+..+.+++.+||+.+|++|||+.+|+++|+++....|
T Consensus 236 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 236 ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 1111111111 111234678999999999999999999999999998755433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.71 Aligned_cols=250 Identities=35% Similarity=0.544 Sum_probs=193.9
Q ss_pred ccceecccCceeEEEeEee-----CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 506 AENKLGEGGFGPVYKGELL-----NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+.+.||.|.||.||+|... .+..|+||.++... .+..+++.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 36789999996543 33478899999999999999999999999988889999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++|+|.++|... ....+++..+..++.||++||.|||+++ ++|+||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2456889999999999999999999988 99999999999999999999999999987743332
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
............|+|||.+....++.++||||||+++|||++ |+.|+..... ..... .......
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~----~~~~~~~--------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIE----KLKQGQR--------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHH----HHHTTEE---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccc----ccccccc---------
Confidence 222333456789999999999999999999999999999999 6777543311 11111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
...+...+..+.+++.+||+.+|.+|||+.|+++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222356788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=324.44 Aligned_cols=270 Identities=29% Similarity=0.388 Sum_probs=203.5
Q ss_pred cCC-CccceecccCceeEEEeEe-----eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Cc
Q 003846 502 NNF-SAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DE 572 (791)
Q Consensus 502 ~~y-~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 572 (791)
++| ++.+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 7889999999999988642 357889999987543 23456788999999999999999999988764 35
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.+++|||+++++|.+++.. ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 7899999999999999843 34889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccc-cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 653 MFGGDELQAN-TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 653 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
.......... .....++..|+|||.+.+..++.++||||||++++||++|..|+........................+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 7654322111 112245667999999998899999999999999999999999865432211111111000000111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..+.......+...+..+.+++.+||+.+|++|||+++++++|+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111122234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=339.25 Aligned_cols=260 Identities=26% Similarity=0.371 Sum_probs=204.8
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 572 (791)
.++|.+.++||+|+||.||+|... .+..||||++..... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 568889999999999999999642 234799999975432 33567899999999996 9999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc----------------------------------------------------------
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK---------------------------------------------------------- 594 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 594 (791)
.++||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999864211
Q ss_pred -----------------------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC
Q 003846 595 -----------------------------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT 639 (791)
Q Consensus 595 -----------------------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~ 639 (791)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124677888899999999999999988 999999999999999
Q ss_pred CCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhh
Q 003846 640 DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLG 718 (791)
Q Consensus 640 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~ 718 (791)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 99999999999987644322222233456788999999999999999999999999999997 8888654321110
Q ss_pred hhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 719 HAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
........ .....+...+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus 349 -~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 349 -FYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -HHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 00111111 00011123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=331.84 Aligned_cols=240 Identities=22% Similarity=0.251 Sum_probs=192.9
Q ss_pred ecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
||+|+||.||++... +++.||+|++.+. .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999664 5889999998653 233456788999999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 999843 345788999999999999999999988 9999999999999999999999999997543221 12234
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ...... ....+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~-~~~~~~----------~~~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMY-RKILQE----------PLRFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHH-HHHHcC----------CCCCCCcC
Confidence 5789999999999999999999999999999999999999753211 1110 100000 00112234
Q ss_pred HHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003846 746 LARYVNVALLCVHENATDRPT---MSEVVSM 773 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt---~~evl~~ 773 (791)
+..+.+++.+||+.||.+||+ +.|++++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 567889999999999999975 5666554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.16 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=204.3
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCc-eeeeeeEEEcCC-----
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRN-LVRLLGCCLDQD----- 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~----- 571 (791)
...|...++||+|+||+||+|+. .+|+.||+|++..... .......+|+.++++++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34567778999999999999954 5689999999976543 24566789999999999999 999999998877
Q ss_pred -cceEEEeecCCCChhHHHhhhccc-cccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 572 -EKILIYEYLPNKSLDSFLFDRAKK-RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
..++|+||+.. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+.+|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 77899999954 899998554322 45777889999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc--
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD-- 726 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 726 (791)
+|+.+.-.. ......++|..|+|||++.+. .|+...||||+|||++||++++.-|....+ .+......+....
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPN 241 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCC
Confidence 999654222 113345789999999999987 799999999999999999998877654433 2222222222111
Q ss_pred ------CCccccccccccCCC-CHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHH--hccC
Q 003846 727 ------NRALDLMDPILENEA-SYP-------MLARYVNVALLCVHENATDRPTMSEVVSM--LTNE 777 (791)
Q Consensus 727 ------~~~~~~~~~~l~~~~-~~~-------~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~ 777 (791)
.....-.+....... +.. ...+..+++.+||+++|.+|.+++.++++ +...
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111111111111110 111 12478899999999999999999999987 5544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.65 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=200.5
Q ss_pred ccCCCccceecccCceeEEEeEeeC--CcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN--GQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+|...+ +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4678999999999999999997543 368999998653 23345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999843 345788899999999999999999988 9999999999999999999999999998654
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ........
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~----~~~i~~~~------- 244 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLI----YQKILEGI------- 244 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHH----HHHHhcCC-------
Confidence 32 2235789999999999998899999999999999999999999753211 000 01111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+...+..+.+++.+||+.||++|+ +++|++++
T Consensus 245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011122345688999999999999995 89999876
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=332.84 Aligned_cols=242 Identities=24% Similarity=0.289 Sum_probs=195.9
Q ss_pred ceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 508 NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.||+|+||.||++.. .+++.||||++.+. .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 46899999999754 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccc
Q 003846 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT 663 (791)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 663 (791)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 345888999999999999999999988 9999999999999999999999999987533221 122
Q ss_pred ccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCH
Q 003846 664 NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743 (791)
Q Consensus 664 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 743 (791)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... ....+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~----~~~~~~----------~~~~p~ 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF----ELILME----------DIKFPR 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHH----HHhccC----------CccCCC
Confidence 3357899999999999999999999999999999999999997532111 000 000000 001122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 744 PMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 744 ~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
..+..+.+++.+||+.||++|| ++.|++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3456788999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=320.95 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=206.2
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46788999999999999999988788899999986533 34578899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998543 3345788889999999999999999987 999999999999999999999999999876543221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......++..|+|||.+....++.++||||||+++|+|++ |+.|+...... ..... ..... ..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~----~~~~~---------~~ 223 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA----LQRGY---------RM 223 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH----HHcCC---------CC
Confidence 1122345678999999998889999999999999999998 88887532211 11111 11110 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
......+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=320.20 Aligned_cols=255 Identities=29% Similarity=0.425 Sum_probs=205.9
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.+.||+|++|.||+|...+++.||||.++... ...+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46788899999999999999987778899999986543 34577899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346789999999999999999999988 999999999999999999999999999876533211
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.......+..|+|||.+.+..++.++||||||++++||++ |+.|+...... . ........ ...
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~----~~~~~~~~---------~~~ 223 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--E----VLQQVDQG---------YRM 223 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--H----HHHHHHcC---------CCC
Confidence 1111223458999999999999999999999999999999 88886532111 0 11111110 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..+...+..+.+++.+|++.+|.+||++.++++.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1112245678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=324.29 Aligned_cols=257 Identities=31% Similarity=0.474 Sum_probs=203.4
Q ss_pred cCCCccceecccCceeEEEeEe-----eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.+|++.++||+|+||.||+|.. ..++.+|+|.+.... .+...++.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677889999999999999964 246789999997543 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhcc--------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 576 IYEYLPNKSLDSFLFDRAK--------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
||||+++++|.+++..... ...+++..+..++.|+++||.|||+++ ++||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 235778888999999999999999988 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 003846 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHA 720 (791)
Q Consensus 642 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 720 (791)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~--- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVI--- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHH---
Confidence 999999999987644332222333456778999999998889999999999999999998 8888643211 1111
Q ss_pred hHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 721 WDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
......... ..+...+..+.+++.+||+.||++||++.+++++|..
T Consensus 237 -~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 -EMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111100 1111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=322.10 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=210.6
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
...+|++.++||.|+||.||+|...+++.+|+|.+.........++.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34678899999999999999998878999999999877665677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999998543 2345788999999999999999999988 99999999999999999999999999987644322
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+...... ... ...... ..
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~----~~~~~~---------~~ 222 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVY----DQITAG---------YR 222 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHH----HHHHhC---------Cc
Confidence 11 12345678999999998899999999999999999998 78887543211 111 111100 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11122345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=319.64 Aligned_cols=252 Identities=29% Similarity=0.427 Sum_probs=201.8
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
++|++.+.||+|+||.||+++..++..+|+|.+... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999998888889999988643 3345688999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+|+|.+++... ...+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988532 235788999999999999999999988 9999999999999999999999999998654332211
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...... ...... . .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~----i~~~~~--~-------~ 221 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEM----ISRGFR--L-------Y 221 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHCCCC--C-------C
Confidence 112234568999999998889999999999999999999 8888653221 111111 111100 0 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
.+...+..+.+++.+||+.+|.+||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11113457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=349.29 Aligned_cols=258 Identities=22% Similarity=0.284 Sum_probs=205.6
Q ss_pred hhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC---
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD--- 571 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 571 (791)
....++|++.+.||+|+||+||+++. .+|+.||||++... .......+.+|+.++..++|+|++++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34567999999999999999999964 57999999998654 3344567889999999999999999988775433
Q ss_pred -----cceEEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 572 -----EKILIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 572 -----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 2579999999999999986533 3456888899999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... ....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~-~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVM-HKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHH-HHHh
Confidence 999999876543322333446799999999999999999999999999999999999999753211 0000 0000
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... . ...+...+..+.+++.+||+.||.+||++.+++++
T Consensus 259 ~~~----~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR----Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC----C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000 0 11122345678999999999999999999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.52 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=198.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999764 688999999875432 234567889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|++ ++|.+++.. ....++++.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777643 3345788899999999999999999988 9999999999999999999999999987543221
Q ss_pred cccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC--------c
Q 003846 659 LQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR--------A 729 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~ 729 (791)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........+. .......... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE-RIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhCCCChhhccchhh
Confidence 11223467899999999875 4588999999999999999999999865332111110 0000000000 0
Q ss_pred cccccc-ccc--CCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDP-ILE--NEAS-------YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~-~l~--~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+ ... .... ...+..+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 000 0000 0123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.61 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=198.3
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.++||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57899999999999999999654 68899999986543 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++ +|.+++.. ....++...+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 88888743 2345788889999999999999999988 9999999999999999999999999997643222
Q ss_pred ccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH--------HhhcCCcc
Q 003846 660 QANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD--------LWKDNRAL 730 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~ 730 (791)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....... .+......
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE--ELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhccccc
Confidence 11223467899999999875 568999999999999999999999975432110 0000000 00000000
Q ss_pred ----ccccccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 ----DLMDPILENE----ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ----~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+..... .......++.+++.+||+.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 011234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.70 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=203.0
Q ss_pred hccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
..++|++.+.||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998643 25679999986432 2345678899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc-------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK-------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
.++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234567788899999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... . .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~----~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--Q----VLRFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--H----HHHHH
Confidence 99999986544332222222345778999999999899999999999999999999 67776532211 1 11111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...... ..+...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111100 0111234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=325.64 Aligned_cols=261 Identities=28% Similarity=0.461 Sum_probs=208.4
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888999999999999999642 34568999997766666778999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhc----------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeE
Q 003846 575 LIYEYLPNKSLDSFLFDRA----------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPK 644 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k 644 (791)
+||||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999985432 2235889999999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHH
Q 003846 645 ISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDL 723 (791)
Q Consensus 645 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 723 (791)
|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..|+...... .. ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~----~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EV----IEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHH
Confidence 999999986644332222223345778999999998899999999999999999998 88886432211 11 111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
........ .+...+..+.+++.+||+.+|.+|||+.|+++.|++...
T Consensus 235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111000 111234578999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=330.13 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=201.3
Q ss_pred cCCCccceecccCceeEEEeEee-CCc----EEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQ----EVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.+|++.+.||+|+||.||+|... +++ .||||+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999753 343 48999987543 34457788999999999999999999999764 5789
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
++||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999854 2345788889999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~----~~~~~~~------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI----SSILEKG------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHhCC-------
Confidence 4332222222344678999999999999999999999999999998 89887532111 00 0111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.....+......+.+++.+||+.+|.+||++.|++..|....
T Consensus 228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000111123457889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=314.71 Aligned_cols=256 Identities=23% Similarity=0.279 Sum_probs=207.1
Q ss_pred hccCCCccceecccCceeEEEeEeeC-CcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..+.|+++++||+|.-|+||++++.+ +..+|+|++.+.. .+...+.+.|-+||+.++||.++.|+..++.++..+|
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34678888999999999999998765 5889999998753 4456677889999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
+||||+||+|..+++ .+..+.++.+.++.++.+|+-||+|||..| ||.|||||+||||.++|++.|+||.|+..+.
T Consensus 155 ~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999875 456678999999999999999999999998 9999999999999999999999999975431
Q ss_pred C---------------------------------Ccc---------------------ccccccccccCcccCchhcccC
Q 003846 656 G---------------------------------DEL---------------------QANTNRIVGTYGYMSPEYALEG 681 (791)
Q Consensus 656 ~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~ 681 (791)
. ... .......+||..|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1 000 0011235899999999999999
Q ss_pred CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCC
Q 003846 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENA 761 (791)
Q Consensus 682 ~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp 761 (791)
..+.++|.|+|||+||||+.|..||........ ...++.+.+.-...+..+..+++||++.|..||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 999999999999999999999999865433211 011111111111112345788999999999999
Q ss_pred CCCCC----HHHHHHH
Q 003846 762 TDRPT----MSEVVSM 773 (791)
Q Consensus 762 ~~RPt----~~evl~~ 773 (791)
++|.. +.||.++
T Consensus 377 ~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhccccchHHhhcC
Confidence 99998 8887765
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=332.26 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=194.9
Q ss_pred ceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 508 NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.||+|+||.||+++. .+|+.||+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999965 46899999998754 2334556778999999999999999999999999999999999999
Q ss_pred ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccc
Q 003846 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT 663 (791)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 663 (791)
+|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888743 346788999999999999999999988 9999999999999999999999999987532221 112
Q ss_pred ccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCH
Q 003846 664 NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743 (791)
Q Consensus 664 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 743 (791)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ... ....... ...+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~----~~~~~~~----------~~~p~ 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLF----ELILMEE----------IRFPR 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHH----HHHhcCC----------CCCCC
Confidence 2357899999999999999999999999999999999999997532211 000 0000000 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 744 PMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 744 ~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
..+..+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 3456788999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=370.11 Aligned_cols=263 Identities=27% Similarity=0.446 Sum_probs=210.9
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
...|...+.||+|+||.||+|.. .+++.||||++...... ..+|++++++++|||||+++++|.+++..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577778999999999999976 57899999998654322 23568899999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++|+|.+++. .++|..+.+++.||++||+|||.+...+|+||||||+||+++.++..++. |+........
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999983 37899999999999999999997655669999999999999999988875 6665432211
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
....+++.|+|||++.+..++.++|||||||++|||++|+.|+............+.............+++.+..
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1236789999999999999999999999999999999999998544333344444544433334444455555533
Q ss_pred C--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCC
Q 003846 740 E--ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780 (791)
Q Consensus 740 ~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 780 (791)
. .......++.+++.+||+.||++||||+|++++|+++...
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 2 3345667888999999999999999999999999886543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.40 Aligned_cols=260 Identities=30% Similarity=0.442 Sum_probs=203.0
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC-C
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ-D 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 571 (791)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 458999999999999999999532 35789999987543 22345678899999999 899999999988754 5
Q ss_pred cceEEEeecCCCChhHHHhhhcc---------------------------------------------------------
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAK--------------------------------------------------------- 594 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 594 (791)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999853211
Q ss_pred -ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCccc
Q 003846 595 -KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673 (791)
Q Consensus 595 -~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~ 673 (791)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 135788999999999999999999988 9999999999999999999999999998764433222233345677899
Q ss_pred CchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHH
Q 003846 674 SPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNV 752 (791)
Q Consensus 674 aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 752 (791)
|||++.+..++.++|||||||+||||++ |..|+....... . ......... ....+......+.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~----~~~~~~~~~---------~~~~~~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E----FCRRLKEGT---------RMRAPEYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H----HHHHHhccC---------CCCCCccCCHHHHHH
Confidence 9999999999999999999999999998 998875322111 0 001111110 001112234678999
Q ss_pred HHHccccCCCCCCCHHHHHHHhccC
Q 003846 753 ALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 753 i~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
+.+||+.+|++||++.|++++|+..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.83 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=204.6
Q ss_pred ccCCCccceecccCceeEEEeEeeC----CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+|.... ...||||.+.... .....++.+|+.++++++||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999997642 4579999987543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
+|||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 346889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .. ........
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~----~~~~~~~~------ 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DV----IKAVEDGY------ 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HH----HHHHHcCC------
Confidence 2222222222345678999999998899999999999999999998 88886432211 11 11111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...+..+.+++.+||+.+|++||++.|++++|+..
T Consensus 226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011122356789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.00 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=201.6
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.++||+|+||.||++... +++.+|+|++... .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999765 5888999988654 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++.. ...+++..+..++.|+++||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999843 345788888999999999999999742 39999999999999999999999999987653321
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchh-h-----h-hhH---------
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLL-G-----H-AWD--------- 722 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~-~-----~-~~~--------- 722 (791)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+........... . . ...
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1234688999999999998999999999999999999999999764322110000 0 0 000
Q ss_pred -----HhhcCC-----ccccccccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 -----LWKDNR-----ALDLMDPILENE----ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 -----~~~~~~-----~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...... .....+...... .......++.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000 000000000000 001134678999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.53 Aligned_cols=242 Identities=26% Similarity=0.325 Sum_probs=194.0
Q ss_pred ceecccCceeEEEeEe----eCCcEEEEEEeccc----CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 508 NKLGEGGFGPVYKGEL----LNGQEVAVKRLSKK----SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++||+|+||.||+++. .+++.||||++.+. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999965 35789999998753 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ...+....+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999998843 345677888899999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... . .. ...... . .
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~---~~-~~~~~~--------~--~ 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--K---TI-DKILKG--------K--L 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--H---HH-HHHHcC--------C--C
Confidence 1122357899999999999988999999999999999999999997532211 0 00 000000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
..+...+..+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11222346788999999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=341.37 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=212.1
Q ss_pred cCCCccceecccCceeEEEeEeeC----CcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
....+.+.||.|.||.|++|+++- ...||||.++.. .+....+|..|+.||.+.+||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345577899999999999998753 346999999865 345677899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
.|||++|+|+.||.. +.+.+.+.+..-++++||.||+||-+.+ .+||||.++|||++.+..+|++|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999954 4466888899999999999999999988 99999999999999999999999999998765
Q ss_pred Ccc-ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 657 DEL-QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 657 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
+.. ...+..-.-+..|.|||.+...+++.++||||||++|||.++ |.+|+=... +.+....++
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---------------NQdVIkaIe 848 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---------------NQDVIKAIE 848 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---------------hHHHHHHHH
Confidence 541 111111122468999999999999999999999999999776 888843222 222333333
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.-.+-..+++.+..|.+|+..|||.|-.+||++.|++.+|.+.
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 4444456667888999999999999999999999999999774
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.77 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=196.3
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.|++.+.||+|+||+||+|.. .+++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999955 468899999997542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999843 345788888999999999999999988 9999999999999999999999999976432100
Q ss_pred c---------------------------------------------ccccccccccCcccCchhcccCCCCcccceeehh
Q 003846 659 L---------------------------------------------QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFG 693 (791)
Q Consensus 659 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 693 (791)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001234799999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 003846 694 VLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALL--CVHENATDRPTMSEVV 771 (791)
Q Consensus 694 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dp~~RPt~~evl 771 (791)
|++|||++|+.||......... ...... ...+.-......+..+.+++.+ |+..+|..||++.|++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~-----~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ-----LKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH-----HHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999997643211100 000000 0000111111234677888887 5556666799999998
Q ss_pred HH
Q 003846 772 SM 773 (791)
Q Consensus 772 ~~ 773 (791)
++
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.46 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=196.2
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
++||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999764 68999999876543 33456789999999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
.+++.. ....+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999843 2345788999999999999999999988 99999999999999999999999999876543221111111
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYP 744 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 744 (791)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+....... ....... ......+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~---------~~~~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQ---------GVRLPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHc---------CCCCCCccc
Confidence 223467999999999899999999999999999998 887764322110 0011110 011111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 745 MLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
.+..+.+++.+||+.+|++|||+.|++++|.
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=335.16 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=203.3
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||+||+|+.. +++.||||++.+.. ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999764 68999999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++... ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56888999999999999999999988 999999999999999999999999999865433
Q ss_pred c---------------------------cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCC
Q 003846 658 E---------------------------LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYH 710 (791)
Q Consensus 658 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~ 710 (791)
. .........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223578999999999999999999999999999999999999975432
Q ss_pred CCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 003846 711 TGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPT-MSEVVSM 773 (791)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~ 773 (791)
.. .. ....... ...+.-......+..+.+++.+|++ ||.+||+ ++|++++
T Consensus 235 ~~-----~~-~~~i~~~------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ-----ET-YNKIINW------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-----HH-HHHHhcc------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 00 0000000 0000101111145778899999998 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=316.70 Aligned_cols=270 Identities=27% Similarity=0.407 Sum_probs=208.3
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHh--cCCCceeeeeeEEEcCC----cce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAK--LQHRNLVRLLGCCLDQD----EKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~ 574 (791)
.++..+.+.||+|.||.||+|++ .|+.||||++...++ ..+.+|.+|.+. |+|+||+.+++.-..++ +++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45678889999999999999988 699999999976554 456677777765 59999999998876554 568
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhh-----ccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH-----QYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-----~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
||.+|.++|||.+||. ...++.+..++++..+|.||++|| .++++.|.|||||++||||..++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999994 367889999999999999999999 4678899999999999999999999999999
Q ss_pred cccccCCC--ccccccccccccCcccCchhcccCC----C--CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh--
Q 003846 650 MARMFGGD--ELQANTNRIVGTYGYMSPEYALEGL----F--SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH-- 719 (791)
Q Consensus 650 la~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~-- 719 (791)
||...... ......+..+||..|||||++.+.. + =..+||||||.|+||+..+..--+........+.+.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99877654 3444556789999999999997542 2 146999999999999987542211111111111111
Q ss_pred ---hhHHhhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 720 ---AWDLWKDNRALDLMDPILENE-ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 720 ---~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..+........+.+.|.+... ...+....+.++++.||..+|..|.|+-.+.+.|.++.
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 112223333344444444332 44557788899999999999999999999999988754
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=320.46 Aligned_cols=265 Identities=29% Similarity=0.421 Sum_probs=205.7
Q ss_pred ccCCCccceecccCceeEEEeEeeC-----------------CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-----------------GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVR 562 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 562 (791)
.++|++.+.||+|+||.||++.... +..||+|++.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999986532 2468999987543 334678899999999999999999
Q ss_pred eeeEEEcCCcceEEEeecCCCChhHHHhhhc--------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCc
Q 003846 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRA--------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634 (791)
Q Consensus 563 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~N 634 (791)
+++++..++..++++||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986533 1235788999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh--CCCCCCCCCCC
Q 003846 635 ILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS--GKKNTGFYHTG 712 (791)
Q Consensus 635 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt--g~~p~~~~~~~ 712 (791)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ +..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986654433333334456789999999998889999999999999999998 455543221
Q ss_pred ccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 713 SLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...........+....... ....+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111111111111000 011112234689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.15 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=204.7
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.+|++.++||+|+||.||+|... .++.||+|++... ....+++.+|++++++++|+||+++++++..+...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999654 5889999998654 334677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ....+++..++.++.|+++||+|||+++ ++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998542 2345788999999999999999999987 999999999999999999999999999876543221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
. ......+..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..+..... ....
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~---------~~~~ 224 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEK---------GYRM 224 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHC---------CCCC
Confidence 1 112234568999999999999999999999999999998 88886532111 11111111 0111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
..+...+..+.+++.+||+.+|++|||+.|++++|+..
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12223456789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=313.85 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=195.0
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----cceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD-----EKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 575 (791)
-.|...+++|.|+||.||+|.+. +++.||||+.-...+. -.+|+++|+++.|||||+++.+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35667789999999999999764 4789999998655432 246899999999999999999886432 2358
Q ss_pred EEeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeeeccccc
Q 003846 576 IYEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARM 653 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgla~~ 653 (791)
||||||. +|.+++... ..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 888888542 23556777888899999999999999987 9999999999999976 9999999999998
Q ss_pred cCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc--
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL-- 730 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 730 (791)
+...+.. .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|...+.. ..+. ...+.+......
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~-eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLV-EIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHH-HHHHHhCCCCHHHH
Confidence 7654432 234668899999999876 7999999999999999999999887653221 1111 111111111100
Q ss_pred --------cccccccc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 --------DLMDPILE-----NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 --------~~~~~~l~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.-.+.+. .-.....+++..+++.++|+++|.+|.++.|++.+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111111 11223356788999999999999999999998754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.16 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=194.4
Q ss_pred cCCCccceecccCceeEEEeEee--CCcEEEEEEecccC--cccHHHHHHHHHHHHhc---CCCceeeeeeEEEc-----
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL--NGQEVAVKRLSKKS--GQGLEELKNETMLIAKL---QHRNLVRLLGCCLD----- 569 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 569 (791)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47889999999999999999752 46889999886542 22234566788777766 69999999999863
Q ss_pred CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 570 QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
....++||||++ ++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 5898888543 2345788999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc---
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD--- 726 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 726 (791)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCCh
Confidence 99865433 2223456899999999999889999999999999999999999997643221 111111000000
Q ss_pred CCc---cccccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 NRA---LDLMDPILEN-------EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ~~~---~~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... .......... ......+..+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 0000000000 0011234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.53 Aligned_cols=271 Identities=26% Similarity=0.400 Sum_probs=202.6
Q ss_pred cCCCccceecccCceeEEEeEe-----eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccce
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKI 574 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 574 (791)
++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788889999999999999864 35789999999877666677899999999999999999999987543 4578
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+|+||+++++|.+++... ...+++..+..++.|+++||+|||+++ ++||||||+||+++.++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 345889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccc-ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH-HhhcCCcccc
Q 003846 655 GGDELQA-NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD-LWKDNRALDL 732 (791)
Q Consensus 655 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 732 (791)
....... ......++..|+|||++.+..++.++||||||++++||++|..++................ ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4332111 1111233456999999998899999999999999999999877643221110000000000 0000000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
+........+...+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 110001111223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.48 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=199.2
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999664 68999999997532 234566789999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999843 345888999999999999999999988 999999999999999999999999998754321
Q ss_pred cccc------------------------------------ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh
Q 003846 658 ELQA------------------------------------NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701 (791)
Q Consensus 658 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt 701 (791)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003846 702 GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPT---MSEVVSM 773 (791)
Q Consensus 702 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~ 773 (791)
|..||...... . ......... ..+.-......++.+.+++.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~--~---~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQ--E---TYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHH--H---HHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99997533211 0 000000000 000000111234678899999997 9999997 9998775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.14 Aligned_cols=256 Identities=28% Similarity=0.451 Sum_probs=204.6
Q ss_pred cCCCccceecccCceeEEEeEee------CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.+|+..++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999999532 356899999887766667889999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhcc------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCe
Q 003846 576 IYEYLPNKSLDSFLFDRAK------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP 643 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 643 (791)
+|||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135788999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhH
Q 003846 644 KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 644 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 722 (791)
||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~----~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAI----E 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHH----H
Confidence 9999999976543322222223345678999999999999999999999999999998 88886432211 000 0
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
...... ....+...+..+.+++.+||+.||++||++.||++.|+
T Consensus 236 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000000 01111223467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.40 Aligned_cols=261 Identities=30% Similarity=0.451 Sum_probs=206.7
Q ss_pred hhccCCCccceecccCceeEEEeEeeC------CcEEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
...++|++.+.||+|+||.||++.... ...+|+|++... ..+...++.+|+.++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678889999999999999997532 367999998754 233456788999999999 799999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhh-------------ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 571 DEKILIYEYLPNKSLDSFLFDR-------------AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
+..+++|||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998542 22456888999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccch
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNL 716 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~ 716 (791)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--E- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--H-
Confidence 9999999999999987654332222222345678999999999999999999999999999997 88886432211 0
Q ss_pred hhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
......... ....+...+..+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 243 ---~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111110 1111223356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.38 Aligned_cols=265 Identities=26% Similarity=0.418 Sum_probs=201.9
Q ss_pred ccCCCccceecccCceeEEEeEeeC---------------CcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN---------------GQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLL 564 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~ 564 (791)
.++|++.++||+|+||.||++.... ...||||+++.. .....+.+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3589999999999999999986532 235899998754 233456789999999999999999999
Q ss_pred eEEEcCCcceEEEeecCCCChhHHHhhhcc---------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcE
Q 003846 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAK---------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 635 (791)
Q Consensus 565 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NI 635 (791)
+++...+..++||||+++++|.+++..... ...+++..+..++.|+++||+|||+++ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854321 124678888999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhC--CCCCCCCCCCc
Q 003846 636 LLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG--KKNTGFYHTGS 713 (791)
Q Consensus 636 Ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg--~~p~~~~~~~~ 713 (791)
+++.++.+||+|||++................++..|+|||++.+..++.++||||||+++++|+++ ..|+.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 9999999999999999765433222222233457789999999988999999999999999999984 445433221
Q ss_pred cchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..........+...... .....+...+..+.+++.+||+.+|++||++.+|++.|..
T Consensus 239 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111111000 0011111234689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.63 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=202.1
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
++|++.+.||+|+||.||+++..++..+|||.+.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999987777789999886433 345778999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998542 236789999999999999999999988 9999999999999999999999999988654332211
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... ........ ..
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~----~~~~~~~~---------~~ 221 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETV----EKVSQGLR---------LY 221 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHH----HHHhcCCC---------CC
Confidence 112245678999999998889999999999999999998 88886533211 010 11111100 00
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
.+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.79 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=195.3
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----cce
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD-----EKI 574 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 574 (791)
+|++.++||+|+||.||+|.. .+++.||||++... ......++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 578889999999999999965 46899999998643 2233456889999999999999999999886432 469
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688888742 345889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcc-ccccccccccCcccCchhccc--CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhh-----------
Q 003846 655 GGDEL-QANTNRIVGTYGYMSPEYALE--GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA----------- 720 (791)
Q Consensus 655 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~----------- 720 (791)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHH
Confidence 32211 111233578999999999876 67899999999999999999999997543211 000000
Q ss_pred hHHhhcCCccccccccccCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 721 WDLWKDNRALDLMDPILENE------ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
............+....... ........+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000110000000 001123567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.23 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=201.3
Q ss_pred CCccceecccCceeEEEeEeeC----CcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc-----
Q 003846 504 FSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE----- 572 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 572 (791)
|.+.+.||+|+||.||+|.... +..||||+++... ....+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999997642 3679999987542 3345678999999999999999999999876554
Q ss_pred -ceEEEeecCCCChhHHHhhhc---cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 573 -KILIYEYLPNKSLDSFLFDRA---KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 573 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985532 2346888899999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
|+++................+..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~----~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYD----YLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHH----HHHcC
Confidence 99987654332222222345678999999988899999999999999999999 8888643221 11111 11111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.. ...+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 232 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 111223456889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=319.14 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=203.2
Q ss_pred hccCCCccceecccCceeEEEeEeeC------CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
.+++|.+.+.||+|++|.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45778999999999999999997643 5678999886543 3344678999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc----ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC---CeEE
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK----KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM---KPKI 645 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl 645 (791)
.++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999855321 235888999999999999999999988 99999999999998765 5999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VM----EFV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----HHH
Confidence 99999987643332222222234568999999999999999999999999999997 888875322111 11 111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
... .....+...+..+.+++.+|++.+|++||++.||+++|.
T Consensus 235 ~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 011112233567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.57 Aligned_cols=257 Identities=31% Similarity=0.469 Sum_probs=202.9
Q ss_pred cCCCccceecccCceeEEEeEeeC------CcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.+|++.++||+|+||.||+|...+ ++.||||++...... ..+.+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357778899999999999997532 578999999755432 3466889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 575 LIYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
+++||+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1235788889999999999999999988 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 003846 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHA 720 (791)
Q Consensus 642 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 720 (791)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...... ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~---- 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DV---- 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HH----
Confidence 999999999886644332222233456789999999998889999999999999999998 77776432111 11
Q ss_pred hHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 721 WDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
......... ...+...+..+.+++.+||+.+|.+||+++|+++.|+.
T Consensus 236 ~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111111 11122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.38 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=196.9
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.++||+|+||.||++.. .+++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999965 46899999998653 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999843 345788889999999999999999998 999999999999999999999999999643211
Q ss_pred cc-------------c--------------------------------cccccccccCcccCchhcccCCCCcccceeeh
Q 003846 658 EL-------------Q--------------------------------ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSF 692 (791)
Q Consensus 658 ~~-------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 692 (791)
.. . .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 00012468999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHH
Q 003846 693 GVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDR---PTMSE 769 (791)
Q Consensus 693 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~e 769 (791)
||++|||++|+.||...... .... ....... .+.-......+..+.+++.+|++ +|.+| +++.|
T Consensus 235 Gvil~elltG~~Pf~~~~~~--~~~~---~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSH--ETYR---KIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHH--HHHH---HHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 99999999999997532211 1000 0000000 00000011234678899999998 66665 69999
Q ss_pred HHHHh
Q 003846 770 VVSML 774 (791)
Q Consensus 770 vl~~L 774 (791)
++++-
T Consensus 302 ~l~hp 306 (377)
T cd05629 302 IKSHP 306 (377)
T ss_pred HhcCC
Confidence 98863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=302.06 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=201.0
Q ss_pred ccCCCccceecccCceeEEEe-EeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++.|++.+.||+|.|+.||+. ...+|+.+|+|++... ...+.+++.+|++|-+.|+||||+++.+...+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 567888899999999999998 4567999999987532 3447789999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgla~~~ 654 (791)
|+|.|++|..-+-. +-..++..+-..++||++||.|+|.++ |+|||+||+|+||.. .-.+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999655532 244566777889999999999999998 999999999999953 345999999999988
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
++... -....|||.|||||++...+|+..+|||+-|||||-|+.|.+||-... ...+.+.. ..... |
T Consensus 164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I----~~g~y----d 230 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQI----KAGAY----D 230 (355)
T ss_pred CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHH----hcccc----C
Confidence 74332 223589999999999999999999999999999999999999964322 22222111 11100 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+..-...+++.++|+++||..||.+|.|+.|.+.+
T Consensus 231 --~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 --YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred --CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 0011112245788999999999999999999998764
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=335.19 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=195.1
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
+|++.++||+|+||+||+|+. .+++.||||++.+.. ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999965 468899999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999843 245788888999999999999999988 9999999999999999999999999975331100
Q ss_pred c---------------------------------------------ccccccccccCcccCchhcccCCCCcccceeehh
Q 003846 659 L---------------------------------------------QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFG 693 (791)
Q Consensus 659 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 693 (791)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 003846 694 VLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPT---MSEV 770 (791)
Q Consensus 694 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~ev 770 (791)
|+||||++|+.||....... ........ ............++.+.+++.+|+ .+|.+|++ +.|+
T Consensus 236 vil~elltG~~Pf~~~~~~~-----~~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLE-----TQMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHH-----HHHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999985432110 00000000 000111111223456778888876 49999997 8887
Q ss_pred HHH
Q 003846 771 VSM 773 (791)
Q Consensus 771 l~~ 773 (791)
+++
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.64 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=208.0
Q ss_pred hccCCCccceecccCceeEEEeEeeC-----CcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc-CCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN-----GQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD-QDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 572 (791)
..++|++.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788999999999999999997765 688999988654 23346778899999999999999999998876 467
Q ss_pred ceEEEeecCCCChhHHHhhhccc-----cccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEee
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKK-----RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISD 647 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 647 (791)
.++++||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 56889999999999999999999987 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhc
Q 003846 648 FGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 648 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+..... ..+.. ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAA----YLKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHH----HHHc
Confidence 999986644332222223345678999999998899999999999999999999 9988753211 11111 1111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
.. ........++.+.+++.+||+.||++|||+.|+++.|++.+.
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 000111234678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.65 Aligned_cols=242 Identities=23% Similarity=0.284 Sum_probs=194.3
Q ss_pred ceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 508 NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.||+|+||.||++.. .+|+.||+|++.+. .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 46899999999754 2234566788999999999999999999999999999999999999
Q ss_pred ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99888743 3468889999999999999999997 56 9999999999999999999999999987533221 11
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~----~~~i~~~~----------~~~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KL----FELILMEE----------IRFP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HH----HHHHhcCC----------CCCC
Confidence 22346899999999999999999999999999999999999997532211 00 00000000 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+..+.+++.+||+.||++|+ ++.|++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 22346788999999999999996 89999866
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.70 Aligned_cols=245 Identities=26% Similarity=0.356 Sum_probs=193.8
Q ss_pred CCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHH---HhcCCCceeeeeeEEEcCCcceEE
Q 003846 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLI---AKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
|++.+.||+|+||.||++... +++.||||++++.. ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999654 68999999997542 23345667776665 456799999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 346889999999999999999999988 99999999999999999999999999875322
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.|+...... ... .......
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~----~~i~~~~-------- 217 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVF----DSIVNDE-------- 217 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhCC--------
Confidence 11 1223457899999999999999999999999999999999999997532211 000 0000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011122356788999999999999999 57777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=332.66 Aligned_cols=260 Identities=18% Similarity=0.201 Sum_probs=195.7
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
...+|++.++||+|+||.||++.. .+++.||+|+... ..+.+|++++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 346899999999999999999955 5689999997532 356789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
++. ++|..++.. ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 985 688877733 345788999999999999999999988 9999999999999999999999999997533221
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCC--cc---chhhhhhHHhhcC------
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTG--SL---NLLGHAWDLWKDN------ 727 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~--~~---~~~~~~~~~~~~~------ 727 (791)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+-..... .. .............
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 11222457999999999999999999999999999999999999875321110 00 0000000000000
Q ss_pred C----ccccc----cc-c-ccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 R----ALDLM----DP-I-LENE-----ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ~----~~~~~----~~-~-l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ..+.. .. . .... .....+..+.+++.+||+.||++|||++|++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00000 00 0 0000 011245678899999999999999999999965
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.16 Aligned_cols=265 Identities=29% Similarity=0.444 Sum_probs=202.6
Q ss_pred ccCCCccceecccCceeEEEeEee-----------------CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-----------------NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVR 562 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 562 (791)
.++|++.++||+|+||.||+++.. ++..+|+|++... .....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998532 2346899998754 3334578899999999999999999
Q ss_pred eeeEEEcCCcceEEEeecCCCChhHHHhhhcc--------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCc
Q 003846 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAK--------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634 (791)
Q Consensus 563 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~N 634 (791)
+++++..++..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 134677889999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh--CCCCCCCCCCC
Q 003846 635 ILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS--GKKNTGFYHTG 712 (791)
Q Consensus 635 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt--g~~p~~~~~~~ 712 (791)
||++.++.++|+|||+++.+.............++..|+|||....+.++.++||||||+++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 9999999999999999986544332222222344678999999888889999999999999999998 5566543221
Q ss_pred ccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 713 SLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..........+.... .... . ..+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 240 -~~~~~~~~~~~~~~~-~~~~---~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 -EQVIENTGEFFRDQG-RQVY---L--PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHHHHHhhcc-cccc---C--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111110 0000 0 1111234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=332.15 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=195.8
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||+||++... +++.||||++.+.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999654 58999999997542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999843 346889999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------------cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCC
Q 003846 658 ELQ---------------------------------ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKK 704 (791)
Q Consensus 658 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~ 704 (791)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 003846 705 NTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVH--ENATDRPTMSEVVSM 773 (791)
Q Consensus 705 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~--~dp~~RPt~~evl~~ 773 (791)
||...... ... ....... ... .... ..+.+..+.+++.+++. .++..||+++|++++
T Consensus 235 Pf~~~~~~--~~~----~~i~~~~-~~~---~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQ--ETY----KKVMNWK-ETL---IFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHH--HHH----HHHHcCc-Ccc---cCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 97532211 110 0000000 000 0011 11234567778877554 234456899999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.96 Aligned_cols=257 Identities=28% Similarity=0.393 Sum_probs=200.1
Q ss_pred cCCCccceecccCceeEEEeEee-CCc----EEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQ----EVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
++|++.+.||+|+||.||+|... +++ .+++|.+.... .....++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 56788899999999999999753 344 47888875433 233467888999999999999999999875 456789
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999853 3346889999999999999999999988 9999999999999999999999999998664
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~--- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--V----PDLLEKGERLA--- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHCCCcCC---
Confidence 4332222333456778999999998899999999999999999998 888875332111 0 11111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
.+......+.+++.+||..+|++|||+.|++++|.....
T Consensus 232 ------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 ------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 011123467889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=313.41 Aligned_cols=260 Identities=23% Similarity=0.376 Sum_probs=207.1
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||+|+. .+++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999965 46899999987642 2333456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
||+++++|.+++.... ....++.+.+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999885432 2345788889999999999999999988 99999999999999999999999999887653
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+........... ...... .
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~--------~ 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC----QKIEQC--------D 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH----HHHhcC--------C
Confidence 321 11234678899999999988899999999999999999999999643221111111 000000 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.........+..+.+++.+||+.+|++||++.|+++.|++..
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 011112234567899999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=326.30 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=193.5
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||+|+.. +++.||||++.+. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999664 5789999998754 233455677899998876 799999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999988843 345788889999999999999999988 9999999999999999999999999987543221 12
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ... ....... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~----~~i~~~~----------~~~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLF----ESILHDD----------VLYP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHH----HHHHcCC----------CCCC
Confidence 23356899999999999999999999999999999999999997643211 111 0010100 0011
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRP-------TMSEVVSM 773 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RP-------t~~evl~~ 773 (791)
...+..+.+++.+||+.||++|| ++.+++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12346788999999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=324.36 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=198.1
Q ss_pred CCCccceecccCceeEEEeEe----eCCcEEEEEEeccc----CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcc
Q 003846 503 NFSAENKLGEGGFGPVYKGEL----LNGQEVAVKRLSKK----SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 573 (791)
+|++.++||+|+||.||+++. .+++.||+|++.+. .....+.+.+|+.++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999865 35789999998653 223346678899999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++|+|.+++.. ...++++.+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999843 345788999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.|+........ ..........
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~------ 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILK------ 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhc------
Confidence 5332211 12235789999999999865 478999999999999999999999864322111 0011110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
.++ ..+...+..+.+++.+||+.||++|| +++|++++
T Consensus 226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011 11122446788999999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.62 Aligned_cols=252 Identities=30% Similarity=0.442 Sum_probs=201.5
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
.+|++.+.||+|+||.||++...++..+|+|++.... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578889999999999999987777789999986433 234678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998532 236789999999999999999999988 9999999999999999999999999997654322111
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... ...... ....
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~~~~---------~~~~ 221 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVV----ESVSAG---------YRLY 221 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHH----HHHHcC---------CcCC
Confidence 111223457999999999999999999999999999999 78887543211 111 001000 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
.+...+..+.+++.+||+.+|++|||+.|++++|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11224568999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.97 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=199.8
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHh--cCCCceeeeeeEEEcCC----cceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAK--LQHRNLVRLLGCCLDQD----EKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~l 575 (791)
......+.||+|.||.||||.+ +++.||||++... ..+.|++|-.|.+. ++|+||+++++.-.... +..|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445567999999999999998 5699999999654 34677778777765 48999999999887665 7899
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc------CCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY------SRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
|+||.+.|+|.++| +...++|....+++..+++||+|||+. .+++|+|||||.+||||..|++..|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 446799999999999999999999963 35789999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCC-CC-----cccceeehhHHHHHHHhCCCCCCCCCCC--cc-------
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGL-FS-----IKSDVFSFGVLLLEILSGKKNTGFYHTG--SL------- 714 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslGvvl~elltg~~p~~~~~~~--~~------- 714 (791)
||..+............+||..|||||++.+.. +. .+.||||+|.|||||+++..-....... ..
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999886554444444479999999999998652 33 4689999999999999976543211111 11
Q ss_pred --chhhhhhHHhhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 715 --NLLGHAWDLWKDNRALDLMDPILENE-ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 715 --~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
...+..+.. ...+..+|.+... .....+..+++.+..||..||+.|.|+.=|.+.+....
T Consensus 442 ~hPt~e~mq~~----VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTLEEMQEL----VVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCCHHHHHHH----HHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 111111111 1112222222211 11134567889999999999999999987777665533
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.90 Aligned_cols=271 Identities=27% Similarity=0.402 Sum_probs=201.7
Q ss_pred cCCCccceecccCceeEEEeEe-----eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccc
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEK 573 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 573 (791)
+-|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3568889999999999999963 357889999987543 33456789999999999999999999998875 567
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235789999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|...........................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433211 111234567789999999988999999999999999999998765322110000000000000000000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
+............+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000111222456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=332.40 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=200.9
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
...++|++.++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999654 6889999998643 2233456788999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|.+++.. ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998843 34778888899999999999999988 999999999999999999999999999865
Q ss_pred CCCccccccccccccCcccCchhcccC----CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEG----LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . ..........
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~----~~~~i~~~~~- 264 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G----TYSKIMDHKN- 264 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--H----HHHHHHcCCC-
Confidence 43221 112235789999999998753 4789999999999999999999997542211 0 0111111000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATD--RPTMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 773 (791)
.+.-......+..+.+++.+||+.+|.+ ||++.|++++
T Consensus 265 -----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000111124568889999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.73 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=200.5
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||++.. .+++.||||++++.. ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999965 468999999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 346888999999999999999999988 999999999999999999999999999876433
Q ss_pred ccccccccccccCcccCchhcc------cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYAL------EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~--- 226 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQR--- 226 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCC---
Confidence 221 222346899999999987 456789999999999999999999997532211 00001010000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+.-......+..+.+++..|++ +|.+|||+.+++++
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 ----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01101111245678899999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.24 Aligned_cols=257 Identities=30% Similarity=0.455 Sum_probs=202.5
Q ss_pred CCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 503 NFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
+|++.+.||+|+||.||+|... ....+|+|.+.... .....++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999653 23568999886543 2345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhc---------------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCc
Q 003846 576 IYEYLPNKSLDSFLFDRA---------------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~N 634 (791)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 1235788889999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCc
Q 003846 635 ILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGS 713 (791)
Q Consensus 635 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~ 713 (791)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222223345678999999988899999999999999999998 88887432211
Q ss_pred cchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
..+...... .....+...+..+.+++.+||+.+|++||++.|+++.|++.
T Consensus 237 -----~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 -----RLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -----HHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111111111 11111222346788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=323.38 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=194.3
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 5889999999754 233455678899988877 799999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 346888999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc---cchhhhhhHHhhcCCccccccccccC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS---LNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence 234578999999999999999999999999999999999999986432211 111111111111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPT------MSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt------~~evl~~ 773 (791)
..+...+..+.+++.+||+.||.+||+ +.|++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 122234567889999999999999998 4676554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.24 Aligned_cols=242 Identities=26% Similarity=0.345 Sum_probs=192.7
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||++... +++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 5889999998753 233456677888888876 699999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988843 345888999999999999999999988 9999999999999999999999999987542221 12
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~----~~~i~~~~----------~~~~ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DL----FEAILNDE----------VVYP 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HH----HHHHhcCC----------CCCC
Confidence 23357899999999999999999999999999999999999997532211 11 11111110 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTM------SEVVSM 773 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 773 (791)
...+..+.+++.+||+.||.+||++ ++++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1245678999999999999999998 565543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.69 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=196.2
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
+|++.+.||+|+||.||+++. .+++.||||++.+.. ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688999999999999999965 458999999986532 2335668899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.+++.. ...++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999843 345778888899999999999999988 9999999999999999999999999975331000
Q ss_pred -----------------------------------------cccccccccccCcccCchhcccCCCCcccceeehhHHHH
Q 003846 659 -----------------------------------------LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLL 697 (791)
Q Consensus 659 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ 697 (791)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011246999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 003846 698 EILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRP---TMSEVVSM 773 (791)
Q Consensus 698 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~evl~~ 773 (791)
||++|+.||........ . .. .... ............+..+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 236 ell~G~~Pf~~~~~~~~--~---~~-i~~~------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET--Q---LK-VINW------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH--H---HH-Hhcc------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999864322110 0 00 0000 000000111123456778888876 4999999 89999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=319.14 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=202.3
Q ss_pred hccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
..++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999643 24579999886443 2234567889999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc-------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK-------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
.++||||+++|+|.+++..... ...+....+..++.||+.||.|||+++ |+||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 233456778899999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ... ...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~----~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVL----KFV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHH
Confidence 99999986544332222222345678999999999999999999999999999998 67776432111 111 001
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...... ..+...+..+.+++.+||+.||++|||+.|+++.|.+
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 235 MDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred HcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 001000 0111224679999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=318.52 Aligned_cols=252 Identities=26% Similarity=0.304 Sum_probs=201.1
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
+|++.++||+|+||+||++.. .+++.||||++.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999965 468999999986532 2223557789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.+++... ....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887542 2345889999999999999999999988 9999999999999999999999999997654322
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||....... ......... .. ..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~---------~~-~~ 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRV---------KE-DQ 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHh---------hh-cc
Confidence 1 123468999999999998899999999999999999999999986432110 000000000 00 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112223556789999999999999999 88899765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=317.10 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=204.9
Q ss_pred ccCCCccceecccCceeEEEeEeeC------CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999996542 4689999986543 23456788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhcc-------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 574 ILIYEYLPNKSLDSFLFDRAK-------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865322 234678889999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhh
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~----~~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVL----KFVI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHH----HHHh
Confidence 9999986654433222233456789999999998889999999999999999998 88886432211 111 1111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..... ..+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 236 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11000 1111235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.30 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=194.5
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
..+|+..++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 356777899999999999999654 68999999986543 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.... ......+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999986432 2455677889999999999999988 9999999999999999999999999998654321
Q ss_pred cccccccccccCcccCchhccc-----CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALE-----GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||........ ........ ..
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~-~~------ 291 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMCAIC-MS------ 291 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHHh-cc------
Confidence 11223578999999998753 2345689999999999999999999863222111 00000000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+..+.+++.+||+.||++|||+.|++++
T Consensus 292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122345678999999999999999999999987
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.86 Aligned_cols=254 Identities=30% Similarity=0.479 Sum_probs=202.5
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357889999999999999999887888999999875433 3567899999999999999999999875 45689999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998542 2345788999999999999999999988 999999999999999999999999999865433211
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .... ...... ...
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~----~~~~~~---------~~~ 222 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVL----EQVERG---------YRM 222 (260)
T ss_pred c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHHcC---------CCC
Confidence 1 112234568999999988899999999999999999999 8888753211 1111 111100 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..+...+..+.+++.+|++.+|.+|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=315.94 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=197.9
Q ss_pred CCccceecccCceeEEEeEeeC-Cc--EEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC------Cc
Q 003846 504 FSAENKLGEGGFGPVYKGELLN-GQ--EVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------DE 572 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 572 (791)
|.+.++||+|+||.||+|...+ ++ .+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999997654 33 6899988653 334467889999999999999999999987532 24
Q ss_pred ceEEEeecCCCChhHHHhhhc---cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 573 KILIYEYLPNKSLDSFLFDRA---KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
.++++||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874321 2345788999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~----~~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SE----IYDYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HH----HHHHHHcCC
Confidence 9987654332222222345778999999999999999999999999999999 7888653221 11 111111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.. ......+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 0111234578999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.19 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=208.7
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999765 7899999988642 2333567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
||+++++|.+++.... ....++.+.+..++.++++||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999985432 3455788999999999999999999988 99999999999999999999999999876543
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+............. .... .
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~--------~ 224 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEKC--------D 224 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh----hhcC--------C
Confidence 221 1123467889999999998889999999999999999999999964332111111100 0000 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.........+..+.+++.+||+.+|++|||+.+++++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001111134567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.88 Aligned_cols=247 Identities=25% Similarity=0.312 Sum_probs=195.5
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCC-ceeeeeeEEEcCCcceEEE
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHR-NLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~ 577 (791)
+|++.+.||+|+||.||+|... +++.||||++.+. .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999654 5789999998753 233456778899999999765 6888999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 345788899999999999999999988 999999999999999999999999998753221
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.|+...... ... ......
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~----~~i~~~---------- 216 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELF----QSIMEH---------- 216 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH----HHHHcC----------
Confidence 1 1223457899999999999999999999999999999999999997532211 111 001000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTM-----SEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~ 773 (791)
....+...+..+.+++.+||+.||.+||+. .+++++
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011122244678899999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=331.45 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=203.8
Q ss_pred hccCCCccceecccCceeEEEeEee------CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCC
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQD 571 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 571 (791)
..++|.+.++||+|+||.||+|+.. .++.||||+++.... ...+.+.+|++++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888899999999999999753 346899999976532 23457889999999997 999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhcc---------------------------------------------------------
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAK--------------------------------------------------------- 594 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 594 (791)
..++|+||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999864211
Q ss_pred --------------------------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEE
Q 003846 595 --------------------------------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636 (791)
Q Consensus 595 --------------------------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NIL 636 (791)
...+++..++.++.||++||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 123567778899999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccc
Q 003846 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLN 715 (791)
Q Consensus 637 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~ 715 (791)
++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 99999999999999986543222122223356788999999998889999999999999999998 888865332111
Q ss_pred hhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 716 LLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
......... .....+...+..+.+++.+||+.+|.+||+++||++.|++.
T Consensus 350 ---~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 ---QFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 001111111 00111222356889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=316.83 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=196.5
Q ss_pred ecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 510 LGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 510 LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
||+|+||+||++.. .+++.+|+|++.+.. ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999965 468899999986542 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccc
Q 003846 586 DSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN 664 (791)
Q Consensus 586 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~ 664 (791)
..++.... ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98875432 3456889999999999999999999988 99999999999999999999999999976543322 122
Q ss_pred cccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHH
Q 003846 665 RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYP 744 (791)
Q Consensus 665 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 744 (791)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..... ...... ...+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~--------~~~~~~--~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ--------RILNDS--VTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHH--------hhcccC--CCCccc
Confidence 347899999999999999999999999999999999999997643221100 00000 000000 011223
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 745 MLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 745 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
.+..+.+++.+||+.||++|| +++|++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 456789999999999999999 77888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.86 Aligned_cols=241 Identities=27% Similarity=0.328 Sum_probs=189.8
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 57889999987532 23344556677777654 899999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|..++.. ...++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999988843 345788899999999999999999988 9999999999999999999999999997643222 22
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~----~~i~~~----------~~~~~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELF----DSILND----------RPHFP 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHcC----------CCCCC
Confidence 23457899999999999999999999999999999999999997532211 110 101000 01112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMS-EVVS 772 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 772 (791)
...+..+.+++.+||+.||.+||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 22346788999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.69 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=195.6
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999654 68899999997542 33456688999999998 699999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 999888743 346889999999999999999999988 999999999999999999999999998743211 112
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc---cchhhhhhHHhhcCCccccccccccC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS---LNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~-- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I-- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--
Confidence 234578999999999999999999999999999999999999986432211 111111111111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPT------MSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt------~~evl~~ 773 (791)
..+...+..+.+++.+||+.||.+||+ ++|++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 112224467889999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=312.89 Aligned_cols=254 Identities=29% Similarity=0.456 Sum_probs=202.2
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.++||+|+||.||+|...+...||+|++.... ...+++.+|++++++++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 46799999999999999999987777789999997533 24567899999999999999999999874 45679999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998543 2345788999999999999999999988 999999999999999999999999999866433221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
. .....++..|+|||+..+..++.++||||||+++|||++ |+.|+...... .. ....... ...
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~----~~~~~~~---------~~~ 222 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV----LDQVERG---------YRM 222 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HH----HHHHhcC---------CCC
Confidence 1 112345678999999988899999999999999999999 77776432211 00 1111000 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
......+..+.+++.+|++.+|++||++.++++.|++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.77 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=202.0
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.++||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999975 56889999999766555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998843 345788899999999999999999987 99999999999999999999999999986543221
Q ss_pred ccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
......++..|+|||.+. ...++.++||||||+++|||++|+.|+......... . ..... ....+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~-----~~~~~---~~~~~~ 230 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-F-----LMSKS---NFQPPK 230 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-e-----eeecC---CCCCCC
Confidence 122346788999999885 345788999999999999999999986432211000 0 00000 000011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.. .....+..+.+++.+||+.+|++|||+++++++|
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 1112356789999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=329.03 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=199.9
Q ss_pred hhhhccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
+....++|++.+.||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3345678999999999999999999764 5889999998642 22234567899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+++|+|.+++.. ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998842 34778889999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccC----CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEG----LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
....... .......||+.|+|||++.+. .++.++||||+||+||||++|+.||..... ............
T Consensus 191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~ 264 (370)
T cd05621 191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKN 264 (370)
T ss_pred ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCc
Confidence 7643221 112345799999999998754 378999999999999999999999753221 111111110000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATD--RPTMSEVVSM 773 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 773 (791)
. +.-......+..+.+++..|++.++.+ ||++.|++++
T Consensus 265 ~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 S-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred c-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 000111123567889999999865544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.57 Aligned_cols=271 Identities=27% Similarity=0.390 Sum_probs=204.8
Q ss_pred cCCCccceecccCceeEEEeEee-----CCcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcc
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-----NGQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEK 573 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 573 (791)
+.|++.+.||+|+||.||++... +++.+|||++...... ..+++.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777899999999999999753 3688999999765443 46789999999999999999999999887 5578
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
+++|||+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998542 335889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532211 111123445679999999988999999999999999999999988643222111100000000000000001
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
+........+...+..+.+++.+||+.+|.+||||.|++++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111222346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=324.08 Aligned_cols=247 Identities=26% Similarity=0.316 Sum_probs=195.5
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEE
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 577 (791)
+|++.+.||+|+||.||+|... +++.||||++.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999654 57899999987542 22345567788888877 5899999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988743 345788899999999999999999988 999999999999999999999999999754322
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .......
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~----~~i~~~~--------- 217 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELF----QSIMEHN--------- 217 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHH----HHHHhCC---------
Confidence 1 1223457899999999999999999999999999999999999997543211 111 1111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTM-----SEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+|++. .++.++
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 01122345678899999999999999984 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.24 Aligned_cols=260 Identities=29% Similarity=0.433 Sum_probs=204.3
Q ss_pred ccCCCccceecccCceeEEEeEee--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL--------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... .....++.+|+.+++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999642 23569999997542 33456788999999999 799999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhcc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAK-------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 235788999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccch
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNL 716 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~ 716 (791)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999976543222221222234568999999999899999999999999999998 7777643211
Q ss_pred hhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
........... ....+...+..+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 249 -~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 -EELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -HHHHHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 01111111110 11112233468889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.72 Aligned_cols=238 Identities=26% Similarity=0.301 Sum_probs=191.1
Q ss_pred ceecccCceeEEEeEe----eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 508 NKLGEGGFGPVYKGEL----LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
+.||+|+||.||+++. .+|+.+|+|++.+.. ......+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999864 357899999997543 2234567789999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999998843 345889999999999999999999988 9999999999999999999999999987653321 1
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
......|++.|+|||++.+..++.++||||||+++|||++|+.|+...... ... ....... ...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~----~~i~~~~----------~~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETM----TMILKAK----------LGM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHH----HHHHcCC----------CCC
Confidence 222357899999999999888999999999999999999999997532210 000 0000000 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003846 742 SYPMLARYVNVALLCVHENATDRPTMSE 769 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RPt~~e 769 (791)
+...+..+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2223467889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=319.43 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=203.9
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 572 (791)
.++|.+.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 467899999999999999999642 34579999987543 33356789999999999 79999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.+++|||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998532 2234789999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... . ........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~----~~~~~~~~---- 260 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-K----FYKLIKEG---- 260 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-H----HHHHHHcC----
Confidence 6543322112222345788999999999999999999999999999998 888865322110 0 00111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.....+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0001111234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.43 Aligned_cols=246 Identities=29% Similarity=0.427 Sum_probs=194.8
Q ss_pred eecccCceeEEEeEe---eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 509 KLGEGGFGPVYKGEL---LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
.||+|+||.||+|.. .+++.+|+|++.... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999954 357889999986543 234577899999999999999999999875 45678999999999
Q ss_pred ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc-c
Q 003846 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA-N 662 (791)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~-~ 662 (791)
+|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 345788999999999999999999988 9999999999999999999999999998765432211 1
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+...... ... ....... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~----~~i~~~~---------~~~~ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVT----QMIESGE---------RMEC 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHCCC---------CCCC
Confidence 112234578999999988889999999999999999998 89887543211 111 1111110 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
+...+..+.+++.+||+.||++||++.+|.+.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 22345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.14 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=207.4
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.+|++.+.||+|+||.||++.. .+++.+|||.+.... .....++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999974 578999999886532 234467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
||+++++|.+++.... ....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885422 3456888999999999999999999988 99999999999999999999999999876543
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+............ ... ....
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~-----~~~~-- 225 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIE-----QCDY-- 225 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh----hhh-----cCCC--
Confidence 321 112346888999999999888999999999999999999999997432211111100 000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
........+..+.+++.+||+.+|++||||.+|++.+++.+
T Consensus 226 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 -PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01111234568999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=317.09 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=203.0
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||.||++... ++..||+|++.... .....++.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999753 46789999987543 33456789999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhc-------------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCc
Q 003846 574 ILIYEYLPNKSLDSFLFDRA-------------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~N 634 (791)
++|+||+++++|.+++.... ....+++..++.++.||+.||+|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996421 1234678888999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCc
Q 003846 635 ILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGS 713 (791)
Q Consensus 635 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~ 713 (791)
|+++.++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876543322222222234667999999998899999999999999999997 7777532111
Q ss_pred cchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
... .......... ..+...+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 239 ~~~----~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEV----IYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHH----HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 011 0111111110 0111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.06 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=210.8
Q ss_pred hhccCCCccceecccCceeEEEeEeeC-CcEEEEEEecccCcc---cHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcc
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQ---GLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 573 (791)
.....|++.+.||+|.||.||++..+. |+.+|+|.+.+.... ..+.+.+|+.+|++++ |||||.+.+.+++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999997654 999999999876433 4578999999999998 99999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC----CCeEEeeec
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD----MKPKISDFG 649 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFg 649 (791)
++|||++.||.|.+.+... .+++.++..++.||+.+++|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998654 2889999999999999999999988 9999999999999533 579999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
++..... .......+||+.|+|||++....|+.++||||+||++|.|++|..||.......... .....+
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~- 254 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGD- 254 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCC-
Confidence 9998765 334456799999999999999999999999999999999999999976543221111 000111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......-...+..+.+++..|+..||.+|+|+.+++++
T Consensus 255 -----~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 -----FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 112222333457789999999999999999999999996
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=315.60 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=201.7
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCc----EEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQ----EVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
..+|++.++||+|+||+||+|+. .+++ .||+|++.... ....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45788889999999999999964 3454 48999987543 3345678899999999999999999999975 4578
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+++||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999853 2346888999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...... ... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~----- 228 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIP----DLLEKGE----- 228 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHCCC-----
Confidence 54322222222344678999999999999999999999999999998 88886532211 111 0111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
....+...+..+.+++.+||+.||++||++.|+++.|+...
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00111223467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.43 Aligned_cols=254 Identities=31% Similarity=0.452 Sum_probs=203.7
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+++.+|+.++++++|+||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 46788899999999999999988889999999987543 3456889999999999999999999986 456789999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999998543 2346788999999999999999999988 999999999999999999999999999766532221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
. .....++..|+|||++....++.++||||||+++|||++ |+.|+..... ..... ..... ...
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~~---------~~~ 222 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQ----NLERG---------YRM 222 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHH----HHHcC---------CCC
Confidence 1 112345678999999998889999999999999999999 9998753221 11110 01110 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..+...+.++.+++.+|++.+|++|||++++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112234679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=320.22 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=205.4
Q ss_pred hccCCCccceecccCceeEEEeEee--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL--------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLD 569 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 569 (791)
..++|.+.+.||+|+||.||+++.. ++..||+|.+.... .....++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888999999999999999631 24579999986542 34457789999999999 89999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEE
Q 003846 570 QDEKILIYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636 (791)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NIL 636 (791)
....++||||+++++|.+++.... ....+++..+..++.||++||.|||+++ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999996532 1245778889999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccc
Q 003846 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLN 715 (791)
Q Consensus 637 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~ 715 (791)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---- 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence 99999999999999987654332222223345678999999998899999999999999999998 6777543211
Q ss_pred hhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 716 LLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
. ........... ...+...+..+.+++.+||+.+|.+|||+.|+++.|+++
T Consensus 246 -~-~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 246 -E-ELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -H-HHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1 11111111110 011123346788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.10 Aligned_cols=260 Identities=30% Similarity=0.422 Sum_probs=200.3
Q ss_pred ccCCCccceecccCceeEEEeEe------eCCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC-C
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ-D 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 571 (791)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36899999999999999999953 357889999997543 23356788999999999 689999999988654 4
Q ss_pred cceEEEeecCCCChhHHHhhhcc---------------------------------------------------------
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAK--------------------------------------------------------- 594 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 594 (791)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 56899999999999999854210
Q ss_pred -------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccccc
Q 003846 595 -------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIV 667 (791)
Q Consensus 595 -------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~ 667 (791)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123677888899999999999999988 9999999999999999999999999998654332212222234
Q ss_pred ccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHH
Q 003846 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPML 746 (791)
Q Consensus 668 gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 746 (791)
++..|+|||.+.+..++.++||||||+++|+|++ |..|+....... . .......... ...+...+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~----~~~~~~~~~~---------~~~~~~~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E----FCRRLKEGTR---------MRAPDYTT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H----HHHHHhccCC---------CCCCCCCC
Confidence 5678999999998899999999999999999997 888865432211 0 0111111100 01111123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 747 ARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 747 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
..+.+++.+||+.+|.+|||+.|++++|+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.20 Aligned_cols=195 Identities=29% Similarity=0.418 Sum_probs=169.4
Q ss_pred CCCccceecccCceeEEEe-EeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-C-----CceeeeeeEEEcCCcceE
Q 003846 503 NFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-H-----RNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l 575 (791)
+|.+.+.||+|+||.|.++ +..+++.||||+++... ....+...|+++|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999 55679999999996543 34567788999999997 4 389999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC--CCeEEeeeccccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD--MKPKISDFGMARM 653 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFgla~~ 653 (791)
|+|.+. -+|.++|..+ +...++...++.++.||+.||..||+.+ |||+||||+||||.+. ..+||+|||.|+.
T Consensus 266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999985 4999999553 4455899999999999999999999988 9999999999999653 4699999999987
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCC
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGF 708 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~ 708 (791)
.....+ ....+..|+|||++.+.+|+.+.|+||||||++||++|.+-|..
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 554332 34678899999999999999999999999999999999876543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.68 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=200.9
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-----cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-----GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
++|.+.+.||+|++|.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999965 468999999886432 1234568899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
|+||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345778888999999999999999988 9999999999999999999999999997654
Q ss_pred CCccccc-cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQAN-TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~------- 223 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIATQP------- 223 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHHHHhccC-------
Confidence 3221111 12345788999999999989999999999999999999999996432111 0000000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+......+.+++.+||+.+|.+|||+.|++++
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 --TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111222345678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.20 Aligned_cols=248 Identities=29% Similarity=0.413 Sum_probs=198.5
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCChh
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLD 586 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 586 (791)
++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999998767999999998765433 5678899999999999999999999999999999999999999999
Q ss_pred HHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccc
Q 003846 587 SFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI 666 (791)
Q Consensus 587 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 666 (791)
+++... ...++...+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998432 335778889999999999999999988 999999999999999999999999999865432222221222
Q ss_pred cccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 667 VGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 667 ~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
..+..|+|||.+.++.++.++|+||||+++|||++ |..|+....... .. ..... ......+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~----~~~~~---------~~~~~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TR----ERIES---------GYRMPAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HH----HHHhc---------CCCCCCCccC
Confidence 34567999999998899999999999999999999 777764332110 00 00100 0011112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 746 LARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
+..+.+++.+|++.+|.+|||+.|+++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.64 Aligned_cols=250 Identities=34% Similarity=0.512 Sum_probs=203.5
Q ss_pred ceecccCceeEEEeEeeC----CcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELLN----GQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||++.... +..||+|.+...... ..+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999997654 788999999765433 367889999999999999999999999999999999999999
Q ss_pred CChhHHHhhhcc------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 583 KSLDSFLFDRAK------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 583 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
++|.+++..... ...+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367899999999999999999999988 99999999999999999999999999987765
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
...........++..|+|||.+....++.++||||+|+++|||++ |..|+...... . .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~----~~~~~~~~~------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--E----VLEYLRKGY------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--H----HHHHHHcCC-------
Confidence 432222334567889999999998899999999999999999999 58887544211 1 111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
....+...+.++.+++.+||+.+|.+|||+.|++++|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112223578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.54 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=192.9
Q ss_pred ceecccCceeEEEeEeeC---CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 508 NKLGEGGFGPVYKGELLN---GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997543 4579999887543 233457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhhcc--ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 584 SLDSFLFDRAK--KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 584 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+|.+++..... ....++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865322 234566778899999999999999988 9999999999999999999999999997654333222
Q ss_pred ccccccccCcccCchhcccC-------CCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 662 NTNRIVGTYGYMSPEYALEG-------LFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+........ ... ..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTY----TVREQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHH----HhhcccCCCC
Confidence 22334577889999998642 35789999999999999996 9999754322111 000 0001111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
++.+. ......+.+++..|+ .+|++|||++||++.|+
T Consensus 232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 123456788999998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.75 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=203.1
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||+|++|.||++... +++.|++|.+... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999664 6899999998643 334567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998643 2456888899999999999999999987 99999999999999999999999999886654321
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
. .....+++.|+|||++.+..++.++|+||||+++++|++|+.|+...... ... ....... ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~~~---------~~ 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALI----LKIIRGV---------FP 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHcCC---------CC
Confidence 1 12346788999999999999999999999999999999999997543211 000 0000000 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=322.68 Aligned_cols=237 Identities=25% Similarity=0.301 Sum_probs=186.5
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHH-HHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETM-LIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||+||+|... +|+.||||++.+.. .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999664 68999999986532 222344555544 56789999999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|..++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999988843 345788889999999999999999988 9999999999999999999999999987532211 22
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~----~~~i~~~--------~~--~~~ 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EM----YDNILNK--------PL--RLK 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HH----HHHHHcC--------CC--CCC
Confidence 23457899999999999999999999999999999999999997532110 10 0101000 00 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMS 768 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~ 768 (791)
...+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12356788999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=293.16 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=200.4
Q ss_pred hhccCCCccceecccCceeEEEe-EeeCCcEEEEEEecccC-----cc---cHHHHHHHHHHHHhc-CCCceeeeeeEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKS-----GQ---GLEELKNETMLIAKL-QHRNLVRLLGCCL 568 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 568 (791)
..-.+|...+.||.|..+.|-+. ...+|+.+|+|++.... +. -.+.-..|+.||+++ .||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567888899999999999888 44578899999886432 11 234456799999998 5999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
.+...++|+|.|+.|.|.++|. ..-.++++...+|++|+.+|+.|||.++ |+||||||+|||++++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999993 4556899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccCcccCchhccc------CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALE------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
|+++.+..... ....+|||+|+|||.+.. ..|+...|+|+.|||||.|+.|.+||= +....-
T Consensus 168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQml------- 235 (411)
T KOG0599|consen 168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQML------- 235 (411)
T ss_pred ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHHHH-------
Confidence 99998765432 335699999999999863 358899999999999999999999951 110000
Q ss_pred HhhcCCccccccccccCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 LWKDNRALDLMDPILENE------ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+.-++.+. .=.+.+....+||.+||+.||.+|.|++|++++
T Consensus 236 ---------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 ---------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ---------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 001111111 112356778999999999999999999998765
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=344.60 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=201.5
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.++||+|+||.||+|... +|+.||||++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999654 58999999987542 223467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhcc--------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 578 EYLPNKSLDSFLFDRAK--------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999854211 233456678899999999999999988 9999999999999999999999999
Q ss_pred cccccCCCcc----------------ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc
Q 003846 650 MARMFGGDEL----------------QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713 (791)
Q Consensus 650 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~ 713 (791)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 001123469999999999999999999999999999999999999975422111
Q ss_pred cchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccC
Q 003846 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRP-TMSEVVSMLTNE 777 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~ 777 (791)
... .. ....+. ........+..+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 i~~---------~~---~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISY---------RD---VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhh---------hh---hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 00 000000 0000112346788999999999999996 667777776553
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.61 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=192.3
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--------
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-------- 570 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 570 (791)
..++|++.++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457899999999999999999965 468899999885432 2345799999999999999999887432
Q ss_pred CcceEEEeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeee
Q 003846 571 DEKILIYEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDF 648 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DF 648 (791)
...++||||+++ +|.+++... .....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 676666432 34456888999999999999999999988 99999999999999665 6999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
|+++.+..... .....+|+.|+|||++.+. .++.++|||||||+||||++|.+||...... .............
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Confidence 99986543221 1234679999999998764 6899999999999999999999997543221 1110000000000
Q ss_pred C----------ccccccc-----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 R----------ALDLMDP-----ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ~----------~~~~~~~-----~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ..+..-+ .+....+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000000 01111111234678999999999999999999998855
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=309.72 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=198.5
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.+.||+|+||.||+|.. .+++.||+|++... ......++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999964 56889999998654 233456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999996552 3567788899999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchh-hhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLL-GHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.....++..|+|||++.+..++.++||||||+++|+|++|+.|+........... ........... .+.+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~- 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL- 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC-
Confidence 2234789999999999998999999999999999999999999754322111110 00000000000 0001
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.....+.++.+++.+||+.+|++||+++|++++-
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1112345789999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=321.49 Aligned_cols=240 Identities=27% Similarity=0.334 Sum_probs=190.4
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||+++.. +|+.||||++++.. ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999764 58899999997542 23445667788888765 899999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999988843 345788899999999999999999988 9999999999999999999999999987432111 12
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... .+ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~----~~~~~~~------~~----~~~ 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DEL----FESIRVD------TP----HYP 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHH----HHHHHhC------CC----CCC
Confidence 2345789999999999999999999999999999999999999753221 111 1111100 01 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMS-EVV 771 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~-evl 771 (791)
......+.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12346788999999999999999985 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.90 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=202.9
Q ss_pred ccCCCccceecccCceeEEEeEeeC-C---cEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-G---QEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..+|+..+.||+|+||.||+|.... + ..+|+|++.... ....+++.+|++++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999997642 3 369999986542 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999843 3356888999999999999999999988 9999999999999999999999999997654
Q ss_pred CCccccc-cccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 656 GDELQAN-TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 656 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
....... ......+..|+|||++....++.++||||||+++|||++ |+.|+...... . ........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~----~~~~i~~~------ 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--E----VMKAINDG------ 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--H----HHHHHhcC------
Confidence 3321111 111223457999999998889999999999999999997 99997432211 1 11111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111122346789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.64 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=199.6
Q ss_pred cCCCccceecccCceeEEEeEeeC-Cc--EEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN-GQ--EVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 576 (791)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 478889999999999999997643 33 4788888643 333456789999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCe
Q 003846 577 YEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP 643 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 643 (791)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985432 1235788899999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhH
Q 003846 644 KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 644 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 722 (791)
||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..|+...... . ...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~----~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--E----LYE 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--H----HHH
Confidence 99999998643211 11111123457999999998899999999999999999997 98887532211 0 111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..... .....+...+..+.+++.+||+.+|.+|||++++++.|++..
T Consensus 230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11100 011111224467889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.64 Aligned_cols=242 Identities=26% Similarity=0.319 Sum_probs=194.2
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||++... +++.||||++++. .....+.+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999664 5789999999754 233456677899999888 699999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999988743 345889999999999999999999988 9999999999999999999999999987532211 11
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .. ........ ...+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~----~~~i~~~~----------~~~~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--EL----FQSILEDE----------VRYP 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HH----HHHHHcCC----------CCCC
Confidence 22346899999999999999999999999999999999999997532211 11 11111110 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTM-----SEVVSM 773 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~ 773 (791)
...+..+.+++.+||+.||.+||++ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2235678999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.78 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=204.4
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
...+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 346899999999999999999964 4689999999977665566788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998832 34788889999999999999999988 9999999999999999999999999987654322
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .......... +.+
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~~~~~~~------~~~- 236 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNGT------PEL- 236 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHHHhcCCC------CCC-
Confidence 1 1123468899999999998889999999999999999999999975322111 0000000000 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+......+.+++.+||..+|++|||+.|++++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122344678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.68 Aligned_cols=247 Identities=29% Similarity=0.386 Sum_probs=197.7
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCChh
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLD 586 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 586 (791)
+.||+|+||.||+|...+++.+|+|++..... .....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999888889999999876543 23456889999999999999999999999999999999999999999
Q ss_pred HHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccc
Q 003846 587 SFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI 666 (791)
Q Consensus 587 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 666 (791)
+++.. ....+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 98843 2345788999999999999999999988 999999999999999999999999998754332211 11122
Q ss_pred cccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 667 VGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 667 ~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
.++..|+|||++....++.++||||||+++|+|++ |..|+...... .. ....... .....+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~----~~~~~~~---------~~~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QA----REQVEKG---------YRMSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HH----HHHHHcC---------CCCCCCCCC
Confidence 34568999999998899999999999999999998 88887532211 10 0111111 011112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 746 LARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
+..+.+++.+|++.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.30 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=193.8
Q ss_pred eecccCceeEEEeEee---CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCC
Q 003846 509 KLGEGGFGPVYKGELL---NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKS 584 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 584 (791)
.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999653 35579999987653 233567899999999999999999999875 457899999999999
Q ss_pred hhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc-cc
Q 003846 585 LDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA-NT 663 (791)
Q Consensus 585 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~-~~ 663 (791)
|.+++.. ....+++..+++++.||++||.|||+++ ++||||||+|||++.++.+||+|||++.......... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999843 3446889999999999999999999988 9999999999999999999999999997654332211 11
Q ss_pred ccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 664 NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 664 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
....++..|+|||.+....++.++||||||+++|||++ |+.|+....... . ....... .....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~---------~~~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--V----MSFIEQG---------KRLDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--H----HHHHHCC---------CCCCCC
Confidence 11233578999999988889999999999999999996 998875332111 0 0111111 011122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...+..+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 2335688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.82 Aligned_cols=260 Identities=29% Similarity=0.444 Sum_probs=203.7
Q ss_pred ccCCCccceecccCceeEEEeEee--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL--------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
.++|.+.++||+|+||.||+++.. ....+|+|+++... .....++.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367888999999999999999642 24578999987542 33456788999999999 699999999999998
Q ss_pred CcceEEEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
...+++|||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999996532 1245788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccch
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNL 716 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~ 716 (791)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H-
Confidence 9999999999999987654322222222234568999999999899999999999999999999 78776432111 1
Q ss_pred hhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.......... ...+...+..+.+++.+||+.+|++|||+.|+++.|.+..
T Consensus 245 ---~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ---LFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111100 0111223457889999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.33 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=192.8
Q ss_pred ecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 510 LGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 510 LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
||+|+||.||+++. .+|+.+|+|++.... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999965 458999999986432 12234556799999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 9887543 2334788888999999999999999988 99999999999999999999999999876543221 123
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
..|+..|+|||++.+..++.++||||+||++|||++|+.|+........ ....... .... .... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~-~~~~--------~~~~-~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRR-TLED--------EVKF-EHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHH-hhcc--------cccc-ccccC
Confidence 4688999999999988899999999999999999999999754322110 0000000 0000 0000 00123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 746 LARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
+..+.+++.+||+.||++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 567899999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.99 Aligned_cols=256 Identities=26% Similarity=0.449 Sum_probs=200.8
Q ss_pred cCCCccceecccCceeEEEeEeeC-C---cEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN-G---QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..|++.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999997643 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999843 2346788999999999999999999988 99999999999999999999999999876543
Q ss_pred Ccccccccc-c--cccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 657 DELQANTNR-I--VGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 657 ~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
......... . ..+..|+|||.+....++.++||||||+++|||++ |..|+...... ..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~----i~~~----- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINA----IEQD----- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHH----HHcC-----
Confidence 322111111 1 12457999999999999999999999999999886 98886432211 11111 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.....+...+..+.+++.+||+.+|.+||++.+++++|+..
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011122346788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.31 Aligned_cols=241 Identities=27% Similarity=0.349 Sum_probs=190.7
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 57899999987542 23345567788888764 899999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999998843 345788889999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ... ...... .+ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~----~~i~~~------~~----~~~ 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELF----QSIRMD------NP----CYP 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhC------CC----CCC
Confidence 23357899999999999999999999999999999999999997532211 111 111000 01 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMS-EVVS 772 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 772 (791)
......+.+++.+||+.||++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 12346788999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.21 Aligned_cols=261 Identities=20% Similarity=0.240 Sum_probs=199.2
Q ss_pred ccCCCccceecccCceeEEEeEee---CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL---NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..+|.+.++||+|+||.||++... .++.||||.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999643 3678999988543 24568999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
|++. ++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 57888772 3456889999999999999999999988 999999999999999999999999999876544
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc-cchhhhhhHHhhcCCc-------
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS-LNLLGHAWDLWKDNRA------- 729 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~------- 729 (791)
..........||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ................
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333344679999999999999999999999999999999999999975432211 0000000000000000
Q ss_pred c---c---cccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 L---D---LMDPILENEAS-------YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~---~---~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. . ........... .....++.+++.+||+.||++|||+.|++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0 00000000000 1124577899999999999999999999976
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.08 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=204.1
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.+.||.|+||.||++.. .|+.||||.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788899999999999999976 589999999976544 5678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999985432 236889999999999999999999988 99999999999999999999999999986632211
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
....+..|+|||.+....++.++||||||++++||++ |+.|+...... .+. ...... ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~~~~---------~~~ 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV----PHVEKG---------YRM 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHhcC---------CCC
Confidence 2234568999999998889999999999999999997 88886533211 111 111110 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..+...+..+.+++.+||+.+|++|||++|++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122235778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.16 Aligned_cols=256 Identities=32% Similarity=0.486 Sum_probs=205.8
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..++|++.++||+|+||.||+|...+++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 356889999999999999999988788899999987543 3457899999999999999999999999998999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998543 2345788999999999999999999988 99999999999999999999999999987653221
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.. ......+..|+|||.+.+..++.++|+||||+++++|++ |+.|+..... ...... .... ..
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~----~~~~---------~~ 222 (261)
T cd05034 159 TA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQ----VERG---------YR 222 (261)
T ss_pred hh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcC---------CC
Confidence 11 112234568999999998899999999999999999998 8988743211 111110 1000 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...+...+..+.+++.+|++.+|.+||+++|+.+.|++
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.87 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=200.5
Q ss_pred hhhhhccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD 571 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 571 (791)
.+....++|++.+.||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.+++.++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455689999999999999999999664 5889999998643 2233456788999999999999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999998843 34778888899999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccC----CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEG----LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...........
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~ 263 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHK 263 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC
Confidence 87643221 112345799999999998754 378999999999999999999999753221 10101100000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHh
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATD--RPTMSEVVSML 774 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L 774 (791)
.. +.-......+..+.+++.+|++.++.+ ||+++|++++.
T Consensus 264 ~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 NS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred Cc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00 000111234567889999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=328.87 Aligned_cols=261 Identities=20% Similarity=0.244 Sum_probs=196.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..+|.+.++||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 557999999999999999999664 47899999643 23467899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+. ++|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 688887743 2346899999999999999999999988 99999999999999999999999999987644322
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCC--ccchhhhhhHHhhcCCc-----cc-
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTG--SLNLLGHAWDLWKDNRA-----LD- 731 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~-----~~- 731 (791)
........||..|+|||++.+..++.++|||||||+||||++|..|+-..... ................. ..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22223457999999999999999999999999999999999987653221111 01111111111110000 00
Q ss_pred ----cc-----------cccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 ----LM-----------DPILENEA---SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ----~~-----------~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+. .+...... .......+.+|+.+||+.||.+|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00000000 00123468899999999999999999999976
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=307.65 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=201.3
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
++|++.++||+|++|.||++....+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999988777789999886443 34567889999999999999999998875 456899999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999998543 2345788899999999999999999988 9999999999999999999999999997654332211
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
.....++..|+|||...+..++.++||||||+++|||++ |+.|+...... ... ...... ....
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~~---------~~~~ 223 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVL----EQVERG---------YRMP 223 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcC---------CCCC
Confidence 112345678999999998899999999999999999999 88886532211 111 111110 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.79 Aligned_cols=240 Identities=22% Similarity=0.340 Sum_probs=188.9
Q ss_pred ceecccCceeEEEeEeeC-------------CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 508 NKLGEGGFGPVYKGELLN-------------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
+.||+|+||.||+|.... ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999997532 2358999887655555667889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC-------eEEee
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK-------PKISD 647 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~D 647 (791)
+||||+++++|+.++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988743 3345888999999999999999999988 999999999999987664 89999
Q ss_pred eccccccCCCccccccccccccCcccCchhcc-cCCCCcccceeehhHHHHHHH-hCCCCCCCCCCCccchhhhhhHHhh
Q 003846 648 FGMARMFGGDELQANTNRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEIL-SGKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 648 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+........ ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence 9998654322 2235778899999887 467899999999999999998 47777543211100 0000
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
... . ....+....+.+++.+||+.||.+||++.|++++|+
T Consensus 223 ~~~--------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ--------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC--------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 0 011122457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=317.24 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=194.7
Q ss_pred ceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||++.. .+++.||||++.+.. ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999965 457899999997542 23456688999999888 699999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999888743 345889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCC-ccchhhhhhHHhhcCCccccccccccCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTG-SLNLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
.....||+.|+|||++.+..++.++||||||++||||++|+.||...... ............... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------PIRI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------CCCC
Confidence 23457899999999999999999999999999999999999998643221 111111111111110 0011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 003846 742 SYPMLARYVNVALLCVHENATDRPTM------SEVVSM 773 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 773 (791)
+...+..+.+++.+||+.||.+||++ ++++++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 22234678899999999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.25 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=192.9
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhc---CCCceeeeeeEEEcC-----C
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKL---QHRNLVRLLGCCLDQ-----D 571 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~ 571 (791)
+|++.+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5788899999999999999654 68899999987542 22234566777777665 699999999988642 3
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..+++|||+++ +|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 46899999985 888887432 2345889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC---C
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN---R 728 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 728 (791)
+...... ......+|..|+|||++.+..++.++||||+||++|||++|++||....... ............ .
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhh
Confidence 8654322 1223467899999999998899999999999999999999999875432211 110110000000 0
Q ss_pred c---c----cccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 A---L----DLMDPILE---NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~---~----~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. . ....+... ..........+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0 00000000 01111234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.95 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=201.9
Q ss_pred cCCCccceecccCceeEEEeEee-C---CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-N---GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.+|++.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999753 2 3379999886542 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++... ...+++.++..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998432 345788999999999999999999988 99999999999999999999999999987643
Q ss_pred Ccccc-ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 657 DELQA-NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 657 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
..... ......++..|+|||.+.+..++.++|+||||+++||+++ |+.|+...... ... .......
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~----~~~~~~~------ 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVI----KAIEEGY------ 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHH----HHHhCCC------
Confidence 32111 1111233568999999998899999999999999999886 99886533211 111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
........+..+.+++.+|++.+|.+||++.++++.|..+
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011122346788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.71 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=199.2
Q ss_pred ccCCCccceecccCceeEEEeEee-CCc--EEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQ--EVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+|... ++. .+|+|.+... ......++.+|++++.++ +|+||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999754 454 4577777543 233456788999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 576 IYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
||||+++++|.+++.... ....+++..++.++.||++||+|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986432 1235788999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 721 (791)
+||+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |..|+...... ...
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~---- 233 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELY---- 233 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHH----
Confidence 999999998642211 11111234567999999988889999999999999999998 89887432211 111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...... .....+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001000 00011112345788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.73 Aligned_cols=238 Identities=24% Similarity=0.294 Sum_probs=187.0
Q ss_pred ceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHH-HHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETM-LIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||++.. .+|+.+|||++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999965 468999999986542 223345555554 46778999999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|..++. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99988874 3346888999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ + ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~----~~~~~~~~--------~--~~~ 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EM----YDNILHKP--------L--VLR 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HH----HHHHHcCC--------c--cCC
Confidence 23457899999999999999999999999999999999999997532211 11 01111100 0 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMSE 769 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~e 769 (791)
...+..+.+++.+|++.+|.+||++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 123457789999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=312.04 Aligned_cols=251 Identities=27% Similarity=0.342 Sum_probs=198.4
Q ss_pred CCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 504 FSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
|+..+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999965 468899999986542 22235577899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999988543 2345888899999999999999999988 9999999999999999999999999987653322
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ .......... ...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~----------~~~ 222 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKE----------VQE 222 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhh----------hhh
Confidence 11234689999999999999999999999999999999999999864322110 0000000000 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
.........+.+++.+||+.||++||| ++|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111223457889999999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.64 Aligned_cols=241 Identities=25% Similarity=0.327 Sum_probs=191.4
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEE
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 577 (791)
+|+..+.||+|+||.||++.. .+|+.||||++.+.. ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367788999999999999965 468899999987542 234456788999998885 577888999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988843 345888999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ... .......
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~----~~i~~~~--------- 217 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELF----QSIMEHN--------- 217 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhCC---------
Confidence 1 1122346899999999999999999999999999999999999997543211 111 1010000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTM 767 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 767 (791)
...+...+..+.+++.+||+.+|.+|++.
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01112234678899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=306.41 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=200.2
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.+++++.....||+|+||.||+|... +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34556666679999999999999754 57889999988776666778999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~ 656 (791)
||+++++|.+++.........+...+..++.||++||+|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999854322212267788899999999999999988 999999999999976 67999999999876543
Q ss_pred CccccccccccccCcccCchhcccCC--CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGL--FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
... ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.|+.......... +. .. .
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~---~~-----~- 226 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FK---VG-----M- 226 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hh---hh-----h-
Confidence 221 122345789999999987643 7899999999999999999999975322111000 00 00 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......+....+.+.+++.+||+.+|.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000111222345678899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.58 Aligned_cols=237 Identities=24% Similarity=0.296 Sum_probs=185.6
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHH-HHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETM-LIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||+|+.. +++.||+|++.+.. .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999764 58899999986532 222344555554 67889999999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
++|..++.. ...++...+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999888743 345778888899999999999999988 9999999999999999999999999987532221 22
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... . ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~----~~~i~~~--------~--~~~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQM----YDNILHK--------P--LQLP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HHH----HHHHhcC--------C--CCCC
Confidence 2345789999999999998999999999999999999999999753211 011 1111000 0 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMS 768 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~ 768 (791)
......+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22346788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.87 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=196.5
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999654 68999999986532 334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999843 345788899999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------------cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCC
Q 003846 658 ELQ---------------------------------ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKK 704 (791)
Q Consensus 658 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~ 704 (791)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113469999999999999999999999999999999999999
Q ss_pred CCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003846 705 NTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPT---MSEVVSM 773 (791)
Q Consensus 705 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~ 773 (791)
||....... . ....... ...+.-......+..+.+++.+++. ||.+|++ +.|++++
T Consensus 235 Pf~~~~~~~--~----~~~i~~~------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQE--T----YRKVMNW------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHH--H----HHHHHcC------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 975432110 0 0000000 0000000011234678889888774 9999985 6777655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=304.70 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=204.1
Q ss_pred ccCCCccceecccCceeEEEeEeeC-CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.+.||+|+||.||++...+ ++.+|+|.+..... .+++.+|++++++++|+||+++++++..+...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999997754 78999999865533 67899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999843 3456889999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......++..|+|||++.+..++.++||||||+++++|++|+.|+.......... .... .....-
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~------~~~~-------~~~~~~ 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF------MIPN-------KPPPTL 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh------hhcc-------CCCCCC
Confidence 1223457889999999999899999999999999999999999976432211000 0000 000001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+......+.+++.+||+.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1122344678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.83 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=200.6
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.++||+|+||.||++... ++..+|+|.+.... ....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999654 58889999886542 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
+++++|.+++.. ...+++..+..++.||++||.|||+. + ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999843 24578889999999999999999974 5 9999999999999999999999999987543221
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccc-hhhhhhHHhhcCC---------
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN-LLGHAWDLWKDNR--------- 728 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~--------- 728 (791)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... .............
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 22346889999999998888999999999999999999999997532211100 0000000000000
Q ss_pred --------ccccccccccC---C-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 729 --------ALDLMDPILEN---E-ASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 729 --------~~~~~~~~l~~---~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
..+..+..... . .....+..+.+++.+||+.+|++|||+.|++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000 0 0011345789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=310.96 Aligned_cols=264 Identities=27% Similarity=0.357 Sum_probs=198.6
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||+|++|.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999764 68999999986542 23356788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
++ ++|.+++........+++..+..++.||++||+|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 588888755444467889999999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhh-------hHHhhcCCccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA-------WDLWKDNRALD 731 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 731 (791)
.......+++.|+|||++.+. .++.++||||||+++++|++|+.|+........ ..... ...+.......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence 111223568899999988754 578999999999999999999998764321100 00000 00000000000
Q ss_pred cccccc----c---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 LMDPIL----E---NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ~~~~~l----~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...... . .......+.++.+++.+||+.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 0 00011235677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.28 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=196.3
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----cce
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD-----EKI 574 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 574 (791)
+|++.++||+|+||.||++.. .+++.||||++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999965 47899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+|+||+. ++|.+++. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777763 3356889999999999999999999988 999999999999999999999999999865
Q ss_pred CCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc---
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL--- 730 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 730 (791)
..... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ................
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHH
Confidence 43221 112234678899999998875 5799999999999999999999998643211 0000000000000000
Q ss_pred -------c-cccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 -------D-LMDPILEN-------EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 -------~-~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. +....... ......++.+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 00000000 0111224678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.72 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=197.8
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|.+.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57889999999999999999654 57889999987543 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++ +|.+++.. ....++...+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 78777743 2345788889999999999999999988 99999999999999999999999999976433221
Q ss_pred ccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhh-----------hHHhhcC
Q 003846 660 QANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA-----------WDLWKDN 727 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~-----------~~~~~~~ 727 (791)
......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..... |......
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhhcch
Confidence 1223467899999998865 468999999999999999999999986432211 10000 0000000
Q ss_pred Ccccccc-ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 728 RALDLMD-PILEN----EASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 728 ~~~~~~~-~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
......+ +.... ......+..+.+++.+||+.||.+|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0000000 00000 00112345788999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=315.10 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=188.2
Q ss_pred cceecccCceeEEEeEee---CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcceEEEeecC
Q 003846 507 ENKLGEGGFGPVYKGELL---NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEKILIYEYLP 581 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 581 (791)
.++||+|+||+||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999754 46789999986542 23567889999999999999999999864 345789999986
Q ss_pred CCChhHHHhhhc------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE----cCCCCeEEeeeccc
Q 003846 582 NKSLDSFLFDRA------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DTDMKPKISDFGMA 651 (791)
Q Consensus 582 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFgla 651 (791)
+ +|.+++.... ....++...+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7877764321 1235788889999999999999999988 9999999999999 45678999999999
Q ss_pred cccCCCccc-cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccc-------hhhhh--
Q 003846 652 RMFGGDELQ-ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN-------LLGHA-- 720 (791)
Q Consensus 652 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~-------~~~~~-- 720 (791)
+........ .......+|+.|+|||++.+. .++.++||||+||++|||++|++||......... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 876543211 222345789999999998874 5899999999999999999999998643322110 00000
Q ss_pred ---------hHHhhc-CCccccccccccC------------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 721 ---------WDLWKD-NRALDLMDPILEN------------EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 721 ---------~~~~~~-~~~~~~~~~~l~~------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
|..... ......+...... .........+.+++.+||+.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0000000000000 0000112457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.37 Aligned_cols=240 Identities=24% Similarity=0.289 Sum_probs=186.6
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHH-HHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNET-MLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||++... +++.||+|++.+.. .....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999654 57889999986532 12233444444 456788999999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
++|.+++.. ...+....+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999998843 345677888889999999999999988 9999999999999999999999999997543221 12
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ....... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~----~~i~~~~----------~~~~ 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMY----DNILNKP----------LQLK 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHH----HHHHhCC----------cCCC
Confidence 23457899999999999999999999999999999999999997532211 110 0000000 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMSEVV 771 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl 771 (791)
...+..+.+++.+||+.||.+||++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 22346788999999999999999887433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.74 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=203.3
Q ss_pred cCCCccceecccCceeEEEeEeeC--------CcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN--------GQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQD 571 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 571 (791)
.+|++.+.||+|+||.||++.... +..||+|.+.... ....+++.+|+++++++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 578899999999999999996421 2368999887543 33467889999999999 7999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 638 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~ 638 (791)
..++++||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986432 2345788889999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchh
Q 003846 639 TDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLL 717 (791)
Q Consensus 639 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~ 717 (791)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H
Confidence 999999999999986644322222222344568999999999999999999999999999998 7777643211 1
Q ss_pred hhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 718 GHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
. ......... ....+...+..+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 244 ~-~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 E-LFKLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred H-HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1 111111110 00111223467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=306.93 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=190.0
Q ss_pred ceecccCceeEEEeEeeC---CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 508 NKLGEGGFGPVYKGELLN---GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996543 3568888876443 333467889999999999999999999999999999999999999
Q ss_pred ChhHHHhhhcc--ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 584 SLDSFLFDRAK--KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 584 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+|.+++..... ....++.....++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233467778899999999999999988 9999999999999999999999999987543332222
Q ss_pred ccccccccCcccCchhccc-------CCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 662 NTNRIVGTYGYMSPEYALE-------GLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+....... .. .... ........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~---~~~~-~~~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VL---KQVV-REQDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH---HHHh-hccCccCC
Confidence 2223355678999998753 356889999999999999999 677765332110 00 0001 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
.+.. ....+..+.+++..|+ .||++|||++||++.|.
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1211 2223456778888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=305.36 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=198.2
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEE-cCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL-DQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~ 580 (791)
++|++.+.||+|+||.||++.. .|+.+|+|.++... ..+.+.+|+.++++++|+|++++++++. +++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788889999999999999976 58889999986433 3567899999999999999999999765 456789999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998543 2345788999999999999999999988 9999999999999999999999999987543221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.....+..|+|||++.+..++.++||||||+++|||++ |+.|+..... .... ...... ...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~-~~~~~~---------~~~ 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVV-PRVEKG---------YKM 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHH-HHHhcC---------CCC
Confidence 12234568999999998899999999999999999997 8888653211 1100 001000 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=322.68 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=196.1
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD----- 571 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 571 (791)
..++|++.+.||+|+||.||++.. .+|+.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999965 46899999998653 2334567889999999999999999999986543
Q ss_pred -cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 572 -EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
..++||||+++ +|.+.+. ..++...+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999976 5555542 23677888899999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-------------chh
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-------------NLL 717 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-------------~~~ 717 (791)
++...... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||........ ...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 97543221 22335789999999999999999999999999999999999999864321100 000
Q ss_pred hh----hhHHhhcCC------cccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 718 GH----AWDLWKDNR------ALDLMDPILE---NEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 718 ~~----~~~~~~~~~------~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.. ......... ..+....... ..........+.+++.+||+.||++|||+.|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00 000000000 0000000000 001111345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=305.53 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=203.3
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.++||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788999999999999999987778889999886543 345678999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2345788889999999999999999987 999999999999999999999999999765433221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......++..|+|||++....++.++|+||||+++|+|++ |+.|+...... ... ........ .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~----~~~~~~~~---------~ 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVI----RALERGYR---------M 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHhCCCC---------C
Confidence 1112345678999999998889999999999999999999 88887532211 111 11111100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
......+..+.+++.+|++.+|++||++.++.+.|++
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112244678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=317.45 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=195.8
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999754 5889999998652 2234566889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ....++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999843 2345788899999999999999999988 999999999999999999999999998765432
Q ss_pred ccccccccccccCcccCchhccc-----CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALE-----GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ...............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~- 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKEHFQ- 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCccc-
Confidence 211 1122468999999999873 4578899999999999999999999753211 111001110000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENAT--DRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~--~RPt~~evl~~ 773 (791)
+. ......+..+.+++.+|+..+++ .||++.+++++
T Consensus 229 ----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 01112456788899987765443 37899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=308.89 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=198.7
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC------
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ------ 570 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------ 570 (791)
.+++.|++.+.||+|+||.||+|... +++.||+|++.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999654 58899999986543 3456788999999998 699999999998753
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999998542 3346788999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+....... .......
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~~~~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFLIPR 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHHHhc
Confidence 97653321 1223356889999999986 3458889999999999999999999975322110 0000000
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. . ........+..+.+++.+||+.+|.+|||+.|++++
T Consensus 231 ~~------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NP------A---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC------C---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0 000111234578899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=304.87 Aligned_cols=249 Identities=33% Similarity=0.452 Sum_probs=198.6
Q ss_pred ceecccCceeEEEeEeeC--C--cEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELLN--G--QEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
++||+|++|.||+|...+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 3 3699999987655 567789999999999999999999999988 888999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc-
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA- 661 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~- 661 (791)
++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999855332 56889999999999999999999988 9999999999999999999999999998765432211
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+...... ...... .... ... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~---~~~~-------~~~--~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKI---DKEG-------ERL--E 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---HhcC-------CcC--C
Confidence 1123456789999999999999999999999999999998 99987432111 111110 0000 000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
.+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=311.16 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=203.8
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 47899999999999999999965 57999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998732 34788889999999999999999988 99999999999999999999999999876543321
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+.......... .... ......
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~--------~~~~~~ 235 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIAT--------NGTPEL 235 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eecc--------CCCCCC
Confidence 1223467889999999999889999999999999999999999975322111000 0000 000000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122344668899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=304.30 Aligned_cols=248 Identities=33% Similarity=0.472 Sum_probs=195.1
Q ss_pred ceecccCceeEEEeEeeC----CcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELLN----GQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999995422 26899999876543 34567899999999999999999999875 4567999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc-
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA- 661 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~- 661 (791)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 36789999999999999999999988 9999999999999999999999999998664332111
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ...... ..... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~----~~~~~---------~~~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAM----LESGE---------RLP 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHH----HHcCC---------cCC
Confidence 1111223567999999998899999999999999999998 8998754321 111111 11110 001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1122346788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.51 Aligned_cols=253 Identities=33% Similarity=0.477 Sum_probs=198.7
Q ss_pred CCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHH--HHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLE--ELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
|++.+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999765 4678999999876543322 3456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++. ....+++..+..++.||++||.+||+++ ++|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999985 4556789999999999999999999998 99999999999999999999999999976411 12
Q ss_pred cccccccccCcccCchhcc-cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.......++..|+|||++. +..++.++||||+|+++++|++|..|+...... +.......... . ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~-~---~~~~~~--- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILK-R---PLPSSS--- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHH-T---HHHHHT---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhccc-c---cccccc---
Confidence 2333457889999999998 888999999999999999999999997644100 00000000000 0 000000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+.+++.+||+.||++||++.|++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.55 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=208.2
Q ss_pred cCCCccceecccCceeEEEeE-eeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
+-|.+.+-||+|.|..|-+|+ .-+|+.||||++.+.. ......+..|++.|+.++|||||+++++...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 458888999999999999995 4589999999997754 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE-cCCCCeEEeeeccccccCCC
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFgla~~~~~~ 657 (791)
+-.+|+|.+||-+ ....+.++.+.+++.||+.|+.|+|+.+ ++||||||+|+.+ ..-|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999954 4456889999999999999999999988 9999999999976 56789999999999877544
Q ss_pred ccccccccccccCcccCchhcccCCCC-cccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFS-IKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. .....+|...|-|||++.+..|+ +++||||||||||-|++|+.||+..-+.. ..-.++|
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------TLTmImD-- 233 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------TLTMIMD-- 233 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------------hhhhhhc--
Confidence 3 23346999999999999999885 67999999999999999999986432211 0111112
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
..-..+...+.++++||..||..||.+|.+.+|++..-
T Consensus 234 CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 234 CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 12334556788999999999999999999999998653
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.22 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=200.0
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcc---------cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQ---------GLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999965 45889999988654321 23568899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++++||+++++|.+++.. ...++...+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 245778888999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccc----ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 653 MFGGDELQA----NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 653 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
......... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~---- 225 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKIG---- 225 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHHh----
Confidence 765322111 112345788999999999888999999999999999999999997642211 0000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ......+...+..+.+++.+||+.||.+||++.|++++
T Consensus 226 --~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 --E----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --c----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 11111222345778999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=304.36 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=200.8
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
+|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999654 6889999988643 3334577889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ....++.+.+..++.||++||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999987432 3345788889999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.|+..... ....... ..... ..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~---------~~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKV-CQGSY---------KP 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHH-hcCCC---------CC
Confidence 11234688899999999988899999999999999999999999753211 0000000 00100 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+...+..+.+++.+||+.||++|||+.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.06 Aligned_cols=251 Identities=32% Similarity=0.495 Sum_probs=197.9
Q ss_pred ceecccCceeEEEeEeeC-------CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 508 NKLGEGGFGPVYKGELLN-------GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999997542 2579999886543 23467889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhc----cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-----CeEEeeecc
Q 003846 580 LPNKSLDSFLFDRA----KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-----KPKISDFGM 650 (791)
Q Consensus 580 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DFgl 650 (791)
+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2234788899999999999999999987 99999999999999887 899999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+................++..|+|||++.+..++.++||||||+++|||++ |+.|+..... .... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~----~~~~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVL----QHVTAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHH----HHHhcCC-
Confidence 976544332222223345778999999999999999999999999999998 8988653211 1111 0000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
....+...+..+.+++.+||+.+|.+||++.+++++|.+
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001122345678999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=309.65 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=202.4
Q ss_pred ccCCCccceecccCceeEEEeEee-CCc----EEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQ----EVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
..+|++.+.||+|+||.||+|... +|+ .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 357888899999999999999754 333 589998876543 345678899999999999999999999987 7889
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+|+||+++|+|.+++.. ....+++..+..++.||++||+|||+++ ++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999853 2345889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.............++..|+|||.+....++.++||||||+++|||++ |+.|+...... ... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~----- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIP----DLLEKGE----- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHH----HHHhCCC-----
Confidence 53322211112234568999999988899999999999999999998 99987543211 111 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
....+......+.+++.+||..+|++||++.++++.|+...
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 229 ----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111123356889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.36 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=209.4
Q ss_pred ccCCCccceecccCceeEEEeEeeC---Cc--EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN---GQ--EVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.+.....++||+|.||.||+|...+ |+ .||||..+.. .....+.|..|..+|++++|||||+++|+|.+. ...
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 3445556789999999999996533 33 4899988763 455678899999999999999999999999764 568
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||||.++-|.|.+||.. ++..++......++.||..||+|||+.. ++||||..+|||+....-+||+|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999954 4556888888999999999999999987 999999999999999999999999999998
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.++.+.... ...-+..|||||.+.-..++.++|||.|||.+||++. |..||....+.+ ..-.+
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI~~i 605 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VIGHI 605 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------eEEEe
Confidence 877665544 4456789999999999999999999999999999876 888976544322 11222
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
+..-+-..++..++.+..++.+||.+||.+||++.|+...|++
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 2222233445567889999999999999999999999888765
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=305.01 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=201.1
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
.+|++.+.||+|+||.||++...+++.+|+|++.... ....++.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999987778899999886433 335678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++.. ....++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999998843 2345788899999999999999999988 9999999999999999999999999987654332211
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... .. .... .....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~---~~-~~~~--~~~~~~----- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVV---ET-INAG--FRLYKP----- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHH---HH-HhCC--CCCCCC-----
Confidence 112234578999999998899999999999999999998 88886532211 111 00 0000 011111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
...+..+.+++.+||+.+|++|||+.|++++|.
T Consensus 224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 113467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=308.08 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=201.1
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35788889999999999999965 46889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998843 345888999999999999999999988 9999999999999999999999999987654321
Q ss_pred ccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.......|+..|+|||++. ...++.++|||||||++|+|++|+.|+....... .. .... ... ...+.
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~----~~~~-~~~---~~~~~ 230 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-AL----FLMT-KSN---FQPPK 230 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hH----Hhhh-ccC---CCCCc
Confidence 1223347899999999875 4568899999999999999999999864322110 00 0000 000 00011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... ....+..+.+++.+||+.+|++|||+++++++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111 11234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.96 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=203.2
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|+..+.||+|+||.||.++. .+++.+++|++... +.....++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578889999999999999854 46889999988654 344567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999985432 456788999999999999999999987 99999999999999999999999999986644332
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+...... ...... .... . .
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~-~~~~--------~-~ 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKI-VQGN--------Y-T 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHH-HcCC--------C-C
Confidence 223356899999999999888999999999999999999999987532110 111110 0000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
......+..+.+++.+||+.+|.+||++.|+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123456788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.85 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=201.9
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.+.|++.++||+|+||.||+|... +++.+|+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367899999999999999999764 5889999999877766678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|..++.+. ...+++..+..++.|+++||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999998887432 345888999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 660 QANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.......+++.|+|||++. ...++.++|||||||++|||++|+.|+...... ..... ..... .
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~-~~~~~-----~ 232 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLK-IAKSE-----P 232 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHH-HhcCC-----C
Confidence 1122346788999999885 345788999999999999999999997532210 00000 00000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.. ..+...+..+.+++.+||+.+|++||+++|++++
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 1112334578899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=317.19 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=209.2
Q ss_pred cCCCccceecccCceeEEEeEeeC-CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.+....++||-|.||.||.|.++. .-.||||.++.. ....++|..|+.+|+.++|||+|+++|+|..+..+|||.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345667899999999999997754 567999999654 456889999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
..|+|.+||.+ .++..++.-..+.++.||+.||.||..++ +|||||..+|+|+.++..+||+||||++.+..+.+.
T Consensus 346 ~yGNLLdYLRe-cnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRE-CNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHH-hchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 99999999954 44556777778899999999999999988 999999999999999999999999999999877654
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.... ..-...|.|||.+.-+.++.|+|||+|||+|||+.| |..|+..... .+++. +++...+-
T Consensus 422 AHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------SqVY~---------LLEkgyRM 485 (1157)
T KOG4278|consen 422 AHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYG---------LLEKGYRM 485 (1157)
T ss_pred cccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HHHHH---------HHhccccc
Confidence 4322 233678999999999999999999999999999998 5556432211 12222 22222333
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
+.+.-.++.+++|+++||+..|.+||++.|+-+.++.
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 3344456789999999999999999999998877765
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=308.37 Aligned_cols=239 Identities=23% Similarity=0.321 Sum_probs=187.0
Q ss_pred eecccCceeEEEeEeeC-------------------------CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeee
Q 003846 509 KLGEGGFGPVYKGELLN-------------------------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRL 563 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 563 (791)
+||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13589999876555455678899999999999999999
Q ss_pred eeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC--
Q 003846 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-- 641 (791)
Q Consensus 564 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-- 641 (791)
++++.++...++||||+++|+|+.++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998843 3456788999999999999999999987 99999999999997654
Q ss_pred -----CeEEeeeccccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHH-hCCCCCCCCCCCcc
Q 003846 642 -----KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEIL-SGKKNTGFYHTGSL 714 (791)
Q Consensus 642 -----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~ell-tg~~p~~~~~~~~~ 714 (791)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3899999998643221 12356788999998876 56899999999999999995 6888865322111
Q ss_pred chhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 715 NLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
... .... ... .+.+....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 230 -~~~----~~~~-------~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KER----FYEK-------KHR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHH----HHHh-------ccC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000 0000 000 11112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=311.85 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=203.7
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35789999999999999999954 57899999999766555667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999873 235789999999999999999999988 99999999999999999999999999876543322
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.|+....... ......... . +.+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~~~~~~~~~-~-----~~~-- 235 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATNG-T-----PEL-- 235 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcC-C-----ccc--
Confidence 1 223468889999999998889999999999999999999999975432110 000000000 0 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1112234578899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.95 Aligned_cols=264 Identities=18% Similarity=0.237 Sum_probs=194.0
Q ss_pred ccceeccc--CceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 506 AENKLGEG--GFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 506 ~~~~LG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
+.++||+| +|++||++.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999965 568999999987542 233456788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++|+|.+++..+. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234788999999999999999999988 999999999999999999999999875443211100
Q ss_pred -----cccccccccCcccCchhccc--CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh---hh---------
Q 003846 661 -----ANTNRIVGTYGYMSPEYALE--GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH---AW--------- 721 (791)
Q Consensus 661 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~---~~--------- 721 (791)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............. ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 01112356778999999976 468999999999999999999999986432211000000 00
Q ss_pred -HHhhcCCcccccc-------------c----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 722 -DLWKDNRALDLMD-------------P----ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 722 -~~~~~~~~~~~~~-------------~----~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
............+ + .............+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000000000000 0 00000112245678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=316.53 Aligned_cols=192 Identities=24% Similarity=0.339 Sum_probs=163.7
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
....+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999664 5778999975432 2356999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+. ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 588887743 3456889999999999999999999988 999999999999999999999999999753222
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCC
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN 705 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p 705 (791)
. ......||+.|+|||++.+..++.++|||||||++|||+++..+
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 1 12234689999999999999999999999999999999986654
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=305.33 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=199.9
Q ss_pred CCCccceecccCceeEEEeEeeCCcEEEEEEecccC------cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 503 NFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS------GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
+|++.+.||+|+||.||+|...+++.+|||.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999987789999999886432 12245688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998432 34778888999999999999999988 99999999999999999999999999876532
Q ss_pred Ccc----ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 657 DEL----QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 657 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
... ........++..|+|||.+.+..++.++||||||+++++|++|+.|+....... .... ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~-~~~---~~~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFY-IGA---HRG 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHH-hhh---ccC
Confidence 111 111223468899999999998889999999999999999999999975322110 0000 000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
..+ ..+...+..+.+++.+||+.+|.+||++.|+++
T Consensus 226 ~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011 112234567899999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=316.23 Aligned_cols=255 Identities=19% Similarity=0.246 Sum_probs=196.4
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.++||+|+||+||+++.. +++.||+|++.+. .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999764 5788999998653 2223455788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 345788889999999999999999988 999999999999999999999999999866433
Q ss_pred ccccccccccccCcccCchhccc-----CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALE-----GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||..... ...............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHEERFQ- 228 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCCCccc-
Confidence 221 1123468999999999875 4678999999999999999999999753221 000000000000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATD--RPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 773 (791)
+ .......+..+.+++.+|+..++.+ |+++++++++
T Consensus 229 ----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0011123567889999999866544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.14 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=199.8
Q ss_pred CCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999764 4778899998766666677889999999999999999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
++|..++.. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999988743 2346889999999999999999999988 9999999999999999999999999987653221 11
Q ss_pred cccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 663 TNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.....++..|+|||++. +..++.++|||||||++|||++|+.|+...... . ....... ... +..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~---~~~~~~~-~~~-----~~~ 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--R---VLLKIAK-SEP-----PTL 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--H---HHHHHhh-cCC-----CCC
Confidence 22346889999999984 345788999999999999999999997532211 0 0000000 000 000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
..+...+..+.+++.+||+.+|.+||++.+++++-
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 01122346789999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=307.23 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=202.1
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999654 68899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999843 26889999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+....... . . ...... ..+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~---~-~~~~~~-----~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--V---L-FLIPKN-----NPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--H---H-HHhhhc-----CCCCCcc
Confidence 11223467889999999998889999999999999999999999975332110 0 0 000000 0011111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ..+..+.+++.+||+.+|++|||+++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 145678899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.47 Aligned_cols=257 Identities=29% Similarity=0.403 Sum_probs=202.8
Q ss_pred cCCCccceecccCceeEEEeEee------CCcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
++|++.+.||+|+||.||+|+.. +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999753 2467999988655433 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccc------cccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 575 LIYEYLPNKSLDSFLFDRAKK------RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
+||||+++++|.+++...... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644322 25889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..|+...... ... ......
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~----~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVL----NRLQAG 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHH----HHHHcC
Confidence 99875432221 12223356778999999988888999999999999999999 67776432211 111 001111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
... .......+..+.+++.+||+.+|.+|||+.|++++|.+
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 100 01112344688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.04 Aligned_cols=264 Identities=25% Similarity=0.371 Sum_probs=204.0
Q ss_pred eehhhhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEE-
Q 003846 492 FSFASVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCL- 568 (791)
Q Consensus 492 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~- 568 (791)
+.++.+....++|++.+.||+|+||.||++.. .+++.+|+|++.... ....++.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44566777889999999999999999999965 458899999886432 2346788999999999 6999999999884
Q ss_pred ----cCCcceEEEeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCe
Q 003846 569 ----DQDEKILIYEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP 643 (791)
Q Consensus 569 ----~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 643 (791)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345679999999999999987543 23456788889999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccCcccCchhccc-----CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhh
Q 003846 644 KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE-----GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLG 718 (791)
Q Consensus 644 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~ 718 (791)
||+|||++........ ......|++.|+|||++.. ..++.++||||+||++|||++|+.|+.......
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 9999999876543221 1223468899999998853 457899999999999999999999975432110
Q ss_pred hhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 719 HAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.... ..... .+... .+......+.+++.+||+.||++|||+.|++++.
T Consensus 237 ~~~~-~~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ALFK-IPRNP-----PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHhh-ccccC-----CCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 00000 00000 0111245788999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.71 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=193.5
Q ss_pred ceecccCceeEEEeEeeC-Cc--EEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELLN-GQ--EVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||+|...+ +. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999997643 43 4688888643 234456788999999999 799999999999999999999999999
Q ss_pred CChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 583 KSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 583 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 1234788899999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
++...... ........+..|+|||++....++.++||||||++++||++ |..||...... .. ........
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~----~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL----YEKLPQGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HH----HHHHhCCC
Confidence 98632211 11111233567999999988899999999999999999997 88887432111 11 11111110
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...+..+.+++.+|++.+|.+|||+.|+++.|+.+
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0011112345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.58 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=204.4
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999664 57889999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++... ...++...+..++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988432 246888999999999999999999988 99999999999999999999999999876543211
Q ss_pred cccccccccCcccCchhcccC---CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 661 ANTNRIVGTYGYMSPEYALEG---LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ ...... . ......+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-----~~~~~~-~---~~~~~~~ 226 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----LFLISK-S---NFPPPKL 226 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-c---cCCCccc
Confidence 11234678899999999876 889999999999999999999999753221110 000000 0 0000011
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1123356789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=305.18 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=190.9
Q ss_pred ceecccCceeEEEeEeeC----CcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc-CCcceEEEeecC
Q 003846 508 NKLGEGGFGPVYKGELLN----GQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD-QDEKILIYEYLP 581 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~~ 581 (791)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997532 457999998643 33446788899999999999999999998764 556789999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc-
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ- 660 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~- 660 (791)
+++|.+++... ...+.+..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998532 234567778899999999999999987 999999999999999999999999999765432211
Q ss_pred -cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCC-CCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 661 -ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK-KNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 661 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.......++..|+|||.+.+..++.++||||||+++|||++|. .|+.... ........ . ... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~---~-~~~---------~ 220 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYL---L-QGR---------R 220 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH---h-cCC---------C
Confidence 1112234567899999999889999999999999999999964 4443211 11111110 0 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...+...+..+.+++.+||+.+|++||++.|+++.|++.
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001112245788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.67 Aligned_cols=255 Identities=19% Similarity=0.248 Sum_probs=195.3
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.++||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999764 4778999998643 2223445788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999853 2345788889999999999999999988 999999999999999999999999998765332
Q ss_pred ccccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~- 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKERFQ- 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCcccc-
Confidence 21 1122357899999999986 34688999999999999999999999753221 111111100000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATD--RPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 773 (791)
. .......+..+.+++.+|+..++.+ |++++|++++
T Consensus 229 ----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0011123567889999988654444 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.00 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=205.7
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.+.||.|+||+||+|.. .++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999975 468899999986543 33567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++........+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433456889999999999999999999988 99999999999999999999999999877654322
Q ss_pred cc--ccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 660 QA--NTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 660 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. ......++..|+|||++... .++.++|+||||+++++|++|+.|+....... ......... .+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~~~~------~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLMLTLQND------PPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hHHHHhcCC------CCC
Confidence 21 22334688999999998877 78999999999999999999999975332211 000101100 011
Q ss_pred ccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEA-SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111 12345678999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.92 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=198.1
Q ss_pred CCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 504 FSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
|+..+.||+|+||+||++.. .+++.+|+|.+.... ......+.+|++++++++|+|++++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999965 468899999986542 22345578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999888543 2346899999999999999999999988 9999999999999999999999999997653221
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........ ........... . .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~------~----~ 222 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLET------E----E 222 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhcc------c----c
Confidence 11234689999999999988999999999999999999999999764321100 00000000000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
......+..+.+++..|++.||++||+ +.|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111223456789999999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.42 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=196.2
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC----
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD---- 571 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 571 (791)
...++|++.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999965 468899999987542 234567788999999999999999999986543
Q ss_pred --cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 572 --EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 572 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
..++||||+++ +|.+.+. ..++...+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999976 5655552 24778888999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH-------
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD------- 722 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~------- 722 (791)
+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... .......
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 239 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCP 239 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 998654322 1223478999999999999999999999999999999999999975432110 0000000
Q ss_pred ------------Hhhc-CCccccc------cccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 ------------LWKD-NRALDLM------DPIL--ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 ------------~~~~-~~~~~~~------~~~l--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.... ....... +... ...........+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000 0000 000111234578899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.37 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=200.6
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.+.||+|+||.||++... +++.||+|.+... ......++.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999764 6899999988654 333456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
+++++|..++........+++..+..++.||++||.|||+. + |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999885433344688999999999999999999974 5 9999999999999999999999999997653221
Q ss_pred cccccccccccCcccCchhcccC------CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEG------LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.|+....... ....... ....
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~-~~~~----- 225 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSA-IVDG----- 225 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHH-Hhhc-----
Confidence 1223578899999998644 35889999999999999999999975422111 1000000 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+...+..+.+++.+||+.+|.+||++.|++++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 ----DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0111223356788999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.34 Aligned_cols=238 Identities=26% Similarity=0.429 Sum_probs=188.3
Q ss_pred ceecccCceeEEEeEeeCCc-----------EEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 508 NKLGEGGFGPVYKGELLNGQ-----------EVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999775433 5788877654433 6788999999999999999999999988 778999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-------CeEEeeec
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-------KPKISDFG 649 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~DFg 649 (791)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985432 26888999999999999999999988 99999999999999888 79999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccC--CCCcccceeehhHHHHHHHhC-CCCCCCCCCCccchhhhhhHHhhc
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEG--LFSIKSDVFSFGVLLLEILSG-KKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
++..... .....++..|+|||++.+. .++.++||||||++++||++| ..|+....... .. ..+..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~----~~~~~ 221 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KE----RFYQD 221 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HH----HHHhc
Confidence 9986543 1123566789999999876 789999999999999999995 55654322110 00 00000
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
. ...+.+....+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 222 ~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 Q-----------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-----------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0001111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.72 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=187.3
Q ss_pred ceecccCceeEEEeEee---CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL---NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~ 582 (791)
.+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 58999999999999764 35789999986543 23567899999999999999999999864 4567899999875
Q ss_pred CChhHHHhhh------ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE----cCCCCeEEeeecccc
Q 003846 583 KSLDSFLFDR------AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DTDMKPKISDFGMAR 652 (791)
Q Consensus 583 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFgla~ 652 (791)
+|.+++... .....+++..+..++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 677766421 12235788889999999999999999988 9999999999999 566789999999998
Q ss_pred ccCCCccc-cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccc-------hhhh----
Q 003846 653 MFGGDELQ-ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN-------LLGH---- 719 (791)
Q Consensus 653 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~-------~~~~---- 719 (791)
........ .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 76543221 122345789999999998764 5899999999999999999999998643322100 0000
Q ss_pred -------hhHHhhcC-Ccccccccc----cc--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 720 -------AWDLWKDN-RALDLMDPI----LE--------NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 720 -------~~~~~~~~-~~~~~~~~~----l~--------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.|...... ......... .. ..........+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 000000000 00 00011123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=320.21 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=195.9
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC------
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------ 570 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 570 (791)
..++|++.+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999965 46889999998753 233456788999999999999999999987643
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
...++||||+++ +|.+++. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346899999975 6666652 23677888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH-------
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL------- 723 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------- 723 (791)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPE 247 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence 98654322 122347899999999999999999999999999999999999998543211 000000000
Q ss_pred -----------hhcCCc-------cccccccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 724 -----------WKDNRA-------LDLMDPIL---ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 724 -----------~~~~~~-------~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...... .+...... ...........+.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00000000 000111123578899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=300.43 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=189.2
Q ss_pred ceecccCceeEEEeEeeCCc---EEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 508 NKLGEGGFGPVYKGELLNGQ---EVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.||+|+||.||++...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999754433 45677665433 334578899999999999999999999999999999999999999
Q ss_pred ChhHHHhhhcc-ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 584 SLDSFLFDRAK-KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 584 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
+|.+++..... ....+...+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865322 234566677899999999999999987 99999999999999999999999999864332222222
Q ss_pred cccccccCcccCchhccc-------CCCCcccceeehhHHHHHHHhC-CCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 663 TNRIVGTYGYMSPEYALE-------GLFSIKSDVFSFGVLLLEILSG-KKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... ...... .. ........+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~---~~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNH---VI-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH---HH-hhcccccCC
Confidence 234567889999998753 2457899999999999999975 556532211 111111 11 111122223
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
+.+.. ...+.+.+++..|| .+|.+||+++||++.|.
T Consensus 232 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222 24467888999999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.21 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=194.6
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-----cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccc
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-----GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEK 573 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 573 (791)
.+|+..+.||+|+||.||+|.. .+++.||+|++.... .+....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999965 468999999886432 12345688999999999999999999998753 566
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++++||+++++|.+++.. ...+++.....++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999843 234788888999999999999999987 99999999999999999999999999876
Q ss_pred cCCCcc-ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDEL-QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~--------- 221 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKI--------- 221 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHH---------
Confidence 532211 11122345788999999999888999999999999999999999997532110 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+......+.+++ +||..+|++||+++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 222 ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 000011122223445667777 6888899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=306.47 Aligned_cols=240 Identities=25% Similarity=0.398 Sum_probs=189.3
Q ss_pred ceecccCceeEEEeEeeC--------CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 508 NKLGEGGFGPVYKGELLN--------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+.||+|+||.||+|.... ..++|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999996532 335888888665555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC--------eEEeeeccc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK--------PKISDFGMA 651 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DFgla 651 (791)
+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998542 336788899999999999999999988 999999999999987765 699999998
Q ss_pred cccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCC-CCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGK-KNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... . ......
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-----~--~~~~~~-- 220 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----K--LQFYED-- 220 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-----H--HHHHHc--
Confidence 654322 224577889999999864 5899999999999999999995 4433211100 0 000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
....+......+.+++.+||+.||++|||++|+++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01112223457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.10 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=200.6
Q ss_pred CCCccceecccCceeEEEeEeeC--CcEEEEEEeccc----------CcccHHHHHHHHHHHHh-cCCCceeeeeeEEEc
Q 003846 503 NFSAENKLGEGGFGPVYKGELLN--GQEVAVKRLSKK----------SGQGLEELKNETMLIAK-LQHRNLVRLLGCCLD 569 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 569 (791)
.|++.+.||+|+||.||++.... ++.+|||.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999997654 688999987532 22234567788888875 799999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcCCCCeEEee
Q 003846 570 QDEKILIYEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDTDMKPKISD 647 (791)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~D 647 (791)
++..+++|||+++++|.+++... .....++...+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 234568888999999999999999996 45 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 648 FGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 648 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..... ....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~~~~-~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SLATK-IVEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HHHHH-Hhhc
Confidence 99998754432 223456889999999999888999999999999999999999996432110 00000 0000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
. ..+. .....+..+.+++.+||+.||++||++.|+..++++
T Consensus 229 ~----~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 V----YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred c----CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0 0111 111234678999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=312.30 Aligned_cols=256 Identities=30% Similarity=0.479 Sum_probs=199.0
Q ss_pred ccCCCccceecccCceeEEEeEee-CCc----EEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQ----EVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.++|+..+.||+|+||.||+|... +|+ .||+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999653 444 578998865432 2344788999999999999999999998754 567
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+++||+++|+|.+++... ...++++.+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998532 345788889999999999999999988 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~----~~~~~~~~~~---- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--E----IPDLLEKGER---- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHCCCC----
Confidence 54332222223345778999999998999999999999999999997 88886432111 0 1111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
. ..+...+..+.+++..||..+|++||+++|++++|+..
T Consensus 230 ---~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ---L--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01111335788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.94 Aligned_cols=267 Identities=21% Similarity=0.257 Sum_probs=193.1
Q ss_pred hhhhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCC------CceeeeeeE
Q 003846 494 FASVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH------RNLVRLLGC 566 (791)
Q Consensus 494 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~ 566 (791)
.+++...+++|++.++||+|+||+||+|.. ..++.||||+++... ....++..|+.+++.++| .++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344555678999999999999999999965 458889999986432 233456678888877754 458899998
Q ss_pred EEcC-CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCC---
Q 003846 567 CLDQ-DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDM--- 641 (791)
Q Consensus 567 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~--- 641 (791)
+... .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 8765 4678899987 6788888743 34688899999999999999999974 6 99999999999998765
Q ss_pred -------------CeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCC
Q 003846 642 -------------KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGF 708 (791)
Q Consensus 642 -------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~ 708 (791)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999875422 122345789999999999999999999999999999999999999864
Q ss_pred CCCCc-cchhhhh----hHHhhc----CCcccccc------ccc---------cCC--CCHHHHHHHHHHHHHccccCCC
Q 003846 709 YHTGS-LNLLGHA----WDLWKD----NRALDLMD------PIL---------ENE--ASYPMLARYVNVALLCVHENAT 762 (791)
Q Consensus 709 ~~~~~-~~~~~~~----~~~~~~----~~~~~~~~------~~l---------~~~--~~~~~~~~l~~li~~cl~~dp~ 762 (791)
..... ....... ...+.. ....++++ +.. ... ........+.+||.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 32210 0000000 000000 00000000 000 000 0001235678999999999999
Q ss_pred CCCCHHHHHHH
Q 003846 763 DRPTMSEVVSM 773 (791)
Q Consensus 763 ~RPt~~evl~~ 773 (791)
+|||++|++++
T Consensus 428 ~R~ta~e~L~H 438 (467)
T PTZ00284 428 KRLNARQMTTH 438 (467)
T ss_pred hCCCHHHHhcC
Confidence 99999999974
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.56 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=202.4
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888899999999999999654 58899999886543 34467889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. .+.+++..+..++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999988743 345788999999999999999999732 39999999999999999999999999986543221
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-c-hhhhhhHHhhcCCccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-N-LLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.....++..|+|||++.+..++.++|||||||++|+|++|+.|+........ . ......... ...+....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 230 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL-----QQIVQEPP 230 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH-----HHHhhccC
Confidence 2234789999999999888999999999999999999999999864332110 0 000000000 00000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
........+..+.+++.+|++.||.+|||+.|++++.-
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00001124467889999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.50 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=198.9
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466678999999999999965 457899999987543 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++. ...+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998873 245788889999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......++..|+|||++.+..++.++||||||++++||++|+.|+........ . . ..... ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~---~-~~~~~---------~~~~ 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--L---F-LIPKN---------SPPT 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--H---h-hhhcC---------CCCC
Confidence 11224578899999999998999999999999999999999998653221110 0 0 00000 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+..+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112244678899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.95 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=200.8
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.++||+|+||.||++.. .+|+.||+|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 578889999999999999965 46899999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988532 2235688889999999999999999987 99999999999999999999999999976543221
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
. .....+++.|+|||++.+..++.++|+||||+++++|++|+.|+..... ........ .... .
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~-~~~~---------~ 219 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKII-RGSY---------P 219 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHh-cCCC---------C
Confidence 1 1234578899999999998999999999999999999999998653211 11111100 0000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.+|.+||++.||+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.57 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=202.8
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.++||.|+||.||++... +++.+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999764 6889999999776666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999843 2345888999999999999999999998 99999999999999999999999999876433211
Q ss_pred ccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 660 QANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
......+++.|+|||.+. ...++.++||||||+++|||++|+.|+....... .. ........
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~----- 225 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-----VL-LKILKSEP----- 225 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-----HH-HHHhcCCC-----
Confidence 122346889999999875 3457889999999999999999999975432110 00 00100000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.+ ..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001 0112234578899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.83 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=201.3
Q ss_pred ccCCCccceecccCceeEEEeEeeC----CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.++|.+.++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999997543 2468999887654 4456789999999999999999999998875 56789
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998432 335788999999999999999999988 9999999999999999999999999998665
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
...... .....++..|+|||.+....++.++||||||++++||++ |..||...... .... ........
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~----~~~~~~~~---- 227 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIG----RIENGERL---- 227 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHH----HHHcCCcC----
Confidence 432211 112234568999999988889999999999999999986 99987543221 1110 01111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..+...+..+.+++.+|+..+|.+|||+.|+++.|++..
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223467899999999999999999999999997743
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.65 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=197.4
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999654 58899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
++ ++|.+++.. ....+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 97 588888743 2345788889999999999999999988 9999999999999999999999999997543221
Q ss_pred ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-ch--------hhhhhHHhhcCCc
Q 003846 660 QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-NL--------LGHAWDLWKDNRA 729 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-~~--------~~~~~~~~~~~~~ 729 (791)
.......+++.|+|||++.+. .++.++||||||+++|||++|+.||........ .. ....|........
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 111223568899999988754 578999999999999999999999764321100 00 0000000000000
Q ss_pred ccc-ccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDL-MDPILEN----EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~-~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... ..+.... ......+..+.+++.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0000000 0111234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=318.40 Aligned_cols=241 Identities=24% Similarity=0.288 Sum_probs=185.9
Q ss_pred ecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc---CCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL---QHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
||+|+||+||+|+.. +++.||||++.+.. ......+..|..++.+. +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999654 58999999986532 12233455666776655 699999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999988843 355888999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred cccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCC
Q 003846 663 TNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . .......... .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~----~~~~i~~~~~------~~~--- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--Q----MYRNIAFGKV------RFP--- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--H----HHHHHHcCCC------CCC---
Confidence 2345789999999998765 4899999999999999999999997532111 0 0111111100 000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 003846 742 SYPMLARYVNVALLCVHENATDRP----TMSEVVSM 773 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RP----t~~evl~~ 773 (791)
....+..+.+++.+||+.||.+|| ++.|++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 011346788999999999999998 56776653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.09 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=198.6
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc----------ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG----------QGLEELKNETMLIAKLQHRNLVRLLGCCLDQD 571 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 571 (791)
+|.+.+.||+|+||.||+|.. .+|+.+|+|.+..... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999954 4689999998853211 12346788999999999999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++||||+++++|.+++... ..++...+..++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998443 45788888999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccCC--CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGL--FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+...............++..|+|||.+.... ++.++|+||||++++||++|..|+..... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~-- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMFKLGNKR-- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHHHhhccc--
Confidence 7654322222223346788999999987654 88999999999999999999999742211 01111111000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.............+..+.+++.+||+.+|.+|||+.|++++
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 ---SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111111112245688999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.66 Aligned_cols=246 Identities=31% Similarity=0.467 Sum_probs=199.0
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
+.|.-.+.||.|+||.||-|+. .+.+.||||++.... .+.+.++..|++.|++++|||.|.+.|||..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4466678899999999999954 568899999997543 345778899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
|||-| +-.++|. ..++++-..++..|..+.++||+|||+++ .||||||..||||++.|.+||+|||.|....
T Consensus 106 EYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 106 EYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 99954 6667762 34456778888999999999999999998 9999999999999999999999999997643
Q ss_pred ccccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
..+.++|||.|||||++. .+.|+-++||||||++..||.-.++|.- ..+. ....+. .... -.
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF-nMNA----MSALYH--IAQN----es 242 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNA----MSALYH--IAQN----ES 242 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc-CchH----HHHHHH--HHhc----CC
Confidence 234579999999999986 5789999999999999999999998831 1111 111111 1110 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
|.+. ....+..++.++..||+.-|.+|||.++++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111 33567889999999999999999999999876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=295.68 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=209.6
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.+-|.++++||+|.||.||++.. .+|+.+|||++... .+..++..|+.++++...|++|+++|.+.....+.+||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 34577889999999999999944 57999999998654 3578899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
|..|+..+.+ +.+++.+.+.++..+++..++||+|||... -||||||..||||+.+|.+||+|||.|..+.+..
T Consensus 110 CGAGSiSDI~--R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM- 183 (502)
T KOG0574|consen 110 CGAGSISDIM--RARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM- 183 (502)
T ss_pred cCCCcHHHHH--HHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-
Confidence 9999999998 456678999999999999999999999876 8999999999999999999999999998765432
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
...+...|||.|||||++..-.|+.++||||||+...||.-|++|+...+....-+. -...+...-
T Consensus 184 -AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------------IPT~PPPTF 249 (502)
T KOG0574|consen 184 -AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------------IPTKPPPTF 249 (502)
T ss_pred -HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------------ccCCCCCCC
Confidence 223457899999999999999999999999999999999999999764433211000 000111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+.++.+++++||-..|++|.|+.+++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2234467889999999999999999999998876
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.93 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=201.7
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC------cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS------GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999964 568999999986533 1235678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeecccccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMF 654 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~ 654 (791)
|+||+++++|.+++.. ...+++..+..++.||++||.|||+++ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 345788889999999999999999988 99999999999998776 5999999999776
Q ss_pred CCCccc--cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 655 GGDELQ--ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 655 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|+.|+........ ...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~---------~ 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFK---------I 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHH---------H
Confidence 543211 112234678899999999888899999999999999999999999754322111 000000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+......+.+++.+|++.+|.+|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00111122333456788999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=303.39 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=202.1
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..|+..++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999754 58899999987543 34567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ..++...+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998832 34778888999999999999999987 99999999999999999999999999976643321
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......++..|+|||++.+..++.++|+||||+++|||++|+.|+........ . .........
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~-------------~~~~~~~~~ 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--L-------------FLIPKNNPP 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--h-------------hhhhcCCCC
Confidence 12234578899999999988899999999999999999999999653221100 0 000111112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233456788999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.48 Aligned_cols=247 Identities=30% Similarity=0.446 Sum_probs=197.8
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
++|++.+.||+|+||.||++.. +++.||+|++.... ..+.+.+|+.++++++|||++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688899999999999999974 78889999986543 346789999999999999999999998654 5799999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++... ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 99999998543 2345788899999999999999999987 999999999999999999999999998754321
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.|+....... . ....... ....
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~---------~~~~ 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--V----KECVEKG---------YRME 217 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--H----HHHHhCC---------CCCC
Confidence 112234568999999998899999999999999999998 888865332110 0 1111110 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.....+..+.+++.+||+.+|.+||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.79 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=199.5
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-cceEEEe
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD-EKILIYE 578 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E 578 (791)
+|++.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999654 57899999986543 334567889999999999999999999876544 5789999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++... ....+++.++..++.+++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998543 3345789999999999999999999988 9999999999999999999999999997664322
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.......+++.|+|||++.+..++.++||||||+++++|++|+.|+..... ...... ......
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~-~~~~~~--------- 219 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYR-IIEGKL--------- 219 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH-HHhcCC---------
Confidence 122234678999999999999999999999999999999999998653211 111111 111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...+..+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11222345688999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.32 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=200.2
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC-----cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-----GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999765 78999999886543 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 235778889999999999999999988 99999999999999999999999999876543
Q ss_pred CccccccccccccCcccCchhcccCC-CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.|+...... ...........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~------- 219 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAVFKIGRSKE------- 219 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHHHHHHhccc-------
Confidence 32 123346788999999988776 899999999999999999999997543210 00111000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+......+.+++.+||+.+|.+||++.|++++
T Consensus 220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011122245678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.16 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=199.4
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999765 58999999886542 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|..++. ....+++..+..++.||++||+|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 2345889999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccch--hh-------hhhHHhhcCC
Q 003846 659 LQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNL--LG-------HAWDLWKDNR 728 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~--~~-------~~~~~~~~~~ 728 (791)
. ......++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... .. .....+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1122357789999999876 468899999999999999999999986433211100 00 0000000000
Q ss_pred cc-ccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 AL-DLMDPILENEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~~-~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. ....+......+ ...+..+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000000000000 1134678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.12 Aligned_cols=244 Identities=29% Similarity=0.453 Sum_probs=201.8
Q ss_pred eecccCceeEEEeEeeC-CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCChhH
Q 003846 509 KLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDS 587 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 587 (791)
.||+|.||+||.|+..+ ...+|||.+..++.+....+..|+.+-+.++|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999997654 56799999988877778889999999999999999999999999999999999999999999
Q ss_pred HHhhhcccccc--CHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-CCCCeEEeeeccccccCCCccccccc
Q 003846 588 FLFDRAKKRLL--YWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPKISDFGMARMFGGDELQANTN 664 (791)
Q Consensus 588 ~l~~~~~~~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~~~~~~~~~ 664 (791)
+|.. +=+++ .+.++-.+.+||++||.|||++. |+|||||-+|+|++ -.|.+||+|||-++.+.+- ...+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 9943 33334 56777789999999999999988 99999999999995 5799999999999876533 34445
Q ss_pred cccccCcccCchhcccC--CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 665 RIVGTYGYMSPEYALEG--LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 665 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
...||.-|||||++..+ .|..++|||||||.+.||.||++||.........+ ++.+ --......+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVG------myKvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVG------MYKVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhc------ceecCCCCc
Confidence 57899999999999865 58999999999999999999999975433221110 0000 001123455
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
...+++.+.+|.+|+.+||.+||++.++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 667889999999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.14 Aligned_cols=253 Identities=30% Similarity=0.405 Sum_probs=207.1
Q ss_pred cCCCccceecccCceeEEEeEee--CCc--EEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL--NGQ--EVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
++....++||+|.||.|++|.+. +|+ .||||.++..... ...+|.+|+.+|-+|+|+|+++|+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 44556689999999999999664 355 5899999876544 67899999999999999999999999988 778899
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
+|+++.|+|.+.|.+ ..+..+.......++.|||.||.||.+++ +|||||..+|+||-....+||+||||.+-++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999976 55666778888899999999999999987 99999999999999999999999999998876
Q ss_pred Ccccc-ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 657 DELQA-NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 657 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.+... ......-...|+|||.+....++.++|||+|||.||||++ |+.||..... ..+.+.+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------~qIL~~iD 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------IQILKNID 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------HHHHHhcc
Confidence 54333 3333455779999999999999999999999999999999 5667543221 11122233
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
..-.-..+...++++++++..||..+|++|||+..+.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2222234455788999999999999999999999997544
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=339.21 Aligned_cols=256 Identities=24% Similarity=0.335 Sum_probs=197.8
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccc
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEK 573 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 573 (791)
...++|.+.++||+|+||+||++... +++.+|+|.+... .......+..|+.++++++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999654 5778999988653 233456788999999999999999999988654 457
Q ss_pred eEEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCC----CCeeecCCCCCcEEEcC---------
Q 003846 574 ILIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSR----LRIIHRDLKASNILLDT--------- 639 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~----~~iiH~Dlkp~NILl~~--------- 639 (791)
+|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999986532 23568999999999999999999998541 34999999999999964
Q ss_pred --------CCCeEEeeeccccccCCCccccccccccccCcccCchhccc--CCCCcccceeehhHHHHHHHhCCCCCCCC
Q 003846 640 --------DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE--GLFSIKSDVFSFGVLLLEILSGKKNTGFY 709 (791)
Q Consensus 640 --------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltg~~p~~~~ 709 (791)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999986543321 223578999999999864 45889999999999999999999997532
Q ss_pred CCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 710 HTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
... . ......... +.+ .....+..+.+||..||+.+|.+||++.|+++
T Consensus 247 ~~~----~-qli~~lk~~-------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNF----S-QLISELKRG-------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcH----H-HHHHHHhcC-------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211 0 111111110 000 01113467899999999999999999999984
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.41 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=198.1
Q ss_pred CCccceecccCceeEEEeEee----CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC------
Q 003846 504 FSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD------ 571 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 571 (791)
|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999653 3688999998654 2334677889999999999999999999886543
Q ss_pred cceEEEeecCCCChhHHHhhhc---cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 572 EKILIYEYLPNKSLDSFLFDRA---KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
..++++||+++|+|..++.... ....++...+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875322 2234788889999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
|+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+..... ..... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~----~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYN----YLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHH----HHHcC
Confidence 99987644332222223345678999999998889999999999999999999 7787643211 11111 11111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.. + ..+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 232 ~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0 01112346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.36 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=196.4
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-----cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccc
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-----GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEK 573 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 573 (791)
.+|++.+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999965 458999999885321 12346788899999999999999999998764 456
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
+++|||+++++|.+++... ..++......++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999988432 34778888999999999999999988 99999999999999999999999999876
Q ss_pred cCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
....... .......++..|+|||++.+..++.++||||||+++|||++|+.|+...... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~-------- 222 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIA-------- 222 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHHHHHh--------
Confidence 5432111 1122346888999999999888999999999999999999999997532110 0000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+......+.+++.+|+. +|++||+++|++++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 -TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0001112233455678899999995 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.47 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=204.9
Q ss_pred hhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecc--cCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcc
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSK--KSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 573 (791)
+......|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-+.+|+.+|.+++ |.+||++++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3456678999999999999999999887788999997753 45667888999999999995 99999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
||||||= ..+|..+|.... ..++.-.+..+..|++.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9999975 558999985432 22332367889999999999999998 99999999999984 57999999999998
Q ss_pred cCCCccccccccccccCcccCchhcccCC-----------CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGL-----------FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
+..+.........+||+.||+||.+.... .+.++||||+|||||+|+.|+.||+......
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--------- 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--------- 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH---------
Confidence 88776666666679999999999986332 5689999999999999999999976433211
Q ss_pred HhhcCCccccccccccCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 LWKDNRALDLMDPILENEASY-PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+...++++.-.-+++. +...++.++++.||+.||.+||+..|++++
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11122333322111111 112238999999999999999999999976
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=300.70 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=202.3
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|+..+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999765 58899999987653 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
+++++|.+++.... ..++...+..++.|+++||+|||+ .+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 567888889999999999999999 77 9999999999999999999999999987653221
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.. ...++..|+|||.+.+..++.++||||||+++++|++|+.|+................ ..... .
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~---------~ 221 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-IVNEP---------P 221 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-HhcCC---------C
Confidence 11 1567889999999999999999999999999999999999976443211111111110 00000 0
Q ss_pred CCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYP-MLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+.. .+..+.++|.+||..+|++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011111 45678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.34 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=203.0
Q ss_pred ehhhhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 493 SFASVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 493 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
...++..+.++|++.+.||+|+||.||++.. .+++.+|+|++.... ...+++.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3455666789999999999999999999965 468899999986532 2346778899999999 799999999998754
Q ss_pred -----CcceEEEeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeE
Q 003846 571 -----DEKILIYEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPK 644 (791)
Q Consensus 571 -----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k 644 (791)
...++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3579999999999999988542 23456788999999999999999999987 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccCcccCchhcccC-----CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh
Q 003846 645 ISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-----LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH 719 (791)
Q Consensus 645 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~ 719 (791)
|+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+...... ..
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----~~ 241 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----KT 241 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----HH
Confidence 9999998865433221 1224678899999988643 3689999999999999999999997532211 00
Q ss_pred hhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 720 AWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.... ....... + ..+......+.+++.+||+.+|++||++.|++++
T Consensus 242 ~~~~-~~~~~~~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LFKI-PRNPPPT-----L--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHH-hcCCCCC-----C--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 0010000 0 0111234578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.87 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=208.3
Q ss_pred CccceecccCceeEEEeEe-eCCc----EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 505 SAENKLGEGGFGPVYKGEL-LNGQ----EVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
+..++||.|+||+||+|.+ ..|+ +||+|++... ..+...++.+|+.+|.+++|||++|++++|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999954 3444 6899988654 4456788999999999999999999999998776 889999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
||+.|+|.++++. .+..+-.+..+.|..|||+||.|||++. ++||||.++||||..-..+||.|||+++....+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999955 4456778999999999999999999887 9999999999999999999999999999987776
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.........-.+.|||-|.+....|+.++|||||||.+||++| |..|+....... ..++++.-.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dlle~ge 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDLLEKGE 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHHHhccc
Confidence 6555555556789999999999999999999999999999998 778865433221 112222212
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
+-..++..+.++.-++.+||..|+..||+++++...+....
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 22233445678899999999999999999999998887644
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=298.34 Aligned_cols=251 Identities=35% Similarity=0.538 Sum_probs=199.5
Q ss_pred CCccceecccCceeEEEeEeeC-----CcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 504 FSAENKLGEGGFGPVYKGELLN-----GQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
+++.+.||.|+||.||++...+ +..||+|.+...... ..+.+.+|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999997643 388999999765433 5678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854222 22889999999999999999999988 999999999999999999999999999876544
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
...... ...+++.|+|||.+.+..++.++||||+|+++++|++ |+.|+..... .... ........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~----~~~~~~~~------- 222 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVL----EYLKKGYR------- 222 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHH----HHHhcCCC-------
Confidence 222211 2236789999999988889999999999999999998 6777543211 1111 11111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
...+...+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011112456789999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.48 Aligned_cols=261 Identities=26% Similarity=0.337 Sum_probs=201.6
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--CcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 577 (791)
++|+..++||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999764 588999999875432 3457789999999999999999999998654 3679999
Q ss_pred eecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
||+++++|.+++... .....++...+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987542 23455788889999999999999999988 99999999999999999999999999875432
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+............. .............+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~- 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-LSYIVNMPNPELKDE- 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH-HHHHhcCCchhhccC-
Confidence 21 113356789999999999999999999999999999999999986543211111111 011111111111000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ......++.+.+++.+||+.+|++|||+.|++++
T Consensus 232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 0012245788999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.06 Aligned_cols=262 Identities=24% Similarity=0.362 Sum_probs=198.5
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999765 589999998865432 235678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.++.. ....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988763 2234789999999999999999999988 9999999999999999999999999988654332
Q ss_pred cccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH-----------Hhhc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD-----------LWKD 726 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~ 726 (791)
.......++..|+|||++.+. .++.++||||||++++||++|++|+..... ......... .+..
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhcc
Confidence 112234578899999998754 578899999999999999999988753221 000000000 0000
Q ss_pred CCcc-ccccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 NRAL-DLMDPILEN-----EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ~~~~-~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.... ....+.... ......+..+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 000000000 0011245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.06 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=199.3
Q ss_pred hhhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEc---
Q 003846 495 ASVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLD--- 569 (791)
Q Consensus 495 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~--- 569 (791)
.++....+.|++.+.||+|+||.||+|.. .+++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34445678999999999999999999965 468899999986543 3346788999999998 69999999999863
Q ss_pred ---CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 570 ---QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 570 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
....+++|||+++|+|.+++... ....+++..+..++.||++||.|||+++ |+|+||||+||+++.++.++|+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 45679999999999999998542 2345778888899999999999999988 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~ 721 (791)
|||++....... .......+++.|+|||++. ...++.++||||||+++|||++|+.|+........ .
T Consensus 164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-----~- 235 (282)
T cd06636 164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-----L- 235 (282)
T ss_pred eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----h-
Confidence 999987653221 1122356889999999886 34678899999999999999999999743221100 0
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ...............+..+.+++.+||+.||.+|||+.|++++
T Consensus 236 --~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 --F------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --h------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 0000000000111234678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.84 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=195.5
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||+|+||.||+|... +|+.+|+|++.... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5788899999999999999664 68999999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++ +|.+++.. ....+++..+..++.||++||.|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 974 77777643 2345889999999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh-----------hcC
Q 003846 660 QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW-----------KDN 727 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~ 727 (791)
.......++..|+|||++.+. .++.++||||||+++|||++|..|+....... .......... ...
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhhc
Confidence 112234568899999998765 47899999999999999999998853221111 0000000000 000
Q ss_pred Ccccccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 RALDLMDPILE----NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........... .......+..+.+++.+||+.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000000 01111245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.09 Aligned_cols=256 Identities=19% Similarity=0.272 Sum_probs=198.3
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999654 57899999987543 233567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++.. ...+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 245788889999999999999999987 999999999999999999999999998642111
Q ss_pred c-------------cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 658 E-------------LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 658 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
. .........++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... ..+. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~~~~----~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EELF----GQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH----HHH
Confidence 0 00011124578899999999988899999999999999999999999742211 1111 100
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.... ...+. .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~---~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDD---IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhcc---cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 00010 011234678999999999999999996666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=302.88 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=203.3
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46899999999999999999964 46889999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998842 34678889999999999999999988 99999999999999999999999999876543322
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......... ....... ...-
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-----~~~~~~~--------~~~~ 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNG--------TPEL 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-----eehhcCC--------CCCC
Confidence 122346888999999998888999999999999999999999997543221100 0000000 0000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+..+.+++.+||+.+|.+||++.|++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122244678899999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.99 Aligned_cols=259 Identities=24% Similarity=0.305 Sum_probs=194.3
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-----
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ----- 570 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 570 (791)
...++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999965 468899999987542 22345677899999999999999999987643
Q ss_pred -CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 571 -DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 571 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
...++++|++ +++|.+++. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468899987 778888763 345889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc--
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD-- 726 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 726 (791)
+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ............
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTPS 236 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 99865432 223468999999999877 56899999999999999999999997542211 000000000000
Q ss_pred ---------CCccccccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 ---------NRALDLMDPILENEAS-------YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ---------~~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+. .+..... ....+.+.+++.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0000000 0122457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=307.41 Aligned_cols=254 Identities=24% Similarity=0.291 Sum_probs=201.5
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcc---cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQ---GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|++|.||++... +++.+|+|.+...... ..+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999665 4899999999765322 4567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+.+++|.+++.. .....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999853 23456888999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCC
Q 003846 658 ELQ---------------------------ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYH 710 (791)
Q Consensus 658 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~ 710 (791)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123467889999999998889999999999999999999999975332
Q ss_pred CCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 003846 711 TGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPT----MSEVVSM 773 (791)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~evl~~ 773 (791)
... . ... .......-......+..+.+++.+||+.||++||+ ++|++++
T Consensus 237 ~~~-~----~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDE-T----FSN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHH-H----HHH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 110 0 000 00111111111114578999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=301.41 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=193.5
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHH-HHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETML-IAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.+.||+|+||.||++... +|+.||+|++.... .....++..|+.+ ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999664 69999999987543 2234455666665 566789999999999999999999999
Q ss_pred ecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 579 YLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 579 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|++ ++|.+++... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888887542 2345688999999999999999999986 5 99999999999999999999999999986543
Q ss_pred CccccccccccccCcccCchhccc----CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALE----GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.|+........ ....... .
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~-~----- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ----QLKQVVE-E----- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH----HHHHHHh-c-----
Confidence 21 1122467889999998865 4568899999999999999999999753221110 0000000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+.. .....+..+.+++.+||+.+|.+||++.|++++
T Consensus 224 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 011235678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.39 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=199.7
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
.|.....||+|+||.||++.. .+++.||||++........+.+.+|+.++++++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344456899999999999965 4588999999876655566778999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 999999873 234788899999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ... .... ..+.+....
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~----~~~~-----~~~~~~~~~-- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAM----RRIR-----DNLPPRVKD-- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHHH-----hcCCCcccc--
Confidence 122346889999999998888999999999999999999999997532110 000 0000 001111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+..+.+++.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234578899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=297.22 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=205.1
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.+.||+|++|.||++... +++.||||++..... .....+.+|+..+.+++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999765 499999999876644 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
+++++|.+++... ..++...+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568899999999999999999999 87 9999999999999999999999999998764433
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ..... ....... . .
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~-~~~~~~~--------~-~ 220 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFEL-MQAICDG--------P-P 220 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHH-HHHHhcC--------C-C
Confidence 221 2346788999999999989999999999999999999999997544321 00000 0000000 0 0
Q ss_pred CCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYP-MLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+.. .+..+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111112 45689999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.28 Aligned_cols=245 Identities=27% Similarity=0.350 Sum_probs=199.8
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999654 58999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++... ..++...+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998432 56788899999999999999999988 999999999999999999999999999876443
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+..... ...........
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~--------- 214 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGK--------- 214 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC---------
Confidence 2234688999999999888899999999999999999999999753221 00111111000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+......+.+++.+||+.||.+|| +++|++++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 011122356888999999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.56 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=198.5
Q ss_pred ccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCC
Q 003846 506 AENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKS 584 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 584 (791)
...+||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3458999999999999654 689999999876555556778899999999999999999999999999999999999999
Q ss_pred hhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccc
Q 003846 585 LDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN 664 (791)
Q Consensus 585 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~ 664 (791)
|..++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ...
T Consensus 105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 998763 245788999999999999999999988 99999999999999999999999999876543221 122
Q ss_pred cccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHH
Q 003846 665 RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYP 744 (791)
Q Consensus 665 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 744 (791)
...++..|+|||++.+..++.++||||||++++||++|+.|+...... .. .. ....... ... .....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~---~~-~~~~~~~-----~~~--~~~~~ 242 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QA---MK-RLRDSPP-----PKL--KNAHK 242 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH---HH-HHhccCC-----CCc--cccCC
Confidence 356889999999999888999999999999999999999997532211 10 00 0100000 000 01112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 745 MLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 745 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
....+.+++.+||+.+|.+||+++|++++-
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 345688999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=296.92 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=199.6
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|+..+.||+|+||.||++.. .+++.+|||.+... .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999965 46889999998654 233467889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~~~ 658 (791)
+++++|.+++... ....+++..+..++.++++||.|||+++ ++|+||+|+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998543 2345788899999999999999999988 99999999999998654 58999999998764332
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... .. ..... ... .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~---~~~~~-~~~---------~ 218 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--AL---VLKIM-SGT---------F 218 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HH---HHHHH-hcC---------C
Confidence 1 12346788999999999888999999999999999999999987533211 01 00000 000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...+..+.+++.+||+.+|.+|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01112245678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=297.88 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=200.7
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcceEEE
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEKILIY 577 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 577 (791)
+|++.+.||.|+||.||++.. .+++.+|+|++... .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999954 46889999998643 23345678899999999999999999998864 34568999
Q ss_pred eecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccC--CCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||+++++|.+++... .....++++.+..++.||++||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 22456888999999999999999999332 233999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
...... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.|+...... .. .......
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~------- 225 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QL----ASKIKEG------- 225 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HH----HHHHhcC-------
Confidence 543321 22346889999999999888999999999999999999999997643211 11 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+...+..+.+++.+|++.+|++|||+.||+++
T Consensus 226 --~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 --KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0111222345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.54 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=197.5
Q ss_pred CCCccceecccCceeEEEeEee---CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccce
Q 003846 503 NFSAENKLGEGGFGPVYKGELL---NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKI 574 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 574 (791)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999764 47899999997633 34456778999999999999999999999988 7889
Q ss_pred EEEeecCCCChhHHHhhhcc--ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC----CCCeEEeee
Q 003846 575 LIYEYLPNKSLDSFLFDRAK--KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT----DMKPKISDF 648 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DF 648 (791)
+||||+++ +|.+++..... ...++...+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666643322 236788899999999999999999988 999999999999999 999999999
Q ss_pred ccccccCCCcc-ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccch-------hhh
Q 003846 649 GMARMFGGDEL-QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNL-------LGH 719 (791)
Q Consensus 649 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~-------~~~ 719 (791)
|++........ ........++..|+|||++.+. .++.++||||||+++++|++|+.|+.......... ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122334678899999988764 58999999999999999999999986543322000 000
Q ss_pred hhHHhhc------------CCccccccccccCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 720 AWDLWKD------------NRALDLMDPILENEAS---------Y--PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 720 ~~~~~~~------------~~~~~~~~~~l~~~~~---------~--~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....... .......+.......+ . .....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 0000000000000000 0 233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.93 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=195.5
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999764 689999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++ +|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 898887432 336788999999999999999999988 99999999999999999999999999875432111
Q ss_pred ccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc---------
Q 003846 660 QANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA--------- 729 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 729 (791)
......++..|+|||++.+ ..++.++||||+|+++|+|++|+.|+....... ......+........
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1112246788999999875 458999999999999999999999975432111 001001100000000
Q ss_pred ---ccccc-----ccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 ---LDLMD-----PILENE-ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ---~~~~~-----~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..... ..+... ........+.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 000000 001112577899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.36 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=200.2
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||+|++|.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 578889999999999999975 468999999987654 33457889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+ +++|.+++... ...+++..+..++.||++||+|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999998543 256889999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC-----------
Q 003846 660 QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN----------- 727 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 727 (791)
.......++..|+|||.+.+. .++.++||||+|++++||++|++++...... .............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhccCc
Confidence 112234688999999998754 4689999999999999999997776432211 1000000000000
Q ss_pred -Ccccccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 -RALDLMDPILE----NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 -~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......+... ..........+.+++.+||+.+|++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00011234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=298.92 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=200.7
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCC-----
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQD----- 571 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~----- 571 (791)
..+++|++.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999764 578999999865543 356789999999999 6999999999997654
Q ss_pred -cceEEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 572 -EKILIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3799999999999999985432 2456888999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhccc-----CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALE-----GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
++....... .......++..|+|||++.. ..++.++||||||++|++|++|+.|+....... .... .
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~ 230 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-----ALFK-I 230 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-----HHHH-h
Confidence 987654322 11223468899999998753 346789999999999999999999975322110 0000 0
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..... +.+ ......+..+.+++.+||..||++|||+.|++++
T Consensus 231 ~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00000 001 1112245678999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.49 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=198.1
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcc-----cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQ-----GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
+|++.+.||+|++|.||+|.. .+++.||||++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477888999999999999965 46899999999754322 345577899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999984322 36889999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC--------
Q 003846 657 DELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN-------- 727 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 727 (791)
... ......+++.|+|||.+.+ ..++.++||||||++++||++|.+|+..... ..............
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhhhhhc
Confidence 321 1122356788999998865 4678999999999999999999777543221 11111111000000
Q ss_pred -CccccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 -RALDLMDPILENE-----ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 -~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
............. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 111235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=302.13 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=196.6
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++++|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999965 4688999999865432 23346788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+. ++|.+++.. ....+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 677666633 2345677888899999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC---------
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN--------- 727 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 727 (791)
.. ......+++.|+|||++.+. .++.++||||||+++|||++|+.|+........ .....+......
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhh
Confidence 11 11233568899999998764 578899999999999999999999864332111 111111100000
Q ss_pred Cccccccccc----cCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 RALDLMDPIL----ENE-----ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ~~~~~~~~~l----~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......... ... ........+.+++.+|++.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000 000 000124578899999999999999999998854
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.30 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=201.3
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999965 4689999999876544 3577899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999843 345788889999999999999999988 99999999999999999999999999987654332
Q ss_pred ccc--cccccccCcccCchhcccCC---CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 660 QAN--TNRIVGTYGYMSPEYALEGL---FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 660 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
... .....++..|+|||++.+.. ++.++||||||+++++|++|+.|+........ ...... .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----~~~~~~-~~-----~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMFHVG-AG-----HK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH----HHHHHh-cC-----CC
Confidence 211 12346788999999998766 89999999999999999999999764321110 000000 00 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.+.. .......+.+++.+||+.+|.+|||+.|++.+
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 01111 11124667899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=301.69 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=200.7
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999765 5889999988653 23345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|++++.+..++. +...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766552 2344788999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH-----------Hhhc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD-----------LWKD 726 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~ 726 (791)
. .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+....... ....... .+..
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhhhccc
Confidence 2 122234678899999999888 88999999999999999999999875432110 0000000 0000
Q ss_pred CC------cccccccc-ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 NR------ALDLMDPI-LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ~~------~~~~~~~~-l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. ..+..++. .....+...+..+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000000 0001111235789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.31 Aligned_cols=250 Identities=30% Similarity=0.462 Sum_probs=203.7
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999765 688999999977655567889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++... ...+++..+..++.|+++||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999998442 256889999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
.....++..|+|||.+.+..++.++|+||||+++++|++|+.|+....... .. .......... .. .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~-----~~--~ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----AL-FKIATNGPPG-----LR--N 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-----HH-HHHHhcCCCC-----cC--c
Confidence 234568899999999998889999999999999999999999975432110 00 0000000000 00 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+..+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124678999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.37 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=199.1
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
-|++.++||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778999999999999965 468899999886433 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999873 235788999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......++..|+|||.+.+..++.++|+||||+++++|++|..|+...... . .... ..... ...
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~---~~~~-~~~~~---------~~~ 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--K---VLFL-IPKNN---------PPT 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--H---HHHH-HhcCC---------CCC
Confidence 122346788999999998888999999999999999999999997532211 0 0000 00000 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+..+.+++.+||+.+|.+||++.|++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112234678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=288.22 Aligned_cols=248 Identities=24% Similarity=0.300 Sum_probs=203.0
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|+..+.||+|.||.|.+++- .+|+.+|+|++++.- ......-..|-++|+..+||.+..+...|+..+.+|.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 457899999999999999999954 469999999998763 2334445679999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||..||.|.-+| .+.+.+++...+.+-.+|+.||.|||+++ |+.||||.+|+|||.+|++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998887 34566777778888999999999999988 9999999999999999999999999998532
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.....+...+|||.|+|||++....|..++|.|.+||++|||++|+.||-...-+ .++.-
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~------------------kLFeL 379 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE------------------KLFEL 379 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh------------------HHHHH
Confidence 2234455689999999999999999999999999999999999999996422111 11111
Q ss_pred ccc--CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 736 ILE--NEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 736 ~l~--~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
++- -.++...+++...|+...|..||.+|. ++.||.++
T Consensus 380 Il~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 380 ILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 111 124445567888999999999999995 56666543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.83 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=198.5
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEeccc-CcccHHHHHHHHHHHHhcC---CCceeeeeeEEEcCCcceEEE
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQ---HRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~ 577 (791)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999965 56899999998654 3344677889999999996 999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998732 36888999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. ......|+..|+|||.+.++ .++.++|+||||+++|+|++|+.|+....... ... ..... ..+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~-~~~~~-----~~~~ 221 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM-LIPKS-----KPPR 221 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-ccccC-----CCCC
Confidence 31 12234688899999988754 57899999999999999999999975322110 000 00000 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+... ..+..+.+++.+||+.||.+||++.|++++
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111 134678899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=289.96 Aligned_cols=252 Identities=29% Similarity=0.419 Sum_probs=205.3
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--CcceEEE
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKILIY 577 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 577 (791)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999765 689999999876542 4567889999999999999999999999988 8899999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998532 27889999999999999999999987 999999999999999999999999999876654
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
..........++..|+|||.+.+...+.++||||||+++++|++|..|+...... ....+.... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~---------~~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----MAALYKIGS---------SGE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHhccc---------cCC
Confidence 3321223456889999999999888999999999999999999999997654311 111111100 001
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+...+..+.+++.+|++.+|.+||++.|++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111222335789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.54 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=199.3
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
.|...++||+|++|.||++.. .+++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344457999999999999965 4688999999876555556778899999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998843 45788899999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+..... .... ....... .+... .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~-~~~~~~~-----~~~~~--~ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAM-KRIRDNL-----PPKLK--N 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHH-HHHHhcC-----CCCCc--c
Confidence 11234688999999999988899999999999999999999999643211 0000 0011110 00111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+..+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11234678999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.59 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=199.4
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
+|++.++||+|++|.||+|... +|+.||||++..... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999764 688999999876533 23567788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++ +|.+++........+++..+..++.||++||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888765444456899999999999999999999988 99999999999999999999999999976533211
Q ss_pred cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC--------Cccc
Q 003846 661 ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN--------RALD 731 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 731 (791)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... ............. ....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcCc
Confidence 11223568899999988764 5789999999999999999999987643221 1000000000000 0000
Q ss_pred ccccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 LMDPILE-------NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....... .......+..+.+++.+|++.||.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 00111234678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.85 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=196.1
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||+|++|.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999654 68999999886543 22346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+. ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5888887442 3456889999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccCcccCchhcccCC-CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC----------
Q 003846 660 QANTNRIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR---------- 728 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 728 (791)
......++..|+|||++.+.. ++.++||||||+++|||++|+.|+....... .............
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHH
Confidence 112235678999999887654 6889999999999999999999875432110 0000000000000
Q ss_pred --ccccccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 --ALDLMDPILEN---EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 --~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+...... .........+.+++.+||+.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=297.99 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=205.0
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..++.|+..+.||+|++|.||++... +++.+|+|++..... ..+.+.+|++++++++|+|++++++++...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45678889999999999999999765 688999999976544 5677899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++.... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999985432 36889999999999999999999987 999999999999999999999999998765432
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... .... .......
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~~------- 234 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-----ALFL-ITTKGIP------- 234 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH-HHhcCCC-------
Confidence 21 1123457889999999998889999999999999999999999965322110 0000 0000000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
........+..+.+++.+|++.+|.+|||+.|++++-
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 0001111346789999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=336.47 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=207.1
Q ss_pred hhhhccCCCccceecccCceeEEEe-EeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
+...+-++....+||.|.||.||.+ ...+|+..|||.++.. .......+.+|..++..|+|||+|+++|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 3455667888889999999999999 5567999999977543 344567788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
+|.||||++|+|.+++. .++..++.....+..|++.|++|||+++ |+||||||.||+|+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999983 2333445555678899999999999999 99999999999999999999999999998
Q ss_pred cCCCc--cccccccccccCcccCchhcccCC---CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 654 FGGDE--LQANTNRIVGTYGYMSPEYALEGL---FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 654 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+.... .........||+-|||||++.+.. ...++||||+|||..||+||++|+......-. +.-++ ..+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-IMy~V----~~g- 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-IMYHV----AAG- 1457 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-HHhHH----hcc-
Confidence 76542 233344678999999999998653 56789999999999999999999765443211 00000 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
-....+...+..-.+++..||+.||++|.++.|++++=
T Consensus 1458 --------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1458 --------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred --------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 12233444677788999999999999999999998774
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=298.19 Aligned_cols=252 Identities=26% Similarity=0.330 Sum_probs=208.7
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
...+.|+..+.||+|+||.||-.+.. +|+.+|.|++.++ ..+......+|-.+|.+++.+.||.+-..++..+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34467888899999999999998654 6999999988654 3445566789999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+|+..|.||+|.-+|+...+ +.++++.++.++.+|+-||++||.+. |+.|||||+|||||+.|+++|+|+|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999988865543 67899999999999999999999987 999999999999999999999999999988
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
....... ..+||.+|||||++.+..|+...|.|||||+||||+.|+.||...... ...+-++
T Consensus 338 ~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---------------vk~eEvd 399 (591)
T KOG0986|consen 338 PEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---------------VKREEVD 399 (591)
T ss_pred CCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---------------hhHHHHH
Confidence 7654332 348999999999999999999999999999999999999997643221 1111112
Q ss_pred ccc---cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003846 735 PIL---ENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVS 772 (791)
Q Consensus 735 ~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 772 (791)
.+. ..+.+...++++.++.+..|+.||++|. .+.+|.+
T Consensus 400 rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 400 RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 111 2234455778899999999999999997 4555544
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.68 Aligned_cols=248 Identities=25% Similarity=0.287 Sum_probs=201.1
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
+|++.+.||.|+||.||++... +++.||+|.+.+.. ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999764 58999999997543 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++... ..+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998432 46788999999999999999999988 9999999999999999999999999998764432
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ......... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~----------~~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---DQIRAKQET----------AD 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH---HHHHHHhcc----------cc
Confidence 12234678899999999988899999999999999999999999764432111 110000000 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTM--SEVVS 772 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~--~evl~ 772 (791)
...+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11222344788999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.39 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=208.8
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQ--GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.....|.+.+.||+|.|+.|.+|+. .++..||||.+.+.... ....+.+|+++|..++|||||+++.+......+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 4467899999999999999999965 46999999999876432 34558899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+.+|.+.++|..+ ..+....+..++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999543 33445888899999999999999998 9999999999999999999999999998876
Q ss_pred CCccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.. ......+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+. ....++-.
T Consensus 207 ~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG------------------~~lk~Lr~ 265 (596)
T KOG0586|consen 207 YG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG------------------QNLKELRP 265 (596)
T ss_pred cc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC------------------cccccccc
Confidence 33 33345699999999999998876 6899999999999999999999653 22223333
Q ss_pred ccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 735 PILENE--ASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 735 ~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
+.+.+. .+...+.++.++++++|-.+|.+|++++++.+.-
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 333332 3334567889999999999999999999987653
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=297.19 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=198.1
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--CcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 576 (791)
++|++.+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999765 588999999875432 2234567899999999999999999999877 789999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 898887432 236889999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh-----------hhHHh
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH-----------AWDLW 724 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~-----------~~~~~ 724 (791)
... ......+++.|+|||.+.+. .++.++|+||||++++||++|+.|+....... .... .|..+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchHHHHHh
Confidence 321 11234568899999998765 46899999999999999999999976432210 0000 00000
Q ss_pred hc------CCccccccccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 725 KD------NRALDLMDPILENEASYP-MLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 725 ~~------~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. ..........+....+.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000000001111111111 35678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=299.44 Aligned_cols=248 Identities=30% Similarity=0.443 Sum_probs=195.7
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG---QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|+..+.||+|+||.||+|... +++.||+|.+..... +...++.+|+++++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 456888999999999999999664 689999999864432 2345788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
+||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 577666632 2345889999999999999999999988 99999999999999999999999999875432
Q ss_pred CccccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
. ....+++.|+|||++. ...++.++||||||+++|||++|+.|+...... ........ ...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~-~~~---- 231 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQ-NDS---- 231 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhc-CCC----
Confidence 2 1235788999999874 456889999999999999999999986432110 00000000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
+ .......+..+.+++.+||+.+|.+||++.+++++.
T Consensus 232 -~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 -P---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -C---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 001122456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=305.64 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=196.8
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC------
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------ 570 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 570 (791)
..++|++.+.||+|+||.||++.. .+++.||||++.+. .....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999965 46899999998643 233456778899999999999999999998644
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
...++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346899999964 78777632 2778888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-------------chh
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-------------NLL 717 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-------------~~~ 717 (791)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .+.
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 986543321 2234678899999999999999999999999999999999999754321000 000
Q ss_pred hh---hhHHhhcCC-------ccccccccc----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 718 GH---AWDLWKDNR-------ALDLMDPIL----ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 718 ~~---~~~~~~~~~-------~~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. ......... ..+...... ........+..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000000 000000000 011111245678899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=297.38 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=195.7
Q ss_pred CCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 504 FSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
|++.+.||.|++|.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999965 479999999987543 223467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
+ ++|.+++.... ...+++..+..++.|+++||.|||+++ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68988874322 246889999999999999999999987 99999999999999999999999999976532211
Q ss_pred cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC---------Ccc
Q 003846 661 ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN---------RAL 730 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~ 730 (791)
......++..|+|||++.+. .++.++||||||+++|+|++|+.|+....... .... ........ ...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFR-IFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCChHHhhhhhhch
Confidence 11223568899999988764 57899999999999999999999875432110 0000 00000000 000
Q ss_pred cccccc------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 DLMDPI------LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~------l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+..... .........+..+.+++.+|++.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 0001112234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=282.10 Aligned_cols=272 Identities=22% Similarity=0.294 Sum_probs=200.4
Q ss_pred ccCCCccceecccCceeEEEeEeeC-----CcEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCceeeeeeEEEc-CCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-----GQEVAVKRLSKKSGQ--GLEELKNETMLIAKLQHRNLVRLLGCCLD-QDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 572 (791)
...|+...+||+|.||.||+|.-.+ ...+|+|+++..... .....-+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999993322 236899999755322 23456789999999999999999999987 677
Q ss_pred ceEEEeecCCCChhHHHhh--hccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC----CCeEEe
Q 003846 573 KILIYEYLPNKSLDSFLFD--RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD----MKPKIS 646 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~ 646 (791)
..|++||.++ +|..+++- ....+.++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999987 77777753 334567899999999999999999999986 9999999999999877 899999
Q ss_pred eeccccccCCCccc-cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCc----c---chh
Q 003846 647 DFGMARMFGGDELQ-ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS----L---NLL 717 (791)
Q Consensus 647 DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~----~---~~~ 717 (791)
|||+++.+.+.-.. ......+-|..|+|||.+.+. .|+.+.|||+.|||+.||++-++-|....... . +..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999998765322 244567889999999999876 69999999999999999999887664432210 1 011
Q ss_pred hhhhHHhhcC---Ccc---------ccccccc-cCCCC--HH--------HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 718 GHAWDLWKDN---RAL---------DLMDPIL-ENEAS--YP--------MLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 718 ~~~~~~~~~~---~~~---------~~~~~~l-~~~~~--~~--------~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
....+....+ +.. ..+.... ....+ .. -++...+|+.++|++||.+|.|++|.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111111000 000 0000000 00000 00 113467999999999999999999999876
Q ss_pred cc
Q 003846 775 TN 776 (791)
Q Consensus 775 ~~ 776 (791)
--
T Consensus 339 yF 340 (438)
T KOG0666|consen 339 YF 340 (438)
T ss_pred cc
Confidence 43
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=290.39 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=194.4
Q ss_pred ecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
||.|++|.||++... +++.+|+|.+.+.. ....+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999764 48999999986543 23456789999999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
.+++.. ...++...+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 234788899999999999999999988 9999999999999999999999999998765432 1223
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|..|+.....+..... .. ..+.......+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~--------~~~~~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY----ND--------ILKGNGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH----HH--------HhccCCCCCCCccc
Confidence 4678899999999888899999999999999999999999764432111111 00 00000111122223
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003846 746 LARYVNVALLCVHENATDRPT-----MSEVVS 772 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt-----~~evl~ 772 (791)
+..+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 568999999999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.15 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=203.5
Q ss_pred cCCCccceecccCceeEEEeEeeC-CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
+.|.++..||.|+||.||+|..++ +-..|-|.+.-.+.+..+++.-||+||+...||+||++++.|..++.+.++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 456778899999999999996554 4456778888788888999999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
.||-.+.++.. -...+....+..+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+...... .
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R 184 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence 99999998854 3456888999999999999999999998 999999999999999999999999998653221 1
Q ss_pred cccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 661 ANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.......|||.|||||+.. ..+|+.++||||||+.|.||..+.+|......... .. .........++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-----ll-KiaKSePPTLl-- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LL-KIAKSEPPTLL-- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-----HH-HHhhcCCCccc--
Confidence 1123468999999999875 56899999999999999999999999543221100 00 00111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+...+..+.+++..||..||..||++.|++++
T Consensus 257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 122356788999999999999999999999876
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.00 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=195.0
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|...++||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 456678999999999999965 458999999987543 234567889999999996 99999999999999999999999
Q ss_pred cCCCChhHHHhh--hccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 580 LPNKSLDSFLFD--RAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 580 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
+.. +|.++... ......+++..+..++.|+++||+|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55554321 12235688899999999999999999975 5 99999999999999999999999999976543
Q ss_pred CccccccccccccCcccCchhcccC---CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEG---LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
... .....++..|+|||++.+. .++.++||||||+++|||++|+.|+.... ........... ..
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~------~~ 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVK------GD 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcC------CC
Confidence 221 1223678899999999876 68999999999999999999999975432 11111110000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+.+........+..+.+++.+||+.+|++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112222223356688999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.35 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=199.2
Q ss_pred CCccceecccCceeEEEeE-eeCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC------cceE
Q 003846 504 FSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD------EKIL 575 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 575 (791)
+...+.||+|+||.||+|+ ..+|+.||||.+++.. ....+...+|+++|++++|+|||+++++-.+.. ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999997 5679999999997753 345677789999999999999999999876543 5689
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc--CCCC--eEEeeeccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--TDMK--PKISDFGMA 651 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~--~~~~--~kl~DFgla 651 (791)
|||||.+|+|...|.+..+...+++.+.+.++.++..||.|||+++ |+||||||.||++- .+|+ .||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988888888999999999999999999999988 99999999999983 3344 799999999
Q ss_pred cccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh-hcCCc
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW-KDNRA 729 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 729 (791)
+.+.++. .....+||..|.+||.+.. ..|+..+|.|||||++|+++||..||............ .|... +....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~-~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI-MWHIITKKPSG 247 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh-hhhhhccCCCc
Confidence 9887654 4556799999999999995 78999999999999999999999998765544321111 11111 11111
Q ss_pred cc-ccc-----cc-----c--cCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003846 730 LD-LMD-----PI-----L--ENEASYPMLARYVNVALLCVHENATDRP 765 (791)
Q Consensus 730 ~~-~~~-----~~-----l--~~~~~~~~~~~l~~li~~cl~~dp~~RP 765 (791)
.. ... +. + ..........++-..+..+|..+|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 10 000 10 1 1112233556677888888999999997
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=296.41 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=194.8
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCc-----
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDE----- 572 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 572 (791)
++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999754 68999999886543 223467888999999995 6999999999987665
Q ss_pred ceEEEeecCCCChhHHHhhhcc--ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeEEeeec
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK--KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFG 649 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFg 649 (791)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+++ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78888754322 346789999999999999999999988 999999999999998 8999999999
Q ss_pred cccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
++..+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..|+....... .............
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 98765332111 112356788999998865 457999999999999999999999875432110 0000000000000
Q ss_pred c------cccc--------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 A------LDLM--------DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~------~~~~--------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. .... .+..........+..+.++|.+||+.||.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0000 0000000011245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=318.17 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=186.9
Q ss_pred hccCCCccceecccCceeEEEeEeeC--CcEEEEEE--------------ec---ccCcccHHHHHHHHHHHHhcCCCce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN--GQEVAVKR--------------LS---KKSGQGLEELKNETMLIAKLQHRNL 560 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~H~ni 560 (791)
..++|++.++||+|+||+||++.... +...++|. +. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999986532 22222221 11 1112234568899999999999999
Q ss_pred eeeeeEEEcCCcceEEEeecCCCChhHHHhhhcc--ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc
Q 003846 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAK--KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 638 (791)
Q Consensus 561 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~ 638 (791)
+++++++...+..++|+|++. ++|.+++..... ........+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 467776643211 122335667789999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCC-CCCCCCCc-cch
Q 003846 639 TDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN-TGFYHTGS-LNL 716 (791)
Q Consensus 639 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p-~~~~~~~~-~~~ 716 (791)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||+||||++|..+ +....... ..+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987653321 112235789999999999999999999999999999999998754 32211110 011
Q ss_pred hhhh-----------------hHHhhcCCcc---ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 717 LGHA-----------------WDLWKDNRAL---DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 717 ~~~~-----------------~~~~~~~~~~---~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.... +......... ..+.+.+.. ......+.+++.+||+.||.+|||+.|++++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 0000000000 000000000 0123467788999999999999999999875
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=293.65 Aligned_cols=245 Identities=25% Similarity=0.348 Sum_probs=192.4
Q ss_pred ecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 510 LGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 510 LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
||+|+||+||++.. .+|+.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999954 468999999986532 22345667899999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
.+++..... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999854332 46788999999999999999999988 9999999999999999999999999987654321 1123
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+........ . .. ....... .....+...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~-~~----~~~~~~~------~~~~~~~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-K-EE----LKRRTLE------MAVEYPDKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-H-HH----HHhcccc------ccccCCccC
Confidence 4578899999999888899999999999999999999999754322110 0 00 0000000 011112223
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 746 LARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
+..+.+++.+||+.+|.+|| ++.+++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 56789999999999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=302.86 Aligned_cols=268 Identities=23% Similarity=0.321 Sum_probs=197.8
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----cc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD-----EK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~ 573 (791)
+++|++.++||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999964 468999999986432 234566888999999999999999999876543 46
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++++||+++ +|.+++ ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 777666 2345888999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc-cccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC----
Q 003846 654 FGGDELQ-ANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN---- 727 (791)
Q Consensus 654 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 727 (791)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+...... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHH
Confidence 5432211 12223568899999998765 46899999999999999999999997532210 0000000000000
Q ss_pred -------Cccccccccc-cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hccCc
Q 003846 728 -------RALDLMDPIL-ENEA-----SYPMLARYVNVALLCVHENATDRPTMSEVVSM--LTNEH 778 (791)
Q Consensus 728 -------~~~~~~~~~l-~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~ 778 (791)
...+...... .... ....+..+.+++.+||+.+|++|||+.|++++ ++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000000 0000 01124678899999999999999999999988 55543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.23 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=191.9
Q ss_pred cceecccCceeEEEeEe-eCCcEEEEEEec--c--cCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc--ceEEEee
Q 003846 507 ENKLGEGGFGPVYKGEL-LNGQEVAVKRLS--K--KSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE--KILIYEY 579 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~Ey 579 (791)
...||+|+|-+||+|.. .+|-.||=-.++ + .++...++|..|+.+|+.|+|||||+++.+..+... ..+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 45899999999999944 457676532221 1 234556899999999999999999999999987766 6789999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~~~ 658 (791)
+..|+|..|+.++ +.++.+.+.+|++||++||.|||++. ++|||||||-+||+|+. -|.+||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999998543 45778889999999999999999986 68999999999999975 5899999999999865433
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
. ....|||.|||||++. ..|++.+||||||+.|+||+|+..|+...... .+.++....+...+.+...
T Consensus 201 a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKKV~SGiKP~sl~kV-- 268 (632)
T KOG0584|consen 201 A----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKKVTSGIKPAALSKV-- 268 (632)
T ss_pred c----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHHHHcCCCHHHhhcc--
Confidence 2 2368999999999887 78999999999999999999999995432211 1222222222222221111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+.++++|.+||.. .++|||+.|+|+.
T Consensus 269 ------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 ------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 235789999999999 9999999999864
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=292.01 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=199.3
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999664 58899999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC-eEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK-PKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DFgla~~~~~~~ 658 (791)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999998543 2335788999999999999999999988 999999999999998864 6999999998664332
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
. ......|++.|+|||++.+..++.++|+||||++++||++|+.|+..... ........ ... ..
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-~~~----~~---- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKIC-QGY----FA---- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHh-ccc----CC----
Confidence 1 11224578899999999988899999999999999999999999753211 11111111 000 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+..+.+++.+|++.+|++|||+.|++++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111234678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.56 Aligned_cols=258 Identities=22% Similarity=0.301 Sum_probs=191.4
Q ss_pred CCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcC-CCceeeeeeEEEcC--CcceEEEe
Q 003846 504 FSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQ--DEKILIYE 578 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E 578 (791)
|++.++||+|+||.||+|.. .+++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778999999999999965 468899999987542 222234457888898885 99999999999987 88999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|++ ++|.+++.. ....+++..+..++.||++||+|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 477777643 2346889999999999999999999988 999999999999999 999999999998664332
Q ss_pred cccccccccccCcccCchhcc-cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH-----------Hhhc
Q 003846 659 LQANTNRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD-----------LWKD 726 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~ 726 (791)
.. ....++..|+|||.+. +..++.++|||||||++|||++|..|+...... +....... ....
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcc
Confidence 11 2245788999999765 456789999999999999999999997543211 11111000 0000
Q ss_pred CCccccccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 NRALDLMDPILEN----EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+.... ......+..+.+++.+||+.+|++||+++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 0011246789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=290.75 Aligned_cols=249 Identities=27% Similarity=0.354 Sum_probs=202.7
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.++||+|+||.||++.. .+++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999954 468899999987542 33456778899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
+++++|.+++.... ....++++.+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999985532 2356788899999999999999999988 9999999999999999999999999998765441
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.....+++.|+|||.+.+..++.++|+||||+++++|++|+.|+...... .+. ..... ...
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~----~~~~~---------~~~ 218 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLR----YKVQR---------GKY 218 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHHhc---------CCC
Confidence 12245788999999999999999999999999999999999997543211 000 00000 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..........+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11222456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.72 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=193.4
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc-----
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE----- 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 572 (791)
-++|++.++||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999654 68999999886442 2233456789999999999999999999876543
Q ss_pred ---ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 573 ---KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 573 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
.++||||+.+ +|.+++.. ....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999975 78777632 2345889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh--
Q 003846 650 MARMFGGDELQ--ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW-- 724 (791)
Q Consensus 650 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-- 724 (791)
++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCC
Confidence 99866433211 112234578899999988765 4789999999999999999999887543211 0000000000
Q ss_pred ------hcCCccccccccc-cCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 725 ------KDNRALDLMDPIL-ENEA---------SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 725 ------~~~~~~~~~~~~l-~~~~---------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+..+... .... .......+.+++.+||+.||.+|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000000 0000 00123467799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.43 Aligned_cols=262 Identities=22% Similarity=0.279 Sum_probs=192.2
Q ss_pred ceeccc--CceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEG--GFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
..||+| +||+||++.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999965 479999999986532 33457788999999999999999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc--
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ-- 660 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~-- 660 (791)
++|.+++.... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999885532 234788888899999999999999988 999999999999999999999999865433211100
Q ss_pred ---cccccccccCcccCchhcccC--CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh---------------h
Q 003846 661 ---ANTNRIVGTYGYMSPEYALEG--LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH---------------A 720 (791)
Q Consensus 661 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~---------------~ 720 (791)
.......++..|+|||++.+. .++.++||||||+++|||++|+.|+............. .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 001112345679999999764 47899999999999999999999976432110000000 0
Q ss_pred hHHhhcC----------------CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 721 WDLWKDN----------------RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 721 ~~~~~~~----------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+... .........+...........+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000000 0000111111222223456789999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=293.14 Aligned_cols=242 Identities=25% Similarity=0.308 Sum_probs=186.8
Q ss_pred eecccCceeEEEeEe-eCCcEEEEEEecccCc---ccHHHHHHHHHHHHh---cCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 509 KLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG---QGLEELKNETMLIAK---LQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
.||+|+||.||++.. .+++.+|+|.+.+... .....+.+|..+++. .+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 4588999998865421 112234445444443 479999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988843 345889999999999999999999988 9999999999999999999999999987553321
Q ss_pred ccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
.....|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||............ ... ......
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~----------~~~~~~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT----------LTVNVE 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH---HHh----------hcCCcC
Confidence 122468999999999874 56899999999999999999999997643222111000 000 001111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 741 ASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
.+...+..+.+++.+||+.||.+|| +++|++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2233456889999999999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=278.14 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=200.8
Q ss_pred ceecccCceeEEEe-EeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 508 NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
+.||+|+|+.|--+ .+.+|.++|||++.+.......++.+|++++...+ |+||+.++++|++++.+|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 57999999999988 56789999999998887778899999999999985 99999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC---CeEEeeeccccccCC--Cc--
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM---KPKISDFGMARMFGG--DE-- 658 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFgla~~~~~--~~-- 658 (791)
..+|++ ...+++.++.+++++|+.||.+||.++ |.||||||+|||-.... .+||+||.|..-+.. +-
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999854 456888999999999999999999998 99999999999986554 489999999754321 11
Q ss_pred -cccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc---
Q 003846 659 -LQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA--- 729 (791)
Q Consensus 659 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 729 (791)
........+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||...-..+-. |..+..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG--------WdrGe~Cr~ 309 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG--------WDRGEVCRV 309 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC--------ccCCCccHH
Confidence 111223457899999999874 336899999999999999999999998765443211 111111
Q ss_pred --cccccccccCC--CCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 --LDLMDPILENE--ASY----PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 --~~~~~~~l~~~--~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..++..+-.+. ++. ..+....+++...+-.|+.+|.++.+++.+
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 11222222222 222 256778899999999999999999999873
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=288.49 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=204.3
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||.|+||.||++... +++.+|+|++..... ....++.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999664 588999999876533 4567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
+++++|.+++.... ....+++..+..++.++++||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999985532 2467889999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.......+++.|+|||.+.+..++.++|+||+|+++++|++|+.|+...... ... ....... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~----~~~~~~~---------~ 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELA----LKILKGQ---------Y 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHH----HHHhcCC---------C
Confidence 1222346888999999999888999999999999999999999997533211 110 1011110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...+..+.+++.+||..+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.99 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=197.0
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccc
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK-----SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEK 573 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 573 (791)
.+|++.+.||+|+||.||+|.. .+++.||+|.+... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999965 46899999987532 223456788999999999999999999998764 457
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++++||+++++|.+++.. ...+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 234778888999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDEL-QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
...... ........++..|+|||.+.+..++.++|+||||+++++|++|+.|+...... ..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~---------~ 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AAIFK---------I 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HHHHH---------H
Confidence 532211 11112346889999999999888999999999999999999999997532110 00000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+......+.+++.+|++ +|.+||++.+++.+
T Consensus 222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00111122233455779999999999 57999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.06 Aligned_cols=261 Identities=24% Similarity=0.321 Sum_probs=196.7
Q ss_pred CCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--CcceEEEe
Q 003846 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKILIYE 578 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 578 (791)
|++.++||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999765 58899999997653 33456788999999999999999999999988 78999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888887432 246889999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC---cc---c
Q 003846 659 LQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR---AL---D 731 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~ 731 (791)
. .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+...... .............. .. +
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhcccccc
Confidence 1 11223356788999998765 46789999999999999999999997543211 11111111000000 00 0
Q ss_pred -----------cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 -----------LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 -----------~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+.......++..+.+++.+||+.+|.+||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000001125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.70 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=195.6
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
+.|+..+.||+|+||.||++.. .+++.+|+|++.... .....++.+|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477788999999999999965 468899999986442 233457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 77777643 2345889999999999999999999988 999999999999999999999999998754321
Q ss_pred ccccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
....+++.|+|||++. ...++.++||||||+++|||++|+.|+...... ... .......
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~---~~~~~~~------- 240 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SAL---YHIAQNE------- 240 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHH---HHHHhcc-------
Confidence 2346788999999874 456899999999999999999999986432110 000 0000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.........+..+.+++.+||+.+|.+||++.|+++++-.
T Consensus 241 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 --SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred --CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0001111234578999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.87 Aligned_cols=260 Identities=17% Similarity=0.206 Sum_probs=183.4
Q ss_pred hccCCCccceecccCceeEEEeEeeC----CcEEEEEEecccCcccH-----------HHHHHHHHHHHhcCCCceeeee
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKSGQGL-----------EELKNETMLIAKLQHRNLVRLL 564 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~ 564 (791)
..++|.+.++||+|+||.||+|...+ +..+|+|+......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999997654 34566665433222111 1122334455667899999999
Q ss_pred eEEEcCC----cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC
Q 003846 565 GCCLDQD----EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD 640 (791)
Q Consensus 565 ~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~ 640 (791)
+++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||.|||+++ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9876544 23677777643 56555522 223467778899999999999999988 9999999999999999
Q ss_pred CCeEEeeeccccccCCCccc-----cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccc
Q 003846 641 MKPKISDFGMARMFGGDELQ-----ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN 715 (791)
Q Consensus 641 ~~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~ 715 (791)
+.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+|+||++|+.||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~- 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN- 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-
Confidence 99999999999876432111 111234699999999999999999999999999999999999999865422111
Q ss_pred hhhhhhHHhhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 716 LLGHAWDLWKDNRALDLMDPILENE-ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
....... +.+.....+. .....+..+.+++..|++.+|++||++.++++.|.
T Consensus 242 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKC--------DFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHH--------HHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1100000 0000000000 01112467889999999999999999999998763
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=297.66 Aligned_cols=265 Identities=26% Similarity=0.321 Sum_probs=196.3
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--CcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 575 (791)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999764 589999999864432 2234567899999999999999999998765 45799
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+.+ +|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 788887432 356888999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH-----------
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL----------- 723 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------- 723 (791)
... .......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.|+...... .........
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhchh
Confidence 332 11122345788999999875 46899999999999999999999987532211 111000000
Q ss_pred hhcCCcccccc---ccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 724 WKDNRALDLMD---PILEN--EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 724 ~~~~~~~~~~~---~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
........... ..... ......+..+.+++.+||+.||++|||+.|++++--
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00000000000 00000 000113567789999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.66 Aligned_cols=263 Identities=23% Similarity=0.305 Sum_probs=194.1
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999764 68899999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeEEeeeccccccCCC
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGGD 657 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~~ 657 (791)
|++ ++|.+++... ....+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 4777776332 2233567788899999999999999987 999999999999985 567999999999765432
Q ss_pred ccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC--------
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR-------- 728 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 728 (791)
. .......+++.|+|||++.+. .++.++||||+|+++|+|++|+.|+...... ..............
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhccccc
Confidence 1 111223568899999988764 5789999999999999999999997643211 00000000000000
Q ss_pred -ccccc--cccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 -ALDLM--DPILEN----EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 -~~~~~--~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..... .+.... ......+..+.+++.+|++.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000000 0111234678899999999999999999999864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.73 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=193.6
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334455555665666544 6999999998754 3445678999999999999999999999999999999999999999
Q ss_pred ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc----
Q 003846 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL---- 659 (791)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~---- 659 (791)
+|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999986432 235788888999999999999999988 99999999999999999999999999875532211
Q ss_pred -ccccccccccCcccCchhcccC--CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhh----HHhh-------
Q 003846 660 -QANTNRIVGTYGYMSPEYALEG--LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW----DLWK------- 725 (791)
Q Consensus 660 -~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~----~~~~------- 725 (791)
........++..|+|||++... .++.++|+||||++++||++|+.||........ ...... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhh
Confidence 1111234567889999998763 588999999999999999999999864322111 000000 0000
Q ss_pred cCCccc----ccccc----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 726 DNRALD----LMDPI----LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 726 ~~~~~~----~~~~~----l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.....+ ..++. ............+.+++.+||+.||++|||++|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000000 00000 01112223456889999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=287.61 Aligned_cols=248 Identities=23% Similarity=0.270 Sum_probs=191.1
Q ss_pred hhhhccCCCcccee--cccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCc
Q 003846 497 VSASTNNFSAENKL--GEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 497 ~~~~~~~y~~~~~L--G~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 572 (791)
+....++|++.+.+ |+|+||.||++.. .+++.+|+|.+........ |+.....+ +||||+++++.+..++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677777776 9999999999965 4688899999865432211 22222222 79999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeeccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMA 651 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla 651 (791)
.++||||+++++|.+++... ..++++.+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999998432 37889999999999999999999988 99999999999999998 9999999998
Q ss_pred cccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
....... ...++..|+|||++.+..++.++||||||+++|||++|+.|+................. .
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~---- 224 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---Q---- 224 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---c----
Confidence 7654321 23578899999999998999999999999999999999999864332221111111000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPT-MSEVVSM 773 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~ 773 (791)
. ........+..+.+++.+||+.+|.+||+ ++|++++
T Consensus 225 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 ---K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 00111135568899999999999999996 6888853
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=290.62 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=195.7
Q ss_pred ecccCceeEEEeEee-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKKSG---QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
||+|+||.||++... +|+.+|+|.+..... ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999775 499999999875433 4567788999999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc------
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL------ 659 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~------ 659 (791)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998532 36889999999999999999999988 99999999999999999999999999876433211
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
........++..|+|||.......+.++||||||+++++|++|+.|+....... .. ....... ...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~-~~~~~~~--------~~~ 220 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IF-QNILNGK--------IEW 220 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HH-HHHhcCC--------cCC
Confidence 112233467889999999998889999999999999999999999975332110 00 0000000 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
......+..+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0001125678999999999999999999666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.20 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=202.1
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|++.+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999654 578999999976643 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998432 56889999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
. .....++..|+|||...+..++.++|||++|+++++|++|+.|+..... ....+... .. ...
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~-~~---------~~~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIV-QD---------DHP 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHh-cc---------CCC
Confidence 1 2234678899999999888889999999999999999999998753221 00011100 00 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.+|++|||+.|++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1122235678899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=321.92 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=188.5
Q ss_pred hhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc------
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD------ 569 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------ 569 (791)
+....+|+..+.||+||||.||+++. -+|+.+|||++... +......+.+|++++++|+|||||+++....+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45667899999999999999999965 48999999999755 34456678899999999999999999752100
Q ss_pred ------------------------------------------------------------------------C-------
Q 003846 570 ------------------------------------------------------------------------Q------- 570 (791)
Q Consensus 570 ------------------------------------------------------------------------~------- 570 (791)
+
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHH
Q 003846 571 ----------------------------------DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616 (791)
Q Consensus 571 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~ 616 (791)
..+||=||||+..+|.+++.++.... .....++++++|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 11256688998888887774432221 356778999999999999
Q ss_pred hhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC----C------------CccccccccccccCcccCchhccc
Q 003846 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG----G------------DELQANTNRIVGTYGYMSPEYALE 680 (791)
Q Consensus 617 LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~ 680 (791)
+|+++ ||||||||.||+|++++.+||+|||+|.... . .......+..+||..|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998721 0 001112345689999999999986
Q ss_pred C---CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc--CCCCHHHHHHHHHHHHH
Q 003846 681 G---LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE--NEASYPMLARYVNVALL 755 (791)
Q Consensus 681 ~---~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~ 755 (791)
. .|+.|+|+||||+||+||+.. |..... ..... ..+-+..+. ..+..+..+.-.++|++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsME-Ra~iL------------~~LR~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLYP---FGTSME-RASIL------------TNLRKGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhcc---CCchHH-HHHHH------------HhcccCCCCCCcccccccchHHHHHHHH
Confidence 5 499999999999999999853 332111 00000 001111111 11223344556799999
Q ss_pred ccccCCCCCCCHHHHHH
Q 003846 756 CVHENATDRPTMSEVVS 772 (791)
Q Consensus 756 cl~~dp~~RPt~~evl~ 772 (791)
|++.||++||||.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999985
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.03 Aligned_cols=264 Identities=27% Similarity=0.349 Sum_probs=197.1
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC--Ccc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ--DEK 573 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 573 (791)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3578999999999999999999764 5889999988643 233445677899999999 999999999998654 357
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888732 26788888999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc---cccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhh--------
Q 003846 654 FGGDELQ---ANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW-------- 721 (791)
Q Consensus 654 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~-------- 721 (791)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+....... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCH
Confidence 6443221 12233568899999998765 467899999999999999999999975432211 000000
Q ss_pred ---HHhhcCCccccccccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 722 ---DLWKDNRALDLMDPILEN------EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 722 ---~~~~~~~~~~~~~~~l~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+.++..... ......+..+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000001111100000 0001135678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=287.99 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=194.0
Q ss_pred CCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhc---CCCceeeeeeEEEcCCc-----
Q 003846 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKL---QHRNLVRLLGCCLDQDE----- 572 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 572 (791)
|++.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999775 489999999974422 2234566788777666 59999999999988776
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.+++|||+++ +|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 788887432 2235889999999999999999999988 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC----
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR---- 728 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 728 (791)
....... .....++..|+|||++.+..++.++|+||||+++|||++|+.|+...... ..............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhc
Confidence 7643321 12235788999999999999999999999999999999998887543221 11111100000000
Q ss_pred --c----ccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 --A----LDLMDPILE---NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 --~----~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ......... ..........+.+++.+||+.||.+||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 000000000 11112345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.50 Aligned_cols=265 Identities=19% Similarity=0.285 Sum_probs=197.8
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEc----CCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLD----QDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 573 (791)
..+|++.+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46899999999999999999965 469999999987542 2345677889999999999999999998763 3457
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+. ++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999996 58888873 2345889999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCccc--cccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH--------
Q 003846 654 FGGDELQ--ANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD-------- 722 (791)
Q Consensus 654 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------- 722 (791)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhH
Confidence 5432211 11123478899999999865 46899999999999999999999997542211 00000000
Q ss_pred ---HhhcCCccccccccc-cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 723 ---LWKDNRALDLMDPIL-ENEA-----SYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 723 ---~~~~~~~~~~~~~~l-~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
...........+... .... ....+..+.+++.+||+.+|.+|||++|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000000000000000 0001 112357899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.78 Aligned_cols=265 Identities=21% Similarity=0.310 Sum_probs=197.9
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-----Cc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-----DE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 572 (791)
.++|.+.+.||+|+||+||++.. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999965 46899999998653 233456678899999999999999999988654 34
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++|+||+. ++|.+++. ....++...+..++.||++||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68888773 2346889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH--------
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL-------- 723 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------- 723 (791)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCChHH
Confidence 654332 11223467889999998875 46899999999999999999999997543210 000000000
Q ss_pred ---hhcCCccccccccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hcc
Q 003846 724 ---WKDNRALDLMDPILEN------EASYPMLARYVNVALLCVHENATDRPTMSEVVSM--LTN 776 (791)
Q Consensus 724 ---~~~~~~~~~~~~~l~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~ 776 (791)
..........+..... ......+..+.+++.+||+.+|++|||++|++++ ++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000000000000000 0011245678999999999999999999999988 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.26 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=196.2
Q ss_pred cceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 507 ENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
..+||+|+||.||++.. .+++.||||++........+.+.+|+.++++++|+|++++++++..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36899999999999966 46899999998665555567789999999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 98873 234788889999999999999999988 99999999999999999999999999876543221 1223
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|..|+...... ..... .... ..+.+.. ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~----~~~~-----~~~~~~~--~~~~ 242 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM----IRDN-----LPPKLKN--LHKV 242 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhh-----CCcccCC--cccC
Confidence 46789999999998888999999999999999999999996532111 00000 0000 0001100 1123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 746 LARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+..+.+++.+||+.+|.+||++.|++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 4567899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.40 Aligned_cols=245 Identities=24% Similarity=0.278 Sum_probs=189.2
Q ss_pred ceecccCceeEEEeEe-eCCcEEEEEEecccCc---ccHHHHHHHHHHH-HhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG---QGLEELKNETMLI-AKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.||+|+||.||+|.. .+++.||||.+.+... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999965 4689999999865432 2223344555444 445899999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
++|.+++.. ...++...+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999843 245788999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
.....++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ..+........ .......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~------~~~~~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRRI------NWPEEVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhccc------CCCCccc
Confidence 12345788999999998888999999999999999999999997532211 01111111100 0011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 743 YPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 743 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1245678999999999999999988766666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=292.62 Aligned_cols=253 Identities=24% Similarity=0.398 Sum_probs=193.3
Q ss_pred ccCCCccceecccCceeEEEeEeeC-CcEEEEEEecccC-cccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 577 (791)
.++|++.+.||+|+||.||+|...+ ++.||||+++... .....++..|+.++.+.. ||||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678889999999999999997754 8999999987543 233455667887777775 999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
||+++ +|..++.. ....+++..+..++.||++||+|||+. + |+||||+|+||+++.++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 77776633 224688889999999999999999974 5 99999999999999999999999999876543
Q ss_pred CccccccccccccCcccCchhcccCC----CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGL----FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
.... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.|+....... ... ..... ...
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~---~~~~~-~~~--- 236 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVL---TKILQ-EEP--- 236 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHH---HHHhc-CCC---
Confidence 2211 2235778999999987553 7899999999999999999999975321110 000 00010 100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
+.... ....+.++.+++.+||+.||.+||++.+++++-
T Consensus 237 --~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 --PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00000 012346789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.35 Aligned_cols=260 Identities=25% Similarity=0.332 Sum_probs=198.2
Q ss_pred CCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
|++.+.||+|++|.||++... +++.+|+|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999654 688999999875432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++ +|.+++... ...+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 888877432 256889999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC---Ccccccc--
Q 003846 661 ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN---RALDLMD-- 734 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 734 (791)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.|+...... +............ ......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--DQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCchHhcccchhhh
Confidence 112224577889999998876 7899999999999999999999887543211 1100000000000 0000000
Q ss_pred ----cccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 ----PILE-------NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ----~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.... .......+..+.+++.+||+.||.+||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 01112245788999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=290.70 Aligned_cols=265 Identities=25% Similarity=0.341 Sum_probs=196.9
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC----
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD---- 571 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 571 (791)
...++|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999764 58899999986543 233456788999999999999999999987655
Q ss_pred ------cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 572 ------EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 572 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
..++|+||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 67666633 2346889999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
+|||++......... ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+..... ...........
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISRLC 234 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Confidence 999999866443221 1112345778999998865 4578999999999999999999998753221 11110111100
Q ss_pred hcCCc---ccc--------cc------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 725 KDNRA---LDL--------MD------PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 725 ~~~~~---~~~--------~~------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..... ... .+ ..... .....+..+.+++.+||+.+|.+||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 000 00 00000 001135678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=288.97 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=199.0
Q ss_pred CCCccceecccCceeEEEeEe----eCCcEEEEEEecccC----cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcc
Q 003846 503 NFSAENKLGEGGFGPVYKGEL----LNGQEVAVKRLSKKS----GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 573 (791)
+|++.+.||+|++|.||++.. .+++.||||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467789999999999999864 357889999986532 22345688999999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 345788889999999999999999987 99999999999999999999999999876
Q ss_pred cCCCccccccccccccCcccCchhcccCC--CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGL--FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
+...... ......++..|+|||.+.+.. .+.++||||||++++||++|..|+....... ..........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~------- 225 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRIL------- 225 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHH-------
Confidence 5433211 112345788999999987665 7889999999999999999999975322111 0000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.. ....+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 226 --~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 226 --KS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --cc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 0111222346788999999999999999999888877763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=282.97 Aligned_cols=271 Identities=25% Similarity=0.350 Sum_probs=216.3
Q ss_pred ehhhhhhhccCCCccceecccCceeEEEeEe------eCCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeee
Q 003846 493 SFASVSASTNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLG 565 (791)
Q Consensus 493 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~ 565 (791)
...++.....+++....+-+|.||+||.|.+ .+.+.|-||.++.. ++-....+..|..++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3445666778899889999999999999944 34566788877654 3445677889999999999999999999
Q ss_pred EEEcC-CcceEEEeecCCCChhHHHh-----hhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC
Q 003846 566 CCLDQ-DEKILIYEYLPNKSLDSFLF-----DRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT 639 (791)
Q Consensus 566 ~~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~ 639 (791)
++.++ +..+.+|.++.-|+|..+|. +....+.+...+...++.|++.|++|||+++ |||.||..+|.++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 99765 56789999999999999997 4455667778888899999999999999998 999999999999999
Q ss_pred CCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhh
Q 003846 640 DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLG 718 (791)
Q Consensus 640 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~ 718 (791)
..++||+|=.+++.+-..++.........+..||+||.+.+..|+.++|||||||+||||+| |+.|+.... ..+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-----PfE 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-----PFE 506 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-----HHH
Confidence 99999999999998766666554444456789999999999999999999999999999998 777743211 111
Q ss_pred hhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCC
Q 003846 719 HAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (791)
.. ...+++. ++ ..+...++++..++..||..+|++||+++|++.-|.+.+.++
T Consensus 507 m~-~ylkdGy-------Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 507 ME-HYLKDGY-------RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred HH-HHHhccc-------ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 11 1111111 11 122235678999999999999999999999999998876554
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=286.99 Aligned_cols=242 Identities=26% Similarity=0.311 Sum_probs=186.7
Q ss_pred eecccCceeEEEeEe-eCCcEEEEEEecccCc---ccHHHHHHHHHH---HHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 509 KLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG---QGLEELKNETML---IAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
.||+|+||.||++.. .+++.||+|.+.+... .....+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 4588999999865421 112233444443 444579999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|..++. ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998874 2346899999999999999999999988 9999999999999999999999999987654321
Q ss_pred ccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.|+........... ..... .. ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~------~~----~~~ 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTL------TM----AVE 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhh------cc----CCC
Confidence 1234689999999998754 689999999999999999999999764322111100 00000 00 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 741 ASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
.+...+..+.+++.+|+..+|.+|| ++.|++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1122356889999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=292.40 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=202.0
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 576 (791)
++|.+.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999664 6899999998653 2233567889999999998 99999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 336899999999999999999999988 99999999999999999999999999986654
Q ss_pred Cccc------------------cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhh
Q 003846 657 DELQ------------------ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLG 718 (791)
Q Consensus 657 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~ 718 (791)
.... .......++..|+|||++.+..++.++||||||++++++++|+.|+....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~- 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TF- 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HH-
Confidence 3221 11223467889999999998889999999999999999999999976432110 00
Q ss_pred hhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 003846 719 HAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTM----SEVVSM 773 (791)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~----~evl~~ 773 (791)
.... ......+...+..+.+++.+||+.+|.+||++ +|++++
T Consensus 232 ---~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 ---QKIL----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ---HHHH----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0000 01111222335678999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=288.26 Aligned_cols=260 Identities=25% Similarity=0.324 Sum_probs=194.5
Q ss_pred CCccceecccCceeEEEeEee-CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEeec
Q 003846 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
|++.+.||+|++|+||+|... +++.||||++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999765 578899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
+++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 789988874322 346889999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH--------HhhcC-Ccc
Q 003846 661 ANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD--------LWKDN-RAL 730 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~-~~~ 730 (791)
.....++..|+|||++.. ..++.++|+||||++++||++|+.|+........ ...... .+.+. ...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ--LYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH--HHHHHHhcCCCChhhhhhHhhhh
Confidence 123467889999998854 4689999999999999999999988754322110 000000 00000 000
Q ss_pred cccccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 DLMDPILE-------NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..++.... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00001124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=293.51 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=196.8
Q ss_pred hhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc-CCcc
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD-QDEK 573 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 573 (791)
...+++|++.+.||+|+||.||++.. .+++.||||++.+. .....+.+.+|+.++++++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678999999999999999999964 47899999988643 22345678899999999999999999999876 5578
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++++||+ +++|.+++. ...++...+..++.||++||+|||+.+ |+||||+|+||+++.++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568888773 235677888899999999999999988 99999999999999999999999999875
Q ss_pred cCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccc--h-------hhhhhHH
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN--L-------LGHAWDL 723 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~--~-------~~~~~~~ 723 (791)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+......... + .......
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 122356889999998766 56899999999999999999999987543211000 0 0000000
Q ss_pred hhcCCccccccccc-cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 724 WKDNRALDLMDPIL-ENEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 724 ~~~~~~~~~~~~~l-~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......+.+.... ....+ ......+.+++.+||+.+|++|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011111111100 01111 1134678999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=270.17 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=194.5
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 578 (791)
++.+.+..||.|..|.|++++.. +|...|||.+.+.. .+..+++...+.++.+-+ +|.||+.+|+|..+....+.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44556678999999999999765 48899999997654 445567777777777664 8999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
.|. ..++.+|.. -...+++..+-++...+++||.||.+++ +|+|||+||+|||+|+.|++||+|||++..+-+..
T Consensus 172 lMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 884 356666633 2334666667789999999999998765 69999999999999999999999999997665432
Q ss_pred cccccccccccCcccCchhccc---CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
..++..|-+.|||||.+.- ..|+.++||||||+.|+||.||+.|+.....+..-+. .+ .+... +
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-kv----ln~eP-----P 313 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-KV----LNEEP-----P 313 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-HH----HhcCC-----C
Confidence 2334578899999999864 4689999999999999999999999775443322111 11 11100 2
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+.+.. ..+..+++++..||+.|+.+||...+++++
T Consensus 314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222211 156789999999999999999999999875
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=287.82 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=196.0
Q ss_pred CCCccceecccCceeEEEeEe----eCCcEEEEEEecccC----cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcc
Q 003846 503 NFSAENKLGEGGFGPVYKGEL----LNGQEVAVKRLSKKS----GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 573 (791)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999965 368899999987532 22346778899999999 599999999999999899
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++|+||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 345778888899999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccCcccCchhcccC--CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEG--LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
....... ......++..|+|||.+... .++.++||||||+++|+|++|+.|+....... ........... .
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~---- 227 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILK-S---- 227 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhc-c----
Confidence 5433221 12234688899999998753 47889999999999999999999975322111 11111100000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
....+......+.+++.+||+.||.+|| ++.+++.+
T Consensus 228 ------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0111222456788999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=292.00 Aligned_cols=250 Identities=30% Similarity=0.430 Sum_probs=195.3
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.+.|+..+.||+|+||.||+|... +++.+|+|.+... ......++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345777889999999999999754 5788999988643 223345788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+. |+|.+++.. ....++...+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 577777633 2345788899999999999999999988 99999999999999999999999999876432
Q ss_pred CccccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
. ....++..|+|||.+. ...++.++||||||+++|+|++|+.|+...... . ..... ....
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~---~~~~~-~~~~----- 230 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S---ALYHI-AQNE----- 230 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--H---HHHHH-hhcC-----
Confidence 2 2345788999999975 356788999999999999999999986432110 0 00000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.........+..+.+++.+||+.+|.+||++.+++++.-.
T Consensus 231 ---~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ---CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 0011112345678899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=291.49 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=193.3
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQD------ 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 571 (791)
.++|++.++||+|+||.||+|... +++.+|||++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999654 689999998865432 22346788999999999999999999876543
Q ss_pred --cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 572 --EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 572 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
..++|+||+.+ +|...+.. ....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999975 66666532 3346889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCcccc---------ccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh
Q 003846 650 MARMFGGDELQA---------NTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH 719 (791)
Q Consensus 650 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~ 719 (791)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|++|+...... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--~~~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--DQLHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 997654322111 11223568889999988654 5899999999999999999999987532221 10001
Q ss_pred hhHHhhcC---------CccccccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 720 AWDLWKDN---------RALDLMDPILENEAS-------YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 720 ~~~~~~~~---------~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........ ......+.......+ ......+.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 000000000000000 1123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=297.42 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=193.9
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD------ 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 571 (791)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.+.. ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999965 468999999986532 223456889999999999999999999987543
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++|+||+.. +|..++ ...++++.+..++.|+++||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 666554 235788899999999999999999988 999999999999999999999999998
Q ss_pred cccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH-------
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL------- 723 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------- 723 (791)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGPE 237 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence 764321 123467889999999876 46899999999999999999999998643211 000000000
Q ss_pred ----hhcCCcccccc--cccc-CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hccCc
Q 003846 724 ----WKDNRALDLMD--PILE-NEA---SYPMLARYVNVALLCVHENATDRPTMSEVVSM--LTNEH 778 (791)
Q Consensus 724 ----~~~~~~~~~~~--~~l~-~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~ 778 (791)
........... +... ... .......+.+++.+||+.||.+||+++|++++ ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000000000 0000 000 01134568899999999999999999999966 55533
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.45 Aligned_cols=244 Identities=29% Similarity=0.452 Sum_probs=191.3
Q ss_pred CCccceecccCceeEEEeEe-eCCcEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 504 FSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG---QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
|...++||+|+||+||+|.. .+++.||+|++..... .....+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66668899999999999965 4688999999865322 2345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+. ++|.+++.. ....+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 577776632 2345888999999999999999999988 99999999999999999999999999864321
Q ss_pred ccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.....++..|+|||++. ...++.++||||||+++|+|++|..|+..... ........... .
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~-~------- 237 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQND-S------- 237 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC-C-------
Confidence 22346788999999984 45688999999999999999999998643211 00111110000 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+++.+||+.+|.+||++.+++++
T Consensus 238 -~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111233568899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=285.27 Aligned_cols=260 Identities=27% Similarity=0.346 Sum_probs=197.6
Q ss_pred CCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
|+..+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999765 58999999997653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
+ ++|.+++.... ..+++..+..++.|+++||+|||+++ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999985432 46889999999999999999999988 99999999999999999999999999986543321
Q ss_pred cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh-----------hhHHhhcCC
Q 003846 661 ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH-----------AWDLWKDNR 728 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~-----------~~~~~~~~~ 728 (791)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+...... ..... .|.......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCcHHHHHhhcccc
Confidence 11223457789999998776 7899999999999999999999887542211 00000 000000000
Q ss_pred -cccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 -ALDLMDPILE---NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 -~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......... ..........+.+++.+||+.+|++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000 00111225679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=292.19 Aligned_cols=265 Identities=22% Similarity=0.296 Sum_probs=195.6
Q ss_pred ccCCCc-cceecccCceeEEEeEee-CCcEEEEEEecccCccc--------------HHHHHHHHHHHHhcCCCceeeee
Q 003846 501 TNNFSA-ENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQG--------------LEELKNETMLIAKLQHRNLVRLL 564 (791)
Q Consensus 501 ~~~y~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~ 564 (791)
.++|.. .+.||+|+||+||+|... +++.||||++....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 467999999999999654 68999999986542211 12577899999999999999999
Q ss_pred eEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeE
Q 003846 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPK 644 (791)
Q Consensus 565 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k 644 (791)
+++..++..++||||++ ++|.+++.. ...++.+....++.|+++||.|||+.+ ++|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 588888732 345788999999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCcc------------ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCC
Q 003846 645 ISDFGMARMFGGDEL------------QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHT 711 (791)
Q Consensus 645 l~DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~ 711 (791)
|+|||++........ ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999976642111 1111223467889999998764 478999999999999999999998764322
Q ss_pred CccchhhhhhHHhhcCCcc---c-----ccccc---ccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 712 GSLNLLGHAWDLWKDNRAL---D-----LMDPI---LEN---EASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~---~-----~~~~~---l~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
. ................ + ...+. ... ......+..+.+++.+||+.+|++|||++|++.+-
T Consensus 240 ~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 I--DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred H--HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1 1111111111000000 0 00000 000 00111346788999999999999999999999765
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=292.76 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=200.0
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----cce
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD-----EKI 574 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 574 (791)
+|++.+.||.|++|.||+|... +++.+|||++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999764 48999999987653 344577899999999999999999999998775 789
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
++|||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 478888732 337889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcc-ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH---------
Q 003846 655 GGDEL-QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL--------- 723 (791)
Q Consensus 655 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------- 723 (791)
..... ........++..|+|||.+.+. .++.++|+||||+++++|++|+.||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChhHh
Confidence 54321 0112234678899999999887 88999999999999999999999975432110 00000000
Q ss_pred --hhcCCcccccccccc------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 724 --WKDNRALDLMDPILE------NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 724 --~~~~~~~~~~~~~l~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+..... .......+..+.+++.+||+.+|.+|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000001000000 00011135678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=296.20 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=197.5
Q ss_pred hccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.++.|.+...+|.|+|+.|-.+. ..+++..+||++.+.. .+-.+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46788888999999999999884 4568899999997652 2345677666665 6999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE-cCCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFgla~~~~~ 656 (791)
|++.++-|.+.+.. .+ .....+..|+.+|+.|+.|||+++ |+||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~---~~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS---KP-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHh---cc-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988776632 22 222677789999999999999998 9999999999999 6999999999999987765
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ .+++...
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------------~ei~~~i 526 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------------IEIHTRI 526 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------------HHHHHhh
Confidence 4 22235688999999999999999999999999999999999997654433 1222222
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
..+.+....+...++|+.+||+.||.+||+|.|+..+=
T Consensus 527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 33334455678899999999999999999999998764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=296.06 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=193.6
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC---------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--------- 570 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------- 570 (791)
..+|.+.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999965 46899999998776666677889999999999999999999876543
Q ss_pred -----CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeE
Q 003846 571 -----DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPK 644 (791)
Q Consensus 571 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~k 644 (791)
...++|+||++ ++|.+++. ...+++..+..++.||++||.|||+++ ++||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999997 58887763 235788999999999999999999988 999999999999974 56789
Q ss_pred EeeeccccccCCCcccc-ccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhh--
Q 003846 645 ISDFGMARMFGGDELQA-NTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA-- 720 (791)
Q Consensus 645 l~DFgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~-- 720 (791)
|+|||++.......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||........ .....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh
Confidence 99999997654321111 1122357889999998754 5688999999999999999999999853321100 00000
Q ss_pred --------hHHhhcCCccccccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 721 --------WDLWKDNRALDLMDPILENEA-----SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 721 --------~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..................... .......+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000000000000000 11234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=283.37 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=194.8
Q ss_pred CCCccceecccCceeEEEeEeeC-CcEEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 503 NFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKK-----SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
+|.+.++||+|+||.||++.... +..+++|.++.. ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999996543 455666665432 122344677899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 577 YEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
+||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23456889999999999999999999988 999999999999975 579999999987654
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.... ......+++.|+|||.+.+..++.++|+||||+++++|++|..|+..... ...... ....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~-~~~~-------- 220 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLR-IVEG-------- 220 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-HHcC--------
Confidence 3221 12234578899999999888899999999999999999999998743211 111000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+...+..+.+++.+||+.+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0111223455688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=294.19 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=196.4
Q ss_pred hhhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-
Q 003846 495 ASVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ- 570 (791)
Q Consensus 495 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~- 570 (791)
.++....++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34556779999999999999999999964 568999999987532 22346688899999999999999999988643
Q ss_pred -----CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 571 -----DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 571 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
...++++|++ +++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 2357777776 779988763 235788999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh-----
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH----- 719 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~----- 719 (791)
+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .+...
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~ 235 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG 235 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 999998764321 123467889999999876 468899999999999999999999975322110 00000
Q ss_pred -----hhHHhhcCCcccc---ccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 720 -----AWDLWKDNRALDL---MDPILENE---ASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 720 -----~~~~~~~~~~~~~---~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
............. +....... ........+.+++.+|++.||.+||++.|++++=
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000000000 00000000 0001245688999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=294.49 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=194.7
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC----
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD---- 571 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 571 (791)
...++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3467899999999999999999964 468999999986432 223456889999999999999999999987654
Q ss_pred --cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 572 --EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 572 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
..++||||+ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 348999998 778988873 245888999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh---------
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH--------- 719 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~--------- 719 (791)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.|+....... .....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence 99765332 123356889999999876 458899999999999999999999976432110 00000
Q ss_pred -hhHHhhcCCccccccc--cccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 720 -AWDLWKDNRALDLMDP--ILEN----EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 720 -~~~~~~~~~~~~~~~~--~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
................ .... .........+.+++.+|++.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000 0000 0011234568899999999999999999999843
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=268.51 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=193.8
Q ss_pred hccCCCcc-ceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEc----CCc
Q 003846 500 STNNFSAE-NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLD----QDE 572 (791)
Q Consensus 500 ~~~~y~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~ 572 (791)
.+++|++. ++||-|-.|.|-.... .+|+++|+|++... ...++|+++--.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677765 4799999999999844 57999999998543 4567888876555 69999999999865 345
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEEeeec
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFG 649 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFg 649 (791)
+++|||.|+||.|...+.++. ...+.+.++..|+.||..|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 678999999999999986543 455788899999999999999999988 999999999999964 5579999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+|+.-.. .......+-||.|.|||++....|+...|+||+||++|-|++|.+||=..+. ..+..-.......+
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~g-- 282 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTG-- 282 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhcc--
Confidence 9987543 2223345779999999999999999999999999999999999999633222 21111111111100
Q ss_pred cccccccccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASY----PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.-.++. ..++...++|+.+|..+|++|.|+.|++.+
T Consensus 283 --------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 283 --------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred --------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 011221 256788999999999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=287.09 Aligned_cols=244 Identities=26% Similarity=0.389 Sum_probs=194.1
Q ss_pred cceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 507 ENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
.+.||.|.||+||-|+. ++|+.||||++.+. ......++++|+.||++++||.||.+-..|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999954 57999999999764 2345688999999999999999999999999999999999999664
Q ss_pred ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC---CCeEEeeeccccccCCCccc
Q 003846 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD---MKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFgla~~~~~~~~~ 660 (791)
-|+-+| ....+.+++.....++.||+.||.|||.++ |+|+||||+||||... .++||+|||+|+.++.....
T Consensus 649 MLEMIL--SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMIL--SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHH--HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 444444 334566777777788999999999999998 9999999999999643 57999999999998866543
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
. ..+|||.|+|||++.+..|...-|+||+|||+|--++|.-||....+- .+.+..+ ..+-..
T Consensus 724 r---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-ndQIQNA--------------aFMyPp 785 (888)
T KOG4236|consen 724 R---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-NDQIQNA--------------AFMYPP 785 (888)
T ss_pred h---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-hHHhhcc--------------ccccCC
Confidence 3 468999999999999999999999999999999999999886432211 0111000 111111
Q ss_pred CCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 741 ASY-PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 741 ~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+. ...+...++|...||..-++|-+..+.+.+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 222 245678899999999999999998876543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=312.97 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=207.5
Q ss_pred hhhhhhccCCCccceecccCceeEEEeEee-CCcEEEEEEecc---cCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC
Q 003846 495 ASVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSK---KSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ 570 (791)
Q Consensus 495 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 570 (791)
.++....++|.+++.||+|+||.|.+++.+ +++.+|+|++.+ .......-|..|-.+|..-+.+-|+.++..|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455566789999999999999999999765 578899999987 2344567789999999999999999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
.++|+|||||+||+|..+|... ..++.+.++.++..|.-||.-||+.| +|||||||+|||||..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999999432 36899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcc----c-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYAL----E-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
+..+..+.. ......+|||.|++||++. + +.|+..+|.||+||++|||+.|..||- ++. +++.......
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY--ads---lveTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY--ADS---LVETYGKIMN 295 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch--HHH---HHHHHHHHhc
Confidence 887764432 2334569999999999986 3 579999999999999999999999952 221 1111111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHh
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPT---MSEVVSML 774 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~L 774 (791)
... .+.=+.....++.+.+||.+.+. +|+.|.. ++++..+-
T Consensus 296 hk~-------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 296 HKE-------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhh-------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 111 11111112366788999999886 8888987 88887653
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=289.72 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=190.3
Q ss_pred CCCccceecccCceeEEEeEee-C--CcEEEEEEecccC--cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC----Cc
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-N--GQEVAVKRLSKKS--GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ----DE 572 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 572 (791)
+|++.+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999754 3 7789999986532 22356778899999999 599999999876432 34
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 68888873 3456888999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhh--------
Q 003846 653 MFGGDELQ--ANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW-------- 721 (791)
Q Consensus 653 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~-------- 721 (791)
.+...... .......|+..|+|||++.+ ..++.++||||+|+++|+|++|+.|+...... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCH
Confidence 65432211 11223578999999998765 46899999999999999999999987543210 0000000
Q ss_pred ---HHhhcCCccccccc---ccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 722 ---DLWKDNRALDLMDP---ILE---NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 722 ---~~~~~~~~~~~~~~---~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.............. ... ..........+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 000 00001124578899999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=309.32 Aligned_cols=259 Identities=30% Similarity=0.430 Sum_probs=204.5
Q ss_pred ccCCCccceecccCceeEEEeEeeC--------CcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN--------GQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
.++..+.+.||+|.||.|++|.... ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3445666799999999999996531 4579999997643 34567899999999999 699999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhc-----------cc--cccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRA-----------KK--RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
+..++|+||+..|+|.++|.... .. ..+...+.+.++.|||.|++||++.. ++||||..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999996544 01 23888999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCcccccc-ccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccc
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANT-NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLN 715 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~ 715 (791)
..+..+||+|||+|+........... ....-...|||||.+....|+.++||||||++||||++ |..|+....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----- 526 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----- 526 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-----
Confidence 99999999999999976655443322 11114567999999999999999999999999999999 566654311
Q ss_pred hhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 716 LLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
......+....+ -+.+.+.....++.++++.||+.+|++||++.|+++.++.
T Consensus 527 ~~~~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 PTEELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred cHHHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 000111111111 1222333346788999999999999999999999999977
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=294.66 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=195.7
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc----
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE---- 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 572 (791)
..++|++.+.||+|++|.||+|... +++.||||++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999764 5889999998653 22344667889999999999999999998876654
Q ss_pred --ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 573 --KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 573 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 79999998 5699888732 45889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhh--------
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW-------- 721 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~-------- 721 (791)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .......
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCH
Confidence 9865432 223467889999998865 36789999999999999999999997532211 0000000
Q ss_pred ---HHhhcCCcccccccccc-CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 722 ---DLWKDNRALDLMDPILE-NE-----ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 722 ---~~~~~~~~~~~~~~~l~-~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+........+..... .. .....+..+.+++.+||+.+|.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000000 00 001135678999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=276.62 Aligned_cols=236 Identities=28% Similarity=0.350 Sum_probs=190.8
Q ss_pred ecccCceeEEEeEee-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 510 LGEGGFGPVYKGELL-NGQEVAVKRLSKKSG---QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 510 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
||+|+||.||++... +++.+|+|.+.+... .....+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999764 589999999875432 2456788999999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 665 (791)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9998432 35788999999999999999999987 9999999999999999999999999998754332 12233
Q ss_pred ccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 666 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
..++..|+|||...+...+.++|+||||+++|+|++|+.|+..... .... ..... . ....+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~----~~~~~--------~--~~~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIY----EKILK--------D--PLRFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH----HHHhc--------C--CCCCCCCC
Confidence 4678899999999988899999999999999999999999753321 0000 00000 0 01112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 003846 746 LARYVNVALLCVHENATDRPTMSE 769 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt~~e 769 (791)
+..+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 567889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=312.20 Aligned_cols=146 Identities=30% Similarity=0.426 Sum_probs=130.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|.+.++||+|+||.||+|... +++.||||+++... ......+.+|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999765 68999999987542 23346788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
|||+++++|.+++.. ...+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999843 235778889999999999999999987 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=276.31 Aligned_cols=257 Identities=28% Similarity=0.374 Sum_probs=198.9
Q ss_pred cCCCccceecccCceeEEEe-EeeCCcEEEEEEeccc--Cc-----ccHHHHHHHHHHHHhcCCCceeeeeeEEE-cCCc
Q 003846 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SG-----QGLEELKNETMLIAKLQHRNLVRLLGCCL-DQDE 572 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~--~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~ 572 (791)
++|-++++||+|||+.||+| ++...+.||||+-... .. ...+...+|.+|-+.|.||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 57888899999999999999 6667889999975432 11 12344668999999999999999999996 5567
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc---CCCCeEEeeec
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---TDMKPKISDFG 649 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFg 649 (791)
+|-|+||++|.+|+-+|. ..+.+++++++.|+.||+.||.||.+.. .+|||-||||.||||- ..|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999984 4467899999999999999999999874 6899999999999994 46889999999
Q ss_pred cccccCCCcccc-----ccccccccCcccCchhccc----CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhh
Q 003846 650 MARMFGGDELQA-----NTNRIVGTYGYMSPEYALE----GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA 720 (791)
Q Consensus 650 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~ 720 (791)
|++.+.++.+.. .+....||..|++||.+.- ..++.|+||||+|||+|..+.|+.||+-......-
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI----- 693 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI----- 693 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-----
Confidence 999987664432 2344679999999998863 35789999999999999999999998753322111
Q ss_pred hHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 721 WDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
..+.......+-.+. .-+..+.+...+|++||++.-++|.+..|+..
T Consensus 694 ---LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 ---LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111110111 11123467789999999999999998888753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=243.93 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=194.3
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+|...++||+|.||+||+|+.. +++.||+|+++..+ +.......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999654 58899999887543 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
|.. +|..+. + .-++.++.+.+..++.|+++||.++|+++ +.||||||+|+|+..+|.+|++|||+++.++-...
T Consensus 83 cdq-dlkkyf-d-slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYF-D-SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHH-H-hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 955 777775 2 34567899999999999999999999998 99999999999999999999999999998764321
Q ss_pred ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCC-CCCCCCCccchhhhhhHHhhcC---Ccc---c
Q 003846 660 QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKN-TGFYHTGSLNLLGHAWDLWKDN---RAL---D 731 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~---~~~---~ 731 (791)
-.+..+-|..|++|+++.+. .|++..|+||.|||+.|+..-..| |.... -...+. ..+...... ... +
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlk-rif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLK-RIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHH-HHHHHhCCCccccCCcccc
Confidence 12234678999999999876 589999999999999999885555 32211 111111 111111111 100 1
Q ss_pred cccccccCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 LMDPILENEAS---------YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ~~~~~l~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+-|-..-..++ +.....=++++.+.+.-+|..|.++++.+++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11100000000 1122234688899999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=272.57 Aligned_cols=219 Identities=21% Similarity=0.136 Sum_probs=175.1
Q ss_pred cCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCChhHHHhh
Q 003846 513 GGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFD 591 (791)
Q Consensus 513 G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 591 (791)
|.+|.||++.. .+++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999955 468999999997643 234455556666799999999999999999999999999999999843
Q ss_pred hccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCc
Q 003846 592 RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671 (791)
Q Consensus 592 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 671 (791)
. ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 2 34888999999999999999999988 9999999999999999999999999886654321 12345678
Q ss_pred ccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHH
Q 003846 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVN 751 (791)
Q Consensus 672 y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 751 (791)
|+|||.+....++.++||||+|+++|||++|+.|+....... .. ...-..+...+..+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------~~----~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------NT----HTTLNIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------cc----ccccCCcccCCHHHHH
Confidence 999999988889999999999999999999997753211100 00 0000111223467889
Q ss_pred HHHHccccCCCCCCCH
Q 003846 752 VALLCVHENATDRPTM 767 (791)
Q Consensus 752 li~~cl~~dp~~RPt~ 767 (791)
++.+|++.||++||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-33 Score=265.76 Aligned_cols=267 Identities=23% Similarity=0.396 Sum_probs=197.0
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--------
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-------- 570 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 570 (791)
..|....+||+|.||.||+|+.. .|+.||+|++.-++ ........+|+++|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666689999999999999654 57889998765432 22345667899999999999999999988532
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
...++|++++++ +|.-+|. .....++..++.+++.++..||.|+|... |+|||+||.|+|++.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 346899999976 7877773 23356888999999999999999999887 99999999999999999999999999
Q ss_pred ccccCCCcc--ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCC-ccchhhh-----hh
Q 003846 651 ARMFGGDEL--QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTG-SLNLLGH-----AW 721 (791)
Q Consensus 651 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~-~~~~~~~-----~~ 721 (791)
++.+..... .......+.|..|++||.+.+. .|+++.|||..|||+.||++|.+-++..... ...++.. ..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987643322 2223345779999999998865 7999999999999999999999876543322 1111111 11
Q ss_pred HHhhcCCcccccccc-----ccCCC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 722 DLWKDNRALDLMDPI-----LENEA--------SYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~-----l~~~~--------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
+.|.+.+...++..+ ..+.. ++-..+...+++.+++..||.+|+++++++.+-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 122222222222211 11110 111124678999999999999999999998764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=289.05 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=211.7
Q ss_pred eehhhhhhhccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEc
Q 003846 492 FSFASVSASTNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLD 569 (791)
Q Consensus 492 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 569 (791)
..++.+...++-|++.+.||.|.+|.||+++ ..+++.+|||++... ....+++..|.++++.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445556677889999999999999999995 457999999998644 34457788899999988 59999999999863
Q ss_pred -----CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeE
Q 003846 570 -----QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPK 644 (791)
Q Consensus 570 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k 644 (791)
++++.||||||.+||..+++.... +..+.++.+..|++.++.||++||... ++|||||-.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 578899999999999999986655 778999999999999999999999987 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccCcccCchhcccC-----CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh
Q 003846 645 ISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-----LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH 719 (791)
Q Consensus 645 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~ 719 (791)
|+|||.+..+...- ...+...|||.|||||++... .|+..+|+||||++..||--|.+|.-..+...
T Consensus 164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------ 235 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------ 235 (953)
T ss_pred Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------
Confidence 99999998765432 333456899999999999743 57889999999999999999999954333211
Q ss_pred hhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 720 AWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.++... -.|...-..+......+.++|..||..|-.+||++.+++++
T Consensus 236 --aLF~Ip-----RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 --ALFLIP-----RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --hhccCC-----CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 001000 01112222344577899999999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=265.35 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=194.9
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG-QGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+.+-...||.|+||+|+|... ..|+..|||+++.... ....++..|.+...+- +.||||+++|.+..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 334456899999999999954 5799999999987643 5667888888876555 799999999999999999999999
Q ss_pred cCCCChhHHHhh--hccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 580 LPNKSLDSFLFD--RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 580 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
| ..||+.+-.. ..++..++++-.-+|....++||.||.+.. .|||||+||+||||+..|.+||+|||++..+.+.
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 9 4577766432 234567888888899999999999998753 6999999999999999999999999999776543
Q ss_pred ccccccccccccCcccCchhcccC--CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEG--LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... +.-.|-..|||||.+... .|+.++||||||++|||+.||+-|+..... +.++...... ++...+
T Consensus 222 iAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~-gdpp~l--- 290 (361)
T KOG1006|consen 222 IAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVI-GDPPIL--- 290 (361)
T ss_pred HHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHc-CCCCee---
Confidence 222 223677899999998743 489999999999999999999998653221 1122111111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
............+.++|.-|+..|.++||.+.+++++
T Consensus 291 -~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 -LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1122223456789999999999999999999998653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=269.74 Aligned_cols=264 Identities=21% Similarity=0.231 Sum_probs=197.1
Q ss_pred hhccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-C-C----ceeeeeeEEEcCC
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-H-R----NLVRLLGCCLDQD 571 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~~~~~~~~ 571 (791)
..+++|.+...+|+|+||.|-... ...+..||||+++.... ..+..+-|+++++++. + | -+|.+.+++.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 447899999999999999999984 34578999999965432 3455677999999994 2 2 3778888899999
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC------------
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT------------ 639 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~------------ 639 (791)
+.|||+|.+ |.|+.++|.. .+...++...++.++.|+++++++||+.. ++|.||||+|||+..
T Consensus 165 hiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999988 6689999843 34456788899999999999999999987 999999999999832
Q ss_pred --------CCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCC
Q 003846 640 --------DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHT 711 (791)
Q Consensus 640 --------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~ 711 (791)
+..+||+|||.|+.-... .+..+.|..|+|||++.+-.++.++||||+||||+||.+|..-|+.-.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 235899999999864322 2457889999999999999999999999999999999999987654332
Q ss_pred Ccc-chh--------hh------hhHHhhcCCcc-----------ccccccc----cCCCCHHHHHHHHHHHHHccccCC
Q 003846 712 GSL-NLL--------GH------AWDLWKDNRAL-----------DLMDPIL----ENEASYPMLARYVNVALLCVHENA 761 (791)
Q Consensus 712 ~~~-~~~--------~~------~~~~~~~~~~~-----------~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dp 761 (791)
-.. .+. .. ..+.+..++.. .+.++.. .......+..++.+|++.||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 110 000 00 01111111000 0000000 001122355679999999999999
Q ss_pred CCCCCHHHHHHH
Q 003846 762 TDRPTMSEVVSM 773 (791)
Q Consensus 762 ~~RPt~~evl~~ 773 (791)
.+|+|+.|++++
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=272.05 Aligned_cols=239 Identities=28% Similarity=0.350 Sum_probs=193.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 575 (791)
..+|..+..||+|+||.|-+++.+ +.+.+|||++++.- ..+.+--..|-++|+.. +-|.++.++.+++.-+.++.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888899999999999999543 46789999998752 22334445677888777 56789999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+.||+|--+++. -+.+.+..+..+|.+||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999877743 344566778899999999999999999 9999999999999999999999999998532
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
-+ ...+...+|||.|+|||++.-.+|+..+|.|||||+||||+.|++||+....+ +++..
T Consensus 502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------------------elF~a 561 (683)
T KOG0696|consen 502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------------------ELFQA 561 (683)
T ss_pred cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------------------HHHHH
Confidence 21 23345679999999999999999999999999999999999999997643322 22222
Q ss_pred ccc--CCCCHHHHHHHHHHHHHccccCCCCCC
Q 003846 736 ILE--NEASYPMLARYVNVALLCVHENATDRP 765 (791)
Q Consensus 736 ~l~--~~~~~~~~~~l~~li~~cl~~dp~~RP 765 (791)
+.. -.++...+.+...+....|...|.+|.
T Consensus 562 I~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 562 IMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 222 224445677888999999999999995
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=285.93 Aligned_cols=262 Identities=21% Similarity=0.270 Sum_probs=181.2
Q ss_pred hccCCCccceecccCceeEEEeEe-----------------eCCcEEEEEEecccCcccHHH--------------HHHH
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-----------------LNGQEVAVKRLSKKSGQGLEE--------------LKNE 548 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E 548 (791)
..++|++.++||+|+||+||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999953 235689999986543322223 3347
Q ss_pred HHHHHhcCCCce-----eeeeeEEEc--------CCcceEEEeecCCCChhHHHhhhc---------------------c
Q 003846 549 TMLIAKLQHRNL-----VRLLGCCLD--------QDEKILIYEYLPNKSLDSFLFDRA---------------------K 594 (791)
Q Consensus 549 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 594 (791)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 677777753 356799999999999999986421 1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccC
Q 003846 595 KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674 (791)
Q Consensus 595 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~a 674 (791)
...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123456778899999999999999987 99999999999999999999999999976543221 11112244789999
Q ss_pred chhcccCC--------------------C--CcccceeehhHHHHHHHhCCC-CCCCCCCCccchh-----hhhhHHhhc
Q 003846 675 PEYALEGL--------------------F--SIKSDVFSFGVLLLEILSGKK-NTGFYHTGSLNLL-----GHAWDLWKD 726 (791)
Q Consensus 675 PE~~~~~~--------------------~--~~~~DvwslGvvl~elltg~~-p~~~~~~~~~~~~-----~~~~~~~~~ 726 (791)
||.+.... + ..+.||||+||++++|++|.. |+.....-..... ...|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99876432 1 134799999999999999875 5432111000000 001111111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 003846 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENA---TDRPTMSEVVSM 773 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp---~~RPt~~evl~~ 773 (791)
... + -...........+++.++|..+| .+|+|++|++++
T Consensus 459 ~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 100 0 00111234678899999999766 689999999976
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=294.55 Aligned_cols=259 Identities=20% Similarity=0.223 Sum_probs=167.5
Q ss_pred hccCCCccceecccCceeEEEeEee-C----CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeE------EE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-N----GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC------CL 568 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 568 (791)
..++|++.++||+|+||.||+|... + +..||||++...... +....| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999764 4 689999988643221 111111 1122222222222221 24
Q ss_pred cCCcceEEEeecCCCChhHHHhhhcc-----------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCC
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAK-----------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 631 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlk 631 (791)
.+...++||||+++++|.+++..... ........+..++.||++||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999999854211 011122345679999999999999988 9999999
Q ss_pred CCcEEEcC-CCCeEEeeeccccccCCCccccccccccccCcccCchhcccC----------------------CCCcccc
Q 003846 632 ASNILLDT-DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG----------------------LFSIKSD 688 (791)
Q Consensus 632 p~NILl~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 688 (791)
|+|||++. ++.+||+|||+++.+.... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5899999999998654322 1222345789999999976432 2345679
Q ss_pred eeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc-CCcc----ccccccccCC------CCHHHHHHHHHHHHHcc
Q 003846 689 VFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD-NRAL----DLMDPILENE------ASYPMLARYVNVALLCV 757 (791)
Q Consensus 689 vwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~l~~~------~~~~~~~~l~~li~~cl 757 (791)
||||||+||||+++..+.... .... ...... +... ....+..... ..........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~------~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN------LIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH------HHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999977653211 0000 000000 0000 0000000000 00001224558999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 003846 758 HENATDRPTMSEVVSM 773 (791)
Q Consensus 758 ~~dp~~RPt~~evl~~ 773 (791)
+.||++|||++|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.94 Aligned_cols=237 Identities=31% Similarity=0.383 Sum_probs=191.6
Q ss_pred CceeEEEeEee-CCcEEEEEEecccCccc-HHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCChhHHHhh
Q 003846 514 GFGPVYKGELL-NGQEVAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFD 591 (791)
Q Consensus 514 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 591 (791)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999775 48999999997665544 68899999999999999999999999999999999999999999999844
Q ss_pred hccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCc
Q 003846 592 RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671 (791)
Q Consensus 592 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 671 (791)
.. .+++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2788999999999999999999987 9999999999999999999999999998765432 2234467889
Q ss_pred ccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHH-HHHHHH
Q 003846 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYP-MLARYV 750 (791)
Q Consensus 672 y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~l~ 750 (791)
|++||.+.+..++.++|||+||+++++|++|..|+...... .. ......... ........ .+..+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~----~~~~~~~~~--------~~~~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LE----LFKKIGKPK--------PPFPPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH----HHHHHhccC--------CCCccccccCCHHHH
Confidence 99999999888999999999999999999999887542111 00 001111000 00000000 346789
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 003846 751 NVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 751 ~li~~cl~~dp~~RPt~~evl~ 772 (791)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=273.63 Aligned_cols=205 Identities=26% Similarity=0.393 Sum_probs=172.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..-|..++-||-|+||.|.++... +...+|+|.+++.+ ......++.|-.||..-..+-||+|+..|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 345778899999999999999554 45678999998764 33455678899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc--
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF-- 654 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~-- 654 (791)
|||++||++-.+|. +.+.++++.++.++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-+
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999984 3455667777889999999999999988 999999999999999999999999997533
Q ss_pred -------CCCccc--c-----------------------------ccccccccCcccCchhcccCCCCcccceeehhHHH
Q 003846 655 -------GGDELQ--A-----------------------------NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLL 696 (791)
Q Consensus 655 -------~~~~~~--~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl 696 (791)
+..+-. . .....+||+.|+|||++....|+..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 111000 0 00124799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCC
Q 003846 697 LEILSGKKNTGFYHT 711 (791)
Q Consensus 697 ~elltg~~p~~~~~~ 711 (791)
|||+.|+.||.....
T Consensus 862 ~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHhhCCCCccCCCC
Confidence 999999999865443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=286.41 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=188.0
Q ss_pred CCccceecccCcee-EEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeecC
Q 003846 504 FSAENKLGEGGFGP-VYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 504 y~~~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
|.-.+.+|.|..|+ ||+|.. +|+.||||++-.. ......+|+..|+.- +|||||++++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456789998887 699977 7899999998543 234667999999888 69999999999999999999999995
Q ss_pred CCChhHHHhhhccc-cccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---C--CCeEEeeeccccccC
Q 003846 582 NKSLDSFLFDRAKK-RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---D--MKPKISDFGMARMFG 655 (791)
Q Consensus 582 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~--~~~kl~DFgla~~~~ 655 (791)
. +|.+++...... ........+.+..|+++||++||+.+ |+||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4 999998553111 11111345778999999999999987 999999999999975 3 468999999999887
Q ss_pred CCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhC-CCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 656 GDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG-KKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 656 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.+... .......||.+|+|||++....-+.++||+|+|||+|+.++| .+||+..-..+.++... ......+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-------NYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-------ccceeee
Confidence 65332 224456899999999999999888999999999999999997 88987543322222111 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+. .+. ...+||.+|+++||..||++.+|+.+
T Consensus 736 ~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 EPL------PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ccC------chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111 011 67799999999999999999999643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=252.54 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=198.9
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 574 (791)
..++|++.+.||+|+|..|..++++ +.+.+|+|++++. ..+..+-.+.|-.+...- +||.+|.+..+++.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3478899999999999999999765 5788999999764 344455567777777665 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
.|.||++||+|--++ .+.+.++++.++.+..+|.-||.|||+++ ||.||||.+|+|+|.+|++||+|+|+.+.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999996554 55677999999999999999999999999 999999999999999999999999999863
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc--cchhhhhhHHhhcCCcccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS--LNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 732 (791)
-.. ...++..+|||.|+|||++.+..|...+|.|+|||+++||+.|+.||+....+. .+...+.+...-+.
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek----- 474 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK----- 474 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-----
Confidence 222 234556899999999999999999999999999999999999999998755332 22222222211111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRP 765 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 765 (791)
.+ ..+...+-....+++.-|..||.+|.
T Consensus 475 ---qi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 ---QI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---cc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11 12223344566888899999999995
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-31 Score=274.39 Aligned_cols=251 Identities=24% Similarity=0.284 Sum_probs=203.2
Q ss_pred ccCCCccceecccCceeEEEeEeeCCc-EEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQ-EVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..++..+.-||-|+||.|-++...+.. .+|+|++++. +....+.+..|-.+|...+.|.||+++.-|.+....|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345666778999999999999775443 3889988764 344567788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
||-|-||.|...|.+ ++.++..++..++..+++|++|||.++ ||.|||||+|+||+.+|-+||.|||+|+.+..
T Consensus 499 mEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999843 455778888899999999999999998 99999999999999999999999999998865
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
... +-..+|||.|.|||++.+...+.++|.||||+++|||++|.+||........ +. .++..+
T Consensus 573 g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt----Yn----------~ILkGi 635 (732)
T KOG0614|consen 573 GRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT----YN----------LILKGI 635 (732)
T ss_pred CCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH----HH----------HHHhhh
Confidence 432 3346999999999999999999999999999999999999999764432210 00 000111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHh
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSML 774 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~L 774 (791)
-.-..+........+++++....+|.+|.- +.++.++-
T Consensus 636 d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 636 DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 111233345567789999999999999985 66776654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=233.09 Aligned_cols=109 Identities=52% Similarity=0.760 Sum_probs=83.3
Q ss_pred CCcEEEEecCCCCCCCC--CCeEEEecCCCEEEecCccceEEee-eccCc--ceeEEEEccCCCeEEecCCCceeeeecC
Q 003846 74 ERTVVWVANRDQPLTSS--SPVLTISSEGNLVIEDGRITYRVSE-NVSSS--QNTTATLLDSGNFVLRNEKLGLLWQSFD 148 (791)
Q Consensus 74 ~~~~vW~an~~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~w~~-~~~~~--~~~~~~l~d~GNlvl~~~~~~~~WqsFd 148 (791)
++||||+|||++|+... ..+|.|+.||||+|+|+.+..+|++ ++.+. .+..|+|+|+|||||+|..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 36999999999999553 4789999999999999998899999 66654 4899999999999999999999999999
Q ss_pred CCCCcccCCCeecceeccCceeEEEEcCCCCCCC
Q 003846 149 YPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPS 182 (791)
Q Consensus 149 ~PtDtllpg~~lg~~~~tg~~~~L~Sw~s~~dps 182 (791)
|||||+||+|+|+.+..+|.+..++||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999988888777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=239.77 Aligned_cols=259 Identities=21% Similarity=0.332 Sum_probs=195.6
Q ss_pred hccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCC--cceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQD--EKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~l 575 (791)
..++|++.+++|+|-|+.||.|. ..+.++++||+++... .+.+.+|+.||..++ ||||++++++..+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35789999999999999999995 4578899999997543 467899999999997 999999999998764 4579
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeeecccccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARMF 654 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgla~~~ 654 (791)
|+||+.+.+...+. +.+...++..++.++++||.|+|+.| |+|||+||.|+++|.. ..++|+|+|+|...
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876664 44667788999999999999999999 9999999999999865 56999999999765
Q ss_pred CCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh---------
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW--------- 724 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 724 (791)
..... .+-.+.+..|--||.+..- .|+..-|+|||||+|..|+..+.||-..+....+++.-+.-+-
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 43321 1223556678899998764 5899999999999999999999997544443333332211110
Q ss_pred ---h--cCCccc--------cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 725 ---K--DNRALD--------LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 725 ---~--~~~~~~--------~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. +..... .....+..+-..-..++..+++.+.|.+|-.+|||++|...+
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 000111 111111111111134788999999999999999999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=230.31 Aligned_cols=208 Identities=26% Similarity=0.370 Sum_probs=169.5
Q ss_pred hhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcc
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 573 (791)
+....+.......||+|++|.|-+.++ .+|+..|||++... +.+..+++.+|+.+..+- .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344455666678999999999998865 57999999999754 344566777888876554 699999999999999999
Q ss_pred eEEEeecCCCChhHHHhh-hccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 574 ILIYEYLPNKSLDSFLFD-RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.+.||.| ..||+.+-.+ ..++..+++...-+|+..+.+||.|||++- .+||||+||+|||++.+|++|+||||.+-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999998 4588877543 345667888888899999999999999864 69999999999999999999999999998
Q ss_pred ccCCCccccccccccccCcccCchhccc----CCCCcccceeehhHHHHHHHhCCCCCCCCC
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALE----GLFSIKSDVFSFGVLLLEILSGKKNTGFYH 710 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvvl~elltg~~p~~~~~ 710 (791)
.+.+..... -..|-..|||||.+.. ..|+.++||||||+.+.||.+++.|++...
T Consensus 198 ~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 765543222 1246678999998863 368999999999999999999999976443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=244.71 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=191.3
Q ss_pred CCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----cceE
Q 003846 504 FSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD-----EKIL 575 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 575 (791)
.+..+.||.|+||.||.++. .+|+.||+|++...- -...+.+.+|+++|...+|.|++..+++..-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999855 579999999986432 224577889999999999999999998876442 4577
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
+.|.| ..+|.+++ .....++...+.-+++||++||+|||+.+ |.||||||.|+|++.+..+||+|||+++.-.
T Consensus 135 ~TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88887 45787776 34456888888899999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC------
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR------ 728 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 728 (791)
.++. ..++..+-|..|+|||++.+. .|+.+.||||+|||+.||+.++.-|+....- ...+...++.....
T Consensus 208 ~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 208 QRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred hhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHH
Confidence 4433 233345678999999999876 6999999999999999999888765543221 11111111111000
Q ss_pred -----cccccccccc-C--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 729 -----ALDLMDPILE-N--------EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 729 -----~~~~~~~~l~-~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
...+++...+ . ..+.....+..++...++..||.+|.+..+.+.++.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0001110000 0 001112345667888999999999999999887763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=235.34 Aligned_cols=211 Identities=38% Similarity=0.620 Sum_probs=183.7
Q ss_pred ecccCceeEEEeEeeC-CcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCChhH
Q 003846 510 LGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDS 587 (791)
Q Consensus 510 LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 587 (791)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999997754 899999999765432 35778999999999999999999999999999999999999999999
Q ss_pred HHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeEEeeeccccccCCCccccccccc
Q 003846 588 FLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGGDELQANTNRI 666 (791)
Q Consensus 588 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~~~~~~~~~~~ 666 (791)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 984321 45788999999999999999999998 999999999999999 89999999999986644321 12234
Q ss_pred cccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHH
Q 003846 667 VGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745 (791)
Q Consensus 667 ~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 745 (791)
.+...|++||..... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999999887 889999999999999999
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 746 LARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 746 ~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
..+.+++..|++.+|.+||++.++++.+
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4678999999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=248.73 Aligned_cols=133 Identities=27% Similarity=0.354 Sum_probs=111.1
Q ss_pred ccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-----C---CceeeeeeEEEc--
Q 003846 501 TNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-----H---RNLVRLLGCCLD-- 569 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~-- 569 (791)
..+|.+.++||-|.|++||++. ..+.+.||+|+.+... ...+....||++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4789999999999999999994 4567899999986443 34566789999999984 3 369999999974
Q ss_pred --CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc
Q 003846 570 --QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 638 (791)
Q Consensus 570 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~ 638 (791)
+.+.+||+|++ |.+|..+|.. ..-+.++...+.+|++||+.||.|||.++ +|||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 56889999999 5577777754 34456889999999999999999999976 799999999999993
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=254.94 Aligned_cols=195 Identities=27% Similarity=0.391 Sum_probs=165.6
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--------cccHHHHHHHHHHHHhcC---CCceeeeeeEEEc
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--------GQGLEELKNETMLIAKLQ---HRNLVRLLGCCLD 569 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 569 (791)
.+|+..+.+|+|+||.|+++..+ +...|+||.+.+.. ....-.+-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45889999999999999999654 46679999887642 112233457999999997 9999999999999
Q ss_pred CCcceEEEeecC-CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 570 QDEKILIYEYLP-NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 570 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
++..+|++|-.. +-+|.+++. .++.+++.++..|++||+.|+++||+++ |+|||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999765 447888873 3456889999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCC
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNT 706 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~ 706 (791)
|.|....+.. ....+||..|.|||++.+..| ....|||++|++||.++....|+
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9998765443 234689999999999999987 57799999999999999888773
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=251.17 Aligned_cols=267 Identities=21% Similarity=0.258 Sum_probs=202.7
Q ss_pred hhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcC------CCceeeeeeEEEcC
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ------HRNLVRLLGCCLDQ 570 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~ 570 (791)
.....+|.+....|+|-|++|.+|.. ..|+.||||++.... ...+.=..|+++|++|+ --|+++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 34557899999999999999999954 458899999996542 23344568999999996 24889999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeeec
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFG 649 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFg 649 (791)
.++|||+|-+ .-+|.++|.....+-.|....+..++.|+.-||..|...+ |+|.||||+|||+.+. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999987 4589999988888888889999999999999999999988 9999999999999875 458999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc-cchh-----------
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS-LNLL----------- 717 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~-~~~~----------- 717 (791)
.|......+. +....+..|.|||++.+-+|+...|+||+||.||||.||+.-|....+.. ..+.
T Consensus 583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9987654432 22345678999999999999999999999999999999997665433211 0000
Q ss_pred ---hhhhHHhhcC----------C--------ccccccc------cc-----cCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003846 718 ---GHAWDLWKDN----------R--------ALDLMDP------IL-----ENEASYPMLARYVNVALLCVHENATDRP 765 (791)
Q Consensus 718 ---~~~~~~~~~~----------~--------~~~~~~~------~l-----~~~~~~~~~~~l~~li~~cl~~dp~~RP 765 (791)
++....+-+. . ....+.| .+ .....+.....+.+|+..|+..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 0000000000 0 0000111 01 0112234567899999999999999999
Q ss_pred CHHHHHHH
Q 003846 766 TMSEVVSM 773 (791)
Q Consensus 766 t~~evl~~ 773 (791)
|..|.|++
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99999865
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=234.86 Aligned_cols=261 Identities=23% Similarity=0.279 Sum_probs=193.8
Q ss_pred ccCCCccceecccCceeEEEe-EeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC------C
Q 003846 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------D 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 571 (791)
..+|.-.+.+|.|.- .|-.+ +.-.++.||+|++... .....++..+|..++..++|+|+++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 467777889999998 55555 4456899999988654 345677888999999999999999999999644 3
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
+.++|||||. .+|...+. ..++-+++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 5689999995 48887774 34667788899999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCC-------------CCccchhh
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYH-------------TGSLNLLG 718 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~-------------~~~~~~~~ 718 (791)
+..+.. -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.... ..+.....
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 864322 34456788999999999999889999999999999999999986554211 00000000
Q ss_pred ----hhhHHhhcCCc--cccccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 719 ----HAWDLWKDNRA--LDLMDPILEN-------EASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 719 ----~~~~~~~~~~~--~~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.+......... .-.+...+.+ +.+......+++++.+||-.+|++|.++++++++=
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 01111110000 0000111111 11112345678999999999999999999999874
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=207.40 Aligned_cols=114 Identities=51% Similarity=0.749 Sum_probs=103.8
Q ss_pred CcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecCccceEEe
Q 003846 35 QVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVS 114 (791)
Q Consensus 35 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 114 (791)
++|.+|++|+|+++.|++|||.+......|.+|||.+.+ +++||.||++.| ....+.|.|+.||+|+|+|.++.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~ 79 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWS 79 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEE
Confidence 578899999999999999999987654599999999877 899999999998 455678999999999999999999999
Q ss_pred eeccC-cceeEEEEccCCCeEEecCCCceeeeecCCC
Q 003846 115 ENVSS-SQNTTATLLDSGNFVLRNEKLGLLWQSFDYP 150 (791)
Q Consensus 115 ~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~WqsFd~P 150 (791)
|++.+ ....+|+|+|||||||++.++.+||||||||
T Consensus 80 S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 80 SNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 99986 5677899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=237.70 Aligned_cols=266 Identities=24% Similarity=0.390 Sum_probs=199.1
Q ss_pred hhhhccCCCccceecccCceeEEEeEee----CCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCC
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQD 571 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 571 (791)
+....+.|..+++||+|.|++||++.+. ..+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999654 36789999987654 3467899999999995 999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeEEeeecc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGM 650 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgl 650 (791)
...+|+||+++....+++. .++...+..+++.+++||+++|.+| ||||||||.|+|.+. -+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999988873 3567888999999999999999999 999999999999975 56789999999
Q ss_pred ccccCCC-------c------cc-----------------------------cccccccccCcccCchhcccC-CCCccc
Q 003846 651 ARMFGGD-------E------LQ-----------------------------ANTNRIVGTYGYMSPEYALEG-LFSIKS 687 (791)
Q Consensus 651 a~~~~~~-------~------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 687 (791)
|...... . .. .......||++|+|||++... ..++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 9721100 0 00 000124699999999998764 578999
Q ss_pred ceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH-----------------HhhcCC---cccc------c--ccccc-
Q 003846 688 DVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD-----------------LWKDNR---ALDL------M--DPILE- 738 (791)
Q Consensus 688 DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~---~~~~------~--~~~l~- 738 (791)
||||.|||++.+++++.||-...++...+.+.+.. .+.... ..++ + .....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999986555443332221100 011000 0000 0 00000
Q ss_pred -------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 -------NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......+..+.+++.+|+..||.+|.|++|.+++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00111234578899999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=227.44 Aligned_cols=198 Identities=36% Similarity=0.503 Sum_probs=171.1
Q ss_pred CCccceecccCceeEEEeEeeC-CcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 504 FSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
|++.+.||+|++|.||++.... ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999997765 889999999866544 67889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+++|.+++..... .+++..+..++.++++++.+||+++ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999999854221 1788889999999999999999987 99999999999999999999999999987654321 1
Q ss_pred ccccccccCcccCchhc-ccCCCCcccceeehhHHHHHHHhCCCCCC
Q 003846 662 NTNRIVGTYGYMSPEYA-LEGLFSIKSDVFSFGVLLLEILSGKKNTG 707 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvvl~elltg~~p~~ 707 (791)
......++..|++||.+ ....++.++|+|+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22334677899999998 66778889999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-27 Score=254.99 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=202.7
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
..++|....++|.|.||.|||++. .+++..|||+++........-++.|+-+++..+|||||.++|.+...+...+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 346889999999999999999965 5689999999998877788888999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+.+|+|.+.- .-...+++.++..+.++.++||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..+....
T Consensus 93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999998875 34566788888899999999999999998 8999999999999999999999999997665332
Q ss_pred cccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.......||+.|||||+.. .+.|..++|||++|+...|+---++|.-..+..... ..... ..+++
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTk---S~~qp 234 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTK---SGFQP 234 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhc---cCCCC
Confidence 1223468999999999875 567999999999999999997777663222211100 00000 01111
Q ss_pred -cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 736 -ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 736 -~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
.++ ......+.+.++++.++..+|++|||++.+++
T Consensus 235 p~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 12234567889999999999999999987665
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=200.52 Aligned_cols=105 Identities=42% Similarity=0.979 Sum_probs=99.5
Q ss_pred eccCcCCCeeeeccccccceeeeEEEEeecCCeeEEEEEccC-ceEEEEEEeeCCcEEEEEEeCCcCcEEEEEecCCcCC
Q 003846 208 WTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKD-SIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSC 286 (791)
Q Consensus 208 w~~g~w~g~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~r~~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 286 (791)
||+|+|||..|+++|+|..+..+.+.|+.+++|.+++|.+.+ +.++|++||.+|++++|.|++..++|.+.|++|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 899999999999999999989999999999999999999966 8899999999999999999999999999999999999
Q ss_pred C---cCCCCccccCCCC-CcccCCCcccCC
Q 003846 287 V---ACGPFSICNTATG-SCQCLQGFFIGS 312 (791)
Q Consensus 287 ~---~CG~~g~C~~~~~-~C~C~~Gf~~~~ 312 (791)
| .||+||+|+.++. .|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9 7999999987654 899999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=217.61 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=185.5
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeE-EEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGC-CLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~ 577 (791)
.+.|.+.+.||+|.||.+-+++++ +.+.+++|.+.... ....+|.+|...--.| .|.||+.-++. |+..+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467999999999999999999765 47789999886543 3467889998776666 48999987765 55666778899
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE-c-CCCCeEEeeeccccccC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-D-TDMKPKISDFGMARMFG 655 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl-~-~~~~~kl~DFgla~~~~ 655 (791)
||+|.|+|.+-+ ....+-+....+++.|++.|+.|+|+++ ++|||||.+|||+ + +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998766 2344666777899999999999999998 9999999999999 3 34479999999998654
Q ss_pred CCccccccccccccCcccCchhccc---C--CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALE---G--LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
... ....-+..|.+||.... + ...+.+|||.||++++.++||+.|++.....+..+. .|..|......
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~--~~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW--EWEQWLKRKNP 247 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH--HHHHHhcccCc
Confidence 321 12234568999997753 2 357889999999999999999999985444443333 33333332222
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVV 771 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 771 (791)
. +.. ...+.++.+.++.++-+..+|++|=...++.
T Consensus 248 ~-----~P~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 248 A-----LPK-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred c-----Cch-hhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 1 111 1123457788999999999999994444433
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=196.19 Aligned_cols=112 Identities=46% Similarity=0.713 Sum_probs=101.7
Q ss_pred CcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecCccceEEe
Q 003846 35 QVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVS 114 (791)
Q Consensus 35 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 114 (791)
+.|..|++|+|+++.|++|||..... ..+.+|||...+ +++||+||++.|+... +.|.|+.||+|+|+|.++.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEE
Confidence 56888999999999999999998654 799999999887 8999999999998654 78999999999999999999999
Q ss_pred eecc-CcceeEEEEccCCCeEEecCCCceeeeecCC
Q 003846 115 ENVS-SSQNTTATLLDSGNFVLRNEKLGLLWQSFDY 149 (791)
Q Consensus 115 ~~~~-~~~~~~~~l~d~GNlvl~~~~~~~~WqsFd~ 149 (791)
|++. +.+..+|+|+|||||||++..+.++||||||
T Consensus 79 S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 9997 4567789999999999999999999999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=267.19 Aligned_cols=197 Identities=20% Similarity=0.229 Sum_probs=137.5
Q ss_pred hcCC-CceeeeeeEE-------EcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 003846 554 KLQH-RNLVRLLGCC-------LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625 (791)
Q Consensus 554 ~l~H-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 625 (791)
.++| +||+++++++ .+.+..+.++||+ +++|.++|.. ....+++..++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5777788877 2334567888987 5699999843 2455889999999999999999999988 9
Q ss_pred eecCCCCCcEEEcCC-------------------CCeEEeeeccccccCCCcc--------------ccccccccccCcc
Q 003846 626 IHRDLKASNILLDTD-------------------MKPKISDFGMARMFGGDEL--------------QANTNRIVGTYGY 672 (791)
Q Consensus 626 iH~Dlkp~NILl~~~-------------------~~~kl~DFgla~~~~~~~~--------------~~~~~~~~gt~~y 672 (791)
+||||||+||||+.. +.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4455666666553211000 0001123578899
Q ss_pred cCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHH
Q 003846 673 MSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNV 752 (791)
Q Consensus 673 ~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 752 (791)
||||++.+..++.++|||||||+||||++|..|+..... ... ..... ...+ ..........++
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~----~~~~~----~~~~-----~~~~~~~~~~~~ 244 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMS----SLRHR----VLPP-----QILLNWPKEASF 244 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHH----HHHHh----hcCh-----hhhhcCHHHHHH
Confidence 999999999999999999999999999998877431110 000 00000 0000 001122345688
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 003846 753 ALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 753 i~~cl~~dp~~RPt~~evl~~ 773 (791)
+.+||+.+|.+||+|.|++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 899999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=205.29 Aligned_cols=166 Identities=22% Similarity=0.168 Sum_probs=124.0
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|+|.+++.. .+..+++..++.++.||++||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 689998843 2456899999999999999999999875 999999999999999 99987654321
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 742 (791)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+.........+. ......... .+. .....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~----~~~~~~~~~---~~~-~~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE----ILLNGMPAD---DPR-DRSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH----HHHHHhccC---Ccc-ccccH
Confidence 2578999999999999999999999999999999999999753321111111 000000000 000 00111
Q ss_pred HHHHH--HHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 743 YPMLA--RYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 743 ~~~~~--~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
..... .+.+++.+||+.+|.+||++.|+++++..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 22223 68999999999999999999999998865
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=220.32 Aligned_cols=167 Identities=19% Similarity=0.192 Sum_probs=130.1
Q ss_pred hhhccCCCccceecccCceeEEEeEee--CCcEEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGELL--NGQEVAVKRLSKK-----SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ 570 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 570 (791)
....++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999664 5778899987533 12235668999999999999999853322 2
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCC-CCCcEEEcCCCCeEEeeec
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDTDMKPKISDFG 649 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DFg 649 (791)
+..++||||+++++|.... .. ....++.++++||.|||+++ |+|||| ||+|||++.++++||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~------~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PH------GDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----cc------chHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 11 11467889999999999988 999999 9999999999999999999
Q ss_pred cccccCCCccccc------cccccccCcccCchhccc
Q 003846 650 MARMFGGDELQAN------TNRIVGTYGYMSPEYALE 680 (791)
Q Consensus 650 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 680 (791)
+++.+........ .....+++.|+|||.+..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9997754321111 124578889999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=213.83 Aligned_cols=258 Identities=24% Similarity=0.288 Sum_probs=193.0
Q ss_pred CCCccceecccCceeEEEeEeeCC--cEEEEEEecccCcccHHHHHHHHHHHHhcCC----CceeeeeeEE-EcCCcceE
Q 003846 503 NFSAENKLGEGGFGPVYKGELLNG--QEVAVKRLSKKSGQGLEELKNETMLIAKLQH----RNLVRLLGCC-LDQDEKIL 575 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 575 (791)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+++ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999976553 5789998876544333378889999999873 5889999998 47778899
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-----CCeEEeeecc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-----MKPKISDFGM 650 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DFgl 650 (791)
||+.+ |.+|.++..... .+.++..+++.|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 779999864433 678999999999999999999999998 9999999999999765 4699999999
Q ss_pred cc--ccCCCcc----ccc--cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 651 AR--MFGGDEL----QAN--TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 651 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
++ .+..... ... .....||..|++++.+.+...+.+.|+||++.++.|++.|..|+........ ...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~--- 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSK--- 248 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHH---
Confidence 98 3322211 111 2235699999999999999999999999999999999999999754332211 000
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
............ .....+..+.++...+-..+..++|....+...|.+
T Consensus 249 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 249 -FEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred -HHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 000000001111 111123445556666666899999999999888755
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=198.69 Aligned_cols=260 Identities=20% Similarity=0.295 Sum_probs=197.8
Q ss_pred hhccCCCccceecccCceeEEEe-EeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 576 (791)
..+-.|++.++||+|.||..+.| .+.+++.||||.-...++ ..+++.|.+..+.|. .++|...+.+..++.+..||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 34678999999999999999999 567899999998766544 467889999999884 78999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-----CCeEEeeeccc
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-----MKPKISDFGMA 651 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DFgla 651 (791)
+|++ |.+|+++. .--++.++.++++.+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|
T Consensus 103 idLL-GPSLEDLF--D~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLF--DLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHH--HHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9998 77999886 345677899999999999999999999998 9999999999999754 45899999999
Q ss_pred cccCCCcccc-----ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc
Q 003846 652 RMFGGDELQA-----NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 652 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
+.+.+..... ......||..||+-....+..-+.+.|+=|||-++.+.|-|..||+....+.. ..-++...+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn---K~kYeKIGe 253 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN---KEKYEKIGE 253 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch---HHHHHHhcc
Confidence 9876554322 23346799999999999999999999999999999999999999876543321 111111222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.....-++....+ .+.++...++..-..+-.+-|+.+=+...+
T Consensus 254 ~Kr~T~i~~Lc~g-----~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 254 TKRSTPIEVLCEG-----FPEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred ccccCCHHHHHhc-----CHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 2111111111111 233444555555556667778776544443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-22 Score=192.42 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=192.1
Q ss_pred hccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCC-CceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH-RNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 577 (791)
..++|.++++||.|+||.+|.|. ..+|++||||.-+..... .++..|.++...++| ..|..+..+..+.+...+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 45789999999999999999994 567999999997665443 567889999999975 68888889999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgla~~~ 654 (791)
|.+ |.+|++++. --.+.++.++++-++-|++.-++|+|.++ +|||||||+|+|..- ..++.|+|||+|+.+
T Consensus 91 dLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 789999873 33456788999999999999999999998 999999999999963 456899999999987
Q ss_pred CCCccc-----cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 655 GGDELQ-----ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 655 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
.+.... .......||..|.+-....+...+.+.|+=|+|.+|..+..|..||+....... .+-++...+...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYEKISEKKM 241 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHHHHHHhhc
Confidence 543221 223456899999998888888889999999999999999999999876433211 011111122222
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+.....+ .+.++.-.+..|-..--++-|+..-+.+.
T Consensus 242 s~~ie~LC~G-----~P~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 242 STPIEVLCKG-----FPAEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred CCCHHHHhCC-----CcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 1111111111 22445555666666666666765544433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-20 Score=198.95 Aligned_cols=262 Identities=29% Similarity=0.390 Sum_probs=197.2
Q ss_pred CCccceecccCceeEEEeEeeCCcEEEEEEecccCcc---cHHHHHHHHHHHHhcCCC-ceeeeeeEEEcCCcceEEEee
Q 003846 504 FSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ---GLEELKNETMLIAKLQHR-NLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey 579 (791)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999765 88999998765433 367899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~~~ 658 (791)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966632211136788889999999999999999998 99999999999999998 79999999998655443
Q ss_pred ccc----ccccccccCcccCchhccc---CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 659 LQA----NTNRIVGTYGYMSPEYALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 659 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
... ......++..|+|||.+.+ ..+....|+|++|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc-
Confidence 221 2355689999999999987 57899999999999999999999995443321 0001111111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.................+.+++..++..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002233577899999999999999999987664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-22 Score=195.16 Aligned_cols=248 Identities=20% Similarity=0.322 Sum_probs=191.8
Q ss_pred CCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 504 FSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
..+..+|.+...|..|+|++ .|..+++|++.... .....+|..|.-.|+...||||+.+++.|....+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 44556899999999999998 56778888876432 3344678889999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe--eeccccccCCCcc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS--DFGMARMFGGDEL 659 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~--DFgla~~~~~~~~ 659 (791)
.|+|..+|++. ..-..+..++.+++.+||+|++|||+..+. |..--|....+++|++.+++|+ |-.++....
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfqe~---- 344 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQEV---- 344 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeeecc----
Confidence 99999999653 345577888999999999999999998732 4444699999999999988773 333332211
Q ss_pred ccccccccccCcccCchhcccCCC---CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLF---SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
...-.|.||+||.++..+- -.++|+|||+++||||.|...||......... .++.-+-
T Consensus 345 -----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------------mkialeg 405 (448)
T KOG0195|consen 345 -----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------------MKIALEG 405 (448)
T ss_pred -----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------hhhhhcc
Confidence 1234689999999986643 46799999999999999999998654432211 0111122
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
++...++..+..+.+++.-|+..||.+||.+..++-.|++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 33444555677889999999999999999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-22 Score=227.25 Aligned_cols=254 Identities=21% Similarity=0.241 Sum_probs=186.3
Q ss_pred ccceecccCceeEEEeEe-eCCcEEEEEEecc-----cCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 506 AENKLGEGGFGPVYKGEL-LNGQEVAVKRLSK-----KSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~-----~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
..+.+|.|++|.|+.... ...+..+.|.... .... ....+..|+-+-..++|+|++..+....+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998877743 3344444444321 1111 11225667777888899999988888877766666699
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++ +|..++.. ...+...++..++.|++.|++|+|+.+ |.|||||++|++++.+|.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99888732 246778889999999999999999999 9999999999999999999999999998764433
Q ss_pred cc--cccccccccCcccCchhcccCCCCc-ccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 659 LQ--ANTNRIVGTYGYMSPEYALEGLFSI-KSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 659 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.. ......+|...|+|||++.+..|.+ ..||||.|+++..|++|+.||......+...... ....+.-..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~~~~~~ 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSDQRNIF 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------ccccccccc
Confidence 22 3445578999999999999999865 5899999999999999999987655443322000 000000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.-.......++.+.+.++.+||+.||.+|.|++++++.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00111122355678899999999999999999999763
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.9e-21 Score=190.64 Aligned_cols=172 Identities=16% Similarity=0.163 Sum_probs=134.9
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHH---H------HHHHHHHHHhcCCCceeeeeeEEEc
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLE---E------LKNETMLIAKLQHRNLVRLLGCCLD 569 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~~~~~~ 569 (791)
...++|++.+.||.|+||.||+.+. ++..+|||.+......... . +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468999999999999999999866 5778999999754332222 2 6799999999999999999888664
Q ss_pred C--------CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 570 Q--------DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 570 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
. ...+|+|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999977631 111 34569999999999998 99999999999999998
Q ss_pred CeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHH
Q 003846 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEIL 700 (791)
Q Consensus 642 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ell 700 (791)
++|+|||.......+... ..++....+..++|+|+||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999998755322111 11344555778999999999987664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=220.88 Aligned_cols=251 Identities=18% Similarity=0.220 Sum_probs=183.4
Q ss_pred CCCccceecccCceeEEEeEeeCCcEEEEEEecccC-cccHHHHHHHHHH--HHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 503 NFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS-GQGLEELKNETML--IAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++...+.||.+.|=+|.+|+..+|. |+||++-+.. ......+.++++- ...++|||.+++.-.-..+.-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677789999999999999988887 9999987655 3344444443333 5556899999998887778888999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc--CCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGD 657 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~--~~~ 657 (791)
..+ +|.+.| ..++.+..-+...|+.|++.||..+|..+ |+|||||.+||||+.-+-+.|+||...+.. +.+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 866 777776 45566777788899999999999999998 999999999999999999999999987643 211
Q ss_pred c---cccccccccccCcccCchhcccC-----------CCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhH
Q 003846 658 E---LQANTNRIVGTYGYMSPEYALEG-----------LFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 658 ~---~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 722 (791)
. ..........-.+|+|||.+... ..+++.||||+||+++||++ |+++|.... ...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---------L~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---------LLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------HHh
Confidence 1 11111122334589999987531 26789999999999999998 466654211 111
Q ss_pred Hhhc--CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 723 LWKD--NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 723 ~~~~--~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
+-.. ....++++.+- ...++.++..|++.||++|.++++.++.-++..
T Consensus 247 Yr~~~~~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred HhccCccCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1111 11111111111 136889999999999999999999999876643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-20 Score=183.71 Aligned_cols=139 Identities=19% Similarity=0.166 Sum_probs=108.3
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcc--c-------HH-----------------HHHHHHHHHHhcCCCce
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ--G-------LE-----------------ELKNETMLIAKLQHRNL 560 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~H~ni 560 (791)
...||+|+||.||+|...+|+.||||+++..... . .. ....|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998778999999999654211 0 11 22359999999988776
Q ss_pred eeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHh-hccCCCCeeecCCCCCcEEEcC
Q 003846 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL-HQYSRLRIIHRDLKASNILLDT 639 (791)
Q Consensus 561 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~iiH~Dlkp~NILl~~ 639 (791)
.....+.. ...+|||||++++++...+. ....++.+.+..++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 23489999999987765432 234578888999999999999999 6777 99999999999998
Q ss_pred CCCeEEeeecccccc
Q 003846 640 DMKPKISDFGMARMF 654 (791)
Q Consensus 640 ~~~~kl~DFgla~~~ 654 (791)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=177.30 Aligned_cols=141 Identities=22% Similarity=0.224 Sum_probs=111.5
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCccc--------------------------HHHHHHHHHHHHhcCCCce
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQG--------------------------LEELKNETMLIAKLQHRNL 560 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 560 (791)
.+.||+|++|.||+|...+|+.||||+++...... ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987789999999987542110 1224579999999999987
Q ss_pred eeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcC
Q 003846 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDT 639 (791)
Q Consensus 561 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~ 639 (791)
.....+... ..+|||||++++++..... ....++......++.|++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444332 3489999999886544321 22346778889999999999999999 87 99999999999999
Q ss_pred CCCeEEeeeccccccCC
Q 003846 640 DMKPKISDFGMARMFGG 656 (791)
Q Consensus 640 ~~~~kl~DFgla~~~~~ 656 (791)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=194.51 Aligned_cols=219 Identities=24% Similarity=0.356 Sum_probs=164.7
Q ss_pred HHhcCCCceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCC
Q 003846 552 IAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 631 (791)
Q Consensus 552 l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlk 631 (791)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++++|++||+|||... . ..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 3568899999999999999999999999999999999954 4456888888999999999999999865 2 3999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccC-------CCCcccceeehhHHHHHHHhCCC
Q 003846 632 ASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-------LFSIKSDVFSFGVLLLEILSGKK 704 (791)
Q Consensus 632 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvvl~elltg~~ 704 (791)
+.|.++|....+||+|||+.................-...|.|||.+.+. ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998776432111222222345689999998764 14678999999999999999999
Q ss_pred CCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 705 NTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 705 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
||......... .+.+... .. .....+.|.+.... ...+.+..++.+||..+|.+||+++++-..++....
T Consensus 157 ~~~~~~~~~~~-~eii~~~-~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRV-KK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCCh-HHHHHHH-Hh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 98764433221 1111111 11 12222333332111 233478899999999999999999999998877543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=168.88 Aligned_cols=184 Identities=18% Similarity=0.160 Sum_probs=138.5
Q ss_pred CccceecccCceeEEEeEeeCCcEEEEEEecccCcc----cHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEee
Q 003846 505 SAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ----GLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++++ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999998865 7888888877554321 1225789999999995 5789999886 456999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCC-CCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
+.|.+|...+. . ....++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99999865431 0 12357889999999999998 999999 7999999999999999999998654322
Q ss_pred cc----c-------ccccccccCcccCchhcccC-CCC-cccceeehhHHHHHHHhCCCCC
Q 003846 659 LQ----A-------NTNRIVGTYGYMSPEYALEG-LFS-IKSDVFSFGVLLLEILSGKKNT 706 (791)
Q Consensus 659 ~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslGvvl~elltg~~p~ 706 (791)
.. . .......++.|++|+...-- ..+ ...+.++-|.-+|.++|+..+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 0 00112357788888755432 233 5678899999999999999873
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=179.45 Aligned_cols=233 Identities=20% Similarity=0.269 Sum_probs=150.1
Q ss_pred CCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCC----------CceeeeeeEEE
Q 003846 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQH----------RNLVRLLGCCL 568 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~~~~~ 568 (791)
.+...+.||.|+++.||.++.. +++++|||++.... ....+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3445678999999999999764 58999999875432 3356777777766665432 12222222221
Q ss_pred ---------cCC--------cceEEEeecCCCChhHHHh---hhccc-cccCHHHHHHHHHHHHHHHHHhhccCCCCeee
Q 003846 569 ---------DQD--------EKILIYEYLPNKSLDSFLF---DRAKK-RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627 (791)
Q Consensus 569 ---------~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH 627 (791)
... ..+++|+-+ .++|.+++. ..... ..+....++.+..|+++.+++||+++ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 235677777 568877753 22221 23334445677799999999999999 999
Q ss_pred cCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhccc--------CCCCcccceeehhHHHHHH
Q 003846 628 RDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE--------GLFSIKSDVFSFGVLLLEI 699 (791)
Q Consensus 628 ~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvvl~el 699 (791)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988765432211 234578999997753 2578999999999999999
Q ss_pred HhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 003846 700 LSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDR 764 (791)
Q Consensus 700 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 764 (791)
++++.|++.......... .-..+. ..++.++.||..+|+.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999875432211100 112233 677889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.6e-20 Score=198.73 Aligned_cols=222 Identities=27% Similarity=0.332 Sum_probs=177.7
Q ss_pred ecccCceeEEEeEe----eCCcEEEEEEecccCcc--cHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEeecCC
Q 003846 510 LGEGGFGPVYKGEL----LNGQEVAVKRLSKKSGQ--GLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 510 LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+|+|.||.|++++. ..|.-+|+|.+++.... .......|..++..++ ||.+|++...++.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998743 34677899988765321 1124456788888887 99999999999999999999999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
|.|...+ .+...........+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9997776 33344556667778889999999999988 999999999999999999999999999876433322
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc--CC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE--NE 740 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~ 740 (791)
+||..|||||++. ....++|.||||++++||++|..||.. +.+..++. -.
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------------~~~~~Il~~~~~ 205 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------------DTMKRILKAELE 205 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------------------HHHHHHhhhccC
Confidence 8999999999998 567899999999999999999999763 11222222 22
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTM 767 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~ 767 (791)
.+......+.+++..++..+|..|.-.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 344566778899999999999999755
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-18 Score=200.18 Aligned_cols=200 Identities=20% Similarity=0.231 Sum_probs=160.1
Q ss_pred hhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC---CCceeeeeeEEEcCCc
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ---HRNLVRLLGCCLDQDE 572 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~ 572 (791)
+.......|.+.+.||+|+||+||+|...+|+.||+|.-+....= +|.--.+++.+|+ -+.|..+..+..-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 344566789999999999999999998878999999997654321 1222223334443 3455566666677888
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-------CCCeEE
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-------DMKPKI 645 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-------~~~~kl 645 (791)
.+||+||.+.|+|.+++. ..+.+++..+..++.|+++.+++||..+ |||+||||+|+||.. ...++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999985 6677899999999999999999999998 999999999999942 345999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCC
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKK 704 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~ 704 (791)
+|||.+..+.--.-.......++|-.+-.+|...+.+++.++|.|.++.+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999876532222233445678899999999999999999999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=166.92 Aligned_cols=136 Identities=21% Similarity=0.281 Sum_probs=106.0
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhc-----CCCceeeeeeEEEcCC---c-ceEE
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-----QHRNLVRLLGCCLDQD---E-KILI 576 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~lV 576 (791)
-.+.||+|+||.||. .-.++.. +||++........+++.+|+.+++.+ .||||+++++++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357899999999996 3234444 79988765555567899999999999 5799999999998874 2 2378
Q ss_pred Eee--cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHH-HHhhccCCCCeeecCCCCCcEEEcC----CCCeEEeeec
Q 003846 577 YEY--LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGL-LYLHQYSRLRIIHRDLKASNILLDT----DMKPKISDFG 649 (791)
Q Consensus 577 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DFg 649 (791)
+|| +++++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 558999999943 124433 45678888887 8999998 999999999999974 3479999955
Q ss_pred ccc
Q 003846 650 MAR 652 (791)
Q Consensus 650 la~ 652 (791)
.+.
T Consensus 155 G~~ 157 (210)
T PRK10345 155 GES 157 (210)
T ss_pred CCc
Confidence 543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-17 Score=165.31 Aligned_cols=148 Identities=18% Similarity=0.144 Sum_probs=114.2
Q ss_pred hhhccCCCccceecccCceeEEEeE--eeCCcEEEEEEecccCcc------------------------cHHHHHHHHHH
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGE--LLNGQEVAVKRLSKKSGQ------------------------GLEELKNETML 551 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~ 551 (791)
...+.-|++.+.||+|++|.||+|. ..+|+.||||++...... ....+.+|+.+
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3444568899999999999999997 568999999998643210 01235689999
Q ss_pred HHhcCCC--ceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecC
Q 003846 552 IAKLQHR--NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRD 629 (791)
Q Consensus 552 l~~l~H~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~D 629 (791)
+.++.+. .+.++++. ...++||||+++.+|...+. ....+.......++.||+.++++||+++ +++|||
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 9999753 34455543 24589999999988876542 2233455567789999999999999876 499999
Q ss_pred CCCCcEEEcCCCCeEEeeeccccccC
Q 003846 630 LKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 630 lkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
|||+||+++ ++.++|+|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999997544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=162.13 Aligned_cols=134 Identities=22% Similarity=0.350 Sum_probs=113.7
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ--------GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
+.||+|++|.||+|.. .|..++||+....... ....+.+|++++..++|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999977 7888999986543211 124577899999999999988877777778888999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++|++|.+++.... + .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999884321 1 77899999999999999988 99999999999999 88999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=158.40 Aligned_cols=144 Identities=21% Similarity=0.209 Sum_probs=113.1
Q ss_pred hhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcc----------------------cHHHHHHHHHHHH
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ----------------------GLEELKNETMLIA 553 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 553 (791)
++......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444445558888999999999999998878999999987543210 1123567899999
Q ss_pred hcCCCc--eeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCC
Q 003846 554 KLQHRN--LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 631 (791)
Q Consensus 554 ~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlk 631 (791)
.+.|++ +++.++ ....++||||+++++|..+.. ......++.++++++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998774 444443 245689999999999976541 1345678899999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccC
Q 003846 632 ASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 632 p~NILl~~~~~~kl~DFgla~~~~ 655 (791)
|+||+++.++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1e-17 Score=179.69 Aligned_cols=175 Identities=27% Similarity=0.347 Sum_probs=131.7
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++.|+++...+|.++|.........++...+.++.|++.|+.| ++ .+|+|+||.||++..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999766666778888999999999999999 55 999999999999999999999999998
Q ss_pred cccCCCc----cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhc
Q 003846 652 RMFGGDE----LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 652 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
....... .........||..||+||++.+..|+.|+|||+||+||+||+. -..+++...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---------------- 467 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---------------- 467 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------------
Confidence 7665443 2234456789999999999999999999999999999999997 222211100
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003846 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev 770 (791)
...++-+..+....-. .-+.-..++.+++...|.+||++.++
T Consensus 468 -t~~d~r~g~ip~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 -TLTDIRDGIIPPEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -hhhhhhcCCCChHHhh-cCcHHHHHHHHhcCCCcccCchHHHH
Confidence 0001111111100000 11233589999999999999955544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=158.03 Aligned_cols=130 Identities=25% Similarity=0.410 Sum_probs=107.3
Q ss_pred eecccCceeEEEeEeeCCcEEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ--------GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.||+|+||.||+|.. +|..+++|+....... ..+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 6789999986543211 1356778999999999887666555666677789999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
+|++|.+++.... ..++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998873211 078999999999999988 99999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.8e-16 Score=179.41 Aligned_cols=137 Identities=23% Similarity=0.396 Sum_probs=112.4
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEeccc-C-------cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK-S-------GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~-~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
...|...++||+|+||+||+|... ++.+++|+.... . ....+.+.+|++++.+++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445567789999999999999764 444555543221 1 1123568899999999999999988888887788
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998873 35678999999999999988 9999999999999 67899999999997
Q ss_pred c
Q 003846 653 M 653 (791)
Q Consensus 653 ~ 653 (791)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3e-16 Score=161.30 Aligned_cols=196 Identities=21% Similarity=0.269 Sum_probs=133.7
Q ss_pred CCCceeeeeeEEEc---------------------------CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHH
Q 003846 556 QHRNLVRLLGCCLD---------------------------QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIE 608 (791)
Q Consensus 556 ~H~niv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 608 (791)
+|||||++.++|.+ +...|+||.-.+. +|.+++. ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh----cCCCchHHHHHHHH
Confidence 59999999987753 2345788876644 8888873 23455667788999
Q ss_pred HHHHHHHHhhccCCCCeeecCCCCCcEEEc--CCC--CeEEeeeccccccCCC----ccccccccccccCcccCchhccc
Q 003846 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLD--TDM--KPKISDFGMARMFGGD----ELQANTNRIVGTYGYMSPEYALE 680 (791)
Q Consensus 609 ~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DFgla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 680 (791)
|+++|+.|||.++ |.|||+|.+|||+. +|+ .+.|+|||.+---... .+....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999993 333 4789999986432211 11111223467788999999874
Q ss_pred CC------CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHH
Q 003846 681 GL------FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVAL 754 (791)
Q Consensus 681 ~~------~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~ 754 (791)
.+ --.|+|.|+.|.+.||+++...||=.....-.+.. ...+.--+.+.. ..+..+++++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r----------~Yqe~qLPalp~----~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR----------TYQESQLPALPS----RVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh----------hhhhhhCCCCcc----cCChHHHHHHH
Confidence 32 12689999999999999999988533111111110 011111122222 23456889999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 003846 755 LCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 755 ~cl~~dp~~RPt~~evl~~ 773 (791)
..|+.||++|++..-....
T Consensus 492 ~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHhcCCccccCCccHHHhH
Confidence 9999999999987654433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-16 Score=180.40 Aligned_cols=209 Identities=23% Similarity=0.319 Sum_probs=139.5
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..+|..++.|-.|+||.||..+++ ..+.+|+|+ .+.+-- +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee------------------
Confidence 467888999999999999999765 467788843 332110 011 22222344443
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC---
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG--- 656 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~--- 656 (791)
|+=..++ ..-+.++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++...-
T Consensus 136 ---gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2222333 111222222 278999999998 99999999999999999999999999865311
Q ss_pred -----Cc-----cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc
Q 003846 657 -----DE-----LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 657 -----~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
.. ..-.....+||+.|+|||++....|...+|.|++|+|+||.+-|+.||...-. ..+...+..
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp--eelfg~vis---- 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EELFGQVIS---- 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH--HHHHhhhhh----
Confidence 00 01112245899999999999999999999999999999999999998643211 111111100
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003846 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRP 765 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 765 (791)
|.+.-.+.......++++++.++|+.+|..|-
T Consensus 273 -------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 -------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -------hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 00001111233456788999999999999995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5e-15 Score=146.95 Aligned_cols=137 Identities=21% Similarity=0.263 Sum_probs=98.9
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcc--cHHH----------------------HHHHHHHHHhcCCCc--e
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ--GLEE----------------------LKNETMLIAKLQHRN--L 560 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 560 (791)
.+.||+|+||+||+|...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999998878999999988653211 1111 135666666664432 4
Q ss_pred eeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcC
Q 003846 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDT 639 (791)
Q Consensus 561 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~ 639 (791)
.+.+++ ...++||||++++.+......... . ......++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 346899999999554321111100 0 15678899999999999998 76 99999999999999
Q ss_pred CCCeEEeeeccccccC
Q 003846 640 DMKPKISDFGMARMFG 655 (791)
Q Consensus 640 ~~~~kl~DFgla~~~~ 655 (791)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 9999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=138.45 Aligned_cols=135 Identities=23% Similarity=0.245 Sum_probs=114.8
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCC--CceeeeeeEEEcCCcceEEEeecCCC
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH--RNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
+.+.||+|.++.||++... +..++||....... ...+.+|+.++..++| .++++++.+....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3578999999999999874 47899999865443 5678999999999976 58999999888888899999999988
Q ss_pred ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 584 SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 584 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
.+..+ +......++.+++++|++||.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 3456678899999999999986545699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-15 Score=120.48 Aligned_cols=59 Identities=49% Similarity=0.959 Sum_probs=52.0
Q ss_pred cccceEEeecccCCCCc-cc-ccCCChhHHHHHhhccCCccccccc---CCCceeeeccccccc
Q 003846 334 REDRFLRMHNVKLPSPD-KV-LKLPGIEECKSACLNNCACTAYAYN---SSGVCSSWDGKLYDL 392 (791)
Q Consensus 334 ~~~~f~~l~~~~~p~~~-~~-~~~~s~~~C~~~Cl~nCsC~a~~~~---~~g~C~~w~g~l~~~ 392 (791)
.+|+|++|++|++|+++ .. ..+.++++|++.|++||||+||+|. .+++|++|+|+|+|+
T Consensus 3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 37999999999999996 33 3668999999999999999999997 357999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-14 Score=145.67 Aligned_cols=134 Identities=24% Similarity=0.289 Sum_probs=104.7
Q ss_pred ceec-ccCceeEEEeEeeCCcEEEEEEecccC-------------cccHHHHHHHHHHHHhcCCCce--eeeeeEEEcCC
Q 003846 508 NKLG-EGGFGPVYKGELLNGQEVAVKRLSKKS-------------GQGLEELKNETMLIAKLQHRNL--VRLLGCCLDQD 571 (791)
Q Consensus 508 ~~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~ 571 (791)
..|| .|+.|+||+++. ++..++||++.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 899999999977 47889999885321 1223567889999999998875 67777654432
Q ss_pred c----ceEEEeecCC-CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 572 E----KILIYEYLPN-KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 572 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
. .++|+|++++ .+|.+++.. ..++.. .+.+|+++|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 689888732 223332 3678999999999998 9999999999999999999999
Q ss_pred eeccccc
Q 003846 647 DFGMARM 653 (791)
Q Consensus 647 DFgla~~ 653 (791)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.9e-16 Score=177.32 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=193.1
Q ss_pred cCCCccceecccCceeEEEeEee--CCcEEEEEEecccC--cccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL--NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 576 (791)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45677788999999999887553 34457777776543 333455566888888887 99999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhh-ccCCCCeeecCCCCCcEEEcCCC-CeEEeeecccccc
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH-QYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMF 654 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~ 654 (791)
.||..++++.+.+. .......+...+..++.|+..++.|+| +.+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999987763 112224566777889999999999999 777 99999999999999999 9999999999887
Q ss_pred CC-Cccccccccccc-cCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 655 GG-DELQANTNRIVG-TYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 655 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............+ .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~-----~~~~~-- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW-----KSNKG-- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee-----ccccc--
Confidence 66 444444455678 9999999999885 45788999999999999999999987655443222211 11110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
...............+++.+++..+|..|.+.+++..
T Consensus 249 ----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 ----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0001111123345678888999999999999888653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=146.53 Aligned_cols=141 Identities=23% Similarity=0.285 Sum_probs=100.7
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCcccH----------------------------------------HHHHH
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGL----------------------------------------EELKN 547 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~~ 547 (791)
+.||.|++|.||+|++.+|+.||||+.+....... -++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864321100 02445
Q ss_pred HHHHHHhcC----CCceeeeeeEEE-cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHH-HHHHhhccC
Q 003846 548 ETMLIAKLQ----HRNLVRLLGCCL-DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ-GLLYLHQYS 621 (791)
Q Consensus 548 E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-aL~~LH~~~ 621 (791)
|++.+.+++ |.+-+.+-.++. .....+|||||++|++|.++...... .. ....++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666552 332233322332 24567999999999999887632211 11 23456666666 467889887
Q ss_pred CCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 622 ~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
++|+|+||.||+++.+++++++|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.9e-13 Score=111.24 Aligned_cols=68 Identities=13% Similarity=0.298 Sum_probs=59.8
Q ss_pred cccceEEeecccCCCCcccccCCChhHHHHHhhc---cCCccccccc-CCCceeeecccc-ccccccccccCccEEEE
Q 003846 334 REDRFLRMHNVKLPSPDKVLKLPGIEECKSACLN---NCACTAYAYN-SSGVCSSWDGKL-YDLEQLSKNEGENIFIK 406 (791)
Q Consensus 334 ~~~~f~~l~~~~~p~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~-~~g~C~~w~g~l-~~~~~~~~~~~~~~~vr 406 (791)
++..|+++.+|++|++.. .+++||+++|++ ||||+||+|. .+++|.+|++++ .++++... .+.++|+|
T Consensus 7 ~~g~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~-~g~~Ly~r 79 (80)
T cd00129 7 SAGTTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFS-HGFDLYEN 79 (80)
T ss_pred cCCeEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccC-CCceeEeE
Confidence 367899999999999854 689999999999 9999999997 556999999999 99888765 58899987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.4e-13 Score=136.17 Aligned_cols=207 Identities=22% Similarity=0.272 Sum_probs=141.8
Q ss_pred HHHHHhcCCCceeeeeeEEEcC-----CcceEEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCC
Q 003846 549 TMLIAKLQHRNLVRLLGCCLDQ-----DEKILIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSR 622 (791)
Q Consensus 549 ~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ 622 (791)
..-|-.+-|.|||+++.|..+. .....+.|||.-|+|..+|.+.. ....++.+...+|+-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3345556799999999987653 34578999999999999997643 4556777888899999999999999975
Q ss_pred CCeeecCCCCCcEEEcCCCCeEEeeeccccccC--CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHH
Q 003846 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFG--GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEIL 700 (791)
Q Consensus 623 ~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ell 700 (791)
++|+|+++.-+-|++..+|-+|+.--.-..... ............+-++|.|||.=.....+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 679999999999999999999984211110000 001111122235678999999877778888999999999999998
Q ss_pred hCCCC-CCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 701 SGKKN-TGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 701 tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
-+..- ...... ... +......+- .+.. ..-+.++..|++.+|..||+|.+++.+.-
T Consensus 277 ilEiq~tnseS~--~~~---------ee~ia~~i~-~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 277 ILEIQSTNSESK--VEV---------EENIANVII-GLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HheeccCCCcce--eeh---------hhhhhhhee-eccC-------ccccCcCcccccCCCCCCcchhhhhcCce
Confidence 87643 111100 000 000000000 0000 11236788899999999999999887653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=142.25 Aligned_cols=249 Identities=23% Similarity=0.282 Sum_probs=181.2
Q ss_pred cCCCccceecc--cCceeEEEeEe---eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcc
Q 003846 502 NNFSAENKLGE--GGFGPVYKGEL---LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 502 ~~y~~~~~LG~--G~fg~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 573 (791)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+..-.++ .|+|.++........+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999966 45888999984432 223333335666666666 499999988888889999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHH----HHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeee
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDF 648 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DF 648 (791)
++-.|++. .+|.++. +.....++......+..+..+ ||.++|..+ ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~--~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYC--HTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhh--hcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 6777776 334455677777888888888 999999988 9999999999999999 88999999
Q ss_pred ccccccCCCcccccc---ccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh
Q 003846 649 GMARMFGGDELQANT---NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 649 gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
|+...+......... .+..+...|++||. ..+.++.+.|||++|.+..+-.++........... |...+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------W~~~r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------WSQLR 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCCC-------ccccc
Confidence 999988765433221 22367889999995 45567899999999999999999876543221111 11111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
.. .+..++......++...+.++++.+|..|++.+.+..
T Consensus 340 ~~--------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QG--------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc--------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11 1112222223345566899999999999999877654
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.5e-12 Score=108.56 Aligned_cols=82 Identities=45% Similarity=0.968 Sum_probs=64.6
Q ss_pred ccccCCCCCccccceEEeecccCCCCcccccCCChhHHHHHhhccCCccccccc-CCCceeeeccccccccccccccCcc
Q 003846 324 ALQCGDNSADREDRFLRMHNVKLPSPDKVLKLPGIEECKSACLNNCACTAYAYN-SSGVCSSWDGKLYDLEQLSKNEGEN 402 (791)
Q Consensus 324 ~l~C~~~~~~~~~~f~~l~~~~~p~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~-~~g~C~~w~g~l~~~~~~~~~~~~~ 402 (791)
+++|..... .++|++++++++|+........++++|++.|++||+|+||+|. .+|+|++|.+.+.+...... .+.+
T Consensus 2 ~~~C~~~~~--~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~-~~~~ 78 (84)
T cd01098 2 PLNCGGDGS--TDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSS-GGGT 78 (84)
T ss_pred CcccCCCCC--CCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecC-CCcE
Confidence 456754211 4789999999999886323677999999999999999999997 57899999988887665333 4678
Q ss_pred EEEEee
Q 003846 403 IFIKLA 408 (791)
Q Consensus 403 ~~vrl~ 408 (791)
+|+|++
T Consensus 79 ~yiKv~ 84 (84)
T cd01098 79 LYLRLA 84 (84)
T ss_pred EEEEeC
Confidence 999874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-11 Score=120.31 Aligned_cols=131 Identities=24% Similarity=0.194 Sum_probs=98.7
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCcee-eeeeEEEcCCcceEEEeecCCCCh
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV-RLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
.+.|+.|.++.||+++. .++.+++|....... ....+.+|+++++.+.+.+++ +++... ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 36789999999999986 478899999765432 234567899999998765544 454443 3346899999999887
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC--CCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
.... .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 111345678999999999876 23469999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.4e-11 Score=133.26 Aligned_cols=145 Identities=19% Similarity=0.242 Sum_probs=94.7
Q ss_pred ccCCCccceecccCceeEEEeEeeC-CcEEEEEEecccCcc----------------------------------cHH--
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQ----------------------------------GLE-- 543 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~-- 543 (791)
...|+. +.||.|++|.||+|++.+ |+.||||+++....+ ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999887 999999999743110 011
Q ss_pred ----HHHHHHHHHHhcC----CCceeeeeeEEEc-CCcceEEEeecCCCChhHHHhhhccc---cccCHHHHHHHHHHHH
Q 003846 544 ----ELKNETMLIAKLQ----HRNLVRLLGCCLD-QDEKILIYEYLPNKSLDSFLFDRAKK---RLLYWETRVKIIEGIA 611 (791)
Q Consensus 544 ----~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia 611 (791)
++.+|+..+.+++ +.+.+.+=.++.+ ....+|||||++|+.+.++-.-...+ ..+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 1344555555542 3333443333333 45678999999999998753111111 11222222223333
Q ss_pred HHHHHhhccCCCCeeecCCCCCcEEEcCCC----CeEEeeeccccccCC
Q 003846 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDM----KPKISDFGMARMFGG 656 (791)
Q Consensus 612 ~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFgla~~~~~ 656 (791)
++..+ ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33455 99999999999999988 999999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.3e-10 Score=109.93 Aligned_cols=136 Identities=15% Similarity=0.143 Sum_probs=99.1
Q ss_pred ceecccCceeEEEeEeeC-------CcEEEEEEecccC------------c----------ccHHHHH----HHHHHHHh
Q 003846 508 NKLGEGGFGPVYKGELLN-------GQEVAVKRLSKKS------------G----------QGLEELK----NETMLIAK 554 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~------------~----------~~~~~~~----~E~~~l~~ 554 (791)
..||.|--+.||.|...+ +..+|||+.+-.. . .....+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999996543 4799999875210 0 0122333 79999999
Q ss_pred cCC--CceeeeeeEEEcCCcceEEEeecCCCChhH-HHhhhccccccCHHHHHHHHHHHHHHHHHh-hccCCCCeeecCC
Q 003846 555 LQH--RNLVRLLGCCLDQDEKILIYEYLPNKSLDS-FLFDRAKKRLLYWETRVKIIEGIAQGLLYL-HQYSRLRIIHRDL 630 (791)
Q Consensus 555 l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~iiH~Dl 630 (791)
+.. -++.+++++ ...+|||||+.+..+.. .+ +...++.+....+..+++.+|..| |+.+ ++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 953 466667754 56789999998754422 22 112344455677889999999999 7777 999999
Q ss_pred CCCcEEEcCCCCeEEeeeccccccC
Q 003846 631 KASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 631 kp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4789999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.1e-10 Score=113.45 Aligned_cols=142 Identities=19% Similarity=0.278 Sum_probs=109.7
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCC--CceeeeeeEEEcCC---cceEEEeecC
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQH--RNLVRLLGCCLDQD---EKILIYEYLP 581 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lV~Ey~~ 581 (791)
+.|+.|..+.||+++..+|+.+++|+...... ....++.+|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999876678999999765432 245678999999999975 34677777766542 5689999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC----------------------------------------
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS---------------------------------------- 621 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~---------------------------------------- 621 (791)
|.++.+.+.. ..++.+....++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765411 24566677778888888888888421
Q ss_pred -------------CCCeeecCCCCCcEEEcC--CCCeEEeeeccccc
Q 003846 622 -------------RLRIIHRDLKASNILLDT--DMKPKISDFGMARM 653 (791)
Q Consensus 622 -------------~~~iiH~Dlkp~NILl~~--~~~~kl~DFgla~~ 653 (791)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-09 Score=103.43 Aligned_cols=131 Identities=23% Similarity=0.353 Sum_probs=102.1
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccC---cc-----cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKS---GQ-----GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..+++|+-..+|.+.. -|.++++|.-.++. ++ ..+.-.+|++++.+++--.|....=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4688999999999966 34456677433321 11 134456899999999776666666677788888999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..++ +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 2567788888889999998 99999999999998765 99999999974
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.8e-10 Score=122.83 Aligned_cols=168 Identities=17% Similarity=0.218 Sum_probs=128.9
Q ss_pred EeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHH
Q 003846 522 ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWE 601 (791)
Q Consensus 522 ~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 601 (791)
+..++.+|.|+..+.......+...+-++.|+.++||||++++......+..|||.|-+. .|..++.+. ...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHH
Confidence 445788999998877666445667888999999999999999999999999999999874 566666332 245
Q ss_pred HHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccC
Q 003846 602 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681 (791)
Q Consensus 602 ~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 681 (791)
....-+.||+.||.+||+.+ .++|++|...-|+|++.|..||++|.++........ .......-..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 56677899999999999765 599999999999999999999999999865433221 11111223345666654433
Q ss_pred CCCcccceeehhHHHHHHHhCC
Q 003846 682 LFSIKSDVFSFGVLLLEILSGK 703 (791)
Q Consensus 682 ~~~~~~DvwslGvvl~elltg~ 703 (791)
. -..|.|.||++++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3569999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-10 Score=127.82 Aligned_cols=250 Identities=19% Similarity=0.180 Sum_probs=177.1
Q ss_pred hhhccCCCccceecccCceeEEEeEe--eCCcEEEEEEecccCcccHHHH--HHHHHHHHhc-CCCceeeeeeEEEcCCc
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL--LNGQEVAVKRLSKKSGQGLEEL--KNETMLIAKL-QHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~~~~~~~~~ 572 (791)
.....+|..+..||.|.|+.|++... .++..+++|.+.+.......++ ..|+.+...+ .|.++++....+...++
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34457888899999999999999853 4578899998876543333332 2455555555 58999998888888888
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeeeccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMA 651 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgla 651 (791)
.++=-||++++++...+ .....+++...+++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||..
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 88999999999887665 33445677788899999999999999877 9999999999999886 78899999998
Q ss_pred cccCCCccccccccccccCcc-cCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 652 RMFGGDELQANTNRIVGTYGY-MSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
..+.-.. ......+..| .+|+......+..+.|+++||.-+.|.+++..-.... ....
T Consensus 415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----------------~~~~ 473 (524)
T KOG0601|consen 415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----------------VQSL 473 (524)
T ss_pred cccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccc-----------------ccce
Confidence 6422111 1111223334 3555556678899999999999999999987531110 0111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.+......... .....+..+...++..++..||.+.++..+.+-
T Consensus 474 ~i~~~~~p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 TIRSGDTPNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eeecccccCCC--chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11111111111 122566778888999999999999988776543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.9e-09 Score=100.26 Aligned_cols=143 Identities=24% Similarity=0.337 Sum_probs=107.7
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEe-cccCcc-------cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRL-SKKSGQ-------GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~-~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
....|-+|+-+.|+++.. .|+...||.- .+.-.. ...+..+|++++.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 356899999999999977 6888777743 332111 2455678999999987656655555677777889999
Q ss_pred eecCC-CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC---eEEeeeccccc
Q 003846 578 EYLPN-KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK---PKISDFGMARM 653 (791)
Q Consensus 578 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFgla~~ 653 (791)
||+++ .++.+++........ ..+....++..|-+.+.-||..+ |+|+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 578888865443322 22333688999999999999998 999999999999976553 58999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.7e-09 Score=114.74 Aligned_cols=169 Identities=22% Similarity=0.326 Sum_probs=129.8
Q ss_pred ceeEEEeE-eeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc----CCcceEEEeecCC-CChhHH
Q 003846 515 FGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD----QDEKILIYEYLPN-KSLDSF 588 (791)
Q Consensus 515 fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~ 588 (791)
-.+.||+. ..+|..|++|+++....+.......-++.++++.|+|||++.+++.. +...++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45678884 45899999999965444444444567889999999999999999873 3456899999986 578777
Q ss_pred Hhhhc------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 589 LFDRA------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 589 l~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
-+... .+...+++..+.++.|+..||.++|+.| +.-+-|.|++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 65432 2345667888999999999999999999 88899999999999999999998888766554
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCC
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN 705 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p 705 (791)
+... -+.+ ..+-|.=.||.+++.|.||...
T Consensus 446 d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE----------------PLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4310 0111 1356888899999999999643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-10 Score=134.33 Aligned_cols=246 Identities=22% Similarity=0.242 Sum_probs=171.8
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
...+.+.+.+-+-.|.++.++.+.-. .|...+.|..... .....+....+-.++-..+||-+++...-+.-.....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35567778888999999999987432 3434444433222 1112233333444444445677776665555667789
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
|+++|+.+++|...|+.. +..+.+-....+..+.++++|||... +.|+|++|.|++...++..+++||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999998888432 34556666777888999999999876 899999999999999999999999843322
Q ss_pred CCC-------------------------cccc----ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCC
Q 003846 655 GGD-------------------------ELQA----NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN 705 (791)
Q Consensus 655 ~~~-------------------------~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p 705 (791)
+.. .... ......+|+.|.+||...+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 0000 01234789999999999999999999999999999999999999
Q ss_pred CCCCCCCccchhhhhhHHhhcCCccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHH
Q 003846 706 TGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS-----YPMLARYVNVALLCVHENATDRPTMS 768 (791)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~ 768 (791)
+..... .+.++.++....+ ........+++...+..+|.+|-.|.
T Consensus 1035 ~na~tp------------------q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETP------------------QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcch------------------hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 653322 2222333332222 22445677889999999999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.1e-08 Score=97.13 Aligned_cols=126 Identities=28% Similarity=0.293 Sum_probs=84.8
Q ss_pred eEEEeEeeCCcEEEEEEecccC--------------c-------c-----cHHHHHHHHHHHHhcCCC--ceeeeeeEEE
Q 003846 517 PVYKGELLNGQEVAVKRLSKKS--------------G-------Q-----GLEELKNETMLIAKLQHR--NLVRLLGCCL 568 (791)
Q Consensus 517 ~Vy~~~~~~g~~vavK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 568 (791)
.||.|...+|..+|||+.+... . . .....++|++.|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899988889999999875310 0 0 123456899999999765 566666542
Q ss_pred cCCcceEEEeecC--CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHH-hhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 569 DQDEKILIYEYLP--NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY-LHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 569 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~-LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
..+|||||++ |..+..+... .++.+....++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 5689999999 6566554311 11134566788888886665 56777 9999999999999988 9999
Q ss_pred eeeccccccC
Q 003846 646 SDFGMARMFG 655 (791)
Q Consensus 646 ~DFgla~~~~ 655 (791)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.2e-08 Score=102.10 Aligned_cols=140 Identities=20% Similarity=0.140 Sum_probs=100.5
Q ss_pred eecccCceeEEEeEeeCCcEEEEEEecccCc-----------ccHHHHHHHHHHHHhcCCCc--eeeeeeEEEc-----C
Q 003846 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSG-----------QGLEELKNETMLIAKLQHRN--LVRLLGCCLD-----Q 570 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~-----~ 570 (791)
.+-+-....|++... +|+.+.||+...... .....+.+|.+.+.++...+ .++++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445667655 788999997743321 11124779999999885433 3445556543 2
Q ss_pred CcceEEEeecCCC-ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-------CCC
Q 003846 571 DEKILIYEYLPNK-SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-------DMK 642 (791)
Q Consensus 571 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-------~~~ 642 (791)
...+||+|++++. +|.+++.+.. ....+......++.++++.+.-||..+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3468999999986 8998874322 233455667789999999999999998 999999999999975 467
Q ss_pred eEEeeeccccc
Q 003846 643 PKISDFGMARM 653 (791)
Q Consensus 643 ~kl~DFgla~~ 653 (791)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.2e-07 Score=97.82 Aligned_cols=258 Identities=17% Similarity=0.140 Sum_probs=157.6
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeE------EEcC-CcceEEE
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGC------CLDQ-DEKILIY 577 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~------~~~~-~~~~lV~ 577 (791)
..+.||+|+.+-+|-.- .-...+-|+..........+. +..|.+. .||-+-.-+.+ .-+. ....++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45789999999999652 223345677766544322222 2233333 46543321111 0112 2256778
Q ss_pred eecCCCC-hhHHHh---hhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 578 EYLPNKS-LDSFLF---DRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 578 Ey~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
..+++.. ...++. ++..-+...|.-.+++++.++.+.+.||++| ..-+|+.++|+|+.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7777642 222221 2234456789999999999999999999998 88899999999999999999998554433
Q ss_pred cCCCccccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhC-CCCCCCCCCCc--cchhh-h-hhHH
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSG-KKNTGFYHTGS--LNLLG-H-AWDL 723 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg-~~p~~~~~~~~--~~~~~-~-~~~~ 723 (791)
...+ ......+|...|.+||.-. +..-+...|.|.||+++++++.| ++|+....... ....+ . +...
T Consensus 167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2211 1122347889999999654 33457889999999999999997 88876432211 11111 0 0000
Q ss_pred hhcCCcccccccccc--CCCC-HHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHhcc
Q 003846 724 WKDNRALDLMDPILE--NEAS-YPMLARYVNVALLCVHE--NATDRPTMSEVVSMLTN 776 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~--~~~~-~~~~~~l~~li~~cl~~--dp~~RPt~~evl~~L~~ 776 (791)
+. ...+.-..... .+.+ ...++.+..+..+|+.. .+.-|||++-.+..|..
T Consensus 244 f~--ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 244 FA--YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred ee--echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 00 00111111111 1111 22456788888999876 35689999987777654
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.8e-07 Score=84.46 Aligned_cols=87 Identities=21% Similarity=0.243 Sum_probs=67.1
Q ss_pred eEEEecCCCEEEecCc-cceEEeeeccCc--ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCce
Q 003846 93 VLTISSEGNLVIEDGR-ITYRVSENVSSS--QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKV 169 (791)
Q Consensus 93 ~l~~~~~g~l~l~~~~-~~~~w~~~~~~~--~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~ 169 (791)
.+.++.||++|+++.. ..++|++++... ....+.|+++|||||++.++.++|+|=.
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t--------------------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT--------------------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc---------------------
Confidence 3567789999999865 579999998643 3478999999999999998899999611
Q ss_pred eEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccC
Q 003846 170 WSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSG 211 (791)
Q Consensus 170 ~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g 211 (791)
....|.+.+.++.+|..+++-.++ .+.|.+.
T Consensus 82 ----------~~~~~~~~~~L~ddGnlvl~~~~~-~~~W~Sf 112 (114)
T smart00108 82 ----------TGANGNYVLVLLDDGNLVIYDSDG-NFLWQSF 112 (114)
T ss_pred ----------cCCCCceEEEEeCCCCEEEECCCC-CEEeCCC
Confidence 013467899999999988775443 5788764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.6e-07 Score=91.26 Aligned_cols=137 Identities=22% Similarity=0.212 Sum_probs=98.1
Q ss_pred CCccceecccCceeEEEeEeeCCcEEEEEEeccc--------------------Cc--ccHHHHHHHHHHHHhcCCC--c
Q 003846 504 FSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--------------------SG--QGLEELKNETMLIAKLQHR--N 559 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--------------------~~--~~~~~~~~E~~~l~~l~H~--n 559 (791)
..+..+||.|--+.||.|...+|.++|||.=+.- +. ......++|.+.|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4456799999999999999989999999943210 00 0133456899999999755 6
Q ss_pred eeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC
Q 003846 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT 639 (791)
Q Consensus 560 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~ 639 (791)
+.+.+++ +...+||||++|-.|...- +..+..-.++..|++-+.-+-..| ++|+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7766643 5668999999997774432 122333344444445444444555 999999999999999
Q ss_pred CCCeEEeeeccccccC
Q 003846 640 DMKPKISDFGMARMFG 655 (791)
Q Consensus 640 ~~~~kl~DFgla~~~~ 655 (791)
+|.+.++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998886543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.3e-07 Score=89.68 Aligned_cols=107 Identities=25% Similarity=0.284 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHHhcCCC--ceeeeeeEEEcCC----cceEEEeecCCC-ChhHHHhhhccccccCHHHHHHHHHHHHHHH
Q 003846 542 LEELKNETMLIAKLQHR--NLVRLLGCCLDQD----EKILIYEYLPNK-SLDSFLFDRAKKRLLYWETRVKIIEGIAQGL 614 (791)
Q Consensus 542 ~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 614 (791)
.....+|...+..+... ..++.+++..... ..+||+|++++. +|.+++..... .+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 45678899988888533 4556677666532 348999999984 89998844222 55667789999999999
Q ss_pred HHhhccCCCCeeecCCCCCcEEEcCCC---CeEEeeecccccc
Q 003846 615 LYLHQYSRLRIIHRDLKASNILLDTDM---KPKISDFGMARMF 654 (791)
Q Consensus 615 ~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFgla~~~ 654 (791)
+-||+.+ |+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.53 E-value=3e-07 Score=83.28 Aligned_cols=87 Identities=22% Similarity=0.248 Sum_probs=67.7
Q ss_pred EEEec-CCCEEEecCc-cceEEeeeccC--cceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCce
Q 003846 94 LTISS-EGNLVIEDGR-ITYRVSENVSS--SQNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKV 169 (791)
Q Consensus 94 l~~~~-~g~l~l~~~~-~~~~w~~~~~~--~~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~ 169 (791)
+.++. ||+||+++.. ..++|++++.. .....+.|+++|||||+|.++.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~-------------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT-------------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc--------------------
Confidence 45666 9999999865 57999999865 356789999999999999999999984210
Q ss_pred eEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 170 WSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 170 ~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
.+.+.+.+.++.+|...++-.+ ..+.|.+..
T Consensus 84 -----------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 -----------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred -----------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 1246789999999998877654 467888754
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.7e-07 Score=79.66 Aligned_cols=100 Identities=22% Similarity=0.254 Sum_probs=72.6
Q ss_pred CEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEe-cCCCCCCCCCCeEEEecCCCEEEecCccceEEeeeccC
Q 003846 41 ETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVA-NRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSS 119 (791)
Q Consensus 41 ~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~ 119 (791)
+.+.+.+|.+.|-|..+|+ |.|.-. .++++|.. +...+.. ..+.+.|+.||||||+|..+.++|++. ..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~~---~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf-~~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYDS---NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSF-DY 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEET---TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEEST-TS
T ss_pred cccccccccccceECCCCe-----EEEEcC---CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeec-CC
Confidence 4566656999999999998 777533 26789999 4333321 456799999999999999999999993 34
Q ss_pred cceeEEEEcc--CCCeEEecCCCceeeeecCCCC
Q 003846 120 SQNTTATLLD--SGNFVLRNEKLGLLWQSFDYPS 151 (791)
Q Consensus 120 ~~~~~~~l~d--~GNlvl~~~~~~~~WqsFd~Pt 151 (791)
...+.+..++ +||++ +.....+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 4667788888 99999 7777789999876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.6e-06 Score=84.11 Aligned_cols=139 Identities=19% Similarity=0.195 Sum_probs=102.9
Q ss_pred ecccCceeEEEeEeeCCcEEEEEEeccc---C---cccHHHHHHHHHHHHhcCC--CceeeeeeEEEcC----CcceEEE
Q 003846 510 LGEGGFGPVYKGELLNGQEVAVKRLSKK---S---GQGLEELKNETMLIAKLQH--RNLVRLLGCCLDQ----DEKILIY 577 (791)
Q Consensus 510 LG~G~fg~Vy~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~----~~~~lV~ 577 (791)
-|+||-+.|++-.+ +|+.+-+|+-... + +-+...|.+|+..|.++.. -.+.+++...... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 45688888998776 4557888876521 1 3467889999999999953 3355555222221 2357999
Q ss_pred eecCC-CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC--eEEeeeccccc
Q 003846 578 EYLPN-KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK--PKISDFGMARM 653 (791)
Q Consensus 578 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFgla~~ 653 (791)
|-+++ -+|.+++.+. .....+......++.+++++++-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 5888887432 2234566777899999999999999998 999999999999987777 99999998764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.9e-06 Score=86.47 Aligned_cols=139 Identities=17% Similarity=0.184 Sum_probs=86.7
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeeEEEcCCcceEEEeecCCCC-
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN--LVRLLGCCLDQDEKILIYEYLPNKS- 584 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gs- 584 (791)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35577888876433 3456789999999986433 4677888877777889999999963
Q ss_pred hhHHHh--------------h-----hcc-ccccCHHHH-HHHHH----------HHHHH-HHHhhc-cCCCCeeecCCC
Q 003846 585 LDSFLF--------------D-----RAK-KRLLYWETR-VKIIE----------GIAQG-LLYLHQ-YSRLRIIHRDLK 631 (791)
Q Consensus 585 L~~~l~--------------~-----~~~-~~~l~~~~~-~~i~~----------~ia~a-L~~LH~-~~~~~iiH~Dlk 631 (791)
+.+.+. + +.- ......... ..+.. .+.+. ..+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221110 0 000 000010000 00100 01111 111111 112457899999
Q ss_pred CCcEEEcCCCCeEEeeecccc
Q 003846 632 ASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 632 p~NILl~~~~~~kl~DFgla~ 652 (791)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999885
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.2e-06 Score=98.69 Aligned_cols=141 Identities=16% Similarity=0.254 Sum_probs=92.9
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCcc--------------------------c----HH----------HHHH
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ--------------------------G----LE----------ELKN 547 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~----~~----------~~~~ 547 (791)
+-|+.++-|.||+|++.+|+.||||+.+..-.+ . .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 579999999999999999999999998653110 0 01 1334
Q ss_pred HHHHHHhcC-----CCceeeeeeEEE-cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHH-HHhhcc
Q 003846 548 ETMLIAKLQ-----HRNLVRLLGCCL-DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGL-LYLHQY 620 (791)
Q Consensus 548 E~~~l~~l~-----H~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~ 620 (791)
|+..+.+++ .+++ ++=.++. -....+|+|||++|-.+.+...-.. ...+.+ .++..++++. ..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhc
Confidence 555555552 2333 2222222 3467799999999999988852222 233333 3333333321 222223
Q ss_pred CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 621 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
+ +.|.|.+|.||+++.+|++.+.|||+...+...
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 4 999999999999999999999999998776543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.2e-08 Score=107.06 Aligned_cols=153 Identities=22% Similarity=0.369 Sum_probs=103.5
Q ss_pred HHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc------ccccc-ccccccCcccCchhcc
Q 003846 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE------LQANT-NRIVGTYGYMSPEYAL 679 (791)
Q Consensus 607 ~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~------~~~~~-~~~~gt~~y~aPE~~~ 679 (791)
+.+++.||.|+|.+. .++|++|.|++|.++..+..||+.|+.+....... +.... .-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999866 69999999999999999999999999986554421 11111 1124567899999999
Q ss_pred cCCCCcccceeehhHHHHHHHhCCCC-CCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccc
Q 003846 680 EGLFSIKSDVFSFGVLLLEILSGKKN-TGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVH 758 (791)
Q Consensus 680 ~~~~~~~~DvwslGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~ 758 (791)
+...+.++|+||+|+++|-+..|..+ +.... ... ...... ...+ .-........+.++++=+.+++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-~~~---~~~~~~-------~~~~-~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANG-GLL---SYSFSR-------NLLN-AGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccC-Ccc---hhhhhh-------cccc-cccccccccCcHHHHHHHHHHhc
Confidence 98899999999999999999955443 22111 000 000000 0000 00001112345678888888999
Q ss_pred cCCCCCCCHHHHHHH
Q 003846 759 ENATDRPTMSEVVSM 773 (791)
Q Consensus 759 ~dp~~RPt~~evl~~ 773 (791)
.++..||++.++...
T Consensus 251 ~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSI 265 (700)
T ss_pred CCcccCcchhhhhcc
Confidence 999999988887544
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.32 E-value=9.3e-07 Score=73.67 Aligned_cols=59 Identities=41% Similarity=0.902 Sum_probs=48.8
Q ss_pred ccceEEeecccCCCCcc-cccCCChhHHHHHhhc-cCCccccccc-CCCceeeec-ccccccc
Q 003846 335 EDRFLRMHNVKLPSPDK-VLKLPGIEECKSACLN-NCACTAYAYN-SSGVCSSWD-GKLYDLE 393 (791)
Q Consensus 335 ~~~f~~l~~~~~p~~~~-~~~~~s~~~C~~~Cl~-nCsC~a~~~~-~~g~C~~w~-g~l~~~~ 393 (791)
.+.|++++++++++... .....++++|++.|++ +|+|.||.|+ .+++|.+|. +.+.+..
T Consensus 3 ~~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred CceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 46799999999996652 2456799999999999 9999999998 478999998 6666554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=8.1e-06 Score=80.91 Aligned_cols=138 Identities=17% Similarity=0.180 Sum_probs=91.4
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHH---------HHHHHHHHhcCCC---ceeeeeeEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEEL---------KNETMLIAKLQHR---NLVRLLGCC 567 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H~---niv~l~~~~ 567 (791)
...+|.+.+.+-......|.+-+. +|+.+++|..+.........| .+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 446777777777766666666655 688999998876543332222 2344444444332 222322222
Q ss_pred Ec-----CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 568 LD-----QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 568 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
.. ....+++|||++|..|.++.. ++. .++..+.+++.-||+.| +.|+|.+|.|++++.+ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 21 234568999999988866531 211 35566778899999998 9999999999999855 4
Q ss_pred eEEeeeccccc
Q 003846 643 PKISDFGMARM 653 (791)
Q Consensus 643 ~kl~DFgla~~ 653 (791)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.9e-05 Score=81.72 Aligned_cols=140 Identities=17% Similarity=0.153 Sum_probs=86.8
Q ss_pred eecccCc-eeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEeecCCCChh
Q 003846 509 KLGEGGF-GPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEYLPNKSLD 586 (791)
Q Consensus 509 ~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 586 (791)
.|-.|.. ..||+.... +..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 778999763 4788888875443 346778999998884 445667888877767789999999998876
Q ss_pred HHHh----------------h-hc-cc-c-ccC--HHHHHHH-----------------------HHHHHHHHHHhh-cc
Q 003846 587 SFLF----------------D-RA-KK-R-LLY--WETRVKI-----------------------IEGIAQGLLYLH-QY 620 (791)
Q Consensus 587 ~~l~----------------~-~~-~~-~-~l~--~~~~~~i-----------------------~~~ia~aL~~LH-~~ 620 (791)
.... . +. .. . ... ....... +.++.+.|.... ..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 0 00 00 0 000 0000000 111111111111 11
Q ss_pred CCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 621 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23458999999999999998778899999885
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.2e-05 Score=82.33 Aligned_cols=144 Identities=24% Similarity=0.239 Sum_probs=85.5
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCC--ceeeeeeEEEcC---CcceEEEeecC
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR--NLVRLLGCCLDQ---DEKILIYEYLP 581 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~---~~~~lV~Ey~~ 581 (791)
++.|+.|..+.||+....+ +.+++|..... .....+.+|..+++.+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999998766 69999997554 4557788999999888533 356677654332 33589999999
Q ss_pred CCChhH----------------HHhh-hc---cccccCHHH---------HHHH------------HHHHHH-HHHHhhc
Q 003846 582 NKSLDS----------------FLFD-RA---KKRLLYWET---------RVKI------------IEGIAQ-GLLYLHQ 619 (791)
Q Consensus 582 ~gsL~~----------------~l~~-~~---~~~~l~~~~---------~~~i------------~~~ia~-aL~~LH~ 619 (791)
+..+.. .+.. +. ......... .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 1110 00 000001000 0000 111222 2333332
Q ss_pred ----cCCCCeeecCCCCCcEEEc-CCCCeEEeeeccccc
Q 003846 620 ----YSRLRIIHRDLKASNILLD-TDMKPKISDFGMARM 653 (791)
Q Consensus 620 ----~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgla~~ 653 (791)
.....++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666678999998853
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.8e-05 Score=79.25 Aligned_cols=151 Identities=20% Similarity=0.235 Sum_probs=98.8
Q ss_pred hhhhhhhccCCCccce---ecccCceeEEEeEeeCCcEEEEEEecccCcc-------------------cHHH-----HH
Q 003846 494 FASVSASTNNFSAENK---LGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ-------------------GLEE-----LK 546 (791)
Q Consensus 494 ~~~~~~~~~~y~~~~~---LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-------------------~~~~-----~~ 546 (791)
...+.....+..+... |..|--..||+|...++..+|||+++..... ...+ ..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 3444444445555444 5567777899998778999999998642111 1111 23
Q ss_pred HHHHHHHhcC--CCceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCC
Q 003846 547 NETMLIAKLQ--HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRL 623 (791)
Q Consensus 547 ~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~ 623 (791)
+|+..|.++. +-.+.+.+.+. +..|||||+....+- .-..+.-.+..++...+..++++.+.-|-. .+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~p---AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~-- 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLP---APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG-- 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCC---CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence 5777777774 44455555443 447999999764210 001112223333566777888888887766 44
Q ss_pred CeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 624 ~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
++|+||+.-|||+. ++.+.|+||+.|....
T Consensus 188 -LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 -LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8999999999997654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.3e-05 Score=78.94 Aligned_cols=105 Identities=24% Similarity=0.257 Sum_probs=84.0
Q ss_pred HHHHHHHHhcCC-CceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCC
Q 003846 546 KNETMLIAKLQH-RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624 (791)
Q Consensus 546 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ 624 (791)
..|..+++.+++ +++++++|.| ..++|.||.+.+++...-..-..-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358889999976 6999999999 45789999998766422000011234679999999999999999999866556
Q ss_pred eeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 625 IIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 625 iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+...|++|+|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999887543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=9e-07 Score=98.02 Aligned_cols=190 Identities=18% Similarity=0.100 Sum_probs=135.9
Q ss_pred hhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCc-eeeeeeEEEcCCcceEE
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN-LVRLLGCCLDQDEKILI 576 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV 576 (791)
+..++.+...+-.++|+++.++|.+-...+....+.+... ...+-++++|.+++||| .++.++-+..++...++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 3445566666789999999999986544444445655432 45567899999999999 77777777777888999
Q ss_pred EeecCCC-ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 577 YEYLPNK-SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 577 ~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
++++..+ +-.... ....-.+..-....+.+.-++++++||+.. =+|+| ||+..+ +..+..||+....+.
T Consensus 313 ~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 9999877 211111 011111222233455666678899999854 48888 776655 788999999987765
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCC
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN 705 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p 705 (791)
... ..+...+++.++|||+..++.+..+.|+|++|+--.+|.-|-+|
T Consensus 383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 443 23446789999999999999999999999999877777777665
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.3e-05 Score=86.86 Aligned_cols=140 Identities=16% Similarity=0.209 Sum_probs=90.9
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCccc-------------------------------------HHHHHHHHH
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQG-------------------------------------LEELKNETM 550 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~ 550 (791)
+-||.-..|.||+|++++|+.||||+-+..-... .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999876421110 011334555
Q ss_pred HHHhc----CCCc------eeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc
Q 003846 551 LIAKL----QHRN------LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620 (791)
Q Consensus 551 ~l~~l----~H~n------iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~ 620 (791)
...+. .|-+ |.+++-.+ .....|+||||+|..+.++-. .....++...+..-+.+...-+-+ ..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf--~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIF--KT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHH--hc
Confidence 44443 3444 33333222 346799999999998877742 233345555444333332222222 23
Q ss_pred CCCCeeecCCCCCcEEEcC----CCCeEEeeeccccccCC
Q 003846 621 SRLRIIHRDLKASNILLDT----DMKPKISDFGMARMFGG 656 (791)
Q Consensus 621 ~~~~iiH~Dlkp~NILl~~----~~~~kl~DFgla~~~~~ 656 (791)
| ++|+|=+|.||+++. ++.+.+-|||+...+..
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4 999999999999984 67899999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=8e-05 Score=90.66 Aligned_cols=79 Identities=20% Similarity=0.381 Sum_probs=58.7
Q ss_pred cceecccCceeEEEeEeeCC---cEEEEEEecccC-cccHHHHHHHHHHHHhcC-CCce--eeeeeEEEcC---CcceEE
Q 003846 507 ENKLGEGGFGPVYKGELLNG---QEVAVKRLSKKS-GQGLEELKNETMLIAKLQ-HRNL--VRLLGCCLDQ---DEKILI 576 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lV 576 (791)
.++|+.|.+..+|+.+..++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46889999999999876554 467888764432 223457889999999995 6654 7888887764 457899
Q ss_pred EeecCCCCh
Q 003846 577 YEYLPNKSL 585 (791)
Q Consensus 577 ~Ey~~~gsL 585 (791)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=9.3e-05 Score=76.18 Aligned_cols=73 Identities=15% Similarity=0.260 Sum_probs=47.6
Q ss_pred ceecccCce-eEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCC---ceeeeeeEEEcCC---cceEEEeec
Q 003846 508 NKLGEGGFG-PVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR---NLVRLLGCCLDQD---EKILIYEYL 580 (791)
Q Consensus 508 ~~LG~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~---~~~lV~Ey~ 580 (791)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|++++..+... .+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 48875 235777875432 2345789999999888532 3445555443322 347899999
Q ss_pred CCCChh
Q 003846 581 PNKSLD 586 (791)
Q Consensus 581 ~~gsL~ 586 (791)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00019 Score=71.13 Aligned_cols=128 Identities=17% Similarity=0.240 Sum_probs=90.1
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccC----------------cccHHHHHHHHHHHHhcC------CCceeeee
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS----------------GQGLEELKNETMLIAKLQ------HRNLVRLL 564 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~ 564 (791)
...||+|+.-.||.= .+.....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 457999999999973 456677888886554 223566677777766665 78999999
Q ss_pred eEEEcCCcceEEEeecCC------CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc
Q 003846 565 GCCLDQDEKILIYEYLPN------KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 638 (791)
Q Consensus 565 ~~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~ 638 (791)
|..+++....+|+|.+.+ -+|.+++. ...++. ...+.+. +-..||-+++ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998764 25777762 233433 3333333 3444555555 99999999999995
Q ss_pred CC--C--CeEEee
Q 003846 639 TD--M--KPKISD 647 (791)
Q Consensus 639 ~~--~--~~kl~D 647 (791)
.. + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 43 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00016 Score=74.45 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=82.7
Q ss_pred ceecccCceeEEEeEeeC--CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeEEEcCCcceEEEeecCCCC
Q 003846 508 NKLGEGGFGPVYKGELLN--GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL-VRLLGCCLDQDEKILIYEYLPNKS 584 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gs 584 (791)
+.|..|-...+|+....+ ++.+++|+....... .....+|+.+++.+...++ +++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 578888899999997654 678999977543222 2234578889988854333 44444332 248999999987
Q ss_pred hhHH-------Hh----------hhccc--------cccC-HHHHHHHHH----------------------HHH---HH
Q 003846 585 LDSF-------LF----------DRAKK--------RLLY-WETRVKIIE----------------------GIA---QG 613 (791)
Q Consensus 585 L~~~-------l~----------~~~~~--------~~l~-~~~~~~i~~----------------------~ia---~a 613 (791)
+... +. ..... .... ++.+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6322 10 00000 0111 122111111 111 11
Q ss_pred HH-Hhhcc-CCCCeeecCCCCCcEEEcC-CCCeEEeeecccc
Q 003846 614 LL-YLHQY-SRLRIIHRDLKASNILLDT-DMKPKISDFGMAR 652 (791)
Q Consensus 614 L~-~LH~~-~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~ 652 (791)
|. .+... ....++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 11111 2346999999999999998 5789999999885
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0001 Score=76.97 Aligned_cols=139 Identities=16% Similarity=0.081 Sum_probs=80.5
Q ss_pred eecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeEEEcCCcceEEEeecCCCChhH
Q 003846 509 KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL-VRLLGCCLDQDEKILIYEYLPNKSLDS 587 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~ 587 (791)
.+..|-...+|+.+ .+++.+++|..............+|.++++.+....+ .+++.... ..+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45668888999887 3677888987654332221245789999998864333 34444432 369999999876642
Q ss_pred H-------H-------hh-hc---cccccCHHH-HHHHHHHH---------HHHHHHhhcc-----CCCCeeecCCCCCc
Q 003846 588 F-------L-------FD-RA---KKRLLYWET-RVKIIEGI---------AQGLLYLHQY-----SRLRIIHRDLKASN 634 (791)
Q Consensus 588 ~-------l-------~~-~~---~~~~l~~~~-~~~i~~~i---------a~aL~~LH~~-----~~~~iiH~Dlkp~N 634 (791)
- + .+ +. ....++... ...+..++ .+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1 00 00 011111111 11111111 1112222111 12458999999999
Q ss_pred EEEcCCCCeEEeeeccccc
Q 003846 635 ILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 635 ILl~~~~~~kl~DFgla~~ 653 (791)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00025 Score=75.57 Aligned_cols=77 Identities=12% Similarity=0.088 Sum_probs=57.6
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCC---CceeeeeeEEEcC---CcceEEEee
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH---RNLVRLLGCCLDQ---DEKILIYEY 579 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~---~~~~lV~Ey 579 (791)
..+.||.|..+.||+....++ .+.+|..+. ......+.+|.+.|+.+.. -.+.++++.+..+ +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 346899999999999876555 466676432 1134688999999999853 4688889887643 568999999
Q ss_pred cCCCCh
Q 003846 580 LPNKSL 585 (791)
Q Consensus 580 ~~~gsL 585 (791)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00016 Score=68.66 Aligned_cols=130 Identities=24% Similarity=0.306 Sum_probs=90.4
Q ss_pred CCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCcee-eeeeEEEcCCcceEEEeecCC
Q 003846 504 FSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV-RLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 504 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
....+.|++|++|.||++.. .|..+|+|+-+.++ ....+..|+++|..++-.++- +++.|. ...+.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence 34557899999999999987 45689999865544 457889999999999876664 344443 23455999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCC-CCcEEEcCCCCeEEeeeccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLK-ASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlk-p~NILl~~~~~~kl~DFgla~~ 653 (791)
-.|.+.-... +. +-+..++++-.-|...+ |-|+.|. |..++|-.++.+.|+||..|+.
T Consensus 97 ~~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8887764210 11 22333445544455555 8888875 5556666666999999999974
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00027 Score=69.41 Aligned_cols=125 Identities=23% Similarity=0.389 Sum_probs=90.7
Q ss_pred cCCCccceecccCc-eeEEEeEeeCCcEEEEEEecc---cC--------c----------ccHHHHHHHHHHHHhcC---
Q 003846 502 NNFSAENKLGEGGF-GPVYKGELLNGQEVAVKRLSK---KS--------G----------QGLEELKNETMLIAKLQ--- 556 (791)
Q Consensus 502 ~~y~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~--- 556 (791)
.+++.++.||.|.- |.||+++. +|+.+|+|.+.. .. . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 99999987 788999999422 10 0 11235778988888885
Q ss_pred CCce--eeeeeEEEcC------------------CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHH
Q 003846 557 HRNL--VRLLGCCLDQ------------------DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616 (791)
Q Consensus 557 H~ni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~ 616 (791)
+.++ |+++|+..-. ....||.||++... .....-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4466 9999987422 01256777765532 1123345677788888
Q ss_pred hhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 617 LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99888 999999999985 4489999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.68 E-value=8.4e-05 Score=88.22 Aligned_cols=198 Identities=21% Similarity=0.223 Sum_probs=138.0
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeEEEcCCcce----EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhh
Q 003846 543 EELKNETMLIAKLQHRNLVRLLGCCLDQDEKI----LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618 (791)
Q Consensus 543 ~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH 618 (791)
.....|...+.++.|+|+++++.+..+..... +..|++..-++...+ ..-..++.+..+.+..++.+||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 33456778888899999999999987655443 345788888887776 34456788899999999999999999
Q ss_pred ccCCCCeeecCCCCC---cEEEcCCCCeEEe--eeccccccCCCccccccccccccCcccCchhcccCCCCc--ccceee
Q 003846 619 QYSRLRIIHRDLKAS---NILLDTDMKPKIS--DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI--KSDVFS 691 (791)
Q Consensus 619 ~~~~~~iiH~Dlkp~---NILl~~~~~~kl~--DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dvws 691 (791)
+.. ..|.-+..+ +--.+.++...++ ||+.+........... ...+..+.+||......+.. ..|+|+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHH
Confidence 875 555544444 4445666777777 8888876654432221 23456777888777665544 479999
Q ss_pred hhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003846 692 FGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVV 771 (791)
Q Consensus 692 lGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 771 (791)
+|..+..+..|..+..... ...+.+..... ....+....|+..++++|+.+.+++
T Consensus 378 lgll~~~~~~~~~i~~~~~---------------------~~~~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA---------------------VPVSLLDVLST----SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHHhhhhhcCccccccc---------------------chhhhhccccc----hhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999999886522111 11111111111 1456778899999999999999999
Q ss_pred HHh
Q 003846 772 SML 774 (791)
Q Consensus 772 ~~L 774 (791)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00075 Score=74.13 Aligned_cols=75 Identities=17% Similarity=0.257 Sum_probs=55.4
Q ss_pred ceecccCceeEEEeEeeCC-cEEEEEEeccc------C-cccHHHHHHHHHHHHhcC---CCceeeeeeEEEcCCcceEE
Q 003846 508 NKLGEGGFGPVYKGELLNG-QEVAVKRLSKK------S-GQGLEELKNETMLIAKLQ---HRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV 576 (791)
+.||.|.+..||++...+| +.++||.-... . +...++...|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999988776 58999974321 1 234567788888888763 2456777766 44667999
Q ss_pred EeecCCCC
Q 003846 577 YEYLPNKS 584 (791)
Q Consensus 577 ~Ey~~~gs 584 (791)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00041 Score=74.07 Aligned_cols=143 Identities=21% Similarity=0.164 Sum_probs=86.8
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeeE------EEcCCcceEEEe
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN--LVRLLGC------CLDQDEKILIYE 578 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~E 578 (791)
.+.|..|....+|+.... +..+++|+... ...+++..|++++..+.+.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457788888899998654 45788998764 23456778888888885332 4454432 123445689999
Q ss_pred ecCCCChhH----HH----------hhhccc--------cccCHHHHH----------HHHHHHHHHHHHhhc----cCC
Q 003846 579 YLPNKSLDS----FL----------FDRAKK--------RLLYWETRV----------KIIEGIAQGLLYLHQ----YSR 622 (791)
Q Consensus 579 y~~~gsL~~----~l----------~~~~~~--------~~l~~~~~~----------~i~~~ia~aL~~LH~----~~~ 622 (791)
|++|..+.. .+ +..... ....|.... .....+..++.++.+ ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 11 100000 001111110 011123334444443 122
Q ss_pred CCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 623 LRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 623 ~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
..++|+|+.|.|||++.++.+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999998853
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00011 Score=60.25 Aligned_cols=49 Identities=27% Similarity=0.500 Sum_probs=38.4
Q ss_pred EeecccCCCCc-ccccCCChhHHHHHhhccCCccccccc-CCCceeeeccc
Q 003846 340 RMHNVKLPSPD-KVLKLPGIEECKSACLNNCACTAYAYN-SSGVCSSWDGK 388 (791)
Q Consensus 340 ~l~~~~~p~~~-~~~~~~s~~~C~~~Cl~nCsC~a~~~~-~~g~C~~w~g~ 388 (791)
.++++.+++.+ ......+.++|++.|+.+|+|.||.|+ .++.|+++.+.
T Consensus 8 ~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 8 QGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred ccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 33567777665 333466999999999999999999998 67899987543
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0018 Score=69.57 Aligned_cols=143 Identities=22% Similarity=0.216 Sum_probs=83.5
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCC--ceeeeeeEE------EcCCcceEEEe
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR--NLVRLLGCC------LDQDEKILIYE 578 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~------~~~~~~~lV~E 578 (791)
.+.++.|....+|+.+..+| .+++|+..... ..+++..|++++..|... .+++++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677887889999875444 67788875422 234566777877777432 244444321 12345689999
Q ss_pred ecCCCChhH-----------HH---hhhccc---------cccCHHHHH------------HHHHHHHHHHHHhhc----
Q 003846 579 YLPNKSLDS-----------FL---FDRAKK---------RLLYWETRV------------KIIEGIAQGLLYLHQ---- 619 (791)
Q Consensus 579 y~~~gsL~~-----------~l---~~~~~~---------~~l~~~~~~------------~i~~~ia~aL~~LH~---- 619 (791)
|++|..+.. .+ +..... ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 11 110000 001111100 011123344555532
Q ss_pred cCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 620 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.....++|+|+++.||+++.++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999998877899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0011 Score=71.08 Aligned_cols=141 Identities=27% Similarity=0.340 Sum_probs=85.0
Q ss_pred ceecccCceeEEEeEeeC-------CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeEEEcCCcceEEEee
Q 003846 508 NKLGEGGFGPVYKGELLN-------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL-VRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey 579 (791)
+.|..|-...+|+.+..+ ++.+++|+..... ....+..+|.+++..+...++ .++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456777778899987654 5789999975543 233456788888888853333 445555432 368999
Q ss_pred cCCCChhHHH-----------------hhhcccc------ccC--HHHHHH--------------------------HHH
Q 003846 580 LPNKSLDSFL-----------------FDRAKKR------LLY--WETRVK--------------------------IIE 608 (791)
Q Consensus 580 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 608 (791)
++|..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764321 0000000 000 101100 111
Q ss_pred HHHHHHHHhhc------cCCCCeeecCCCCCcEEEcCC----CCeEEeeeccccc
Q 003846 609 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDTD----MKPKISDFGMARM 653 (791)
Q Consensus 609 ~ia~aL~~LH~------~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgla~~ 653 (791)
.+.+.+..|.. ..+..++|+|+.|.|||++.+ +.+.++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234579999999999999985 8899999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0043 Score=67.02 Aligned_cols=142 Identities=21% Similarity=0.211 Sum_probs=78.8
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCC--ceeeeee------EEEcCCcceEEEe
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR--NLVRLLG------CCLDQDEKILIYE 578 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~------~~~~~~~~~lV~E 578 (791)
.+.|+.|....+|+.+..+| .+++|+... ...+.+..|+.++..|... .+.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677788889999876555 688998752 2234455566666666322 2333332 1123455789999
Q ss_pred ecCCCChhH-----------HH---hhhcc--------ccccCH-HHHHH------------HHHH-HHHHHHHhhcc--
Q 003846 579 YLPNKSLDS-----------FL---FDRAK--------KRLLYW-ETRVK------------IIEG-IAQGLLYLHQY-- 620 (791)
Q Consensus 579 y~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~------------i~~~-ia~aL~~LH~~-- 620 (791)
|++|..+.. .| +.... ...+.+ ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 11 10000 001111 11110 1111 11122222211
Q ss_pred --CCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 621 --SRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 621 --~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
-+..++|+|++|.|||++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999976666899999885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0046 Score=65.11 Aligned_cols=31 Identities=29% Similarity=0.568 Sum_probs=26.0
Q ss_pred CCeeecCCCCCcEEEcCCCC-eEEeeeccccc
Q 003846 623 LRIIHRDLKASNILLDTDMK-PKISDFGMARM 653 (791)
Q Consensus 623 ~~iiH~Dlkp~NILl~~~~~-~kl~DFgla~~ 653 (791)
..++|+|++|.|||++.+++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997565 46999999864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0052 Score=66.98 Aligned_cols=141 Identities=17% Similarity=0.238 Sum_probs=83.2
Q ss_pred ceecccCceeEEEeEeeC-----CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeEEEcCCcceEEEeecC
Q 003846 508 NKLGEGGFGPVYKGELLN-----GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL-VRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~ 581 (791)
+.|-.|-...+|+....+ ++.+++|+.........+ -.+|..+++.+...++ .++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456567788899886532 367899988665443333 3779999988864444 3555655332 5899998
Q ss_pred CCChhHH-------H----------hhhc-cc-c-ccCHHHHHHHHHHH-----------------HHHHHHh----hc-
Q 003846 582 NKSLDSF-------L----------FDRA-KK-R-LLYWETRVKIIEGI-----------------AQGLLYL----HQ- 619 (791)
Q Consensus 582 ~gsL~~~-------l----------~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~aL~~L----H~- 619 (791)
+.+|..- + +... .. . ...++...++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 0 0000 00 0 11122222332111 1112122 21
Q ss_pred cCCCCeeecCCCCCcEEEcC-CCCeEEeeeccccc
Q 003846 620 YSRLRIIHRDLKASNILLDT-DMKPKISDFGMARM 653 (791)
Q Consensus 620 ~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~~ 653 (791)
..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 47899999999864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0043 Score=65.38 Aligned_cols=74 Identities=18% Similarity=0.254 Sum_probs=50.0
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC---CCceeeeeeEEEcCCcceEEEeecCC
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ---HRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
..+.|+.|.-..+|+.+ .+++.+.||.-. ......|..|++-|+.|. --.+++++++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34679999999999987 578899999875 233467888999888883 44678899998888888999999987
Q ss_pred C
Q 003846 583 K 583 (791)
Q Consensus 583 g 583 (791)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0013 Score=68.25 Aligned_cols=137 Identities=15% Similarity=0.132 Sum_probs=94.2
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecc--c-------C-----------ccc--HHHHHHHHHHHHhcCC-C
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSK--K-------S-----------GQG--LEELKNETMLIAKLQH-R 558 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~-------~-----------~~~--~~~~~~E~~~l~~l~H-~ 558 (791)
.-+.+.++||-|--+-||.+-..+|++.++|.=+. . . ... .-...+|...|+.+.. .
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 34677899999999999999888899999984211 0 0 111 1223468888888853 2
Q ss_pred -ceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 559 -NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 559 -niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
-+.+.+++ ...++|||++.+-.|...- ...+.. .+...+..-+.-|-.+| +||+|..--||++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeee------ecCChH---HHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 34455543 4568999999988875442 112223 33333444445566667 9999999999999
Q ss_pred cCCCCeEEeeecccccc
Q 003846 638 DTDMKPKISDFGMARMF 654 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~ 654 (791)
++++.++++||-.....
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999876543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.012 Score=62.37 Aligned_cols=119 Identities=19% Similarity=0.286 Sum_probs=75.6
Q ss_pred CcEEEEEEecc--cCcccHHHHHHHHHHHHhcCC--CceeeeeeEEEcCC--cceEEEeecCCCChhHHHhhhccccccC
Q 003846 526 GQEVAVKRLSK--KSGQGLEELKNETMLIAKLQH--RNLVRLLGCCLDQD--EKILIYEYLPNKSLDSFLFDRAKKRLLY 599 (791)
Q Consensus 526 g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~ 599 (791)
+++++|. ... ..........+|+++|+.+.- .-+.+.+++|.++. ..+.||+|++|..+...+...
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~------- 119 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE------- 119 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-------
Confidence 7778888 331 223345667788888888743 34556677777666 669999999884332221100
Q ss_pred HHHHHHHH-HHHHHHHHHhhc-------------------------------------------------------cCCC
Q 003846 600 WETRVKII-EGIAQGLLYLHQ-------------------------------------------------------YSRL 623 (791)
Q Consensus 600 ~~~~~~i~-~~ia~aL~~LH~-------------------------------------------------------~~~~ 623 (791)
.....++ ..+++.|+.||+ .++.
T Consensus 120 -~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 120 -SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred -cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 0001111 133333444432 1235
Q ss_pred CeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 624 RIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 624 ~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
.++|+|+++.||+++.++.+-|.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 799999999999999999999999999975
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.02 Score=62.77 Aligned_cols=73 Identities=12% Similarity=0.089 Sum_probs=51.0
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEeccc----C---cccHHHHHHHHHHHHhcC---CCceeeeeeEEEcCCcceEE
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKK----S---GQGLEELKNETMLIAKLQ---HRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV 576 (791)
.+.||.|....||+... .++.++||+-... . +....+-..|++.|+.+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999876 4567999975421 1 123444555677776653 347888888876 557889
Q ss_pred EeecCC
Q 003846 577 YEYLPN 582 (791)
Q Consensus 577 ~Ey~~~ 582 (791)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.018 Score=62.12 Aligned_cols=73 Identities=16% Similarity=0.245 Sum_probs=49.0
Q ss_pred eecccCceeEEEeEeeCC-cEEEEEEecc-------cCcccHHHHHHHHHHHHhcC--CC-ceeeeeeEEEcCCcceEEE
Q 003846 509 KLGEGGFGPVYKGELLNG-QEVAVKRLSK-------KSGQGLEELKNETMLIAKLQ--HR-NLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 509 ~LG~G~fg~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lV~ 577 (791)
.||.|....||++...+| +.|+||.-.. ..+-..++..-|.+.|+... -| .+++++. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999987654 6899995431 12334566667888886653 34 3444443 3566677999
Q ss_pred eecCCC
Q 003846 578 EYLPNK 583 (791)
Q Consensus 578 Ey~~~g 583 (791)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.021 Score=60.51 Aligned_cols=141 Identities=19% Similarity=0.197 Sum_probs=96.4
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEeccc-----C-----------------cccHHH----HHHHHHHHHhcCCCce
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKK-----S-----------------GQGLEE----LKNETMLIAKLQHRNL 560 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~-----~-----------------~~~~~~----~~~E~~~l~~l~H~ni 560 (791)
-..|..|--..||.+...+|..+|||+++-. + ....+. ...|++.|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3468889999999999889999999987521 0 001111 2468888888865554
Q ss_pred eeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC
Q 003846 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD 640 (791)
Q Consensus 561 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~ 640 (791)
.-.--+.. ...+|||+++....- .....+...++...+..+-.+++.-+.-|-+.+ +++|.||.--|+|+ .+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HD 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-EC
Confidence 32211111 244799999864222 111223445667778888888888888887766 59999999999988 56
Q ss_pred CCeEEeeeccccccC
Q 003846 641 MKPKISDFGMARMFG 655 (791)
Q Consensus 641 ~~~kl~DFgla~~~~ 655 (791)
|.+.|+|-+.+....
T Consensus 301 G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHD 315 (520)
T ss_pred CEEEEEEccccccCC
Confidence 789999998886543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.024 Score=61.80 Aligned_cols=74 Identities=14% Similarity=0.146 Sum_probs=51.3
Q ss_pred cceecccCceeEEEeEeeC-CcEEEEEEecc------cCcccHHHHHHHHHHHHhcC--CC-ceeeeeeEEEcCCcceEE
Q 003846 507 ENKLGEGGFGPVYKGELLN-GQEVAVKRLSK------KSGQGLEELKNETMLIAKLQ--HR-NLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--H~-niv~l~~~~~~~~~~~lV 576 (791)
.+.||.|.-.-||++...+ ++.|+||.-.. .-+-..++..-|.+.|+... -| .+++++. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 3679999999999998743 66899995421 12345677777888888763 34 3455553 355667889
Q ss_pred EeecCC
Q 003846 577 YEYLPN 582 (791)
Q Consensus 577 ~Ey~~~ 582 (791)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.046 Score=59.25 Aligned_cols=141 Identities=17% Similarity=0.247 Sum_probs=81.3
Q ss_pred ceecccCceeEEEeEeeC----CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELLN----GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL-VRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
+.|-.|-...+|+....+ +..|++|+....... .-.-.+|..+++.+...++ +++++++.. .+|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~----G~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN----GMIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC----cEeehhhcC
Confidence 456567778889886533 237889987654433 2334678899988865554 455655532 258999987
Q ss_pred CChhHH-------H-------hh-hccc----c-ccCHHHHHHHHHHH----------------------HHHHHHh---
Q 003846 583 KSLDSF-------L-------FD-RAKK----R-LLYWETRVKIIEGI----------------------AQGLLYL--- 617 (791)
Q Consensus 583 gsL~~~-------l-------~~-~~~~----~-~l~~~~~~~i~~~i----------------------a~aL~~L--- 617 (791)
.+|..- + .. +... . ...+..+.++..++ .+-+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 00 0000 0 11122222222211 1111111
Q ss_pred h-c-cCCCCeeecCCCCCcEEEcC-CCCeEEeeeccccc
Q 003846 618 H-Q-YSRLRIIHRDLKASNILLDT-DMKPKISDFGMARM 653 (791)
Q Consensus 618 H-~-~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~~ 653 (791)
. . ..+.-++|+|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1 12235899999999999975 57899999999864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.021 Score=57.57 Aligned_cols=31 Identities=39% Similarity=0.560 Sum_probs=22.2
Q ss_pred CCeeecCCCCCcEEE-cCCCCeEEeeeccccc
Q 003846 623 LRIIHRDLKASNILL-DTDMKPKISDFGMARM 653 (791)
Q Consensus 623 ~~iiH~Dlkp~NILl-~~~~~~kl~DFgla~~ 653 (791)
.-++|+|+.|.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 458999999999999 8899999999999863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 791 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-44 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-44 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-44 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-42 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-41 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 418 bits (1078), Expect = e-142
Identities = 112/299 (37%), Positives = 156/299 (52%), Gaps = 22/299 (7%)
Query: 489 LPLFSFASVSASTNNFSAE------NKLGEGGFGPVYKGELLNGQEVAVKRLSK----KS 538
FSF + TNNF NK+GEGGFG VYKG +N VAVK+L+ +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 70
Query: 539 GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLL 598
+ ++ E ++AK QH NLV LLG D D+ L+Y Y+PN SL L L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 599 YWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658
W R KI +G A G+ +LH+ IHRD+K++NILLD KISDFG+AR
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLG 718
T+RIVGT YM+PE L G + KSD++SFGV+LLEI++G H LL
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE-HREPQLLLD 245
Query: 719 HAWDLWKDNRAL-DLMDPILENEASYPM--LARYVNVALLCVHENATDRPTMSEVVSML 774
++ + + + D +D + + + +VA C+HE RP + +V +L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-138
Identities = 115/298 (38%), Positives = 174/298 (58%), Gaps = 6/298 (2%)
Query: 488 WLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLE-ELK 546
L FS + +++NFS +N LG GGFG VYKG L +G VAVKRL ++ QG E + +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 547 NETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL-LYWETRVK 605
E +I+ HRNL+RL G C+ E++L+Y Y+ N S+ S L +R + + L W R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR 665
I G A+GL YLH + +IIHRD+KA+NILLD + + + DFG+A++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-A 194
Query: 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGF---YHTGSLNLLGHAWD 722
+ GT G+++PEY G S K+DVF +GV+LLE+++G++ + + LL
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780
L K+ + L+D L+ + + + VALLC + +RP MSEVV ML + L
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-121
Identities = 105/313 (33%), Positives = 172/313 (54%), Gaps = 7/313 (2%)
Query: 465 SSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELL 524
S + + S + +TNNF + +G G FG VYKG L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 525 NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKS 584
+G +VA+KR + +S QG+EE + E ++ +H +LV L+G C +++E ILIY+Y+ N +
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 585 LDSFLFDRAKKRL-LYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP 643
L L+ + + WE R++I G A+GL YLH + IIHRD+K+ NILLD + P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 644 KISDFGMARMF-GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
KI+DFG+++ D+ +T + GT GY+ PEY ++G + KSDV+SFGV+L E+L
Sbjct: 179 KITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 703 KKNTGFYH-TGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENA 761
+ +NL A + + + ++DP L ++ L ++ + A+ C+ ++
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 762 TDRPTMSEVVSML 774
DRP+M +V+ L
Sbjct: 298 EDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 1e-90
Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 29/308 (9%)
Query: 492 FSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETML 551
++ + G FG V+K +L + VAVK + Q + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQN-EYEVYS 71
Query: 552 IAKLQHRNLVRLLGCCL----DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII 607
+ ++H N+++ +G + LI + SL FL K ++ W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 608 EGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660
E +A+GL YLH+ + I HRD+K+ N+LL ++ I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 661 ANTNRIVGTYGYMSPEYALEGL-----FSIKSDVFSFGVLLLEILSGKKNTGF----YHT 711
+T+ VGT YM+PE + ++ D+++ G++L E+ S Y
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 712 GSLNLLGHAWDL--WKDNRALDLMDPILENE-ASYPMLARYVNVALLCVHENATDRPTMS 768
+G L ++ P+L + + +A C +A R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 769 EVVSMLTN 776
V +T
Sbjct: 308 CVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 2e-77
Identities = 71/329 (21%), Positives = 124/329 (37%), Gaps = 46/329 (13%)
Query: 492 FSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNET-- 549
+ + S +N +G G +G VYKG L + + VAVK S + Q NE
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 550 MLIAKLQHRNLVRLLGCCL-----DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV 604
+ ++H N+ R + + E +L+ EY PN SL +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 605 KIIEGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG-- 656
++ + +GL YLH + + I HRDL + N+L+ D ISDFG++ G
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 657 ----DELQANTNRIVGTYGYMSPEYALEGLFSI--------KSDVFSFGVLLLEILSGKK 704
E VGT YM+PE LEG ++ + D+++ G++ EI
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 705 NTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN----------EASYPMLARYVNVAL 754
+ + + ++ D+ + + + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 755 LCVHENATDRPTMSEVVSMLTNEHLVLPR 783
C ++A R T + ++ R
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-62
Identities = 68/277 (24%), Positives = 125/277 (45%), Gaps = 30/277 (10%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLL 564
+ K+G G FG V++ +G +VAVK L ++ + + E E ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
G ++ EYL SL L + L R+ + +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
I+HR+LK+ N+L+D K+ DFG++R+ L + + GT +M+PE + +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSN 217
Query: 685 IKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYP 744
KSDV+SFGV+L E+ + ++ W + ++ +
Sbjct: 218 EKSDVYSFGVILWELATLQQ------------------PWGNLNPAQVVAAVGFKCKR-L 258
Query: 745 MLARYVNVALL-----CVHENATDRPTMSEVVSMLTN 776
+ R +N + C RP+ + ++ +L
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-62
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 24/271 (8%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
E +G G FG V K + ++VA+K++ +S + E ++++ H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
CL+ L+ EY SL + L + +QG+ YLH +I
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 627 HRDLKASNILLDTDMK-PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
HRDLK N+LL KI DFG A ++Q + G+ +M+PE +S
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 686 KSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745
K DVFS+G++L E+++ +K + W + R P+++N +
Sbjct: 183 KCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTRP-----PLIKN-----L 229
Query: 746 LARYVNVALLCVHENATDRPTMSEVVSMLTN 776
++ C ++ + RP+M E+V ++T+
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-60
Identities = 71/309 (22%), Positives = 117/309 (37%), Gaps = 49/309 (15%)
Query: 507 ENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG+G FG K G+ + +K L + + E ++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
I EY+ +L + ++ W RV + IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR------------IVGTYGYM 673
IHRDL + N L+ + ++DFG+AR+ ++ Q R +VG +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
+PE + K DVFSFG++L EI+ A + M
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLPRT----M 230
Query: 734 DPILENEASYPMLA------RYVNVALLCVHENATDRPTMSEVVSML------TNEHLVL 781
D L + + + C + RP+ ++ L HL L
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
Query: 782 PRRNNQLSR 790
+ QL R
Sbjct: 291 GPQLEQLDR 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-60
Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 35/282 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRL----SKKSGQGLEELKNETMLIAKLQHRNLVR 562
E +G GGFG VY+ G EVAVK + Q +E ++ E L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
L G CL + L+ E+ L+ L + + + V IA+G+ YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 623 LRIIHRDLKASNILLDTDMKP--------KISDFGMARMFGGDELQANTNRIVGTYGYMS 674
+ IIHRDLK+SNIL+ ++ KI+DFG+AR + + G Y +M+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMA 182
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
PE +FS SDV+S+GVLL E+L+G+ + ++ L A+ + + AL
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFR--GIDGLAVAYGVAMNKLAL---- 233
Query: 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
PI + + C + + RP+ + ++ LT
Sbjct: 234 PIPST-----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-59
Identities = 72/285 (25%), Positives = 135/285 (47%), Gaps = 37/285 (12%)
Query: 507 ENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQG-------LEELKNETMLIAKLQHR 558
E ++G+GGFG V+KG L+ + VA+K L +G +E + E +++ L H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N+V+L G + ++ E++P L L K + W +++++ IA G+ Y+
Sbjct: 84 NIVKLYGLMHNP--PRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 619 QYSRLRIIHRDLKASNILLDT-----DMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
I+HRDL++ NI L + + K++DFG+++ + + + ++G + +M
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 674 SPE--YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731
+PE A E ++ K+D +SF ++L IL+G+ + S + + ++
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREEGLRP- 249
Query: 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
I E+ R NV LC + RP S +V L+
Sbjct: 250 ---TIPED-----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 8e-58
Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 23/273 (8%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLL 564
++G G FG VYKG +G +VAVK L+ + Q L+ KNE ++ K +H N++ +
Sbjct: 29 GQRIGSGSFGTVYKG-KWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
G I + ++ SL L A + + + I A+G+ YLH
Sbjct: 87 GYSTAPQLAI-VTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE---YALEG 681
IIHRDLK++NI L D KI DFG+A ++ G+ +M+PE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
+S +SDV++FG++L E+++G+ Y N + + + + + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP---YS-NINNRDQIIEMVGRGSL----SPDLSKVRS 252
Query: 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ P R + C+ + +RP+ +++ +
Sbjct: 253 NCP--KRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-57
Identities = 56/276 (20%), Positives = 110/276 (39%), Gaps = 33/276 (11%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLL 564
KL E G ++KG G ++ VK L + S + + E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 565 GCCLDQDEKIL--IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
G C I ++P SL + L + ++ VK +A+G+ +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG- 681
L I L + ++++D DM +IS + F + + +++PE AL+
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKK 183
Query: 682 ---LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
+D++SF VLL E+++ + + L+ + + + + I
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREV---PFA--DLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ +C++E+ RP +V +L
Sbjct: 239 ---------HVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-56
Identities = 70/297 (23%), Positives = 129/297 (43%), Gaps = 40/297 (13%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLL 564
+G+G FG VY G +G EVA++ + + + L+ K E M + +H N+V +
Sbjct: 38 GELIGKGRFGQVYHG-RWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
G C+ +I ++L S + R K +L +I + I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI---VGTYGYMSPE----- 676
I+H+DLK+ N+ D + K I+DFG+ + G + +++ G +++PE
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 677 ----YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732
+ FS SDVF+ G + E+ + + + + W + +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FK--TQPAEAIIWQMGTGMK---- 260
Query: 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNNQLS 789
+ + ++ L C +RPT ++++ ML LP+RN +LS
Sbjct: 261 PNLS---QIGMG--KEISDILLFCWAFEQEERPTFTKLMDMLEK----LPKRNRRLS 308
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-55
Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 43/300 (14%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNET--MLIAKLQHRNLVRLL 564
+G+G +G V++G G+ VAVK S + + ET L+H N++ +
Sbjct: 13 LECVGKGRYGEVWRG-SWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 565 GCCLDQDEKI----LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH-- 618
+ LI Y SL +L + L + ++I+ IA GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 619 ---QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIVGTYGYM 673
+ I HRDLK+ NIL+ + + I+D G+A M ++L N VGT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 674 SPE------YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW-DLWKD 726
+PE + D+++FG++L E+ + G + D+ +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-----PFYDVVPN 239
Query: 727 NRALDLMD----------PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ + + M I S P L + C ++N + R T + LT
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-53
Identities = 71/296 (23%), Positives = 119/296 (40%), Gaps = 35/296 (11%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNET--MLIAKLQHRNLVRLL 564
++G+G +G V+ G G++VAVK ET ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMG-KWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 565 GCCLDQDEKI----LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH-- 618
+ LI +Y N SL +L K L ++ +K+ GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 619 ---QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIVGTYGYM 673
+ I HRDLK+ NIL+ + I+D G+A F +E+ N VGT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 674 SPEYALEGL-------FSIKSDVFSFGVLLLEILSGKKNTGF---YHTGSLNLLGH--AW 721
PE L+ I +D++SFG++L E+ + G Y +L+ ++
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 722 DLWKDNRALDLMDP-ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ ++ + + P +S L + + C N R T V L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 8e-52
Identities = 69/300 (23%), Positives = 116/300 (38%), Gaps = 43/300 (14%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNET--MLIAKLQHRNLVRLL 564
+ +G+G FG V++G G+EVAVK S + E L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRG-KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 565 GCCLDQDEKI----LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ- 619
+ L+ +Y + SL +L + + E +K+ A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 620 ----YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIVGTYGYM 673
+ I HRDLK+ NIL+ + I+D G+A D + N VGT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 674 SPEYALEGL-------FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD 726
+PE L+ ++D+++ G++ EI G + L +DL
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY----YDLVPS 273
Query: 727 NRALDLMD----------PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ +++ M I S L + C + N R T + L+
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-48
Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 36/290 (12%)
Query: 507 ENKLGEGGFGPVYKGELL-----NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+LG+G FG V G+ VAVK+L + + L + + E ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 562 RLLGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ G C + LI EYLP SL +L + K + ++ I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG-----YMS 674
R IHRDL NIL++ + + KI DFG+ ++ D+ V G + +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYA 185
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
PE E FS+ SDV+SFGV+L E+ + + + + ++G+ L++
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF--HLIE 243
Query: 735 PILENEASYPMLAR--------YVNVALLCVHENATDRPTMSEVVSMLTN 776
+ N L R Y + C + N RP+ ++ +
Sbjct: 244 LLKNNG----RLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 36/290 (12%)
Query: 507 ENKLGEGGFGPVYKGELL-----NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+LG+G FG V G+ VAVK+L + + L + + E ++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 562 RLLGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ G C + LI EYLP SL +L + K + ++ I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG-----YMS 674
R IHRDL NIL++ + + KI DFG+ ++ D+ V G + +
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYA 216
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
PE E FS+ SDV+SFGV+L E+ + + + + ++G+ L++
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF--HLIE 274
Query: 735 PILENEASYPMLAR--------YVNVALLCVHENATDRPTMSEVVSMLTN 776
+ N L R Y + C + N RP+ ++ +
Sbjct: 275 LLKNNG----RLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 70/283 (24%), Positives = 108/283 (38%), Gaps = 43/283 (15%)
Query: 507 ENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELK---NETMLIAKLQHRNLVR 562
++G G FG V+ G L + VAVK + + E ++ + H N+VR
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
L+G C + ++ E + +FL R + L +T ++++ A G+ YL
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES--- 231
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
IHRDL A N L+ KISDFGM+R A+ + +PE G
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 683 FSIKSDVFSFGVLLLEILS-------GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735
+S +SDV+SFG+LL E S N + K R +
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-----------FVEKGGR----LPC 336
Query: 736 ILENEASYPMLA--RYVNVALLCVHENATDRPTMSEVVSMLTN 776
P L + C RP+ S + L +
Sbjct: 337 --------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-47
Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
++G G FG V+ G LN +VA+K + ++ E+ E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
CL+Q L+ E++ + L +L R ++ L ET + + + +G+ YL +I
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLF 683
HRDL A N L+ + K+SDFGM R D+ ++T GT + SPE +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182
Query: 684 SIKSDVFSFGVLLLEILS 701
S KSDV+SFGVL+ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 83/290 (28%), Positives = 120/290 (41%), Gaps = 38/290 (13%)
Query: 507 ENKLGEGGFGPVYKGELLN-----GQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNL 560
LGEG FG V G+ VAVK L +G Q K E ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 561 VRLLGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
++ GCC D L+ EY+P SL +L + + + + I +G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG-----YM 673
IHRDL A N+LLD D KI DFG+A+ V G +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWY 204
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
+PE E F SDV+SFGV L E+L+ ++ T L L+G A R +L+
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 734 DPILENEASYPM-------LARYVNVALLCVHENATDRPTMSEVVSMLTN 776
E + Y ++ C A+ RPT ++ +L
Sbjct: 265 ------ERGERLPRPDKCPAEVY-HLMKNCWETEASFRPTFENLIPILKT 307
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 39/291 (13%)
Query: 507 ENKLGEGGFGPVYKGELL-----NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
++LG+G FG V G VAVK+L + + E ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 562 RLLGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ G + L+ EYLP+ L FL + + L + I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG-----YMS 674
R +HRDL A NIL++++ KI+DFG+A++ D+ +V G + +
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 198
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
PE + +FS +SDV+SFGV+L E+ + K+ + S L L+
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLL 254
Query: 734 DPILENEASYPMLAR--------YVNVALLCVHENATDRPTMSEVVSMLTN 776
+ + E + L + + LC + DRP+ S + L
Sbjct: 255 ELLEEGQ----RLPAPPACPAEVH-ELMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+LG G FG V G+ +VAVK + K+ +E E + KL H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
C + ++ EY+ N L ++L R+ + L +++ + +G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLF 683
HRDL A N L+D D+ K+SDFGM R D+ ++ GT + +PE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKY 182
Query: 684 SIKSDVFSFGVLLLEILS 701
S KSDV++FG+L+ E+ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G+G FG V G+ G +VAVK + K+ + E ++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 567 CLDQDEKILI-YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
+++ + I EY+ SL +L R + L + +K + + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG-GDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG------YMSPEYAL 679
+HRDL A N+L+ D K+SDFG+ + + + +PE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAPEALR 187
Query: 680 EGLFSIKSDVFSFGVLLLEILS 701
E FS KSDV+SFG+LL EI S
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+LG G FG V G+ +VA+K + K+ +E E ++ L H LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
C Q +I EY+ N L ++L R + + +++ + + + + YL + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLF 683
HRDL A N L++ K+SDFG++R DE ++ G+ + PE + F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198
Query: 684 SIKSDVFSFGVLLLEILS 701
S KSD+++FGVL+ EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-46
Identities = 72/288 (25%), Positives = 123/288 (42%), Gaps = 36/288 (12%)
Query: 507 ENKLGEGGFGPVYKGELL-----NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNL 560
LGEG FG V G++VAVK L +SG + +LK E ++ L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 561 VRLLGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
V+ G C + LI E+LP+ SL +L K + + ++K I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG-----YM 673
+ +HRDL A N+L++++ + KI DFG+ + D+ V +
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWY 196
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
+PE ++ F I SDV+SFGV L E+L+ + L ++G R ++ +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
Query: 734 DPILENEASYPM-------LARYVNVALLCVHENATDRPTMSEVVSML 774
+ + Y + C ++R + ++
Sbjct: 257 ------KEGKRLPCPPNCPDEVY-QLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-45
Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 33/275 (12%)
Query: 507 ENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
++KLG G +G VY+G VAVK L K+ +EE E ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
C + +I E++ +L +L + ++ + + + I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-AVVLLYMATQISSAMEYL---EKKNF 339
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
IHR+L A N L+ + K++DFG++R+ GD A+ + +PE FSI
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398
Query: 686 KSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745
KSDV++FGVLL EI + G + D + + + E Y M
Sbjct: 399 KSDVWAFGVLLWEIAT---------------YGMSPYPGIDLS--QVYELL---EKDYRM 438
Query: 746 LA------RYVNVALLCVHENATDRPTMSEVVSML 774
+ + C N +DRP+ +E+
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 507 ENKLGEGGFGPVYKGELLNG------QEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
+ +LGEG FG V+ E N VAVK L + ++ + E L+ LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-------------VKII 607
V+ G C D D I+++EY+ + L+ FL ++ + + + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTN-- 664
IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + +
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 665 ---RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
R +M PE + F+ +SDV+SFGV+L EI +
Sbjct: 197 LPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-45
Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 54/290 (18%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE-----VAVKRLSKKSGQG-LEELKNETMLIAKLQHRNL 560
LG G FG VYKG + E VA+K L + + +E+ +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
RLLG CL LI + +P L ++ R K + + + IA+G+ YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG-----YMSP 675
R++HRDL A N+L+ T KI+DFG+A++ G +E + + G +M+
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMAL 188
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA--WDLWKDNRALDLM 733
E L +++ +SDV+S+GV + E+++ G + ++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT---------------FGSKPYDGI--PAS--EIS 229
Query: 734 DPILENEASY----PML---ARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ E P + Y + C +A RP E++ +
Sbjct: 230 SIL---EKGERLPQPPICTIDVY-MIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-45
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 507 ENKLGEGGFGPVYKGELLNG----QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLV 561
+G G FG VY G LL+ AVK L++ + + E +++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 562 RLLGCCLDQDEKIL-IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
LLG CL + L + Y+ + L +F+ R + + + +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG------YMS 674
+ + +HRDL A N +LD K++DFG+AR D + G +M+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILS 701
E F+ KSDV+SFGVLL E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-45
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G+G FG V G+ G +VAVK + K+ + E ++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 567 CLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
+++ + ++ EY+ SL +L R + L + +K + + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG-GDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG------YMSPEYAL 679
+HRDL A N+L+ D K+SDFG+ + + +PE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 359
Query: 680 EGLFSIKSDVFSFGVLLLEILS 701
E FS KSDV+SFG+LL EI S
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE------VAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
+ +LGEG FG V+ E N VAVK L + S ++ + E L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR------------VKIIE 608
VR G C + ++++EY+ + L+ FL L + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG 668
+A G++YL + L +HRDL N L+ + KI DFGM+R D + R VG
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217
Query: 669 TYG-----YMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M PE L F+ +SDV+SFGV+L EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 507 ENKLGEGGFGPVYKGELLNG-QEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
++KLG G +G VY+G VAVK L K+ +EE E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
C + +I E++ +L +L + ++ + + + I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-AVVLLYMATQISSAMEYL---EKKNF 132
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN-----RIVGTYGYMSPEYALE 680
IHRDL A N L+ + K++DFG++R+ GD A+ + + +PE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186
Query: 681 GLFSIKSDVFSFGVLLLEILS 701
FSIKSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 73/221 (33%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 507 ENKLGEGGFGPVYKGELLNG------QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRN 559
+LGE FG VYKG L Q VA+K L K G EE ++E ML A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-------------VKI 606
+V LLG +I+ Y + L FL R+ + V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTN- 664
+ IA G+ YL S ++H+DL N+L+ + KISD G+ R ++ D + N
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 665 ----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
R +M+PE + G FSI SD++S+GV+L E+ S
Sbjct: 191 LLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE----VAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLV 561
+ +G+G FG VY GE ++ + A+K LS+ + +E E +L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 562 RLLGCCLDQDEKILI-YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
L+G L + + Y+ + L F+ R+ +R + + +A+G+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY--GYMSPEYA 678
+ + +HRDL A N +LD K++DFG+AR E + + + E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 679 LEGLFSIKSDVFSFGVLLLEILS 701
F+ KSDV+SFGVLL E+L+
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 70/198 (35%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+LG G FG V+ G +VAVK L K+ + E L+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
+ I I EY+ N SL FL + +L + + IA+G+ ++ I
Sbjct: 77 VTQEPIYI-ITEYMENGSLVDFLKTPSGIKLT-INKLLDMAAQIAEGMAFI---EERNYI 131
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLF 683
HRDL+A+NIL+ + KI+DFG+AR+ +E A G + +PE G F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187
Query: 684 SIKSDVFSFGVLLLEILS 701
+IKSDV+SFG+LL EI++
Sbjct: 188 TIKSDVWSFGILLTEIVT 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-44
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 507 ENKLGEGGFGPVYKGELL----NGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQHRN 559
E +G G G V G L VA+K L K+G + ++ E ++ + H N
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
++RL G +++ EY+ N SLD+FL R V ++ G+ G+ YL
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL-- 167
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY------- 672
S L +HRDL A N+L+D+++ K+SDFG++R+ D
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTTGGK 215
Query: 673 -----MSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+PE FS SDV+SFGV++ E+L+
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-43
Identities = 66/198 (33%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
E KLG G FG V+ +VAVK + K +E E ++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
+ I I E++ SL FL + + IA+G+ ++ + I
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPEYALEGLF 683
HRDL+A+NIL+ + KI+DFG+AR+ +E A G + +PE G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362
Query: 684 SIKSDVFSFGVLLLEILS 701
+IKSDV+SFG+LL+EI++
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE-----VAVKRLSKKSG-QGLEELKNETMLIAKLQHRNL 560
LG G FG V+KG + E V +K + KSG Q + + + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
VRLLG C ++ + +YLP SL + R + L + + IA+G+ YL
Sbjct: 78 VRLLGLCPGSSLQL-VTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG-----YMSP 675
++HR+L A N+LL + + +++DFG+A + D+ Q + +M+
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMAL 186
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILS 701
E G ++ +SDV+S+GV + E+++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 507 ENKLGEGGFGPVYKGELLNG----QEVAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLV 561
+G G FG VY G LL+ AVK L++ + G + + E +++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 562 RLLGCCLDQDEKIL-IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
LLG CL + L + Y+ + L +F+ R + + + +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG------YMS 674
+ + +HRDL A N +LD K++DFG+AR D + + G +M+
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILS 701
E F+ KSDV+SFGVLL E+++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE---VAVKRLSKKSGQGLEELKN---ETMLIAKLQHRNL 560
+ +LG G FG V +G ++ VA+K L K G + + E ++ +L + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
VRL+G C + + + E L FL K+ + +++ ++ G+ YL
Sbjct: 73 VRLIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG------YMS 674
+HRDL A N+LL KISDFG+++ G D+ + + +
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYA 181
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILS 701
PE FS +SDV+S+GV + E LS
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-43
Identities = 81/274 (29%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
E KLG+G FG V+ G VA+K L K E E ++ KL+H LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
++ I + EY+ SL FL + L V + IA G+ Y+ R+ +
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIK 686
HRDL+A+NIL+ ++ K++DFG+AR+ +E A + +PE AL G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 687 SDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPML 746
SDV+SFG+LL E+ + G NR +++D + E Y M
Sbjct: 362 SDVWSFGILLTELTT---------------KGRVPYPGMVNR--EVLDQV---ERGYRMP 401
Query: 747 A------RYVNVALLCVHENATDRPTMSEVVSML 774
++ C + +RPT + + L
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 26/209 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE-----VAVKRLSKKSGQGLEELKN---ETMLIAKLQHR 558
+ +G G FG VYKG L VA+K L K+G ++ + E ++ + H
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N++RL G ++I EY+ N +LD FL R K V ++ GIA G+ YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL- 163
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG------Y 672
+ + +HRDL A NIL+++++ K+SDFG++R+ D T T G +
Sbjct: 164 --ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRW 216
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+PE F+ SDV+SFG+++ E+++
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 5e-43
Identities = 81/274 (29%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
E KLG+G FG V+ G VA+K L K E E ++ KL+H LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
++ I + EY+ SL FL + L V + IA G+ Y+ R+ +
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIK 686
HRDL+A+NIL+ ++ K++DFG+AR+ +E A + +PE AL G F+IK
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 687 SDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPML 746
SDV+SFG+LL E+ + G NR +++D + E Y M
Sbjct: 445 SDVWSFGILLTELTT---------------KGRVPYPGMVNR--EVLDQV---ERGYRMP 484
Query: 747 A------RYVNVALLCVHENATDRPTMSEVVSML 774
++ C + +RPT + + L
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 22/211 (10%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQE-----VAVKRLSKKSGQG-LEELKNETMLIAKL 555
F LG G FG VYKG + E VA+K L + + +E+ +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
+ ++ RLLG CL LI + +P L ++ R K + + + IA+G+
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG---- 671
YL R++HRDL A N+L+ T KI+DFG+A++ G +E + + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 672 -YMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+ E L +++ +SDV+S+GV + E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-43
Identities = 63/299 (21%), Positives = 109/299 (36%), Gaps = 68/299 (22%)
Query: 507 ENKLGEGGFGPVYKGEL--------LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR 558
LG+G F ++KG L+ EV +K L K E +++KL H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
+LV G C+ DE IL+ E++ SLD++L + K + ++++ + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL- 129
Query: 619 QYSRLRIIHRDLKASNILLDTDMKP--------KISDFGMARMFGGDELQANTNRIVGTY 670
+IH ++ A NILL + K+SD G++ +
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------I 176
Query: 671 GY-----MSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA-WDL 723
+ PE ++ +D +SFG L EI S G
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS---------------GGDKPLSA 221
Query: 724 WKDNRALDL------MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
R L + P A N+ C+ RP+ ++ L +
Sbjct: 222 LDSQRKLQFYEDRHQLPA--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 83/282 (29%), Positives = 122/282 (43%), Gaps = 35/282 (12%)
Query: 447 KYREEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSAST----- 501
+ + P+ + L F +E E + S + P + FA ++S
Sbjct: 8 HHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKE 67
Query: 502 ---NNFSAENKLGEGGFGPVYKGELLNG------QEVAVKRLSKK-SGQGLEELKNETML 551
N + LG G FG VY+G++ +VAVK L + S Q + E ++
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 552 IAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR----AKKRLLYWETRVKII 607
I+K H+N+VR +G L + ++ E + L SFL + ++ L + +
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTN 664
IA G YL IHRD+ A N LL KI DFGMAR D +A
Sbjct: 188 RDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYY 240
Query: 665 RIVGTYGY-----MSPEYALEGLFSIKSDVFSFGVLLLEILS 701
R G M PE +EG+F+ K+D +SFGVLL EI S
Sbjct: 241 R-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 48/286 (16%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
+F +G GGFG V+K + ++G+ +KR+ + E+ + E +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 561 VRLLGCCLDQDEKI----------------LIYEYLPNKSLDSFLFDRAKKRLLYWETRV 604
V GC D + E+ +L+ ++ ++ + L +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN 664
++ E I +G+ Y+H ++I+RDLK SNI L + KI DFG+ D
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RT 179
Query: 665 RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724
R GT YMSPE + + D+++ G++L E+L T F
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFE--------------- 223
Query: 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
DL D I+ + + + + LL DRP SE+
Sbjct: 224 TSKFFTDLRDGIISD--IFDKKEKTLLQKLLSK--KPEDRPNTSEI 265
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE----VAVKRLSKK--SGQGLEELKNETMLIAKLQHRNL 560
LGEG FG V +G L VAVK + S + +EE +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 561 VRLLGCCLDQD-----EKILIYEYLPNKSLDSFLFDR---AKKRLLYWETRVKIIEGIAQ 612
+RLLG C++ + ++I ++ L ++L + + +T +K + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTN-----RI 666
G+ YL S +HRDL A N +L DM ++DFG+++ ++ GD + +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214
Query: 667 VGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+++ E + +++ KSDV++FGV + EI +
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNG------QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRN 559
LG G FG VY+G++ +VAVK L + S Q + E ++I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR----AKKRLLYWETRVKIIEGIAQGLL 615
+VR +G L + ++ E + L SFL + ++ L + + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 616 YLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
YL IHRD+ A N LL KI DFGMAR D +A+ R G
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAM 206
Query: 673 -----MSPEYALEGLFSIKSDVFSFGVLLLEILS 701
M PE +EG+F+ K+D +SFGVLL EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE----VAVKRLSKKSGQGLEELKN---ETMLIAKLQHRN 559
+ +G G FG V G L + VA+K L K G ++ ++ E ++ + H N
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
++RL G +++ EY+ N SLDSFL R V ++ GIA G+ YL
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL-- 163
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPE 676
S + +HRDL A NIL+++++ K+SDFG+ R+ D A T R G + SPE
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPE 220
Query: 677 YALEGLFSIKSDVFSFGVLLLEILS 701
F+ SDV+S+G++L E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 507 ENKLGEGGFGPVYKGELL----NGQEVAVKRL---SKKSGQGLEELKNETMLIAKLQHRN 559
KLG+G FG V +GE VAVK L + +++ E + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
L+RL G L K+ + E P SL L R + T + +A+G+ YL
Sbjct: 83 LIRLYGVVLTPPMKM-VTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL-- 137
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT---YGYMSPE 676
R IHRDL A N+LL T KI DFG+ R ++ + + +PE
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 194
Query: 677 YALEGLFSIKSDVFSFGVLLLEILS 701
FS SD + FGV L E+ +
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 38/229 (16%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL--------NGQEVAVKRLSKK-SGQGLEELKNETMLI 552
+ + LGEG FG V E + VAVK L + + L +L +E ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 553 AKL-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-- 609
+ +H+N++ LLG C +I EY +L +L R + Y ++ E
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGD 657
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 658 ELQANTN-----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+ TN + +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 67/274 (24%), Positives = 125/274 (45%), Gaps = 22/274 (8%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRL---SKKSGQGLEELKNETMLIAKLQH 557
NF E K+G G F VY+ LL+G VA+K++ + + E L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLLY 616
N+++ ++ +E ++ E L + K++ L E V K + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
+H R++HRD+K +N+ + K+ D G+ R F A++ +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
E ++ KSD++S G LL E+ + + ++ +NL + + + P+
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCD-----YPPL 258
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
+ S + + +C++ + RP ++ V
Sbjct: 259 PSDHYSEEL----RQLVNMCINPDPEKRPDVTYV 288
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 507 ENKLGEGGFGPVYKGELLNG----QEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNL 560
LG+G FG V + +L +VAVK L + +EE E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 561 VRLLGCCLDQDEKI------LIYEYLPNKSLDSFLFDR---AKKRLLYWETRVKIIEGIA 611
+L+G L K +I ++ + L +FL L +T V+ + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTN-----R 665
G+ YL S IHRDL A N +L DM ++DFG++R ++ GD + +
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+++ E + L+++ SDV++FGV + EI++
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 508 NKLGEGGFGPVYKGELLNGQE------VAVKRLSKK-SGQGLEELKNETMLIAKLQHRNL 560
+LG+G FG VY+G + VA+K +++ S + E NE ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFL-------FDRAKKRLLYWETRVKIIEGIAQG 613
VRLLG ++I E + L S+L + +++ IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTN-----RIV 667
+ YL + + +HRDL A N ++ D KI DFGM R ++ D + R
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+MSPE +G+F+ SDV+SFGV+L EI +
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-42
Identities = 79/312 (25%), Positives = 129/312 (41%), Gaps = 68/312 (21%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL--------NGQEVAVKRLSKK-SGQGLEELKNETMLI 552
+ + LGEG FG V E + VAVK L + + L +L +E ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 553 AKL-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-- 609
+ +H+N++ LLG C +I EY +L +L R + Y ++ E
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 610 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGD 657
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 658 ELQANTN-----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-------GKKN 705
+ TN + +M+PE + +++ +SDV+SFGVL+ EI + G
Sbjct: 258 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311
Query: 706 TGFYHTGSLNLLGHAWDLWKDNRALDLMD-PILENEASYPMLARYVNVALLCVHENATDR 764
+ L + +R MD P Y + C H + R
Sbjct: 312 EELFK-----------LLKEGHR----MDKPANCTNELY-------MMMRDCWHAVPSQR 349
Query: 765 PTMSEVVSMLTN 776
PT ++V L
Sbjct: 350 PTFKQLVEDLDR 361
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-42
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 43/229 (18%)
Query: 507 ENKLGEGGFGPVYKGELLNG------QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRN 559
+GEG FG V++ VAVK L ++ S + + E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR---------------- 603
+V+LLG C L++EY+ L+ FL + +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 604 -----VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGD 657
+ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R ++ D
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 658 ELQANTN-----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+A+ N R +M PE ++ +SDV+++GV+L EI S
Sbjct: 229 YYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 507 ENKLGEGGFGPVYKGELLNG------QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRN 559
LGEG FG V K + VAVK L + S L +L +E ++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG---------- 609
+++L G C +LI EY SL FL + K Y +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 610 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGD 657
I+QG+ YL + ++++HRDL A NIL+ K KISDFG++R ++ D
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 658 ELQANTN-----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+ + +M+ E + +++ +SDV+SFGVLL EI++
Sbjct: 205 SYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-42
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE---VAVKRLSKK--SGQGLEELKNETMLIAKL-QHRNL 560
++ +GEG FG V K + A+KR+ K+ S + E ++ KL H N+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-------------VKII 607
+ LLG C + L EY P+ +L FL +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN--- 664
+A+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R G + T
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 665 --RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
R +M+ E +++ SDV+S+GVLL EI+S
Sbjct: 204 PVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 508 NKLGEGGFGPVYKGELLN------GQEVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRN 559
LG G FG V + + + VAVK L + + L +E ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 560 LVRLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG--------- 609
+V LLG C + +I E+ +L ++L + + + Y + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 610 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTN 664
+A+G+ +L + + IHRDL A NILL KI DFG+AR ++ + +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 665 -----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+ +M+PE + +++I+SDV+SFGVLL EI S
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 28/224 (12%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQE------VAVKRLSKK-SGQGLEELKNETMLIAK 554
N S LG G FG V + + VAVK L E L +E +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 555 L-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG---- 609
L H N+V LLG C ++I EY L +FL + + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 610 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGD 657
+A+G+ +L + IHRDL A NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
N + +M+PE +++ +SDV+S+G+ L E+ S
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 72/293 (24%), Positives = 115/293 (39%), Gaps = 44/293 (15%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLS-KKSGQGLEELKNETMLIAKLQHRN 559
+F LG GGFG V++ + ++ A+KR+ E++ E +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 560 LVRLLGCCLDQDE---------KILIY---EYLPNKSLDSFLFDRAKKRLLYWETRVKII 607
+VR L+++ K+ +Y + ++L ++ R + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT---- 663
IA+ + +LH ++HRDLK SNI D K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 664 ------NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLL 717
VGT YMSPE +S K D+FS G++L E+L F T +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFS-TQMERVR 235
Query: 718 GHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
D R L P+ YP V + + +RP +
Sbjct: 236 -----TLTDVRNLK-FPPLFTQ--KYPCEYVMVQ---DMLSPSPMERPEAINI 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 507 ENKLGEGGFGPVYKGELLNG---QEVAVKRLSKKSG----QGLEELKNETMLIAKLQHRN 559
+ +LG G FG V KG + VAVK L K+ +EL E ++ +L +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+VR++G C + + + E L+ +L + + + + ++++ ++ G+ YL
Sbjct: 80 IVRMIGICEAESWML-VMEMAELGPLNKYL--QQNRHVK-DKNIIELVHQVSMGMKYL-- 133
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG------YM 673
+HRDL A N+LL T KISDFG+++ DE +
Sbjct: 134 -EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWY 187
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILS 701
+PE FS KSDV+SFGVL+ E S
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 493 SFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETM 550
F S+S +S ++G GG V++ Q A+K ++ + Q L+ +NE
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 551 LIAKLQHRNL--VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIE 608
+ KLQ + +RL + ++ E N L+S+L + KK + WE + +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWK 134
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG 668
+ + + +HQ+ I+H DLK +N L+ D K+ DFG+A D + VG
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 669 TYGYMSPEYALEGL------------FSIKSDVFSFGVLLLEILSGK 703
T YM PE A++ + S KSDV+S G +L + GK
Sbjct: 191 TVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE----VAVKRLSK-KSGQGLEELKNETMLIAKLQHRNLV 561
LGEG FG VY+G N + VAVK K + E+ +E +++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+L+G ++ I I E P L +L K L T V I + + YL
Sbjct: 77 KLIGIIEEEPTWI-IMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---E 130
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY--------- 672
+ +HRD+ NIL+ + K+ DFG++R ++ Y
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-------------YYKASVTRLP 177
Query: 673 ---MSPEYALEGLFSIKSDVFSFGVLLLEILS 701
MSPE F+ SDV+ F V + EILS
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE----VAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLV 561
+GEG FG V++G ++ + VA+K S E+ E + + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+L+G + I I E L SFL + +K L + + ++ L YL
Sbjct: 80 KLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---E 133
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY--------- 672
R +HRD+ A N+L+ ++ K+ DFG++R Y
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------------YYKASKGKLP 180
Query: 673 ---MSPEYALEGLFSIKSDVFSFGVLLLEILS 701
M+PE F+ SDV+ FGV + EIL
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHR 558
+ K+GEG FG + +G++ +K +S+ S + EE + E ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N+V+ + ++ +Y L + + K L + + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+I+HRD+K+ NI L D ++ DFG+AR+ A +GT Y+SPE
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK 703
++ KSD+++ G +L E+ + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-41
Identities = 63/263 (23%), Positives = 107/263 (40%), Gaps = 33/263 (12%)
Query: 465 SSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAEN--------KLGEGGFG 516
+ E + + + L S+S N + ++G GG
Sbjct: 11 VPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSS 70
Query: 517 PVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNL--VRLLGCCLDQDE 572
V++ Q A+K ++ + Q L+ +NE + KLQ + +RL +
Sbjct: 71 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130
Query: 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKA 632
++ E N L+S+L + KK + WE + + + + +HQ+ I+H DLK
Sbjct: 131 IYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKN-MLEAVHTIHQH---GIVHSDLKP 183
Query: 633 SNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL---------- 682
+N L+ D K+ DFG+A D + VG YM PE A++ +
Sbjct: 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSRENGKSK 241
Query: 683 --FSIKSDVFSFGVLLLEILSGK 703
S KSDV+S G +L + GK
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGK 264
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-41
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 10/210 (4%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHR 558
++ +G G +G K +G+ + K + + L +E L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 559 NLVRLLGCCLDQDEKIL--IYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLL 615
N+VR +D+ L + EY L S + K+R E V +++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 616 YLHQ--YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
H+ ++HRDLK +N+ LD K+ DFG+AR+ D A T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
SPE ++ KSD++S G LL E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 68/298 (22%), Positives = 122/298 (40%), Gaps = 40/298 (13%)
Query: 497 VSASTNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL 555
V ++ KLGEGGF V E L +G A+KR+ Q EE + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 556 QHRNLVRLLGCCLDQDEK----ILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGI 610
H N++RL+ CL + L+ + +L + + K E ++ ++ GI
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-----MFGGDELQANTNR 665
+GL +H HRDLK +NILL + +P + D G + G + +
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 666 I--VGTYGYMSPE-YALEGLFSI--KSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA 720
T Y +PE ++++ I ++DV+S G +L ++ G+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE---------------GP 245
Query: 721 WDLWKDNRALDLMDPILENEASYPMLARY----VNVALLCVHENATDRPTMSEVVSML 774
+D + D + ++N+ S P R+ + + + RP + ++S L
Sbjct: 246 YD--MVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-41
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQE------VAVKRLSKK-SGQGLEELKNETMLIAK 554
NN LG G FG V + + VAVK L E L +E +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 555 L-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR---------- 603
L QH N+V LLG C ++I EY L +FL +++
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 604 -VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQA 661
+ +AQG+ +L + IHRD+ A N+LL KI DFG+AR +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
N + +M+PE + +++++SDV+S+G+LL EI S
Sbjct: 223 KGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-41
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNL--VRL 563
++G GG V++ Q A+K ++ + Q L+ +NE + KLQ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
+ ++ E N L+S+L + KK + WE + + + + + +HQ+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTIHQH--- 127
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE------- 676
I+H DLK +N L+ D K+ DFG+A D + VGT YM PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 677 ----YALEGLFSIKSDVFSFGVLLLEILSGK 703
+ S KSDV+S G +L + GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-41
Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 38/224 (16%)
Query: 507 ENKLGEGGFGPVYKGELLN--------GQEVAVKRLSKK-SGQGLEELKNETMLIAKL-Q 556
LGEG FG V E + +VAVK L + + L +L +E ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG------- 609
H+N++ LLG C +I EY +L +L R L Y E
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 610 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQAN 662
+A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR + D +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 663 TN-----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
TN + +M+PE + +++ +SDV+SFGVLL EI +
Sbjct: 251 TNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-40
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE---VAVKRL-SKKSGQGLEELKNETMLIAKLQHRNLVR 562
+ +LG G FG V +G ++ VA+K L EE+ E ++ +L + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
L+G C + + + E L FL K+ + +++ ++ G+ YL
Sbjct: 401 LIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG------YMSPE 676
+HR+L A N+LL KISDFG+++ G D+ + + +PE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPE 509
Query: 677 YALEGLFSIKSDVFSFGVLLLEILS 701
FS +SDV+S+GV + E LS
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN 559
++F LG+G FG V K L+ + A+K++ + L + +E ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 560 LVRLLGCCLDQDEKIL----------IY---EYLPNKSLDSFLFDRAKKRLLYWETRV-- 604
+VR L++ + ++ EY N +L +D L +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT- 663
++ I + L Y+H IIHRDLK NI +D KI DFG+A+
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 664 -----------NRIVGTYGYMSPE-YALEGLFSIKSDVFSFGVLLLEILSG 702
+GT Y++ E G ++ K D++S G++ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 72/296 (24%), Positives = 111/296 (37%), Gaps = 63/296 (21%)
Query: 441 RWRRKLKYREEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAW-LPLFSFASVSA 499
+++++ +Y + + Q D + D W P
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYD---------LKWEFPR-------- 44
Query: 500 STNNFSAENKLGEGGFGPVYKGELLNGQE------VAVKRLSKK-SGQGLEELKNETMLI 552
N LG G FG V + VAVK L +K E L +E ++
Sbjct: 45 --ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102
Query: 553 AKL-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-- 609
+L H N+V LLG C LI+EY L ++L + +K
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 610 ------------------IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651
+A+G+ +L +HRDL A N+L+ KI DFG+A
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 652 R-MFGGDELQANTN-----RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
R + N + +M+PE EG+++IKSDV+S+G+LL EI S
Sbjct: 220 RDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568
LG+G +G VY G +L N +A+K + ++ + + L E L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 569 DQDEKILIY-EYLPNKSLDSFLFDRAKKRLLYWETRVKII-EGIAQGLLYLHQYSRLRII 626
+ + I I+ E +P SL + L + L E + + I +GL YLH +I+
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 627 HRDLKASNILLDTDM-KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE---YALEGL 682
HRD+K N+L++T KISDFG ++ G + T GT YM+PE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG- 201
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
+ +D++S G ++E+ +GK
Sbjct: 202 YGKAADIWSLGCTIIEMATGK 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-38
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 507 ENKLGEGGFGPVYKGELLNGQE----VAVKRL-SKKSGQGLEELKNETMLIAKLQHRNLV 561
+GEG FG V++G ++ + VA+K + S E+ E + + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+L+G + I I E L SFL + +K L + + ++ L YL
Sbjct: 455 KLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
R +HRD+ A N+L+ ++ K+ DFG++R + + +M+PE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFR 567
Query: 682 LFSIKSDVFSFGVLLLEILS 701
F+ SDV+ FGV + EIL
Sbjct: 568 RFTSASDVWMFGVCMWEILM 587
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKKS--GQGLEE-LKNETMLIAKLQHRNLVRLLG 565
LG+GGF ++ + + A K + K E + E + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFD--RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
D D ++ E +SL + + +K L E R + I G YLH+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---N 160
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
R+IHRDLK N+ L+ D++ KI DFG+A D + + GT Y++PE +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218
Query: 684 SIKSDVFSFGVLLLEILSGK 703
S + DV+S G ++ +L GK
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKKS--GQGLEE-LKNETMLIAKLQHRNLVRLLG 565
LG+GGF ++ + + A K + K E + E + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFD--RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
D D ++ E +SL + + +K L E R + I G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RN 134
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
R+IHRDLK N+ L+ D++ KI DFG+A D + + GT Y++PE +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 192
Query: 684 SIKSDVFSFGVLLLEILSGK 703
S + DV+S G ++ +L GK
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
++G G F VYKG + EVA + K + + K E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 566 CCLDQDEK----ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+ +L+ E + + +L ++L + +++ + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 622 RLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
IIHRDLK NI + KI D G+A + + ++GT +M+PE E
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE 204
Query: 681 GLFSIKSDVFSFGVLLLEILSGK 703
+ DV++FG+ +LE+ + +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 66/282 (23%), Positives = 108/282 (38%), Gaps = 35/282 (12%)
Query: 498 SASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELK---NETMLIA 553
S +F ++LG G +G V+K +G+ AVKR S +G ++ E
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHE 111
Query: 554 KL-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIA 611
K+ QH VRL + L E SL + L E +V +
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLP--EAQVWGYLRDTL 167
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
L +LH ++H D+K +NI L + K+ DFG+ G G
Sbjct: 168 LALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEV--QEGDPR 221
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731
YM+PE L+G + +DVFS G+ +LE+ + H G + W+ R
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNME---LPHGG---------EGWQQLRQGY 268
Query: 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773
L R +V ++ + + R T ++++
Sbjct: 269 LPPEFTAG---LSSELR--SVLVMMLEPDPKLRATAEALLAL 305
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 58/287 (20%), Positives = 107/287 (37%), Gaps = 49/287 (17%)
Query: 503 NFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNET-MLIAKLQHRNLV 561
+F ++ LG G G + + + ++VAVKR+ + E +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDR-AKKRLLYWETRVK-IIEGIAQGLLYLHQ 619
R D+ + + E L + +K + +++ GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 620 YSRLRIIHRDLKASNILL-----DTDMKPKISDFGMARMFGGDEL-QANTNRIVGTYGYM 673
L I+HRDLK NIL+ +K ISDFG+ + + + + GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 674 SPEY---ALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730
+PE + + D+FS G + ++S H + +A
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS--------------HPFGKSLQRQAN 239
Query: 731 DLMDPILENEASYPMLARYVNVALL-------CVHENATDRPTMSEV 770
IL S L + ++ + + RP+ V
Sbjct: 240 -----ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKKS--GQGLEE-LKNETMLIAKLQHRNLVRLLG 565
LG+G F VY+ + G EVA+K + KK+ G+ + ++NE + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D + L+ E N ++ +L +R K E R + I G+LYLH + I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEAR-HFMHQIITGMLYLHSH---GI 133
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
+HRDL SN+LL +M KI+DFG+A + T + GT Y+SPE A +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGL 191
Query: 686 KSDVFSFGVLLLEILSGK 703
+SDV+S G + +L G+
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 20/216 (9%)
Query: 495 ASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEE-LKNETMLI 552
+ + + ++G G FG V++ + G + AVK++ LE E +
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVAC 104
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IA 611
A L +V L G + + E L SL + K+ E R G
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQAL 160
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARMFGGDELQANTNR---IV 667
+GL YLH RI+H D+KA N+LL +D + + DFG A D L + I
Sbjct: 161 EGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
GT +M+PE + K D++S ++L +L+G
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQH 557
+ + KLG G +G V + + E A+K + K S +L E ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLLY 616
N+++L D+ L+ E LFD R+ + E II+ + G+ Y
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 617 LHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
LH+ I+HRDLK N+LL++ D KI DFG++ +F + +GT Y+
Sbjct: 152 LHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYI 205
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+PE L + K DV+S GV+L +L+G
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQH 557
++ LG+G FG V K + + QE AVK ++K + + E L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLLY 616
N+++L D ++ E LFD KR + E +II+ + G+ Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 617 LHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
+H+ I+HRDLK NILL++ D KI DFG++ F + +GT Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYI 190
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILSG 702
+PE L G + K DV+S GV+L +LSG
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-35
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQ 556
++ + + LG+G FG V + + GQE AVK +SK+ E L E L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLL 615
H N+++L D+ L+ E LFD R + E +II + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 616 YLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
Y+H+ +I+HRDLK N+LL++ D +I DFG++ F + +GT Y
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYY 194
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
++PE L G + K DV+S GV+L +LSG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 498 SASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKS-GQGLEELKNETMLIAKL 555
S S + + + LG+G V++G G A+K + S + ++ E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 556 QHRNLVRLLGC--CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQG 613
H+N+V+L K+LI E+ P SL + L + + L + ++ + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 614 LLYLHQYSRLRIIHRDLKASNILL----DTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+ +L + I+HR++K NI+ D K++DFG AR DE + + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGT 178
Query: 670 YGYMSPE--------YALEGLFSIKSDVFSFGVLLLEILSGK 703
Y+ P+ + + D++S GV +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 498 SASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKS-GQGLEELKNETMLIAKL 555
S S + + + LG+G V++G G A+K + S + ++ E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 556 QHRNLVRLLGC--CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQG 613
H+N+V+L K+LI E+ P SL + L + + L + ++ + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 614 LLYLHQYSRLRIIHRDLKASNILL----DTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+ +L + I+HR++K NI+ D K++DFG AR DE + + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGT 178
Query: 670 YGYMSPE--------YALEGLFSIKSDVFSFGVLLLEILSGK 703
Y+ P+ + + D++S GV +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEE-LKNETMLIAKLQH 557
+F LG+G FG VY E + +A+K L K G+E L+ E + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL 617
N++RL G D LI EY P ++ L + + T I +A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSYC 125
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H R+IHRD+K N+LL + + KI+DFG + + GT Y+ PE
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPEM 178
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
+ K D++S GVL E L GK
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-34
Identities = 71/311 (22%), Positives = 104/311 (33%), Gaps = 74/311 (23%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNE-TMLIAKLQHRNL 560
N +E LG G G V G+ VAVKR+ + E +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG--------IAQ 612
+R + E L D + + + E E IA
Sbjct: 72 IRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDT-------------DMKPKISDFGMARMFGGDE- 658
G+ +LH L+IIHRDLK NIL+ T +++ ISDFG+ + +
Sbjct: 127 GVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 659 -LQANTNRIVGTYGYMSPEYALEGLFSI-------KSDVFSFGVLLLEILSGKKNTGFYH 710
+ N N GT G+ +PE E D+FS G + ILS K F
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-HPFGD 242
Query: 711 T---------GSLNLLGHAWDLWKD--NRALDLMDPILENEASYPMLARYVNVALLCVHE 759
G +L + A DL+ ++
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS------------------QMIDH-- 282
Query: 760 NATDRPTMSEV 770
+ RPT +V
Sbjct: 283 DPLKRPTAMKV 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 10/201 (4%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVR 562
++ K+G+G G VY ++ GQEVA+++++ + E + NE +++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
L L DE ++ EYL SL D + + + Q L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS--- 134
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
++IHRD+K+ NILL D K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
+ K D++S G++ +E++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 509 KLGEGGFGPVYKGE-LLNGQEVAVKRLS---KKSGQGLEELKNETMLIAKLQHRNLVRLL 564
KLG GG VY E + +VA+K + ++ + L+ + E ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624
+ D L+ EY+ +L ++ L +T + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS 684
I+HRD+K NIL+D++ KI DFG+A+ L TN ++GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATD 190
Query: 685 IKSDVFSFGVLLLEILSGK 703
+D++S G++L E+L G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/301 (19%), Positives = 104/301 (34%), Gaps = 52/301 (17%)
Query: 495 ASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKR--LSKKSGQGLEELKNETML 551
S T F K+G G FG V+K + L+G A+KR + E
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 552 IAKL-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG- 609
A L QH ++VR + D ++ EY SL + + + + E +K +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP-------------------KISDFGM 650
+ +GL Y+H + ++H D+K SNI + P KI D G
Sbjct: 124 VGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGKKNTGFY 709
+ G +++ E E K+D+F+ + ++ +
Sbjct: 181 VTRIS------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP----- 229
Query: 710 HTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSE 769
L D W + R L P + S + + +H + RP+
Sbjct: 230 -------LPRNGDQWHEIRQGRL--PRIPQVLSQEF----TELLKVMIHPDPERRPSAMA 276
Query: 770 V 770
+
Sbjct: 277 L 277
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 57/221 (25%), Positives = 87/221 (39%), Gaps = 27/221 (12%)
Query: 507 ENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLL 564
L EGGF VY+ + + +G+E A+KRL + + E + KL H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 565 GCCLDQDEK-------ILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLLY 616
E+ L+ L L FL + L V KI + + +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL-SCDTVLKIFYQTCRAVQH 151
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF-----------GGDELQANTNR 665
+H + IIHRDLK N+LL K+ DFG A ++ R
Sbjct: 152 MH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 666 IVGTYGYMSPE-YALEGLFSI--KSDVFSFGVLLLEILSGK 703
T Y +PE L F I K D+++ G +L + +
Sbjct: 211 -NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG+G FG V K + + QE AVK ++K + + E L+ KL H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQGLLYLHQYSRLR 624
D ++ E L FD KR + E +II+ + G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 625 IIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
I+HRDLK NILL++ D KI DFG++ F + +GT Y++PE L G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRG 197
Query: 682 LFSIKSDVFSFGVLLLEILSG 702
+ K DV+S GV+L +LSG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK-------------SGQGLEELK 546
++ KLG G +G V E E A+K + K + EE+
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 547 NETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-K 605
NE L+ L H N+++L D+ L+ E+ L F++ R + E
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAAN 150
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQAN 662
I++ I G+ YLH+ I+HRD+K NILL+ + KI DFG++ F D
Sbjct: 151 IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-- 205
Query: 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
+GT Y++PE L+ ++ K DV+S GV++ +L G
Sbjct: 206 -RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
+G G +G V + A K++ K + ++ K E ++ L H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGLLYLHQYSRLRII 626
D + L+ E LF+R + ++ E+ +I++ + + Y H+ L +
Sbjct: 76 EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVA 128
Query: 627 HRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
HRDLK N L T D K+ DFG+A F ++ VGT Y+SP+ LEGL+
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-VLEGLY 184
Query: 684 SIKSDVFSFGVLLLEILSG 702
+ D +S GV++ +L G
Sbjct: 185 GPECDEWSAGVMMYVLLCG 203
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 10/201 (4%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVR 562
+ K+GEG G V E +G++VAVK + + Q E L NE +++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSR 622
+ L +E ++ E+L +L D + L E + E + Q L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
+IHRD+K+ +ILL D + K+SDFG D + + +VGT +M+PE L
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217
Query: 683 FSIKSDVFSFGVLLLEILSGK 703
++ + D++S G++++E++ G+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 496 SVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNE-TMLI 552
S+ ++ +LG G +G V K + +GQ +AVKR+ Q + L + + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIA 611
+ V G + + + E + + SLD F K E + KI I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+ L +LH S+L +IHRD+K SN+L++ + K+ DFG++ D++ + + G
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCKP 174
Query: 672 YMSPE----YALEGLFSIKSDVFSFGVLLLEILSGK 703
YM+PE + +S+KSD++S G+ ++E+ +
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 69/340 (20%), Positives = 110/340 (32%), Gaps = 93/340 (27%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLS-KKSGQGLEELKNETMLIAKLQHRN 559
+F +G GGFG V++ + ++ A+KR+ E++ E +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 560 LVRLLGCC-----------------------------------------LDQDEKILIYE 578
+VR +D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 579 YLPNKSLDSFLF------------DRAKKRLLYWETRV----KIIEGIAQGLLYLHQYSR 622
L S +L+ D +R + I IA+ + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN----------RIVGTYGY 672
++HRDLK SNI D K+ DFG+ DE + VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732
MSPE +S K D+FS G++L E+L T + D+
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS------TQM----------ERVRIITDV 286
Query: 733 MDPILEN--EASYPMLARYVNVALLCVHENATDRPTMSEV 770
+ YP V + + T+RP +++
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATDI 323
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 498 SASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQG-LEELKNETMLIAKL 555
++F ++LG G G V+K +G +A K + + ++ E ++ +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQGL 614
+V G E + E++ SLD L KK E + K+ + +GL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGL 144
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
YL + +I+HRD+K SNIL+++ + K+ DFG++ + AN+ VGT YMS
Sbjct: 145 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYMS 198
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGK 703
PE +S++SD++S G+ L+E+ G+
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 1e-32
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 503 NFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEE-LKNETMLIAKLQHRNL 560
+ + +LG GGFG V + G++VA+K+ ++ E E ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 561 VRLL------GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGL 614
V D +L EY L +L L ++ I+ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKP---KISDFGMARMFGGDELQANTNRIVGTYG 671
YLH+ RIIHRDLK NI+L + KI D G A+ EL VGT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTE--FVGTLQ 188
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
Y++PE + +++ D +SFG L E ++G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 20/248 (8%)
Query: 464 NSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSA----ENKLGEGGFGPVY 519
+ S K + D W + V + +LG G FG V+
Sbjct: 10 HGSKVRGKYDGPKINDYDKFYEDIW-KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 520 KG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578
+ E G+ K ++ +KNE ++ +L H L+ L D+ E +LI E
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128
Query: 579 YLPNKSLDSFLFDR-AKKRLLYWETRV-KIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636
+L LFDR A + E V + +GL ++H+ I+H D+K NI+
Sbjct: 129 FLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIM 181
Query: 637 LDT--DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGV 694
+T KI DFG+A DE+ T + +PE +D+++ GV
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 695 LLLEILSG 702
L +LSG
Sbjct: 239 LGYVLLSG 246
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVR 562
+ +LG+G FG VYK G A K + KS + LE+ E ++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII-EGIAQGLLYLHQYS 621
LLG + ++ E+ P ++D+ + + L E +++++ + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLT--EPQIQVVCRQMLEALNFLHS-- 135
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE----- 676
RIIHRDLKA N+L+ + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 -KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGK 703
+ + K+D++S G+ L+E+ +
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 42/203 (20%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 509 KLGEGGFGPVYKGE--LLNGQEVAVKRLSKKSGQGLEE-LKNETMLIAKLQHRNLVRLL- 564
+ GG G +Y +NG+ V +K L + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 565 -GCCLDQDEKILIY---EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
D+ + Y EY+ +SL + L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
+ +++ DLK NI+L + + K+ D G + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV-R 250
Query: 681 GLFSIKSDVFSFGVLLLEILSGK 703
++ +D+++ G L +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL 273
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-32
Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 23/252 (9%)
Query: 464 NSSTETSKNELSDGRAGKSKSTDAWL----PLFSFASVSASTNNFSA----ENKLGEGGF 515
+ ++ G+ S + D ++ + V ++ +LG G F
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 516 GPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574
G V++ E G A K + E ++ E ++ L+H LV L D +E +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 575 LIYEYLPNKSLDSFLFDR-AKKRLLYWETRV-KIIEGIAQGLLYLHQYSRLRIIHRDLKA 632
+IYE++ LF++ A + E + + + +GL ++H+ +H DLK
Sbjct: 231 MIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKP 283
Query: 633 SNILLDTDMKP--KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVF 690
NI+ T K+ DFG+ + + GT + +PE A +D++
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340
Query: 691 SFGVLLLEILSG 702
S GVL +LSG
Sbjct: 341 SVGVLSYILLSG 352
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSK-KSGQGLEELKNETMLIAKLQHR 558
+ F + KLG G FG V+ E +G E +K ++K +S +E+++ E ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR----AKKRLLYWETRV-KIIEGIAQG 613
N++++ D ++ E L +R + E V ++++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTY 670
L Y H ++H+DLK NIL KI DFG+A +F DE GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTA 190
Query: 671 GYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
YM+PE + + K D++S GV++ +L+G
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 35/228 (15%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK-----------------SGQGLEE 544
N++ L +G F + E + + A+K+ K ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 545 LKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFL------FDRAKKRLL 598
KNE +I +++ + G + DE +IYEY+ N S+ F +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 599 YWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658
+ II+ + Y+H + I HRD+K SNIL+D + + K+SDFG + +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 659 LQANTNRIVGTYGYMSPEYALEGLFSI---KSDVFSFGVLLLEILSGK 703
++ GTY +M PE S K D++S G+ L +
Sbjct: 207 IK--G--SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 58/202 (28%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG-LEELKNETMLIAKLQHRNLV 561
F+ K+G+G FG V+KG + + VA+K + + + +E+++ E ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+ G L + +I EYL S L + L I+ I +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH--- 136
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT +M+PE +
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 682 LFSIKSDVFSFGVLLLEILSGK 703
+ K+D++S G+ +E+ G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 28/257 (10%)
Query: 464 NSSTETSKNELSDGRAGKSKSTDAWL-------PLFSFASVSASTNNFSA------ENKL 510
+ S +L++ KSK T A F V+A ++ L
Sbjct: 38 EAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEIL 97
Query: 511 GEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD 569
G G FG V+K E G ++A K + + + EE+KNE ++ +L H NL++L
Sbjct: 98 GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES 157
Query: 570 QDEKILIYEYLPNKSLDSFLFDR-AKKRLLYWETRV-KIIEGIAQGLLYLHQYSRLRIIH 627
+++ +L+ EY+ LFDR + E ++ I +G+ ++HQ + I+H
Sbjct: 158 KNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILH 210
Query: 628 RDLKASNILLDT--DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
DLK NIL + KI DFG+AR + E GT +++PE S
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSF 267
Query: 686 KSDVFSFGVLLLEILSG 702
+D++S GV+ +LSG
Sbjct: 268 PTDMWSVGVIAYMLLSG 284
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 509 KLGEGGFGPVYKGE-LLNGQEVAVKRLS---KKSGQGLEELKNETMLIAKLQHRNLVRLL 564
LG GG V+ L + ++VAVK L + + E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 565 GCCLDQDEKILIY----EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
+ + EY+ +L + + + +++I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ-ANTNRIVGTYGYMSPEYAL 679
+ IIHRD+K +NI++ K+ DFG+AR T ++GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 680 EGLFSIKSDVFSFGVLLLEILSGK 703
+SDV+S G +L E+L+G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEE-LKNETMLIAKLQH 557
++F LG+G FG VY E N +A+K L K +G+E L+ E + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL 617
N++R+ D+ L+ E+ P L L + R + + E +A L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEE-LADALHYC 130
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H ++IHRD+K N+L+ + KI+DFG + T + GT Y+ PE
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLPPEM 183
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGK 703
K D++ GVL E L G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN 559
F KLGEG +G VYK GQ VA+K++ + L+E+ E ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII-EGIAQGLLYLH 618
+V+ G + ++ EY S+ + K L E + I + +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLT--EDEIATILQSTLKGLEYLH 142
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+R IHRD+KA NILL+T+ K++DFG+A + NT ++GT +M+PE
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK 703
E ++ +D++S G+ +E+ GK
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 507 ENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG G F V+ + L G+ A+K + K L+NE ++ K++H N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQGLLYLHQYSRLR 624
L+ + + LFDR +R +Y E +I+ + + YLH+
Sbjct: 74 IYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NG 126
Query: 625 IIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
I+HRDLK N+L T + K I+DFG+++M + GT GY++PE +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAPEVLAQK 182
Query: 682 LFSIKSDVFSFGVLLLEILSG 702
+S D +S GV+ +L G
Sbjct: 183 PYSKAVDCWSIGVITYILLCG 203
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 48/207 (23%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN 559
+ LG G FG V++ E + + K + K G +K E ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRN 62
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR-AKKRLLYWETRV-KIIEGIAQGLLYL 617
++ L +E ++I+E++ +F+R E + + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 618 HQYSRLRIIHRDLKASNILLDT--DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
H I H D++ NI+ T KI +FG AR + + Y +P
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSG 702
E + S +D++S G L+ +LSG
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 52/379 (13%), Positives = 105/379 (27%), Gaps = 79/379 (20%)
Query: 443 RRKLKYREEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTN 502
R L ++ + + L I + + +E A ST W F S
Sbjct: 11 RENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGE 70
Query: 503 ---NFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSK---KSGQGLEELKNETMLIAKL 555
LG+ + + G+ V ++++K E + + L
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 556 Q-------------------------HRNLVRLLGCCLDQDE-KILIYEYLPNKSLDSF- 588
+ + ++R+ D +L +F
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 589 --LFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645
L + + L R+++ + + L LH Y ++H L+ +I+LD +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFL 247
Query: 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-----------EGLFSIKSDVFSFGV 694
+ F G + G+ PE L + D ++ G+
Sbjct: 248 TGFEHLVRDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301
Query: 695 LLLEILSGKKNTGFYHTGSLNLLGHAWDL-WKDNRALDLMDPILENEASYPMLARYVNVA 753
++ I L + AL + I + + P R +
Sbjct: 302 VIYWIWCAD-------------------LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
Query: 754 LLCVHENATDRPTMSEVVS 772
L DR + +
Sbjct: 343 FLRY--PKEDRLLPLQAME 359
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 33/227 (14%), Positives = 61/227 (26%), Gaps = 30/227 (13%)
Query: 500 STNNFSAENKLGEGGFGPVYKGE------LLNGQEVAVKRLSKKSGQGLEELKNETMLIA 553
+ + LGEG F VY+ N Q+ +K + +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV------KII 607
++ L Q+ +L+ E + L + E +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMPQGLVISFA 178
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP-----------KISDFGMARMFGG 656
+ + +H IIH D+K N +L + D G +
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
T G+ E ++ + D F + +L G
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 496 SVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNE-TMLI 552
+ + ++G G +G V K +GQ +AVKR+ + ++L + +++
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM 75
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV--KIIEGI 610
+V+ G + + + E + + S D F + KI
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY 670
+ L +L L+IIHRD+K SNILLD K+ DFG++ + G
Sbjct: 135 VKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCR 189
Query: 671 GYMSPE----YALEGLFSIKSDVFSFGVLLLEILSGK 703
YM+PE A + ++SDV+S G+ L E+ +G+
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 501 TNNFSAE----NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIA 553
+ FS +LG+G F V + G E A K ++ K S + ++L+ E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQ 612
KLQH N+VRL ++ L+++ + LF+ R Y E I+ I +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGT 669
+ Y H I+HR+LK N+LL + K++DFG+A E + GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
GY+SPE + +S D+++ GV+L +L G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 25/208 (12%)
Query: 507 ENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEEL----------KNETMLIAKL 555
+G GG G VY+ E + + VA+K +S E L + E +L
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMS-------ETLSSDPVFRTRMQREARTAGRL 91
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
Q ++V + + + + L + L R + L V I+ I L
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRA-VAIVRQIGSALD 148
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
H HRD+K NIL+ D + DFG+A ++L VGT YM+P
Sbjct: 149 AAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAP 204
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGK 703
E E + ++D+++ +L E L+G
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-31
Identities = 37/302 (12%), Positives = 85/302 (28%), Gaps = 65/302 (21%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSK---KSGQGLEELKNETMLIAKLQ--------- 556
LG+ + G+ V ++++K E + + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 557 -------------HRNLVRLLGCCLDQDEKILIYEYLP-------NKSLDSFLFDRAKK- 595
+++ LD+ + ++ + ++ L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 596 RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655
+ L R+++ + + L LH ++H L+ +I+LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 656 GDELQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYH 710
G + R + L + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------- 314
Query: 711 TGSLNLLGHAWDL-WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSE 769
L D+ AL + I + + P R + L DR +
Sbjct: 315 ------------LPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--PKEDRLLPLQ 360
Query: 770 VV 771
+
Sbjct: 361 AM 362
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 62/244 (25%), Positives = 94/244 (38%), Gaps = 33/244 (13%)
Query: 477 GRAGKSKSTDAWLPLFSFASVSASTNNFSAE----NKLGEGGFGPVYKG-ELLNGQEVAV 531
G G S L + + F +G+G F V + GQ+ AV
Sbjct: 1 GSPGISGGGGGILDM------ADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAV 54
Query: 532 K-----RLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLD 586
K + + G E+LK E + L+H ++V LL +++E++
Sbjct: 55 KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD-- 112
Query: 587 SFLFDR----AKKRLLYWETRVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-- 639
L A +Y E + I + L Y H IIHRD+K +LL +
Sbjct: 113 --LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKE 167
Query: 640 -DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLE 698
K+ FG+A G L A VGT +M+PE + DV+ GV+L
Sbjct: 168 NSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225
Query: 699 ILSG 702
+LSG
Sbjct: 226 LLSG 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK------SGQGLEELKNETMLIA 553
+ + +LG G F V K E G E A K + K+ G EE++ E ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQ 612
++ H N++ L ++ + +LI E + LFD ++ E I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKP----KISDFGMARMFGGDELQANTNRIVG 668
G+ YLH +I H DLK NI+L P K+ DFG+A I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
T +++PE +++D++S GV+ +LSG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK------SGQGLEELKNETMLIA 553
+++ +LG G F V K + G+E A K + K+ G EE++ E ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQ 612
+++H N++ L ++ + +LI E + LFD ++ E + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKP----KISDFGMARMFGGDELQANTNRIVG 668
G+ YLH RI H DLK NI+L P K+ DFG+A I G
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
T +++PE +++D++S GV+ +LSG
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKS------GQGLEELKNETMLIA 553
+ + +LG G F V K E G E A K + K+ G EE++ E ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQ 612
++ H N++ L ++ + +LI E + LFD ++ E I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKP----KISDFGMARMFGGDELQANTNRIVG 668
G+ YLH +I H DLK NI+L P K+ DFG+A I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
T +++PE +++D++S GV+ +LSG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK------SGQGLEELKNETMLIA 553
+ + +LG G F V K E G + A K + K+ G E+++ E ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV-KIIEGIAQ 612
++QH N++ L ++ + ILI E + LFD ++ E + ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKP----KISDFGMARMFGGDELQANTNRIVG 668
G+ YLH L+I H DLK NI+L P KI DFG+A I G
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
T +++PE +++D++S GV+ +LSG
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLG 565
+LG+G F V + G E A K ++ K S + ++L+ E + KLQH N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQGLLYLHQYSRLR 624
++ L+++ + LF+ R Y E I+ I + + Y H
Sbjct: 96 SIQEESFHYLVFDLVTG----GELFEDIVAREFYSEADASHCIQQILESIAYCHS---NG 148
Query: 625 IIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
I+HR+LK N+LL + K++DFG+A E + GT GY+SPE +
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD 205
Query: 682 LFSIKSDVFSFGVLLLEILSG 702
+S D+++ GV+L +L G
Sbjct: 206 PYSKPVDIWACGVILYILLVG 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 497 VSASTNNFSAE----NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEE--LKNET 549
+ + F+ E +LG+G F V + ++L GQE A ++ K + L+ E
Sbjct: 2 ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61
Query: 550 MLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIE 608
+ L+H N+VRL ++ LI++ + LF+ R Y E I+
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG----GELFEDIVAREYYSEADASHCIQ 117
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNR 665
I + +L+ HQ + ++HR+LK N+LL + K++DFG+A G++
Sbjct: 118 QILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172
Query: 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
GT GY+SPE + + D+++ GV+L +L G
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 25/249 (10%), Positives = 56/249 (22%), Gaps = 43/249 (17%)
Query: 490 PLFSFASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK---SGQGLEEL 545
+ +S L G V+ ++ ++ A+K + S LE L
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 546 KNETMLIAKLQHRNLVRLLGCC--------------------------LDQDEKILIYEY 579
T A+L + +L+
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 580 LP---NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636
+ F + + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226
Query: 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL--EGLFSIKSDVFSFGV 694
+ D + + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 695 LLLEILSGK 703
+ +
Sbjct: 282 SIYRVWCLF 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 22/221 (9%)
Query: 498 SASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS-KKSGQGLEELKNETMLIAKL 555
S + +++ + +G G V ++VA+KR++ +K ++EL E +++
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIE--GIA-- 611
H N+V + +DE L+ + L S+ D K + E + +++ IA
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 612 -----QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM-ARMFGGDELQANTNR 665
+GL YLH + IHRD+KA NILL D +I+DFG+ A + G ++ N R
Sbjct: 127 LREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 666 --IVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGK 703
VGT +M+PE + + K+D++SFG+ +E+ +G
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 45/222 (20%), Positives = 85/222 (38%), Gaps = 18/222 (8%)
Query: 495 ASVSASTNNFSAENKLGEG--GFGPVYKG-ELLNGQEVAVKR--LSKKSGQGLEELKNET 549
+S + +G+G V G+ V V+R L S + + L+ E
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 550 MLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII-E 608
+ H N+V + +E ++ ++ S + + E + I +
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN--ELAIAYILQ 135
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT----- 663
G+ + L Y+H + +HR +KAS+IL+ D K +S +
Sbjct: 136 GVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 664 NRIVGTYGYMSPEYALEGL--FSIKSDVFSFGVLLLEILSGK 703
V ++SPE + L + KSD++S G+ E+ +G
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 31/278 (11%)
Query: 443 RRKLKYREEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTN 502
RR +PSQ L ++ + ++ +S + LP ++ A
Sbjct: 37 RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK--EFYQ 94
Query: 503 NFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG--------LEELKNETMLIA 553
+ ++ +G G V + G E AVK + + + E + ET ++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 554 KL-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVKIIEGI 610
++ H +++ L+ L+++ + L FD K L ETR I+ +
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMRSL 209
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY 670
+ + +LH I+HRDLK NILLD +M+ ++SDFG + E + GT
Sbjct: 210 LEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTP 263
Query: 671 GYMSPE------YALEGLFSIKSDVFSFGVLLLEILSG 702
GY++PE + + D+++ GV+L +L+G
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 33/272 (12%)
Query: 495 ASVSASTNNFSA-----ENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNE 548
S + + F E+ LGEG V L+ QE AVK + K+ G + E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 549 TMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKI 606
++ + Q HRN++ L+ ++D L++E + S+ KR + E +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVV 116
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMF--GGDELQA 661
++ +A L +LH I HRDLK NIL + KI DF + GD
Sbjct: 117 VQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 662 NTNR---IVGTYGYMSPEYALEGLFSI------KSDVFSFGVLLLEILSGKKNTGFYHTG 712
+T G+ YM+PE +E + D++S GV+L +LSG F
Sbjct: 174 STPELLTPCGSAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVILYILLSGY--PPFVGRC 230
Query: 713 SLNLLGHAWDLWKDNRALDLMDPILENEASYP 744
+ + + L + I E + +P
Sbjct: 231 GSDCGWDRGEACPACQN-MLFESIQEGKYEFP 261
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 56/257 (21%), Positives = 89/257 (34%), Gaps = 62/257 (24%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK-----SGQGLEELKNETMLIAK 554
+ + +G+G +G V E A+K ++K + + +E +K E L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRV---------- 604
L H N+ RL D+ L+ E L D+ + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 605 -------------------------------KIIEGIAQGLLYLHQYSRLRIIHRDLKAS 633
I+ I L YLH I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 634 NILLDTD--MKPKISDFGMARMFGGDELQANT--NRIVGTYGYMSPEYALEGL---FSIK 686
N L T+ + K+ DFG+++ F GT +++PE L + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPK 256
Query: 687 SDVFSFGVLLLEILSGK 703
D +S GVLL +L G
Sbjct: 257 CDAWSAGVLLHLLLMGA 273
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS---KKSGQGLEELKNETMLIAKLQHRN 559
FS ++G G FG VY ++ N + VA+K++S K+S + +++ E + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII-EGIAQGLLYLH 618
++ GC L + L+ EY + D L + KK L E + + G QGL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQ--EVEIAAVTHGALQGLAYLH 171
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE-- 676
+IHRD+KA NILL K+ DFG A AN+ VGT +M+PE
Sbjct: 172 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVI 222
Query: 677 -YALEGLFSIKSDVFSFGVLLLEILSGK 703
EG + K DV+S G+ +E+ K
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-29
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHR-NLVRLL 564
+LG G F V + GQE A K L K+ E+ +E ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRV-KIIEGIAQGLLYLHQYS 621
+ E ILI EY + F + + E V ++I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149
Query: 622 RLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
I+H DLK NILL + KI DFGM+R G I+GT Y++PE
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 679 LEGLFSIKSDVFSFGVLLLEILSG 702
+ +D+++ G++ +L+
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTH 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGL---------EELKNETMLIAKL-QH 557
LG G V + +E AVK + G E E ++ K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQGLLY 616
N+++L L+++ + L FD +++ E KI+ + + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICA 139
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
LH+ L I+HRDLK NILLD DM K++DFG + E + GT Y++PE
Sbjct: 140 LHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPE 193
Query: 677 ------YALEGLFSIKSDVFSFGVLLLEILSG 702
+ + D++S GV++ +L+G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSK----KSGQGLEELKNETMLIAKLQHRNLVRLL 564
LGEG +G V + AVK L K + G +K E L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 565 GCCLDQDEKILIY---EYLPNKSLDSFLFDR-AKKRLLYWETRVK---IIEGIAQGLLYL 617
L +EK +Y EY + + D +KR + +I+G+ YL
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YL 125
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA---RMFGGDELQANTNRIVGTYGYMS 674
H I+H+D+K N+LL T KIS G+A F D+ + G+ +
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QGSPAFQP 179
Query: 675 PEYA--LEGLFSIKSDVFSFGVLLLEILSGK 703
PE A L+ K D++S GV L I +G
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 52/237 (21%), Positives = 101/237 (42%), Gaps = 20/237 (8%)
Query: 475 SDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKR 533
S G +GK A N+ ++G G G V+K G +AVK+
Sbjct: 2 SSGSSGKQTGYL----TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ 57
Query: 534 L-SKKSGQGLEELKNE-TMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFD 591
+ + + + + + +++ +V+ G + + + E + +
Sbjct: 58 MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLK 114
Query: 592 RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651
+ + + K+ I + L YL + +IHRD+K SNILLD + K+ DFG++
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 652 RMFGGDELQANTNRIVGTYGYMSPE-----YALEGLFSIKSDVFSFGVLLLEILSGK 703
D+ + + G YM+PE + + I++DV+S G+ L+E+ +G+
Sbjct: 173 GRL-VDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 22/216 (10%)
Query: 499 ASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVK--RLSKKSG---QGLEELKNETMLI 552
+S++ F KLG G + VYKG G VA+K +L + G + E+ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPN---KSLDSFLFDRAKKRLLYWETRVK-IIE 608
+L+H N+VRL +++ L++E++ N K +DS + L VK
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE--LNLVKYFQW 115
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVG 668
+ QGL + H+ +I+HRDLK N+L++ + K+ DFG+AR F G + ++ +V
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV- 170
Query: 669 TYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
T Y +P+ + +S D++S G +L E+++GK
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
+LG G VY+ + + A+K L K + + ++ E ++ +L H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQGLLYLHQYSRLRII 626
E L+ E + L FDR ++ Y E ++ I + + YLH+ I+
Sbjct: 118 ETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 627 HRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
HRDLK N+L T D KI+DFG++++ L + GT GY +PE +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAY 227
Query: 684 SIKSDVFSFGVLLLEILSG 702
+ D++S G++ +L G
Sbjct: 228 GPEVDMWSVGIITYILLCG 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 507 ENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLL 564
+ LGEG F K + Q AVK +SK+ + E + + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQGLLYLHQYSRL 623
DQ L+ E L L F+R KK+ + ET I+ + + ++H +
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 624 RIIHRDLKASNILL---DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
++HRDLK N+L + +++ KI DFG AR+ D T T Y +PE +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQ 183
Query: 681 GLFSIKSDVFSFGVLLLEILSG 702
+ D++S GV+L +LSG
Sbjct: 184 NGYDESCDLWSLGVILYTMLSG 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-28
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEE--------LKNETMLIAKLQHRN 559
LG G G V E ++VA++ +SK+ ++ E ++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVKIIEGIAQGLLYL 617
++++ D ++ ++ E + L FD+ KRL + + + YL
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQMLLAVQYL 255
Query: 618 HQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
H+ IIHRDLK N+LL + D KI+DFG +++ G L + GT Y++
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLA 309
Query: 675 PE---YALEGLFSIKSDVFSFGVLLLEILSG 702
PE ++ D +S GV+L LSG
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 18/201 (8%)
Query: 508 NKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G G + + E AVK + K EE +L+ QH N++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDV 84
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR-VKIIEGIAQGLLYLHQYSRLRI 625
D ++ E + L D+ ++ + E ++ I + + YLH +
Sbjct: 85 YDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLHA---QGV 137
Query: 626 IHRDLKASNILL---DTDMKP-KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
+HRDLK SNIL + + +I DFG A+ + T T +++PE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQ 195
Query: 682 LFSIKSDVFSFGVLLLEILSG 702
+ D++S GVLL +L+G
Sbjct: 196 GYDAACDIWSLGVLLYTMLTG 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEE--------LKNETMLIAKLQHRN 559
LG G G V E ++VA+K +SK+ ++ E ++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVKIIEGIAQGLLYL 617
++++ D ++ ++ E + L FD+ KRL + + + YL
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQMLLAVQYL 130
Query: 618 HQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
H IIHRDLK N+LL + D KI+DFG +++ G L + GT Y++
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLA 184
Query: 675 PE---YALEGLFSIKSDVFSFGVLLLEILSG 702
PE ++ D +S GV+L LSG
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 63/212 (29%), Positives = 113/212 (53%), Gaps = 25/212 (11%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKN--------ETMLIA 553
+ K+GEG +G VYK + G+ VA+KR+ L+ E L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQ 612
+L H N+V L+ + L++E++ K L L D K L ++++K + + +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQ--DSQIKIYLYQLLR 130
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
G+ + HQ+ RI+HRDLK N+L+++D K++DFG+AR F G +++ T+ +V T Y
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWY 185
Query: 673 MSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
+P+ + +S D++S G + E+++GK
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEE-LKNETMLIAKLQHRNLVRLLGCC 567
LGEG +G V + + VAVK + K E +K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVK---IIEGIAQGLLYLHQYSR 622
+ + + L EY L FDR + + + ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE------ 676
+ I HRD+K N+LLD KISDFG+A +F + + N++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSG 702
+ DV+S G++L +L+G
Sbjct: 184 FH--AE---PVDVWSCGIVLTAMLAG 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 504 FSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLV 561
F +G G +G VYKG + GQ A+K + +G EE+K E ++ K HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 562 RLLGCCLDQDEKI------LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII-EGIAQGL 614
G + ++ L+ E+ S+ + + L E + I I +GL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIAYICREILRGL 142
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
+LHQ ++IHRD+K N+LL + + K+ DFG++ + NT +GT +M+
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMA 197
Query: 675 PE-----YALEGLFSIKSDVFSFGVLLLEILSGK 703
PE + + KSD++S G+ +E+ G
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN--------ETMLI 552
+ K+GEG +G V+K + VA+KR+ L++ E L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIA 611
+L+H+N+VRL + L++E+ + L + D L VK + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF-DSCNGDLD--PEIVKSFLFQLL 111
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+GL + H ++HRDLK N+L++ + + K+++FG+AR F G ++ + +V T
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLW 166
Query: 672 YMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGKK 704
Y P+ L+S D++S G + E+ + +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+G+G F V +L G+EVA+K + K + L++L E ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVK---IIEGIAQGLLYLHQYS 621
+ LI EY + FD A R+ E R K I+ + Y H
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH--- 131
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
+ RI+HRDLKA N+LLD DM KI+DFG + F + G Y +PE
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPE----- 183
Query: 682 LFS------IKSDVFSFGVLLLEILSGK 703
LF + DV+S GV+L ++SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEE-LKNETMLIAKLQHRNLVRLLGCC 567
LGEG +G V + + VAVK + K E +K E + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVK---IIEGIAQGLLYLHQYSR 622
+ + + L EY L FDR + + + ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE------ 676
+ I HRD+K N+LLD KISDFG+A +F + + N++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSG 702
+ DV+S G++L +L+G
Sbjct: 184 FH--AE---PVDVWSCGIVLTAMLAG 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKN--------ETMLIA 553
+ K+GEG +G VYK + G+ A+K++ LE+ E ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQ 612
+L+H N+V+L + +L++E+L + L L D + L K + +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL-DVCEGGLE--SVTAKSFLLQLLN 111
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
G+ Y H R++HRDLK N+L++ + + KI+DFG+AR F G ++ T+ IV T Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWY 166
Query: 673 MSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
+P+ + +S D++S G + E+++G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVK--RLSKKSG---QGLEELKNETMLIAKL 555
+ +KLGEG + VYKG L VA+K RL + G + E+ L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQGL 614
+H N+V L + L++EYL +K L +L D + VK + + +GL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIIN--MHNVKLFLFQLLRGL 113
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
Y H+ +++HRDLK N+L++ + K++DFG+AR + N +V T Y
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRP 168
Query: 675 PEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
P+ L +S + D++ G + E+ +G+
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 510 LGEGGFGPVYKG-ELLNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLG 565
LGEG F V EL +E A+K L K+ + + E ++++L H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D ++ Y N L ++ R TR E I L YLH I
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAE-IVSALEYLHG---KGI 151
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
IHRDLK NILL+ DM +I+DFG A++ + QA N VGT Y+SPE E
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 686 KSDVFSFGVLLLEILSGK 703
SD+++ G ++ ++++G
Sbjct: 212 SSDLWALGCIIYQLVAGL 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 28/208 (13%)
Query: 507 ENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLL 564
+ LG G G V + GQ+ A+K L + + E + ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 565 GCCLDQDEKI----LIYEYLPNKSLDSFLFDR--AKKRLLYWETRV-KIIEGIAQGLLYL 617
+ +I E + L F R + + E +I+ I + +L
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 618 HQYSRLRIIHRDLKASNILL---DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
H I HRD+K N+L + D K++DFG A+ + LQ T Y++
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVA 197
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSG 702
PE + D++S GV++ +L G
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 47/229 (20%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKK-----------------SGQGLEELKNETML 551
+G+G +G V + A+K LSKK ++ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 552 ------IA---KLQHRNLVRLLGCCLDQDEKILIY---EYLPNKSLDSFLFDRAKKRLLY 599
IA KL H N+V+L+ LD + +Y E + + + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 600 WETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF-GGDE 658
+ + + +G+ YLH +IIHRD+K SN+L+ D KI+DFG++ F G D
Sbjct: 136 EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 659 LQANTNRIVGTYGYMSPEYALEGLFSI----KSDVFSFGVLLLEILSGK 703
L +NT VGT +M+PE +L I DV++ GV L + G+
Sbjct: 193 LLSNT---VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 497 VSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN-------- 547
V + + + LGEG F VYK + Q VA+K++ E K+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALR 61
Query: 548 ETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-I 606
E L+ +L H N++ LL + L+++++ L+ + L + +K
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVII-KDNSLVLT--PSHIKAY 117
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI 666
+ QGL YLHQ+ I+HRDLK +N+LLD + K++DFG+A+ F G +A T+++
Sbjct: 118 MLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQV 173
Query: 667 VGTYGYMSPEYALEGLFSIKS-----DVFSFGVLLLEILSGK 703
V T Y +PE LF + D+++ G +L E+L
Sbjct: 174 V-TRWYRAPEL----LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 32/217 (14%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKK--------SGQGLEELKNETMLIA 553
+S + LG G FG V+ +EV VK + K+ L ++ E +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVKIIEGIA 611
+++H N++++L +Q L+ E + LD LF RL I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLD--LFAFIDRHPRLDEPLAS-YIFRQLV 140
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+ YL IIHRD+K NI++ D K+ DFG A +L GT
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIE 194
Query: 672 YMSPEYALEGLFSIKS------DVFSFGVLLLEILSG 702
Y +PE + +++S GV L ++
Sbjct: 195 YCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 24/252 (9%)
Query: 465 SSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGE-L 523
S + G + L + + LG GGFG VY G +
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRV 65
Query: 524 LNGQEVAVKRLSKK------SGQGLEELKNETMLIAKLQHR--NLVRLLGCCLDQDEKIL 575
+ VA+K + K + E +L+ K+ ++RLL D +L
Sbjct: 66 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125
Query: 576 IYEYLPNKSLDSFLFD--RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 633
I E P D LFD + L R + + + + H ++HRD+K
Sbjct: 126 ILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDE 178
Query: 634 NILLDTD-MKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS-IKSDVFS 691
NIL+D + + K+ DFG + GT Y PE+ + + V+S
Sbjct: 179 NILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 692 FGVLLLEILSGK 703
G+LL +++ G
Sbjct: 235 LGILLYDMVCGD 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNET----------MLIAKLQHR 558
LG+GGFG V+ G L + +VA+K + + G L + + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVKIIEGIAQGLLY 616
++RLL Q+ +L+ E P + D LFD K L +R + + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSR-CFFGQVVAAIQH 154
Query: 617 LHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
H ++HRD+K NIL+D K+ DFG + + GT Y P
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT----DFDGTRVYSPP 207
Query: 676 EYALEGLFS-IKSDVFSFGVLLLEILSG 702
E+ + + + V+S G+LL +++ G
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 498 SASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN--------E 548
+ S + + KLGEG +G VYK + + + VA+KR+ LE + E
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIRE 83
Query: 549 TMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN---KSLDSFL-FDRAK-KRLLYWETR 603
L+ +LQHRN++ L LI+EY N K +D K LY
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY---- 139
Query: 604 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP-----KISDFGMARMFGGDE 658
+ G+ + H R +HRDLK N+LL KI DFG+AR F G
Sbjct: 140 -----QLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIP 190
Query: 659 LQANTNRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
++ T+ I+ T Y PE L +S D++S + E+L
Sbjct: 191 IRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 24/234 (10%)
Query: 478 RAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRL-- 534
S D F S+ + +GEG +G V K G+ VA+K+
Sbjct: 5 HHHHSSGVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60
Query: 535 -SKKSG---QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLF 590
+ E+K L+ +L+H NLV LL C + L++E++ + ++ L
Sbjct: 61 SDDDKMVKKIAMREIK----LLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL- 114
Query: 591 DRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650
+ L Y + K + I G+ + H + IIHRD+K NIL+ K+ DFG
Sbjct: 115 ELFPNGLDYQVVQ-KYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 170
Query: 651 ARMFGGDELQANTNRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
AR + + + T Y +PE + + + DV++ G L+ E+ G+
Sbjct: 171 ARTL-AAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 24/221 (10%)
Query: 498 SASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETML--IAK 554
S +T+ + ++G G +G VYK + +G VA+K + +G G + + +A
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 555 LQ------HRNLVRLL----GCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETR 603
L+ H N+VRL+ D++ K+ L++E++ ++ L ++L L
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLP--AET 121
Query: 604 VK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662
+K ++ +GL +LH I+HRDLK NIL+ + K++DFG+AR++ A
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MAL 176
Query: 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
T +V T Y +PE L+ ++ D++S G + E+ K
Sbjct: 177 TPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 34/209 (16%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSK---KSGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG G FG V GE L G +VAVK L++ +S + ++K E + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVK---IIEGIAQGLLYLHQY 620
+ ++ EY+ L FD R+ E R I+ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH-- 128
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE---- 676
R ++HRDLK N+LLD M KI+DFG++ M E T+ G+ Y +PE
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVISG 184
Query: 677 --YALEGLFSIKSDVFSFGVLLLEILSGK 703
YA G + D++S GV+L +L G
Sbjct: 185 RLYA--GP---EVDIWSCGVILYALLCGT 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVK--RLSK-KSG---QGLEELKNETMLIAK 554
+ K+GEG +G V+K GQ VA+K S+ L E++ ++ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR----MLKQ 58
Query: 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQG 613
L+H NLV LL + L++EY + ++ L DR ++ + E VK I Q
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVP--EHLVKSITWQTLQA 114
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYM 673
+ + H++ IHRD+K NIL+ K+ DFG AR+ + + T Y
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYR 169
Query: 674 SPEYALEGLFSIKS-----DVFSFGVLLLEILSGK 703
SPE L DV++ G + E+LSG
Sbjct: 170 SPEL----LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 65/250 (26%), Positives = 108/250 (43%), Gaps = 24/250 (9%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNETMLIAKL 555
+ F LG GGFG V+ ++ ++ A K+L+KK +G + E ++AK+
Sbjct: 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGL 614
R +V L + + L+ + + +++ + + E R I GL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
+LHQ II+RDLK N+LLD D +ISD G+A + + GT G+M+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMA 357
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
PE L + D F+ GV L E+++ + F G + +L
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR--GPFRARG------------EKVENKELKQ 403
Query: 735 PILENEASYP 744
+LE +YP
Sbjct: 404 RVLEQAVTYP 413
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 35/209 (16%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSK---KSGQGLEELKNETMLIAKLQHRNLVRLLG 565
LGEG FG V Q+VA+K +S+ K ++ E + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVK---IIEGIAQGLLYLHQY 620
+ +++ EY + LFD KKR+ E R II I Y H
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE---- 676
R +I+HRDLK N+LLD ++ KI+DFG++ + T+ G+ Y +PE
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPEVING 181
Query: 677 --YALEGLFSIKSDVFSFGVLLLEILSGK 703
YA + DV+S G++L +L G+
Sbjct: 182 KLYA-----GPEVDVWSCGIVLYVMLVGR 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/223 (26%), Positives = 114/223 (51%), Gaps = 34/223 (15%)
Query: 500 STNNFSAENKLGEGGFGPVYKG--ELLNGQEVAVKRL---SKKSG---------QGLEEL 545
+ + ++GEG +G V+K G+ VA+KR+ + + G L L
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 546 KNETMLIAKLQHRNLVRLL----GCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYW 600
+ +H N+VRL D++ K+ L++E++ ++ L ++L D+ + +
Sbjct: 69 ETF-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPT 119
Query: 601 ETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660
ET ++ + +GL +LH + R++HRDLK NIL+ + + K++DFG+AR++
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--M 174
Query: 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
A T+ +V T Y +PE L+ ++ D++S G + E+ K
Sbjct: 175 ALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSK---KSGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG G FG V G+ L G +VAVK L++ +S + +++ E + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVK---IIEGIAQGLLYLHQY 620
+ ++ EY+ L FD RL E+R I+ G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH-- 133
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE---- 676
R ++HRDLK N+LLD M KI+DFG++ M E T+ G+ Y +PE
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVISG 189
Query: 677 --YALEGLFSIKSDVFSFGVLLLEILSGK 703
YA + D++S GV+L +L G
Sbjct: 190 RLYA-----GPEVDIWSSGVILYALLCGT 213
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
++ +G G FG V++ +L+ EVA+K++ + EL+ ++ ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 561 VRLLGCCLDQDEKI------LIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQG 613
V L +K L+ EY+P +++ AK + +K + + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKP-KISDFGMARMFGGDELQANTNRIVGTYGY 672
L Y+H + I HRD+K N+LLD K+ DFG A++ + N + I Y Y
Sbjct: 154 LAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-Y 207
Query: 673 MSPEYALEGLF-----SIKSDVFSFGVLLLEILSGK 703
+PE +F + D++S G ++ E++ G+
Sbjct: 208 RAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 52/257 (20%), Positives = 91/257 (35%), Gaps = 33/257 (12%)
Query: 464 NSSTETSKNELSDGRAGKSKSTDAWLPLFSFAS-VSASTNNFSAE-----NKLGEGGFGP 517
+ L A P F S + N + LG G G
Sbjct: 18 APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGK 77
Query: 518 VYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKI- 574
V + ++ A+K L + + E L + ++VR++ +
Sbjct: 78 VLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132
Query: 575 ---LIYEYLPNKSLDSFLFDR--AKKRLLYWETRV-KIIEGIAQGLLYLHQYSRLRIIHR 628
++ E L L F R + + E +I++ I + + YLH + I HR
Sbjct: 133 CLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHR 185
Query: 629 DLKASNILL---DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
D+K N+L + K++DFG A+ T T Y++PE +
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTT--PCYTPYYVAPEVLGPEKYDK 242
Query: 686 KSDVFSFGVLLLEILSG 702
D++S GV++ +L G
Sbjct: 243 SCDMWSLGVIMYILLCG 259
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 56/212 (26%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 509 KLGEGGFGPVYKG---ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
K+G G +G VYK + + ++ A+K++ + +G + + E L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 566 CCLD-QDEKI-LIYEYLPN---KSLDSFLFDRAKKRLLYW-ETRVK-IIEGIAQGLLYLH 618
L D K+ L+++Y + + +A K+ + VK ++ I G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 619 QYSRLRIIHRDLKASNILLDTDMKP----KISDFGMARMFGGDELQANTN--RIVGTYGY 672
++HRDLK +NIL+ + KI+D G AR+F L+ + +V T+ Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWY 201
Query: 673 MSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
+PE L ++ D+++ G + E+L+ +
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 38/227 (16%)
Query: 500 STNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN--------ETM 550
+ + K+G+G FG V+K GQ+VA+K++ +E K E
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIK 68
Query: 551 LIAKLQHRNLVRLLGCCLDQDEKI--------LIYEYLPNKSLD-SFLFDRAKKRLLYWE 601
++ L+H N+V L+ C + L++++ D + L +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFT--L 123
Query: 602 TRVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG---GD 657
+ +K +++ + GL Y+H+ +I+HRD+KA+N+L+ D K++DFG+AR F
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 658 ELQANTNRIVGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGK 703
+ TNR+V T Y PE L E + D++ G ++ E+ +
Sbjct: 181 QPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 36/208 (17%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEE-LKNETMLIAKLQHRNLVRLLGCC 567
+G G FG L + VAVK + + G ++E ++ E + L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDR--AKKRLLYWETRVK---IIEGIAQGLLYLHQYSR 622
L +I EY L ++R R E R ++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---S 134
Query: 623 LRIIHRDLKASNILLDTDMKP--KISDFGMARMFGGDELQANTNRIVGTYGYMSPE---- 676
++I HRDLK N LLD P KI DFG ++ +T VGT Y++PE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLR 191
Query: 677 --YALEGLFSIKSDVFSFGVLLLEILSG 702
Y G +DV+S GV L +L G
Sbjct: 192 QEYD--GK---IADVWSCGVTLYVMLVG 214
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 35/255 (13%)
Query: 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNE-TML-- 551
+ N+FS +G GGFG VY + ++ A+K L KK QG NE ML
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 552 IAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGI 610
++ +V + D+ I + + L + ++ E ++ I
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAEI 301
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY 670
GL ++H +++RDLK +NILLD +ISD G+A F + + VGT+
Sbjct: 302 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTH 354
Query: 671 GYMSPEYALEGLFSIKS-DVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729
GYM+PE +G+ S D FS G +L ++L G + F + KD
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKT-----------KDKH- 400
Query: 730 LDLMDPILENEASYP 744
++ L P
Sbjct: 401 -EIDRMTLTMAVELP 414
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-23
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 13/209 (6%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNETMLIAKL 555
+ N F LG+GGFG V ++ ++ A K+L KK +G NE ++ K+
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGL 614
R +V L +D L+ + L + + E R I GL
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
LH R RI++RDLK NILLD +ISD G+A + VGT GYM+
Sbjct: 300 EDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMA 353
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGK 703
PE ++ D ++ G LL E+++G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN 559
+++ +G G FG VY+ +L +G+ VA+K++ + EL+ ++ KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 560 LVRLLGCCLDQDEKI------LIYEYLPNKSLDSFLFDRAKKRLLYWETRVK-IIEGIAQ 612
+VRL EK L+ +Y+P +++ ++ + VK + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKP-KISDFGMARMFGGDELQANTNRIVGTYG 671
L Y+H I HRD+K N+LLD D K+ DFG A+ E N + I Y
Sbjct: 168 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY- 221
Query: 672 YMSPEYALEGLFSIKS-----DVFSFGVLLLEILSGK 703
Y +PE +F DV+S G +L E+L G+
Sbjct: 222 YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 37/232 (15%)
Query: 493 SFASVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKR-LSKKSGQG--LEELKNE 548
+ + F E G+G FG V G+ G VA+K+ + + L+ ++
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-- 71
Query: 549 TMLIAKLQHRNLVRLLGCCLDQDEK-------ILIYEYLP---NKSLDSFLFDRAKKRLL 598
+A L H N+V+L E+ ++ EY+P ++ ++ + +
Sbjct: 72 --DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 599 YWETRVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPKISDFGMARMFGG 656
+K + + + + LH S + + HRD+K N+L++ D K+ DFG A+
Sbjct: 130 L----IKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKS-----DVFSFGVLLLEILSGK 703
E N I Y Y +PE +F + D++S G + E++ G+
Sbjct: 185 SE--PNVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 23/200 (11%), Positives = 61/200 (30%), Gaps = 43/200 (21%)
Query: 509 KLGEGGFGPVYKG--ELLNGQEVAVKRLSKKSG---QGLEELKNETMLIAKLQHRNLVRL 563
G ++ L ++VA+ + + L+E + T+ ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623
L + +++ E++ SL + A ++ ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQ----EVADTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
+ S + + D ++ M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179
Query: 684 SIKSDVFSFGVLLLEILSGK 703
+ + D+ G L +L +
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 70/302 (23%), Positives = 114/302 (37%), Gaps = 33/302 (10%)
Query: 450 EEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVS--ASTNNFSAE 507
EERE + + + + E+ S ++ A S A + N F
Sbjct: 94 EEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYL 153
Query: 508 NKLGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRL 563
LG+G FG V + A+K L K+ + + E ++ +H L L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYSR 622
D + EY L F + ++ E R + I L YLH S
Sbjct: 214 KYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALDYLH--SE 267
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
+++RDLK N++LD D KI+DFG+ + D T GT Y++PE +
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDND 325
Query: 683 FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742
+ D + GV++ E++ G+ FY+ + L + IL E
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR--LPFYN---------------QDHE-KLFELILMEEIR 367
Query: 743 YP 744
+P
Sbjct: 368 FP 369
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 20/246 (8%)
Query: 464 NSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSAST-NNFSAENKLGEGGFGPVYKGE 522
N++ +E + +K+ + +L + S + + + F LG G FG V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 523 L-LNGQEVAVKRLSK----KSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577
+G A+K L K K Q +E NE ++ + LV+L D ++
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRLRIIHRDLKASNIL 636
EY+ + S L R R E + I YLH +I+RDLK N+L
Sbjct: 121 EYVAGGEMFSHL--RRIGRFS--EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLL 173
Query: 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLL 696
+D +++DFG A+ ++ T + GT ++PE L ++ D ++ GVL+
Sbjct: 174 IDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 697 LEILSG 702
E+ +G
Sbjct: 229 YEMAAG 234
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HR 558
+++ KLG G + V++ + N ++V VK L + ++K E ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 559 NLVRLLGCCLDQDEK--ILIYEYLPNKSLDSF---LFDRAKKRLLYWETRVKIIEGIAQG 613
N++ L D + L++E++ N L D + +Y I +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY---------EILKA 142
Query: 614 LLYLHQYSRLRIIHRDLKASNILLD-TDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
L Y H S I+HRD+K N+++D K ++ D+G+A Q R+ Y +
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-F 196
Query: 673 MSPEYALEGLFSIKS-DVFSFGVLLLEILSGKK 704
PE ++ S D++S G +L ++ K+
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 28/255 (10%)
Query: 472 NELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAEN-----KLGEGGFGPVYKGELLNG 526
+E ++ + K+ +L + E+ +G G FG V +L N
Sbjct: 39 DECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA 98
Query: 527 QEV-AVKRLSKKSGQGLEEL---KNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582
+V A+K L+K E + E ++ + + L D + L+ +Y
Sbjct: 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158
Query: 583 KSLDSFLFDRAKKRLLYWETRVK--IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD 640
L L + + RL E + + E + + +HQ L +HRD+K NIL+D +
Sbjct: 159 GDL-LTLLSKFEDRLP--EEMARFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMN 211
Query: 641 MKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKS------DVFSFGV 694
+++DFG D ++ VGT Y+SPE L+ + K D +S GV
Sbjct: 212 GHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE-ILQAMEGGKGRYGPECDWWSLGV 269
Query: 695 LLLEILSGKKNTGFY 709
+ E+L G+ T FY
Sbjct: 270 CMYEMLYGE--TPFY 282
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 35/252 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEELKN---ETMLIAKLQH 557
++F +G+G FG V + + +++ A+K ++K+ E++N E ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK--IIEGIAQGLL 615
LV L D+++ ++ + L L ++ + + E VK I E + L
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFICE-LVMALD 129
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
YL RIIHRD+K NILLD I+DF +A M + + GT YM+P
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 676 E---YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732
E +S D +S GV E+L G+ ++ S + ++
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR--RPYHIRSSTSS-------------KEI 228
Query: 733 MDPILENEASYP 744
+ +YP
Sbjct: 229 VHTFETTVVTYP 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 36/93 (38%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR-MFGGDELQANTNRIVG 668
+A+G+ +L + + IHRDL A NILL KI DFG+AR ++ + + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS 701
+M+PE + +++I+SDV+SFGVLL EI S
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 35/162 (21%), Positives = 56/162 (34%), Gaps = 23/162 (14%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQGLEELKNE----TML 551
+ LG G FG V + + + VAVK L K G E + +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKIL 79
Query: 552 IAKLQHRNLVRLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI 610
I H N+V LLG C + +I E+ +L ++L R + +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYK 129
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652
+G + + I DLK + + S F +
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 44/206 (21%), Positives = 78/206 (37%), Gaps = 48/206 (23%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGC 566
LG G G V + ++ A+K L + + E L + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 567 CLDQDEKI----LIYEYLPNKSLDSFLFDR--AKKRLLYWETRV-KIIEGIAQGLLYLHQ 619
+ ++ E L L F R + + E +I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 620 YSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
+ I HRD+K N+L + + K++DFG A+ E Y
Sbjct: 136 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTG------EKYDK---- 177
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSG 702
D++S GV++ +L G
Sbjct: 178 ---------SCDMWSLGVIMYILLCG 194
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 70/243 (28%), Positives = 115/243 (47%), Gaps = 36/243 (14%)
Query: 510 LGEGGFGPVYKGELLNGQEV----AVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRL 563
LG+G FG V+ + ++G + A+K L K + + K E ++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 564 LGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYS 621
+ K+ LI ++L L F R K +++ E VK + +A L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
L II+RDLK NILLD + K++DFG+++ E +A + GT YM+PE
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRR 201
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
+ +D +SFGVL+ E+L+G F +R + M IL+ +
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGT--LPFQG---------------KDRK-ETMTMILKAKL 243
Query: 742 SYP 744
P
Sbjct: 244 GMP 246
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 46/245 (18%), Positives = 92/245 (37%), Gaps = 51/245 (20%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR 558
S+ +S LG G FG V + + +G+ A+K++ + EL ++ L H
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDHV 60
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYW------------------ 600
N+++L+ ++ P+ +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 601 -ETRVKIIEG-------------------IAQGLLYLHQYSRLRIIHRDLKASNILLD-T 639
+T K+++ + + + ++H L I HRD+K N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 640 DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLE 698
D K+ DFG A+ + + I + Y +PE L ++ D++S G + E
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 699 ILSGK 703
++ GK
Sbjct: 235 LILGK 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 38/245 (15%)
Query: 510 LGEGGFGPVYKGELLNGQEV----AVKRLSKKS----GQGLEELKNETMLIAKLQHRNLV 561
LG+GG+G V++ + G A+K L K + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 562 RLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQ 619
L+ K+ LI EYL L F + ++ ++ E + I+ L +LHQ
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
II+RDLK NI+L+ K++DFG+ + D +T GT YM+PE +
Sbjct: 140 ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILM 194
Query: 680 EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739
+ D +S G L+ ++L+G F +NR +D IL+
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGA--PPFTG---------------ENRK-KTIDKILKC 236
Query: 740 EASYP 744
+ + P
Sbjct: 237 KLNLP 241
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 34/241 (14%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLG 565
LG+G FG V A+K L K+ + + E+ ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 566 CCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYSRL 623
+++ + EY L F + ++ E R + I L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
+++RD+K N++LD D KI+DFG+ + D T GT Y++PE + +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 182
Query: 684 SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743
D + GV++ E++ G+ FY+ + L + IL E +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR--LPFYN---------------QDHE-RLFELILMEEIRF 224
Query: 744 P 744
P
Sbjct: 225 P 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEEL---KNETMLIAKLQHRNLVRLLG 565
+G G F V ++ +V A+K ++K E+ + E ++ R + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK--IIEGIAQGLLYLHQYSRL 623
D++ L+ EY L L + +R+ + + E I + +H+ L
Sbjct: 129 AFQDENYLYLVMEYYVGGDL-LTLLSKFGERIP--AEMARFYLAE-IVMAIDSVHR---L 181
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE------- 676
+HRD+K NILLD +++DFG D + VGT Y+SPE
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGG 240
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFY 709
G + + D ++ GV E+ G+ T FY
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQ--TPFY 271
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-17
Identities = 66/243 (27%), Positives = 101/243 (41%), Gaps = 37/243 (15%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNE-TMLIAKLQHRNLVRLL 564
LG+G FG V E E+ AVK L K +E E +L + L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRL 623
C D + EY+ L ++ + E IA GL +L
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---K 461
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEYALEG 681
II+RDLK N++LD++ KI+DFGM + ++ G T GT Y++PE
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQ 517
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
+ D ++FGVLL E+L+G+ F ++ +L I+E+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQ--APFEG---------------EDED-ELFQSIMEHNV 559
Query: 742 SYP 744
+YP
Sbjct: 560 AYP 562
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 68/241 (28%), Positives = 100/241 (41%), Gaps = 33/241 (13%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNE-TMLIAKLQHRNLVRLL 564
LG+G FG V + ++ AVK L K +E E +L H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 565 GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSRL 623
C D + E++ L +K + E R + I L++LH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISALMFLHD---K 143
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
II+RDLK N+LLD + K++DFGM + + + T GT Y++PE E L+
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLY 201
Query: 684 SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743
D ++ GVLL E+L G F +N DL + IL +E Y
Sbjct: 202 GPAVDWWAMGVLLYEMLCGH--APFEA---------------ENED-DLFEAILNDEVVY 243
Query: 744 P 744
P
Sbjct: 244 P 244
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 65/244 (26%), Positives = 103/244 (42%), Gaps = 39/244 (15%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNE-TMLIAKLQHRNLVRLL 564
LG+G FG V E E+ AVK L K +E E +L + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 565 GCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSR 622
C +++ + EY+ L ++ + E IA GL +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS--- 139
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEYALE 680
II+RDLK N++LD++ KI+DFGM + ++ G T GT Y++PE
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAY 195
Query: 681 GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740
+ D ++FGVLL E+L+G+ F ++ +L I+E+
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQ--APFEG---------------EDED-ELFQSIMEHN 237
Query: 741 ASYP 744
+YP
Sbjct: 238 VAYP 241
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 70/301 (23%), Positives = 114/301 (37%), Gaps = 52/301 (17%)
Query: 452 REPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLG 511
+P + L+ + +++ G + + F F V +G
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAK---PSDFHFLKV------------IG 47
Query: 512 EGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEELKNETM-----LIAKLQHRNLVRLLG 565
+G FG V + AVK L KK+ +E K+ M L+ ++H LV L
Sbjct: 48 KGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH-IMSERNVLLKNVKHPFLVGLH- 105
Query: 566 CCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI-IEGIAQGLLYLHQYSRL 623
+K+ + +Y+ L F ++ + E R + IA L YLH L
Sbjct: 106 FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 158
Query: 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF 683
I++RDLK NILLD+ ++DFG+ + +T GT Y++PE + +
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPY 216
Query: 684 SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743
D + G +L E+L G FY N A ++ D IL
Sbjct: 217 DRTVDWWCLGAVLYEMLYGL--PPFYS---------------RNTA-EMYDNILNKPLQL 258
Query: 744 P 744
Sbjct: 259 K 259
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 510 LGEGGFGPVY----KGELLNGQEVAVKRLSK----KSGQGLEELKNETMLIAKLQHRNLV 561
LG G FG V+ + NG+ A+K L K + Q +E +E ++++ + H ++
Sbjct: 14 LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFII 69
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK--IIEGIAQGLLYLHQ 619
R+ G D + +I +Y+ L S L R +R K E + L YLH
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFP--NPVAKFYAAE-VCLALEYLHS 124
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
II+RDLK NILLD + KI+DFG A+ + T + GT Y++PE
Sbjct: 125 KD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVS 176
Query: 680 EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739
++ D +SFG+L+ E+L+G T FY N + + IL
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGY--TPFYD---------------SNT-MKTYEKILNA 218
Query: 740 EASYP 744
E +P
Sbjct: 219 ELRFP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 66/242 (27%), Positives = 101/242 (41%), Gaps = 35/242 (14%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEELKNETM-----LIAKLQHRNLVRL 563
LG+G FG V+ E + A+K L K ++++ TM L +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFLTHM 83
Query: 564 LGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSR 622
++ + EYL L + + +R I GL +LH
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAAEIILGLQFLHS--- 136
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL 682
I++RDLK NILLD D KI+DFGM + + + NT GT Y++PE L
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 194
Query: 683 FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEAS 742
++ D +SFGVLL E+L G+ + F+ + +L I +
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQ--SPFHG---------------QDEE-ELFHSIRMDNPF 236
Query: 743 YP 744
YP
Sbjct: 237 YP 238
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKKSGQGLEEL---KNETMLIAKLQHRNLVRLLG 565
+G G FG V + ++V A+K LSK + E ++A +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRI 625
D ++ EY+P L + + + + R E + L +H +
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE-VVLALDAIHS---MGF 189
Query: 626 IHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE----YALEG 681
IHRD+K N+LLD K++DFG + + + VGT Y+SPE +G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDG 248
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFY 709
+ + D +S GV L E+L G T FY
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGD--TPFY 274
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 59/244 (24%), Positives = 105/244 (43%), Gaps = 30/244 (12%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNE-TMLIAKLQHRNLVRLL 564
+G G + V L + A++ + K+ + ++ ++ E + H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 565 GCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSR 622
C + ++ + EY+ L +++ E + I+ L YLH+
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLHE--- 171
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEYALE 680
II+RDLK N+LLD++ K++D+GM + + GD T+ GT Y++PE
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRG 227
Query: 681 GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740
+ D ++ GVL+ E+++G+ + F GS D N L ILE +
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGR--SPFDIVGS-------SDNPDQNTEDYLFQVILEKQ 278
Query: 741 ASYP 744
P
Sbjct: 279 IRIP 282
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 30/244 (12%)
Query: 510 LGEGGFGPVYKGELLNGQEV-AVKRLSKK---SGQGLEELKNE-TMLIAKLQHRNLVRLL 564
+G G + V L + A+K + K+ + ++ ++ E + H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 565 GCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEG-IAQGLLYLHQYSR 622
C + ++ + EY+ L +++ E + I+ L YLH+
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLHE--- 128
Query: 623 LRIIHRDLKASNILLDTDMKPKISDFGMAR--MFGGDELQANTNRIVGTYGYMSPEYALE 680
II+RDLK N+LLD++ K++D+GM + + GD T+ GT Y++PE
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRG 184
Query: 681 GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740
+ D ++ GVL+ E+++G+ + F GS D N L ILE +
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGR--SPFDIVGS-------SDNPDQNTEDYLFQVILEKQ 235
Query: 741 ASYP 744
P
Sbjct: 236 IRIP 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 43/197 (21%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG------LEELKNETMLIA 553
+ + + +G G +G V + + L + VA+K++ + L E+ ++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 554 KLQHRNLVRLLGCC----LDQDEKI-LIYEYLP---NKSLDS--FLFDRAKKRLLYWETR 603
+L H ++V++L +++ +++ ++ E K + +L + K LLY
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY---- 163
Query: 604 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT 663
+ G+ Y+H S I+HRDLK +N L++ D K+ DFG+AR E +
Sbjct: 164 -----NLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 664 NRIVGTYGYMSPEYALE 680
I M+
Sbjct: 216 LPISPREDDMNLVTFPH 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 47/226 (20%), Positives = 82/226 (36%), Gaps = 38/226 (16%)
Query: 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAK------ 554
+ ++ + + G +G V G G VA+KR+ G + K
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 555 -----LQHRNLVRLLGC----CLDQDEKI-LIYEYLPN------KSLDSFLFDRAKKRLL 598
H N++ L K+ L+ E + + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 599 YWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658
Y I GL LH+ ++HRDL NILL + I DF +AR D
Sbjct: 141 Y---------HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 659 LQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGK 703
+ + V Y +PE ++ F+ D++S G ++ E+ + K
Sbjct: 189 NKTHY---VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQ 556
+ +G G G V + + + VA+K+LS+ Q K E +L+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 557 HRNLVRLL------GCCLDQDEKILIYEYLP---NKSLDSFLFDRAKKRLLYWETRVKII 607
H+N++ LL + + ++ E + + + L LLY
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY-------- 134
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIV 667
+ G+ +LH IIHRDLK SNI++ +D KI DFG+AR T V
Sbjct: 135 -QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-V 187
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
T Y +PE L + D++S G ++ E++ G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-16
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQ 556
+ +G G G V + + + VA+K+LS+ Q K E +L+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 557 HRNLVRLL-----GCCLDQDEKI-LIYEYLP---NKSLDSFLFDRAKKRLLYWETRVKII 607
H+N++ LL L++ + + L+ E + + + L LLY
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY-------- 171
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIV 667
+ G+ +LH IIHRDLK SNI++ +D KI DFG+AR G + V
Sbjct: 172 -QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---V 224
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
T Y +PE L + D++S G ++ E++ K
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSK------KSGQGLEELKNETMLIA 553
+ + +G G +G V + +G++VA+K+LS+ + + EL L+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 554 KLQHRNLVRLL-----GCCLDQDEKI-LIYEYLP---NKSLDSFLFDRAKKRLLYWETRV 604
+QH N++ LL L L+ ++ K + + + L+Y
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY----- 133
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN 664
+ +GL Y+H ++HRDLK N+ ++ D + KI DFG+AR + T
Sbjct: 134 ----QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TG 182
Query: 665 RIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGK 703
V T Y +PE L ++ D++S G ++ E+L+GK
Sbjct: 183 Y-VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 69/248 (27%), Positives = 111/248 (44%), Gaps = 36/248 (14%)
Query: 510 LGEGGFGPVYKGELLNGQEV----AVKRLSKKS----GQGLEELKNE-TMLIAKLQHRNL 560
LG G +G V+ ++G + A+K L K + + E + E +L Q L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK--IIEGIAQGLLYLH 618
V L + + LI +Y+ L F +R + E V+ + E I L +LH
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGE-IVLALEHLH 176
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+ L II+RD+K NILLD++ ++DFG+++ F DE + GT YM+P+
Sbjct: 177 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIV 232
Query: 679 LEGLFSIKSDV--FSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
G V +S GVL+ E+L+G + F G + N ++ I
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDG------------EKNSQAEISRRI 278
Query: 737 LENEASYP 744
L++E YP
Sbjct: 279 LKSEPPYP 286
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG-----LEELKNETMLIAK 554
++ + +GEG +G V + LN VA+K++S Q L E+K ++ +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 555 LQHRNLVRLLGC----CLDQDEKI-LIYEYLP---NKSLDS-FLFDRAKKRLLYWETRVK 605
+H N++ + ++Q + + ++ + + K L + L + LY
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY------ 135
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN--T 663
I +GL Y+H S ++HRDLK SN+LL+T KI DFG+AR+ D T
Sbjct: 136 ---QILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 664 NRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGK 703
V T Y +PE L ++ D++S G +L E+LS +
Sbjct: 190 EY-VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 509 KLGEGGFGPVYKGE-LLNGQEVAVKRL-SKKSG--QGLEELK-------NETMLIAKLQH 557
KLG G F V+ + ++N VA+K + K +E+K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 558 RNLVRLLGC-----------CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKI 606
++++LL + ++E L ++L + + + + + +I
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVM-------VFEVL-GENLLALIKKYEHRGIPLIYVK-QI 136
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP------KISDFGMARMFGGDELQ 660
+ + GL Y+H R IIH D+K N+L++ P KI+D G A + +
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY- 192
Query: 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
TN I T Y SPE L + +D++S L+ E+++G
Sbjct: 193 --TNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 52/233 (22%), Positives = 103/233 (44%), Gaps = 52/233 (22%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS--------KKSGQGLEELKNETML 551
+++F ++ LGEG +G V G+ VA+K++ ++ L E+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIK----I 62
Query: 552 IAKLQHRNLVRLLGC----CLDQDEKI-LIYEYLP---NKSLDS-FLFDRAKKRLLYWET 602
+ +H N++ + + ++ +I E + ++ + + L D + +Y
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY--- 119
Query: 603 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662
+ + LH + +IHRDLK SN+L++++ K+ DFG+AR+ DE A+
Sbjct: 120 ------QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAAD 168
Query: 663 TNRIVGTYGYMSPEY-------ALEGLFSIKS-----DVFSFGVLLLEILSGK 703
+ G M E+ A E + + DV+S G +L E+ +
Sbjct: 169 NSEPTGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH-RN 559
N + K+G G FG +Y G + G+EVA+K K+ L E+ + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ + C + D +++ E L SL+ LF+ ++ +T + + + + + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSL-KTVLLLADQMISRIEYIHS 123
Query: 620 YSRLRIIHRDLKASNILLDTDMKPK---ISDFGMARMF----GGDELQANTNR-IVGTYG 671
+ IHRD+K N L+ K I DFG+A+ + + N+ + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 672 YMSPEYALEGLF-SIKSDVFSFGVLLLEILSGK 703
Y S G+ S + D+ S G +L+ G
Sbjct: 181 YASI-NTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 1e-13
Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
N F K+G G FG +Y G + +EVA+K + K+ L E+ + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 561 V-RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ + ++ D +L+ + L SL+ LF+ ++L +T + + + + + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSL-KTVLMLADQMINRVEFVHS 121
Query: 620 YSRLRIIHRDLKASNILLDTDMKPK---ISDFGMARMFGGDELQANTNR---------IV 667
S +HRD+K N L+ + I DFG+A+ + +T++ +
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKNLT 174
Query: 668 GTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGK 703
GT Y S G+ S + D+ S G +L+ L G
Sbjct: 175 GTARYASV-NTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 50/233 (21%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS-------KKSGQGLEELKNETMLI 552
+ + LG GG G V+ + + VA+K++ K + L E+K +I
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIK----II 62
Query: 553 AKLQHRNLVRLL--------------GCCLDQDEKILIYEYLP---NKSLDS-FLFDRAK 594
+L H N+V++ G + + ++ EY+ L+ L +
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA 122
Query: 595 KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGMARM 653
+ +Y + +GL Y+H + ++HRDLK +N+ ++T D+ KI DFG+AR+
Sbjct: 123 RLFMY---------QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 654 FGGDELQAN--TNRIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGK 703
+ +V T Y SP L ++ D+++ G + E+L+GK
Sbjct: 171 MDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 2e-13
Identities = 36/199 (18%), Positives = 62/199 (31%), Gaps = 46/199 (23%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRL--------SKKSGQGLEELKNETML 551
T K+GEG FG V++ + VA+K + + + EE+ E ++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 552 IAKLQ---------HRNLVRLLGCCLDQDE--KILIYEY------------LPNKSLDSF 588
+L + L Q +L+ + P+ D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 589 LF------------DRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636
LF ++ + +L T I+ + L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 637 LDTDMKPKISDFGMARMFG 655
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 50/250 (20%), Positives = 100/250 (40%), Gaps = 54/250 (21%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG------LEELKNETMLIA 553
+N+ ++ +G G +G VY + + VA+K++++ L E+ ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 554 KLQHRNLVRLLGCC----LDQDEKI-LIYEYLP---NKSLDS--FLFDRAKKRLLYWETR 603
+L+ ++RL L + +++ ++ E K + FL + K +LY
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY---- 136
Query: 604 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT 663
+ G ++H IIHRDLK +N LL+ D K+ DFG+AR ++
Sbjct: 137 -----NLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 664 NRIVGTYGYMSP---------EY-------ALEGLFSIKS-----DVFSFGVLLLEILSG 702
N + + A E + ++ D++S G + E+L+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 703 KKNTGFYHTG 712
++ T
Sbjct: 249 LQSHINDPTN 258
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQ 556
+ +G G +G V + G +VA+K+L + Q K E L+ ++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR 82
Query: 557 HRNLVRLL------GCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI 610
H N++ LL D + L+ ++ + L K L + ++ +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQM 137
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY 670
+GL Y+H IIHRDLK N+ ++ D + KI DFG+AR + V T
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-----VVTR 189
Query: 671 GYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGK 703
Y +PE L ++ D++S G ++ E+++GK
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 50/219 (22%), Positives = 85/219 (38%), Gaps = 30/219 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH-RN 559
NF K+G G FG + G+ L + VA+K KS +L E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ ++ ++ E L SL+ LFD + +T + I + + Y+H
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSL-KTVLMIAIQLISRMEYVHS 123
Query: 620 YSRLRIIHRDLKASNILLDTDMKPK-----ISDFGMARMFGGDELQANTNR--------- 665
+ +I+RD+K N L+ I DF +A+ + + T +
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKHIPYREHKS 176
Query: 666 IVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGK 703
+ GT YMS G S + D+ + G + + L G
Sbjct: 177 LTGTARYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 30/176 (17%), Positives = 68/176 (38%), Gaps = 29/176 (16%)
Query: 502 NNFSAENKLGEGGFGPVYKGE---------LLNGQEVAVKRLSKKSGQGLEELK------ 546
+ ++ G +Y+ Q+ ++K L K G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 547 -----NETMLIAKLQHRNLVRLLGCCLDQDE-KILIYEYLPNKSLDSFLFDRAKKRLLYW 600
N+ + + +G + QD+ + L+ L +SL S D + K +L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSE 158
Query: 601 ETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI--SDFGMARMF 654
+ +++ + L +LH+ +H ++ A NI +D + + ++ + +G A +
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN---ETMLIAKLQ 556
+ + +G G +G V + G VAVK+LS+ Q + K E L+ ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMK 86
Query: 557 HRNLVRLL-----GCCLDQDEKI-LIYEYLP---NKSLDS-FLFDRAKKRLLYWETRVKI 606
H N++ LL L++ + L+ + N + L D + L+Y
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY------- 139
Query: 607 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRI 666
I +GL Y+H IIHRDLK SN+ ++ D + KI DFG+AR +
Sbjct: 140 --QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY----- 189
Query: 667 VGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGK 703
V T Y +PE L ++ D++S G ++ E+L+G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 30/219 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH-RN 559
++ ++GEG FG +++G LLN Q+VA+K ++S L++E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ + + +L+ + L SL+ L D ++ +T + + + +H+
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGRKFSV-KTVAMAAKQMLARVQSIHE 124
Query: 620 YSRLRIIHRDLKASNILLDTDMKPK-----ISDFGMARMFGGDELQANTNR--------- 665
S +++RD+K N L+ + DFGM + + T +
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY----RDPVTKQHIPYREKKN 177
Query: 666 IVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGK 703
+ GT YMS G S + D+ + G + + L G
Sbjct: 178 LSGTARYMSI-NTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 501 TNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRL-SKKS--GQGLEELKNETMLIAKLQ 556
+ + ++ +G+G FG V K + + VA+K + +KK+ Q E++ L+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMN 108
Query: 557 HR------NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI 610
+V L + ++ L++E L + +L L + + + TR K + +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTR-KFAQQM 166
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP--KISDFGMARMFGGDELQANTNRIVG 668
LL+L L IIH DLK NILL + KI DFG + G + + +
Sbjct: 167 CTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI----YQYIQ 220
Query: 669 TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+ Y SPE L + + D++S G +L+E+ +G+
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 54/239 (22%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLS---------KKSGQGLEELKNETM 550
+ KLG+G +G V+K + G+ VAVK++ +++ E+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIM---I 61
Query: 551 LIAKLQHRNLVRLLGCCL-DQDEKI-LIYEYLP---NKSLDS-FLFDRAKKRLLYWETRV 604
L H N+V LL D D + L+++Y+ + + + L K+ ++Y
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY----- 116
Query: 605 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN 664
+ + + YLH S ++HRD+K SNILL+ + K++DFG++R F N
Sbjct: 117 ----QLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 665 RIVGTYGYMSP--------EY-------ALEGLFSIKS-----DVFSFGVLLLEILSGK 703
+ + +Y A E L D++S G +L EIL GK
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 48/231 (20%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQ------EVAVKRLSKKSGQGLEELKNETML---- 551
+ +G+GGFG +Y ++ + + VK +G ELK
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 552 -IAKLQHRNLVRLLG----------CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYW 600
I K ++ LG + + +I + L +++ KR
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSR- 151
Query: 601 ETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI--SDFGMARMF---- 654
+T +++ I L Y+H++ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 655 GGDELQANTNR-IVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGK 703
A+ R GT + S + A G+ S + D+ G +++ L+G
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 50/218 (22%)
Query: 510 LGEGGFGPVYKGE-LLNGQEVAVKRL-SKKS--GQGLEELK----------NETMLIAKL 555
+G+G FG V K Q VA+K + ++K Q EE++ + TM + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 556 ----QHRN---LV-RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKII 607
RN + LL L YE + F +K
Sbjct: 165 LENFTFRNHICMTFELLSMNL--------YELIKKNKFQGFSLPLVRK----------FA 206
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP--KISDFGMARMFGGDELQANTNR 665
I Q L LH + RIIH DLK NILL + K+ DFG + + +
Sbjct: 207 HSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRV----YT 258
Query: 666 IVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
+ + Y +PE L + + D++S G +L E+L+G
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 41/199 (20%), Positives = 77/199 (38%), Gaps = 33/199 (16%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVA---VKRLSKKSGQGLEELKNETML-----I 552
N + K+G GGFG +Y ++ A VK +++G ELK + I
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 553 AKLQHRNLVRLLG----------CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWET 602
K R + LG + + ++ E L L + + T
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGT--FKKST 152
Query: 603 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI--SDFGMARMF----GG 656
+++ + L Y+H+ +H D+KA+N+LL ++ +D+G++ +
Sbjct: 153 VLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 657 DELQANTNR-IVGTYGYMS 674
+ Q N + GT + S
Sbjct: 210 KQYQENPRKGHNGTIEFTS 228
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-10
Identities = 23/119 (19%), Positives = 39/119 (32%), Gaps = 13/119 (10%)
Query: 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPL 87
+D L+ G + +L G + Y VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLVLYDNN---------RAVWASGTNGK- 48
Query: 88 TSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQS 146
+S VL + ++GNLVI G S + N L N V+ + +W +
Sbjct: 49 -ASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 1e-09
Identities = 97/588 (16%), Positives = 179/588 (30%), Gaps = 164/588 (27%)
Query: 222 PEM-TLNYIFNYS-LYTDENET---YFIYSIKDSI-ISRCILDVSGQ----VEQM----- 266
P M T YI LY D N+ Y + ++ + + + +L++ ++ +
Sbjct: 105 PSMMTRMYIEQRDRLYND-NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK 163
Query: 267 SWLGA-------RQAWF---IFWSQPRTSCVACGPFSICNTATGSCQCLQGFFIGSDKNL 316
+W+ Q IFW CN+ + LQ D N
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 317 -SECVRRTALQCGDNSADREDRFLRMHNVKLPSPDKVLKLPGIEECKSACLN--NCAC-- 371
S + ++ +S E R L P + +L L + + N N +C
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSK---PYENCLLVLLNV--QNAKAWNAFNLSCKI 268
Query: 372 ---TAYAYNSSGVCSSWDGKLYDLEQ----LSKNEGENIFIK---LAASELPKPGGNKEL 421
T + + + S+ L+ L+ +E +++ +K +LP+ E+
Sbjct: 269 LLTTRFKQVTDFL-SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR-----EV 322
Query: 422 LWITVIVVPLLLTASYI-------FLRWRRKLKYREEREPSQDMLLFDINSSTETSKNEL 474
L P L S I W ++ + + E+S N L
Sbjct: 323 LTTN----PRRL--SIIAESIRDGLATWDNWKHVNCDK----------LTTIIESSLNVL 366
Query: 475 S--DGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVK 532
+ R +F SV F + ++ + + V V
Sbjct: 367 EPAEYRK-----------MFDRLSV------FPPSAHIPTILLSLIWFDVIKSDVMVVVN 409
Query: 533 RLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR 592
+L K S L+ K + + + L+ K+ L +D +
Sbjct: 410 KLHKYS------------LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHY---N 454
Query: 593 AKKRLLYWETRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDTD-MKPKIS 646
K + ++ Y + + + R + LD ++ KI
Sbjct: 455 IPKTFDSDDLIPPYLDQ------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR 508
Query: 647 DFGMARMFGGDELQANTNRIVGTY-GYMS---PEYALEGLFSIKSDVFSFGVLLLEILSG 702
A G L NT + + Y Y+ P+Y E L + + F L +I
Sbjct: 509 HDSTAWNASGSIL--NTLQQLKFYKPYICDNDPKY--ERLV---NAILDF---LPKI--- 555
Query: 703 KKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYV 750
+ +LL A LM +EA + + V
Sbjct: 556 --EENLICSKYTDLLRIA-----------LMAE---DEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 72/471 (15%), Positives = 143/471 (30%), Gaps = 139/471 (29%)
Query: 386 DGKLYDLEQ-----LSKNEGENIFIKLAASELPKPGGNKELLWI-----TVIV---VPLL 432
+ D++ LSK E ++I + A G L W +V V +
Sbjct: 32 NFDCKDVQDMPKSILSKEEIDHIIMSKDAVS-----GTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 433 LTASYIFL--RWRRKLKYREEREPSQDMLLFDINSSTETSKNELSDGRAGKSKSTDAWLP 490
L +Y FL + E+R+PS ++ ++ L +
Sbjct: 87 LRINYKFLMSPIKT-----EQRQPSMMTRMY------IEQRDRLYNDN-----------Q 124
Query: 491 LFSFASVSASTNNFSAENKL------------GEGGFGPVYKGELLNGQEVAVKRLSKKS 538
+F+ +VS L G G G K+
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG--------------------KT 164
Query: 539 GQGLEELKNETMLIAKLQHRNLVRL----LGCCLDQDEKI-----LIYEYLPNKSLDSFL 589
+ + L K+Q + ++ L C + + L+Y+ PN + S
Sbjct: 165 -----WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 590 FDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI---- 645
K R+ + ++ LL Y ++ +++ + ++ KI
Sbjct: 220 SSNIKLRIHSIQAELRR-------LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272
Query: 646 SDFGMARMFGGDELQANTN---RIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSG 702
+ D L A T + ++P+ L D L E+L+
Sbjct: 273 RFKQVT-----DFLSAATTTHISLDHHSMTLTPDEVKS-LLLKYLDC-RPQDLPREVLTT 325
Query: 703 KKNTGFYHTGSLNLLG-------HAWDLWKD----------NRALDLMDPILENEASYPM 745
+ L+++ WD WK +L++++P E +
Sbjct: 326 -------NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP-AEYRKMFDR 377
Query: 746 LARY---VNV--ALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNNQLSRM 791
L+ + ++ LL + + + VV+ L LV + +
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 1e-05
Identities = 47/350 (13%), Positives = 100/350 (28%), Gaps = 123/350 (35%)
Query: 3 SFSICLLI---------ISAFSMQFSLVV---DAVSDTDSLSVGQVITRSETLVSSGKFF 50
+ CLL+ +AF++ +++ TD LS S S
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFK-QVTDFLSAATTTHISLDHHSMT--- 297
Query: 51 ELGFFRPGQSRNY---YVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIED- 106
P + ++ Y+ +++P + +++P +S + +
Sbjct: 298 ----LTPDEVKSLLLKYLDCRPQDLPREVL-----------TTNP-RRLSIIAESIRDGL 341
Query: 107 GRITY-------RVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMK 159
+++ + SS N L+ + ++L + P +P +
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNV----LEPAEYRKMFDRLSVF------PPSAHIPTIL 391
Query: 160 LGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYI-- 217
L +W D D + + K + +SL+++ T + Y+
Sbjct: 392 LS------LIWF--------DVIKSDVMVVVN--KLHKYSLVEKQPKESTISIPSIYLEL 435
Query: 218 --------------------------FSLVPEMTLNYIFN---YSLYTDENETYFIYSIK 248
L+P Y ++ + L E+ +
Sbjct: 436 KVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE------R 489
Query: 249 DSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRTSCVA-CGPFSICNT 297
++ LD +L + I R A SI NT
Sbjct: 490 MTLFRMVFLD-------FRFLEQK----I-----RHDSTAWNASGSILNT 523
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 90/662 (13%), Positives = 178/662 (26%), Gaps = 193/662 (29%)
Query: 10 IISAFSMQFSLVVDAVSDTDSLSVGQVITRSET--LVSSGKFFELGFFRPGQSRNYYVGI 67
I+S F F D D ++++ E ++ S S +
Sbjct: 21 ILSVFEDAFVDNFDCKDVQDMPK--SILSKEEIDHIIMSK---------DAVSGTLRL-F 68
Query: 68 WY-----KNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQN 122
W + + ++ V V + S I +E + +T E N
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSP----IKTEQR---QPSMMTRMYIEQRDRLYN 121
Query: 123 TTATLLDSGNFVLRNEKL-----GLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKS 177
V R + L + + G+ G +GK W +
Sbjct: 122 DNQVFAK--YNVSRLQPYLKLRQAL--LELRPAKNVLIDGVL-G----SGKTW-VALDVC 171
Query: 178 RDDPSVGDAELKMEPG--------KSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYI 229
+ KM+ ++ ++++ Q + Y ++
Sbjct: 172 LSY----KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-------YQIDPNWTSRSDHS 220
Query: 230 FNYSLYTDENETYFIYSIKDSIISRCIL---DVSGQVEQMSWLGARQAWFIFWSQPRTSC 286
N L + +K C+L +V +
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV-------------------QN---AKA 258
Query: 287 VACGPFSICNTATGSCQCLQGFFIGSDKNLSECVRRTALQCGDNSADREDRFLRMHNVKL 346
F++ SC+ L K +++ + SA H+
Sbjct: 259 WN--AFNL------SCKIL---LTTRFKQVTDFL----------SAATTTHISLDHHSMT 297
Query: 347 PSPDKVL------------KLPGIEECKSACLNNCACTAYAYNSSGVCSSWDG-KLYD-- 391
+PD+V LP E + + A + ++WD K +
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLP-REVLTTNPR---RLSIIAESIRDGLATWDNWKHVNCD 353
Query: 392 ---------LEQLSKNEGENIFIKLAASELPK----PGGNKELLWITVI------VVPLL 432
L L E +F +L+ P P L+W VI VV L
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSV--FPPSAHIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 433 LTASYIFLRWRRKLKYREEREPSQDMLLFDINSSTETSK---NELSDG-RAGKSKSTDAW 488
S + + ++ S + ++ E + D K+ +D
Sbjct: 412 HKYSLVE-KQPKESTI------SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 489 LPL------FSF-------ASVSASTNNFSA--------ENKLGEGGFGPVYKGELLNG- 526
+P +S F E K+ G +LN
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 527 QEVAV--KRLSKKSG---QGLEELKN-----ETMLIAKLQHRNLVRLLGCCLDQDEKILI 576
Q++ + + + + + E LI ++ +L+R+ L +++ +
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI-CSKYTDLLRI---ALMAEDEAIF 580
Query: 577 YE 578
E
Sbjct: 581 EE 582
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.4 bits (137), Expect = 4e-09
Identities = 42/289 (14%), Positives = 84/289 (29%), Gaps = 31/289 (10%)
Query: 19 SLVVDAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVG--IWYKNIPERT 76
+ + T L Q ++ + L+S + F+L G G +W N +
Sbjct: 5 TRIPFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPF 64
Query: 77 VVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTAT-----LLDSG 131
+ R++ +P+ G + + R +++N + + N L D G
Sbjct: 65 SSTIPLRNKK----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDG 120
Query: 132 NFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKME 191
N VL + + + L + + + S+ +
Sbjct: 121 NIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASK----------LVF 170
Query: 192 PGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKDSI 251
G N + W +G V + N + +Y N +
Sbjct: 171 QGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLV----VYGAGNAVLWHSHTGGHA 226
Query: 252 ISRCILDVSGQV----EQMSWLGARQAWFIFWSQPRTSCVACGPFSICN 296
+ L +G + E+ W AR + + R P I
Sbjct: 227 SAVLRLQANGSIAILDEKPVW--ARFGFQPTYRHIRKINPDQKPIDIWT 273
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 54/264 (20%), Positives = 93/264 (35%), Gaps = 86/264 (32%)
Query: 509 KLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ--------HRN 559
KLG G F V+ + + VA+K + K + E +E L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 560 LVRLLGC-----------CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIE 608
+V+LL C+ ++E L L ++ ++ + L KII+
Sbjct: 103 VVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWI-IKSNYQGLPLPCVKKIIQ 153
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTD---------------------------- 640
+ QGL YLH ++ RIIH D+K NILL +
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 641 ---------------------MKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+K KI+D G A + + T Y S E +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHF----TEDIQTRQYRSLEVLI 266
Query: 680 EGLFSIKSDVFSFGVLLLEILSGK 703
++ +D++S + E+ +G
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-08
Identities = 18/122 (14%), Positives = 35/122 (28%), Gaps = 16/122 (13%)
Query: 29 DSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLT 88
+ L+ G+ + ++L + Y W +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLVLYDHSTSV---------WASNTGILGK 50
Query: 89 SSSPVLTISSEGNLVIEDGRITYRVSENVSSSQ-NTTATLLDSGNFVLRNEKLGLLWQSF 147
+ S+GN V+ D + + N L + GN V+ +W +
Sbjct: 51 KGC-KAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTG 106
Query: 148 DY 149
Y
Sbjct: 107 TY 108
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 50/237 (21%), Positives = 74/237 (31%), Gaps = 68/237 (28%)
Query: 509 KLGEGGFGPVYKG--ELLNGQEVAVK--RLSKK-SGQGLEEL----------KNETMLIA 553
LGEG FG V + +VA+K R K E+ K L
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 554 KL----QHRN---LV-RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK 605
+ + LLG +E+L + + +
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKNT--------FEFLKENNFQPYPLPHVRH---------- 127
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP-------------------KIS 646
+ + L +LH ++ H DLK NIL +++
Sbjct: 128 MAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
DFG A F + IV T Y PE LE ++ DV+S G +L E G
Sbjct: 185 DFGSA-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 53/237 (22%), Positives = 83/237 (35%), Gaps = 68/237 (28%)
Query: 509 KLGEGGFGPVYKG--ELLNGQEVAVK--RLSKK-SGQGLEELK----------NETMLIA 553
LGEG FG V + G+ VAVK + + E++ N T
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 554 KL----QHRN---LV-RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVK 605
++ +H +V LLG Y+++ F D +K
Sbjct: 81 QMLEWFEHHGHICIVFELLGLST--------YDFIKENGFLPFRLDHIRK---------- 122
Query: 606 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP-------------------KIS 646
+ I + + +LH ++ H DLK NIL K+
Sbjct: 123 MAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
DFG A + + + +V T Y +PE L +S DV+S G +L+E G
Sbjct: 180 DFGSA-TYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-07
Identities = 26/119 (21%), Positives = 37/119 (31%), Gaps = 17/119 (14%)
Query: 29 DSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLT 88
+ L GQ + +L + + L Y G +W +N D+
Sbjct: 3 NVLLSGQTLHADHSLQAGA--YTLTIQNKCNLVKYQNG---------RQIWASNTDRR-- 49
Query: 89 SSSPVLTISSEGNLVIEDGRITYRVSENVSSSQ-NTTATLLDSGNFVLRNEKLGLLWQS 146
S LT+ S+GNLVI D L G FV+ LW
Sbjct: 50 GSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV---LWSL 105
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 52/231 (22%)
Query: 509 KLGEGGFGPVYKGE-LLNGQEVAVK--RLSKK-SGQGLEELKNETMLIAKLQHR-----N 559
K+G+G FG V + + N + AVK R KK + E ++ K+Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDDINNNN 97
Query: 560 LVRLLGC-------CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ 612
+V+ G CL I+E L SL + + + I +
Sbjct: 98 IVKYHGKFMYYDHMCL-------IFEPL-GPSLYEIITRNNYNGFHIEDIK-LYCIEILK 148
Query: 613 GLLYLHQYSRLRIIHRDLKASNILL--DTDMKPKISDFGMARMFGGDELQANTNRI---- 666
L YL ++ + H DLK NILL K I+ + + + I
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 667 ----------VGTY----GYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
G+ Y +PE L + + SD++SFG +L E+ +G
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 5e-06
Identities = 19/80 (23%), Positives = 31/80 (38%), Gaps = 1/80 (1%)
Query: 67 IWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTAT 126
I + E + + Q L SS T+ S+ NLV+ D + S ++ A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGAT-GCRAV 61
Query: 127 LLDSGNFVLRNEKLGLLWQS 146
L G V+ + + W S
Sbjct: 62 LQSDGLLVILTAQNTIRWSS 81
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-05
Identities = 13/65 (20%), Positives = 30/65 (46%), Gaps = 1/65 (1%)
Query: 82 NRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGNFVLRNEKLG 141
D LT+ + L + + NLV+ G+ ++ S + ++ L G +++++
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGKYGWQ-SNTHGNGEHCFLRLNHKGELIIKDDDFK 74
Query: 142 LLWQS 146
+W S
Sbjct: 75 TIWSS 79
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-05
Identities = 21/119 (17%), Positives = 34/119 (28%), Gaps = 17/119 (14%)
Query: 29 DSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLT 88
+ L G+ ++ E L + + Y V W N
Sbjct: 2 NILYSGETLSPGEFLNNGR--YVFIMQEDCNLVLYDVDKPI---------WATNTGGL-- 48
Query: 89 SSSPVLTISSEGNLVIEDGRITYRVSENVSSSQ-NTTATLLDSGNFVLRNEKLGLLWQS 146
L++ S+GNLV+ R + N N L N V+ W +
Sbjct: 49 DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA---RWAT 104
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 14/84 (16%), Positives = 27/84 (32%), Gaps = 4/84 (4%)
Query: 67 IWYKNIPERTVVWVANRDQPLTSSSP----VLTISSEGNLVIEDGRITYRVSENVSSSQN 122
I + P+ + + + L + ++ NLV+ D +
Sbjct: 3 IIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNG 62
Query: 123 TTATLLDSGNFVLRNEKLGLLWQS 146
A L G V+ + +WQS
Sbjct: 63 CRAVLQPDGVLVVITNENVTVWQS 86
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 21/119 (17%), Positives = 35/119 (29%), Gaps = 16/119 (13%)
Query: 29 DSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLT 88
+SLS + +L G + L Y G W +N +
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNFVLYDSGKPV---------WASNTGGLGS 51
Query: 89 SSSPVLTISSEGNLVIEDGRITYR-VSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQS 146
L + GNLVI D ++ + L N V+ ++W +
Sbjct: 52 GCRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWAT 105
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 38/168 (22%), Positives = 67/168 (39%), Gaps = 27/168 (16%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK-SGQGLEEL--KNETMLIAKLQ 556
E+ +G+G + + L+ + +R+ K + L+E K+ T A+
Sbjct: 334 GKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYL 393
Query: 557 HRNLVRLLGCC------LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI 610
LV+ G +D D K ++ Y+ K + E + I I
Sbjct: 394 A--LVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVI-----------EDNLDIAYKI 440
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658
+ + LH + +IH DL SN + D D+ I DFG+ ++ DE
Sbjct: 441 GEIVGKLH---KNDVIHNDLTTSNFIFDKDL--YIIDFGLGKISNLDE 483
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 791 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.86 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.86 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.83 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.76 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.74 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.71 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.67 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.61 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.59 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.58 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.42 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.35 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.16 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.12 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.3 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.09 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.61 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.54 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.48 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.43 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 87.42 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 86.32 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 85.71 | |
| 3hms_A | 101 | Hepatocyte growth factor; HGF/SF, hormone/growth f | 81.54 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=444.24 Aligned_cols=263 Identities=27% Similarity=0.450 Sum_probs=217.3
Q ss_pred cCCCccceecccCceeEEEeEee------CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
++|.+.++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888899999999999999763 478899999987777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhc----------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 576 IYEYLPNKSLDSFLFDRA----------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
|||||++|+|.++|.... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2356899999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+. ...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~----~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVI----ECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHH----HHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH----HHH
Confidence 99999987765544444445679999999999999999999999999999999998 8999764321 1111 111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCC
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (791)
..+.. ...+...++.+.+|+.+||+.||++||||+||++.|+++....|
T Consensus 244 ~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 244 TQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 11111 11222345688999999999999999999999999987654444
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=447.03 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=208.6
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.++|.+.++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++++|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356778899999999999999753 47899999998877777889999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhc------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 575 LIYEYLPNKSLDSFLFDRA------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
||||||++|+|.++|.... ....+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999996532 2346899999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 721 (791)
+||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||..... ....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~---- 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAI---- 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHH----
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHH----
Confidence 99999999997765544444455689999999999999999999999999999999999 8999764321 1111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCC
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 780 (791)
.....+. ....+...++.+.+|+.+||+.||++||||+||+++|+.+...
T Consensus 271 ~~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111 0112223456789999999999999999999999999886543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=435.13 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=206.5
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.+++++.++||+|+||+||+|++. ..||||+++.. +.+..++|.+|++++++++|||||++++++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 457788899999999999999864 36999998643 34456789999999999999999999998864 56899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
||++|+|.++|.. ....+++..++.|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999953 3456899999999999999999999988 9999999999999999999999999998765444
Q ss_pred cccccccccccCcccCchhccc---CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||....... .......... ..+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-----~~~~~~~~~~----~~p 257 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-----QIIFMVGRGY----ASP 257 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHHTTC----CCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-----HHHHHHhcCC----CCC
Confidence 3334455689999999999964 468999999999999999999999986432211 1111111110 011
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCC
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRR 784 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 784 (791)
.+ ...+...+..+.+|+.+||+.||++||||.||+++|+.+..++|..
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~ 305 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC-
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCC
Confidence 11 1122234567899999999999999999999999998876666653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=438.56 Aligned_cols=256 Identities=31% Similarity=0.480 Sum_probs=211.2
Q ss_pred CCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 503 NFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
++++.++||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999762 46889999997543 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 576 IYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
|||||++|+|.++|.... ....+++..++.|+.|||+||+|||+++ |+||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996532 1346899999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 721 (791)
+||+|||+++.....+.........||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~---- 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVV---- 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHH----
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHH----
Confidence 99999999987765544444555689999999999999999999999999999999998 8999754321 1111
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.....+.. ...+...+..+.+|+.+||+.||++||||+||+++|+.
T Consensus 258 ~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 258 EMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111111 11222345678999999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=433.00 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=209.2
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
+.|++.++||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5699999999999999999966 469999999998766666778899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999999843 45899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ..... ...... .+. ..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~----~i~~~~-----~~~--~~ 291 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMK----MIRDNL-----PPR--LK 291 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH----HHHHSS-----CCC--CS
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHH----HHHcCC-----CCC--CC
Confidence 223346899999999999999999999999999999999999999753211 11111 111110 000 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....++.+.+|+.+||+.||++|||++|++++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112345788999999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=436.02 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=202.4
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.++|++.++||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999965 46999999999754 3345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||++||+|.++|... ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999542 3445788889999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ..+. .. ......
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~---~~-i~~~~~-------- 242 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLV---LK-IISGSF-------- 242 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH---HH-HHHTCC--------
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH---HH-HHcCCC--------
Confidence 1 122346899999999999999999999999999999999999999854221 1111 11 111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...+.++.+||.+||+.||++|||++|++++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01122345688999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=429.67 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=208.8
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999965 56999999999753 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||++||+|.++|.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999953 356899999999999999999999998 999999999999999999999999999987655
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.........+||+.|||||++.+..|+.++||||+||+||||++|+.||.... ...+... .....
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~----i~~~~--------- 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLIFAK----IIKLE--------- 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH----HHHTC---------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH----HHcCC---------
Confidence 44444556799999999999999999999999999999999999999985321 1111111 11110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVV 771 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 771 (791)
-..+...++++.+|+.+||+.||++|||++|++
T Consensus 251 -~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 011223456789999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=426.79 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=203.4
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.+.|++.++||+|+||.||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35678888999999999999975 4699999999975432 24699999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeeccccccCCCc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMFGGDE 658 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~~~ 658 (791)
++||+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+| ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999953 346899999999999999999999998 99999999999999988 69999999999775433
Q ss_pred ccc---ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 659 LQA---NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 659 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +.... ......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i---~~~~~~------ 274 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKI---ASEPPP------ 274 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHH---HHSCCG------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHH---HcCCCC------
Confidence 221 2234579999999999999999999999999999999999999986432221 11111 111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
....+...++.+.+++.+||+.||++|||+.|++++|..
T Consensus 275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 011223345788999999999999999999999988754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=433.76 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=209.7
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.+.|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35799999999999999999965 46999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
|+||+|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999999842 45899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .... ....... .+.+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~----~~i~~~~-----~~~~-- 367 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAM----KMIRDNL-----PPRL-- 367 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH----HHHHHSC-----CCCC--
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH----HHHHcCC-----CCCC--
Confidence 223356899999999999999999999999999999999999999753211 1111 1111110 0011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+..+.+|+.+||+.||++|||+.|++++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112245688999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=411.48 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=190.9
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999965 469999999997542 334577999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6799988843 356899999999999999999999998 999999999999999999999999999875433
Q ss_pred ccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. .....+||+.|||||++.+..+ +.++||||+||+||||++|+.||..... ..+. .......
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~----~~i~~~~-------- 228 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLF----KNISNGV-------- 228 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHTC--------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHH----HHHHcCC--------
Confidence 2 2234689999999999998876 5899999999999999999999853211 1111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...++.+.+++.+||+.||++|||++|++++
T Consensus 229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01112245678999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=428.24 Aligned_cols=264 Identities=30% Similarity=0.410 Sum_probs=214.2
Q ss_pred hhhhccCCCccceecccCceeEEEeEeeC------CcEEEEEEecccCc-ccHHHHHHHHHHHHhcCC-CceeeeeeEEE
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSG-QGLEELKNETMLIAKLQH-RNLVRLLGCCL 568 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~~~~~ 568 (791)
-+...++|++.++||+|+||+||+|.... ++.||||++..... ...++|.+|+++|.+++| ||||+++|+|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 34456789999999999999999997543 46799999976543 345679999999999965 89999999997
Q ss_pred cC-CcceEEEeecCCCChhHHHhhhcc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCc
Q 003846 569 DQ-DEKILIYEYLPNKSLDSFLFDRAK-------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634 (791)
Q Consensus 569 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~N 634 (791)
+. +..+||||||++|+|.++|..... ...+++..++.++.|||+||+|||+++ ||||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccc
Confidence 65 568999999999999999965332 345889999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCc
Q 003846 635 ILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGS 713 (791)
Q Consensus 635 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~ 713 (791)
|||+.++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.......
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999997765544444455689999999999999999999999999999999998 899976433211
Q ss_pred cchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
........+. ....+...++++.+++.+||+.||++|||+.||+++|+.+
T Consensus 296 -----~~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 296 -----EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp -----HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111111111 1112223456789999999999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=413.18 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=196.3
Q ss_pred CccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc----CCcceEEE
Q 003846 505 SAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD----QDEKILIY 577 (791)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 577 (791)
++.++||+|+||+||+|.. .+++.||||++... .....+.|.+|++++++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999965 46899999999654 33446779999999999999999999999875 34579999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-CCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~ 656 (791)
||+++|+|.++|.. ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999953 356889999999999999999999875 3599999999999998 479999999999986433
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... .............. .
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i~~~~~~~----~ 250 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVKPA----S 250 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCCCG----G
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHHHcCCCCC----C
Confidence 2 2234689999999998865 6999999999999999999999998532211 01111111111000 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+...++++.+|+.+||+.||++|||++|++++
T Consensus 251 ----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 ----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111123578899999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=417.73 Aligned_cols=270 Identities=24% Similarity=0.314 Sum_probs=200.8
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC----cceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD----EKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~ 577 (791)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999987 7999999999654322 223345666677889999999999998764 468999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-----CCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
||+++|+|.++|.. ..++++.+.+++.|+++||+|||++ ...+|+||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999943 3588999999999999999999986 12359999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccCcccCchhcccC------CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh-----
Q 003846 653 MFGGDELQ--ANTNRIVGTYGYMSPEYALEG------LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH----- 719 (791)
Q Consensus 653 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~----- 719 (791)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||+.|+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543221 223346899999999999764 46789999999999999999998765433322111110
Q ss_pred hhHHhhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 720 AWDLWKDNRALDLMDPILENE-ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.............+++.+... ...+.+..+.+|+.+||+.||++||||.||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 000000000111122222111 1234567889999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=416.67 Aligned_cols=248 Identities=25% Similarity=0.298 Sum_probs=196.5
Q ss_pred cCCCccceecccCceeEEEeEee----CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
++|++.+.||+|+||+||+|+.. +++.||||++++.. .....++.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999652 47889999997542 2234578899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||++||+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999953 346899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... ......+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ..+... .....
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~----i~~~~------- 242 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTM----ILKAK------- 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHCC-------
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHH----HHcCC-------
Confidence 332 223346899999999999999999999999999999999999999853211 111111 11110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
...+...++++.+|+.+||+.||++||| ++|++++
T Consensus 243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0112234578899999999999999998 4677753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=405.61 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=189.5
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc-------
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE------- 572 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------- 572 (791)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4688999999999999999965 4699999999975443 345678999999999999999999999876543
Q ss_pred -----ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEee
Q 003846 573 -----KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISD 647 (791)
Q Consensus 573 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 647 (791)
.++||||+++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999966555555667778899999999999999998 99999999999999999999999
Q ss_pred eccccccCCCcccc----------ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchh
Q 003846 648 FGMARMFGGDELQA----------NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLL 717 (791)
Q Consensus 648 Fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~ 717 (791)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence 99998775432211 1233579999999999999999999999999999999996 543110 000
Q ss_pred hhhhHHhhcCCccccccccccCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 718 GHAWDLWKDNRALDLMDPILENEASY---PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~l~~~~~~---~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... ... .....+. ...+.+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~-~~~------------~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 RTL-TDV------------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH-HHH------------HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH-HHH------------hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 000 1111121 233567789999999999999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=395.52 Aligned_cols=203 Identities=26% Similarity=0.386 Sum_probs=173.0
Q ss_pred hhhhhccCCCccceecccCceeEEEeEee----CCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
.+....++|++.++||+|+||+||+|+.+ +++.||||++.+.. ...++.+|+++|+.+ +|||||++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34455688999999999999999999653 46889999986543 346788999999998 699999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeeec
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFG 649 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFg 649 (791)
++.++||||+++|+|.+++. .+++.++..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999882 4888999999999999999999998 9999999999999877 899999999
Q ss_pred cccccCCCccc--------------------------cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhC
Q 003846 650 MARMFGGDELQ--------------------------ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSG 702 (791)
Q Consensus 650 la~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg 702 (791)
+|+........ ......+||+.|||||++.+. .++.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432111 112235799999999999876 589999999999999999999
Q ss_pred CCCCCCC
Q 003846 703 KKNTGFY 709 (791)
Q Consensus 703 ~~p~~~~ 709 (791)
+.||...
T Consensus 244 ~~Pf~~~ 250 (361)
T 4f9c_A 244 RYPFYKA 250 (361)
T ss_dssp CSSSSCC
T ss_pred CCCCCCC
Confidence 9998543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=401.33 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=200.9
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEc------CC
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLD------QD 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 571 (791)
.++|++.+.||+|+||+||+|.. .+|+.||||++++.. ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999965 579999999997543 3345678899999999999999999999764 35
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..+|||||++ |+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6799999996 67988884 3457899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc--ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 652 RMFGGDEL--QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 652 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||..... ...............
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--VHQLQLIMMVLGTPS 283 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCC
Confidence 87644321 2233456899999999998875 569999999999999999999999864321 111111111000000
Q ss_pred c-----------ccccccccc-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 A-----------LDLMDPILE-NEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~-----------~~~~~~~l~-~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ...+..... ...+ ...+..+.+|+.+||+.||++|||++|++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000 0001 1124678899999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.90 Aligned_cols=283 Identities=36% Similarity=0.610 Sum_probs=239.5
Q ss_pred eehhhhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC
Q 003846 492 FSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD 571 (791)
Q Consensus 492 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 571 (791)
+.+.++...+++|++.+.||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44556677889999999999999999999998889999999998777677788999999999999999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
..++||||+++|+|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999985432 2235889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCC-ccchhhhhhHHhhcCCc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTG-SLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 729 (791)
++...............||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ......+..........
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98755433333334456899999999999999999999999999999999999998654332 23333444344444555
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.+.+++.+........+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 566666666667778889999999999999999999999999999874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=375.28 Aligned_cols=234 Identities=20% Similarity=0.207 Sum_probs=186.4
Q ss_pred hccccCCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCC----CCeEEEec
Q 003846 23 DAVSDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSS----SPVLTISS 98 (791)
Q Consensus 23 ~~~~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~----~~~l~~~~ 98 (791)
+++++.|+|++|++|++|++|+|++|.|+||||+++ ++|+ |+ +.+ |||+|||++|++++ +++|+|+.
T Consensus 9 ~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~ 79 (276)
T 3m7h_A 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAF 79 (276)
T ss_dssp CCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEE
T ss_pred eccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeC
Confidence 456788999999999999999999999999999654 5777 76 677 99999999999875 78899999
Q ss_pred CCCEEE--ecCccceEEeeeccC------cceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCcee
Q 003846 99 EGNLVI--EDGRITYRVSENVSS------SQNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVW 170 (791)
Q Consensus 99 ~g~l~l--~~~~~~~~w~~~~~~------~~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~~ 170 (791)
||+||| .|+++.++|+|+++. ..+..|+|+|+|||||+| +.+|||| |||||+|||||||.+.++|..
T Consensus 80 ~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~- 154 (276)
T 3m7h_A 80 YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSE- 154 (276)
T ss_dssp EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEE-
T ss_pred CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCcc-
Confidence 999999 788899999999865 356899999999999998 7899999 999999999999999999876
Q ss_pred EEEEcCCCCCCCCCceEEEeecCCCceEEeec-CCeEEeccCcCCCeeeeccccccceeeeEEEEeecCC-eeEEEEEcc
Q 003846 171 SLTSWKSRDDPSVGDAELKMEPGKSNAFSLMK-RSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDEN-ETYFIYSIK 248 (791)
Q Consensus 171 ~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~-~~~~~w~~g~w~g~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 248 (791)
| ++.+||++|.|++.++++|. +++++ ++.+||++|.|++.. ..+......++.++.+++ ....+++..
T Consensus 155 -L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~~vWsS~t~~ 224 (276)
T 3m7h_A 155 -L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNAVLWHSHTGG 224 (276)
T ss_dssp -E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC----CEEEECTTSCEEEECTTSCEEEECSCTT
T ss_pred -c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCcEEEEecCCC
Confidence 5 77899999999999999985 34444 568999999997632 111111122333444433 233333222
Q ss_pred CceEEEEEEeeCCcEEEEEEeCCcCcEEEEEecCCc
Q 003846 249 DSIISRCILDVSGQVEQMSWLGARQAWFIFWSQPRT 284 (791)
Q Consensus 249 ~s~~~r~~L~~~G~l~~~~w~~~~~~W~~~~~~p~~ 284 (791)
....|++|+.||++++|.| ...|..++.+|+.
T Consensus 225 -~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 225 -HASAVLRLQANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp -CTTCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred -CCCEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence 3348999999999999999 3567777766653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=379.15 Aligned_cols=289 Identities=39% Similarity=0.656 Sum_probs=241.2
Q ss_pred CCceehhhhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEE
Q 003846 489 LPLFSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCC 567 (791)
Q Consensus 489 l~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~ 567 (791)
+..+++.++....++|++.+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999887899999999976432 2334789999999999999999999999
Q ss_pred EcCCcceEEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 568 LDQDEKILIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 568 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
.+.+..++||||+++|+|.+++.... ....+++..+..++.||++||.|||++...+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999996543 33458999999999999999999999822239999999999999999999999
Q ss_pred eeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCC---CCCccchhhhhhHH
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFY---HTGSLNLLGHAWDL 723 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~---~~~~~~~~~~~~~~ 723 (791)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... .........+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987653322 2223356899999999999999999999999999999999999998632 22233344444444
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..........+..+........+..+.+++.+||+.||.+|||+.||+++|++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 4555566666777777778888999999999999999999999999999998743
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=411.46 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=208.8
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999965 46999999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC--CCeEEeeeccccccCCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD--MKPKISDFGMARMFGGD 657 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFgla~~~~~~ 657 (791)
|+||+|.++|.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998843 3356889999999999999999999998 9999999999999854 89999999999987543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. ....+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ...... ...... ..
T Consensus 311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~~~----i~~~~~------~~ 375 (573)
T 3uto_A 311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRN----VKSCDW------NM 375 (573)
T ss_dssp SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH----HHTTCC------CC
T ss_pred Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHH----HHhCCC------CC
Confidence 22 2345899999999999999999999999999999999999999753221 111111 111000 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+||.+||+.||.+|||+.|++++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111235678999999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=402.01 Aligned_cols=250 Identities=25% Similarity=0.278 Sum_probs=200.3
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHH---HHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELK---NETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
-++|++.+.||+|+||.||+|+. .+|+.||||++.+.. ......+. .++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 47899999999999999999965 469999999996531 22223333 446677778999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
+|||||++||+|.++|.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999953 356899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
+.... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||........ .. ........
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~-i~~~i~~~----- 409 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRMTLTM----- 409 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HH-HHHHHHHC-----
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HH-HHHhhcCC-----
Confidence 65432 234689999999999975 5799999999999999999999999864322211 00 00000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
....+...+..+.+||.+||+.||++|++ ++|++++
T Consensus 410 -----~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -----CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 01122234578899999999999999998 7888754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.92 Aligned_cols=283 Identities=40% Similarity=0.587 Sum_probs=229.2
Q ss_pred CCceehhhhhhhccCCCcc------ceecccCceeEEEeEeeCCcEEEEEEeccc----CcccHHHHHHHHHHHHhcCCC
Q 003846 489 LPLFSFASVSASTNNFSAE------NKLGEGGFGPVYKGELLNGQEVAVKRLSKK----SGQGLEELKNETMLIAKLQHR 558 (791)
Q Consensus 489 l~~~~~~~~~~~~~~y~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~ 558 (791)
...|++.++..++++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568888999999998877 8999999999999986 6889999998653 233467899999999999999
Q ss_pred ceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc
Q 003846 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 638 (791)
Q Consensus 559 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~ 638 (791)
||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||.|||+++ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999976555567899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhh
Q 003846 639 TDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLG 718 (791)
Q Consensus 639 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~ 718 (791)
.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|+.|+........ ...
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLD 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHH
Confidence 999999999999987654333333344578999999998865 588999999999999999999999865433221 111
Q ss_pred hhhHHhh-cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 719 HAWDLWK-DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 719 ~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
....... .....+.+++.+ .......+..+.+++.+||+.||.+|||+.|++++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111111 111222233322 2345667889999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=366.36 Aligned_cols=267 Identities=25% Similarity=0.416 Sum_probs=206.9
Q ss_pred hhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.+....++|++.++||+|+||+||+|+. +|+.||||++.... ....+++.+|++++++++||||+++++++.+.+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3344567899999999999999999976 78999999987553 33456789999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++++|.+++........+++..+..++.||++||+|||+++ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999965544456899999999999999999999875 3499999999999999999999999999976
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... ......
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~---~~~~~~------ 255 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVA---AVGFKC------ 255 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHH---HHHHSC------
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---HHHhcC------
Confidence 44322 12234578999999999999999999999999999999999999976432110 000 000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 780 (791)
.....+...+..+.+++.+||+.||.+|||+.|+++.|+.....
T Consensus 256 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 256 ---KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01112223446789999999999999999999999999875443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=364.66 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=213.1
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.++||+|+||+||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46788999999999999999976 46899999999777777788899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999854 2456889999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccc------------cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 660 QAN------------TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 660 ~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
... .....||+.|+|||++.+..++.++||||||+++|||++|..|+...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~------ 237 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR------ 237 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh------
Confidence 111 11457999999999999999999999999999999999999987654332211110000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCC
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 780 (791)
.......+...+..+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 238 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 238 -------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -------HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0011111122335688999999999999999999999999875433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=360.27 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=209.2
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
..++|++.++||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 357899999999999999999964 5689999999977666667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999843 35888999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ .
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~--------~ 235 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTP--------E 235 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCSC--------C
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCC--------C
Confidence 2 223457999999999999999999999999999999999999997532211 011111111100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...+..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11122345678999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=372.84 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=213.0
Q ss_pred hccCCCccceecccCceeEEEeEee--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL--------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLD 569 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 569 (791)
..++|++.+.||+|+||.||+|+.. ++..||||+++... ....+++.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3478999999999999999999753 35679999997653 33467899999999999 89999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhhcc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEE
Q 003846 570 QDEKILIYEYLPNKSLDSFLFDRAK-------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636 (791)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NIL 636 (791)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999965431 245788999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccc
Q 003846 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLN 715 (791)
Q Consensus 637 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~ 715 (791)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... .
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~ 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999987665443333444567889999999999999999999999999999999 99987643221 1
Q ss_pred hhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 716 LLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
+. ....... ....+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 314 ~~----~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LF----KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HH----HHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1111111 11122234567899999999999999999999999998743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=366.20 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=206.6
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999976 57999999999654 334567788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999998543 45889999999999999999999998 99999999999999999999999999987653
Q ss_pred CccccccccccccCcccCchhcccCCCC-cccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFS-IKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.. ......||+.|+|||++.+..+. .++|||||||++|||++|+.||...... .+. .......
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~----~~i~~~~------- 230 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELR----ERVLRGK------- 230 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHCC-------
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhCC-------
Confidence 32 22345799999999999988765 8999999999999999999997543211 110 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+|||++|++++
T Consensus 231 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ---YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01122245678899999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=362.79 Aligned_cols=271 Identities=24% Similarity=0.327 Sum_probs=208.8
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc----ce
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE----KI 574 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~ 574 (791)
...++|++.++||+|+||.||+|+. .++.||||++.... .....+.+|+.++++++||||+++++++..... .+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3457899999999999999999976 48999999996543 234456679999999999999999999987554 59
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc----------CCCCeeecCCCCCcEEEcCCCCeE
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY----------SRLRIIHRDLKASNILLDTDMKPK 644 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~----------~~~~iiH~Dlkp~NILl~~~~~~k 644 (791)
+||||+++|+|.+++.. ..+++..+..++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 99999999999999843 3488999999999999999999988 6 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccCcccCchhcccC-----CCCcccceeehhHHHHHHHhCCCCCCCCCCCccc-hhh
Q 003846 645 ISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-----LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN-LLG 718 (791)
Q Consensus 645 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~-~~~ 718 (791)
|+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ...
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999877655443344446799999999999863 4667899999999999999999998654332111 100
Q ss_pred hh-----hHHhhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 719 HA-----WDLWKDNRALDLMDPILENE-ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 719 ~~-----~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.. ..............+.+... .....+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00000000000111111111 11235667999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=362.36 Aligned_cols=276 Identities=25% Similarity=0.377 Sum_probs=208.3
Q ss_pred ccCCCccceecccCceeEEEeEe-----eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Ccc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 573 (791)
.++|++.++||+|+||+||+++. .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 47899999999999999999973 36889999999877777778899999999999999999999998653 568
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhh-hHHhhcCCccc
Q 003846 654 FGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA-WDLWKDNRALD 731 (791)
Q Consensus 654 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 731 (791)
....... .......++..|+|||++.+..++.++||||||+++|||++|..|+.............. ..........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 222234577889999999999999999999999999999999988654221100000000 00000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCC
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (791)
.+........+...+..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111111222334578999999999999999999999999998765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.20 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=213.3
Q ss_pred ceehhhhhhhccC----------CCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCc
Q 003846 491 LFSFASVSASTNN----------FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN 559 (791)
Q Consensus 491 ~~~~~~~~~~~~~----------y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n 559 (791)
.++++++..+++. |+..++||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3566666665543 667789999999999999765 69999999998777677788999999999999999
Q ss_pred eeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC
Q 003846 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT 639 (791)
Q Consensus 560 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~ 639 (791)
|+++++++...+..++||||+++++|.+++. ...+++..+..++.||++||.|||+++ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999883 345889999999999999999999988 999999999999999
Q ss_pred CCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh
Q 003846 640 DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH 719 (791)
Q Consensus 640 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~ 719 (791)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ....
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~-- 250 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAM-- 250 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH--
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH--
Confidence 99999999999987654321 22345799999999999999999999999999999999999999753221 1111
Q ss_pred hhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 720 AWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
........ +.+ ......+..+.+++.+||+.||++|||+.|++++-
T Consensus 251 --~~~~~~~~-----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 251 --KRLRDSPP-----PKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp --HHHHHSSC-----CCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred --HHHhcCCC-----CCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 11111100 000 01122346789999999999999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=363.03 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=207.9
Q ss_pred ccCCCccceecccCceeEEEeEee----CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 468999999999999999999764 3456999999764 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999843 3356889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 656 GDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 656 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... ... ......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~----~~~~~~------ 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVI----SSVEEG------ 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHH----HHHHTT------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHH----HHHHcC------
Confidence 43221 12223456788999999999999999999999999999999 99997533211 111 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
.....+...+..+.+++.+||+.||.+|||+.|+++.|+....
T Consensus 271 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 ---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111222345678999999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=369.10 Aligned_cols=269 Identities=29% Similarity=0.402 Sum_probs=214.6
Q ss_pred eehhhhhhhccCCCccceecccCceeEEEeEe------eCCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeee
Q 003846 492 FSFASVSASTNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRL 563 (791)
Q Consensus 492 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 563 (791)
+.........++|++.++||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455566788999999999999999999963 346789999997643 33456799999999999 79999999
Q ss_pred eeEEEcCCc-ceEEEeecCCCChhHHHhhhcc------------------------------------------------
Q 003846 564 LGCCLDQDE-KILIYEYLPNKSLDSFLFDRAK------------------------------------------------ 594 (791)
Q Consensus 564 ~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 594 (791)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987655 8999999999999999965432
Q ss_pred ---------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 595 ---------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 595 ---------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122888999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
........||+.|+|||++.+..++.++||||||+++|||++ |+.|+........ ......... .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~~---------~ 314 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGT---------R 314 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----HHHHHHHTC---------C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-----HHHHHHcCC---------C
Confidence 333445678999999999999999999999999999999998 9999754332211 111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111222346789999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=352.57 Aligned_cols=270 Identities=20% Similarity=0.270 Sum_probs=214.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC--cceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD--EKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV 576 (791)
.++|++.++||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 468999999999999999999765 48999999997543 344677889999999999999999999998765 67999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE----cCCCCeEEeeecccc
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DTDMKPKISDFGMAR 652 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFgla~ 652 (791)
|||+++++|.+++........+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555899999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCccccccccccccCcccCchhcc--------cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYAL--------EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||.......... .......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII 240 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHHHh
Confidence 7654332 22357899999999986 4678999999999999999999999986433321111 1111111
Q ss_pred hcCC---ccc---c------ccc--cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 725 KDNR---ALD---L------MDP--ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 725 ~~~~---~~~---~------~~~--~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.... ... . ... .............+.+++.+||+.||++|||++|++++..+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1100 000 0 000 111234456788899999999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=373.17 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=210.2
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..++|.+.++||+|+||.||+|... +++.||||+++... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4568889999999999999999775 68999999987543 233456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999853 3345889999999999999999999998 999999999999999999999999999875544
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
..........+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... . .........
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~----~~~~~~~~~-------- 332 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--Q----TREFVEKGG-------- 332 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--H----HHHHHHTTC--------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHcCC--------
Confidence 33222223346788999999999999999999999999999998 89887543211 1 111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
....+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 333 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 333 -RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 01112223467889999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.00 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=211.2
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..++|++.+.||+|+||.||+++..++..||||++.... ...+++.+|++++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 457899999999999999999988888899999997543 3457799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999998543 345889999999999999999999998 99999999999999999999999999987654432
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.. .....+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ....... .
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~----~~~~~~~---------~ 223 (268)
T 3sxs_A 160 VS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VV----LKVSQGH---------R 223 (268)
T ss_dssp EE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH----HHHHTTC---------C
T ss_pred hc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HH----HHHHcCC---------C
Confidence 22 223456778999999999899999999999999999999 999975432211 00 0011100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
...+...+..+.+++.+||+.||.+|||+.|++++|+...
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0111123457889999999999999999999999998865
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.20 Aligned_cols=249 Identities=23% Similarity=0.286 Sum_probs=205.5
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999764 6899999999754 234567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998843 346889999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+. .......
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~----~~i~~~~-------- 221 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLF----ELILMEE-------- 221 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCC--------
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHH----HHHHcCC--------
Confidence 22 223346899999999999999999999999999999999999999753211 1111 1111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011223456789999999999999999 89999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=350.21 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=210.1
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.+.||+|+||.||+|...+++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46789999999999999999988889999999997543 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999843 3456889999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+...... ... ...... ...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~----~~~~~~---------~~~ 226 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVV----EDISTG---------FRL 226 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH----HHHHTT---------CCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHH----HHHhcC---------ccC
Confidence 12223456788999999999999999999999999999999 89887543211 111 101111 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
..+...+..+.+++.+||+.||++|||+.|++++|+++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11122346789999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.85 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=205.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999664 78999999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999883 3445889999999999999999999988 9999999999999999999999999998764333
Q ss_pred cccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............ +.....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~-------- 226 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT-------- 226 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH-----HHTTCT--------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----Hhcccc--------
Confidence 3333345689999999999988775 78999999999999999999998654332221111 111100
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
........+..+.+++.+||+.||++|||+.|++++-
T Consensus 227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0001122346788999999999999999999998763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.76 Aligned_cols=263 Identities=29% Similarity=0.431 Sum_probs=214.1
Q ss_pred hhhccCCCccceecccCceeEEEeEe------eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ 570 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 570 (791)
....++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34467899999999999999999965 245789999997543 34567889999999999999999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhcc---------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecC
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAK---------------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRD 629 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~D 629 (791)
+..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999965432 234889999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCC
Q 003846 630 LKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGF 708 (791)
Q Consensus 630 lkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~ 708 (791)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655443333344567889999999999999999999999999999999 9999754
Q ss_pred CCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 709 YHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..... . ........ ....+...++.+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 256 ~~~~~--~----~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 256 IPPER--L----FNLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CCGGG--H----HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHH--H----HHHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 32211 1 11111111 11112234567899999999999999999999999998743
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=348.78 Aligned_cols=262 Identities=27% Similarity=0.339 Sum_probs=201.2
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHh--cCCCceeeeeeEEEcC----Ccc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAK--LQHRNLVRLLGCCLDQ----DEK 573 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~ 573 (791)
..++|++.+.||+|+||+||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999987 7999999998654 34556667777766 7999999999997653 457
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhh--------ccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
++||||+++|+|.+++. ...+++..+..++.||++||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999983 346889999999999999999999 666 999999999999999999999
Q ss_pred eeeccccccCCCccc--cccccccccCcccCchhcccC------CCCcccceeehhHHHHHHHhC----------CCCCC
Q 003846 646 SDFGMARMFGGDELQ--ANTNRIVGTYGYMSPEYALEG------LFSIKSDVFSFGVLLLEILSG----------KKNTG 707 (791)
Q Consensus 646 ~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvvl~elltg----------~~p~~ 707 (791)
+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.|+.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999865443222 122335799999999999876 455799999999999999999 66654
Q ss_pred CCCCCccchhhhhhHHhhcCCccccccccc-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 708 FYHTGSLNLLGHAWDLWKDNRALDLMDPIL-ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
............ ....... ...+.. ........+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDM-RKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHH-HHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhh-hHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 332222111111 1101000 001111 1112234678899999999999999999999999999763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=359.68 Aligned_cols=253 Identities=25% Similarity=0.301 Sum_probs=205.0
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG------QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
..++|++.+.||+|+||.||++... +|+.||||++.+... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999764 689999999976432 235789999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC----CeEEeee
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM----KPKISDF 648 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DF 648 (791)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999843 456889999999999999999999998 99999999999998877 7999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...... .....
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~~~~----i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLAN----ITAVS 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH----HHTTC
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhcC
Confidence 9998765432 22345799999999999999999999999999999999999999753211 111100 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. .+.+.. ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~--~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 Y--DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp C--CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C--CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000000 01134678899999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.97 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=197.2
Q ss_pred ccCCCccceecccCceeEEEeEee----CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+++.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999764 4778999999754 33456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999953 3446889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 656 GDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 656 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... ... .....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~----~~i~~------- 265 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVI----KAVDE------- 265 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHH----HHHHT-------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHc-------
Confidence 43211 11122345778999999999999999999999999999998 99997533211 111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
......+...+..+.+++.+||+.||++||++.|++++|+..
T Consensus 266 --~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 266 --GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp --TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111112223456789999999999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.62 Aligned_cols=267 Identities=26% Similarity=0.404 Sum_probs=215.2
Q ss_pred hhhhhccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCL 568 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 568 (791)
.+....++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34556789999999999999999999764 34889999997653 334677999999999999999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhcc---------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeee
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAK---------------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH 627 (791)
+.+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 99999999999999999999965321 256889999999999999999999998 999
Q ss_pred cCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCC
Q 003846 628 RDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNT 706 (791)
Q Consensus 628 ~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~ 706 (791)
|||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999987654433333344578899999999999999999999999999999999 99887
Q ss_pred CCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCC
Q 003846 707 GFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780 (791)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 780 (791)
...... .. .......... ..+...+..+.+++.+||+.||.+|||+.|++++|+++...
T Consensus 278 ~~~~~~--~~----~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAHE--EV----IYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCHH--HH----HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCChH--HH----HHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 532211 11 1111111110 11223346789999999999999999999999999986543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=361.55 Aligned_cols=267 Identities=28% Similarity=0.411 Sum_probs=211.0
Q ss_pred hhccCCCccceecccCceeEEEeEee------CCcEEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
...++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34578999999999999999999752 4568999999754 233457899999999999 899999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhcc--------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCC
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAK--------------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDL 630 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dl 630 (791)
+..++||||+++|+|.+++..... ...+++..+..++.||++||+|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 999999999999999999965322 134789999999999999999999998 999999
Q ss_pred CCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCC
Q 003846 631 KASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFY 709 (791)
Q Consensus 631 kp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~ 709 (791)
||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..|+...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654433333344567889999999999999999999999999999998 99997644
Q ss_pred CCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCC
Q 003846 710 HTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782 (791)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (791)
..... ........ .....+...+..+.+++.+||+.||.+|||+.|++++|+......+
T Consensus 279 ~~~~~-----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDAN-----FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSHH-----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHHH-----HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 32211 11111111 1111122235678999999999999999999999999988665443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.86 Aligned_cols=263 Identities=29% Similarity=0.420 Sum_probs=214.2
Q ss_pred hhccCCCccceecccCceeEEEeEee--------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL--------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCL 568 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 568 (791)
...++|.+.++||+|+||.||+|+.. .+..||||++.... ....+++.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999752 23579999997653 34457889999999999 8999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhcc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcE
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAK-------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 635 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NI 635 (791)
+++..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999965432 245899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCcc
Q 003846 636 LLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSL 714 (791)
Q Consensus 636 Ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~ 714 (791)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987765443344445577899999999999999999999999999999999 99887533211
Q ss_pred chhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 715 NLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
. ......... ....+...+..+.+++.+||+.||++|||++|++++|+.+..
T Consensus 301 ~----~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 E----LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp H----HHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111111111 111112234678999999999999999999999999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.02 Aligned_cols=263 Identities=24% Similarity=0.404 Sum_probs=195.6
Q ss_pred hhhhccCCCccceecccCceeEEEeEeeCC----cEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELLNG----QEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ 570 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 570 (791)
+....++|++.+.||+|+||.||+|..... ..||||++... .....+++.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 345568899999999999999999976543 27999999754 344567899999999999999999999999887
Q ss_pred Ccc------eEEEeecCCCChhHHHhhhcc---ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 571 DEK------ILIYEYLPNKSLDSFLFDRAK---KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 571 ~~~------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
+.. ++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 665 999999999999999865432 225889999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 003846 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHA 720 (791)
Q Consensus 642 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 720 (791)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~--- 249 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIY--- 249 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH---
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHH---
Confidence 999999999987655443333334467889999999999999999999999999999999 89887543221 111
Q ss_pred hHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 721 WDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....... ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 250 -~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 -NYLIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp -HHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1011110 0111223446789999999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.68 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=208.1
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
...++|++.+.||+|+||.||+++..+++.||||++.... ...+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4467899999999999999999998888899999997543 345789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999854 2345889999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... ... ...... .
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~----~~~~~~---------~ 238 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETA----EHIAQG---------L 238 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH----HHHHTT---------C
T ss_pred c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHH----HHHhcc---------c
Confidence 2 12223456788999999999999999999999999999998 99997543211 110 001110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...+..+.+++.+||+.||.+|||++|++++|.++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111122346788999999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=356.85 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=200.8
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE------ 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 572 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999765 79999999997543 3356789999999999999999999999866542
Q ss_pred ---------------------------------------------------ceEEEeecCCCChhHHHhhhccccccCHH
Q 003846 573 ---------------------------------------------------KILIYEYLPNKSLDSFLFDRAKKRLLYWE 601 (791)
Q Consensus 573 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 601 (791)
.++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 68999999999999999776666666777
Q ss_pred HHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc----------cccccccccCc
Q 003846 602 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ----------ANTNRIVGTYG 671 (791)
Q Consensus 602 ~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~----------~~~~~~~gt~~ 671 (791)
.+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999998 999999999999999999999999999877544211 12233579999
Q ss_pred ccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHH
Q 003846 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVN 751 (791)
Q Consensus 672 y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 751 (791)
|+|||++.+..++.++||||||+++|||++|..|+... .. ........ ............+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~-~~~~~~~~---------~~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VR-IITDVRNL---------KFPLLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HH-HHHHHHTT---------CCCHHHHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HH-HHHHhhcc---------CCCcccccCChhHHH
Confidence 99999999999999999999999999999987662100 00 00000000 000011223467789
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 003846 752 VALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 752 li~~cl~~dp~~RPt~~evl~~ 773 (791)
++.+||+.||++|||+.|++++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=351.76 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=202.7
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..++|++.++||+|+||+||+|+..+|+.||||++.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 357899999999999999999988889999999997543 223567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 78777743 3445889999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc-------
Q 003846 658 ELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA------- 729 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 729 (791)
. .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ .............
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGT
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhh
Confidence 2 12223478999999999876 5689999999999999999999999865433211 1111111100000
Q ss_pred ---------cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 ---------LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ---------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
................+.++.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000000011134578899999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=355.27 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=205.0
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999654 58899999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC--CCCeEEeeeccccccCCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT--DMKPKISDFGMARMFGGD 657 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFgla~~~~~~ 657 (791)
+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999843 3346889999999999999999999998 999999999999987 789999999999876543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..... ....... ....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~----i~~~~~~--~~~~- 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIEN----IMNAEYT--FDEE- 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH----HHHTCCC--CCHH-
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHH----HHcCCCC--CChh-
Confidence 2 223457899999999999988999999999999999999999997542211 11110 0000000 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.....+..+.+++.+||+.||.+|||+.|++++-
T Consensus 226 ---~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ---hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 0011346789999999999999999999999854
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=366.52 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=208.2
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.++||+|+||.||+|... +++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999742 4678999999654 344556788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhc----cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC---CeEEe
Q 003846 574 ILIYEYLPNKSLDSFLFDRA----KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM---KPKIS 646 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 646 (791)
++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996543 2245889999999999999999999998 99999999999999555 59999
Q ss_pred eeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhh
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..|+...... ... ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~----~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL----EFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----HHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHH
Confidence 9999986533322233334567899999999999999999999999999999998 99887543211 111 1111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
... ....+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 1111222346788999999999999999999999999763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=348.82 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=205.5
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999965 468999999985432 33457789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998533 45889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......... .. +.
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~-~~-----~~ 231 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQD-SV-----PN 231 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHSS-CC-----CC
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhhc-cC-----CC
Confidence 321 2223457899999999999999999999999999999999999997543211 000111110 00 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccCcC
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRP-TMSEVVSMLTNEHL 779 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~~ 779 (791)
.........+..+.+++.+||+.||.+|| +++++.+.|+....
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00111122346789999999999999998 99999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=350.81 Aligned_cols=263 Identities=26% Similarity=0.428 Sum_probs=204.1
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.+.||+|+||.||+++. .++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 46788899999999999999987 5889999998643 34578999999999999999999999886 4589999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC-eEEeeeccccccCCCcc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK-PKISDFGMARMFGGDEL 659 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DFgla~~~~~~~~ 659 (791)
++++|.+++........++...++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999966554556788899999999999999999943234999999999999998887 799999999765422
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......... .+... .... +
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~-~~~~-----~---- 223 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWAVH-NGTR-----P---- 223 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHHHH-TTCC-----C----
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHHHh-cCCC-----C----
Confidence 223468999999999999999999999999999999999999986433221111 11111 1100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCCCC
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNN 786 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~ 786 (791)
......+..+.+++.+||+.||++|||++|++++|+.....++..+.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 11112346788999999999999999999999999886655554443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=361.37 Aligned_cols=274 Identities=26% Similarity=0.364 Sum_probs=212.1
Q ss_pred ccCCCccceecccCceeEEEeEe-----eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 573 (791)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999973 4688999999987776677889999999999999999999999874 4557
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999998543 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 654 FGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 654 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.|+........................+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6543221 222335688889999999999999999999999999999999998643221100000000000000000011
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
+........+...+..+.+++.+||+.||.+|||+.|++++|+....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111122233455789999999999999999999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=345.69 Aligned_cols=253 Identities=32% Similarity=0.489 Sum_probs=197.0
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC----cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS----GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+|.. .++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46789999999999999999986 58999999987543 23357889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC--------CCCeEEeee
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT--------DMKPKISDF 648 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~--------~~~~kl~DF 648 (791)
|||+++++|.+++. ...+++..+..++.|+++||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999883 346889999999999999999999987556899999999999986 778999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
|++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+....... ........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~-- 229 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYGVAMN-- 229 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHTS--
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHhhhcC--
Confidence 9998654332 123478999999999999999999999999999999999999975432110 00110000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
......+...+..+.+++.+||+.||.+|||+.|++++|+.
T Consensus 230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 -------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11111222334678999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=372.70 Aligned_cols=270 Identities=27% Similarity=0.420 Sum_probs=212.7
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
...++|++.++||+|+||.||+|...++..||||+++... ...+++.+|++++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456788999999999999999998888889999997543 346789999999999999999999999876 67899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999532 2345889999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. ......++..|+|||++.+..++.++||||||++||||++ |+.|+...... ... ...... .
T Consensus 335 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~----~~i~~~---------~ 398 (452)
T 1fmk_A 335 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVL----DQVERG---------Y 398 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTT---------C
T ss_pred ee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcC---------C
Confidence 21 1223356789999999999999999999999999999999 89887532211 111 111111 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCCCCcCCC
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNNQLSR 790 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 790 (791)
....+...+..+.+++.+||+.||++|||++++++.|+......+...++..+
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~~~ 451 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSCC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccccC
Confidence 11112234567899999999999999999999999999977766666555554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=352.97 Aligned_cols=263 Identities=28% Similarity=0.399 Sum_probs=213.4
Q ss_pred hhccCCCccceecccCceeEEEeEe------eCCcEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKKSG-QGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
...++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999974 3467899999975533 3457789999999999 899999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhcc---------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcE
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAK---------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 635 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NI 635 (791)
+..++||||+++|+|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999965432 224889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCcc
Q 003846 636 LLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSL 714 (791)
Q Consensus 636 Ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~ 714 (791)
|++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999987765443333344567889999999999999999999999999999999 9998764332211
Q ss_pred chhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 715 NLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
........ .....+...+..+.+++.+||+.||.+|||+.|++++|++..
T Consensus 257 -----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 -----FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp -----HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11111111 111111223467899999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=373.33 Aligned_cols=262 Identities=28% Similarity=0.417 Sum_probs=212.8
Q ss_pred hhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
....++|++.++||+|+||.||+|...+++.||||+++... ...+++.+|+.++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34567899999999999999999998888999999997644 45788999999999999999999999986 66789999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999543 2235788899999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.... .....++..|+|||++....++.++||||||++||||++ |+.|+...... .... .....
T Consensus 338 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~----~i~~~--------- 401 (454)
T 1qcf_A 338 EYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERG--------- 401 (454)
T ss_dssp HHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH----HHHHT---------
T ss_pred ceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcC---------
Confidence 2211 223356788999999999999999999999999999999 99997543211 1111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCC
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (791)
.....+...+..+.+++.+||+.||++|||+++|++.|++.....
T Consensus 402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 011112234567899999999999999999999999999865543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.84 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=200.4
Q ss_pred ccCCCccceecccCceeEEEeEee-CCc----EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQ----EVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.++|++.++||+|+||+||+|... +++ +||+|.+... .....+++.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467899999999999999999753 444 4688887543 3345678999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+|+||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999854 3456889999999999999999999998 999999999999999999999999999887
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~----~~~~~~------ 235 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKG------ 235 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH----HHHHTT------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HH----HHHHcC------
Confidence 65544333344567889999999999999999999999999999999 999976432211 11 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.....+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 236 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 236 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11112223446789999999999999999999999998763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=355.85 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=202.9
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|.+.+.||+|+||.||+|.. .+++.||||++.+.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999975 578999999986532 23346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+ +|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788888744 345889999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ...+..
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~ 222 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNS 222 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCS
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHc
Confidence 322 234579999999999988776 7899999999999999999999754322110 000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ....+...+..+.+++.+||+.||.+|||++|++++
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 011222345678999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.05 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=200.1
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 574 (791)
..++|++.+.||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999764 5899999999754 233456788999999988 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999854 345889999999999999999999998 999999999999999999999999999854
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. .......
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~----~~i~~~~------ 240 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DDLF----EAILNDE------ 240 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCC------
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HHHH----HHHHcCC------
Confidence 3222 223346899999999999999999999999999999999999999753221 1111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTM------SEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 773 (791)
...+...+..+.+++.+||+.||++||++ +|++++
T Consensus 241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 01122245678999999999999999998 777653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.66 Aligned_cols=272 Identities=26% Similarity=0.389 Sum_probs=206.6
Q ss_pred ccCCCccceecccCceeEEEeEe-----eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Cc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 572 (791)
.++|++.++||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688899999999999999973 468999999997543 34567899999999999999999999999876 66
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 79999999999999998443 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 653 MFGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 653 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
........ .......+|..|+|||++.+..++.++||||||+++|+|++|..|+.........................
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76544321 22334568889999999999999999999999999999999998743211000000000000000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.+........+...++.+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111111112233457899999999999999999999999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.92 Aligned_cols=262 Identities=22% Similarity=0.337 Sum_probs=200.5
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.+.||+|+||+||+|+..+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999988789999999986543 23357788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 88888743 3356888999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC--------cc
Q 003846 660 QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR--------AL 730 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~ 730 (791)
......+|+.|+|||++.+. .++.++||||||+++|||++|+.||...... .............. ..
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhcc
Confidence 12234689999999999764 5899999999999999999999998643211 11111111000000 00
Q ss_pred cccccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 DLMDPILE-------NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...++... .......+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00011100 01112245678899999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.38 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=204.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG------QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||.||++... +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467899999999999999999764 689999999875432 2467899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC----CeEEeeec
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM----KPKISDFG 649 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFg 649 (791)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999843 356889999999999999999999998 99999999999999887 89999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ...... ......
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~----~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLAN----VSAVNY 234 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH----HHHTCC
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHH----HHhcCC
Confidence 998765332 22345799999999999999999999999999999999999999753221 111100 000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ..... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 235 -~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -E-FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -C-CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -C-cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000 01124678899999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=358.87 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=199.0
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCC--CceeeeeeEEEcCCcce
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQH--RNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~ 574 (791)
...++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++.+++..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 456789999999999999999998888999999998654 33445788999999999986 99999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 568899999853 346889999999999999999999998 99999999999997 678999999999877
Q ss_pred CCCccccccccccccCcccCchhccc-----------CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALE-----------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 723 (791)
.............||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~- 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHA- 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHH-
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----HHHHH-
Confidence 55443333345679999999999865 678999999999999999999999985322211 11111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.+++......+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 233 --------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 233 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1111111111222235788999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=351.70 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=204.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999764 68999999997542 23467788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999853 345888999999999999999999988 99999999999999999999999999987543
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... .......
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~----~~i~~~~-------- 219 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTY----EKILNAE-------- 219 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH----HHHHHCC--------
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHH----HHHHhCC--------
Confidence 2 2345799999999999999999999999999999999999999753211 1111 1111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 011223446789999999999999999 89998854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=353.95 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=212.9
Q ss_pred hhhhhccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCL 568 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 568 (791)
+.....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 44556789999999999999999999654 37889999997543 334567889999999999999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhcc-------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAK-------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
+.+..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 99999999999999999999865322 145688999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhh
Q 003846 642 KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHA 720 (791)
Q Consensus 642 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 720 (791)
.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~---- 249 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QV---- 249 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HH----
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HH----
Confidence 999999999986654433333334567889999999999999999999999999999999 78886533211 11
Q ss_pred hHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 721 WDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
......... ...+...+..+.+++.+||+.||.+|||+.|++++|++.
T Consensus 250 ~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 250 LRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 111111111 011123346789999999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.11 Aligned_cols=273 Identities=29% Similarity=0.372 Sum_probs=208.7
Q ss_pred cCC-CccceecccCceeEEEeEe-----eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--Cc
Q 003846 502 NNF-SAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DE 572 (791)
Q Consensus 502 ~~y-~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 572 (791)
++| ++.++||+|+||+||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8899999999999988753 368899999997653 34467789999999999999999999999874 56
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 7899999999999999843 34889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 653 MFGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 653 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
........ .......+|..|+|||++.+..++.++||||||+++|+|++|+.|+........................+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 76543221 22234567888999999999999999999999999999999999865422110000000000000001111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCC
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (791)
.+........+...+..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111122223334578999999999999999999999999998765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.34 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=203.1
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 574 (791)
..++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3468999999999999999999764 58899999997642 23345678899999887 8999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999853 346889999999999999999999998 999999999999999999999999999853
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc---chhhhhhHHhhcCCccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL---NLLGHAWDLWKDNRALD 731 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 731 (791)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..............
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 3221 223446899999999999999999999999999999999999999864322111 01111111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTM------SEVVSM 773 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 773 (791)
...+...+..+.+++.+||+.||++||++ +|++++
T Consensus 279 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 -------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11222345678999999999999999985 666654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.50 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=206.9
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999664 6899999999776655667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC--CCCeEEeeeccccccCCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT--DMKPKISDFGMARMFGGD 657 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFgla~~~~~~ 657 (791)
+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 3346889999999999999999999998 999999999999974 578999999999876543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ...... ..
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~----i~~~~~------~~ 269 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQN----VKRCDW------EF 269 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH----HHHCCC------CC
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCCC------CC
Confidence 22 2234789999999999999999999999999999999999999754221 111111 000000 01
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+++.+||+.||++|||+.|++++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111112245678999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.83 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=204.2
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK-----SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.++|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999965 46899999998642 1224678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC---eEEeeecc
Q 003846 575 LIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK---PKISDFGM 650 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFgl 650 (791)
+||||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988885543 3345788999999999999999999998 999999999999987655 99999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. ..........
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~----~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RL----FEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HH----HHHHHHTCCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HH----HHHHHcCCCC
Confidence 987654322 12345799999999999999999999999999999999999999754211 11 1111111000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+... ...+..+.+++.+||+.||++|||+.|++++
T Consensus 251 --~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 1134678999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=352.16 Aligned_cols=246 Identities=23% Similarity=0.270 Sum_probs=193.0
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.++||+|+||+||+|... +|+.||||++.... .....++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999765 69999999986543 22334455666666555 899999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67898888543 356899999999999999999999988 99999999999999999999999999987643
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
... .....||+.|+|||++.+ .++.++||||||+++|||++|..|+.... .+.......
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~-------- 268 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGY-------- 268 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTC--------
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccC--------
Confidence 322 223468999999998876 78999999999999999999976642210 011111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+..+.+++.+||+.||++|||++|++++
T Consensus 269 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0000111234678999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=358.06 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=204.4
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..++|++.+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999654 68999999997543 33457789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC---CeEEeeeccccc
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM---KPKISDFGMARM 653 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFgla~~ 653 (791)
|||+++|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998843 356889999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+. ......... .
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~----~~i~~~~~~-~- 249 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLY----AQIKAGAYD-Y- 249 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHTCCC-C-
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH----HHHHhCCCC-C-
Confidence 653321 2345799999999999999999999999999999999999999753221 1111 111111000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+++.+||+.||++|||+.|++++
T Consensus 250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000011234678999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=355.24 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=202.7
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcE----EEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQE----VAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.++|++.+.||+|+||.||+|... +++. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 367899999999999999999753 4544 7888875432 334466788999999999999999999886 56789
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999853 3456889999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.............+|..|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~---- 235 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VP----DLLEKGER---- 235 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HH----HHHHTTCB----
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HH----HHHHcCCC----
Confidence 65544444445678889999999999999999999999999999999 999976433211 11 11111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 236 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 236 -----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp -----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011111234577899999999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.12 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=206.7
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 47899999999999999999975 5799999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC-----eEEeeeccccc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK-----PKISDFGMARM 653 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DFgla~~ 653 (791)
|+ +++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 456899999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 654 FGGDELQA-----NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 654 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~-~~i~~~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERY-QKIGDTK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHH-HHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHH-HHHHhhh
Confidence 65432211 12346899999999999999999999999999999999999999875432211 1000 0000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
..... ..+.. ..+ .+.+++..||+.||.+||+++++++.|++.
T Consensus 237 ~~~~~-~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 237 RATPI-EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHSCH-HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccCCH-HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00000 00000 012 789999999999999999999999988653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=373.04 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=212.0
Q ss_pred hccCCCccceecccCceeEEEeEeeC-CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
...+|++.++||+|+||.||+|.... ++.||||+++... ...++|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 35678889999999999999997754 8899999997543 346889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999543 3355889999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. ......++..|+|||++....++.++||||||++||||++ |+.|+...... ... ..... ..
T Consensus 373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~---------~~ 436 (495)
T 1opk_A 373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----ELLEK---------DY 436 (495)
T ss_dssp EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH----HHHHT---------TC
T ss_pred ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHc---------CC
Confidence 22 2223456789999999999999999999999999999999 88887543221 111 11111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
....+...+..+.+|+.+||+.||.+|||+.|+++.|+...
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11122234567899999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=365.49 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=204.0
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..++|++.+.||+|+||.||++.. .+|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999964 578999999987543 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc---CCCCeEEeeeccccc
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---TDMKPKISDFGMARM 653 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFgla~~ 653 (791)
|||+++|+|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998853 345889999999999999999999998 99999999999998 568899999999987
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||..... .... .........
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~----~~i~~~~~~--- 231 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLY----QQIKAGAYD--- 231 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH----HHHHHTCCC---
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHH----HHHHhCCCC---
Confidence 654322 22345799999999999999999999999999999999999999753221 1111 111111000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........++.+.+++.+||+.||.+|||+.|++++
T Consensus 232 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 ---FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0001111235678999999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.24 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=200.7
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.++||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999764 68999999997543 3345778899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 55555432 3456899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccCcccCchhcccCC-CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc------
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD------ 731 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 731 (791)
.......||+.|+|||++.+.. ++.++||||||+++|||++|..|+-.... ...................
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHHhCCCChhhhhhhcc
Confidence 2223457899999999998765 89999999999999999999888532211 1111111111110000000
Q ss_pred cc---------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 LM---------DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. ............+..+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000011112345678999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=347.98 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=196.1
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc--------------------------ccHHHHHHHHHHHH
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG--------------------------QGLEELKNETMLIA 553 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 553 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999965 4689999999865421 12356889999999
Q ss_pred hcCCCceeeeeeEEEc--CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCC
Q 003846 554 KLQHRNLVRLLGCCLD--QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 631 (791)
Q Consensus 554 ~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlk 631 (791)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 3456899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCC---CCcccceeehhHHHHHHHhCCCCCCC
Q 003846 632 ASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGL---FSIKSDVFSFGVLLLEILSGKKNTGF 708 (791)
Q Consensus 632 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvvl~elltg~~p~~~ 708 (791)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 123457899999999998765 47889999999999999999999753
Q ss_pred CCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 709 YHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... .... ........ ........+..+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~--~~~~----~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERI--MCLH----SKIKSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSH--HHHH----HHHHHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccH--HHHH----HHHhcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 211 0110 11111100 000111234678999999999999999999999764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=351.23 Aligned_cols=270 Identities=26% Similarity=0.409 Sum_probs=202.9
Q ss_pred hhhhhhccCCCccceecccCceeEEEeEee----CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 003846 495 ASVSASTNNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCL 568 (791)
Q Consensus 495 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 568 (791)
.++....++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 445556788999999999999999999664 3458999998754 3334577899999999999999999999998
Q ss_pred cCCc-----ceEEEeecCCCChhHHHhhh---ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC
Q 003846 569 DQDE-----KILIYEYLPNKSLDSFLFDR---AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD 640 (791)
Q Consensus 569 ~~~~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~ 640 (791)
+.+. .++||||+++++|.+++... .....+++..++.++.||++||.|||+++ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7653 49999999999999998543 23456899999999999999999999988 9999999999999999
Q ss_pred CCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhh
Q 003846 641 MKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGH 719 (791)
Q Consensus 641 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~ 719 (791)
+.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..|+...... ....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~- 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYD- 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH-
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHH-
Confidence 9999999999987654433333334567889999999999999999999999999999999 88887543221 1111
Q ss_pred hhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCC
Q 003846 720 AWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (791)
...... ....+...+..+.+++.+||+.||.+|||+.|++++|+.....+|
T Consensus 261 ---~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 ---YLLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ---HHHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ---HHHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111110 011112234678999999999999999999999999988665554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.68 Aligned_cols=265 Identities=18% Similarity=0.231 Sum_probs=210.5
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356899999999999999999974 579999999986543 235678899999999 7999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC-----eEEeeecccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK-----PKISDFGMAR 652 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DFgla~ 652 (791)
||+ +++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999998542 345899999999999999999999988 999999999999987776 9999999998
Q ss_pred ccCCCccc-----cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-chhhhhhHHhhc
Q 003846 653 MFGGDELQ-----ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-NLLGHAWDLWKD 726 (791)
Q Consensus 653 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~ 726 (791)
........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 76544321 122345799999999999999999999999999999999999999875432211 111111000000
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCC
Q 003846 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (791)
....+ +. ...+..+.+++.+||+.||++|||++||++.|+++...+
T Consensus 240 ~~~~~-----~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 240 TPLRE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp SCHHH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccHHH-----HH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 00000 00 123467899999999999999999999999998754443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=365.67 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=205.8
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-cceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD-EKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~ 577 (791)
...++|++.++||+|+||.||+|.. .|+.||||+++... ..+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3456788999999999999999987 58899999997653 4578999999999999999999999987765 689999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999643 2334788999999999999999999998 999999999999999999999999999854322
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.....+++.|+|||++.+..++.++||||||++||||++ |+.|+....... ... .....
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~--------- 402 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKG--------- 402 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH----HHHTT---------
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcC---------
Confidence 112356889999999999999999999999999999998 999976443221 111 11111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.....+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 01112223457889999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.49 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=210.4
Q ss_pred hccCCCccceecccCceeEEEeEe--------eCCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL--------LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLD 569 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 569 (791)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 457899999999999999999975 346789999997543 34467789999999999 89999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhhcc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEE
Q 003846 570 QDEKILIYEYLPNKSLDSFLFDRAK-------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636 (791)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NIL 636 (791)
.+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965332 234889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccc
Q 003846 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLN 715 (791)
Q Consensus 637 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~ 715 (791)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... .
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~ 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--H
Confidence 99999999999999987765443333344567889999999999899999999999999999999 99887533211 1
Q ss_pred hhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 716 LLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
+. ....... ....+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 268 ~~----~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 268 LF----KLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HH----HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 1111111 01112223467899999999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.60 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=209.7
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.+.||+|+||.||++...+++.||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467889999999999999999888899999999976543 4578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++++|.+++.. ....+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 99999999853 3346889999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
.......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+...... ... ....... ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~i~~~~---------~~ 224 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVV----EDISTGF---------RL 224 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH----HHHHTTC---------CC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHH----HHHhcCC---------cC
Confidence 12223456789999999999999999999999999999999 88887542211 111 1111110 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..+...+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111223467899999999999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=357.98 Aligned_cols=270 Identities=18% Similarity=0.250 Sum_probs=205.7
Q ss_pred hhccCCCccceeccc--CceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 499 ASTNNFSAENKLGEG--GFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
...++|++.++||+| +||.||+++.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 346789999999999 99999999765 69999999997543 34457788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999998543 2345889999999999999999999998 99999999999999999999999999865
Q ss_pred cCCCc-----cccccccccccCcccCchhccc--CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh--
Q 003846 654 FGGDE-----LQANTNRIVGTYGYMSPEYALE--GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW-- 724 (791)
Q Consensus 654 ~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-- 724 (791)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~ 256 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPC 256 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C-------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HhcCCCCc
Confidence 43221 1111223478999999999987 5799999999999999999999999865332211000 000000
Q ss_pred --hcC------------------Ccccccc---c------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 725 --KDN------------------RALDLMD---P------ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 725 --~~~------------------~~~~~~~---~------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... ...+... + ..........+..+.+|+.+||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 0000000 0 00001112235678999999999999999999999876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=356.61 Aligned_cols=250 Identities=26% Similarity=0.328 Sum_probs=203.3
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcc
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 573 (791)
...++|++.+.||+|+||.||+|+.. +|+.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999764 68999999997542 33466788999999887 899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999853 345889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... .......
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~----~~i~~~~----- 234 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELF----HSIRMDN----- 234 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCC-----
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHHhCC-----
Confidence 43222 123346899999999999999999999999999999999999999753221 1111 1111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMS-EVVS 772 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 772 (791)
...+...+..+.+++.+||+.||++||++. |+++
T Consensus 235 -----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 011222456789999999999999999997 6653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.80 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=195.5
Q ss_pred hccCCCccceecccCceeEEEeEeeC----CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
..++|++.+.||+|+||.||+|.... +..||||++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45789999999999999999997643 4579999987543 344677899999999999999999999984 56789
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999853 2345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... ..... ......
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~----i~~~~~---- 235 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGER---- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCC----
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHH----HHcCCC----
Confidence 543221 1223456789999999999999999999999999999997 88887643221 11111 111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...+...+..+.+++.+||+.||++|||+.|++++|+.+
T Consensus 236 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111223456789999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.00 Aligned_cols=255 Identities=28% Similarity=0.525 Sum_probs=203.3
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcc-------cHHHHHHHHHHHHhcCCCceeeeeeEEEcCC
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQ-------GLEELKNETMLIAKLQHRNLVRLLGCCLDQD 571 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 571 (791)
..++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 357899999999999999999976 47899999998654322 1267899999999999999999999986544
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC-----eEEe
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK-----PKIS 646 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~ 646 (791)
++||||+++++|.+++.. ....+++..+..++.|+++||+|||+++ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999988843 3456899999999999999999999875 34999999999999988776 9999
Q ss_pred eeccccccCCCccccccccccccCcccCchhcc--cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYAL--EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
|||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..............
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---- 242 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI---- 242 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH----
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH----
Confidence 9999975432 223357899999999984 45678999999999999999999999865443322111111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
... ......+...+..+.+++.+||+.||.+|||++|+++.|++
T Consensus 243 ~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 REE--------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHS--------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred hcc--------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 000 11111222345678999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=354.01 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=203.9
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||++... +++.||||++.+. .....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999654 5889999998653 234567889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999843 446889999999999999999999998 99999999999999999999999999987653
Q ss_pred CccccccccccccCcccCchhccc---CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ........
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~---~~~~~~~~------ 235 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE---IVHTFETT------ 235 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH---HHHHHHHC------
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH---HHHHHhhc------
Confidence 32 2334689999999999874 458999999999999999999999986433221110 00101000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPT-MSEVVS 772 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 772 (791)
....+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122234568899999999999999998 777765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.63 Aligned_cols=262 Identities=25% Similarity=0.422 Sum_probs=196.1
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
...++|++.++||+|+||.||+|+. ...||||++.... ....+.+.+|+.++++++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 3457899999999999999999975 3469999987543 34467799999999999999999999965 55678999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999843 3456889999999999999999999998 99999999999999999999999999986554
Q ss_pred CccccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
...........||+.|+|||++. +..++.++||||||+++|||++|+.||....... ...............
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIEMVGRGSLSPDL 247 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-----HHHHHHHHTSCCCCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcccccCcch
Confidence 33333334467899999999987 5678899999999999999999999976432211 111111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
. ......+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 248 ~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 S-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp T-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 111223468899999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.76 Aligned_cols=254 Identities=22% Similarity=0.259 Sum_probs=194.6
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
..++|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999765 68999999996543 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC--eEEeeeccccccCC
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK--PKISDFGMARMFGG 656 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFgla~~~~~ 656 (791)
|+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999843 345889999999999999999999998 999999999999987765 99999999974322
Q ss_pred CccccccccccccCcccCchhcccCCCCcc-cceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIK-SDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
. .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........ ......... ..
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~-~~-------- 237 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRIL-SV-------- 237 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHH-TT--------
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHh-cC--------
Confidence 2 12234579999999999988887655 8999999999999999999864332211 111111000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..........+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000111234678999999999999999999999886
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.17 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=204.6
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367899999999999999999764 68999999986542 23467889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998543 45889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ........
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~----~~~i~~~~-------- 254 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQI----YEKIVSGK-------- 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH----HHHHHHCC--------
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHH----HHHHHcCC--------
Confidence 2 2345799999999999999999999999999999999999999753211 111 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+||+ ++|++++
T Consensus 255 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0112234567899999999999999998 8888764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=349.05 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=203.7
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367899999999999999999764 58999999997642 33456688999999988 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999853 345889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc---chhhhhhHHhhcCCcccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL---NLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 732 (791)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..............
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 221 223346899999999999999999999999999999999999999864322110 00111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTM------SEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+||++ .|++++
T Consensus 236 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 ------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 01222345678999999999999999995 677654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.97 Aligned_cols=271 Identities=23% Similarity=0.265 Sum_probs=211.6
Q ss_pred hhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc----CCc
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD----QDE 572 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~ 572 (791)
....++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34567899999999999999999976 5799999999977666677889999999999999999999999973 346
Q ss_pred ceEEEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
.++||||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 789999999999999986532 3456899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCcccc-------ccccccccCcccCchhcccCC---CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 003846 652 RMFGGDELQA-------NTNRIVGTYGYMSPEYALEGL---FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 652 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~ 721 (791)
.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+.............
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-- 259 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-- 259 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH--
Confidence 7653221110 012245799999999987554 7899999999999999999999975321111111000
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCC
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRR 784 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 784 (791)
.. ...........+..+.+++.+||+.||.+|||+.|++++|+.+....|.+
T Consensus 260 --~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 260 --VQ---------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp --HH---------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred --hh---------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00 00111111223467999999999999999999999999999877655443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.57 Aligned_cols=269 Identities=29% Similarity=0.393 Sum_probs=213.6
Q ss_pred ehhhhhhhccCCCccceecccCceeEEEeEe------eCCcEEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCceeeee
Q 003846 493 SFASVSASTNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKKSG-QGLEELKNETMLIAKL-QHRNLVRLL 564 (791)
Q Consensus 493 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~ 564 (791)
.........++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344455678999999999999999999964 3468899999976533 3456789999999999 799999999
Q ss_pred eEEEcCC-cceEEEeecCCCChhHHHhhhcc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCC
Q 003846 565 GCCLDQD-EKILIYEYLPNKSLDSFLFDRAK-------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDL 630 (791)
Q Consensus 565 ~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dl 630 (791)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9988765 48999999999999999965332 123788999999999999999999998 999999
Q ss_pred CCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCC
Q 003846 631 KASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFY 709 (791)
Q Consensus 631 kp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~ 709 (791)
||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654433333344567899999999999999999999999999999998 99997543
Q ss_pred CCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 710 HTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..... .......... ...+...+..+.+++.+||+.||.+|||+.|++++|+...
T Consensus 255 ~~~~~-----~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 255 KIDEE-----FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCSHH-----HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHH-----HHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 32211 1111111110 1111223467899999999999999999999999998743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=350.52 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=194.5
Q ss_pred ccCCCccceecccCceeEEEeEe----eCCcEEEEEEecccC----cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL----LNGQEVAVKRLSKKS----GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+++. .+++.||||++++.. ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999976 468999999997642 2345667899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999853 345788899999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...... .. ...
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~---i~-~~~---- 237 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KKTIDK---IL-KCK---- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH---HH-HTC----
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HHHHHH---HH-hCC----
Confidence 543221 122345789999999999999999999999999999999999999753221 111110 00 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+...+..+.+++.+||+.||++|| ++.|++++
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011223456789999999999999999 78888775
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.29 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=203.7
Q ss_pred ccCCCccceecccCceeEEEeEeeC-C-------cEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-G-------QEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678999999999999999996543 3 5799999987777777889999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC--------eE
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK--------PK 644 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~--------~k 644 (791)
.++||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999954 3345889999999999999999999998 999999999999998887 99
Q ss_pred EeeeccccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH
Q 003846 645 ISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723 (791)
Q Consensus 645 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 723 (791)
|+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+....... . . ...
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~---~-~~~ 230 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-R---K-LQF 230 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-H---H-HHH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-H---H-HHH
Confidence 9999999754322 23457889999999987 679999999999999999999655432111110 0 0 000
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
.... ...+...+..+.+++.+||+.||++|||+.|++++|+....
T Consensus 231 ~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhcc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0000 00111123467899999999999999999999999998654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.63 Aligned_cols=264 Identities=29% Similarity=0.413 Sum_probs=211.4
Q ss_pred hhhhccCCCccceecccCceeEEEeEeeC------CcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEE
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCL 568 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 568 (791)
.....++|++.+.||+|+||.||+|.... ...||||++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456889999999999999999997532 3479999997653 33457789999999999 8999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhcc-----------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAK-----------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
+.+..++||||+++|+|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999965321 345788999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccch
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNL 716 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~ 716 (791)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..|+........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence 9999999999999986644332223334567889999999999999999999999999999998 8888754322110
Q ss_pred hhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
........ .....+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 276 ---~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 ---FYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ---HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111 00111112346789999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=356.39 Aligned_cols=247 Identities=28% Similarity=0.357 Sum_probs=196.4
Q ss_pred cceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 507 ENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
.+.||+|+||.||+|.. .+|+.||||++........+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999965 46899999999877666678899999999999999999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE--cCCCCeEEeeeccccccCCCcccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--DTDMKPKISDFGMARMFGGDELQANT 663 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl--~~~~~~kl~DFgla~~~~~~~~~~~~ 663 (791)
.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 998854 3345889999999999999999999998 9999999999999 5678999999999987654322 2
Q ss_pred ccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCH
Q 003846 664 NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASY 743 (791)
Q Consensus 664 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 743 (791)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ... ... . .......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~---i~~-~~~-~-----~~~~~~~ 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNN---ILA-CRW-D-----LEDEEFQ 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH---HHH-TCC-C-----SCSGGGT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---HHh-ccC-C-----CChhhhc
Confidence 2346999999999999999999999999999999999999997543211 11111 000 000 0 0000011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 744 PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 744 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+..+.+++.+||+.||.+|||+.|++++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 234678999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=358.78 Aligned_cols=254 Identities=25% Similarity=0.328 Sum_probs=198.6
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcC--CCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQ--HRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~l 575 (791)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++++++ ||||+++++++...+..++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34679999999999999999998878999999998654 3345678999999999996 5999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 134 v~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 568899999854 236788899999999999999999988 99999999999995 6899999999998765
Q ss_pred CCccccccccccccCcccCchhccc-----------CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALE-----------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
............||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ......
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~~~- 280 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAI- 280 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHH-
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HHHHHH-
Confidence 4433333345679999999999875 368999999999999999999999985322111 111111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
+++......+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 281 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 281 --------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp --------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 111111111111245788999999999999999999998763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=353.01 Aligned_cols=250 Identities=26% Similarity=0.298 Sum_probs=203.5
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 574 (791)
..++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999765 4789999999754 234567788999999988 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998532 45889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ......
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~----~i~~~~------ 237 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQ----SIMEHN------ 237 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHCC------
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHH----HHHhCC------
Confidence 3221 223346899999999999999999999999999999999999999753211 11111 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+||+ ++|++++
T Consensus 238 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0112234568899999999999999995 5777765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.03 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=211.7
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
...++|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 35678999999999999999999765 48899999996543 35678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999998542 3456889999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..|+....... .. ..... .
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~----~~~~~---------~ 228 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY----ELLEK---------D 228 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH----HHHHT---------T
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHhc---------c
Confidence 32 22233467889999999999999999999999999999999 888875432211 11 11111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.....+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11112223456789999999999999999999999998763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.90 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=203.9
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.++||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467999999999999999999764 4779999999877666778999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE---cCCCCeEEeeeccccccCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgla~~~~~ 656 (791)
+++++|.+++.. ...+++..+..++.|+++||+|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998854 345889999999999999999999998 9999999999999 7889999999999987654
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. ......||+.|+|||++.+. ++.++||||||+++|||++|+.|+...... ... ........
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~----~~~~~~~~------- 224 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVM----LKIREGTF------- 224 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHCCC-------
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHH----HHHHhCCC-------
Confidence 32 22335789999999988654 899999999999999999999997543211 100 00111100
Q ss_pred ccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASY----PMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+. ..+..+.+++.+||+.||.+|||+.|++++
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 ---TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 134678999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.35 Aligned_cols=264 Identities=19% Similarity=0.251 Sum_probs=208.6
Q ss_pred ehhhhhhhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 003846 493 SFASVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCL 568 (791)
Q Consensus 493 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 568 (791)
.+.++....++|++.++||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34456667889999999999999999999765 47899999996532 222344889999999999999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
+.+..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999953 2456899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 723 (791)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ........
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--~~~~~~i~-- 294 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIM-- 294 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHH--
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--hHHHHhhh--
Confidence 99987654322 2223458999999999987 45789999999999999999999999753221 11111110
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003846 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATD--RPTMSEVVSM 773 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 773 (791)
.... ... . .......+..+.+++.+||+.+|++ ||+++|++++
T Consensus 295 -~~~~--~~~---~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 -NHKE--RFQ---F-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -THHH--HCC---C-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -hccc--ccc---C-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000 000 0 0011123567899999999888888 9999999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=375.26 Aligned_cols=269 Identities=27% Similarity=0.421 Sum_probs=214.7
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
...++|++.++||+|+||.||+|...++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788999999999999999998888899999997644 346789999999999999999999999876 67899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.++|... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999542 2345889999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. ......++..|+|||++....++.++||||||++||||++ |+.|+...... ... ...... .
T Consensus 418 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~----~~i~~~---------~ 481 (535)
T 2h8h_A 418 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVL----DQVERG---------Y 481 (535)
T ss_dssp HH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHH----HHHHTT---------C
T ss_pred ee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcC---------C
Confidence 11 1223356789999999999999999999999999999999 89887532211 111 111111 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCCCCcCC
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNNQLS 789 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~ 789 (791)
....+...+..+.+|+.+||+.||++|||+++|+++|+.........-++..
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~ 533 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC--
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCccc
Confidence 1111223456789999999999999999999999999987665544444433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=362.38 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=207.1
Q ss_pred hhhhhhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC
Q 003846 495 ASVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ 570 (791)
Q Consensus 495 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 570 (791)
.++....++|++.+.||+|+||+||+++.. +++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345566789999999999999999999765 58899999986531 22345578999999999999999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999843 35888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCC----CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGL----FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
++....... ......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||..... ....... ...
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i---~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKI---MNH 288 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH---HTH
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--hhHHHHH---Hhc
Confidence 987654322 1223468999999999998665 88999999999999999999999753221 1111110 000
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHh
Q 003846 727 NRALDLMDPILENEASYPMLARYVNVALLCVHENATD--RPTMSEVVSML 774 (791)
Q Consensus 727 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L 774 (791)
.. .+.-......+..+.+|+.+||+.+|.+ ||+++|++++-
T Consensus 289 ~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 289 KN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred cc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 00 0000011123467899999999999988 99999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=364.28 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=205.0
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999764 79999999996542 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3456899999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .+. .......
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~----~~i~~~~------- 232 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLF----KKICDGI------- 232 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHH----HHHHTTC-------
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHH----HHHhcCC-------
Confidence 322 234579999999999998765 78999999999999999999997643211 111 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 233 -~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 -F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 1111234678999999999999999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=345.12 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=190.5
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.++||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999965 468999999987543 3345778899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhc---cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 579 YLPNKSLDSFLFDRA---KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 579 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
|++ ++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999885532 1245888999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC------
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR------ 728 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 728 (791)
... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..............
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCTTTCGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhHhhh
Confidence 322 122335789999999999864 6899999999999999999999998643221 11111111000000
Q ss_pred --cccccc------------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 --ALDLMD------------PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 --~~~~~~------------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...... ..+........+..+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 000111111234678999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.04 Aligned_cols=258 Identities=30% Similarity=0.440 Sum_probs=208.6
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
..++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 357899999999999999999998888899999996543 34678999999999999999999999986 4568999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999998432 2236889999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.|+...... ... ...... ..
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~----~~~~~~---------~~ 228 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI----QNLERG---------YR 228 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTT---------CC
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHH----HHHhcc---------cC
Confidence 2 1223456789999999998899999999999999999999 88887532211 111 111111 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
...+...+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 11112234678999999999999999999999999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=350.26 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=190.1
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34678999999999999999999765 57899999997543 3467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgla~~~ 654 (791)
||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999843 345889999999999999999999998 999999999999975 889999999999865
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .......... ..
T Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~-~~-- 270 (349)
T 2w4o_A 202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEY-YF-- 270 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCC-CC--
T ss_pred Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCC-cc--
Confidence 4332 12345789999999999999999999999999999999999999753322110 0111111100 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+++.+||+.||++|||+.|++++
T Consensus 271 ---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ---ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112235678999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.29 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=199.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcE----EEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQE----VAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
.++|++.++||+|+||.||+|... +++. ||+|.+... .....+++.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999753 4554 577777543 3456788999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+|+||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999854 3356889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ... .....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~----~~~~~------ 235 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEKG------ 235 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHHTT------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHcC------
Confidence 54443333334567889999999999999999999999999999999 999976432211 110 01111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.....+...+..+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 236 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 236 ---ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111112224467899999999999999999999999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.52 Aligned_cols=264 Identities=23% Similarity=0.259 Sum_probs=194.4
Q ss_pred hhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEc----
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLD---- 569 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~---- 569 (791)
.+.....+|++.++||+|+||.||++.. .+++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 3444567899999999999999999975 468999999997776666788999999999996 9999999999952
Q ss_pred ----CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 570 ----QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 570 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
....++||||+. |+|.+++........+++..+..++.||+.||.|||+++ .+|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 334689999996 799999866555667999999999999999999999874 34999999999999999999999
Q ss_pred eeeccccccCCCcccc----------ccccccccCcccCchhc---ccCCCCcccceeehhHHHHHHHhCCCCCCCCCCC
Q 003846 646 SDFGMARMFGGDELQA----------NTNRIVGTYGYMSPEYA---LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTG 712 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~ 712 (791)
+|||+++......... ......+|+.|+|||++ .+..++.++||||||+++|||++|+.|+......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765432111 11134689999999998 5667899999999999999999999997532211
Q ss_pred ccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 713 SLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
. ..............+..+.+++.+||+.||.+|||+.|++++|+....
T Consensus 260 ~------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 R------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 011111111111122457899999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=351.95 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=202.5
Q ss_pred hhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK-----SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD 569 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 569 (791)
++....++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4556678999999999999999999965 46889999998653 34456789999999999999999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhhc-------------------------------------cccccCHHHHHHHHHHHHH
Q 003846 570 QDEKILIYEYLPNKSLDSFLFDRA-------------------------------------KKRLLYWETRVKIIEGIAQ 612 (791)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~ 612 (791)
.+..++||||+++|+|.+++.... ....+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999984211 1223456778889999999
Q ss_pred HHHHhhccCCCCeeecCCCCCcEEEcCCC--CeEEeeeccccccCCCcc--ccccccccccCcccCchhccc--CCCCcc
Q 003846 613 GLLYLHQYSRLRIIHRDLKASNILLDTDM--KPKISDFGMARMFGGDEL--QANTNRIVGTYGYMSPEYALE--GLFSIK 686 (791)
Q Consensus 613 aL~~LH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DFgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 686 (791)
||+|||+++ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998776 899999999986533211 112334579999999999975 678999
Q ss_pred cceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 003846 687 SDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPT 766 (791)
Q Consensus 687 ~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt 766 (791)
+||||||+++|||++|+.||...... . ........... .........+..+.+++.+||+.||.+|||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~--~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA--D---TISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH--H---HHHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH--H---HHHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999997543211 1 11111111100 000011123467899999999999999999
Q ss_pred HHHHHHH
Q 003846 767 MSEVVSM 773 (791)
Q Consensus 767 ~~evl~~ 773 (791)
+.|++++
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.12 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=195.2
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc---
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK--- 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--- 573 (791)
.++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 57899999999999999999975 578999999997643 33456788999999999999999999999876554
Q ss_pred -eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 574 -ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 574 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
++||||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999853 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 653 MFGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 653 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~- 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIP- 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCC-
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcCCCCC-
Confidence 76543221 2223457899999999999999999999999999999999999997542211 1111111111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH-HHHhcc
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV-VSMLTN 776 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev-l~~L~~ 776 (791)
+. ......+..+.+++.+||+.||.+||++.++ .+.|..
T Consensus 239 ---~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 ---PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ---HH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---cc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 00 0001134678999999999999999966554 444443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.92 Aligned_cols=209 Identities=30% Similarity=0.356 Sum_probs=181.0
Q ss_pred CCceehhhhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-----CCceee
Q 003846 489 LPLFSFASVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-----HRNLVR 562 (791)
Q Consensus 489 l~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~ 562 (791)
...+++.......++|++.++||+|+||.||+|+. .+++.||||++... ......+..|+.++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34456666667789999999999999999999976 46889999999643 334567788999999996 999999
Q ss_pred eeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---
Q 003846 563 LLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT--- 639 (791)
Q Consensus 563 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~--- 639 (791)
+++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 99999998543 2345889999999999999999999998 999999999999975
Q ss_pred ----------------------CCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHH
Q 003846 640 ----------------------DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLL 697 (791)
Q Consensus 640 ----------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ 697 (791)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999864332 23457899999999999999999999999999999
Q ss_pred HHHhCCCCCCC
Q 003846 698 EILSGKKNTGF 708 (791)
Q Consensus 698 elltg~~p~~~ 708 (791)
||++|+.||..
T Consensus 251 ell~g~~pf~~ 261 (360)
T 3llt_A 251 ELYTGSLLFRT 261 (360)
T ss_dssp HHHHSSCSCCC
T ss_pred HHHHCCCCCCC
Confidence 99999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.00 Aligned_cols=268 Identities=25% Similarity=0.330 Sum_probs=199.9
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhc--CCCceeeeeeEEEcC----Cc
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL--QHRNLVRLLGCCLDQ----DE 572 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~----~~ 572 (791)
...++|++.++||+|+||.||+|+. .++.||||++.... ...+..|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 4457899999999999999999987 48999999986432 34455566666554 899999999999887 67
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC-----CCCeeecCCCCCcEEEcCCCCeEEee
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS-----RLRIIHRDLKASNILLDTDMKPKISD 647 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl~D 647 (791)
.++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++. +.+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 8999999999999999843 35889999999999999999999870 11299999999999999999999999
Q ss_pred eccccccCCCcccc--ccccccccCcccCchhcccCCCCcc------cceeehhHHHHHHHhCCC----------CCCCC
Q 003846 648 FGMARMFGGDELQA--NTNRIVGTYGYMSPEYALEGLFSIK------SDVFSFGVLLLEILSGKK----------NTGFY 709 (791)
Q Consensus 648 Fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslGvvl~elltg~~----------p~~~~ 709 (791)
||+++......... ......||+.|+|||++.+.....+ +||||||+++|||++|.. |+...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998765432221 1224579999999999988766655 999999999999999944 43322
Q ss_pred CCCccchhhhhhHHhhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 710 HTGSLNLLGHAWDLWKDNRALDLMDPILENE-ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
......... ...... .....+..... .....+..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 266 ~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 266 VPSDPSYED-MREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SCSSCCHHH-HHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCchhh-hHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 211111110 000000 01111111111 112567789999999999999999999999999987553
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.54 Aligned_cols=272 Identities=18% Similarity=0.188 Sum_probs=203.3
Q ss_pred ccCCCccceecccCceeEEEeEee----CCcEEEEEEecccCcc-----------cHHHHHHHHHHHHhcCCCceeeeee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKKSGQ-----------GLEELKNETMLIAKLQHRNLVRLLG 565 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~ 565 (791)
.++|++.+.||+|+||.||+|... ++..+|||++...... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999765 5788999998765322 1234667888999999999999999
Q ss_pred EEEc----CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC
Q 003846 566 CCLD----QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM 641 (791)
Q Consensus 566 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~ 641 (791)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67789999999 9999999843 237899999999999999999999998 99999999999999887
Q ss_pred --CeEEeeeccccccCCCccc-----cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc
Q 003846 642 --KPKISDFGMARMFGGDELQ-----ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL 714 (791)
Q Consensus 642 --~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~ 714 (791)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 111345799999999999999999999999999999999999999854322211
Q ss_pred chhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCC
Q 003846 715 NLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRR 784 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 784 (791)
... ......... ....+..... ....+..+.+++.+||+.||++|||++||++.|++....++..
T Consensus 269 ~~~-~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 333 (345)
T 2v62_A 269 AVQ-TAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPL 333 (345)
T ss_dssp HHH-HHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCC
T ss_pred HHH-HHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCC
Confidence 111 111111000 0000000000 0123467899999999999999999999999999876655443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.11 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=206.2
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999764 68999999986543 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++. ....+++..+..++.||++||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999883 3346889999999999999999999998 9999999999999999999999999998654333
Q ss_pred cccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.........|++.|+|||++.+..+ +.++||||||+++|||++|+.|+........... .+.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~-------- 226 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKT-------- 226 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH-----HHHTTCT--------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH-----Hhhhccc--------
Confidence 2233344678999999999987765 7899999999999999999999865433221111 1111100
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000111234678899999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=341.46 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=206.7
Q ss_pred ccCCCccc-eecccCceeEEEeEee---CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAEN-KLGEGGFGPVYKGELL---NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.++|.+.+ .||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 9999999999999653 57889999997643 34567899999999999999999999999 5567899
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999843 3456889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 656 GDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 656 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... ... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~----~~i~~~~----- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQGK----- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH----HHHHTTC-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHH----HHHhcCC-----
Confidence 43221 22223456889999999998899999999999999999998 99997543221 111 1111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...+..+.+++.+||+.||++||++.|++++|+..
T Consensus 231 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112223456899999999999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=337.78 Aligned_cols=254 Identities=20% Similarity=0.333 Sum_probs=204.3
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC--CcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ--DEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 576 (791)
.++|++.++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46789999999999999999987 58999999997643 34456799999999999999999999999887 778999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++... ....+++..+..++.||++||+|||+++ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999542 2335899999999999999999999865 3499999999999999999999999998764322
Q ss_pred CccccccccccccCcccCchhcccCCCCc---ccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSI---KSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
....+|+.|+|||++.+..++. ++||||||+++|||++|+.|+....... .........
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~------ 227 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEG------ 227 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHSC------
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhcC------
Confidence 2346799999999998765544 8999999999999999999975432111 001111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.....+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 ---LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111122234567899999999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.37 Aligned_cols=270 Identities=20% Similarity=0.281 Sum_probs=212.9
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC--cceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD--EKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV 576 (791)
.++|.+.++||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 468999999999999999999764 48999999997543 344677889999999999999999999998765 67999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE----cCCCCeEEeeecccc
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DTDMKPKISDFGMAR 652 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFgla~ 652 (791)
|||+++|+|.+++........+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999966555555899999999999999999999998 9999999999999 778889999999998
Q ss_pred ccCCCccccccccccccCcccCchhccc--------CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALE--------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII 240 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHh
Confidence 7654322 223578999999999875 567889999999999999999999986543322111 1111111
Q ss_pred hcCCc--cc-c---------ccc--cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 725 KDNRA--LD-L---------MDP--ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 725 ~~~~~--~~-~---------~~~--~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
..... .. . ... .............+.+++.+||+.||++||++.|+++.++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 11100 00 0 000 111234456788899999999999999999999999988764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=351.84 Aligned_cols=256 Identities=16% Similarity=0.174 Sum_probs=208.1
Q ss_pred hhhhhccCCCccceecccCceeEEEe------EeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC---CCceeeeeeE
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKG------ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ---HRNLVRLLGC 566 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~------~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~ 566 (791)
++....++|.+.++||+|+||.||+| ...+++.||||++.... ..++..|++++.+++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34456788999999999999999999 34568999999997543 457788888888887 9999999999
Q ss_pred EEcCCcceEEEeecCCCChhHHHhhhc--cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-----
Q 003846 567 CLDQDEKILIYEYLPNKSLDSFLFDRA--KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT----- 639 (791)
Q Consensus 567 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~----- 639 (791)
+...+..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 999999999999999999999996532 3466999999999999999999999988 999999999999998
Q ss_pred ------CCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc
Q 003846 640 ------DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713 (791)
Q Consensus 640 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~ 713 (791)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976543322333345679999999999999999999999999999999999999964322211
Q ss_pred cchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhccC
Q 003846 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDR-PTMSEVVSMLTNE 777 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R-Pt~~evl~~L~~~ 777 (791)
. .....+... ...+.+.+++..|++.+|.+| |++.++.+.|++.
T Consensus 293 ~-----------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 C-----------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp E-----------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred e-----------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 011111111 224577899999999999999 6888888888764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=341.15 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=205.8
Q ss_pred CCCccceecccCceeEEEeEeeC----CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc-eEE
Q 003846 503 NFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK-ILI 576 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV 576 (791)
.|...++||+|+||.||+|...+ +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999997533 2379999987543 34567889999999999999999999999877665 999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+.+++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999843 3456788999999999999999999998 99999999999999999999999999986654
Q ss_pred Cccc--cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 657 DELQ--ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 657 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ....... .....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~----~~~~~------ 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHF----LAQGR------ 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHH----HHTTC------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHH----hhcCC------
Confidence 3321 222345678999999999999999999999999999999996665322111 1111110 11110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCC
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPR 783 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 783 (791)
....+...+..+.+++.+||+.||.+|||+.|+++.|+++...+..
T Consensus 246 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 ---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1111222346789999999999999999999999999886555543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.00 Aligned_cols=252 Identities=25% Similarity=0.300 Sum_probs=204.4
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG------QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||.||++... +|+.||||++..... ...+++.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999764 689999999875432 1367899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC----CeEEeeec
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM----KPKISDFG 649 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFg 649 (791)
++||||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999843 345788999999999999999999998 99999999999999888 79999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+..... ..... .......
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~----~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLA----NITSVSY 235 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHH----HHHTTCC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--HHHHH----HHHhccc
Confidence 998765432 12345789999999999999999999999999999999999999753221 11110 0000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+... ...+..+.+++.+||+.||++|||+.|++++
T Consensus 236 --~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 --DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 1124578899999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=342.26 Aligned_cols=263 Identities=27% Similarity=0.385 Sum_probs=204.4
Q ss_pred hccCCCccceecccCceeEEEeEeeC----CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEE-cCCcc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCL-DQDEK 573 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~ 573 (791)
...+|++.++||+|+||.||+|...+ ...+|||.+.... ....+.+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 44678889999999999999997533 2358999987543 344678899999999999999999999865 45677
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999843 3456788999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc--cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCC-CCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 654 FGGDELQ--ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK-KNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 654 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++|. +|+....... .... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~----~~~~~-- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY----LLQGR-- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHH----HHTTC--
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHH----HhcCC--
Confidence 6543321 1222346788999999999999999999999999999999954 4543222111 1110 00000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCC
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (791)
....+...+..+.+++.+||+.||.+|||+.|+++.|+.+...+.
T Consensus 250 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 001111234678999999999999999999999999988655444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=345.09 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=199.8
Q ss_pred ccCCCcc-ceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAE-NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.++|++. +.||+|+||.||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578774 7899999999999964 47999999999877666678899999999985 7999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC---eEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK---PKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFgla~~~ 654 (791)
||+++++|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998543 45889999999999999999999998 999999999999998776 999999999765
Q ss_pred CCCcc-----ccccccccccCcccCchhccc-----CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchh-------
Q 003846 655 GGDEL-----QANTNRIVGTYGYMSPEYALE-----GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLL------- 717 (791)
Q Consensus 655 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~------- 717 (791)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223468999999999875 5688999999999999999999999865433221100
Q ss_pred --hhhhHHhhcCCccccccccccCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 718 --GHAWDLWKDNRALDLMDPILENEASY----PMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 718 --~~~~~~~~~~~~~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
........... ...+. ..+..+.+++.+||+.||++|||+.|++++-
T Consensus 245 ~~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 245 CQNMLFESIQEGK----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHHCC----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHhccC----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 00001111000 00111 1346789999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.55 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=184.8
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999975 579999999986532 2335788999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999843 3356889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ . . .....
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-------~-----~~~~~ 227 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L-------N-----KVVLA 227 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSS
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H-------H-----HHhhc
Confidence 3221 12235789999999999999999999999999999999999999764322110 0 0 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0 01112234678899999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=360.12 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=207.0
Q ss_pred ehhhhhhhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 003846 493 SFASVSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCL 568 (791)
Q Consensus 493 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 568 (791)
.+.+.....++|++.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455567789999999999999999999764 69999999997532 223455889999999999999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
+.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999543 346889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcc-------cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhh
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYAL-------EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~ 721 (791)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||..... .......
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i- 282 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--AETYGKI- 282 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH-
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--HHHHHHH-
Confidence 99987654322 1223458999999999997 35689999999999999999999999753221 1111110
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDR---PTMSEVVSM 773 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~~ 773 (791)
.... .....+. .....+..+.+++.+||+ +|.+| |+++|++++
T Consensus 283 --~~~~--~~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 283 --VHYK--EHLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --HTHH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --Hhcc--cCcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0000 0000010 111235688999999999 99998 699999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.54 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=204.3
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc---------
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD--------- 569 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 569 (791)
..++|++.+.||+|+||.||+|... +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999765 79999999997543 356789999999999999999998864
Q ss_pred -------CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 570 -------QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 570 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
....++||||+++++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34578999999999999998543 3356889999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|||++|..|+... .....
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHH
Confidence 99999999987654322 22346899999999999999999999999999999999999874210 00111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCC
Q 003846 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (791)
.... ..+ +...+..+.+++.+||+.||.+|||+.|++++|.......
T Consensus 230 ~~~~--------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 DLRD--------GII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHT--------TCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred Hhhc--------ccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1111 111 1123456889999999999999999999999998765443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=352.20 Aligned_cols=267 Identities=17% Similarity=0.219 Sum_probs=203.4
Q ss_pred hccCCCccceecccCceeEEEeEeeC------CcEEEEEEecccCccc-----------HHHHHHHHHHHHhcCCCceee
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQG-----------LEELKNETMLIAKLQHRNLVR 562 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 562 (791)
..++|++.++||+|+||.||+|.... ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999997654 4789999987654221 122334666677788999999
Q ss_pred eeeEEEcC----CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc
Q 003846 563 LLGCCLDQ----DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 638 (791)
Q Consensus 563 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~ 638 (791)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 3479999999 9999999854 3456899999999999999999999998 99999999999999
Q ss_pred --CCCCeEEeeeccccccCCCcccc-----ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCC
Q 003846 639 --TDMKPKISDFGMARMFGGDELQA-----NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHT 711 (791)
Q Consensus 639 --~~~~~kl~DFgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~ 711 (791)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||++||||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765432211 11234599999999999999999999999999999999999999874322
Q ss_pred CccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 712 GSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.. .......... .....+.+++.+.. ...+..+.+++..||+.||.+||++.++++.|++.
T Consensus 267 ~~-~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 DP-KYVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp CH-HHHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CH-HHHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 21 1111111111 11122222222211 11246788999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=366.44 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=194.9
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|++.++||+|+||.||++.. .+|+.||||++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999965 46899999999753 33445677889999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||||+++|+|.+++.. ...+++..+..++.||++||+|||+ ++ |+||||||+||||+.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999843 3468899999999999999999998 77 999999999999999999999999999864
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||..... ..+. .......
T Consensus 300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~----~~i~~~~------ 365 (446)
T 4ejn_A 300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLF----ELILMEE------ 365 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCC------
T ss_pred cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHH----HHHHhCC------
Confidence 3322 223346899999999999999999999999999999999999999753221 1111 0010000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+|| +++|++++
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 011222456789999999999999999 99999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.04 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=199.1
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-----cccHHHHHHHHHHHHhcC---CCceeeeeeEEEcC
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-----GQGLEELKNETMLIAKLQ---HRNLVRLLGCCLDQ 570 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 570 (791)
..++|++.++||+|+||+||+|.. .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999975 568999999986432 122356777888877774 99999999999876
Q ss_pred C-----cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEE
Q 003846 571 D-----EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKI 645 (791)
Q Consensus 571 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl 645 (791)
. ..++||||+. ++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4689999997 5999998543 2334899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--HHHHHHHHHHC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 9999998654332 223457899999999999999999999999999999999999997543221 11111111110
Q ss_pred cCCcc------ccccccccCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 DNRAL------DLMDPILENE-------ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 ~~~~~------~~~~~~l~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..... .......... .....+..+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000 0000000000 001234678999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=338.47 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=199.1
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|.+.++||+|+||.||++.. .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46799999999999999999965 468899999987653 3456889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE---cCCCCeEEeeecccccc
Q 003846 579 YLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DTDMKPKISDFGMARMF 654 (791)
Q Consensus 579 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgla~~~ 654 (791)
|+++++|.+++... .....+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998653 23466899999999999999999999998 9999999999999 55688999999999865
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||....... .. ........
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~----~~~~~~~~----- 242 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQ----QKATYKEP----- 242 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHCCC-----
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HH----hhhccCCc-----
Confidence 4432 123457899999999875 568999999999999999999999975432111 00 00000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... ....+.++.+.+++.+||+.||++|||+.|++++
T Consensus 243 -~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 243 -NYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -CCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -ccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0001134678899999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.06 Aligned_cols=273 Identities=25% Similarity=0.387 Sum_probs=209.2
Q ss_pred ccCCCccceecccCceeEEEeEe-----eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC--cc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-----LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD--EK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~ 573 (791)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46788999999999999999973 468999999998776667788999999999999999999999987654 67
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998542 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhh-hHHhhcCCccc
Q 003846 654 FGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA-WDLWKDNRALD 731 (791)
Q Consensus 654 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 731 (791)
....... .......++..|+|||++.+..++.++||||||+++|||++|..|+.............. ..........+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 112234567889999999998899999999999999999999988643210000000000 00000000001
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.+........+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111122234578999999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.80 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=203.8
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999965 45899999998654 3334577889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC---eEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK---PKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFgla~~~ 654 (791)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888843 345889999999999999999999998 999999999999987665 999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+...... ... .........
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~----~~~~~~~~~---- 225 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLY----AQIKAGAYD---- 225 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHTCCC----
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHH----HHHHhcccc----
Confidence 54322 22357899999999999999999999999999999999999997532211 111 111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+..+.+++.+||+.||++|||+.|++++
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000111234678899999999999999999999885
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.98 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=201.8
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999975 57899999999753 23446778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 576 IYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||||+++++|.+++.... ....+++..+..++.||++||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999986532 3456889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.|+........... .........
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~---- 256 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC----KKIEQCDYP---- 256 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH----HHHHTTCSC----
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH----HHhhcccCC----
Confidence 43321 12234689999999999999999999999999999999999999753322111111 111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCC
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (791)
.......+..+.+++.+||+.||.+|||+.|++++|+++.+..+
T Consensus 257 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 ----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 00112234678999999999999999999999999988665443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=337.86 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=202.5
Q ss_pred hccCCCccceecccCceeEEEeEeeC----CcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
..++|++.+.||+|+||.||+|...+ +..||||++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999997543 346999998765 33456789999999999999999999999764 4568
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999854 2345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+....... .... .....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~----~~~~~----- 231 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGV----LEKGD----- 231 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHH----HHHTC-----
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHH----HhcCC-----
Confidence 543221 1223456889999999999999999999999999999998 999975432211 1111 11110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...++.+.+++.+||+.||++|||+.|++++|+.+
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 ----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0011122346789999999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=338.11 Aligned_cols=249 Identities=27% Similarity=0.348 Sum_probs=201.6
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
+.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999654 57799999986532 2345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998543 45888999999999999999999988 9999999999999999999999999986543
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+...... .. .......
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~-------- 222 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ET----YKRISRV-------- 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH----HHHHHHT--------
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HH----HHHHHhC--------
Confidence 322 22357899999999999999999999999999999999999997532211 00 0000000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
....+...+..+.+++.+||+.||.+|||++|++++-
T Consensus 223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0111222346788999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.69 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=200.1
Q ss_pred ccCCCccceecccCceeEEEeEeeC-----CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-----GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
..+|++.+.||+|+||.||+|.... +..||||++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678888999999999999997643 2459999997543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999853 3356889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 655 GGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 655 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... ... .......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~----~~~~~~~---- 267 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVM----KAINDGF---- 267 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH----HHHHTTC----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHH----HHHHCCC----
Confidence 543211 11222356788999999999999999999999999999999 99997532211 111 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...+..+.+++.+||+.||.+||++.|++++|+..
T Consensus 268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111223456789999999999999999999999999763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=337.95 Aligned_cols=247 Identities=21% Similarity=0.332 Sum_probs=199.9
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 575 (791)
..++|++.+.||+|+||.||+|... +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3578999999999999999999765 7999999998754 233456788999999999 99999999999999999999
Q ss_pred EEeecCCCChhHHHhhhcc-ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC--------------
Q 003846 576 IYEYLPNKSLDSFLFDRAK-KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-------------- 640 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-------------- 640 (791)
||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965432 256889999999999999999999998 9999999999999844
Q ss_pred -----CCeEEeeeccccccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCcc
Q 003846 641 -----MKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL 714 (791)
Q Consensus 641 -----~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~ 714 (791)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998765432 23589999999999876 66789999999999999999987643211
Q ss_pred chhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 715 NLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+........ ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 236 -----~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -----QWHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0111111111 11112234678999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=340.57 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=204.4
Q ss_pred hhhccCCCccc-eecccCceeEEEeEee---CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC
Q 003846 498 SASTNNFSAEN-KLGEGGFGPVYKGELL---NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD 571 (791)
Q Consensus 498 ~~~~~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 571 (791)
....++|.+.+ .||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456788888 9999999999999542 46889999997543 23367899999999999999999999999 567
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 78999999999999999854 345889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 652 RMFGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 652 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
......... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+...... .. ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~----~~~~~~~~- 237 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV----TAMLEKGE- 237 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTTC-
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HH----HHHHHcCC-
Confidence 876543221 11222356788999999998889999999999999999999 99997543211 11 11111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...+..+.+++.+||+.||.+||++.|+++.|++.
T Consensus 238 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 238 --------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111223456799999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=352.90 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=196.1
Q ss_pred cCCCccceecccCceeEEEeEeeC--C--cEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc-CCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN--G--QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD-QDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l 575 (791)
..|++.+.||+|+||.||+|...+ + ..||||.+... .....+++.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 456778899999999999997542 2 36899998654 33456789999999999999999999998765 457799
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999843 3445788899999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc--ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 656 GDELQA--NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 656 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+|+....... .... ......
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~----~~~~~~--- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY----LLQGRR--- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHH----HHTTCC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHH----HHcCCC---
Confidence 432211 1223467789999999999999999999999999999999 566654332211 1111 111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPR 783 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 783 (791)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+...+..
T Consensus 315 ------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 315 ------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 011122346789999999999999999999999999886555543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.42 Aligned_cols=262 Identities=25% Similarity=0.308 Sum_probs=198.3
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.++||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999764 589999999865432 235678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999998873 2355889999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH-----------Hhhc
Q 003846 659 LQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD-----------LWKD 726 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~ 726 (791)
. ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.|+........ ...... .+..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhccccccccccccc
Confidence 1 1223478999999999976 5789999999999999999999999864332111 000000 0000
Q ss_pred CCcccccc-ccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 NRALDLMD-PILENEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ~~~~~~~~-~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........ +....... ...+..+.+++.+||+.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000 00000000 1234578899999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=344.86 Aligned_cols=249 Identities=24% Similarity=0.256 Sum_probs=179.1
Q ss_pred ceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
+.||+|+||.||++... +++.||||++.+. ....+.+|+.++++++ ||||+++++++.++...++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999764 6899999999653 3467889999999997 99999999999999999999999999999
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC---CeEEeeeccccccCCCccccc
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM---KPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFgla~~~~~~~~~~~ 662 (791)
.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 165 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P 165 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence 999853 356899999999999999999999998 99999999999998766 899999999986543321 2
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-chhhhhhHHhhcCCccccccccccCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-NLLGHAWDLWKDNRALDLMDPILENEA 741 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~ 741 (791)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ............... ......
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCccc
Confidence 2335789999999999999999999999999999999999999865332110 000011111111100 000000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 742 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+..+.+++.+||+.||.+|||++|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01235688999999999999999999999865
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=346.31 Aligned_cols=260 Identities=29% Similarity=0.431 Sum_probs=203.9
Q ss_pred hccCCCccceecccCceeEEEeEe------eCCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL------LNGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
..++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999973 35778999999654 34456678999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc----ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEE
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK----KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKI 645 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl 645 (791)
.++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999965432 245888999999999999999999998 999999999999984 446999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+...... ... ...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~----~~~ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL----EFV 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----HHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH----HHH
Confidence 99999986544433333334567899999999999999999999999999999998 88887532211 111 111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
..... ...+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 259 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11100 111122346789999999999999999999999999763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=348.28 Aligned_cols=270 Identities=24% Similarity=0.365 Sum_probs=196.1
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHH--HHhcCCCceeeeeeEEEc-----CCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETML--IAKLQHRNLVRLLGCCLD-----QDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~-----~~~~ 573 (791)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999976 78999999986543 2344444444 445899999999986542 2245
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc---------CCCCeeecCCCCCcEEEcCCCCeE
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY---------SRLRIIHRDLKASNILLDTDMKPK 644 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~---------~~~~iiH~Dlkp~NILl~~~~~~k 644 (791)
++||||+++|+|.+++.. ...++..+..++.||++||+|||++ + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999843 2347888999999999999999998 6 99999999999999999999
Q ss_pred EeeeccccccCCCcc------ccccccccccCcccCchhccc-------CCCCcccceeehhHHHHHHHhCCCCCCCCCC
Q 003846 645 ISDFGMARMFGGDEL------QANTNRIVGTYGYMSPEYALE-------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHT 711 (791)
Q Consensus 645 l~DFgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvvl~elltg~~p~~~~~~ 711 (791)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+-....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 111223579999999999987 4567899999999999999999776532221
Q ss_pred CccchhhhhhHHhhcCC--------ccccccccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCC
Q 003846 712 GSLNLLGHAWDLWKDNR--------ALDLMDPILEN--EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVL 781 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 781 (791)
................. ......+.+.. ......+..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11000000000000000 00001111111 112236678999999999999999999999999998855433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.27 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=201.2
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEE-EcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC-LDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~ 577 (791)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .+++.+|++++++++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999975 5789999998755432 24578899999999988877766665 5667779999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE---cCCCCeEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DTDMKPKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgla~~~ 654 (791)
||+ +++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999853 2345899999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCccc-----cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-chhhhhhHHhhcCC
Q 003846 655 GGDELQ-----ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-NLLGHAWDLWKDNR 728 (791)
Q Consensus 655 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 728 (791)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 544321 122345789999999999999999999999999999999999999875433211 11111100000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.+.... ..+..+.+++.+||+.||++|||++|+++.|++..
T Consensus 239 -----~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 239 -----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -----HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hhhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 000001 12467899999999999999999999999998743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=372.55 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=201.3
Q ss_pred cCCCccc-eecccCceeEEEeEee---CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAEN-KLGEGGFGPVYKGELL---NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
+++.+.+ +||+|+||.||+|... ++..||||+++... ....+++.+|++++++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999664 46679999997653 3457889999999999999999999999976 568999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999843 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 657 DELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 657 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... .......+++.|+|||++.+..++.++|||||||+||||++ |+.|+...... ... .......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~----~~i~~~~------ 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQGK------ 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHH----HHHHTTC------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHH----HHHHcCC------
Confidence 3221 11122345689999999999999999999999999999998 99997643221 111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
....+...+..+.+++.+||+.||++||++.+|++.|+...
T Consensus 557 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 557 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11122234578999999999999999999999999998743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=341.02 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=205.8
Q ss_pred hhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHh--cCCCceeeeeeEEEcCC----
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAK--LQHRNLVRLLGCCLDQD---- 571 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~---- 571 (791)
....++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34457899999999999999999987 6999999998643 34677889999887 78999999999998876
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhh--------ccCCCCeeecCCCCCcEEEcCCCCe
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDTDMKP 643 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~iiH~Dlkp~NILl~~~~~~ 643 (791)
..++||||+++|+|.+++.. ..+++..+..++.||++||.||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999843 35889999999999999999999 666 9999999999999999999
Q ss_pred EEeeeccccccCCCcccc--ccccccccCcccCchhcccC------CCCcccceeehhHHHHHHHhC----------CCC
Q 003846 644 KISDFGMARMFGGDELQA--NTNRIVGTYGYMSPEYALEG------LFSIKSDVFSFGVLLLEILSG----------KKN 705 (791)
Q Consensus 644 kl~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvvl~elltg----------~~p 705 (791)
||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765432211 22345799999999999876 234789999999999999999 555
Q ss_pred CCCCCCCccchhhhhhHHhhcCCccccccccccC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 706 TGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN-EASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
+............. ...... ....+.+.. ......+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 267 ~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 267 YYDLVPSDPSVEEM-RKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTSCSSCCHHHH-HHHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCcCcccHHHH-HHHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 54332221111111 111111 111111111 112356678999999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=333.56 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=205.2
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEE-EcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC-LDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~ 577 (791)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++++++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999975 5799999999865433 34688999999999988876666655 5666779999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE---cCCCCeEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DTDMKPKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgla~~~ 654 (791)
||+ +++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 9999999843 2346899999999999999999999998 9999999999999 58899999999999876
Q ss_pred CCCcccc-----ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc-cchhhhhhHHhhcCC
Q 003846 655 GGDELQA-----NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS-LNLLGHAWDLWKDNR 728 (791)
Q Consensus 655 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~ 728 (791)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 5443211 1234579999999999999999999999999999999999999987543221 111111110000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.+.+. ...+..+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 239 -----~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 -----IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -----HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00001 112467899999999999999999999999998743
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.25 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=201.2
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
++|.....||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999975 468899999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-CCCeEEeeeccccccCCCcc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~~~~ 659 (791)
++++|.+++........+++..+..++.||++||.|||+++ |+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999965544445678888999999999999999998 999999999999987 8999999999998764322
Q ss_pred ccccccccccCcccCchhcccCC--CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGL--FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.|+........... ..... ..
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~---------~~ 243 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF----KVGMF---------KV 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH----HHHHH---------CC
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH----hhccc---------cc
Confidence 1123457899999999997654 88999999999999999999999753322111000 00000 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+...+..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111222345678999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.66 Aligned_cols=243 Identities=22% Similarity=0.327 Sum_probs=202.1
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc--------ccHHHHHHHHHHHHhcCCCceeeeeeEEEcC
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG--------QGLEELKNETMLIAKLQHRNLVRLLGCCLDQ 570 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 570 (791)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999964 5689999999875431 1334677899999999999999999999999
Q ss_pred CcceEEEeecCCC-ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 571 DEKILIYEYLPNK-SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 571 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99998843 345889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 9987654322 223578999999999998876 8899999999999999999999753211
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....... .+...+..+.+++.+||+.||++|||+.|++++
T Consensus 236 ---~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 111134678999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=348.72 Aligned_cols=248 Identities=31% Similarity=0.457 Sum_probs=200.1
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688899999999999999975 579999999997543 23346788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||++ |+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 578777743 2356889999999999999999999998 99999999999999999999999999976542
Q ss_pred CccccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
. ....||+.|+|||++. +..++.++||||||+++|||++|+.|+..... ............
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~----- 270 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES----- 270 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC-----
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCC-----
Confidence 2 2357899999999985 56789999999999999999999999753221 111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
+.. .....+..+.+++.+||+.||++|||++|++++.
T Consensus 271 -~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 271 -PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 001 1112346788999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.36 Aligned_cols=260 Identities=23% Similarity=0.257 Sum_probs=194.6
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD----- 571 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 571 (791)
..++|++.++||+|+||+||+|.. .+++.||||++... .....+++.+|+.+++.++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999965 46899999999754 3445677889999999999999999999997654
Q ss_pred -cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 572 -EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
..++||||++++ |.+.+. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 459999999865 555552 23788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh-----
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK----- 725 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 725 (791)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ...........
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPE 285 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence 98764322 233458999999999999999999999999999999999999998643211 10000000000
Q ss_pred -------------cCC-------ccccccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 -------------DNR-------ALDLMDPILENE---ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 -------------~~~-------~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... ....+...+... .....+..+.+|+.+||+.||++|||++|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000000 001125678999999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=352.85 Aligned_cols=246 Identities=23% Similarity=0.279 Sum_probs=191.0
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHH-HHhcCCCceeeeeeEEEcCCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETML-IAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
..++|++.+.||+|+||.||+++.. +++.||||++.+.. ......+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3468999999999999999999764 58899999997653 2234556677776 56789999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999853 345788899999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... .......
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~----~~i~~~~------ 255 (373)
T 2r5t_A 190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMY----DNILNKP------ 255 (373)
T ss_dssp BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HHHH----HHHHHSC------
T ss_pred ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHH----HHHHhcc------
Confidence 3221 223456899999999999999999999999999999999999999753211 1111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSE 769 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 769 (791)
...+...+..+.+++.+||+.||.+||++.+
T Consensus 256 ----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0111223467899999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=360.84 Aligned_cols=256 Identities=26% Similarity=0.332 Sum_probs=208.6
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
...++|++.+.||+|+||.||+++.. +|+.||||++.+. .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34578999999999999999999764 6999999999653 2334567889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999998543 2345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...........
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~~------- 404 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV------- 404 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHHC-------
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhcc-------
Confidence 54322 2234899999999999999999999999999999999999999865332211 01111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
....+...+..+.+++.+||+.||.+|| +++|++++
T Consensus 405 ---~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 ---PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1112223457889999999999999999 78999865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.17 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=198.0
Q ss_pred hccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-CcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-DEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E 578 (791)
..++|++.+.||+|+||.||+++. .|+.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 357899999999999999999976 58999999986543 457899999999999999999999997655 47899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++... ....+++..+..++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999998543 2234788899999999999999999998 9999999999999999999999999997644321
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
....+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... ... ...... .
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~----~~~~~~---------~ 231 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV----PRVEKG---------Y 231 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHH----HHHTTT---------C
T ss_pred -----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHhcC---------C
Confidence 22356889999999999999999999999999999998 99987643221 111 111111 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
....+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1111223456789999999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=338.12 Aligned_cols=258 Identities=20% Similarity=0.300 Sum_probs=202.1
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEc--CCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLD--QDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV 576 (791)
.++|++.++||+|+||.||+|.. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 47899999999999999999965 57899999998643 3477899999999997 9999999999987 5678999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeeccccccC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMFG 655 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~~ 655 (791)
|||+++++|.+++. .++...+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998872 3788899999999999999999998 99999999999999777 89999999998765
Q ss_pred CCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh--------hhHHhh-
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH--------AWDLWK- 725 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~~~- 725 (791)
.... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.|+.........+... ......
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 4322 233478999999999987 678999999999999999999999975433221111100 000000
Q ss_pred -------------cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 -------------DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 -------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....................+..+.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000011111122222222356789999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.13 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=191.5
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCC--cc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQD--EK 573 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~ 573 (791)
..++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999965 56899999998653 3344567889999999997 999999999998654 67
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||++ ++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 589888743 46888999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCc-------------------cccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCc
Q 003846 654 FGGDE-------------------LQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713 (791)
Q Consensus 654 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~ 713 (791)
+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~- 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM- 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 54311 0111234579999999999987 67899999999999999999999998643211
Q ss_pred cchhhhhhHHhhcCCcc-----------ccc----------cccccC------------CCCHHHHHHHHHHHHHccccC
Q 003846 714 LNLLGHAWDLWKDNRAL-----------DLM----------DPILEN------------EASYPMLARYVNVALLCVHEN 760 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~-----------~~~----------~~~l~~------------~~~~~~~~~l~~li~~cl~~d 760 (791)
................ ..+ ...... ......++.+.+|+.+||+.|
T Consensus 238 -~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 238 -NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp -HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred -HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1111110000000000 000 000000 000012457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 003846 761 ATDRPTMSEVVSM 773 (791)
Q Consensus 761 p~~RPt~~evl~~ 773 (791)
|++|||++|++++
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=332.64 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=201.0
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc------ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG------QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999765 689999999875421 2467899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC----CeEEeeec
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM----KPKISDFG 649 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFg 649 (791)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999843 345889999999999999999999998 99999999999998877 89999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
++........ .....+++.|+|||++.+..++.++||||||+++|+|++|+.|+...... .. .........
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ET----LTNISAVNY 228 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH----HHHHHTTCC
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HH----HHHhHhccc
Confidence 9987643321 22346899999999999999999999999999999999999997543211 00 010100000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....... ...+..+.+++.+||+.||++|||+.|++++
T Consensus 229 --~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 --DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000000 1124578899999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.96 Aligned_cols=265 Identities=15% Similarity=0.172 Sum_probs=205.8
Q ss_pred ccCCCccceecccCceeEEEeEeeC---------CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceee---------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN---------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVR--------- 562 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 562 (791)
.++|++.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999997653 789999998654 46789999999999999988
Q ss_pred ------eeeEEEc-CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcE
Q 003846 563 ------LLGCCLD-QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 635 (791)
Q Consensus 563 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NI 635 (791)
+++++.. +...++||||+ +++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6677766 67789999999 99999999543 2456899999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEeeeccccccCCCccc-----cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCC
Q 003846 636 LLDTDM--KPKISDFGMARMFGGDELQ-----ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGF 708 (791)
Q Consensus 636 Ll~~~~--~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~ 708 (791)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876533211 112335799999999999999999999999999999999999999875
Q ss_pred CCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCC
Q 003846 709 YHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLV 780 (791)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 780 (791)
.............. +. ............ ....+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 271 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 271 CLPNTEDIMKQKQK-FV-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GTTCHHHHHHHHHH-HH-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHh-cc-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 43222211111111 11 011111111100 011246789999999999999999999999999875443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=356.64 Aligned_cols=197 Identities=25% Similarity=0.400 Sum_probs=154.9
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-----Cc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-----DE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 572 (791)
.++|++.+.||+|+||+||+|.. .+++.||||++... .....+++.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999965 46899999998653 333457789999999999999999999999543 56
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+ +++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 568988873 3456889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-------------------------cccccccccCcccCchhc-ccCCCCcccceeehhHHHHHHHhCCC
Q 003846 653 MFGGDELQ-------------------------ANTNRIVGTYGYMSPEYA-LEGLFSIKSDVFSFGVLLLEILSGKK 704 (791)
Q Consensus 653 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvvl~elltg~~ 704 (791)
........ ......+||+.|+|||++ ....++.++|||||||+||||++|..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 76432111 122345789999999986 45679999999999999999999543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=355.59 Aligned_cols=244 Identities=14% Similarity=0.179 Sum_probs=190.6
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHH---HHHHhcCCCceeeee-------e
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNET---MLIAKLQHRNLVRLL-------G 565 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~ 565 (791)
..++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 457899999999999999999975 56999999999743 334567889999 455556899999998 6
Q ss_pred EEEcCC-----------------cceEEEeecCCCChhHHHhhhcc----ccccCHHHHHHHHHHHHHHHHHhhccCCCC
Q 003846 566 CCLDQD-----------------EKILIYEYLPNKSLDSFLFDRAK----KRLLYWETRVKIIEGIAQGLLYLHQYSRLR 624 (791)
Q Consensus 566 ~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ 624 (791)
++.+.+ ..++||||+ +|+|.+++..... ...+++..+..++.||++||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 665543 278999999 6899999965321 123445778889999999999999998
Q ss_pred eeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccC-----------CCCcccceeehh
Q 003846 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-----------LFSIKSDVFSFG 693 (791)
Q Consensus 625 iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG 693 (791)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986432 2223467 999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 694 VLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 694 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
|+||||++|+.||....... ........ ....+..+.+++.+||+.||++|||+.|++++
T Consensus 301 ~il~elltg~~Pf~~~~~~~------------------~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALG------------------GSEWIFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHHSSCCC------C------------------CSGGGGSS--CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHHCCCCCccccccc------------------chhhhhhh--ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999975322111 00111110 01224678999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=347.18 Aligned_cols=254 Identities=20% Similarity=0.239 Sum_probs=191.4
Q ss_pred ccCCCcc-ceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHh-cCCCceeeeeeEEEc----CCcc
Q 003846 501 TNNFSAE-NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAK-LQHRNLVRLLGCCLD----QDEK 573 (791)
Q Consensus 501 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~ 573 (791)
.++|.+. +.||+|+||+||++... +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3566665 68999999999999654 689999999853 2467788888754 589999999999875 5668
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEEeeecc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGM 650 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl 650 (791)
++||||+++|+|.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998542 2345889999999999999999999988 999999999999997 78999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ............
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~i~~~~~~ 285 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQYE 285 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC--SHHHHHHHTCCC
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH--HHHHHHHcCccc
Confidence 98654322 2234578999999999999999999999999999999999999986433221100 000001101000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.........+..+.+|+.+||+.||++|||+.|++++-
T Consensus 286 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 286 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00001112456789999999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.61 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=201.8
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|.+.+.||+|+||.||+++.. +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467899999999999999999764 6899999999866555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE---cCCCCeEEeeeccccccCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgla~~~~~ 656 (791)
+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998854 245888999999999999999999998 9999999999999 7889999999999975433
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+..... .... ........ .
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~----~~i~~~~~------~ 225 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLF----EKIKEGYY------E 225 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH----HHHHHCCC------C
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH----HHHHcCCC------C
Confidence 2 12234689999999999999999999999999999999999999753221 1111 11111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+..+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111112345678999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=353.77 Aligned_cols=200 Identities=25% Similarity=0.397 Sum_probs=167.3
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-----Cc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-----DE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 572 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 57899999999999999999965 45889999999754 333457889999999999999999999999876 56
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||++ ++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 59999883 3356899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--------------------cccccccccCcccCchhc-ccCCCCcccceeehhHHHHHHHhCCCCCC
Q 003846 653 MFGGDELQ--------------------ANTNRIVGTYGYMSPEYA-LEGLFSIKSDVFSFGVLLLEILSGKKNTG 707 (791)
Q Consensus 653 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvvl~elltg~~p~~ 707 (791)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76543211 122456899999999986 45679999999999999999999766654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.68 Aligned_cols=266 Identities=24% Similarity=0.318 Sum_probs=197.3
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcc-----cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQ-----GLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
...++|++.+.||+|+||.||+|... +|+.||||++...... ....+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999764 5899999998753221 13467899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 88888743 3356888999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc-
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL- 730 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 730 (791)
...... .......+|+.|+|||++.+. .++.++||||||+++|||++|..|+..... .................
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHcCCCChhh
Confidence 764332 122345789999999999764 589999999999999999999988754321 11111111111100000
Q ss_pred -----ccccccc---cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 731 -----DLMDPIL---ENEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 731 -----~~~~~~l---~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
...+... ....+ ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000000 00011 12346789999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.59 Aligned_cols=253 Identities=20% Similarity=0.259 Sum_probs=200.1
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..++|++.+.||+|+||.||++... +++.||||++.+.... ..+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999664 6899999999765432 35688888888 7999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC----CCeEEeeeccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD----MKPKISDFGMARM 653 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgla~~ 653 (791)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+..+ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999843 346889999999999999999999998 9999999999998543 3599999999987
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...........
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~i~~~~~---- 240 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILARIGSGKF---- 240 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHHHHHHCCC----
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHHHHccCCc----
Confidence 644321 223457899999999999888999999999999999999999998643222111 11111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..........+..+.+++.+||+.||++|||+.|++++
T Consensus 241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111112345678999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.50 Aligned_cols=259 Identities=21% Similarity=0.229 Sum_probs=198.8
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999764 68899999997543 22357789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998542 45889999999999999999999998 99999999999999999999999999986654
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
... .......+++.|+|||++.+..++.++||||||+++|||++|+.||...... ......... .. .
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~-~~---~-- 253 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQA-IP---R-- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSC-CC---C--
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccC-CC---C--
Confidence 322 1223457899999999999999999999999999999999999997542211 000101100 00 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccCcC
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRP-TMSEVVSMLTNEHL 779 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~~ 779 (791)
........+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0011122345788999999999999999 99999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.95 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=193.1
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
...++|++.++||+|+||+||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4457899999999999999999964 4789999999975432 234567899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-----CCCCeEEeeecc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----TDMKPKISDFGM 650 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-----~~~~~kl~DFgl 650 (791)
||||+++ +|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 99998843 345889999999999999999999998 99999999999994 455699999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC-
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR- 728 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 728 (791)
++...... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..............
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCch
Confidence 98764332 122334689999999999875 5899999999999999999999997543221 11111110000000
Q ss_pred -----------cccc----ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 -----------ALDL----MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 -----------~~~~----~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+. ....+........+..+.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 00000000001134678899999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.07 Aligned_cols=255 Identities=13% Similarity=0.108 Sum_probs=182.7
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc---ccHHHHHHHHHHHHhc--CCCceeeee-------eEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG---QGLEELKNETMLIAKL--QHRNLVRLL-------GCC 567 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~ 567 (791)
..+|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45688999999999999999975 4789999999987542 3456677885555544 699988755 444
Q ss_pred EcC-----------------CcceEEEeecCCCChhHHHhhhccccccCHHHH------HHHHHHHHHHHHHhhccCCCC
Q 003846 568 LDQ-----------------DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETR------VKIIEGIAQGLLYLHQYSRLR 624 (791)
Q Consensus 568 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~aL~~LH~~~~~~ 624 (791)
... ...++||||++ |+|.+++... ...+.+..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 23699999999 8999999653 233455555 678899999999999998
Q ss_pred eeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhccc--CCCCcccceeehhHHHHHHHhC
Q 003846 625 IIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE--GLFSIKSDVFSFGVLLLEILSG 702 (791)
Q Consensus 625 iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltg 702 (791)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654321 13456799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 703 KKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 703 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.||.......... +.....................+..+.+++.+||+.||++|||+.|++++
T Consensus 290 ~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 290 FLPFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SCSTTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCcCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99986543221110 00000000000111111112345788999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.35 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=188.0
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999965 468999999986543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhh-----ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 577 YEYLPNKSLDSFLFDR-----AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
|||+++++|.+++... .....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642 12455889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc---ccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 652 RMFGGDEL---QANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 652 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........ . .... ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~~-~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--L---MLTL-QN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--H---HHHH-TS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--H---HHHh-cc
Confidence 76643211 111233578999999999876 5689999999999999999999999765432211 0 0001 11
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..................+..+.+++.+||+.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111111111111112234678899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.48 Aligned_cols=254 Identities=25% Similarity=0.355 Sum_probs=188.4
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc-c-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG-Q-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..++|++.+.||+|+||.||++.. .+|+.||||++..... . ..+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999975 5789999999975422 2 233344555668888999999999999999999999
Q ss_pred EeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 577 YEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
|||+++ +|.+++... .....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999974 888877542 3456789999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhc----ccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYA----LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.|+.......... ........
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~-- 231 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL----KQVVEEPS-- 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH----HHHHHSCC--
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH----HHHhccCC--
Confidence 44322 2234689999999996 45678999999999999999999999976432211111 11111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+++.+||+.||++|||+.|++++
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 232 -------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 011111234678999999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.56 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=206.3
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..++|++.++||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 346789999999999999999965 468999999987543 345688999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++. ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999983 346889999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+...... ... . ...... .+.+
T Consensus 173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~---~-~~~~~~-----~~~~ 239 (303)
T 3a7i_A 173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVL---F-LIPKNN-----PPTL 239 (303)
T ss_dssp BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH---H-HHHHSC-----CCCC
T ss_pred cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHH---H-HhhcCC-----CCCC
Confidence 22 223457899999999999999999999999999999999999997533211 000 0 000110 0111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
. ...+..+.+++.+||+.||.+|||+.|++++.
T Consensus 240 ~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 E----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp C----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred c----cccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 1 12346789999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.22 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=196.3
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999765 69999999986532 33467889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998543 35788999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... .....+++.|+|||++.+..+ +.++||||||+++|+|++|+.|+...... . ..........
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~----~~~~~~~~~~------ 228 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--T----LFKKIRGGVF------ 228 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H----HHHHHHHCCC------
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--H----HHHHhhcCcc------
Confidence 322 223468999999999988765 68999999999999999999997532211 1 1111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 229 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111234678899999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.38 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=202.0
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEE--EEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEV--AVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+|+.. +++.+ |||++... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367899999999999999999654 56644 99988653 333456789999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 576 IYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
||||+++++|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999986532 2346889999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhh
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAW 721 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 721 (791)
+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... .. .
T Consensus 181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~----~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL----Y 251 (327)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH----H
T ss_pred EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HH----H
Confidence 999999999743211 11223456889999999998899999999999999999998 99997533211 11 1
Q ss_pred HHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 722 DLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 722 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...... .....+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 252 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 01111223446789999999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.48 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=203.6
Q ss_pred hhhhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--------ccHHHHHHHHHHHHhc-CCCceeeeeeE
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--------QGLEELKNETMLIAKL-QHRNLVRLLGC 566 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~ 566 (791)
.....++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999775 699999999865431 1245678999999999 79999999999
Q ss_pred EEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 567 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
+......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999853 345889999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccCcccCchhccc------CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhh
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALE------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHA 720 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~ 720 (791)
|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....
T Consensus 243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~--- 314 (365)
T 2y7j_A 243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILML--- 314 (365)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---
T ss_pred ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHH---
Confidence 999998765432 1234578999999999863 3588999999999999999999999753211 1110
Q ss_pred hHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 721 WDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 721 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......... ...+.. . ..+..+.+++.+||+.||++|||+.|++++
T Consensus 315 -~~i~~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 -RMIMEGQYQ-FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -HHHHHTCCC-CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHHHhCCCC-CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000010000 000000 0 123568899999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.52 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=191.5
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--------cccHHHHHHHHHHHHhcCCCceeeeeeEEEc
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--------GQGLEELKNETMLIAKLQHRNLVRLLGCCLD 569 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 569 (791)
...++|.+.++||+|+||.||+|.. .+++.||||++.+.. ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467899999999999999999965 468999999986532 1123357899999999999999999999754
Q ss_pred CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC---CeEEe
Q 003846 570 QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM---KPKIS 646 (791)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 646 (791)
+..++||||+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 55799999999999998873 3456889999999999999999999998 99999999999997544 59999
Q ss_pred eeccccccCCCccccccccccccCcccCchhccc---CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 723 (791)
|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ +...
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~---- 356 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQ---- 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHH----
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHH----
Confidence 999998765332 2234579999999999863 5688999999999999999999999864322211 1110
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....... .. +... ...+..+.+++.+||+.||++|||++|++++
T Consensus 357 i~~~~~~-~~-~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYN-FI-PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCC-CC-HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCC-CC-chhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111000 00 0000 1134678999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=333.08 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=203.6
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999764 57899999986532 23457789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998543 35889999999999999999999988 99999999999999999999999999976543
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+...... .. ........
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~----~~~~~~~~-------- 228 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ET----HRRIVNVD-------- 228 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH----HHHHHTTC--------
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HH----HHHHhccc--------
Confidence 22 22357899999999999999999999999999999999999997543211 00 00011100
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...+..+.+++.+||+.||.+|||++|++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 01122234678999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.77 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=204.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 575 (791)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999764 68999999997543 3445778999999999999999999998854 567899
Q ss_pred EEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccC--CCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 576 IYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
||||+++++|.+++.... ....+++..+..++.||++||+|||+++ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996533 2345889999999999999999999875 2349999999999999999999999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+..... .... ........
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~----~~i~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELA----GKIREGKF--- 233 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHTCC---
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHH----HHHhhccc---
Confidence 7643321 11234689999999999999999999999999999999999999764321 1111 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...+...+..+.+++.+||+.||.+|||+.|+++++..
T Consensus 234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 01122345678999999999999999999999998765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.40 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=205.5
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3468999999999999999999765 58899999986542 3345778899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998743 346889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+....... .........
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~------- 231 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE------- 231 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-------
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhhcc-------
Confidence 3221 1233578999999999999999999999999999999999999975432110 001111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
...+...+..+.+++.+||+.||++|||++|++++-
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 232 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 011122346788999999999999999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.88 Aligned_cols=260 Identities=28% Similarity=0.396 Sum_probs=197.8
Q ss_pred hccCCCccceecccCceeEEEeEee--CCc--EEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL--NGQ--EVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
..++|++.+.||+|+||.||+|+.. +++ .||||++... .....+.+.+|++++++++||||+++++++..+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3578999999999999999999753 233 6899998754 2345678899999999999999999999998765
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++|+||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 88999999999999998543 355889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 653 MFGGDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 653 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
........ .......+|..|+|||++.+..++.++||||||+++|+|++ |+.|+...... ... ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~~~~~~~-- 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QIL---HKIDKEGE-- 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HHHHTSCC--
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHH---HHHHccCC--
Confidence 76543322 12233467888999999998889999999999999999999 99997543211 111 11101100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcC
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHL 779 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 779 (791)
....+...+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 011112345678999999999999999999999999987553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=344.30 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=203.3
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.++||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999764 6899999998765 33445778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
|+++++|.+++... ..+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998542 4588899999999999999999985 7 999999999999999999999999999754321
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh----------h-------
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH----------A------- 720 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~----------~------- 720 (791)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2233578999999999999999999999999999999999999986432211000000 0
Q ss_pred -------hHHhhcCCcccccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 721 -------WDLWKDNRALDLMDPILE----NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 721 -------~~~~~~~~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..........+..+.... .......+..+.+++.+||+.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000000110000 00111235678999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=344.28 Aligned_cols=255 Identities=25% Similarity=0.321 Sum_probs=203.7
Q ss_pred ccCCCccceecccCceeEEEeEe----eCCcEEEEEEecccC----cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCC
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL----LNGQEVAVKRLSKKS----GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQD 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+++. .+++.||||++++.. ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999976 368999999987532 23446678899999999 6999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++||||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998543 45889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccC--CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEG--LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+.+..... .......||+.|+|||++.+. .++.++||||||++||||++|+.||........ .......... .
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~-~-- 281 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILK-S-- 281 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHH-C--
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhc-c--
Confidence 87643322 222345799999999999863 578999999999999999999999864332211 1111000000 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHh
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSML 774 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L 774 (791)
....+...+..+.+++.+||+.||.+|| +++|++++.
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0112223446788999999999999999 999999876
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.84 Aligned_cols=216 Identities=16% Similarity=0.131 Sum_probs=172.3
Q ss_pred ccCCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEe
Q 003846 26 SDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIE 105 (791)
Q Consensus 26 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~ 105 (791)
++.|+|.+|++|.+|++| ++|.|+|||+.+++ +.+|.. +++||+|||+.| ..+.|+|+.||||||+
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~~----~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES----SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEEC----CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 667999999999999999 59999999998876 444442 799999999988 5678999999999999
Q ss_pred cCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcc-cCCCeeccee-ccCc-----eeEEEEcCC
Q 003846 106 DGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTF-LPGMKLGYSR-KTGK-----VWSLTSWKS 177 (791)
Q Consensus 106 ~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtl-lpg~~lg~~~-~tg~-----~~~L~Sw~s 177 (791)
|+++.++|+|++... ....|+|+|+|||||++. ++||||||||||+ ||+| |.|. .+|+ +++|+|
T Consensus 72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s--- 143 (236)
T 1dlp_A 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHA--- 143 (236)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECS---
T ss_pred cCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEEc---
Confidence 999999999998653 456899999999999964 8999999999888 7776 6665 6665 667874
Q ss_pred CCCCCCCceEEEeecCCCceEEeecCCeEEeccCcCCCeeeeccccccceeeeEEEEeecCCeeEEEEEccCceEEEEEE
Q 003846 178 RDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGYIFSLVPEMTLNYIFNYSLYTDENETYFIYSIKDSIISRCIL 257 (791)
Q Consensus 178 ~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~w~g~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~r~~L 257 (791)
.+||++|.|++.++++| ++++++++.+||++++|++. +...++|.....+ +.+..++++.+.+|...+....|++|
T Consensus 144 ~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~~~~rl~L 219 (236)
T 1dlp_A 144 TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSAGRYVFVL 219 (236)
T ss_dssp SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCSSSCCEEEE
T ss_pred CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCCCCCEEEEE
Confidence 78999999999999998 67778888899999999764 5666776543321 11222344555555544445689999
Q ss_pred eeCCcEEEEE
Q 003846 258 DVSGQVEQMS 267 (791)
Q Consensus 258 ~~~G~l~~~~ 267 (791)
++||++++|.
T Consensus 220 d~dG~l~ly~ 229 (236)
T 1dlp_A 220 QPDRNLAIYG 229 (236)
T ss_dssp CSSSCEEEEC
T ss_pred cCCCcEEEeC
Confidence 9999999994
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=357.41 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=201.9
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
..++|++.++||+|+||+||++... +++.||||++.+. .......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3468999999999999999999764 6899999998643 234567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc---CCCCeEEeeeccccc
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---TDMKPKISDFGMARM 653 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFgla~~ 653 (791)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988543 45889999999999999999999998 99999999999995 566799999999987
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ..... ........
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~----~i~~~~~~--- 240 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILK----RVETGKYA--- 240 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHTCCC---
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH----HHHhCCCC---
Confidence 64432 2234579999999999876 599999999999999999999999753221 11111 11111000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+..+.+++.+||+.||.+|||+.|++++
T Consensus 241 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011235678999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=355.19 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=207.0
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|.+.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3468899999999999999999764 69999999996542 2345778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 576 IYEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999986533 2446889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..........
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~-~~~~~i~~~~------ 409 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NK-ELKQRVLEQA------ 409 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HH-HHHHHHHHCC------
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HH-HHHHHHhhcc------
Confidence 54322 12335899999999999999999999999999999999999999864322111 00 1111110000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTM-----SEVVS 772 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~ 772 (791)
...+...+..+.+++.+||+.||++||++ +|+++
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11222345788999999999999999965 66764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=339.87 Aligned_cols=264 Identities=24% Similarity=0.300 Sum_probs=206.8
Q ss_pred eehhhhhhhccCCCcc-ceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcC-CCceeeeeeE
Q 003846 492 FSFASVSASTNNFSAE-NKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQ-HRNLVRLLGC 566 (791)
Q Consensus 492 ~~~~~~~~~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~ 566 (791)
..+.......++|.+. +.||+|+||.||+|... +++.||||++... .......+.+|+.++.+++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444555667788887 88999999999999664 6899999998754 2344678999999999995 6999999999
Q ss_pred EEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCe
Q 003846 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKP 643 (791)
Q Consensus 567 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~ 643 (791)
+.+.+..++||||+++|+|.+++.. .....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 9999999999999999999998843 23456889999999999999999999998 999999999999988 7899
Q ss_pred EEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH
Q 003846 644 KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723 (791)
Q Consensus 644 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 723 (791)
||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....
T Consensus 174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~---- 244 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ETYLN---- 244 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----
T ss_pred EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHH----
Confidence 9999999987643321 22357899999999999999999999999999999999999997543211 10000
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
.... ............+..+.+++.+||+.||.+|||++|++++-
T Consensus 245 i~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 245 ISQV------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HHHT------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred HHhc------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 0000 00011111122456788999999999999999999998763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=333.81 Aligned_cols=252 Identities=22% Similarity=0.258 Sum_probs=199.2
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC----cccHHHHHHHHHHHHhcCCCceeeeeeEEE--cCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS----GQGLEELKNETMLIAKLQHRNLVRLLGCCL--DQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~ 573 (791)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999976 468899999997542 334678999999999999999999999985 44578
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||++++ |.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 76766432 3456889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccCcccCchhcccCC--CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGL--FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.|+..... ... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~i~~~~~-- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKL----FENIGKGSY-- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHH----HHHHHHCCC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHH----HHHHhcCCC--
Confidence 65433333334457899999999998654 47899999999999999999999763221 111 111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 231 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 --------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111234678899999999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=341.88 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=193.6
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQ-GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.++||+|+||+||+|... +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999764 6899999998654322 122455799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 97 588888743 3456888999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC---cccccc-
Q 003846 660 QANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR---ALDLMD- 734 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 734 (791)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .............. ......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhcc
Confidence 12223478999999999886 56899999999999999999999998643211 11111111100000 000000
Q ss_pred --------ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 --------PILEN----EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 --------~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.... ......+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0011234678899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.12 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=205.2
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4578999999999999999999764 5789999998654 23346778899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998743 346889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... . ........
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-~~~~~~~~------- 257 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----T-YLRIKKNE------- 257 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H-HHHHHHTC-------
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-----H-HHHHhcCC-------
Confidence 3221 2233578999999999999999999999999999999999999975432110 0 01111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+......+.+++.+||+.||++|||+.|++++
T Consensus 258 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111234578899999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=347.43 Aligned_cols=261 Identities=20% Similarity=0.273 Sum_probs=196.5
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc------ce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE------KI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~ 574 (791)
..+|++.+.||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999998877778999988654322 2369999999999999999999965443 68
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-CCCCeEEeeeccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPKISDFGMARM 653 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgla~~ 653 (791)
+||||++++.+............+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988655544433344567899999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc------
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD------ 726 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 726 (791)
...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 643322 2234789999999998765 5899999999999999999999998643211 111000000000
Q ss_pred ----CCccccccccc-----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 ----NRALDLMDPIL-----ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ----~~~~~~~~~~l-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+..-+.. ........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000 000111234688999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.35 Aligned_cols=265 Identities=24% Similarity=0.362 Sum_probs=199.5
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG--QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.++|++.+.||+|+||.||++... +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999764 589999999865432 23456789999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988763 2345889999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccch---------hhhhhHHhhcC
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNL---------LGHAWDLWKDN 727 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~ 727 (791)
. .......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.......... .......+...
T Consensus 178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 2 122234789999999999875 78999999999999999999999976433211000 00000001100
Q ss_pred C-ccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 R-ALDLMDPILENEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ~-~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. ......+....... ...+..+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00011111111111 1235789999999999999999999998864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.83 Aligned_cols=262 Identities=26% Similarity=0.327 Sum_probs=201.7
Q ss_pred eehhhhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcC--CCceeeeeeEE
Q 003846 492 FSFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQ--HRNLVRLLGCC 567 (791)
Q Consensus 492 ~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~ 567 (791)
+.+.++....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 5556666778899999999999999999998888999999998654 3345678899999999997 59999999999
Q ss_pred EcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEee
Q 003846 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISD 647 (791)
Q Consensus 568 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 647 (791)
.+.+..++||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 568899999853 346788999999999999999999998 999999999999964 8999999
Q ss_pred eccccccCCCccccccccccccCcccCchhccc-----------CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccch
Q 003846 648 FGMARMFGGDELQANTNRIVGTYGYMSPEYALE-----------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNL 716 (791)
Q Consensus 648 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~ 716 (791)
||++................||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 247 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-- 247 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--
Confidence 999987654433323334578999999999875 4688999999999999999999999754322111
Q ss_pred hhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
..... .++......+...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 248 --~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 248 --KLHAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp --HHHHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --HHHHH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11111 111111111112246788999999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.23 Aligned_cols=254 Identities=23% Similarity=0.389 Sum_probs=199.8
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3578999999999999999999765 589999999987776778899999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++++|.+++... ...+++..+..++.||++||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999998542 345889999999999999999999998 9999999999999999999999999976432111
Q ss_pred cccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.......||+.|+|||++. +..++.++||||||+++|+|++|+.|+...... .......... ....
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~- 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSD-PPTL- 242 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSC-CCCC-
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHHHhccC-Cccc-
Confidence 1122346899999999984 567899999999999999999999997643211 0011111110 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1112234678999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.18 Aligned_cols=266 Identities=20% Similarity=0.307 Sum_probs=200.3
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------- 570 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 570 (791)
.++|++.++||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999976 578999999986543 23356788999999999999999999999873
Q ss_pred -CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 571 -DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 571 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
+..++||||+++ +|.+.+.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457999999986 77666633 3345889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc--ccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh--
Q 003846 650 MARMFGGDEL--QANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW-- 724 (791)
Q Consensus 650 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-- 724 (791)
+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... ..........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~ 247 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGS 247 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCC
Confidence 9987653221 122234578999999999876 46899999999999999999999997643221 1111110000
Q ss_pred ---------hcCCccccccccccCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 725 ---------KDNRALDLMDPILENEASYP-------MLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 725 ---------~~~~~~~~~~~~l~~~~~~~-------~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
......+.+........... ..+.+.+|+.+||+.||++|||++|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 00000000000000111111 135688999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=344.48 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=195.0
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC-----
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD----- 571 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 571 (791)
..++|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999965 46999999998653 2334567889999999999999999999998763
Q ss_pred -cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 572 -EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999843 45888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC-
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR- 728 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 728 (791)
++..... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||...... ..............
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence 9875432 234578999999999987 67999999999999999999999997643211 11111000000000
Q ss_pred ----------cc-------ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ----------AL-------DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ----------~~-------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. ......+ .......+..+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 0000000 01111234678999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=368.79 Aligned_cols=248 Identities=28% Similarity=0.400 Sum_probs=196.7
Q ss_pred ceecccCceeEEEeEee---CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELL---NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
++||+|+||.||+|... .++.||||+++... ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999553 46789999997643 3346889999999999999999999999964 568899999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc-c
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ-A 661 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~-~ 661 (791)
|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999943 356889999999999999999999998 999999999999999999999999999876543321 2
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......+|+.|+|||++.+..++.++||||||++||||++ |+.|+...... .. ........ ...
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~----~~~i~~~~---------~~~ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV----TAMLEKGE---------RMG 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTTC---------CCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCC---------CCC
Confidence 2223456789999999999999999999999999999998 99997543221 11 11111111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.+...+..+.+++.+||+.||++|||+.+|++.|++.
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2223457889999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=358.95 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=204.0
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..++|++.+.||+|+||.||++... +|+.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3568999999999999999999764 78999999986542 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE---cCCCCeEEeeecccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DTDMKPKISDFGMAR 652 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgla~ 652 (791)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999998843 345889999999999999999999998 9999999999999 567899999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ..... ........
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~----~i~~~~~~-- 245 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILK----KVEKGKYT-- 245 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHCCCC--
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHH----HHHcCCCC--
Confidence 765432 1233579999999999876 699999999999999999999999754321 11111 11111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+..+.+++.+||+.||.+|||+.|++++
T Consensus 246 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 ----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000111245678999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=356.68 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=199.8
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc-------------ccHHHHHHHHHHHHhcCCCceeeeee
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-------------QGLEELKNETMLIAKLQHRNLVRLLG 565 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~ 565 (791)
..++|++.++||+|+||+||+|... +++.||||++.+... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999764 588999999875421 34577899999999999999999999
Q ss_pred EEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC---C
Q 003846 566 CCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM---K 642 (791)
Q Consensus 566 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~---~ 642 (791)
++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998854 345889999999999999999999998 99999999999998776 6
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
+||+|||++....... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||...... ... .
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~----~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DII----K 257 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----H
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHH----H
Confidence 9999999998765432 223457999999999887 46899999999999999999999997643211 111 1
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........ ..... ....+..+.+++.+||+.||.+|||++|++++
T Consensus 258 ~i~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111000 00000 01134678999999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=370.15 Aligned_cols=250 Identities=26% Similarity=0.302 Sum_probs=204.6
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcce
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 574 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999754 5889999999753 234457788999999988 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998543 45889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||..... ..+. .......
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~----~~i~~~~------ 558 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELF----QSIMEHN------ 558 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHSSC------
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHH----HHHHhCC------
Confidence 3322 223446899999999999999999999999999999999999999754221 1111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTM-----SEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~ 773 (791)
...+...+..+.+|+.+||+.||++||++ +||+++
T Consensus 559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 11222345789999999999999999997 777653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=357.37 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=197.4
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.++|++.++||+|+||+||+|+.. +++.||||++.+.. ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999764 68899999987543 334678899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC---CCeEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD---MKPKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFgla~~~ 654 (791)
||+++|+|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.. +.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999888433 45888999999999999999999998 9999999999999764 55999999999876
Q ss_pred CCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... ... ......... ...
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~----~~i~~~~~~-~~~ 258 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EIL----RKVEKGKYT-FDS 258 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHTCCC-CCS
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhCCCC-CCc
Confidence 5432 223457999999999886 56999999999999999999999997643211 111 111111000 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+. ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 259 ~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 PE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00 01234678899999999999999999998864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=331.05 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=198.2
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc----CCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD----QDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~ 572 (791)
..+.|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345678888999999999999965 46889999998654 34456778999999999999999999999875 345
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-CCCCeEEeeeccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPKISDFGMA 651 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgla 651 (791)
.++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ .+|+||||||+|||++ .++.+||+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 7999999999999999843 245888999999999999999999875 3499999999999997 7899999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
....... .....||+.|+|||++. ..++.++||||||+++|+|++|+.|+........ ............
T Consensus 180 ~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~ 249 (290)
T 1t4h_A 180 TLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGVKPA 249 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTCCCG
T ss_pred ccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHhccCCcc
Confidence 7544322 22346899999999876 4589999999999999999999999754322111 111111111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...++.+.+++.+||+.||.+|||+.|++++
T Consensus 250 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0111123578999999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.42 Aligned_cols=262 Identities=20% Similarity=0.251 Sum_probs=195.8
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-------
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------- 570 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 570 (791)
...++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999965 5799999999865432 234799999999999999999998543
Q ss_pred -------------------------------CcceEEEeecCCCChhHHHhhh-ccccccCHHHHHHHHHHHHHHHHHhh
Q 003846 571 -------------------------------DEKILIYEYLPNKSLDSFLFDR-AKKRLLYWETRVKIIEGIAQGLLYLH 618 (791)
Q Consensus 571 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH 618 (791)
...++||||++ ++|.+.+... .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 23789999998 5888877542 34567899999999999999999999
Q ss_pred ccCCCCeeecCCCCCcEEEc-CCCCeEEeeeccccccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHH
Q 003846 619 QYSRLRIIHRDLKASNILLD-TDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLL 696 (791)
Q Consensus 619 ~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl 696 (791)
+++ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 988 99999999999998 689999999999987644322 2234789999999998875 589999999999999
Q ss_pred HHHHhCCCCCCCCCCCccchhhhhhHHhhc----------CCcccccccc-----ccCCCCHHHHHHHHHHHHHccccCC
Q 003846 697 LEILSGKKNTGFYHTGSLNLLGHAWDLWKD----------NRALDLMDPI-----LENEASYPMLARYVNVALLCVHENA 761 (791)
Q Consensus 697 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-----l~~~~~~~~~~~l~~li~~cl~~dp 761 (791)
|||++|+.||...... +........... ....+..-+. .....+...+..+.+++.+||+.||
T Consensus 233 ~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999998643211 111111000000 0000000000 0111122245678999999999999
Q ss_pred CCCCCHHHHHHH
Q 003846 762 TDRPTMSEVVSM 773 (791)
Q Consensus 762 ~~RPt~~evl~~ 773 (791)
++|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.97 Aligned_cols=270 Identities=21% Similarity=0.263 Sum_probs=199.3
Q ss_pred ehhhhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCc-----------ccHHHHHHHHHHHHhcCCCcee
Q 003846 493 SFASVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSG-----------QGLEELKNETMLIAKLQHRNLV 561 (791)
Q Consensus 493 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv 561 (791)
...++....++|++.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 34567788899999999999999999999888899999999865322 1237889999999999999999
Q ss_pred eeeeEEEcC-----CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEE
Q 003846 562 RLLGCCLDQ-----DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 636 (791)
Q Consensus 562 ~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NIL 636 (791)
++++++... ...++||||++ |+|.+++. .....+++..+..++.||++||.|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 34699999998 58887774 33456899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccc
Q 003846 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN 715 (791)
Q Consensus 637 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~ 715 (791)
++.++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~ 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--N 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--H
Confidence 9999999999999997543322 2233578999999999887 67899999999999999999999997643211 1
Q ss_pred hhhhhhHHhhcCC-----------ccccccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 716 LLGHAWDLWKDNR-----------ALDLMDPILEN-------EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 716 ~~~~~~~~~~~~~-----------~~~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
............. ..+.+...... ......+..+.+++.+||+.||.+|||+.|++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111100000000 00000000000 0011234678899999999999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=337.40 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=200.5
Q ss_pred ceehhhhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEE
Q 003846 491 LFSFASVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCL 568 (791)
Q Consensus 491 ~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 568 (791)
.++..++....++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 345556666788999999999999999999976 468999999986543 3457889999999999 7999999999998
Q ss_pred c------CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC
Q 003846 569 D------QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK 642 (791)
Q Consensus 569 ~------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~ 642 (791)
. .+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 7 45789999999999999998543 3456888999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchh
Q 003846 643 PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLL 717 (791)
Q Consensus 643 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~ 717 (791)
+||+|||++....... .......||+.|+|||++. +..++.++||||||+++|+|++|+.|+......
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----- 240 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----- 240 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----
Confidence 9999999998654322 1122347899999999987 567899999999999999999999997532211
Q ss_pred hhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 718 GHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......... .. .. .....+..+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~-~~-----~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 RALFLIPRNP-AP-----RL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHHSC-CC-----CC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhcCc-cc-----cC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111110 00 00 111234678999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.50 Aligned_cols=260 Identities=22% Similarity=0.263 Sum_probs=192.0
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD------ 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 571 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999965 46899999998753 2334567889999999999999999999998665
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++||||+++ +|.+++. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 6777763 34788999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH---------
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD--------- 722 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~--------- 722 (791)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence 8654322 123357899999999999999999999999999999999999998643211 00000000
Q ss_pred ----------HhhcCC------ccccccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 723 ----------LWKDNR------ALDLMDPILENEA---SYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 723 ----------~~~~~~------~~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
...... ....+........ ....+..+.+|+.+||+.||++|||++|++++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000 0000000000000 112367899999999999999999999998863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.64 Aligned_cols=262 Identities=23% Similarity=0.259 Sum_probs=201.2
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcC--------CCceeeeeeEEE---
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ--------HRNLVRLLGCCL--- 568 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~--- 568 (791)
.++|++.++||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999965 46889999999643 344577889999999985 788999999998
Q ss_pred -cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCC-----
Q 003846 569 -DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDM----- 641 (791)
Q Consensus 569 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~----- 641 (791)
+....++||||+ +++|.+++... ....+++..+..++.||++||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 55666655432 335688999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CeEEeeeccccccCCCccccccccccccCcccCchh
Q 003846 642 --------------------------------------------KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677 (791)
Q Consensus 642 --------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 677 (791)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999865432 233478999999999
Q ss_pred cccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccc----hhhhhhHHhhc---------CCccccccc------c--
Q 003846 678 ALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN----LLGHAWDLWKD---------NRALDLMDP------I-- 736 (791)
Q Consensus 678 ~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~----~~~~~~~~~~~---------~~~~~~~~~------~-- 736 (791)
+.+..++.++|||||||+||||++|+.||......... ........... ....+.+.. .
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999998754432211 00000000000 000000000 0
Q ss_pred -----------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 -----------LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 -----------l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
-....+...+..+.+|+.+||+.||++|||++|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0012345567889999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.21 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=202.6
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC---------cccHHHHHHHHHHHHhcC-CCceeeeeeEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS---------GQGLEELKNETMLIAKLQ-HRNLVRLLGCCL 568 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~ 568 (791)
..++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999764 68999999986543 123456789999999996 999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeee
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDF 648 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 648 (791)
..+..++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999854 346889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcc------cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYAL------EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
|++....... ......+++.|+|||++. ...++.++||||||+++|+|++|+.|+..... .... .
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~----~ 239 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLML----R 239 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----H
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHH----H
Confidence 9998765332 123357899999999985 45688999999999999999999999753221 1110 0
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........ .........+..+.+++.+||+.||.+|||+.|++++
T Consensus 240 ~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 01111000 0001112345678999999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.62 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=200.0
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
...++|++.+.||+|+||.||+|... +|+.||||++.... ..+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999764 58999999997543 3578899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++++|.+++.. ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999843 3456889999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+...... ....... ...... .
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~~~-----~ 245 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMIP-TNPPPT-----F 245 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHH-HSCCCC-----C
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHh-cCCCcc-----c
Confidence 21 223357899999999999999999999999999999999999997533211 0011000 000000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0112234678999999999999999999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=341.02 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=204.6
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCccc-----------------HHHHHHHHHHHHhcCCCceeee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQG-----------------LEELKNETMLIAKLQHRNLVRL 563 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 563 (791)
.++|++.+.||+|+||.||+|.. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999988 99999999986542111 1789999999999999999999
Q ss_pred eeEEEcCCcceEEEeecCCCChhHH------HhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEE
Q 003846 564 LGCCLDQDEKILIYEYLPNKSLDSF------LFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNIL 636 (791)
Q Consensus 564 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NIL 636 (791)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||++||.|||+ ++ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 225678999999999999999999998 87 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccC-CCCc-ccceeehhHHHHHHHhCCCCCCCCCCCcc
Q 003846 637 LDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSI-KSDVFSFGVLLLEILSGKKNTGFYHTGSL 714 (791)
Q Consensus 637 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslGvvl~elltg~~p~~~~~~~~~ 714 (791)
++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.|+...... .
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~ 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-V 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-H
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-H
Confidence 999999999999999876443 22345789999999999887 6666 999999999999999999998654321 1
Q ss_pred chhhhhhHHhhcCCccc------ccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 715 NLLGHAWDLWKDNRALD------LMDPILE---NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~~------~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... .......... ...+... .......+..+.+++.+||+.||.+|||+.|++++
T Consensus 260 ~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ELF----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHH----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHH----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 1111110000 0000000 00112345688999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.75 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=202.0
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-----C
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-----D 571 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 571 (791)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3457899999999999999999965 468899999997543 33457789999999999999999999999765 3
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 5799999997 489888732 45889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccc-ccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 652 RMFGGDELQA-NTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 652 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ...............
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQ 253 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHHHHHHHHHCSCCH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHHHhCCCCH
Confidence 8765432211 2234589999999998765 45899999999999999999999997643321 111111110000000
Q ss_pred c-----------ccccccc-cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 730 L-----------DLMDPIL-ENEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 730 ~-----------~~~~~~l-~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
. ....... ....+ ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0 0000000 00001 11346789999999999999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=347.05 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=204.5
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCC-CceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH-RNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.++||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 57899999999999999999975 5699999998865433 2457899999999987 556666667777888899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE---cCCCCeEEeeeccccccC
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DTDMKPKISDFGMARMFG 655 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFgla~~~~ 655 (791)
|+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999853 2346899999999999999999999998 9999999999999 688999999999998765
Q ss_pred CCcccc-----ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-chhhhhhHHhhcCCc
Q 003846 656 GDELQA-----NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-NLLGHAWDLWKDNRA 729 (791)
Q Consensus 656 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 729 (791)
...... ......||+.|+|||++.+..++.++||||||++||||++|+.||........ ...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i----~~~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----SEKKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH----HHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH----hhccc
Confidence 443211 12246799999999999999999999999999999999999999875433211 111111 00100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...+... .. ..+..+.+++..||+.||.+||++.+|++.|+++
T Consensus 234 ~~~~~~l-~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSIEAL-CR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCHHHH-HT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccHHHH-hc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111110 01 1236789999999999999999999999998764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.63 Aligned_cols=260 Identities=23% Similarity=0.297 Sum_probs=193.6
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC------cc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD------EK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~ 573 (791)
..+|++.+.||+|+||.||+|+.. +|+.||||++..... .+.+|++++++++|||||++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346889999999999999999764 589999999865432 2347999999999999999999986422 25
Q ss_pred eEEEeecCCCChhHHHhh-hccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeeeccc
Q 003846 574 ILIYEYLPNKSLDSFLFD-RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMA 651 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFgla 651 (791)
++||||+++ +|.+++.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999986 56665543 234567899999999999999999999988 9999999999999965 56899999999
Q ss_pred cccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh-----
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK----- 725 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 725 (791)
+....... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||...... ...........
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 87643322 2235789999999999765 7999999999999999999999997643211 11111111000
Q ss_pred -----cCCccccccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 -----DNRALDLMDPILEN-----EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 -----~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+...+.+.. ......+..+.+|+.+||+.||.+|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00001110111110 0111234688999999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.29 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=194.7
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--------cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--------GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999965 458999999986532 122345889999999999999999999987654
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC---eEEeee
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK---PKISDF 648 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DF 648 (791)
.++||||+++++|.+++. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999884 3456889999999999999999999998 999999999999987665 999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
|++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.|+....... .+... ..
T Consensus 162 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~----~~ 233 (322)
T 2ycf_A 162 GHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQ----IT 233 (322)
T ss_dssp TTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHH----HH
T ss_pred ccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHH----HH
Confidence 99987653321 22346899999999974 4678999999999999999999999976433221 11111 01
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
..... ..+... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11000 000000 113467899999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.39 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=194.1
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEE-----------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCL----------- 568 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----------- 568 (791)
.++|++.+.||+|+||.||+|... +++.||||++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999765 48999999998777667788999999999999999999999874
Q ss_pred ---cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-CCCCeE
Q 003846 569 ---DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPK 644 (791)
Q Consensus 569 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~k 644 (791)
+....++||||++ |+|.+++. ...+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456789999998 59999883 345888999999999999999999998 99999999999997 567999
Q ss_pred EeeeccccccCCCcc-ccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 645 ISDFGMARMFGGDEL-QANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 645 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
|+|||+++....... ........+|..|+|||++.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILE 239 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 999999987643221 112233467899999998875 67899999999999999999999997643221 11100000
Q ss_pred Hhhc----------CCcccccccccc-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 LWKD----------NRALDLMDPILE-NEA-----SYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 ~~~~----------~~~~~~~~~~l~-~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.... ......+..... ... ....+..+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 000000000000 000 01235678999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=344.47 Aligned_cols=199 Identities=25% Similarity=0.295 Sum_probs=171.5
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc------CCCceeeeeeEEEcCCc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL------QHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~ 572 (791)
...+|++.++||+|+||.||+|.. .+++.||||++... .....++.+|+++++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 356899999999999999999965 45899999999653 33456778899988887 57799999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC--eEEeeecc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK--PKISDFGM 650 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFgl 650 (791)
.++||||+. ++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 5898888543 2345889999999999999999999998 999999999999999987 99999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCC
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFY 709 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~ 709 (791)
++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9764432 22357899999999999999999999999999999999999997643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=337.36 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=199.9
Q ss_pred hhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
....++|++.+.||+|+||.||+|... ..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 345678999999999999999999764 359999986542 3334567889999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999843 3346889999999999999999999998 99999999999998 6899999999987653
Q ss_pred CCcc---ccccccccccCcccCchhccc---------CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH
Q 003846 656 GDEL---QANTNRIVGTYGYMSPEYALE---------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723 (791)
Q Consensus 656 ~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 723 (791)
.... ........|++.|+|||++.+ ..++.++||||||+++|||++|+.|+...... .. ...
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~---~~~- 254 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AI---IWQ- 254 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HH---HHH-
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH---HHH-
Confidence 2211 122223468999999999874 35789999999999999999999997543211 11 111
Q ss_pred hhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCC
Q 003846 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLP 782 (791)
Q Consensus 724 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 782 (791)
...... +... ....+..+.+++.+||+.||.+|||+.|++++|+.......
T Consensus 255 ~~~~~~-----~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 255 MGTGMK-----PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHTTCC-----CCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred hccCCC-----CCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111 1110 01123468899999999999999999999999998665443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.04 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=192.5
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc----------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD---------- 569 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 569 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46789999999999999999975 47899999999643 3446788999999999999999999998865
Q ss_pred ---CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 570 ---QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 570 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
....++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3456899999999999999954 3345778889999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCcc------------ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCc
Q 003846 647 DFGMARMFGGDEL------------QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713 (791)
Q Consensus 647 DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~ 713 (791)
|||++........ ........||+.|+|||++.+. .++.++||||||+++|||++ |+.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 9999986543210 1122345689999999999865 78999999999999999998 3221100
Q ss_pred cchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. ......... ............+..+.+++.+||+.||.+|||+.|++++
T Consensus 234 --~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 --RV-NILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HH-HHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --HH-HHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 001111110 1111122233345678899999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.15 Aligned_cols=268 Identities=22% Similarity=0.308 Sum_probs=184.0
Q ss_pred ccCCCc-cceecccCceeEEEeEee---CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcce
Q 003846 501 TNNFSA-ENKLGEGGFGPVYKGELL---NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEKI 574 (791)
Q Consensus 501 ~~~y~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 574 (791)
.+.|++ .++||+|+||+||+|+.. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345665 458999999999999764 57899999996543 23578899999999999999999999954 66789
Q ss_pred EEEeecCCCChhHHHhhhc------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE----cCCCCeE
Q 003846 575 LIYEYLPNKSLDSFLFDRA------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DTDMKPK 644 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl----~~~~~~k 644 (791)
+||||+++ +|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 7877774322 1224889999999999999999999998 9999999999999 7789999
Q ss_pred EeeeccccccCCCcc-ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-------c
Q 003846 645 ISDFGMARMFGGDEL-QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-------N 715 (791)
Q Consensus 645 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-------~ 715 (791)
|+|||+++....... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||........ .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987654321 1223346789999999999874 589999999999999999999999864432100 0
Q ss_pred hhhhhhHHhhcCCc---cc---------c---ccccccCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003846 716 LLGHAWDLWKDNRA---LD---------L---MDPILENEAS---------YPMLARYVNVALLCVHENATDRPTMSEVV 771 (791)
Q Consensus 716 ~~~~~~~~~~~~~~---~~---------~---~~~~l~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~evl 771 (791)
.............. .. . +......... ......+.+|+.+||+.||.+|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 01111000000000 00 0 0000000000 00135688999999999999999999999
Q ss_pred HHh
Q 003846 772 SML 774 (791)
Q Consensus 772 ~~L 774 (791)
++=
T Consensus 333 ~hp 335 (405)
T 3rgf_A 333 QDP 335 (405)
T ss_dssp TSG
T ss_pred cCh
Confidence 864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=337.88 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=190.2
Q ss_pred hhhhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc--
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE-- 572 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-- 572 (791)
......++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3456678999999999999999999976 468999999986543 234456778888999999999999999976443
Q ss_pred -----ceEEEeecCCCChhHHHhh-hccccccCHHHHHHHHHHHHHHHHHhh--ccCCCCeeecCCCCCcEEEcC-CCCe
Q 003846 573 -----KILIYEYLPNKSLDSFLFD-RAKKRLLYWETRVKIIEGIAQGLLYLH--QYSRLRIIHRDLKASNILLDT-DMKP 643 (791)
Q Consensus 573 -----~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~~LH--~~~~~~iiH~Dlkp~NILl~~-~~~~ 643 (791)
.++||||++++ |...+.. ......+++..+..++.||+.||.||| +++ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 68999999874 4444332 345567888999999999999999999 777 999999999999997 8999
Q ss_pred EEeeeccccccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH
Q 003846 644 KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 644 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 722 (791)
||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... ........
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHH
Confidence 9999999987654332 2234789999999998765 4899999999999999999999997643221 11111100
Q ss_pred H-----------hhcC-Ccccccc------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 L-----------WKDN-RALDLMD------PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 ~-----------~~~~-~~~~~~~------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. .... ....... ...........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000 0000000 000011112246789999999999999999999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=331.38 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=200.8
Q ss_pred hhccCCCccceecccCceeEEEeEe--eCCcEEEEEEecccC--cccHHHHHHHHHHHHhc---CCCceeeeeeEEE---
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL--LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKL---QHRNLVRLLGCCL--- 568 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~--- 568 (791)
...++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568899999999999999999976 468899999986532 22234566787777766 8999999999987
Q ss_pred --cCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 569 --DQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 569 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
.....++||||++ |+|.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 6999998543 2345889999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
|||+++...... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...... ............
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCC
Confidence 999998654322 223457899999999999999999999999999999999999997643211 111111110000
Q ss_pred CCcc----------ccccc---cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 NRAL----------DLMDP---ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 ~~~~----------~~~~~---~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.... ..+.. ..........+..+.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00000 00001112245678899999999999999999999965
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.85 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=184.1
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC------
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------ 570 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 570 (791)
..++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999964 56899999998653 233457788999999999999999999999754
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
...++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5579999999 6899888732 46889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC-
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR- 728 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 728 (791)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...............
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGA 251 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCH
Confidence 9865432 234578999999999987 6789999999999999999999999864321 111111111000000
Q ss_pred ----------cccccccccc-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ----------ALDLMDPILE-NEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ----------~~~~~~~~l~-~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....+..... .... ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000 0001 1124678899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=324.83 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=201.8
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999764 68999999986542 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC---CCeEEeeecccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD---MKPKISDFGMAR 652 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFgla~ 652 (791)
|+||+++++|.+++... ..+++..+..++.||++||.|||+++ ++||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999888543 45889999999999999999999998 9999999999999764 469999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
....... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.|+..... .... ..........
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~----~~~~~~~~~~- 241 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDIL----KRVETGKYAF- 241 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCCCCC-
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHH----HHHHcCCCCC-
Confidence 7643321 223468899999998875 489999999999999999999999754221 1111 1111111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. .. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 242 -~--~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 -D--LP--QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -C--SG--GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -C--ch--hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 00 001234678999999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=330.46 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=179.2
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHH-HHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETM-LIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478899999999999999999764 68999999997643 233445566666 677789999999999999999999999
Q ss_pred eecCCCChhHHHhhh--ccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 578 EYLPNKSLDSFLFDR--AKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||+++ +|.+++... .....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 887777432 2246688999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhc----ccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYA----LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
..... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.|+.........+ ....
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~ 243 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----------TQVV 243 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----------HHHh
Confidence 43321 2234689999999998 45678999999999999999999999976432111000 0000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
....+.+........+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000011111111224567899999999999999999999865
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.03 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=202.1
Q ss_pred ccCCCccceecccCceeEEEeEe--eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCC------ceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL--LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR------NLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||++.. .+++.||||++... ....+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999965 36889999999643 33457788999999998765 49999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-------------
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT------------- 639 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~------------- 639 (791)
.++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999998543 2245788999999999999999999998 999999999999987
Q ss_pred ------CCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc
Q 003846 640 ------DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713 (791)
Q Consensus 640 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~ 713 (791)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999864322 234578999999999999999999999999999999999999986432211
Q ss_pred cchhhhhhHHhh--------cCCccc---------------------cccccc-cCCCCHHHHHHHHHHHHHccccCCCC
Q 003846 714 LNLLGHAWDLWK--------DNRALD---------------------LMDPIL-ENEASYPMLARYVNVALLCVHENATD 763 (791)
Q Consensus 714 ~~~~~~~~~~~~--------~~~~~~---------------------~~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~ 763 (791)
.......... ...... ...+.. ........++.+.+++.+||+.||.+
T Consensus 242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 0000000000 000000 000000 01122345678999999999999999
Q ss_pred CCCHHHHHHH
Q 003846 764 RPTMSEVVSM 773 (791)
Q Consensus 764 RPt~~evl~~ 773 (791)
|||+.|++++
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.71 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=198.8
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-----Cc
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-----DE 572 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 572 (791)
..++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999764 68999999996543 33456788999999999999999999998764 66
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+. ++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 799999997 589888743 45889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccc--------ccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH
Q 003846 653 MFGGDELQA--------NTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723 (791)
Q Consensus 653 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 723 (791)
......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~ 238 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLLIFGI 238 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHH
Confidence 765332111 1223478999999998765 678999999999999999999999986432110 00000000
Q ss_pred hhcCCc------------ccccccccc-CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 724 WKDNRA------------LDLMDPILE-NE-----ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 724 ~~~~~~------------~~~~~~~l~-~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...... .+....... .. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000000000 00 001234678899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=335.72 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=196.1
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc---
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK--- 573 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--- 573 (791)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457899999999999999999965 468999999997542 33457788999999999999999999999877655
Q ss_pred ---eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 574 ---ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 574 ---~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
++||||+. ++|.+++ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 5887776 233889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC-
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR- 728 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 728 (791)
++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..............
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGT 263 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCcH
Confidence 9865432 233578999999999987 68999999999999999999999998643211 11111100000000
Q ss_pred ----------ccccccccccCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ----------ALDLMDPILENE------ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ----------~~~~~~~~l~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
............ .....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000 001235688999999999999999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=359.19 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=203.3
Q ss_pred hhhccCCCccceecccCceeEEEeEeeC----CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 572 (791)
....++|++.+.||+|+||.||+|.... +..||||++.... ....+.+.+|+.++++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445789999999999999999997642 5679999987543 334578899999999999999999999985 467
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+++|+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 8999999999999999853 2345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .... .......
T Consensus 540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~----~i~~~~~-- 610 (656)
T 2j0j_A 540 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIG----RIENGER-- 610 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHHHTCC--
T ss_pred ecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHH----HHHcCCC--
Confidence 76543221 1223456789999999999999999999999999999997 88887543211 1111 1111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...+...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 611 -------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111223346789999999999999999999999999764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=339.89 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=188.3
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445556889999999998776678999999998653 245678999999886 8999999999999999999999999
Q ss_pred CCCChhHHHhhhcccc----ccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-------------CCe
Q 003846 581 PNKSLDSFLFDRAKKR----LLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-------------MKP 643 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-------------~~~ 643 (791)
+ |+|.+++....... ...+..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999985432211 1133456789999999999999998 9999999999999754 489
Q ss_pred EEeeeccccccCCCccc--cccccccccCcccCchhccc-------CCCCcccceeehhHHHHHHHh-CCCCCCCCCCCc
Q 003846 644 KISDFGMARMFGGDELQ--ANTNRIVGTYGYMSPEYALE-------GLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGS 713 (791)
Q Consensus 644 kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~ 713 (791)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|+.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999877543221 12234579999999999976 568999999999999999999 899975332111
Q ss_pred cchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... ...... .+..........+..+.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~i-------~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 SNI-------IRGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHH-------HHTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH-------hcCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 000 000000 0111112234567889999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=330.15 Aligned_cols=203 Identities=27% Similarity=0.353 Sum_probs=170.9
Q ss_pred hhhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CC-----ceeeeeeEEEcC
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HR-----NLVRLLGCCLDQ 570 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~ 570 (791)
....++|++.+.||+|+||+||+|... +++.||||++... .....++.+|+++++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344689999999999999999999654 6889999999643 334567788999998885 44 499999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc--CCCCeEEeee
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--TDMKPKISDF 648 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DF 648 (791)
+..++||||++ ++|.+++... ....+++..+..++.||+.||.|||.+. .+|+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 4999998543 2245889999999999999999999531 2499999999999994 5788999999
Q ss_pred ccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCC
Q 003846 649 GMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFY 709 (791)
Q Consensus 649 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~ 709 (791)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999876432 22357899999999999999999999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=330.75 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=195.6
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc-----
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE----- 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 572 (791)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999965 469999999996542 3345678899999999999999999999987654
Q ss_pred -ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 573 -KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 573 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
.++||||++ ++|.+++. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877762 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC---
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN--- 727 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 727 (791)
+..... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .............
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTE 246 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHHCBCCHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 865322 223478999999999887 67899999999999999999999997643211 1111100000000
Q ss_pred ---------------CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 ---------------RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ---------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.........+ .......+..+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01112345789999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.75 Aligned_cols=255 Identities=20% Similarity=0.224 Sum_probs=174.1
Q ss_pred hccCCCccc-eecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEc----CCcc
Q 003846 500 STNNFSAEN-KLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLD----QDEK 573 (791)
Q Consensus 500 ~~~~y~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 573 (791)
..++|.+.+ .||+|+||.||+|... +++.||||++.... .........++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357888855 6999999999999765 69999999986431 222233344667799999999999976 3457
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEEeeecc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGM 650 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl 650 (791)
++||||+++|+|.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998543 2346889999999999999999999998 999999999999976 45599999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ......
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~------ 245 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRI------ 245 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhh------
Confidence 98654322 223478999999999988899999999999999999999999975433221100 000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
...............+..+.+++.+||+.||++|||+.|++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 246 RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000001111123456789999999999999999999999854
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=331.73 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=199.3
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-----------CCceeeeeeEEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-----------HRNLVRLLGCCL 568 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~ 568 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999975 56899999999643 334567889999999886 899999999998
Q ss_pred cCC----cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEc-----
Q 003846 569 DQD----EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLD----- 638 (791)
Q Consensus 569 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~----- 638 (791)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 679999999 88999998543 234588999999999999999999998 7 99999999999995
Q ss_pred -CCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc---
Q 003846 639 -TDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL--- 714 (791)
Q Consensus 639 -~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~--- 714 (791)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3447999999999865432 2234789999999999999999999999999999999999999875432211
Q ss_pred -chhhhhhHHhhc------------------CCcccccc--------ccc--cCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003846 715 -NLLGHAWDLWKD------------------NRALDLMD--------PIL--ENEASYPMLARYVNVALLCVHENATDRP 765 (791)
Q Consensus 715 -~~~~~~~~~~~~------------------~~~~~~~~--------~~l--~~~~~~~~~~~l~~li~~cl~~dp~~RP 765 (791)
............ ......+. ..+ ....+...+..+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 000000000000 00000000 000 1123456778999999999999999999
Q ss_pred CHHHHHHH
Q 003846 766 TMSEVVSM 773 (791)
Q Consensus 766 t~~evl~~ 773 (791)
|++|++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=338.14 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=188.8
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 577 (791)
....+|.+.+.||+|+||+||.....+++.||||++...... .+.+|+++++++ +|||||++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 445678999999999999976665668999999999654332 356899999999 7999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-----CCCeEEeeecccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-----DMKPKISDFGMAR 652 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFgla~ 652 (791)
||++ |+|.+++... ........+..++.||++||.|||+++ |+||||||+|||++. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 5999998532 233445567899999999999999998 999999999999953 3358899999998
Q ss_pred ccCCCcc-ccccccccccCcccCchhcc---cCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 653 MFGGDEL-QANTNRIVGTYGYMSPEYAL---EGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 653 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
....... ........||+.|+|||++. ...++.++|||||||++|||++ |..|+........ .. ....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------~~-~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------NI-LLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------HH-HTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------HH-Hhcc
Confidence 7653321 12233457999999999998 4567889999999999999999 8888743221110 00 0000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.... ...........+.+++.+||+.||.+|||+.|++++
T Consensus 245 ~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 245 CSLD------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCCT------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcc------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 011122345668899999999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.35 Aligned_cols=244 Identities=23% Similarity=0.371 Sum_probs=199.1
Q ss_pred hhhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcc------cHHHHHHHHHHHHhcC--CCceeeeeeEEE
Q 003846 498 SASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQ------GLEELKNETMLIAKLQ--HRNLVRLLGCCL 568 (791)
Q Consensus 498 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~ 568 (791)
....++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34467899999999999999999964 56899999998754321 2245678999999996 599999999999
Q ss_pred cCCcceEEEeecCC-CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-CCCCeEEe
Q 003846 569 DQDEKILIYEYLPN-KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPKIS 646 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~ 646 (791)
+.+..++|+||+.+ ++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899999854 346888999999999999999999998 99999999999999 78999999
Q ss_pred eeccccccCCCccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhh
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+..... ...
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----------~~~ 257 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIR 257 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHH
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------hhc
Confidence 999998765432 223468999999999987765 6889999999999999999999753210 000
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. .... ...+..+.+++.+||+.||++|||++|++++
T Consensus 258 ~~-------~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 GQ-------VFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CC-------CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc-------cccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0011 1234678899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.94 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=191.6
Q ss_pred hhccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcc------cHHHHHHHHHHHHhc----CCCceeeeeeEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQ------GLEELKNETMLIAKL----QHRNLVRLLGCC 567 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~~~~ 567 (791)
...++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4467899999999999999999965 46889999999754321 223456799999998 899999999999
Q ss_pred EcCCcceEEEee-cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-CCCCeEE
Q 003846 568 LDQDEKILIYEY-LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPKI 645 (791)
Q Consensus 568 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl 645 (791)
...+..++|+|| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999854 345889999999999999999999998 99999999999999 8899999
Q ss_pred eeeccccccCCCccccccccccccCcccCchhcccCCCC-cccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 646 SDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFS-IKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 646 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
+|||++....... .....|++.|+|||++.+..+. .++||||||+++|||++|+.|+..... ..
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~ 246 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------IL 246 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HH
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------Hh
Confidence 9999998765432 2234689999999999877664 589999999999999999999753210 00
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 774 (791)
... ...+...+..+.+++.+||+.||++|||++|++++-
T Consensus 247 -~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 247 -EAE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp -HTC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred -hhc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 011122346788999999999999999999999853
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=322.12 Aligned_cols=254 Identities=22% Similarity=0.395 Sum_probs=180.3
Q ss_pred hhccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcc--cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQ--GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
...++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.++..+++.++||||+++++++.+.+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34578899999999999999999764 6899999999765322 22334455567888899999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||||+ ++.+..+... ....+++..+..++.||++||.|||++ + |+||||||+|||++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 4555555422 235688999999999999999999985 7 999999999999999999999999999765
Q ss_pred CCCccccccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
..... .....+|+.|+|||++. ...++.++||||||+++|||++|+.|+....... ... ....... .
T Consensus 176 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~---~~~~~~~-~ 247 (318)
T 2dyl_A 176 VDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EVL---TKVLQEE-P 247 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHH---HHHHHSC-C
T ss_pred cCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HHH---HHHhccC-C
Confidence 43321 22346899999999995 4568899999999999999999999976432211 111 0111110 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.... ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 248 -----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 -----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00110 01234678899999999999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=325.77 Aligned_cols=260 Identities=22% Similarity=0.256 Sum_probs=198.8
Q ss_pred ccCCCccceecccCceeEEEeEee-CC-cEEEEEEecccCcccHHHHHHHHHHHHhcCCCc------eeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NG-QEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN------LVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999753 34 78999999643 344577889999999997665 9999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE---------------
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--------------- 637 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl--------------- 637 (791)
.++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 56676666432 2346889999999999999999999988 9999999999999
Q ss_pred ----cCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCc
Q 003846 638 ----DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713 (791)
Q Consensus 638 ----~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~ 713 (791)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999864322 233578999999999999999999999999999999999999986433211
Q ss_pred cchhhhhhHHhhc--------CCcccc---------------------ccccc-cCCCCHHHHHHHHHHHHHccccCCCC
Q 003846 714 LNLLGHAWDLWKD--------NRALDL---------------------MDPIL-ENEASYPMLARYVNVALLCVHENATD 763 (791)
Q Consensus 714 ~~~~~~~~~~~~~--------~~~~~~---------------------~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~ 763 (791)
........... ...... ..+.. ...........+.+++.+||+.||++
T Consensus 247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 00000000000 000000 00000 00112234668999999999999999
Q ss_pred CCCHHHHHHH
Q 003846 764 RPTMSEVVSM 773 (791)
Q Consensus 764 RPt~~evl~~ 773 (791)
|||+.|++++
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=348.55 Aligned_cols=262 Identities=25% Similarity=0.322 Sum_probs=198.6
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc------CCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD------QDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 572 (791)
.++|++.++||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 37899999999999999999965 46899999998754 34456778999999999999999999998765 667
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCC---eEEeeec
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMK---PKISDFG 649 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFg 649 (791)
.++||||+++|+|.+++........+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999976555556889999999999999999999988 999999999999997765 9999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhH-----Hh
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWD-----LW 724 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~~ 724 (791)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........ ..
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-QWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-HSSTTCC------CC
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-hhhhhhhcccchhhh
Confidence 9987654322 234578999999999999999999999999999999999999975421100 00000000 00
Q ss_pred hcC--Ccccccccc--ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003846 725 KDN--RALDLMDPI--LENEASYPMLARYVNVALLCVHENATDRPTMSE 769 (791)
Q Consensus 725 ~~~--~~~~~~~~~--l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 769 (791)
... ......... .........+..+.+++.+||+.||++|||+.|
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000 000000011 112233446788999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.00 Aligned_cols=231 Identities=13% Similarity=0.072 Sum_probs=181.7
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG---QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 468999999999999999999764 489999999976532 3347889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++.. . ....++.+++.||++||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 1 355678899999999999999998 9999999999999999999997443
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
|++ .++.++||||||+++|||++|+.||.......... ... ...... ..
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--~~~-----~~~~~~--~~ 223 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--PAE-----RDTAGQ--PI 223 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--ECC-----BCTTSC--BC
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--HHH-----HHhccC--CC
Confidence 333 26889999999999999999999976433211000 000 000000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.........+..+.+++.+||+.||++| |+.|+++.|+...
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0000111234678999999999999999 9999999998743
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=345.56 Aligned_cols=238 Identities=21% Similarity=0.325 Sum_probs=191.8
Q ss_pred ccCCCccceecccCceeEEEeEee--CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc-----
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL--NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE----- 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 572 (791)
.++|++.+.||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999764 58999999986543 3445678899999999999999999999987766
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.+|||||+++++|.+++.. .+++..+..++.||++||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 6889999999999999999999998 9999999999999885 99999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
..... ....||+.|+|||++.+.. +.++||||||++||+|++|..|+.......
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------- 283 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------- 283 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence 76432 3457999999999987654 899999999999999999987754211100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhcc
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPT-MSEVVSMLTN 776 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~L~~ 776 (791)
.............+.+++.+||+.||.+||+ ++++.+.|..
T Consensus 284 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ---LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0001111123467889999999999999995 5666665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=324.87 Aligned_cols=244 Identities=15% Similarity=0.189 Sum_probs=179.8
Q ss_pred hhccCCCccceecccCceeEEEeE-eeCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCC-Cce---------ee--
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQH-RNL---------VR-- 562 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~ni---------v~-- 562 (791)
.....|...+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+.+++.++| +|. +.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 344567788999999999999997 4569999999987432 2346789999999999987 221 11
Q ss_pred ----------eeeEEEc-----CCcceEEEeecCCCChhHHHhh----hccccccCHHHHHHHHHHHHHHHHHhhccCCC
Q 003846 563 ----------LLGCCLD-----QDEKILIYEYLPNKSLDSFLFD----RAKKRLLYWETRVKIIEGIAQGLLYLHQYSRL 623 (791)
Q Consensus 563 ----------l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~ 623 (791)
+..++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 1111111 12345666654 6899988842 123456778889999999999999999998
Q ss_pred CeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhc----------ccCCCCcccceeehh
Q 003846 624 RIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA----------LEGLFSIKSDVFSFG 693 (791)
Q Consensus 624 ~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG 693 (791)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999999865432 234467 999999999 555688999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003846 694 VLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772 (791)
Q Consensus 694 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 772 (791)
|++|||++|+.||....... .....+.... ..++.+.+++.+||+.||++|||+.|+++
T Consensus 305 vil~elltg~~Pf~~~~~~~------------------~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALG------------------GSEWIFRSCK--NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGS------------------CSGGGGSSCC--CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCCCCCCCcchhh------------------hHHHHHhhcc--cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999975332111 1111111111 12367899999999999999999776643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=304.19 Aligned_cols=228 Identities=21% Similarity=0.267 Sum_probs=178.0
Q ss_pred ccCCCcc-ceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHH-HhcCCCceeeeeeEEEc----CCcc
Q 003846 501 TNNFSAE-NKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLI-AKLQHRNLVRLLGCCLD----QDEK 573 (791)
Q Consensus 501 ~~~y~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~ 573 (791)
.++|.+. +.||+|+||.||++.. .+++.||||++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 7799999999999965 5689999999853 24677889888 55689999999999986 6678
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEEeeecc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGM 650 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl 650 (791)
++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998543 2346889999999999999999999998 999999999999998 78999999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
+.... +..++.++||||||+++|||++|+.||......... ....
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~ 211 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK 211 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHH
Confidence 96532 234677999999999999999999997543221100 0000
Q ss_pred ccccccccCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 DLMDPILENEAS----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+.. .....+ ...+..+.+++.+||+.||++|||+.|++++
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 TRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 000111 1135678999999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=315.16 Aligned_cols=244 Identities=16% Similarity=0.151 Sum_probs=184.7
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--------cccHHHHHHHHHHHHhcC---------CCceeee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--------GQGLEELKNETMLIAKLQ---------HRNLVRL 563 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 563 (791)
.++|++.++||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999987 78999999997642 234578899999999886 7777776
Q ss_pred eeEEE-----------------c-------------CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHH
Q 003846 564 LGCCL-----------------D-------------QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQG 613 (791)
Q Consensus 564 ~~~~~-----------------~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a 613 (791)
.+++. + .+..++||||+++|++.+.+. ...+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 66543 2 678899999999997766652 2457899999999999999
Q ss_pred HHHhh-ccCCCCeeecCCCCCcEEEcCCC--------------------CeEEeeeccccccCCCccccccccccccCcc
Q 003846 614 LLYLH-QYSRLRIIHRDLKASNILLDTDM--------------------KPKISDFGMARMFGGDELQANTNRIVGTYGY 672 (791)
Q Consensus 614 L~~LH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 672 (791)
|+||| +++ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999875432 34799999
Q ss_pred cCchhcccCCCCcccceeehhHH-HHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHH
Q 003846 673 MSPEYALEGLFSIKSDVFSFGVL-LLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVN 751 (791)
Q Consensus 673 ~aPE~~~~~~~~~~~DvwslGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 751 (791)
+|||++.+.. +.++||||++++ .+++++|..|+.... ............. ..............++.+.+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHH
Confidence 9999998776 899999998777 788888988853100 0000000000000 00000111112346788999
Q ss_pred HHHHccccCCCCCCCHHHHH-HH
Q 003846 752 VALLCVHENATDRPTMSEVV-SM 773 (791)
Q Consensus 752 li~~cl~~dp~~RPt~~evl-~~ 773 (791)
|+.+||+.| |++|++ ++
T Consensus 315 li~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHhccC-----CHHHHHhcC
Confidence 999999976 999998 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=282.56 Aligned_cols=185 Identities=18% Similarity=0.154 Sum_probs=130.8
Q ss_pred eecccCceeEEEe-EeeCCcEEEEEEecccC----------cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEE
Q 003846 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKS----------GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 509 ~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 576 (791)
.++.|+.|.+..+ +...|+.+|||.+.+.. ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4667777777665 34568999999986531 23456799999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||++|++|.++|.+ ...++. .+|+.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999953 234443 358999999999999999 99999999999999999999999999987654
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCC
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN 705 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p 705 (791)
.. ......+||+.|||||++.+. +..++|+|++|+++++|.++..+
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 32 223346899999999998764 67789999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=255.55 Aligned_cols=185 Identities=20% Similarity=0.216 Sum_probs=146.5
Q ss_pred CccceecccCceeEEEeEeeCCcEEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 505 SAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQ--------GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
...++||+|+||.||+++. .++.+|+|+....... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999944 6889999986543211 234589999999999999999777777788888999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5689999999999999998 999999999999998 999999999998754
Q ss_pred Ccccc-----ccccccccCcccCchhccc--CCCCcccceeehhHHHHHHHhCCCCC
Q 003846 657 DELQA-----NTNRIVGTYGYMSPEYALE--GLFSIKSDVFSFGVLLLEILSGKKNT 706 (791)
Q Consensus 657 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvvl~elltg~~p~ 706 (791)
..... ......||+.|||||++.. ..|+...|+|+..+-..+.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1234689999999999987 56888999999999888888777653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=212.93 Aligned_cols=152 Identities=18% Similarity=0.127 Sum_probs=122.5
Q ss_pred hhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCc------------------ccHHHHHHHHHHHHhcCC
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSG------------------QGLEELKNETMLIAKLQH 557 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H 557 (791)
.+......|.+.+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34455667778899999999999999887799999999864321 13456889999999999
Q ss_pred CceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 558 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
| +++.+++. .+..++||||+++++|.+ +. ......++.||++||.|||+++ |+||||||+|||+
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 66666543 356799999999999987 41 1234579999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccCcccCchhccc
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 680 (791)
+ ++.+||+|||+++. +..++|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9 99999999999963 345788998753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=171.66 Aligned_cols=104 Identities=16% Similarity=0.241 Sum_probs=92.1
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
.|+|.+||.|.+|+.|.| |.|.|.|+.+|+ |.++. ..++||+|||+.|... .+.|+|+.||||||+|+
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECC
Confidence 378999999999999998 889999999998 88875 3589999999999744 46899999999999999
Q ss_pred ccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeee
Q 003846 108 RITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQS 146 (791)
Q Consensus 108 ~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~Wqs 146 (791)
++.++|+|+++.. ...+|+|+||||||||+. .||||
T Consensus 69 ~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 69 SGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp TCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred CcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 9999999998754 567899999999999964 69998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-21 Score=171.76 Aligned_cols=109 Identities=22% Similarity=0.298 Sum_probs=95.3
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
+|+|.+|+.|.+|++|+ ++|.|+|+|+.+|+ | ++|+ .+++||.||++.| +..+.|.|+.||||||+|.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECC
Confidence 48999999999999999 99999999999987 4 5565 3799999999877 3456899999999999999
Q ss_pred ccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCC
Q 003846 108 RITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPS 151 (791)
Q Consensus 108 ~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~Pt 151 (791)
++.++|+|.+... +...++|+|+|||||++. ++||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 8999999998755 455899999999999985 7999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-21 Score=172.95 Aligned_cols=107 Identities=16% Similarity=0.245 Sum_probs=94.8
Q ss_pred ccCCcccCCCcccCCCEEe--eCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEE
Q 003846 26 SDTDSLSVGQVITRSETLV--SSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLV 103 (791)
Q Consensus 26 ~~~~~l~~~~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~ 103 (791)
++.|+|.+|++|.+|++|+ |++|.|+|+|+.+|+ + +||++ +++||+||++.| +.++.|.|+.|||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 6789999999999999999 999999999999887 3 57875 799999999877 445789999999999
Q ss_pred EecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeee
Q 003846 104 IEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQS 146 (791)
Q Consensus 104 l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~Wqs 146 (791)
|+|.++.++|+|.+... +...++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 99999999999998654 45689999999999998 389997
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-20 Score=167.49 Aligned_cols=109 Identities=23% Similarity=0.296 Sum_probs=94.3
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
.|||.+||+|.+|++|+ +|.|+|+|+.+|+ +.+ |. .+++||+||++.|. .++.|.|+.||||||+|.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lvl-y~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LVK-YQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EEE-EE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EEE-Ee---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 48999999999999998 8999999998886 433 54 47999999999883 457899999999999998
Q ss_pred ccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCC
Q 003846 108 RITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSH 152 (791)
Q Consensus 108 ~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtD 152 (791)
++.++|+|++... +...++|+|+|||||++. ++||||.+++.
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 8899999998743 456899999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.6e-20 Score=164.28 Aligned_cols=109 Identities=20% Similarity=0.293 Sum_probs=94.0
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
+|||.+||.|.+|++| ++|.|+|+|+.+|+ |. +|.. +++||+||++.+ +.++.|.|..||||||+|
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----lv-l~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----LV-LYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----EE-EEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----EE-EEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 5899999999999999 58999999999987 43 4654 689999999764 345689999999999999
Q ss_pred ccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCC
Q 003846 108 RITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYP 150 (791)
Q Consensus 108 ~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~P 150 (791)
++.++|+|.+... +...++|+++|||||++..+.++||||+|.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 7889999988654 456899999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-19 Score=159.71 Aligned_cols=104 Identities=19% Similarity=0.263 Sum_probs=89.4
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
.+||.|||.|.+|++|+ +|.|+|+|+.+|+ |.+ |.. +++||.+|++.+ +..+.|.|+.||||||+|.
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECC
Confidence 36899999999999996 7999999999987 544 543 689999999876 4457899999999999999
Q ss_pred ccceEEeeeccCcc-eeEEEEccCCCeEEecCCCceeeeec
Q 003846 108 RITYRVSENVSSSQ-NTTATLLDSGNFVLRNEKLGLLWQSF 147 (791)
Q Consensus 108 ~~~~~w~~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~WqsF 147 (791)
++.++|++++.... ..+|+|+||||||||++ ++|||=
T Consensus 68 ~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 68 RNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp TSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred CCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 88999999987553 46899999999999985 899973
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=180.37 Aligned_cols=138 Identities=16% Similarity=0.183 Sum_probs=107.5
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcE--EEEEEecccCcc------------------------cHHHHHHHHHHHHh
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQE--VAVKRLSKKSGQ------------------------GLEELKNETMLIAK 554 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 554 (791)
.-|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3466788999999999999977 68999 999987543111 11367899999999
Q ss_pred cCCCce--eeeeeEEEcCCcceEEEeecCC-C----ChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhh-ccCCCCee
Q 003846 555 LQHRNL--VRLLGCCLDQDEKILIYEYLPN-K----SLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH-QYSRLRII 626 (791)
Q Consensus 555 l~H~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ii 626 (791)
++|+++ +.++.. ...+|||||+.+ | +|.++... .++..+..++.||++||.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988754 444432 467899999942 4 56555421 234567899999999999999 887 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 627 HRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 627 H~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=153.24 Aligned_cols=104 Identities=21% Similarity=0.251 Sum_probs=88.7
Q ss_pred ccCCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEe
Q 003846 26 SDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIE 105 (791)
Q Consensus 26 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~ 105 (791)
+++|||.|||.|.+|+.|+| |.|.|.|+.+|+ |.+ |.. .+||.+|++.. +..+.|.|+.||||||+
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 67899999999999999998 559999988887 777 443 48999999863 44568999999999999
Q ss_pred cCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeee
Q 003846 106 DGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQS 146 (791)
Q Consensus 106 ~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~Wqs 146 (791)
|.++.++|++++... +..+|+|+||||||||+ ..+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 999999999998654 34789999999999998 389996
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=149.20 Aligned_cols=107 Identities=16% Similarity=0.235 Sum_probs=92.0
Q ss_pred ccCCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEe
Q 003846 26 SDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIE 105 (791)
Q Consensus 26 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~ 105 (791)
.+.|+|.+||.|.+|+.|.+ |.|.|.|+.+|+ |.++.. ...++||.+|+..+ +..+.|.|+.||||||+
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~--~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG--SKTNIVWESGTSGR--GQHCFMRLGHSGELDIT 72 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET--TTTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC--CCCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence 46799999999999999974 899999999998 888543 14789999999876 34568999999999999
Q ss_pred cCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeee
Q 003846 106 DGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQS 146 (791)
Q Consensus 106 ~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~Wqs 146 (791)
|.++.++|++++... +..+|+|+||||||||+ ..+|+|
T Consensus 73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 998899999998654 34689999999999997 589997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.3e-17 Score=144.98 Aligned_cols=108 Identities=20% Similarity=0.291 Sum_probs=90.5
Q ss_pred ccCCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEe
Q 003846 26 SDTDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIE 105 (791)
Q Consensus 26 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~ 105 (791)
.|.|||.|||.|.+|+.| .+|.|.|.|+.+|+ |.+. .. +|.+|+..+ +..+.|.|+.||||||+
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl~-~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVLY-NG------NWQSNTANN--GRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEEE-TT------TEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEEE-eC------eEEcCCCCC--CCcEEEEEcCCCeEEEE
Confidence 378999999999999999 57999999999988 5553 21 699998765 34578999999999999
Q ss_pred cCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCC
Q 003846 106 DGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPG 157 (791)
Q Consensus 106 ~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg 157 (791)
|.++.++|++++... ...+|+|+||||||||+ ..+|+| .|.+||
T Consensus 65 d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 65 NGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp CTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred eCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 998899999998654 35689999999999997 589996 555554
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-16 Score=142.05 Aligned_cols=96 Identities=16% Similarity=0.275 Sum_probs=78.9
Q ss_pred CCCCCCCeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeeccee
Q 003846 86 PLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSR 164 (791)
Q Consensus 86 p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~ 164 (791)
|+.+...+|.|+.||||+|++. +.++|++++... ...+|+|+++|||||++ ++.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~---------------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT---------------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC----------------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc----------------
Confidence 3334556899999999999987 789999998754 45789999999999999 7889999994
Q ss_pred ccCceeEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCcCCC
Q 003846 165 KTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDG 215 (791)
Q Consensus 165 ~tg~~~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~w~g 215 (791)
+|++|.|++.++++|...++ .+.+.+||++++|+|
T Consensus 77 ---------------~~~~g~~~l~l~~dGnlvl~-~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ---------------NRQNGNYYLILQRDRNVVIY-DNSNNAIWATHTNVG 111 (112)
T ss_dssp ---------------CCSCCCCEEEECTTSCEEEE-CTTSCEEEECCCCCC
T ss_pred ---------------cCCCCCEEEEEeCCCcEEEE-CCCCceEEECCCccC
Confidence 45678999999999984333 235779999999987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=140.20 Aligned_cols=89 Identities=19% Similarity=0.313 Sum_probs=74.7
Q ss_pred CCCCeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccC
Q 003846 89 SSSPVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTG 167 (791)
Q Consensus 89 ~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg 167 (791)
+...+|.|+.||||||+| .+.++|++++... ...+++|+++|||||++.++.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~-------------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK-------------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC--------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecC--------------------
Confidence 335689999999999999 4789999998754 357899999999999999899999999
Q ss_pred ceeEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCcC
Q 003846 168 KVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVW 213 (791)
Q Consensus 168 ~~~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~w 213 (791)
+++++|.|++.++++|. ++++++ +||+++.+
T Consensus 78 -----------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 -----------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 34567999999999998 444554 79999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-16 Score=171.18 Aligned_cols=144 Identities=14% Similarity=0.158 Sum_probs=103.3
Q ss_pred hhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--------------cccHHH--------HHHHHHHHHh
Q 003846 497 VSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--------------GQGLEE--------LKNETMLIAK 554 (791)
Q Consensus 497 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~--------~~~E~~~l~~ 554 (791)
+.....-|++.++||+|+||.||+|...+|+.||||+++... ...... ..+|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 333344589999999999999999988899999999875321 001111 1345666666
Q ss_pred cCCCceeeeeeEEEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCc
Q 003846 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 634 (791)
Q Consensus 555 l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~N 634 (791)
+.+.++.-..-+. ....+|||||+++++|.++. ..+....++.||+.+|.+||+++ ||||||||.|
T Consensus 170 L~~~gv~vp~p~~--~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N 235 (397)
T 4gyi_A 170 LYEEGFPVPEPIA--QSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFN 235 (397)
T ss_dssp HHHTTCSCCCEEE--EETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred HHhcCCCCCeeee--ccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 6544432111111 12347999999998886543 12345678899999999999988 9999999999
Q ss_pred EEEcCCC----------CeEEeeecccccc
Q 003846 635 ILLDTDM----------KPKISDFGMARMF 654 (791)
Q Consensus 635 ILl~~~~----------~~kl~DFgla~~~ 654 (791)
||+++++ .+.|+||+.+...
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9998876 3899999988654
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=134.88 Aligned_cols=102 Identities=18% Similarity=0.175 Sum_probs=84.8
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
.|+|.|||.|.+|+.| .+|.|.|.|+.+|+ |.+ |.. .. ||.+|+..+ +..+.|.|+.||||||+|.
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 5899999999999999 47999999999988 666 332 23 999999876 3456899999999999998
Q ss_pred ccc-eEEeeeccC---cceeEEEEccCCCeEEecCCCceeeee
Q 003846 108 RIT-YRVSENVSS---SQNTTATLLDSGNFVLRNEKLGLLWQS 146 (791)
Q Consensus 108 ~~~-~~w~~~~~~---~~~~~~~l~d~GNlvl~~~~~~~~Wqs 146 (791)
++. ++|+|++.. ....+++|++|||||||+ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 775 599999642 245789999999999997 689996
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.59 E-value=4.8e-15 Score=133.21 Aligned_cols=85 Identities=19% Similarity=0.281 Sum_probs=72.8
Q ss_pred CeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCcee
Q 003846 92 PVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVW 170 (791)
Q Consensus 92 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~~ 170 (791)
.+|.|+.||||+|++. +.++|++++... ....|+|+|+|||||+|.++.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~----------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP----------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS-----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC-----------------------
Confidence 4699999999999997 789999998754 357899999999999999899999999
Q ss_pred EEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 171 SLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 171 ~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
++|++|.|++.++++|. +++++ .+||++|+
T Consensus 88 --------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999998 44454 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.4e-15 Score=131.95 Aligned_cols=90 Identities=22% Similarity=0.294 Sum_probs=76.0
Q ss_pred CCeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCce
Q 003846 91 SPVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKV 169 (791)
Q Consensus 91 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~ 169 (791)
...|.|+.||||+|++ .+.++|++++... ....++|+++|||||+|.++.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~-------------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW-------------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC--------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC--------------------
Confidence 3579999999999998 4789999998754 35789999999999999888999999997
Q ss_pred eEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCcCCCe
Q 003846 170 WSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWDGY 216 (791)
Q Consensus 170 ~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~w~g~ 216 (791)
|++|.|++.++++|. +++++. +||++++|...
T Consensus 80 -----------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 -----------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356889999999997 445554 89999999753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6.1e-13 Score=137.76 Aligned_cols=111 Identities=16% Similarity=0.286 Sum_probs=88.7
Q ss_pred ccCCcccCCCc----ccCCCEEeeC----CCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEe
Q 003846 26 SDTDSLSVGQV----ITRSETLVSS----GKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTIS 97 (791)
Q Consensus 26 ~~~~~l~~~~~----l~~~~~l~s~----~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~ 97 (791)
..+|||.||+. |..|+.|.|. .|.|.|.+...|+ +.+| .+ ..+++|.+++..+ +. ..|.++
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dGn-----lvLy-~~--~~~~yW~Sgt~~~--~~-~~l~l~ 202 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGN-----LVAY-GP--NGAATWNAGTQGK--GA-VRAVFQ 202 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTSC-----EEEE-CT--TSSEEEECCCTTT--TC-CEEEEC
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCce-----EEEE-eC--CCeEEEECCCCCC--cc-EEEEEc
Confidence 57899999999 8899998654 3555555544443 3343 22 2689999999876 22 689999
Q ss_pred cCCCEEEecCccceEEeeeccCcceeEEEEccCCCeEEecCCCceeeeecCC
Q 003846 98 SEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQSFDY 149 (791)
Q Consensus 98 ~~g~l~l~~~~~~~~w~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~WqsFd~ 149 (791)
.||+|+++|.++..+|++++......+|+|++||||||++. +++||||||
T Consensus 203 ~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 203 GDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp TTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 99999999998889999998765668999999999999986 689999997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.3e-12 Score=114.63 Aligned_cols=94 Identities=19% Similarity=0.280 Sum_probs=74.6
Q ss_pred CCCCCCCCCeEEEecCCCEEEecC-ccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeec
Q 003846 84 DQPLTSSSPVLTISSEGNLVIEDG-RITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLG 161 (791)
Q Consensus 84 ~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg 161 (791)
+.|+.+...+|.|+.||||||++. .+.++|++++... .+..++|+++|||||+|.++.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~------------ 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV------------ 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC------------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc------------
Confidence 344545567899999999999998 4889999998754 45789999999999999888899996321
Q ss_pred ceeccCceeEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 162 YSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 162 ~~~~tg~~~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
-..|.|.+.++.+|...++- .++|.+|+
T Consensus 86 -------------------~~~~~~~~~L~~dGnlvly~----~~~W~s~~ 113 (113)
T 3mez_B 86 -------------------GQEGDYVLILQINGQAVVYG----PAVWSTAA 113 (113)
T ss_dssp -------------------CSSSCCEEEECTTSCEEEEC----SEEEESCC
T ss_pred -------------------CCCCCEEEEEcCCceEEEec----CCEecCCC
Confidence 01256899999999888773 57898874
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=6.5e-12 Score=111.27 Aligned_cols=89 Identities=13% Similarity=0.230 Sum_probs=71.0
Q ss_pred CCCCeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCc-eeeeecCCCCCcccCCCeecceecc
Q 003846 89 SSSPVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLG-LLWQSFDYPSHTFLPGMKLGYSRKT 166 (791)
Q Consensus 89 ~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~-~~WqsFd~PtDtllpg~~lg~~~~t 166 (791)
.....|.|+.||||||++.++ +|++++... ....++|+++|||||++.++. ++|||..+
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~----------------- 79 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS----------------- 79 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-----------------
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-----------------
Confidence 445689999999999999876 999998754 357999999999999998765 59998731
Q ss_pred CceeEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 167 GKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 167 g~~~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
.....|.|.+.++.+|...++- .++|.++.
T Consensus 80 ------------~~~~~~~~~l~Lq~dGNlvly~----~~~W~s~t 109 (111)
T 3mez_A 80 ------------VNTVRGNYAATLGPDQHVTIYG----PAIWSTPA 109 (111)
T ss_dssp ------------CCCCSSCCEEEECTTSCEEEEC----SEEEECCC
T ss_pred ------------cCCCCcCEEEEECCCCeEEEec----cCEEccCC
Confidence 0113478999999999988773 67898864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=8.9e-12 Score=129.18 Aligned_cols=145 Identities=16% Similarity=0.099 Sum_probs=114.8
Q ss_pred hhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEE
Q 003846 499 ASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 499 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 577 (791)
.....|++...++.|+.+.||++.. +++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3445788888899999999999975 47899999986532223356889999999984 678889999998888899999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC------------------------------------
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS------------------------------------ 621 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------ 621 (791)
||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876531 12334578899999999999811
Q ss_pred --------------------CCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 622 --------------------RLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 622 --------------------~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
+..++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876666799999875
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.16 E-value=9.2e-11 Score=103.66 Aligned_cols=84 Identities=15% Similarity=0.322 Sum_probs=67.7
Q ss_pred CCeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCce
Q 003846 91 SPVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKV 169 (791)
Q Consensus 91 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~ 169 (791)
...|.|+.||||||++. .++|++++... ....++|+++|||||+|.++.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------
Confidence 36799999999999987 58999998754 346899999999999999889999974310
Q ss_pred eEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccC
Q 003846 170 WSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSG 211 (791)
Q Consensus 170 ~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g 211 (791)
..|.|.+.++.+|...++- .++|.+|
T Consensus 84 ------------~~~~~~~~L~~dGNlvly~----~~~W~t~ 109 (110)
T 3r0e_B 84 ------------KQGEYVLILQDDGFGVIYG----PAIFETS 109 (110)
T ss_dssp ------------SSSCCEEEECTTSCEEEEC----SEEEESC
T ss_pred ------------CCCCEEEEEcCCccEEEec----CCEecCC
Confidence 1356889999999887763 4788876
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.15 E-value=7.3e-11 Score=104.11 Aligned_cols=89 Identities=21% Similarity=0.332 Sum_probs=70.4
Q ss_pred CCCCCCCeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeeccee
Q 003846 86 PLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSR 164 (791)
Q Consensus 86 p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~ 164 (791)
|+++....|.|+.||||||+++ +|++++... ....++|+++|||||+|.++.++|+|-.
T Consensus 17 ~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t---------------- 76 (109)
T 3r0e_A 17 HLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGA---------------- 76 (109)
T ss_dssp EEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCC----------------
T ss_pred EeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCC----------------
Confidence 3334556899999999999985 699998754 3578999999999999988889997521
Q ss_pred ccCceeEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCcC
Q 003846 165 KTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVW 213 (791)
Q Consensus 165 ~tg~~~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~w 213 (791)
....+.|.+.++.+|...++- .+.|.++.|
T Consensus 77 ---------------~~~~~~~~~~L~~dGNlvly~----~~~W~s~t~ 106 (109)
T 3r0e_A 77 ---------------QSVKGNYAAVVHPDGRLVVFG----PSVFKIDPW 106 (109)
T ss_dssp ---------------CCSSSCCEEEEETTTEEEEEC----SEEEEECTT
T ss_pred ---------------cCCCcCEEEEEcCCCeEEEEe----cCEECCCCc
Confidence 012357899999999877763 689999887
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=6.6e-11 Score=122.14 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=102.8
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN--LVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~E 578 (791)
...+.+....+.|..+.||++...+|+.++||+.... ....+.+|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445543333456669999998767888999997543 2356788999999986544 5668888888888899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC-------------------------------------
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS------------------------------------- 621 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------- 621 (791)
|++|.+|. ... . ....++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 210 1 12356777888888888643
Q ss_pred ------------------CCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 622 ------------------RLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 622 ------------------~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
+..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999853
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=2.3e-10 Score=101.05 Aligned_cols=86 Identities=16% Similarity=0.223 Sum_probs=68.6
Q ss_pred CCeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCce
Q 003846 91 SPVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKV 169 (791)
Q Consensus 91 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~ 169 (791)
...|.|+.||||||++. +.++|++++... ....++|+++|||||+|.++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence 35799999999999997 689999998754 357899999999999998889999975321
Q ss_pred eEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 170 WSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 170 ~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
..+.|.+.++.+|...++- .+.|.++.
T Consensus 80 ------------~~~~~~~~L~ddGNlvly~----~~~W~s~t 106 (109)
T 3dzw_A 80 ------------ENGNYVCVLQKDRNVVIYG----TARWATGT 106 (109)
T ss_dssp ------------SSSCEEEEECTTSCEEEEE----SCCCCCCC
T ss_pred ------------CCCCEEEEEeCCCEEEEEC----CCEEeCCC
Confidence 1256889999999877663 26787764
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.04 E-value=8.9e-10 Score=96.34 Aligned_cols=76 Identities=22% Similarity=0.276 Sum_probs=61.8
Q ss_pred CeEEEecCCCEEEecCccceEEeeeccCc--ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCce
Q 003846 92 PVLTISSEGNLVIEDGRITYRVSENVSSS--QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKV 169 (791)
Q Consensus 92 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~--~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~ 169 (791)
-+|.|+.|||||||+. +.++|++++... .+..++|++||||||+|.++.++|+|=.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC---------------------
Confidence 3689999999999985 468999998644 4578999999999999999999998521
Q ss_pred eEEEEcCCCCCCCCCceEEEeecCCCceEE
Q 003846 170 WSLTSWKSRDDPSVGDAELKMEPGKSNAFS 199 (791)
Q Consensus 170 ~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~ 199 (791)
....+.+.+.++.+|...++
T Consensus 79 ----------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ----------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ----------CCCSSCEEEEECTTSCEEEE
T ss_pred ----------CCCCCCEEEEEeCCCeEEEE
Confidence 11346788999999987765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.5e-09 Score=116.06 Aligned_cols=142 Identities=15% Similarity=0.249 Sum_probs=107.0
Q ss_pred ccceecccCceeEEEeEeeCCcEEEEEEec--ccC-cccHHHHHHHHHHHHhcC--CCceeeeeeEEEcC---CcceEEE
Q 003846 506 AENKLGEGGFGPVYKGELLNGQEVAVKRLS--KKS-GQGLEELKNETMLIAKLQ--HRNLVRLLGCCLDQ---DEKILIY 577 (791)
Q Consensus 506 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~ 577 (791)
..+.|+.|.++.||+.+.. +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3578999999999999764 4688899875 321 123457889999999997 45688899888776 3479999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC------------------------------------
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS------------------------------------ 621 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------ 621 (791)
||++|..+.+.. ...++...+..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998884321 123567788899999999999999731
Q ss_pred -------------------CCCeeecCCCCCcEEEcCCCC--eEEeeeccccc
Q 003846 622 -------------------RLRIIHRDLKASNILLDTDMK--PKISDFGMARM 653 (791)
Q Consensus 622 -------------------~~~iiH~Dlkp~NILl~~~~~--~kl~DFgla~~ 653 (791)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997754 68999999864
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.90 E-value=4.9e-09 Score=106.44 Aligned_cols=87 Identities=23% Similarity=0.317 Sum_probs=69.5
Q ss_pred CeEEEecCCCEEEecCccceEEeeeccCcceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCceeE
Q 003846 92 PVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWS 171 (791)
Q Consensus 92 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~~~ 171 (791)
-+|.|+.||||+|+++ +.+||.+++......+++|+++|||||+|.++.++|+|+++.
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~--------------------- 85 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG--------------------- 85 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC---------------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc---------------------
Confidence 4688899999999986 689999998766677899999999999999999999998751
Q ss_pred EEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCcCC
Q 003846 172 LTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVWD 214 (791)
Q Consensus 172 L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~w~ 214 (791)
+.|.|.+.++.+|...++ . .++|.+..+.
T Consensus 86 ----------~~~~~~~~l~d~Gnlvl~--~--~~~W~S~~~p 114 (236)
T 1dlp_A 86 ----------SIGNYVLVLQPDRTVTIY--G--PGLWDSGTSN 114 (236)
T ss_dssp ----------CSSCCEEEECSSSCEEEE--C--SEEEECSCCC
T ss_pred ----------cCCcEEEEEeCCCCEEEe--c--CCEEECCCCC
Confidence 235677888777776654 2 2788887654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.6e-09 Score=113.17 Aligned_cols=186 Identities=19% Similarity=0.238 Sum_probs=121.7
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCc--eeeeeeEEEcCC---cceEEEeec
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRN--LVRLLGCCLDQD---EKILIYEYL 580 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~Ey~ 580 (791)
.+.++.|....||+.. +.+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3579999999999873 56889986432 34577899999998883 333 445555543333 347899999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC---------------------------------------
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS--------------------------------------- 621 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--------------------------------------- 621 (791)
+|.+|.+... ..++.+++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 23566777788888888888888511
Q ss_pred ----------------CCCeeecCCCCCcEEEcC--CCCeEEeeeccccccCCCc-ccccccc-----------ccccCc
Q 003846 622 ----------------RLRIIHRDLKASNILLDT--DMKPKISDFGMARMFGGDE-LQANTNR-----------IVGTYG 671 (791)
Q Consensus 622 ----------------~~~iiH~Dlkp~NILl~~--~~~~kl~DFgla~~~~~~~-~~~~~~~-----------~~gt~~ 671 (791)
...++|+|++|.||+++. ...+.|+||+.+....... ....... ......
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 235899999999999998 4567899999986532110 0000000 000001
Q ss_pred ccC-chhcccCCCCcccceeehhHHHHHHHhCCCC
Q 003846 672 YMS-PEYALEGLFSIKSDVFSFGVLLLEILSGKKN 705 (791)
Q Consensus 672 y~a-PE~~~~~~~~~~~DvwslGvvl~elltg~~p 705 (791)
... |+..... ....+.|+++.+++.+.+|+.+
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHH
Confidence 111 2211111 1225889999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.8e-06 Score=91.25 Aligned_cols=136 Identities=21% Similarity=0.209 Sum_probs=95.1
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCC---ceeeeeeEEE-cCCcceEEEeecCC
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR---NLVRLLGCCL-DQDEKILIYEYLPN 582 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~Ey~~~ 582 (791)
.+.++.|....||+. |+.++||+-. .......+.+|+++|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356889999999987 6778899853 223456789999999999752 3667777764 44567899999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc------------------------------------------
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY------------------------------------------ 620 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------------------------------------------ 620 (791)
.+|.+... ..++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88876321 1123344444555555555555532
Q ss_pred ---------------CCCCeeecCCCCCcEEEcC---CCCe-EEeeeccccc
Q 003846 621 ---------------SRLRIIHRDLKASNILLDT---DMKP-KISDFGMARM 653 (791)
Q Consensus 621 ---------------~~~~iiH~Dlkp~NILl~~---~~~~-kl~DFgla~~ 653 (791)
....++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.5e-06 Score=89.98 Aligned_cols=136 Identities=19% Similarity=0.217 Sum_probs=100.5
Q ss_pred ceecccCce-eEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEeecCCCC
Q 003846 508 NKLGEGGFG-PVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYEYLPNKS 584 (791)
Q Consensus 508 ~~LG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gs 584 (791)
+.+..|..| .||+.... ++..++||+-... ....+.+|..+|+.+. +-.+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 355666665 58987654 4667899986432 3567889999998884 4457788999999899999999999988
Q ss_pred hhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC-------------------------------------------
Q 003846 585 LDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS------------------------------------------- 621 (791)
Q Consensus 585 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------------- 621 (791)
+.+.... .......++.++++.|..||...
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8766421 12334456677777777777421
Q ss_pred ------------CCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 622 ------------RLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 622 ------------~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999999853
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=1.4e-06 Score=94.16 Aligned_cols=80 Identities=8% Similarity=-0.039 Sum_probs=57.3
Q ss_pred cee-cccCceeEEEeEee-------CCcEEEEEEecccC---cccHHHHHHHHHHHHhcC-C--CceeeeeeEEEcC---
Q 003846 508 NKL-GEGGFGPVYKGELL-------NGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQ-H--RNLVRLLGCCLDQ--- 570 (791)
Q Consensus 508 ~~L-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--- 570 (791)
+.| +.|....+|+.+.. +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998764 26789999865432 111246788999998884 3 3577888887655
Q ss_pred CcceEEEeecCCCChhH
Q 003846 571 DEKILIYEYLPNKSLDS 587 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~ 587 (791)
+..++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2.6e-05 Score=85.43 Aligned_cols=75 Identities=12% Similarity=0.188 Sum_probs=50.7
Q ss_pred cceecccCceeEEEeEee-CCcEEEEEEecccCc-------ccHHHHHHHHHHHHhcCC--C-ceeeeeeEEEcCCcceE
Q 003846 507 ENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-------QGLEELKNETMLIAKLQH--R-NLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~~~~~~~~~~~l 575 (791)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 368999999999999654 468899997643211 234567789999988742 3 34455543 3556789
Q ss_pred EEeecCCC
Q 003846 576 IYEYLPNK 583 (791)
Q Consensus 576 V~Ey~~~g 583 (791)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=2.8e-05 Score=83.07 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=80.8
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCC--Cceeeeee------EEEcCCcceEEEee
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH--RNLVRLLG------CCLDQDEKILIYEY 579 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~------~~~~~~~~~lV~Ey 579 (791)
+.|+.|..+.||+....+| .+++|+.... ..++..|+.+++.+.. -.+++++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999976444 5899998652 2445556666665531 12344443 12345667899999
Q ss_pred cCCCChh-----------HH---Hhhhccc---c--------ccCHHH-------------------------------H
Q 003846 580 LPNKSLD-----------SF---LFDRAKK---R--------LLYWET-------------------------------R 603 (791)
Q Consensus 580 ~~~gsL~-----------~~---l~~~~~~---~--------~l~~~~-------------------------------~ 603 (791)
++|.++. +. ++..... . ...|.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987653 11 1111110 0 011211 0
Q ss_pred HHHHHHHHHHHHHhhc----------cCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 604 VKIIEGIAQGLLYLHQ----------YSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 604 ~~i~~~ia~aL~~LH~----------~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
..+...+.+++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224445666653 123569999999999999888899999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.0001 Score=76.91 Aligned_cols=80 Identities=19% Similarity=0.250 Sum_probs=60.6
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-C--CceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-H--RNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV~E 578 (791)
......+.+|.|..+.||+.++.+|+.++||+-..........|..|++.|+.+. . -.++++++. +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3455567899999999999999999999999876555444567889999999884 2 234555554 24589999
Q ss_pred ecCCCCh
Q 003846 579 YLPNKSL 585 (791)
Q Consensus 579 y~~~gsL 585 (791)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00014 Score=76.58 Aligned_cols=75 Identities=21% Similarity=0.154 Sum_probs=61.4
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC---CCceeeeeeEEEcCCcceEEEeecCCC
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ---HRNLVRLLGCCLDQDEKILIYEYLPNK 583 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~~g 583 (791)
.+.|+.|....+|+.+. +++.++||+.... ....+..|++.|+.+. ...+++++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46799999999999976 5778899987542 3567889999998884 367888999888888899999999998
Q ss_pred Ch
Q 003846 584 SL 585 (791)
Q Consensus 584 sL 585 (791)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00029 Score=77.68 Aligned_cols=73 Identities=14% Similarity=0.162 Sum_probs=46.3
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEeccc------C-c--ccHHHHHHHHHHHHh-cCCCceeeeeeEEEcCCcceEE
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKK------S-G--QGLEELKNETMLIAK-LQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~------~-~--~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV 576 (791)
.+.||.|..+.||++.. +++.++||..... . . .....+..|+..+.. ..+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999964 5778999943211 1 1 122334444443322 2234567777665 5678999
Q ss_pred Eeec-CC
Q 003846 577 YEYL-PN 582 (791)
Q Consensus 577 ~Ey~-~~ 582 (791)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00049 Score=72.72 Aligned_cols=142 Identities=16% Similarity=0.127 Sum_probs=79.7
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeeE------EEcCCcceEEEee
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN--LVRLLGC------CLDQDEKILIYEY 579 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~Ey 579 (791)
+.|+.|....+|+....+| .+++|+.... ...+++..|+.++..+...+ +.+++.. ....+..++++||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999976555 6889988652 12245667888887774222 3334321 1223556899999
Q ss_pred cCCCChhH----H----------Hhhhccc---c------ccCHHHHHH------------HHHHHHHHHHHhhcc----
Q 003846 580 LPNKSLDS----F----------LFDRAKK---R------LLYWETRVK------------IIEGIAQGLLYLHQY---- 620 (791)
Q Consensus 580 ~~~gsL~~----~----------l~~~~~~---~------~l~~~~~~~------------i~~~ia~aL~~LH~~---- 620 (791)
++|..+.. . ++..... . ...|..... +...+.+.+..+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99876421 0 1111000 0 001111000 011234445555421
Q ss_pred CCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 621 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23469999999999999987666899999885
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00044 Score=76.40 Aligned_cols=72 Identities=19% Similarity=0.307 Sum_probs=50.5
Q ss_pred ceecccCceeEEEeEeeC--------CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeEEEcCCcceEEEe
Q 003846 508 NKLGEGGFGPVYKGELLN--------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL-VRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E 578 (791)
+.|+.|....+|+....+ ++.+++|+.... ...+.+.+|..+++.+...++ +++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 578889999999997653 578999988432 122566689999988853333 567765532 38999
Q ss_pred ecCCCCh
Q 003846 579 YLPNKSL 585 (791)
Q Consensus 579 y~~~gsL 585 (791)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00095 Score=69.86 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=77.2
Q ss_pred cceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeEEEcCCcceEEEeec-CCCC
Q 003846 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL-VRLLGCCLDQDEKILIYEYL-PNKS 584 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~-~~gs 584 (791)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 67889987643221 1223568888877743233 455544 344567999999 6655
Q ss_pred hhHHH---------------hh-hcccccc----C-HHHHHHHHH--------------HHHHHHH----Hhhc-cCCCC
Q 003846 585 LDSFL---------------FD-RAKKRLL----Y-WETRVKIIE--------------GIAQGLL----YLHQ-YSRLR 624 (791)
Q Consensus 585 L~~~l---------------~~-~~~~~~l----~-~~~~~~i~~--------------~ia~aL~----~LH~-~~~~~ 624 (791)
|.... .+ +...... . +.....+.. .+.+.+. .|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 53210 00 0000000 0 011111100 0111111 1111 12345
Q ss_pred eeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 625 IIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 625 iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 6677889999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0011 Score=71.76 Aligned_cols=141 Identities=19% Similarity=0.256 Sum_probs=83.3
Q ss_pred ceecccCceeEEEeEee--------CCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEe
Q 003846 508 NKLGEGGFGPVYKGELL--------NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 578 (791)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 57777888889998764 2478999986432 234566779999998884 3223566766543 39999
Q ss_pred ecCCCChhHH--------------Hhh-hcc----cccc--CHHHHHHHHHHHHH-------------------HHHHh-
Q 003846 579 YLPNKSLDSF--------------LFD-RAK----KRLL--YWETRVKIIEGIAQ-------------------GLLYL- 617 (791)
Q Consensus 579 y~~~gsL~~~--------------l~~-~~~----~~~l--~~~~~~~i~~~ia~-------------------aL~~L- 617 (791)
|++|.+|..- |.+ +.. .+.. .+..+.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 000 000 1111 12344444433321 12222
Q ss_pred ---hc-cCCCCeeecCCCCCcEEEcCC----CCeEEeeeccccc
Q 003846 618 ---HQ-YSRLRIIHRDLKASNILLDTD----MKPKISDFGMARM 653 (791)
Q Consensus 618 ---H~-~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgla~~ 653 (791)
.. .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 123469999999999999876 7899999999863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0025 Score=67.56 Aligned_cols=141 Identities=15% Similarity=0.138 Sum_probs=73.1
Q ss_pred ceecccCcee-EEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCC--CceeeeeeEEEcCCcceEEEeecCCCC
Q 003846 508 NKLGEGGFGP-VYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH--RNLVRLLGCCLDQDEKILIYEYLPNKS 584 (791)
Q Consensus 508 ~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gs 584 (791)
+.|+.|+... +|+....+|+.+++|....... +++..|+.+++.+.. -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565555444 6677553467787876543221 234566777776642 2355667664332 378999998776
Q ss_pred hhHHHhhhc---------------------c--ccccCHHHHH-------H-H------------HHHHHHHHHHhh---
Q 003846 585 LDSFLFDRA---------------------K--KRLLYWETRV-------K-I------------IEGIAQGLLYLH--- 618 (791)
Q Consensus 585 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-i------------~~~ia~aL~~LH--- 618 (791)
+.+.+.... . ....+..... . + ...+.+.+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654432110 0 0011111000 0 0 001111222221
Q ss_pred ccCCCCeeecCCCCCcEEEcCC----CCeEEeeeccccc
Q 003846 619 QYSRLRIIHRDLKASNILLDTD----MKPKISDFGMARM 653 (791)
Q Consensus 619 ~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFgla~~ 653 (791)
......++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6799999999864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0016 Score=72.34 Aligned_cols=73 Identities=12% Similarity=0.107 Sum_probs=48.7
Q ss_pred ceecccCceeEEEeEeeC-CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeEEEcCCcceEEEeecCCCCh
Q 003846 508 NKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL-VRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
+.|+.|-...+|+....+ ++.+++|+........ ..-.+|..+++.+...++ .++++.+. -.+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCccC
Confidence 578889999999997754 4788999875432221 122589999998865444 56777662 2369999997655
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0033 Score=66.42 Aligned_cols=142 Identities=14% Similarity=0.149 Sum_probs=82.9
Q ss_pred ceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCC--ceeeeeeE-----EEcCCcceEEEeec
Q 003846 508 NKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHR--NLVRLLGC-----CLDQDEKILIYEYL 580 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~-----~~~~~~~~lV~Ey~ 580 (791)
..|+ |....||+....+|+.+++|+..... ...+.+..|..++..+... .+++++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877678789999986321 2346777888888887422 24445443 11234457899999
Q ss_pred CCCChhH----H----------Hhhhcc------ccccCHHHH----------------------HHHHHHHHHHHHHhh
Q 003846 581 PNKSLDS----F----------LFDRAK------KRLLYWETR----------------------VKIIEGIAQGLLYLH 618 (791)
Q Consensus 581 ~~gsL~~----~----------l~~~~~------~~~l~~~~~----------------------~~i~~~ia~aL~~LH 618 (791)
+|..+.. . ++.... ....++... ...+..++..+..+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865421 1 111000 011111110 111122222222221
Q ss_pred c-cCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 619 Q-YSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 619 ~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 4 899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0016 Score=70.39 Aligned_cols=73 Identities=16% Similarity=0.145 Sum_probs=45.0
Q ss_pred ceecccCceeEEEeEeeC---------CcEEEEEEecccCcccHHHHHHHHHHHHhcCCCc-eeeeeeEEEcCCcceEEE
Q 003846 508 NKLGEGGFGPVYKGELLN---------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRN-LVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~ 577 (791)
+.|+.|....+|+....+ ++.+++|+....... ......|.++++.+...+ ..++++.. .-.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 567888889999987643 268888887543221 123467888888875333 44666544 237899
Q ss_pred eecCCCCh
Q 003846 578 EYLPNKSL 585 (791)
Q Consensus 578 Ey~~~gsL 585 (791)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.01 Score=63.18 Aligned_cols=32 Identities=22% Similarity=0.402 Sum_probs=28.2
Q ss_pred CCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 622 ~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888999999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0058 Score=59.52 Aligned_cols=103 Identities=14% Similarity=0.040 Sum_probs=67.1
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccccc
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN 662 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 662 (791)
-+|.++|. ..+.++++++++.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 37888883 45678999999999999999987762111 01 1233457899999999998864 1110
Q ss_pred cccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCC
Q 003846 663 TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN 705 (791)
Q Consensus 663 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p 705 (791)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123455787653 4557888999999999999875544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.014 Score=63.98 Aligned_cols=74 Identities=14% Similarity=0.149 Sum_probs=49.4
Q ss_pred cceecccCceeEEEeEeeC--------CcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEE
Q 003846 507 ENKLGEGGFGPVYKGELLN--------GQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 577 (791)
.+.|..|-...+|+....+ ++.+++|+....... .....+|.++++.+. +.-..++++.+ .-++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3577788889999987653 578999986543322 223467888888884 32245556533 237899
Q ss_pred eecCCCCh
Q 003846 578 EYLPNKSL 585 (791)
Q Consensus 578 Ey~~~gsL 585 (791)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.43 E-value=0.2 Score=54.30 Aligned_cols=30 Identities=30% Similarity=0.411 Sum_probs=25.4
Q ss_pred CeeecCCCCCcEEE------cCCCCeEEeeeccccc
Q 003846 624 RIIHRDLKASNILL------DTDMKPKISDFGMARM 653 (791)
Q Consensus 624 ~iiH~Dlkp~NILl------~~~~~~kl~DFgla~~ 653 (791)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999999864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=87.42 E-value=6.5 Score=39.63 Aligned_cols=71 Identities=14% Similarity=0.130 Sum_probs=43.2
Q ss_pred EEEEeecCCCCcEEEEecCCCC--CC----CCCCeEEEecCCCEEEecCccceEEeeeccC-cceeEEEEccCCCeEEec
Q 003846 65 VGIWYKNIPERTVVWVANRDQP--LT----SSSPVLTISSEGNLVIEDGRITYRVSENVSS-SQNTTATLLDSGNFVLRN 137 (791)
Q Consensus 65 ~~iw~~~~~~~~~vW~an~~~p--~~----~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~-~~~~~~~l~d~GNlvl~~ 137 (791)
+.+| +...++++|......+ ++ ...+.+.++.++.+..+|.+|..+|.-.+.. .....++.+.+||+++-+
T Consensus 17 v~~~--d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~ 94 (276)
T 3no2_A 17 IAII--NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAW 94 (276)
T ss_dssp EEEE--ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEE
T ss_pred EEEE--ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEe
Confidence 4444 3346788999887642 11 1223444455555666677888999987642 233456677777777754
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=86.32 E-value=0.39 Score=38.73 Aligned_cols=35 Identities=31% Similarity=0.808 Sum_probs=30.3
Q ss_pred ccCCChhHHHHHhhccCCccccccc-CCCceeeecc
Q 003846 353 LKLPGIEECKSACLNNCACTAYAYN-SSGVCSSWDG 387 (791)
Q Consensus 353 ~~~~s~~~C~~~Cl~nCsC~a~~~~-~~g~C~~w~g 387 (791)
....++++|+..|+.+=.|.||.|+ .+..|++-.+
T Consensus 27 ~~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 27 KRASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp EECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred ccCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 3456999999999999999999999 7789988654
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=85.71 E-value=6.2 Score=39.80 Aligned_cols=65 Identities=12% Similarity=0.102 Sum_probs=40.6
Q ss_pred CCCcEEEEecCCC-CCC---CCCC-eEEEecCC-CEEEecCc-cceEEeeeccCc------ceeEEEEccCCCeEEec
Q 003846 73 PERTVVWVANRDQ-PLT---SSSP-VLTISSEG-NLVIEDGR-ITYRVSENVSSS------QNTTATLLDSGNFVLRN 137 (791)
Q Consensus 73 ~~~~~vW~an~~~-p~~---~~~~-~l~~~~~g-~l~l~~~~-~~~~w~~~~~~~------~~~~~~l~d~GNlvl~~ 137 (791)
+.+.++|...+.. |.. ...+ .+....++ .++..|.+ |.++|.-..... ....+.++.+||+++.+
T Consensus 153 ~~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 153 PNGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp TTSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred CCCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 3489999998753 321 1122 33333333 46666776 899999764321 24567888899998876
|
| >3hms_A Hepatocyte growth factor; HGF/SF, hormone/growth factor, disulfide bond, glycoprotein, kringle, pyrrolidone carboxylic acid, serine protea homolog; 1.70A {Homo sapiens} SCOP: g.10.1.1 PDB: 3hmt_A 2hgf_A 3hmr_A | Back alignment and structure |
|---|
Probab=81.54 E-value=0.76 Score=38.62 Aligned_cols=50 Identities=22% Similarity=0.482 Sum_probs=38.0
Q ss_pred ccceEEeecccCCCCc-----ccccCCChhHHHHHhhcc----CCccccccc-CCCceee
Q 003846 335 EDRFLRMHNVKLPSPD-----KVLKLPGIEECKSACLNN----CACTAYAYN-SSGVCSS 384 (791)
Q Consensus 335 ~~~f~~l~~~~~p~~~-----~~~~~~s~~~C~~~Cl~n----CsC~a~~~~-~~g~C~~ 384 (791)
-++|.+..++.+...+ ......+.|+|.+.|.++ =.|.||.|+ .+..|.+
T Consensus 14 L~~y~kTeg~~L~~~~~~~~~~~~~~~s~eeCA~kC~~~~~~~F~CRAF~y~~k~q~C~l 73 (101)
T 3hms_A 14 IHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLW 73 (101)
T ss_dssp GGGEEEEEEEEEEECCTTCCCEEEECSCHHHHHHHHHHCTTCSSCCCEEEEETTTTEEEE
T ss_pred HHHhhhcCCeEEeccCCCccceeeccCCHHHHHHHHHhccCCCcceeeeEEecCCCcEEE
Confidence 4778888888764422 224456999999999995 689999998 6669976
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 791 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-71 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-50 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-25 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-18 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-16 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-15 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-12 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-12 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 3e-71
Identities = 66/285 (23%), Positives = 125/285 (43%), Gaps = 19/285 (6%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+ ++G G FG VYKG+ V + ++ + Q L+ KNE ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+G + ++ ++ SL L K + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-- 679
IIHRDLK++NI L D+ KI DFG+A + ++ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 680 -EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
+ +S +SDV++FG++L E+++G+ + + +N + + +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSN---INNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPR 783
N + C+ + +RP ++++ + LP+
Sbjct: 237 N-----CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-67
Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 21/273 (7%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+ + ++G G FG V+ G LN +VA+K + ++ E+ E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+L G CL+Q L++E++ + L + R ++ L ET + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
+IHRDL A N L+ + K+SDFGM R D+ ++ + SPE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
+S KSDV+SFGVL+ E+ S K + ++ + + L P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLYKPRLAST- 229
Query: 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ C E DRP S ++ L
Sbjct: 230 ------HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 3e-67
Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 29/293 (9%)
Query: 507 ENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+ +G+G FG V++G+ G+EVAVK S + + + E L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 567 CLDQDEKI----LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ--- 619
+ L+ +Y + SL +L + + E +K+ A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 620 --YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF--GGDELQANTNRIVGTYGYMSP 675
+ I HRDLK+ NIL+ + I+D G+A D + N VGT YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 676 EYALEGL------FSIKSDVFSFGVLLLEILSGKKNTGFYHTGS-----LNLLGHAWDLW 724
E + + ++D+++ G++ EI G + L + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 725 KDNRALDLMDP-ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ + P I S L + C + N R T + L+
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 2e-65
Identities = 78/273 (28%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+LG G FG V+ G +VAVK L K+ + E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
RL Q+ +I EY+ N SL FL + +L + + IA+G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
IHRDL+A+NIL+ + KI+DFG+AR+ +E A + +PE G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
F+IKSDV+SFG+LL EI++ + + + + ++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR--------------IPYPGMTNPEVIQNLERGYRMVR 231
Query: 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ LC E DRPT + S+L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-65
Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 21/275 (7%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+ + +LG G FG V G+ +VA+K + K+ +E E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+L G C Q +I EY+ N L ++L + + + +++ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
+ +HRDL A N L++ K+SDFG++R DE ++ + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
FS KSD+++FGVL+ EI S K ++ + ++ + + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYR 222
Query: 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ + + C HE A +RPT ++S + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-64
Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 21/273 (7%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+ E KLG+G FG V+ G VA+K L K E E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
+L ++ ++ EY+ SL FL + L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM- 132
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEG 681
+HRDL+A+NIL+ ++ K++DFG+AR+ +E A + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
F+IKSDV+SFG+LL E+ + + + + LD ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPC 235
Query: 742 SYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
++ C + +RPT + + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 1e-63
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 21/274 (7%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
+ + ++KLG G +G VY+G VAVK L + + + +EE E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
V+LLG C + +I E++ +L +L + ++ + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
+ IHRDL A N L+ + K++DFG++R+ GD A+ + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 681 GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740
FSIKSDV++FGVLL EI + + + ++ +L++ E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRME 236
Query: 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ + C N +DRP+ +E+
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-63
Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 33/288 (11%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+G+G FG V G+ G +VAVK + + + E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 562 RLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
+LLG +++ + ++ EY+ SL +L R + +L + +K + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 621 SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE 680
+HRDL A N+L+ D K+SDFG+ + E + + + +PE E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 681 GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740
FS KSDV+SFG+LL EI S + Y L + +D D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLK---DVVPRVEKGYKMDAPDGCPP-- 227
Query: 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNNQL 788
V C H +A RP+ ++ L EH+ + ++L
Sbjct: 228 -------AVYEVMKNCWHLDAAMRPSFLQLREQL--EHI----KTHEL 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 3e-63
Identities = 68/300 (22%), Positives = 125/300 (41%), Gaps = 36/300 (12%)
Query: 492 FSFASVSASTNNFSAE---------NKLGEGGFGPVYKGELL----NGQEVAVKRLSKK- 537
F+F + + F+ E +G G FG V G L VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 538 SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL 597
+ + + +E ++ + H N++ L G ++I E++ N SLDSFL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 598 LYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657
V ++ GIA G+ YL +HRDL A NIL+++++ K+SDFG++R D
Sbjct: 127 --VIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 658 ELQANTNRIVG---TYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL 714
+G + +PE F+ SDV+S+G+++ E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 715 NLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ + ++ ++ + + L C ++ RP ++V+ L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 7e-63
Identities = 64/300 (21%), Positives = 120/300 (40%), Gaps = 39/300 (13%)
Query: 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGL-EELKNETMLIAKLQHR 558
++F ++LG G G V+K +G +A K + + + ++ E ++ +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
+V G E + E++ SLD L K + + K+ + +GL YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+ +I+HRD+K SNIL+++ + K+ DFG++ N VGT YMSPE
Sbjct: 122 --EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERL 175
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK------------------------KNTGFYHTGSL 714
+S++SD++S G+ L+E+ G+ + T
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 715 NLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVAL----LCVHENATDRPTMSEV 770
L + D +L+D I+ + C+ +N +R + ++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 4e-61
Identities = 69/301 (22%), Positives = 121/301 (40%), Gaps = 45/301 (14%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQGLE-ELKNETMLIAK 554
NN +GEG FG V++ VAVK L +++ ++ + + E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL----------------- 597
+ N+V+LLG C L++EY+ L+ FL + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 598 ----LYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653
L ++ I +A G+ YL + + +HRDL N L+ +M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713
+ +M PE ++ +SDV+++GV+L EI S +Y
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-YYGMAH 248
Query: 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773
++ +D L + N+ LC + DRP+ + +
Sbjct: 249 EEVI----YYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 774 L 774
L
Sbjct: 296 L 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-60
Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 26/280 (9%)
Query: 501 TNNFS-AENKLGEGGFGPVYKGELL---NGQEVAVKRLSKKSGQG-LEELKNETMLIAKL 555
+N A+ +LG G FG V +G +VA+K L + + + EE+ E ++ +L
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
+ +VRL+G C + +L+ E L FL K+ + +++ ++ G+
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMK 123
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQAN-TNRIVGTYGYMS 674
YL + +HRDL A N+LL KISDFG+++ G D+ + + +
Sbjct: 124 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
PE FS +SDV+S+GV + E LS + + K + ++
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFIE 226
Query: 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
E + C DRP V +
Sbjct: 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-60
Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 503 NFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKSGQG-LEELKNETMLIAKLQH 557
+F +G G FG VY G LL+ AVK L++ + G + + E +++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 558 RNLVRLLGCCLDQDEKI-LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
N++ LLG CL + ++ Y+ + L +F+ + + + +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGM-- 143
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR--IVGTYGYMS 674
+ + +HRDL A N +LD K++DFG+AR E + N+ +M+
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
E F+ KSDV+SFGVLL E+++ Y +N L + R
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYP--DVNTFDITVYLLQGRR------ 252
Query: 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775
+ P+ V L C H A RP+ SE+VS ++
Sbjct: 253 LLQPEYCPDPL----YEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 4e-60
Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 27/276 (9%)
Query: 507 ENKLGEGGFGPVYKGELLN---GQEVAVKRLSKKSGQG--LEELKNETMLIAKLQHRNLV 561
+ +LG G FG V KG + VAVK L ++ +EL E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
R++G C + + +L+ E L+ +L + R + + ++++ ++ G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTN-RIVGTYGYMSPEYALE 680
+HRDL A N+LL T KISDFG+++ DE + +PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 681 GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740
FS KSDV+SFGVL+ E S + + K + +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERMG 230
Query: 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
++ LC + +RP + V L N
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 6e-60
Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 504 FSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQG---LEELKNETMLIAKLQHRN 559
FS ++G G FG VY + N + VA+K++S Q +++ E + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
++ GC L + L+ EY + D K+ L + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+IHRD+KA NILL K+ DFG A + A N VGT +M+PE L
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 680 ---EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
EG + K DV+S G+ +E+ K ++ +++ L H N + L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSALYH----IAQNESPALQSGH 238
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772
N C+ + DRPT ++
Sbjct: 239 WSEYF--------RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 8e-60
Identities = 71/299 (23%), Positives = 114/299 (38%), Gaps = 39/299 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSGQG-LEELKNETMLIAK 554
N S LG G FG V + VAVK L + E L +E +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 555 L-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL---------------L 598
L H N+V LLG C ++I EY L +FL + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 599 YWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658
E + +A+G+ +L IHRDL A NILL KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLG 718
+M+PE +++ +SDV+S+G+ L E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 719 HAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777
+ D++ ++ + A ++ C + RPT ++V ++ +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-60
Identities = 77/304 (25%), Positives = 122/304 (40%), Gaps = 44/304 (14%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSKKSGQG-LEELKNETMLIAK 554
N LG G FG V +VAVK L +K+ E L +E ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 555 L-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKK------------------ 595
L H N+V LLG C LI+EY L ++L + +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 596 --RLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653
+L +E + +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGS 713
D +M+PE EG+++IKSDV+S+G+LL EI S G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL----GVNPYPG 269
Query: 714 LNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773
+ + + + L ++ +D E + C ++ RP+ + S
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATE---------EIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 774 LTNE 777
L +
Sbjct: 321 LGCQ 324
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 26/269 (9%)
Query: 508 NKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGC 566
+LG+G FG VYK + A K + KS + LE+ E ++A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRII 626
++ ++ E+ ++D+ + + +R L + + L YLH +II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKII 132
Query: 627 HRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL-----EG 681
HRDLKA NIL D K++DFG++ + ++ +GT +M+PE + +
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 190
Query: 682 LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEA 741
+ K+DV+S G+ L+E+ + + + +L + P L +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE--PPHHELNPMRVL---------LKIAKSEPPTLAQPS 239
Query: 742 SYPMLARYVNVALLCVHENATDRPTMSEV 770
+ + + C+ +N R T S++
Sbjct: 240 RWSSNFK--DFLKKCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 8e-59
Identities = 61/274 (22%), Positives = 121/274 (44%), Gaps = 30/274 (10%)
Query: 507 ENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRL 563
+ ++G G F VYKG EVA L + + + K E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 564 LGCCLDQDEK----ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+ +L+ E + + +L ++L + +++ + I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 620 YSRLRIIHRDLKASNILL-DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+ IIHRDLK NI + KI D G+A + ++GT +M+PE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM- 184
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
E + DV++FG+ +LE+ + + + +A +++ R + P
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYP--YSEC------QNAAQIYR--RVTSGVKPASF 234
Query: 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772
++ + P + + C+ +N +R ++ ++++
Sbjct: 235 DKVAIPEVK---EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 9e-59
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 22/274 (8%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRN 559
++ LGEG +G V + VAVK + K E +K E + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+V+ G + + + L EY L + + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
+ I HRD+K N+LLD KISDFG+A +F + + N++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 680 EGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
F + DV+S G++L +L+G+ + + WK+ + ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233
Query: 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVS 772
+ + + + EN + R T+ ++
Sbjct: 234 SAP--------LALLHKILVENPSARITIPDIKK 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-58
Identities = 67/282 (23%), Positives = 123/282 (43%), Gaps = 26/282 (9%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELLNGQE-----VAVKRLSKKSGQG-LEELKNETMLIA 553
+ + + +G G FG VYKG L VA+K L + + E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 554 KLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQG 613
+ H N++RL G ++I EY+ N +LD F R K V ++ GIA G
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRGIAAG 122
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT-NRIVGTYGY 672
+ YL + +HRDL A NIL+++++ K+SDFG++R+ D T + +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732
+PE F+ SDV+SFG+++ E+++ + + ++ +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMKA 225
Query: 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
++ + + + C + RP +++VS+L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-58
Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRN 559
++ +G G +G K +G+ + K L S + L +E L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 560 LVRLLGCCLDQDEKIL--IYEYLPNKSLDSFLFDRAKKR-LLYWETRVKIIEGIAQGLLY 616
+VR +D+ L + EY L S + K+R L E ++++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 617 LHQYSR--LRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
H+ S ++HRDLK +N+ LD K+ DFG+AR+ D A VGT YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 675 PEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734
PE ++ KSD++S G LL E+ + + +L
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP------------------PFTAFSQKELAG 224
Query: 735 PILENEASYPMLARYV-----NVALLCVHENATDRPTMSEVV 771
I E + + + + ++ RP++ E++
Sbjct: 225 KIREGK--FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-57
Identities = 71/279 (25%), Positives = 112/279 (40%), Gaps = 34/279 (12%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL 555
+ +F LG+G FG VY + +A+K L K +L+ E + + L
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
+H N++RL G D LI EY P ++ L K + I +A L
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 120
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
Y H R+IHRD+K N+LL + + KI+DFG + + GT Y+ P
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 173
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735
E + K D++S GVL E L GK ++ N +
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYKR 215
Query: 736 ILENEASYP--MLARYVNVALLCVHENATDRPTMSEVVS 772
I E ++P + ++ + N + RP + EV+
Sbjct: 216 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-57
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 26/277 (9%)
Query: 504 FSAENKLGEGGFGPVYKGELLNGQE-----VAVKRLSK-KSGQGLEELKNETMLIAKLQH 557
F LG G FG VYKG + E VA+K L + S + +E+ +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 558 RNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL 617
++ RLLG CL LI + +P L ++ + K + + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYL 127
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
R++HRDL A N+L+ T KI+DFG+A++ G +E + + +M+ E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737
L +++ +SDV+S+GV + E+++ +D + +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEKGE 230
Query: 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ + C +A RP E++
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 7e-57
Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 38/291 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNG---QEVAVKRLSK-KSGQGLEELKNETMLIAKL-Q 556
N+ ++ +GEG FG V K + + A+KR+ + S + E ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDR-------------AKKRLLYWETR 603
H N++ LLG C + L EY P+ +L FL + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 604 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT 663
+ +A+G+ YL Q + IHRDL A NIL+ + KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 664 NRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL 723
+M+ E +++ SDV+S+GVLL EI+S T + L
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-TPYCGMTCAELYEKLPQG 242
Query: 724 WKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
++ + L+ D + + + C E +RP+ ++++ L
Sbjct: 243 YRLEKPLNCDDEVYD-------------LMRQCWREKPYERPSFAQILVSL 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 7e-57
Identities = 68/279 (24%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 493 SFASVSASTNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETML 551
S SV ++ K+G+G G VY ++ GQEVA+++++ + E + NE ++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 552 IAKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIA 611
+ + ++ N+V L L DE ++ EYL SL + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECL 126
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
Q L +LH ++IHRD+K+ NILL D K++DFG + Q+ + +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731
+M+PE + K D++S G++ +E++ G+ + + L L
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL---------YLIAT 230
Query: 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
P L+N + R + C+ + R + E+
Sbjct: 231 NGTPELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 75/286 (26%), Positives = 105/286 (36%), Gaps = 35/286 (12%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKK---SGQGLEELKNETMLIAK 554
+ KLG+G FG V +GE VAVK L + +++ E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGL 614
L HRNL+RL G L K+ + E P SL L T + +A+G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 124
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG-GDELQANTNRIVGTYGYM 673
YL R IHRDL A N+LL T KI DFG+ R D+ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 674 SPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733
+PE FS SD + FGV L E+ + + W ++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQIL 224
Query: 734 DPILENEASYPMLARY----VNVALLCVHENATDRPTMSEVVSMLT 775
I + P NV + C DRPT + L
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-55
Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 31/290 (10%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLN------GQEVAVKRLSK-KSGQGLEELKNETMLIAK 554
+ +LG+G FG VY+G VA+K +++ S + E NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL-------LYWETRVKII 607
++VRLLG ++I E + L S+L +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 608 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIV 667
IA G+ YL+ + +HRDL A N ++ D KI DFGM R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 668 GTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN 727
+MSPE +G+F+ SDV+SFGV+L EI + + Y S +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNE---QVLRFVMEG 251
Query: 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777
LD D + + +C N RP+ E++S + E
Sbjct: 252 GLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 76/297 (25%), Positives = 114/297 (38%), Gaps = 38/297 (12%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSGQG--LEELKNETMLIA 553
+ LG G FG V + + + VAVK L + + + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 554 KLQHRNLVRLLGCCLDQDEKILI-YEYLPNKSLDSFLFDR-------------AKKRLLY 599
H N+V LLG C +++ E+ +L ++L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 600 WETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659
E + +A+G+ +L + IHRDL A NILL KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH 719
+M+PE + +++I+SDV+SFGVLL EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEE 245
Query: 720 AWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
K+ + D L C H + RPT SE+V L N
Sbjct: 246 FCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-52
Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 30/274 (10%)
Query: 503 NFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHR 558
+F LGEG F V EL +E A+K L K+ + + E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
V+L D ++ Y N L ++ + ET + A+ + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFY--TAEIVSALE 122
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
IIHRDLK NILL+ DM +I+DFG A++ + QA N VGT Y+SPE
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
E SD+++ G ++ ++++G ++ + I++
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQKIIK 224
Query: 739 NEASYP--MLARYVNVALLCVHENATDRPTMSEV 770
E +P + ++ + +AT R E+
Sbjct: 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 78/296 (26%), Positives = 123/296 (41%), Gaps = 40/296 (13%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL--------NGQEVAVKRLSKK-SGQGLEELKNETMLI 552
+ LGEG FG V E + +VAVK L + + L +L +E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 553 AKL-QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRL-------------L 598
+ +H+N++ LLG C +I EY +L +L R L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 599 YWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658
+ V +A+G+ YL + IHRDL A N+L+ D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLG 718
T +M+PE + +++ +SDV+SFGVLL EI + + Y + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246
Query: 719 HAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSML 774
+ L K+ +D + C H + RPT ++V L
Sbjct: 247 --FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-51
Identities = 58/280 (20%), Positives = 109/280 (38%), Gaps = 26/280 (9%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKSGQGL-EELKNETMLIAKLQ 556
+GEG FG V++G ++ VA+K + + E+ E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
H ++V+L+G + + +I E L SFL R L + + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
L R +HRD+ A N+L+ ++ K+ DFG++R ++ +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
F+ SDV+ FGV + EIL + ++ L +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPMPPNC 234
Query: 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
++ C + + RP +E+ + L+
Sbjct: 235 PP---------TLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (460), Expect = 2e-51
Identities = 60/272 (22%), Positives = 110/272 (40%), Gaps = 23/272 (8%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
+++ +LG G FG V++ E G A K + E ++ E ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
V L D +E ++IYE++ L + D K + + V+ + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 621 SRLRIIHRDLKASNILLDTDM--KPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
+H DLK NI+ T + K+ DFG+ + + GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
+D++S GVL +LSG + F L R + D ++
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETL----------RNVKSCDWNMD 245
Query: 739 NEASYPMLARYVNVALLCVHENATDRPTMSEV 770
+ A + + + + R T+ +
Sbjct: 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 6e-50
Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 35/278 (12%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
+ + +LG G FG V++ E G+ K ++ +KNE ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
+ L D+ E +LI E+L L + A+ + + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 621 SRLRIIHRDLKASNILLDT--DMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
I+H D+K NI+ +T KI DFG+A DE+ T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738
+D+++ GVL +LSG + L+ + +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKR 242
Query: 739 NEASYPMLARY------VNVALLCVHENATDRPTMSEV 770
+ + A + + + R T+ +
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-47
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 26/291 (8%)
Query: 501 TNNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQG-LEELKNETMLIAKLQHR 558
++ + +GEG +G V + +N VA+K++S Q + E ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N++ + + + YL + + L+ K + L + + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANT-NRIVGTYGYMSPEY 677
++HRDLK SN+LL+T KI DFG+AR+ D V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 678 ALEGLFSIKS-DVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
L KS D++S G +L E+LS + F L+ L H + DL I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR--PIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 737 LENEASYPMLARYVNVALL-----------------CVHENATDRPTMSEV 770
+Y + + N + N R + +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (426), Expect = 1e-46
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL 555
+ N+FS +G GGFG VY G+ A+K L KK QG NE ++++ +
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 556 Q---HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ 612
+V + D+ I + + L L + + I
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIIL 118
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGY 672
GL ++H +++RDLK +NILLD +ISD G+A F + + VGT+GY
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGY 171
Query: 673 MSPEYALEGL-FSIKSDVFSFGVLLLEILSGK 703
M+PE +G+ + +D FS G +L ++L G
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 4e-46
Identities = 55/284 (19%), Positives = 100/284 (35%), Gaps = 24/284 (8%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
N + K+G G FG +Y G + G+EVA+K K+ +L E+ + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
+ + C + + ++ L SL+ R +T + + + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIH-- 120
Query: 621 SRLRIIHRDLKASNIL---LDTDMKPKISDFGMARMFGGDELQAN-----TNRIVGTYGY 672
IHRD+K N L I DFG+A+ + + + GT Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732
S L S + D+ S G +L+ G + K + +++
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ +E C D+P S + + N
Sbjct: 240 LCKGYPSEF--------ATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-46
Identities = 55/271 (20%), Positives = 102/271 (37%), Gaps = 36/271 (13%)
Query: 509 KLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCC 567
LG G FG V++ E + + K + K G +K E ++ +HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 568 LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627
+E ++I+E++ + + L V + + + L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 628 RDLKASNILLDTD--MKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSI 685
D++ NI+ T KI +FG AR + N + Y +PE + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182
Query: 686 KSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPM 745
+D++S G L+ +LSG + +++ I+ E ++
Sbjct: 183 ATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMNAEYTFDE 224
Query: 746 LARY------VNVALLCVHENATDRPTMSEV 770
A ++ + + R T SE
Sbjct: 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (416), Expect = 8e-46
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKL 555
S +F LG G FG V+ NG+ A+K L K+ + +E +E ++++ +
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
H ++R+ G D + +I +Y+ LF +K + K A+ L
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGG----ELFSLLRKSQRFPNPVAKFY--AAEVCL 115
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
L II+RDLK NILLD + KI+DFG A+ + T + GT Y++P
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAP 170
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGKK 704
E ++ D +SFG+L+ E+L+G
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (412), Expect = 9e-46
Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 40/290 (13%)
Query: 501 TNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQG---LEELKNETMLIAKLQ 556
++ + LG GG V+ L ++VAVK L + + E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 557 HRNLVRLLGCCLDQDEKI----LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ 612
H +V + + ++ EY+ +L + + + + +++I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG-GDELQANTNRIVGTYG 671
L + H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731
Y+SPE A +SDV+S G +L E+L+G+ + + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP------------------PFTGDSPVS 221
Query: 732 LMDPILENEASYPML------ARYVNVALLCVHENATDRP-TMSEVVSML 774
+ + + P A V L + +N +R T +E+ + L
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 1e-45
Identities = 65/281 (23%), Positives = 112/281 (39%), Gaps = 38/281 (13%)
Query: 501 TNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEE-LKNETMLIAKLQHR 558
+ + + LG G F V E + VA+K ++KK+ +G E ++NE ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N+V L LI + + L + +K ++I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 619 QYSRLRIIHRDLKASNILL---DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
I+HRDLK N+L D D K ISDFG+++M + + GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735
E + +S D +S GV+ +L G + D L +
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYP------------------PFYDENDAKLFEQ 220
Query: 736 ILENEASYPMLAR------YVNVALLCVHENATDRPTMSEV 770
IL+ E + + + ++ R T +
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (403), Expect = 2e-44
Identities = 59/291 (20%), Positives = 108/291 (37%), Gaps = 50/291 (17%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGL---------EELKNETMLI 552
N+ + LG G V + +E AVK + G E E ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 553 AKLQ-HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIA 611
K+ H N+++L L+++ + L +L +K L + KI+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 612 QGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+ + LH +L I+HRDLK NILLD DM K++DFG + E + GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 672 YMSPEYALEGL------FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWK 725
Y++PE + + + D++S GV++ +L+G +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PFW 216
Query: 726 DNRALDLMDPILENEASYPML------ARYVNVALLCVHENATDRPTMSEV 770
+ + ++ I+ + ++ + R T E
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (404), Expect = 2e-44
Identities = 49/286 (17%), Positives = 98/286 (34%), Gaps = 26/286 (9%)
Query: 502 NNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL 560
++ ++GEG FG +++G LLN Q+VA+K ++S +L++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 561 VRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
+ + + ++ L SL+ L R +T + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 621 SRLRIIHRDLKASNILLDTDMKP-----KISDFGMARMFGGDELQAN-----TNRIVGTY 670
+++RD+K N L+ + DFGM + + + + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 671 GYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730
YMS L S + D+ + G + + L G A + K R
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--------AATNKQKYERIG 229
Query: 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776
+ E + + P + + +
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-44
Identities = 66/275 (24%), Positives = 104/275 (37%), Gaps = 33/275 (12%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKN----ETMLIAKLQ 556
+F LG+G FG V+ E Q A+K L K ++++ + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 557 HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
H L + ++ + EYL L + K I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
LH I++RDLK NILLD D KI+DFGM + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 677 YALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736
L ++ D +SFGVLL E+L G+ + +L I
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFHSI 215
Query: 737 LENEASYP--MLARYVNVALLCVHENATDRPTMSE 769
+ YP + ++ + R +
Sbjct: 216 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 64/294 (21%), Positives = 120/294 (40%), Gaps = 31/294 (10%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELL--NGQEVAVKRLSKKSGQGLEELK-----NETMLI 552
+ + ++GEG +G V+K L G+ VA+KR+ ++G+ L +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 553 AKLQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDS---FLFDRAKKRLLYWETRVKIIEG 609
+H N+VRL C L + +D D+ + + ET ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 610 IAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGT 669
+ +GL +LH R++HRDLK NIL+ + + K++DFG+AR++ +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
Query: 670 YGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729
Y +PE L+ ++ D++S G + E+ K F + ++ LG D+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK--PLFRGSSDVDQLGKILDVIGLPGE 236
Query: 730 LDLMDPILENEASYPMLARY-------------VNVALLCVHENATDRPTMSEV 770
D + ++ + ++ L C+ N R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 29/296 (9%)
Query: 508 NKLGEGGFGPVYKGELLN-GQEVAVKRLSKKSGQGLEE-----LKNETMLIAKLQHRNLV 561
+ LGEG F VYK N Q VA+K++ ++ E L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 562 RLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS 621
LL + L+++++ + +L + QGL YLHQ+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 622 RLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALE- 680
I+HRDLK +N+LLD + K++DFG+A+ FG V T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175
Query: 681 GLFSIKSDVFSFGVLLLEILSGK-----KNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735
++ + D+++ G +L E+L + T LG + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 736 ILENEASYPMLARYVNVA-----LL--CVHENATDRPTMSEVVSM--LTNEHLVLP 782
++ P+ + L+ N R T ++ + M +N P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 4e-42
Identities = 60/285 (21%), Positives = 118/285 (41%), Gaps = 24/285 (8%)
Query: 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVK--RLSKKSGQGLEELKNETMLIAKLQHRN 559
+ K+GEG +G VYK + G+ A+K RL K+ E ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+V+L + +L++E+L + L T + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYAL 679
R++HRDLK N+L++ + + KI+DFG+AR FG + + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 680 -EGLFSIKSDVFSFGVLLLEILSGK-------------KNTGFYHTGSLNLLGHAWDLWK 725
+S D++S G + E+++G + T + + +L K
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
+ + +P+ + +++ + + R T +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-41
Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 32/290 (11%)
Query: 503 NFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLV 561
+++ +G G FG VY+ +L +G+ VA+K++ + E ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 562 RLLGCCLDQDEK------ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
RL EK L+ +Y+P K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 616 YLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
Y+H I HRD+K N+LLD D K+ DFG A+ E + + + Y +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 675 PEYALEGL-FSIKSDVFSFGVLLLEILSGK-----KNTGFYHTGSLNLLGHAWDLWKDNR 728
PE ++ DV+S G +L E+L G+ + + +LG
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 729 ALDLMDPILENEASYPMLARYVN------VALL--CVHENATDRPTMSEV 770
+ + ++P + +AL + T R T E
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 62/285 (21%), Positives = 115/285 (40%), Gaps = 24/285 (8%)
Query: 503 NFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRN 559
NF K+GEG +G VYK L G+ VA+K++ + E L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 560 LVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ 619
+V+LL +++ L++E+L D + + + + QGL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 620 YSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE-YA 678
+ R++HRDLK N+L++T+ K++DFG+AR FG V T Y +PE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK-------------KNTGFYHTGSLNLLGHAWDLWK 725
+S D++S G + E+++ + + T + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
+ ++ P+ ++ +H + R +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-41
Identities = 61/286 (21%), Positives = 111/286 (38%), Gaps = 44/286 (15%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKS------GQGLEELKNETMLIAK 554
+ + +LG G F V K E G + A K + K+ G E+++ E ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 555 LQHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGL 614
+QH N++ L ++ + ILI E + L FL +K L E + ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 615 LYLHQYSRLRIIHRDLKASNILLDTDMKP----KISDFGMARMFGGDELQANTNRIVGTY 670
++ L+I H DLK NI+L P KI DFG+A I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 671 GYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730
+++PE +++D++S GV+ +LSG + +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------------------SPFLGDTKQ 222
Query: 731 DLMDPILENEASYP------MLARYVNVALLCVHENATDRPTMSEV 770
+ + + + A + + ++ R T+ +
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-41
Identities = 61/280 (21%), Positives = 101/280 (36%), Gaps = 42/280 (15%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKKSGQGLEELKN------ETMLIAK 554
+ + LG GGFG VY G + + VA+K + K EL N E +L+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 555 LQ--HRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQ 612
+ ++RLL D +LI E ++ L E + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARMFGGDELQANTNRIVGTYG 671
+ + H ++HRD+K NIL+D + + K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRV 174
Query: 672 YMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730
Y PE+ + V+S G+LL +++ G F H + + +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFFRQRVSSECQ 232
Query: 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
L+ C+ +DRPT E+
Sbjct: 233 HLIR--------------------WCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 7e-40
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 12/208 (5%)
Query: 500 STNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKK---SGQGLEELKNETMLIAKL 555
+ N+F LG+G FG V G+ A+K L K+ + + E+ ++
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 556 QHRNLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
+H L L D + EY LF + ++ E R + A+ +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFY--GAEIVS 116
Query: 616 YLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSP 675
L +++RD+K N++LD D KI+DFG+ + D A GT Y++P
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAP 174
Query: 676 EYALEGLFSIKSDVFSFGVLLLEILSGK 703
E + + D + GV++ E++ G+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 54/273 (19%), Positives = 100/273 (36%), Gaps = 29/273 (10%)
Query: 507 ENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLL 564
LG G G V + ++ A+K L + + E L + Q ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 565 GCCLDQDEK----ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY 620
+ +++ E L L S + DR + +I++ I + + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHS- 129
Query: 621 SRLRIIHRDLKASNILLDTDMKP---KISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
+ I HRD+K N+L + K++DFG A+ T Y++PE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEV 184
Query: 678 ALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737
+ D++S GV++ + G+ S + L + + R P
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYIL-----LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEV 770
E + + + T R T++E
Sbjct: 240 EWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 55/301 (18%), Positives = 115/301 (38%), Gaps = 36/301 (11%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQG--LEELKNETMLIAKLQ 556
+ + K+G+G FG V+K GQ+VA+K++ ++ + E ++ L+
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 557 HRNLVRLLGCCLDQDEKI--------LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIE 608
H N+V L+ C + L++++ + K ++++
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQ 124
Query: 609 GIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR--I 666
+ GL Y+H+ +I+HRD+KA+N+L+ D K++DFG+AR F +
Sbjct: 125 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 667 VGTYGYMSPEYAL-EGLFSIKSDVFSFGVLLLEILSGKK------NTGFYHTGSLNLLGH 719
V T Y PE L E + D++ G ++ E+ + S
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 720 AWDLWKDNRALDLMDPILENEASYPMLARYVNVALL----------CVHENATDRPTMSE 769
++W + +L + + + + + + + + R +
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 770 V 770
Sbjct: 302 A 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-38
Identities = 60/287 (20%), Positives = 109/287 (37%), Gaps = 26/287 (9%)
Query: 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHR 558
+ K+GEG +G V+K + + VA+KR+ E L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N+VRL + L++E+ F VK + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD----LDPEIVKSF--LFQLLKGLG 115
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
++HRDLK N+L++ + + K+++FG+AR F G ++ + +V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL--------WKDNRAL 730
L+S D++S G + E+ + + F + L + L W L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR-PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 731 DLMDPILENEASYPMLARYVNVA-----LL--CVHENATDRPTMSEV 770
P A+ ++ + LL + N R + E
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 1e-36
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 21/243 (8%)
Query: 465 SSTETSKNELSDGRAGKSKSTDAWLPLFSFASVSASTNNFSAENKLGEGGFGPVYKGE-L 523
S E+ K L+ + K + + +A + F LG G FG V +
Sbjct: 10 SEQESVKEFLAKAKEDFLKK------WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 524 LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580
+G A+K L K+ + +E NE ++ + LV+L D ++ EY+
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD 640
+ S L + I YLH L +I+RDLK N+L+D
Sbjct: 124 AGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 641 MKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEIL 700
+++DFG A+ G T + GT ++PE L ++ D ++ GVL+ E+
Sbjct: 178 GYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 701 SGK 703
+G
Sbjct: 233 AGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-35
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHR 558
+ +G G +G V + G +VA+K+L + S + E L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 559 NLVRLLGCCLDQDEKILIYE-YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYL 617
N++ LL + + YL + + L K L + ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 618 HQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEY 677
H IIHRDLK N+ ++ D + KI DFG+AR + V T Y +PE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEV 189
Query: 678 ALEGL-FSIKSDVFSFGVLLLEILSGK 703
L + ++ D++S G ++ E+++GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 6e-34
Identities = 45/210 (21%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 500 STNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-H 557
+ +++ KLG G + V++ + N ++V VK L +++K E ++ L+
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGG 89
Query: 558 RNLVRLLGCCLDQDEK--ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLL 615
N++ L D + L++E++ N + L ++ R + I + L
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALD 143
Query: 616 YLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFGMARMFGGDELQANTNRIVGTYGYMS 674
Y H + I+HRD+K N+++D + K ++ D+G+A + + N V + +
Sbjct: 144 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKG 197
Query: 675 PEYALE-GLFSIKSDVFSFGVLLLEILSGK 703
PE ++ ++ D++S G +L ++ K
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 9e-34
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 500 STNNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKKS----GQGLEELKNETML 551
NF LG G +G V+ + G+ A+K L K + + E + E +
Sbjct: 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 552 IAKLQHR-NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGI 610
+ ++ LV L + + LI +Y+ L + L R + + E V+I +
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIY--V 135
Query: 611 AQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTY 670
+ +L L +L II+RD+K NILLD++ ++DFG+++ F DE + GT
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTI 194
Query: 671 GYMSPEYALEGL--FSIKSDVFSFGVLLLEILSGK 703
YM+P+ G D +S GVL+ E+L+G
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 9/205 (4%)
Query: 502 NNFSAENKLGEGGFGPVYKG-ELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHR 558
+ +G G G V + + + VA+K+LS+ + + E +L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 559 NLVRLLGCCLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLH 618
N++ LL Q + L + + L E ++ + G+ +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 619 QYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYA 678
IIHRDLK SNI++ +D KI DFG+AR G + V T Y +PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVI 190
Query: 679 LEGLFSIKSDVFSFGVLLLEILSGK 703
L + D++S G ++ E++ K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-31
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 501 TNNFSAENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQH 557
+ + +G G +G V G VAVK+LS+ S + E L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 558 RNLVRLLGCCLDQDEKILI-YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLY 616
N++ LL YL + + L + K + L + +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 617 LHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPE 676
+H IIHRDLK SN+ ++ D + KI DFG+AR V T Y +PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPE 188
Query: 677 YALEGL-FSIKSDVFSFGVLLLEILSGK 703
L + ++ D++S G ++ E+L+G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (298), Expect = 9e-30
Identities = 43/212 (20%), Positives = 86/212 (40%), Gaps = 18/212 (8%)
Query: 507 ENKLGEGGFGPVYKGE-LLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLG 565
KLG G F V+ + ++N VA+K + + E ++E L+ ++ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 566 CCLDQDEKILIYEYLPNKSL-------------DSFLFDRAKKRLLYWETRVKIIEGIAQ 612
+ K+L + + L + + R + +I + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 613 GLLYLHQYSRLRIIHRDLKASNILLDT-DMKPKISDFGMARMFGGDELQANTNRIVGTYG 671
GL Y+H+ R IIH D+K N+L++ D + +A + + + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 672 YMSPEYALEGLFSIKSDVFSFGVLLLEILSGK 703
Y SPE L + +D++S L+ E+++G
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (252), Expect = 3e-25
Identities = 35/206 (16%), Positives = 69/206 (33%), Gaps = 35/206 (16%)
Query: 508 NKLGEGGFGPVYKGELLNGQEVAVK--RLSKKSGQ--------GLEELKNETMLIAKLQH 557
+GEG V+ E VK ++ S + G + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 558 RNLVRLLGCC----LDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQG 613
R L +L G + ++ E + K + + E ++++ I +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 614 LLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNR-IVGTYGY 672
+ + I+H DL N+L+ + I DF + G + + R + Y
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171
Query: 673 MSPEYALEGLFSIKSDVFSFGVLLLE 698
S Y + D+ S +L+
Sbjct: 172 FSRTY------RTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 80.4 bits (198), Expect = 1e-18
Identities = 16/85 (18%), Positives = 28/85 (32%)
Query: 67 IWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTAT 126
I Y + Q L S L++ ++ NLV+ D + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 127 LLDSGNFVLRNEKLGLLWQSFDYPS 151
L +G + + +W S + S
Sbjct: 72 LQPNGRMDVLTNQNIAVWTSGNSRS 96
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 72.7 bits (178), Expect = 3e-16
Identities = 22/115 (19%), Positives = 45/115 (39%), Gaps = 10/115 (8%)
Query: 36 VITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLT 95
++T E L +G+ ++ + + + ++ + T VW +N
Sbjct: 3 LLTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYDHS----TSVWASNTGILGKKGC-KAV 56
Query: 96 ISSEGNLVIEDG-RITYRVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQSFDY 149
+ S+GN V+ D + S +V + N L + GN V+ +W + Y
Sbjct: 57 LQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 70.4 bits (172), Expect = 3e-15
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 1/81 (1%)
Query: 67 IWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTAT 126
I + E + + Q L SS T+ S+ NLV+ D + S N + + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWAS-NTAGATGCRAV 61
Query: 127 LLDSGNFVLRNEKLGLLWQSF 147
L G V+ + + W S
Sbjct: 62 LQSDGLLVILTAQNTIRWSSG 82
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 62.9 bits (152), Expect = 1e-12
Identities = 23/123 (18%), Positives = 39/123 (31%), Gaps = 13/123 (10%)
Query: 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPL 87
+D L+ G + +L G + Y VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLVLYDNNR---------AVWASGTNGK- 48
Query: 88 TSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQSF 147
+S VL + ++GNLVI G S + N L N V+ + +W +
Sbjct: 49 -ASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATH 107
Query: 148 DYP 150
Sbjct: 108 TNV 110
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 62.3 bits (151), Expect = 2e-12
Identities = 22/122 (18%), Positives = 37/122 (30%), Gaps = 17/122 (13%)
Query: 29 DSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLT 88
+ L G+ ++ E L F Y V W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCNLVLYDVDKPI---------WATNTGGL-- 48
Query: 89 SSSPVLTISSEGNLVIEDGRITYRVSENVS-SSQNTTATLLDSGNFVLRNEKLGLLWQSF 147
S S L++ ++GNLV+ + + N + N L N V+ W +
Sbjct: 49 SRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATG 105
Query: 148 DY 149
+
Sbjct: 106 TH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 45.0 bits (106), Expect = 3e-06
Identities = 16/123 (13%), Positives = 31/123 (25%), Gaps = 19/123 (15%)
Query: 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPL 87
L + S ++ + N + Y N +W N
Sbjct: 14 PQILHATE----SLEILFGTHVYRFIMQTDC---NL---VLYDN---NNPIWATNTGGLG 60
Query: 88 TSSSPVLTISSEGNLVIEDGRITYRVSENVS-SSQNTTATLLDSGNFVLRNEKLGLLWQS 146
+ +G LV+ V+ + + L N V+ + LW +
Sbjct: 61 NGCR--AVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA---LWAT 115
Query: 147 FDY 149
Sbjct: 116 QTV 118
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 791 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.84 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.83 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.69 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.65 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.63 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.46 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.26 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.18 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.08 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.08 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.7 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.67 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.86 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 86.19 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 86.17 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.92 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.83 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.41 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.61 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=414.97 Aligned_cols=265 Identities=26% Similarity=0.419 Sum_probs=206.4
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.++||+|+||+||+|+.. ..||||+++.. +....+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999763 46999998654 34567889999999999999999999998754 56899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999853 3456899999999999999999999988 9999999999999999999999999998765544
Q ss_pred cccccccccccCcccCchhccc---CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.........||+.|||||++.+ ..++.++|||||||+||||+||+.||....... ........... .+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-----~~~~~~~~~~~----~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIFMVGRGYL----SP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHHHTSC----CC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-----HHHHHHhcCCC----CC
Confidence 4444455689999999999864 358999999999999999999999976432211 11111111110 01
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCC
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPR 783 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 783 (791)
.+ ...+...++.+.+++.+||+.||++||||+|++++|+.+...+|+
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence 11 111222346789999999999999999999999999987766663
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=413.18 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=205.2
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.++||+|+||+||+|.. .+|+.||||++.... .+..+++.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999976 469999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999983 3456899999999999999999999998 99999999999999999999999999987654443
Q ss_pred ccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.......+||+.|||||++.+..+ +.++||||+||+||||++|+.||............ ...... .
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-----~~~~~~--------~ 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT--------Y 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-----HHTTCT--------T
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-----HhcCCC--------C
Confidence 344455689999999999998876 67899999999999999999998654332211110 111100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......++.+.+|+.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01112234678899999999999999999999753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=411.21 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=199.3
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
++|++.++||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++|||||++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578889999999999999999888999999999754 3456789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+|+|.+++.. ....++++.++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999999843 3456889999999999999999999988 999999999999999999999999999876544322
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCC-CCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKK-NTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......||+.|+|||++.+..++.++|||||||++|||+|+.. |+.... ...+... .... ....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~----i~~~---------~~~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVED----ISTG---------FRLY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHH----HHHT---------CCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHhc---------CCCC
Confidence 2223578999999999999999999999999999999999654 433211 1111111 1111 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.+...++++.+++.+||+.||++||||+||+++|+++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1122346789999999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=410.04 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=209.0
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.++||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35899999999999999999965 56999999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++|+|.+++.+ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988732 45889999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccC
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILEN 739 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 739 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .-
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~~~~--------~~ 236 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTP--------EL 236 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCSC--------CC
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----HHHHHHHhCCCC--------CC
Confidence 223457999999999999999999999999999999999999997532211 111111111100 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 740 EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 740 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...++.+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122345788999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=405.90 Aligned_cols=246 Identities=26% Similarity=0.345 Sum_probs=205.4
Q ss_pred cCCCccceecccCceeEEEeEee-CCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56899999999999999999764 6899999998643 2345678899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999853 345889999999999999999999998 999999999999999999999999999865433
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||..... .... .......
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~----~~i~~~~--------- 220 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETY----KRISRVE--------- 220 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH----HHHHTTC---------
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHH----HHHHcCC---------
Confidence 2 2345799999999999999999999999999999999999999753211 1111 1111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...+...++.+.+++.+||+.||++|||++|++++
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 01122245678999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=407.53 Aligned_cols=255 Identities=30% Similarity=0.435 Sum_probs=206.7
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.++||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46788899999999999999998888999999997543 456789999999999999999999998754 5679999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+........
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999987443 2345899999999999999999999988 999999999999999999999999999987644322
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......||+.|+|||++.+..++.++|||||||+||||+||..|+...... .... ...... ....
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~----~~i~~~---------~~~~ 230 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVI----QNLERG---------YRMV 230 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHH----HHHHTT---------CCCC
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHhc---------CCCC
Confidence 223457899999999999999999999999999999999976653322111 1111 111111 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.+...++.+.+|+.+||+.||++||||+||++.|++
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 122344678999999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-48 Score=409.56 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=211.9
Q ss_pred hccCCCccceecccCceeEEEeEee-CCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
..++|++.++||+|+||+||+|... +++.||||+++... ...++|.+|++++++++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467888999999999999999765 58899999986543 456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998543 3457889999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.. ......|++.|+|||++.+..++.++|||||||++|||++|..|+...... . ......... ..
T Consensus 170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~----~~~~~i~~~---------~~ 234 (287)
T d1opja_ 170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-S----QVYELLEKD---------YR 234 (287)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-H----HHHHHHHTT---------CC
T ss_pred ce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-H----HHHHHHhcC---------CC
Confidence 22 222346889999999999999999999999999999999987764321111 1 111111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
...+...++.+.+|+.+||+.||++||||+||++.|+...
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1222234568999999999999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=398.63 Aligned_cols=253 Identities=28% Similarity=0.434 Sum_probs=211.5
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecC
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLP 581 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 581 (791)
++|++.++||+|+||+||+|+.++++.||||++++.. ...++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6789999999999999999998888899999997643 346789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcccc
Q 003846 582 NKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQA 661 (791)
Q Consensus 582 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 661 (791)
+|+|.+++.. ....+++..+.+++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999999743 4456888999999999999999999988 999999999999999999999999999876554332
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......+|+.|+|||++.+..++.++||||||+++|||+| |+.||+..... .+... .... ....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~----i~~~---------~~~~ 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEH----IAQG---------LRLY 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHH----HHTT---------CCCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHH----HHhC---------CCCC
Confidence 2234578999999999999999999999999999999998 78887644321 11111 1111 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.+...++.+.+++.+||+.||++|||++|++++|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122234678999999999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=408.11 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=206.9
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
+.|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5689999999999999999975 468999999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++|+|.+++.+ ....+++..+..++.||++||.|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 99999998743 2356899999999999999999999998 9999999999999999999999999997643221
Q ss_pred cccccccccCcccCchhcc-----cCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 661 ANTNRIVGTYGYMSPEYAL-----EGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
.......||+.|+|||++. +..|+.++|||||||+||||++|+.||...... .... .... ....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~---~i~~-~~~~----- 233 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLL---KIAK-SEPP----- 233 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHH---HHHH-SCCC-----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHH---HHHc-CCCC-----
Confidence 1223457999999999984 456899999999999999999999997543211 1111 1111 1100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.-..+...++.+.+|+.+||+.||++|||++|++++
T Consensus 234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001122345788999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=405.54 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=195.5
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEc--CCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLD--QDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 576 (791)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999965 468999999987543 3345678999999999999999999999975 4557899
Q ss_pred EeecCCCChhHHHhhhc-cccccCHHHHHHHHHHHHHHHHHhhccC--CCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 577 YEYLPNKSLDSFLFDRA-KKRLLYWETRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
|||+++|+|.+++.... ....+++..++.++.||++||.|||+++ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986533 3457899999999999999999999864 23599999999999999999999999999987
Q ss_pred cCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 654 FGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 654 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+. .........
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~----~~i~~~~~~--- 232 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELA----GKIREGKFR--- 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH----HHHHHTCCC---
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHH----HHHHcCCCC---
Confidence 654321 22346899999999999999999999999999999999999999753221 1111 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..+...++.+.+|+.+||+.||++|||++|++++
T Consensus 233 ------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 ------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122345679999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-48 Score=408.77 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=197.0
Q ss_pred cCCCccceecccCceeEEEeEee-CC---cEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NG---QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
++|++.++||+|+||+||+|+.. ++ ..||||++... .....++|.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56778899999999999999764 23 35899988654 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++.. ....+++.+++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998843 3456899999999999999999999988 99999999999999999999999999987654
Q ss_pred Cccccc---cccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccc
Q 003846 657 DELQAN---TNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDL 732 (791)
Q Consensus 657 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (791)
...... .....||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+... ...+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~----i~~~----- 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINA----IEQD----- 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH----HHTT-----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcC-----
Confidence 432221 122467899999999999999999999999999999998 89997543211 11111 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 733 MDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 733 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.....+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 250 ----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 ----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112233457789999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=401.97 Aligned_cols=270 Identities=26% Similarity=0.404 Sum_probs=211.4
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
.++|++.++||+|+||+||+|+..+++.||||+++.. ....+.|.+|+.++++++|||||++++++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3579999999999999999999888889999999654 345678999999999999999999999985 45689999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++|+|..++... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 999999988543 3345899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 661 ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
.......||+.|+|||++.+..++.++||||||++||||++|..|+...... ...... .... ....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~----i~~~---------~~~~ 234 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQ----VERG---------YRMP 234 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHH----HHTT---------CCCC
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHH----HHhc---------CCCC
Confidence 2223457899999999999999999999999999999999977664322211 111111 1111 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCCCCcCCCC
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRRNNQLSRM 791 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~ 791 (791)
.+...++++.+++.+||+.||++||||+||+++|++.-...+.+.+|.+++
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~~~ 285 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 285 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSCCC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCCCC
Confidence 222345678999999999999999999999999988666665566665553
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=411.50 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=207.2
Q ss_pred ccCCCccceecccCceeEEEeEeeC-C-----cEEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN-G-----QEVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 572 (791)
.++|++.++||+|+||+||+|+... + ..||||++... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678899999999999999997643 2 36999998654 334557789999999998 89999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhcc--------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCC
Q 003846 573 KILIYEYLPNKSLDSFLFDRAK--------------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKA 632 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp 632 (791)
.++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965321 245889999999999999999999988 99999999
Q ss_pred CcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCC
Q 003846 633 SNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHT 711 (791)
Q Consensus 633 ~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~ 711 (791)
+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655443333445678999999999999999999999999999999998 8999764332
Q ss_pred CccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003846 712 GSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLT 775 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 775 (791)
.. . ........ .....+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~-~----~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA-N----FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH-H----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH-H----HHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1 11111111 111122234578999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=412.74 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=205.3
Q ss_pred hccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
..++|++.++||+|+||+||+|+. .+|+.||||+++... ....+++.+|+.+|++++|||||++++++.++++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999975 468999999997543 344578899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-CCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
||+++|+|.+++.+ ...+++..+..++.||++||.|||++ + |+||||||+||||+.++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999854 34588999999999999999999974 6 99999999999999999999999999986532
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHH-------------
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDL------------- 723 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------------- 723 (791)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.................
T Consensus 158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2 22346899999999999999999999999999999999999999865332211000000000
Q ss_pred -------hhc----CCccccccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 724 -------WKD----NRALDLMDPILEN----EASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 724 -------~~~----~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... ....+..+..... ......+.++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 0000000000000 0001134678999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=408.13 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=202.4
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999976 46999999998653 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998743 356889999999999999999999998 999999999999999999999999999887654
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..+. .......
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~----~~i~~~~--------- 226 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIF----QKIIKLE--------- 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHTTC---------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHH----HHHHcCC---------
Confidence 434444456899999999999999999999999999999999999999763211 1111 1111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVV 771 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 771 (791)
...+...++.+.+|+.+||+.||++|||++|++
T Consensus 227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 011223456789999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.6e-47 Score=409.28 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=208.8
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
-++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999975 46999999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc--CCCCeEEeeeccccccCCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--TDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFgla~~~~~~ 657 (791)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999843 3456899999999999999999999998 99999999999996 4678999999999876543
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||..... ...... ...... ..
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~----i~~~~~------~~ 244 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRN----VKSCDW------NM 244 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHTCC------CS
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCCC------CC
Confidence 32 2345899999999999999999999999999999999999999753211 111111 100000 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........++.+.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112235678999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=402.55 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=206.8
Q ss_pred cCCCccc-eecccCceeEEEeEee---CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAEN-KLGEGGFGPVYKGELL---NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
++|.+.+ +||+|+||+||+|... ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999653 35579999997543 3456789999999999999999999999865 568999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++. ..+..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999873 33456899999999999999999999988 99999999999999999999999999998765
Q ss_pred Cccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 657 DELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 657 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. .....+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~----~~i~~~~------ 229 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQGK------ 229 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH----HHHHTTC------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCC------
Confidence 4322 22334578999999999999999999999999999999998 89997643221 111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
....+...++.+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 230 ---~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122334578899999999999999999999999987643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=399.13 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=199.9
Q ss_pred cCCCccceecccCceeEEEeEeeCC-----cEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNG-----QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
..|++.++||+|+||+||+|.+... ..||||++... ......+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999976542 46999999654 33345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+.+++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999988743 3456889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQ-ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
..... .......||+.|+|||++.+..++.++|||||||+||||++|..|+...... ..+ ......+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~----~~~i~~~------- 229 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEV----MKAINDG------- 229 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHH----HHHHHTT-------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHH----HHHHhcc-------
Confidence 43222 2223356899999999999999999999999999999999976664322111 111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.....+...+..+.+|+.+||+.||++||||.||+++|+.+.
T Consensus 230 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111222234567899999999999999999999999998643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=398.39 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=197.6
Q ss_pred ceecccCceeEEEeEeeC---CcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeecCC
Q 003846 508 NKLGEGGFGPVYKGELLN---GQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYLPN 582 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 582 (791)
++||+|+||+||+|...+ ++.||||+++.. +....++|.+|++++++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999997543 568999999654 23345789999999999999999999999865 567899999999
Q ss_pred CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc-c
Q 003846 583 KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ-A 661 (791)
Q Consensus 583 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~-~ 661 (791)
|+|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999843 355899999999999999999999988 999999999999999999999999999876544322 2
Q ss_pred ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccccccccccCC
Q 003846 662 NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILENE 740 (791)
Q Consensus 662 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 740 (791)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+ ......+. ...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~----~~~i~~~~---------~~~ 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV----TAMLEKGE---------RMG 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTTC---------CCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HH----HHHHHcCC---------CCC
Confidence 2334578999999999999999999999999999999998 89997643211 11 11111111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 741 ASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 741 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.+...+..+.+|+.+||+.||++|||++||++.|+.
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 222345688999999999999999999999988865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=394.29 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=195.4
Q ss_pred CccceecccCceeEEEeEee-CCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc----CCcceEEE
Q 003846 505 SAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD----QDEKILIY 577 (791)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 577 (791)
++.++||+|+||+||+|... +++.||||++... .....+.+.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999764 6889999998654 33446778999999999999999999999865 34568999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc-CCCCeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-TDMKPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~ 656 (791)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+|||++ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999853 346889999999999999999999875 4599999999999996 578999999999986433
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||....... ............. .
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i~~~~~~~----~ 233 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVKPA----S 233 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTCCCG----G
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHHHcCCCCc----c
Confidence 2 2234589999999998865 59999999999999999999999975322111 1111111111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.+...++++.+|+.+||+.||++|||++|++++
T Consensus 234 ----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 ----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111123568899999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-47 Score=402.97 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=190.6
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999764 68999999997543 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc---CCCCeEEeeeccccccC
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---TDMKPKISDFGMARMFG 655 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFgla~~~~ 655 (791)
|+++|+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. .++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999843 456899999999999999999999998 99999999999994 57899999999998654
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDP 735 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (791)
... .....+||+.|||||++.+..++.++|||||||+||||++|+.||...... ... ....... .
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~----~~i~~~~------~ 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLF----EQILKAE------Y 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH----HHHHTTC------C
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHH----HHHhccC------C
Confidence 332 223457999999999999999999999999999999999999997532211 111 1111110 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 736 ILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 736 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..........++.+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111122345788999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-46 Score=406.49 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=208.9
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999965 57999999999876666667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc--CCCCeEEeeeccccccCCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--TDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFgla~~~~~~ 657 (791)
+++|+|.+++. .....+++..++.++.||++||.|||+++ |+||||||+||||+ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988763 23446899999999999999999999998 99999999999998 6789999999999887644
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. .....||+.|+|||++.+..++.++|||||||+||||++|+.||..... ...... ..... ...
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~----i~~~~------~~~ 247 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQN----VKRCD------WEF 247 (352)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH----HHHCC------CCC
T ss_pred Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCC------CCC
Confidence 32 2335789999999999999999999999999999999999999753221 111111 11110 001
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111222345678999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-47 Score=400.36 Aligned_cols=265 Identities=26% Similarity=0.390 Sum_probs=212.7
Q ss_pred hhhhhccCCCccceecccCceeEEEeEee------CCcEEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeEEE
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKSG-QGLEELKNETMLIAKLQHRNLVRLLGCCL 568 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 568 (791)
+++...++|++.++||+|+||+||+|+.. +++.||||+++.... +..++|.+|++++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999764 357899999976543 34567999999999999999999999999
Q ss_pred cCCcceEEEeecCCCChhHHHhhhc---------------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeee
Q 003846 569 DQDEKILIYEYLPNKSLDSFLFDRA---------------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIH 627 (791)
Q Consensus 569 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH 627 (791)
+.+..+++|||+++|+|.++++... ....+++..++.++.||++||+|||+++ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999996432 1234788999999999999999999988 999
Q ss_pred cCCCCCcEEEcCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCC-CC
Q 003846 628 RDLKASNILLDTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKK-NT 706 (791)
Q Consensus 628 ~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~-p~ 706 (791)
|||||+||||+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||+||||++|.. |+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987655444444445678999999999999999999999999999999999964 54
Q ss_pred CCCCCCccchhhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 707 GFYHTGSLNLLGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
..... .... .....+.. ...+...++++.+|+.+||+.||++||||.||+++|+++.
T Consensus 244 ~~~~~--~e~~----~~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAH--EEVI----YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCH--HHHH----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCH--HHHH----HHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 43211 1111 11111111 1122234467899999999999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=399.55 Aligned_cols=246 Identities=30% Similarity=0.461 Sum_probs=200.4
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG---QGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
+.|+..++||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588899999999999999965 5689999999976532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|..++. ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999976653 3356899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccccccccCcccCchhccc---CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALE---GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... ........... .
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~~~i~~~~-~----- 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNE-S----- 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSC-C-----
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCC-C-----
Confidence 224579999999999864 4689999999999999999999999753211 11111111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
+.. .+...++.+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 001 111234678999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=392.47 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=204.9
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC------cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS------GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999976 569999999986532 22467899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC----CeEEeeec
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM----KPKISDFG 649 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFg 649 (791)
+|||||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999854 346899999999999999999999998 99999999999998776 49999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA 729 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+++....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..... .......
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~----~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLA----NVSAVNY 233 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHTTCC
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HHHHH----HHHhcCC
Confidence 9987654322 2345789999999999999999999999999999999999999753221 11110 0000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..........+..+.+|+.+||+.||++|||++|++++
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000001134678899999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=398.30 Aligned_cols=249 Identities=23% Similarity=0.286 Sum_probs=207.0
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 576 (791)
.++|++.+.||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999975 57999999999754 234567889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++.. ...++++.++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999843 356888999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. ......+||+.|+|||++.+..|+.++||||+||+||||++|+.||..... ..+. .......
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~----~~i~~~~-------- 221 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLF----ELILMEE-------- 221 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCC--------
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHH----HHHhcCC--------
Confidence 32 223346899999999999999999999999999999999999999754321 1111 1111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
...+...++.+.+||.+||+.||++||+ ++|++++
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1122234567899999999999999994 8888874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-46 Score=392.93 Aligned_cols=261 Identities=30% Similarity=0.407 Sum_probs=199.4
Q ss_pred hccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCC
Q 003846 500 STNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQD 571 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 571 (791)
..++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3468999999999999999999753 35689999997543 33456778888888877 6899999999987654
Q ss_pred -cceEEEeecCCCChhHHHhhhcc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 572 -EKILIYEYLPNKSLDSFLFDRAK-------------KRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 572 -~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
..++||||+++|+|.++|..... ...+++..++.++.||++||.|||+++ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 67999999999999999965332 345889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCC-CCCCCCCCCccch
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK-KNTGFYHTGSLNL 716 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~-~p~~~~~~~~~~~ 716 (791)
+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. .|+....... .
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~- 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E- 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-H-
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-H-
Confidence 999999999999998766554444445568999999999999999999999999999999999975 4654322211 1
Q ss_pred hhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.......+.. ...+...++++.+++.+||+.||++|||++|++++|+++
T Consensus 246 ---~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 ---FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ---HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111111 112223446789999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=395.62 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=201.2
Q ss_pred cCCCccceecccCceeEEEeEee-CCc----EEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL-NGQ----EVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.+|++.++||+|+||+||+|... +|+ +||||+++.. +.+..++|.+|++++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999653 444 6899988653 445678899999999999999999999999865 5678
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
++||+.+|+|.+++.. ....+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988743 4567889999999999999999999988 9999999999999999999999999999876
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
............||+.|+|||++.+..++.++|||||||+||||+| |+.|+....... +. .....+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~----~~i~~~------- 229 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKG------- 229 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HH----HHHHHT-------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcC-------
Confidence 5544444444578999999999999999999999999999999998 788865432211 11 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.....+...++.+.+|+.+||+.||++|||+.|++++|...
T Consensus 230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11112223456789999999999999999999999988653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=385.55 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=197.8
Q ss_pred ccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-CcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-DEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey 579 (791)
.++|++.++||+|+||.||+|+. .|+.||||+++.. ...+++.+|++++++++||||+++++++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35678889999999999999987 6889999999654 3457899999999999999999999999654 567999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+++|+|.++|... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999999643 2345889999999999999999999987 999999999999999999999999999865432
Q ss_pred ccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 660 QANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.|+...... ++... .... ..
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~----i~~~---------~~ 218 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPR----VEKG---------YK 218 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHH----HTTT---------CC
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcC---------CC
Confidence 223467899999999999999999999999999999998 67775433211 11111 1111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
.+.+...++++.+|+.+||+.||++||||.|++++|+++
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 122333446889999999999999999999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-45 Score=393.01 Aligned_cols=245 Identities=26% Similarity=0.349 Sum_probs=204.2
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++.+.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5689999999999999999976 46999999999653 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+++|+|..++. ....++...+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998874 3445778888999999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
....+||+.|||||++.+..++.++|||||||+||||++|+.||..... .... ......
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~----~~i~~~---------- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTY----EKILNA---------- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH----HHHHHC----------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--HHHH----HHHHcC----------
Confidence 2346899999999999999999999999999999999999999753211 1111 001011
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
....+...++.+.+++.+||+.||.+|| |++|++++
T Consensus 217 ~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0112223456789999999999999996 89999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=384.79 Aligned_cols=256 Identities=29% Similarity=0.391 Sum_probs=196.6
Q ss_pred ccCCCccceecccCceeEEEeEeeC--C--cEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN--G--QEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||.||+|+... + ..||||++.+. ..+..++|.+|++++++++|||||++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3678999999999999999997532 2 37899998754 33446789999999999999999999999975 467
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
++||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999998754 3456899999999999999999999988 99999999999999999999999999998
Q ss_pred cCCCcccc-ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 654 FGGDELQA-NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 654 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
........ ......|+..|+|||++.+..++.++||||||+++|||+| |+.||...... ... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~---~~i~~~~---- 231 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QIL---HKIDKEG---- 231 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HHHHTSC----
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHH---HHHHhCC----
Confidence 75543222 2334567889999999999999999999999999999998 89997532211 111 1111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.....+...+..+.+++.+||+.||++||||.||++.|.+
T Consensus 232 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111122334678999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=384.70 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=195.8
Q ss_pred ccCCCccceecccCceeEEEeEeeC----CcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceE
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN----GQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKIL 575 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 575 (791)
.++|++.+.||+|+||.||+|.... +..||||+++... ....+.+.+|+.++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578999999999999999997642 4568999986543 334577999999999999999999999985 467899
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccC
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFG 655 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 655 (791)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998743 3456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccchhhhhhHHhhcCCcccccc
Q 003846 656 GDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMD 734 (791)
Q Consensus 656 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (791)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |.+|+...... .+.. .......
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~----~i~~~~~----- 227 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIG----RIENGER----- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH----HHHTTCC-----
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHH----HHHcCCC-----
Confidence 4322 22234578999999999999999999999999999999998 78887543321 1111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 735 PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 735 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
...+...++.+.+|+.+||+.||++|||+.||+++|+.+
T Consensus 228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112223456899999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=389.98 Aligned_cols=261 Identities=27% Similarity=0.390 Sum_probs=211.7
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 572 (791)
.++|++.++||+|+||.||+|+.. +++.||||+++... .....++.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 468888999999999999999752 46789999997643 33456789999999999 69999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhc---------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 573 KILIYEYLPNKSLDSFLFDRA---------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
.++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999996532 2335889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCC-CCCCCCCccch
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKN-TGFYHTGSLNL 716 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p-~~~~~~~~~~~ 716 (791)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+|+..| +...... ..+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHH
Confidence 99999999999999987655444444557899999999999999999999999999999999995444 4332221 111
Q ss_pred hhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
...... ......+...+..+.+|+.+||+.||++||||+|++++|+++.
T Consensus 258 ----~~~i~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 258 ----YKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ----HHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHhc---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 111111 1111122234568999999999999999999999999998643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-45 Score=384.23 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=200.4
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCc----
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDE---- 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 572 (791)
.++|++.+.||+|+||+||+|.. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46899999999999999999965 579999999997543 3345678999999999999999999999986543
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++||||+++++|.+++.. ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 6899999999999988743 346889999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCc-cccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccc
Q 003846 653 MFGGDE-LQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALD 731 (791)
Q Consensus 653 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (791)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||..... .............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~~~~~~~-- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPI-- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCC--
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHHHhcCCC--
Confidence 654332 22233446899999999999999999999999999999999999999753221 1111111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccC
Q 003846 732 LMDPILENEASYPMLARYVNVALLCVHENATDRP-TMSEVVSMLTNE 777 (791)
Q Consensus 732 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~ 777 (791)
.........++.+.+++.+||+.||++|| |++|+++.|.++
T Consensus 233 -----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 -----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00111122346789999999999999999 899999888653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=387.48 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=207.9
Q ss_pred ccCCCccceecccCceeEEEeEeeC--------CcEEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeEEEcC
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELLN--------GQEVAVKRLSKKS-GQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQ 570 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 570 (791)
.++|++.+.||+|+||.||+|+... +..||||++++.. .....++.+|...+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4688889999999999999997532 3479999997654 34467888999999888 799999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEE
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRA-------------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 637 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl 637 (791)
+..++||||+++|+|.++|.... ....+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999996543 2346899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHh-CCCCCCCCCCCccch
Q 003846 638 DTDMKPKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILS-GKKNTGFYHTGSLNL 716 (791)
Q Consensus 638 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~ellt-g~~p~~~~~~~~~~~ 716 (791)
+.++.+||+|||+++...............+|+.|+|||.+.++.|+.++||||||+++|||++ |+.|+......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 9999999999999987765554444555688999999999999999999999999999999998 67776532211
Q ss_pred hhhhhHHhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003846 717 LGHAWDLWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNE 777 (791)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 777 (791)
........+.. ...+...+.++.+|+.+||+.||++|||+.||++.|+++
T Consensus 245 --~~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 --ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp --HHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11122222111 112223456799999999999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.1e-45 Score=380.07 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=204.0
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc---------ccHHHHHHHHHHHHhcC-CCceeeeeeEEEcC
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG---------QGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQ 570 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 570 (791)
++|++.+.||+|+||+||+|+. .+|+.||||++.+... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999975 5799999999876431 12346889999999997 99999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecc
Q 003846 571 DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGM 650 (791)
Q Consensus 571 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgl 650 (791)
+..+|||||+++|+|.++|.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999953 346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccCcccCchhccc------CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALE------GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW 724 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 724 (791)
++....... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||..... .... ...
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~~----~~i 227 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLML----RMI 227 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHHH----HHH
Confidence 987654322 234579999999999863 3478899999999999999999999764321 1111 111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 725 KDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 725 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
...... .........++++.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111100 1111122355789999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=387.07 Aligned_cols=252 Identities=20% Similarity=0.256 Sum_probs=203.7
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... ....+.+|+++|++++|||||++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 46899999999999999999965 4689999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC--CCeEEeeeccccccCCC
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD--MKPKISDFGMARMFGGD 657 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFgla~~~~~~ 657 (791)
+++|+|.+++.. ....++++++..++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999843 3346899999999999999999999998 9999999999999854 58999999999876443
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.. .....+|+.|+|||.+.+..++.++||||+||++|+|++|+.||...... ..... ...... .+...
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~----i~~~~~--~~~~~- 225 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIEN----IMNAEY--TFDEE- 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH----HHHTCC--CCCHH-
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCCC--CCChh-
Confidence 22 23357899999999999999999999999999999999999997543211 11110 000000 00000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.....+.++.+|+.+||+.||++|||++|++++
T Consensus 226 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000134678999999999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-45 Score=386.63 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=211.1
Q ss_pred ccCCCccceecccCceeEEEeEee------CCcEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL------NGQEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEK 573 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 573 (791)
.++|++.++||+|+||+||+|... +++.||||+++.. ..+....|.+|++++++++|||||++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888999999999999999653 3578999999754 334456789999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhhc-------cccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 574 ILIYEYLPNKSLDSFLFDRA-------KKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
++||||+++|+|.+++.... ....+++..+.+++.|+++||.|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999986432 1234688899999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCC-CCCCCCCCCccchhhhhhHHhh
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGK-KNTGFYHTGSLNLLGHAWDLWK 725 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 725 (791)
|||+++...............+|+.|+|||.+.+..++.++||||||++||||+||. .|+..... ... .....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~~----~~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQV----LRFVM 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHH----HHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HHH----HHHHH
Confidence 999998776554444445567899999999999999999999999999999999985 55432211 111 11111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 726 DNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 726 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.+.. ...+...+..+.+++.+||+.||++||||+||+++|++..
T Consensus 250 ~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred hCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1111 1111223467999999999999999999999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-45 Score=392.58 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=204.8
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 577 (791)
++|++++.||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999976 46999999998643 2345678899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGD 657 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 657 (791)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999854 346889999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccccccc
Q 003846 658 ELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPIL 737 (791)
Q Consensus 658 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 737 (791)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.... ....... .....
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~----i~~~~--------- 254 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEK----IVSGK--------- 254 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH----HHHCC---------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHH----HhcCC---------
Confidence 234589999999999999999999999999999999999999975321 1111111 11110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 738 ENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 738 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
...+...++.+.+++.+||+.||.+|+ |++|++++
T Consensus 255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 011223456789999999999999994 89999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=382.53 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=204.3
Q ss_pred cceecccCceeEEEeEeeCC----cEEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-CcceEEEeec
Q 003846 507 ENKLGEGGFGPVYKGELLNG----QEVAVKRLSKK-SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-DEKILIYEYL 580 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey~ 580 (791)
.++||+|+||+||+|.+.++ ..||||++++. +....++|.+|++++++++|||||+++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999976432 35899999753 445568899999999999999999999998764 5789999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999843 4445678889999999999999999988 999999999999999999999999999876544322
Q ss_pred c--ccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccccc
Q 003846 661 A--NTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPILE 738 (791)
Q Consensus 661 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 738 (791)
. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+...... .+.... ...+..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~----i~~g~~--------- 252 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVY----LLQGRR--------- 252 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH----HHTTCC---------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHH----HHcCCC---------
Confidence 2 223357899999999999999999999999999999999988876432211 111111 111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCcCCCCCC
Q 003846 739 NEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEHLVLPRR 784 (791)
Q Consensus 739 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 784 (791)
...+...++.+.+|+.+||+.||++||+|.||+++|+.+..+...+
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 0111223467899999999999999999999999998866554443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=387.73 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=202.4
Q ss_pred cCCCccceecccCceeEEEeEeeC-Cc--EEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLN-GQ--EVAVKRLSKK-SGQGLEELKNETMLIAKL-QHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 576 (791)
++|++.++||+|+||.||+|...+ |. .||||++... .....+++.+|+++|+++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999997653 44 4788887543 344567899999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhh-------------ccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCe
Q 003846 577 YEYLPNKSLDSFLFDR-------------AKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKP 643 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~ 643 (791)
|||+++|+|.++|+.. .....+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23467899999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCC-CCCCCCCCccchhhhhhH
Q 003846 644 KISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKK-NTGFYHTGSLNLLGHAWD 722 (791)
Q Consensus 644 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~-p~~~~~~~~~~~~~~~~~ 722 (791)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. |+.... ...+...
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~--- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEK--- 238 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH---
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHH---
Confidence 999999997643221 1223468999999999999999999999999999999999765 543221 1111111
Q ss_pred HhhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 723 LWKDNRALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 723 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
.... .....+...++.+.+|+.+||+.||++||||+||+++|+++.
T Consensus 239 -i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 239 -LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -GGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 011122234578999999999999999999999999987743
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=380.91 Aligned_cols=270 Identities=23% Similarity=0.331 Sum_probs=203.6
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|++.++||+|+||+||+|.. .+|+.||||+++... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999965 579999999996543 2346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
|+.++.+ .++. ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~-~~~~-~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLK-KFMD-ASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHH-HHHH-HTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchh-hhhh-hhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9976544 4442 234456899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhcccCC-CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC---ccc---
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR---ALD--- 731 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 731 (791)
.......||+.|+|||++.... ++.++||||+||++|+|++|+.||...... .............. ...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccc
Confidence 2233457999999999887665 588999999999999999999998643211 11111000000000 000
Q ss_pred c--cccccc--CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hccCcCC
Q 003846 732 L--MDPILE--NEA-----SYPMLARYVNVALLCVHENATDRPTMSEVVSM--LTNEHLV 780 (791)
Q Consensus 732 ~--~~~~l~--~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~~~~ 780 (791)
. ...... ... ....+..+.+|+.+||+.||++|||++|++++ ++++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0 000000 000 01234678999999999999999999999997 6665443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=382.67 Aligned_cols=271 Identities=24% Similarity=0.317 Sum_probs=199.0
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC----cceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD----EKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~ 577 (791)
++|.+.++||+|+||.||+|+. +|+.||||+++..... ....+.|+..+.+++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4577788999999999999986 7899999998654321 122334555556789999999999998654 468999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhcc-----CCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
||+++|+|.++|.+ ..++++.+..++.|++.||+|||+. .+.+|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 3588999999999999999999974 12459999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccccCcccCchhcccCC------CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh-----
Q 003846 653 MFGGDEL--QANTNRIVGTYGYMSPEYALEGL------FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH----- 719 (791)
Q Consensus 653 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~----- 719 (791)
....... ........||+.|+|||++.+.. ++.++|||||||+||||+||..|+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 7654322 22233468999999999987643 6779999999999999999998865433222111100
Q ss_pred hhHHhhcCCccccccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCc
Q 003846 720 AWDLWKDNRALDLMDPILENEA-SYPMLARYVNVALLCVHENATDRPTMSEVVSMLTNEH 778 (791)
Q Consensus 720 ~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 778 (791)
...........+..++.+.... .......+.+++.+||+.||++|||+.||+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0000000001111122221111 2234567899999999999999999999999997643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-44 Score=388.41 Aligned_cols=249 Identities=26% Similarity=0.297 Sum_probs=198.5
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC---cccHHHHHH---HHHHHHhcCCCceeeeeeEEEcCCcce
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS---GQGLEELKN---ETMLIAKLQHRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 574 (791)
++|++.+.||+|+||.||+|+. .+|+.||||++.+.. ......+.+ |+++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999976 469999999986431 222333444 466777778999999999999999999
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+||||+++|+|.++|.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999854 345788999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCccccc
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLM 733 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (791)
.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||......... . ..... ..
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~-~~~~~-~~------ 223 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E-IDRMT-LT------ 223 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--H-HHHHS-SS------
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--H-HHHhc-cc------
Confidence 5432 234579999999999975 56899999999999999999999998653322111 0 00000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003846 734 DPILENEASYPMLARYVNVALLCVHENATDRPT-----MSEVVSM 773 (791)
Q Consensus 734 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 773 (791)
.....+...++.+.+||.+||+.||++||| ++|++++
T Consensus 224 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 ---MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 001112224567899999999999999999 7888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=378.11 Aligned_cols=261 Identities=25% Similarity=0.303 Sum_probs=196.8
Q ss_pred cceecccCceeEEEeEe-eCCcEEEEEEecccCcc-----cHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEeec
Q 003846 507 ENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQ-----GLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEYL 580 (791)
Q Consensus 507 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 580 (791)
+++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999975 46999999998654321 2356889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCccc
Q 003846 581 PNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDELQ 660 (791)
Q Consensus 581 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 660 (791)
.++++..++ .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 988776654 34556888999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc------ccc
Q 003846 661 ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL------DLM 733 (791)
Q Consensus 661 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 733 (791)
.....+||+.|+|||++... .++.++|||||||++|||++|+.||..... .+............... ...
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHHHHHHHHhcCCCChhhccchhccc
Confidence 22345799999999998754 689999999999999999999999754322 11111111111000000 000
Q ss_pred c-cccc--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hccC
Q 003846 734 D-PILE--NEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM--LTNE 777 (791)
Q Consensus 734 ~-~~l~--~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~ 777 (791)
. .... ...+ ...++.+.+|+.+||+.||++|||++|++++ +++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 0000 0011 1234678999999999999999999999985 5543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=387.08 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=201.5
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc---CcccHHHHHHHHHHHH-hcCCCceeeeeeEEEcCCcceEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK---SGQGLEELKNETMLIA-KLQHRNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV 576 (791)
++|++.+.||+|+||+||+|.. .+|+.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5789999999999999999966 46999999999753 2334566777777765 68999999999999999999999
Q ss_pred EeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCC
Q 003846 577 YEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGG 656 (791)
Q Consensus 577 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 656 (791)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999853 345788999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcccccccc
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRALDLMDPI 736 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (791)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ........ +
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~----~~~i~~~~------~- 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EEL----FHSIRMDN------P- 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH----HHHHHHCC------C-
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHH----HHHHHcCC------C-
Confidence 32 223346899999999999999999999999999999999999999853221 111 11111110 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003846 737 LENEASYPMLARYVNVALLCVHENATDRPTMS-EVVS 772 (791)
Q Consensus 737 l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 772 (791)
..+...+..+.+|+.+||+.||++|||+. |+++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11222456789999999999999999995 6754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=383.33 Aligned_cols=253 Identities=21% Similarity=0.236 Sum_probs=197.4
Q ss_pred ccCCCccc-eecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeEEEc----CCcc
Q 003846 501 TNNFSAEN-KLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKL-QHRNLVRLLGCCLD----QDEK 573 (791)
Q Consensus 501 ~~~y~~~~-~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~ 573 (791)
.++|.+.+ .||+|+||+||+|.. .+++.||||+++. ...+.+|++++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788875 599999999999965 5799999999854 25678899987655 89999999999875 4567
Q ss_pred eEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC---CCCeEEeeecc
Q 003846 574 ILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT---DMKPKISDFGM 650 (791)
Q Consensus 574 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFgl 650 (791)
++||||++||+|.++|... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999542 2346899999999999999999999998 999999999999985 56799999999
Q ss_pred ccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 651 ARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 651 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
|+....... .....||+.|+|||++.+..|+.++|||||||+||+|+||+.||........ ...........
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~--- 232 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMG--- 232 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC---
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcC---
Confidence 987654332 2345799999999999999999999999999999999999999854322110 00000000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
............++++.+|+.+||+.||++|||+.|++++
T Consensus 233 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 ---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000011112245789999999999999999999999885
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-43 Score=373.68 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=202.4
Q ss_pred cCCCccceecccCceeEEEeEeeCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEee
Q 003846 502 NNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYEY 579 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 579 (791)
++|++.++||+|+||+||+|+..+|+.||||++.... ....+++.+|+.+|++++|||||++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999988889999999996543 33467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCcc
Q 003846 580 LPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDEL 659 (791)
Q Consensus 580 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 659 (791)
+.++.+..+. .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9887776665 34467999999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC-----------
Q 003846 660 QANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN----------- 727 (791)
Q Consensus 660 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 727 (791)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... +............
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhhh
Confidence 22234689999999998765 5799999999999999999999998643211 1111111000000
Q ss_pred ----CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 ----RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.......+..........+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001111111122245678999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=372.91 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=197.9
Q ss_pred hccCCCccceecccCceeEEEeEe-eC-CcEEEEEEecccC--cccHHHHHHHHHHHHhc---CCCceeeeeeEEEc---
Q 003846 500 STNNFSAENKLGEGGFGPVYKGEL-LN-GQEVAVKRLSKKS--GQGLEELKNETMLIAKL---QHRNLVRLLGCCLD--- 569 (791)
Q Consensus 500 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~--- 569 (791)
+.++|+++++||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357899999999999999999975 34 6779999986532 22234566777777666 79999999999863
Q ss_pred --CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEee
Q 003846 570 --QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISD 647 (791)
Q Consensus 570 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 647 (791)
....+++|||+.++++.... ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHH--HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 34578999999988775443 344566889999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC
Q 003846 648 FGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN 727 (791)
Q Consensus 648 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..............
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCC
Confidence 9998764432 223346899999999999999999999999999999999999999864321 11111111100000
Q ss_pred C------c----ccccc---ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 R------A----LDLMD---PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ~------~----~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
. . ..... ...........++.+.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0 00000 000011112245678899999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=369.50 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=195.7
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCc------ccHHHHHHHHHHHHhcC--CCceeeeeeEEEcCC
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSG------QGLEELKNETMLIAKLQ--HRNLVRLLGCCLDQD 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~ 571 (791)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+... ....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999965 5689999999875321 11234678999999996 899999999999999
Q ss_pred cceEEEeecCC-CChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCC-CCeEEeeec
Q 003846 572 EKILIYEYLPN-KSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTD-MKPKISDFG 649 (791)
Q Consensus 572 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFg 649 (791)
..++||||+.+ +++.+++.. ...++++.+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 577777633 356889999999999999999999998 9999999999999854 799999999
Q ss_pred cccccCCCccccccccccccCcccCchhcccCCC-CcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCC
Q 003846 650 MARMFGGDELQANTNRIVGTYGYMSPEYALEGLF-SIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNR 728 (791)
Q Consensus 650 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+|+...... .....||+.|+|||++.+..+ +.++||||+||+||||++|+.||.... . .....
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~-------i~~~~- 220 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E-------IIRGQ- 220 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H-------HHHCC-
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----H-------Hhhcc-
Confidence 998654332 234579999999999987765 677999999999999999999975321 0 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 729 ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 729 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. .+...++++.+++.+||+.||++|||++|++++
T Consensus 221 ------~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ------VF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------cC----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 111234678999999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=371.24 Aligned_cols=259 Identities=23% Similarity=0.269 Sum_probs=194.9
Q ss_pred CCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeEEEcC------CcceE
Q 003846 503 NFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------DEKIL 575 (791)
Q Consensus 503 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 575 (791)
+|+..++||+|+||+||+|+. .+|+.||||++.+... .+.+|+++|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 577889999999999999976 4699999999976432 234799999999999999999998643 23689
Q ss_pred EEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeecccccc
Q 003846 576 IYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMF 654 (791)
Q Consensus 576 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~ 654 (791)
||||++++.+..+.........+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755555433445667899999999999999999999988 99999999999999775 8999999999876
Q ss_pred CCCccccccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh-----------hhH
Q 003846 655 GGDELQANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH-----------AWD 722 (791)
Q Consensus 655 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~-----------~~~ 722 (791)
...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .... .+.
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhh
Confidence 543322 23579999999998875 478999999999999999999999986433211 1000 000
Q ss_pred HhhcC----CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 723 LWKDN----RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 723 ~~~~~----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..... ..................++.+.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 0000000001111122345678999999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=368.80 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=197.3
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC----cce
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS-GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD----EKI 574 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 574 (791)
+.+|+++++||+|+||+||+|.. .+|+.||||++.+.. ....+++.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46899999999999999999964 579999999997543 334567899999999999999999999997653 345
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccccc
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMF 654 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~ 654 (791)
+++||+.+|+|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66777889999999843 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccCcccCchhccc-CCCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc--
Q 003846 655 GGDELQ-ANTNRIVGTYGYMSPEYALE-GLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL-- 730 (791)
Q Consensus 655 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 730 (791)
...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--HHHHHHhhhccCCChhhh
Confidence 443222 22344679999999999854 56789999999999999999999998543211 0000000000000000
Q ss_pred ---------ccccccc-cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 731 ---------DLMDPIL-ENEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 731 ---------~~~~~~l-~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
....... ....+ ...+.++.+|+.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00001 1123578899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=360.06 Aligned_cols=265 Identities=20% Similarity=0.290 Sum_probs=196.3
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEc--------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLD-------- 569 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 569 (791)
-++|++.++||+|+||+||+|+. .+|+.||||++... .....+++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999975 57999999998654 33346778999999999999999999999865
Q ss_pred CCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeec
Q 003846 570 QDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFG 649 (791)
Q Consensus 570 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFg 649 (791)
....++||||++++.+..+. .....++...+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34578999999887776543 34456788899999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhc
Q 003846 650 MARMFGGDELQ--ANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKD 726 (791)
Q Consensus 650 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 726 (791)
+++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHHHHhcCC
Confidence 99876543222 122235799999999998765 6899999999999999999999998542211 111111110000
Q ss_pred -----------CCccccccccccCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 727 -----------NRALDLMDPILENEASYP-------MLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 727 -----------~~~~~~~~~~l~~~~~~~-------~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
......+........... ..+.+.+|+.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000111111111111 13467789999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-41 Score=361.00 Aligned_cols=257 Identities=20% Similarity=0.302 Sum_probs=198.1
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcC--CcceEEE
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQ--DEKILIY 577 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~ 577 (791)
++|+++++||+|+||+||+|+. .+|+.||||+++... .+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999976 569999999986543 467899999999995 99999999999854 5689999
Q ss_pred eecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCC-CeEEeeeccccccCC
Q 003846 578 EYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDM-KPKISDFGMARMFGG 656 (791)
Q Consensus 578 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~ 656 (791)
||+++++|..+. +.+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 35889999999999999999999998 99999999999998765 599999999987654
Q ss_pred CccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhh--------hhHHhh--
Q 003846 657 DELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGH--------AWDLWK-- 725 (791)
Q Consensus 657 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~~~-- 725 (791)
... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+............. ......
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 322 2345789999999998865 57999999999999999999999976543321110000 000000
Q ss_pred cCC------------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 726 DNR------------ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 726 ~~~------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
... .................++++.+|+.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000011111111222345678999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-41 Score=356.02 Aligned_cols=259 Identities=22% Similarity=0.292 Sum_probs=196.2
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCceee-eeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNLVR-LLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~E 578 (791)
.++|++.++||+|+||.||+|+. .+|+.||||++..... .+++..|++++++++|+|++. +..+..+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46899999999999999999965 5689999999865433 246789999999998776555 4555677788899999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEc---CCCCeEEeeeccccccC
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---TDMKPKISDFGMARMFG 655 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFgla~~~~ 655 (791)
|+. ++|...+. .....+++..+..++.|+++||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 84 ~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcC-Cchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 994 56655553 23456899999999999999999999998 99999999999986 45579999999999875
Q ss_pred CCccc-----cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccch-hhhhhHHhhcCCc
Q 003846 656 GDELQ-----ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNL-LGHAWDLWKDNRA 729 (791)
Q Consensus 656 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 729 (791)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence 43221 22334679999999999999999999999999999999999999986544322111 100000000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 730 LDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 730 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
.+.+.. ..++++.+++..||+.+|++||+++++.+.|++
T Consensus 237 ----~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 237 ----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp ----HHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ----hhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 000111 134678999999999999999999998887765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=363.51 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=194.6
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeEEEcCC------
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKK--SGQGLEELKNETMLIAKLQHRNLVRLLGCCLDQD------ 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 571 (791)
.++|+++++||+|+||+||+|.. .+|+.||||++++. +....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999965 46999999999754 3334567889999999999999999999998655
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++||||+ +.+|..++. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 557776652 346899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHh------
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLW------ 724 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------ 724 (791)
+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.|+...... ..........
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAE 241 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--HHHHHHHhccCCCcHH
Confidence 875432 2345789999999998765 5789999999999999999999997543211 0000000000
Q ss_pred --hcCC----------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hccC
Q 003846 725 --KDNR----------ALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM--LTNE 777 (791)
Q Consensus 725 --~~~~----------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~ 777 (791)
.... ..+.....+ .......++.+.+|+.+||+.||++|||++|++++ ++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000 000000000 01112234678899999999999999999999986 5543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=355.58 Aligned_cols=263 Identities=21% Similarity=0.264 Sum_probs=203.6
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcCCcceEEEe
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 578 (791)
++|+++++||+|+||+||+|+. .+++.||||+++... ....+++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999975 578999999986543 3346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccccccCCCc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMARMFGGDE 658 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 658 (791)
++.+++|..++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888763 3456788999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccCcccCchhcccCC-CCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCc--------
Q 003846 659 LQANTNRIVGTYGYMSPEYALEGL-FSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRA-------- 729 (791)
Q Consensus 659 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 729 (791)
. ......+++.|+|||.+.... ++.++||||+||++|||++|+.|+-..... ................
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-HHHHHHHHhhcCCCChhhhhhhhh
Confidence 2 222346788999999988665 699999999999999999999986332211 1111111111110000
Q ss_pred ------ccccc-ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 730 ------LDLMD-PILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 730 ------~~~~~-~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
..... ...........++.+.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000111122345678899999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-40 Score=351.24 Aligned_cols=259 Identities=18% Similarity=0.245 Sum_probs=203.8
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcCC-CceeeeeeEEEcCCcceEEEe
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQH-RNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E 578 (791)
.++|++.++||+|+||+||+|+. .+|+.||||++..... .+++++|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 47899999999999999999975 4689999998865432 3457889999999975 899999999999999999999
Q ss_pred ecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcC-----CCCeEEeeeccccc
Q 003846 579 YLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDT-----DMKPKISDFGMARM 653 (791)
Q Consensus 579 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFgla~~ 653 (791)
|+ +++|.+++.. ....++..++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6899888743 3456889999999999999999999998 999999999999974 57899999999987
Q ss_pred cCCCccc-----cccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccc-hhhhhhHHhhcC
Q 003846 654 FGGDELQ-----ANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN-LLGHAWDLWKDN 727 (791)
Q Consensus 654 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~ 727 (791)
....... .......||+.|||||++.+..++.++||||||+++|||++|+.||......... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6543211 1233467999999999999999999999999999999999999998754332211 111110000000
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003846 728 RALDLMDPILENEASYPMLARYVNVALLCVHENATDRPTMSEVVSMLTN 776 (791)
Q Consensus 728 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 776 (791)
...+ +.. ..++++.+++..|++.+|++||+++.+.+.|++
T Consensus 236 ~~~~-----l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----hcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 0000 111 123578899999999999999999998887765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=355.92 Aligned_cols=253 Identities=25% Similarity=0.318 Sum_probs=201.0
Q ss_pred cCCCccceecccCceeEEEeEee----CCcEEEEEEecccC----cccHHHHHHHHHHHHhcCC-CceeeeeeEEEcCCc
Q 003846 502 NNFSAENKLGEGGFGPVYKGELL----NGQEVAVKRLSKKS----GQGLEELKNETMLIAKLQH-RNLVRLLGCCLDQDE 572 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 572 (791)
++|++.+.||+|+||+||+|... +|+.||||++++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999642 47899999986532 2345678899999999976 899999999999999
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.+++|||+.+|+|.+++... ..++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998543 34677888999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccCcccCchhcccC--CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcCCcc
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEG--LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDNRAL 730 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||........ ...........
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~~~~~~~--- 251 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 251 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC---
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcccC---
Confidence 76543322 22345799999999999765 478899999999999999999999865432221 11111111000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003846 731 DLMDPILENEASYPMLARYVNVALLCVHENATDRP-----TMSEVVSM 773 (791)
Q Consensus 731 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 773 (791)
....+...+..+.+++.+||+.||.+|| |++|++++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0111223457899999999999999999 58999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=356.00 Aligned_cols=261 Identities=22% Similarity=0.233 Sum_probs=190.0
Q ss_pred ccCCCccceecccCceeEEEeEee-CCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC------C
Q 003846 501 TNNFSAENKLGEGGFGPVYKGELL-NGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ------D 571 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 571 (791)
.++|++.++||+|+||+||+|... +|+.||||++.+.. .....++.+|+.++++++|||||++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999754 69999999997543 33456788999999999999999999999643 5
Q ss_pred cceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeeccc
Q 003846 572 EKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMA 651 (791)
Q Consensus 572 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla 651 (791)
..++||||+.++.+. .+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHH-HH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHH-hh-----hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 679999999776554 33 234788999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCccc----------------
Q 003846 652 RMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLN---------------- 715 (791)
Q Consensus 652 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~---------------- 715 (791)
+...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||.........
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8654332 223457899999999999999999999999999999999999998543211000
Q ss_pred -hhhhhhHHhhcCC------ccccccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 716 -LLGHAWDLWKDNR------ALDLMDPILENE---ASYPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 716 -~~~~~~~~~~~~~------~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
............. ............ .....+..+.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000 000111111111 112356788999999999999999999999866
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=356.90 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=194.8
Q ss_pred ccCCCccceecccCceeEEEeEe-eCCcEEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeEEEcC-----Cc
Q 003846 501 TNNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKS--GQGLEELKNETMLIAKLQHRNLVRLLGCCLDQ-----DE 572 (791)
Q Consensus 501 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 572 (791)
.++|++.++||+|+||+||+|+. .+|+.||||++.+.. ....+++.+|+.+|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999965 579999999997543 33456788999999999999999999998643 34
Q ss_pred ceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 573 KILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 573 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.++++||+.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577888899999999983 245899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccCcccCchhcccC-CCCcccceeehhHHHHHHHhCCCCCCCCCCCccchhhhhhHHhhcC----
Q 003846 653 MFGGDELQANTNRIVGTYGYMSPEYALEG-LFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSLNLLGHAWDLWKDN---- 727 (791)
Q Consensus 653 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 727 (791)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .............
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHH
Confidence 5432 22345789999999987765 4689999999999999999999998643211 0000000000000
Q ss_pred ----Cc---ccccccccc-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003846 728 ----RA---LDLMDPILE-NEAS-----YPMLARYVNVALLCVHENATDRPTMSEVVSM 773 (791)
Q Consensus 728 ----~~---~~~~~~~l~-~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 773 (791)
.. ......... .... ...++.+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 000000000 0000 1134678899999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-35 Score=321.98 Aligned_cols=263 Identities=20% Similarity=0.232 Sum_probs=193.9
Q ss_pred cCCCccceecccCceeEEEeEe-eCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-----------CCceeeeeeEEEc
Q 003846 502 NNFSAENKLGEGGFGPVYKGEL-LNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-----------HRNLVRLLGCCLD 569 (791)
Q Consensus 502 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 569 (791)
++|+++++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999975 579999999997543 23467788999998875 5789999988865
Q ss_pred C--CcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcCCCC----
Q 003846 570 Q--DEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDTDMK---- 642 (791)
Q Consensus 570 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~~~~---- 642 (791)
. ...+++++++..+..............++...+..++.||++||+|||+ ++ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4556777777666555444445566778889999999999999999997 66 999999999999986654
Q ss_pred --eEEeeeccccccCCCccccccccccccCcccCchhcccCCCCcccceeehhHHHHHHHhCCCCCCCCCCCcc-chhhh
Q 003846 643 --PKISDFGMARMFGGDELQANTNRIVGTYGYMSPEYALEGLFSIKSDVFSFGVLLLEILSGKKNTGFYHTGSL-NLLGH 719 (791)
Q Consensus 643 --~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvvl~elltg~~p~~~~~~~~~-~~~~~ 719 (791)
++++|||.+..... ......||+.|+|||++....++.++||||+||++++|++|+.||........ .....
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 99999999976432 22345799999999999999999999999999999999999999864332110 00000
Q ss_pred ---hhHHh------------------hcCCccccccc----------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003846 720 ---AWDLW------------------KDNRALDLMDP----------ILENEASYPMLARYVNVALLCVHENATDRPTMS 768 (791)
Q Consensus 720 ---~~~~~------------------~~~~~~~~~~~----------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 768 (791)
..... ........+.. ..........+..+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 00000 00000000000 001223445678899999999999999999999
Q ss_pred HHHHH
Q 003846 769 EVVSM 773 (791)
Q Consensus 769 evl~~ 773 (791)
|++++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99986
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.88 E-value=1.4e-22 Score=178.86 Aligned_cols=111 Identities=19% Similarity=0.288 Sum_probs=95.8
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
+|||.|||.|.+|+.|+| |.|+|.|+.+|+ |.|+. ..++||.||++.|. ..+.|.|+.||+|+|+|+
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKA--SGCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCC--CCcEEEEeccccEEEEec
Confidence 599999999999999985 999999999998 88875 36899999999874 345799999999999997
Q ss_pred ccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCC
Q 003846 108 RITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSH 152 (791)
Q Consensus 108 ~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtD 152 (791)
++ .+|++++... +..+|+|+||||||||+.++.++|||+.+|+|
T Consensus 68 ~~-~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp TE-EEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred CC-eEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 54 5666666544 56689999999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.1e-22 Score=196.98 Aligned_cols=163 Identities=18% Similarity=0.206 Sum_probs=120.9
Q ss_pred CccceecccCceeEEEeEeeCCcEEEEEEecccCc------------------ccHHHHHHHHHHHHhcCCCceeeeeeE
Q 003846 505 SAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSG------------------QGLEELKNETMLIAKLQHRNLVRLLGC 566 (791)
Q Consensus 505 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 566 (791)
.+.++||+|+||+||+|...+|+.||||+++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999888899999998753210 012334578899999999999988765
Q ss_pred EEcCCcceEEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccCCCCeeecCCCCCcEEEcCCCCeEEe
Q 003846 567 CLDQDEKILIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDTDMKPKIS 646 (791)
Q Consensus 567 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 646 (791)
. ..+++|||+++..+.+ ++......++.|++++|.|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 3489999998865532 344566789999999999999998 9999999999999965 58999
Q ss_pred eeccccccCCCccccccccccccCcccCc------hhcccCCCCcccceeehhHHH
Q 003846 647 DFGMARMFGGDELQANTNRIVGTYGYMSP------EYALEGLFSIKSDVFSFGVLL 696 (791)
Q Consensus 647 DFgla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslGvvl 696 (791)
|||+|......... .|... |. -...|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99999765422111 11111 11 135678899999975433
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.84 E-value=2.7e-21 Score=168.78 Aligned_cols=106 Identities=19% Similarity=0.216 Sum_probs=92.9
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
.|+|.+||.|.+|+.|. +|.|+|.|+.+|+ |.||.. .++||.||++.| +..+.|.|+.||||+|+|+
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV----DKPIWATNTGGL--SRSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC----CceeeEeCCCCC--CCccEEEEeccceEEEECC
Confidence 37899999999999995 6999999999998 888753 589999999988 4456799999999999999
Q ss_pred ccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCC
Q 003846 108 RITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDY 149 (791)
Q Consensus 108 ~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~ 149 (791)
++.++|++++... ...+|+|+||||||||+. .+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 9999999998655 445789999999999964 58999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.83 E-value=1.3e-20 Score=164.50 Aligned_cols=107 Identities=18% Similarity=0.251 Sum_probs=92.9
Q ss_pred CCcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecC
Q 003846 28 TDSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDG 107 (791)
Q Consensus 28 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 107 (791)
.|+|.|||.|.+|++|.+ |.|.|+|+.+|+ |.++. ..++||+||++.|... .+.|.|+.||+|||+|+
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeC
Confidence 378999999999999974 889999999998 77764 3589999999999744 46799999999999999
Q ss_pred ccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCC
Q 003846 108 RITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDY 149 (791)
Q Consensus 108 ~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~ 149 (791)
++.++|+|+++.. +...|+|+||||||||+. .+|||+-|
T Consensus 69 ~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred CCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 9999999998753 566899999999999964 69999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.69 E-value=1.2e-17 Score=147.70 Aligned_cols=102 Identities=21% Similarity=0.213 Sum_probs=88.2
Q ss_pred EEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceee
Q 003846 66 GIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLW 144 (791)
Q Consensus 66 ~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~W 144 (791)
.|||..+++.+++|++|++.|+....-+|.|+.||||||++. +.++|++++... ...+|+|+++|||||+|.+++++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 589999999999999999999988888999999999999986 567899998765 467899999999999999999999
Q ss_pred eecCCCCCcccCCCeecceeccCceeEEEEcCCCCCCCCCceEEEeecCCCceEE
Q 003846 145 QSFDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFS 199 (791)
Q Consensus 145 qsFd~PtDtllpg~~lg~~~~tg~~~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~ 199 (791)
||+. +.++|.|.+.++++|...++
T Consensus 90 ~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9974 23568899999999988766
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.65 E-value=4e-16 Score=137.41 Aligned_cols=102 Identities=12% Similarity=0.194 Sum_probs=83.3
Q ss_pred CcccCCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecCc
Q 003846 29 DSLSVGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGR 108 (791)
Q Consensus 29 ~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 108 (791)
++|.+||+| .+.+..|.|.|.|+.+|+ |.++ . ..++||.||+..|. ....|.|+.||+|+|+|++
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~---~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D---NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E---CCeEEEEecCCCCC--cceEEEEEeCCCEEEECCC
Confidence 555555555 346679999999999999 7775 2 36899999998773 3467999999999999999
Q ss_pred cceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecC
Q 003846 109 ITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFD 148 (791)
Q Consensus 109 ~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd 148 (791)
+.++|++++... +..+|+|+||||||||+ .++|||-.
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 999999998765 45578999999999995 47999864
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.63 E-value=5.1e-17 Score=142.12 Aligned_cols=110 Identities=24% Similarity=0.289 Sum_probs=94.9
Q ss_pred EEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecCccceEEeeeccCcceeEEEEccCCCeEEecCCCceeeee
Q 003846 67 IWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVSENVSSSQNTTATLLDSGNFVLRNEKLGLLWQS 146 (791)
Q Consensus 67 iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~Wqs 146 (791)
|||.-.++.+..|..+.+.++.....+|.|+.||||||+++ +.++|++++.+..+.++.|+++|||||++.++.+||||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 67776777888899999999988888999999999999985 56899999987778899999999999999999999997
Q ss_pred cCCCCCcccCCCeecceeccCceeEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 147 FDYPSHTFLPGMKLGYSRKTGKVWSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 147 Fd~PtDtllpg~~lg~~~~tg~~~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
+. +.++|.|.+.++++|...++ +.++|.+|.
T Consensus 82 ~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 82 GT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred CC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 63 34679999999999997665 347898874
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.46 E-value=4.9e-14 Score=122.89 Aligned_cols=97 Identities=21% Similarity=0.242 Sum_probs=77.7
Q ss_pred CcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecCccceEEe
Q 003846 35 QVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYRVS 114 (791)
Q Consensus 35 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 114 (791)
|.|.++|.| .+|.|.|.|+.+|+ |.|+. .+.+||.+|...+ ..+.+.|+.||||||+|.++.++|+
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEE
Confidence 445555555 46889999999999 88864 3578999996542 3467899999999999999999999
Q ss_pred eeccCc-ceeEEEEccCCCeEEecCCCceeeeecC
Q 003846 115 ENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFD 148 (791)
Q Consensus 115 ~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd 148 (791)
+.+... +..+++|++|||||||+ ..+|+|-.
T Consensus 81 S~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 81 SGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred cCCCCCCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 998754 45579999999999995 47999753
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.26 E-value=4.2e-12 Score=111.65 Aligned_cols=98 Identities=14% Similarity=0.191 Sum_probs=76.4
Q ss_pred CCCcccCCCEEeeCCCeEEEEeeCCCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCCCeEEEecCCCEEEecCccceE
Q 003846 33 VGQVITRSETLVSSGKFFELGFFRPGQSRNYYVGIWYKNIPERTVVWVANRDQPLTSSSPVLTISSEGNLVIEDGRITYR 112 (791)
Q Consensus 33 ~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ 112 (791)
+.+.|.+++.| ..|.|.|.|..+|+ |.|+. .+.+||.++.. ..+....+.|+.+|||||+|.++.++
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~l 88 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD----RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIAV 88 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB----TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEEE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec----CCcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCCCEE
Confidence 34555555555 35779999999998 87764 35788999854 33455679999999999999999999
Q ss_pred EeeeccCc-ceeEEEEccCCCeEEecCCCceeeee
Q 003846 113 VSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQS 146 (791)
Q Consensus 113 w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~Wqs 146 (791)
|++++... +..+++|++|||||||+ ..+|.|
T Consensus 89 W~S~t~~~~~~~~l~Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 89 WTSGNSRSAGRYVFVLQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp EECCCCCSSSCCEEEECSSSCEEEEC---CCCCBC
T ss_pred EEeCCCCCCCcEEEEECCCCcEEEeC---CCcccC
Confidence 99998654 45578999999999995 368875
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.18 E-value=4.1e-11 Score=103.36 Aligned_cols=85 Identities=18% Similarity=0.247 Sum_probs=67.3
Q ss_pred CeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCcee
Q 003846 92 PVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVW 170 (791)
Q Consensus 92 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~~ 170 (791)
-+|.|+.||||||++. +.++|++++.+. ....++|+++|||||+++++.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS------------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS------------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC------------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc------------------------
Confidence 3689999999999985 468999998765 35689999999999999999999985
Q ss_pred EEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 171 SLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 171 ~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
......+.|.+.++.+|...++ +.+.|.++.
T Consensus 76 -------~t~~~~~~~~l~L~ddGNlVly----~~~~W~S~t 106 (108)
T d1jpca_ 76 -------NTGGQNGNYVCILQKDRNVVIY----GTDRWATGT 106 (108)
T ss_dssp -------CCCCSCSCEEEEECTTSCEEEE----ECCCCCCCC
T ss_pred -------cccCCCCcEEEEEcCCCCEEEe----CCCcccCCC
Confidence 1112346788999999988776 234677654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.08 E-value=2.3e-10 Score=99.94 Aligned_cols=84 Identities=19% Similarity=0.296 Sum_probs=68.4
Q ss_pred eEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCceeE
Q 003846 93 VLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVWS 171 (791)
Q Consensus 93 ~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~~~ 171 (791)
.|.|+.||||||++++ .++|++++.+. .++.+.++++|||||+|.++.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~~-~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNN-NPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEETT-EEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEECC-eEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence 5899999999999865 57999998765 4689999999999999999999998521
Q ss_pred EEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 172 LTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 172 L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
.-+.|.|.+.++.+|...++ +.++|.++.
T Consensus 89 --------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 89 --------AGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp --------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred --------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 11347789999999988876 346888864
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.08 E-value=5.1e-10 Score=96.39 Aligned_cols=86 Identities=22% Similarity=0.334 Sum_probs=67.9
Q ss_pred CeEEEecCCCEEEecCccceEEeeeccCc--ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCce
Q 003846 92 PVLTISSEGNLVIEDGRITYRVSENVSSS--QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKV 169 (791)
Q Consensus 92 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~--~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~ 169 (791)
-.|.|+.||||||++. +.++|++++... .+..+.|+++|||||++.++.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s----------------------- 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS----------------------- 76 (109)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC-----------------------
T ss_pred EEEEecCCCeEEEEeC-CEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE-----------------------
Confidence 3689999999999974 568999998753 46789999999999999999999985
Q ss_pred eEEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCcC
Q 003846 170 WSLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGVW 213 (791)
Q Consensus 170 ~~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~w 213 (791)
.+..+.|.|.+.++++|...++ ...+|.++.+
T Consensus 77 --------~t~~~~~~~~l~L~ddGNlvly----~~~~W~S~t~ 108 (109)
T d1kj1a_ 77 --------HSVRGNGNYVLVLQEDGNVVIY----GSDIWSTGTY 108 (109)
T ss_dssp --------CCCCCSSCCEEEECTTSCEEEE----CCEEEECCCC
T ss_pred --------eeECCCCCEEEEEeCCCcEEEE----CCCEecCCCc
Confidence 1112347789999999988765 2468887653
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.70 E-value=3e-08 Score=85.77 Aligned_cols=87 Identities=15% Similarity=0.290 Sum_probs=66.4
Q ss_pred CeEEEecCCCEEEecCccceEEeeeccCc-ceeEEEEccCCCeEEecCCCceeeeecCCCCCcccCCCeecceeccCcee
Q 003846 92 PVLTISSEGNLVIEDGRITYRVSENVSSS-QNTTATLLDSGNFVLRNEKLGLLWQSFDYPSHTFLPGMKLGYSRKTGKVW 170 (791)
Q Consensus 92 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~WqsFd~PtDtllpg~~lg~~~~tg~~~ 170 (791)
-.|.|+.||||||++. +.++|++++... .++.++|+.+|||||++. ++.+|.|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s------------------------ 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWAS------------------------ 74 (112)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEEC------------------------
T ss_pred EEEEEcCCCCEEEEcC-CcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEE------------------------
Confidence 4699999999999984 568999988754 567899999999999986 4556653
Q ss_pred EEEEcCCCCCCCCCceEEEeecCCCceEEeecCCeEEeccCc
Q 003846 171 SLTSWKSRDDPSVGDAELKMEPGKSNAFSLMKRSQIVWTSGV 212 (791)
Q Consensus 171 ~L~Sw~s~~dps~G~~s~~~~~~~~~~~~~~~~~~~~w~~g~ 212 (791)
...-..|.|.+.++.+|...++- ....+.|.|+.
T Consensus 75 -------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT 108 (112)
T ss_dssp -------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred -------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence 11223467899999999987764 33457898865
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.56 E-value=1.2e-07 Score=95.39 Aligned_cols=149 Identities=16% Similarity=0.114 Sum_probs=105.3
Q ss_pred hhhhhccCCCccceecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcce
Q 003846 496 SVSASTNNFSAENKLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKI 574 (791)
Q Consensus 496 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 574 (791)
++......|+..+..+-++...||+... +++.++||+...........+.+|...+..+. +-.+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445556777666555455578998864 56778899887665555566788999988774 445678888888888899
Q ss_pred EEEeecCCCChhHHHhhhccccccCHHHHHHHHHHHHHHHHHhhccC---------------------------------
Q 003846 575 LIYEYLPNKSLDSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQYS--------------------------------- 621 (791)
Q Consensus 575 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--------------------------------- 621 (791)
+|||+++|.++.+.... ......++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999888654311 1122345556666666666421
Q ss_pred -----------------------CCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 622 -----------------------RLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 622 -----------------------~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
...++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877677999998853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=1.2e-05 Score=79.55 Aligned_cols=131 Identities=19% Similarity=0.183 Sum_probs=87.6
Q ss_pred eecccCc-eeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcC--CCceeeeeeEEEcCCcceEEEeecCCCCh
Q 003846 509 KLGEGGF-GPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQ--HRNLVRLLGCCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 509 ~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 585 (791)
.+..|.. ..||+....++..++||...... ...+..|+..++.+. .-.+.+++.+..+++..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455543 67899988778889999865443 235677888887774 33467788888888888999999998766
Q ss_pred hHHHhhhccccccCHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 003846 586 DSFLFDRAKKRLLYWETRVKIIEGIAQGLLYLHQ---------------------------------------------- 619 (791)
Q Consensus 586 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~---------------------------------------------- 619 (791)
.+.. .. ....+.++++.|+-||+
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 00 01112223333333332
Q ss_pred ---------cCCCCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 620 ---------YSRLRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 620 ---------~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
..+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1123479999999999999877778999998853
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.61 E-value=0.00014 Score=76.86 Aligned_cols=75 Identities=13% Similarity=0.210 Sum_probs=49.8
Q ss_pred ceecccCceeEEEeEeeC-CcEEEEEEeccc-------CcccHHHHHHHHHHHHhcC-C--CceeeeeeEEEcCCcceEE
Q 003846 508 NKLGEGGFGPVYKGELLN-GQEVAVKRLSKK-------SGQGLEELKNETMLIAKLQ-H--RNLVRLLGCCLDQDEKILI 576 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV 576 (791)
+.||.|....||+....+ ++.++||.-... .+...++...|++.|+.+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999997654 678999964321 1223455667888887763 3 345556544 45677899
Q ss_pred EeecCCCC
Q 003846 577 YEYLPNKS 584 (791)
Q Consensus 577 ~Ey~~~gs 584 (791)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.80 E-value=0.0015 Score=68.53 Aligned_cols=72 Identities=17% Similarity=0.218 Sum_probs=50.4
Q ss_pred ceecccCceeEEEeEeeCC--------cEEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeEEEcCCcceEEEe
Q 003846 508 NKLGEGGFGPVYKGELLNG--------QEVAVKRLSKKSGQGLEELKNETMLIAKLQ-HRNLVRLLGCCLDQDEKILIYE 578 (791)
Q Consensus 508 ~~LG~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 578 (791)
+.|+.|-.-.+|+....++ +.|.+++... ........+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 6788899999999976543 4566766642 223455678999999885 4334577777643 68999
Q ss_pred ecCCCCh
Q 003846 579 YLPNKSL 585 (791)
Q Consensus 579 y~~~gsL 585 (791)
|+++.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.74 E-value=0.0023 Score=65.25 Aligned_cols=138 Identities=14% Similarity=0.151 Sum_probs=79.6
Q ss_pred cCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce--eeeee-----EEEcCCcceEEEeecCCCCh
Q 003846 513 GGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL--VRLLG-----CCLDQDEKILIYEYLPNKSL 585 (791)
Q Consensus 513 G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lV~Ey~~~gsL 585 (791)
+..-.||+++..+|+.+++|+.+.. ....+++..|...+..|...++ +..+. .....+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3346899999989999999997643 2346778889998888753222 11111 12345566889999887543
Q ss_pred hH-----H------H---hhh------cccc-------------------ccCHHHHHHHHHHHHHHHHHhh----ccCC
Q 003846 586 DS-----F------L---FDR------AKKR-------------------LLYWETRVKIIEGIAQGLLYLH----QYSR 622 (791)
Q Consensus 586 ~~-----~------l---~~~------~~~~-------------------~l~~~~~~~i~~~ia~aL~~LH----~~~~ 622 (791)
.. + + +.. .... .++.+....+...+.+.+..+. +..+
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 21 1 1 000 0001 1111111122222222333332 2234
Q ss_pred CCeeecCCCCCcEEEcCCCCeEEeeeccccc
Q 003846 623 LRIIHRDLKASNILLDTDMKPKISDFGMARM 653 (791)
Q Consensus 623 ~~iiH~Dlkp~NILl~~~~~~kl~DFgla~~ 653 (791)
..+||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 568999999999999743 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.67 E-value=0.062 Score=53.62 Aligned_cols=157 Identities=14% Similarity=0.030 Sum_probs=82.1
Q ss_pred ehhhhhhhccCCCccc-----eecccCceeEEEeEeeCCcEEEEEEecccCcccHHHHHHHHHHHHhcCCCce--eeeee
Q 003846 493 SFASVSASTNNFSAEN-----KLGEGGFGPVYKGELLNGQEVAVKRLSKKSGQGLEELKNETMLIAKLQHRNL--VRLLG 565 (791)
Q Consensus 493 ~~~~~~~~~~~y~~~~-----~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~ 565 (791)
+.+++.....+|.+.+ .|..|---+.|+.+..+| .+++|+..... ..+++..|++++..+.+.++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 3455555566676643 344666788899987555 58999986432 23455667777777743222 11111
Q ss_pred ------EEEcCCcceEEEeecCCCChhHH-----------H---hhh------------------------ccccccCHH
Q 003846 566 ------CCLDQDEKILIYEYLPNKSLDSF-----------L---FDR------------------------AKKRLLYWE 601 (791)
Q Consensus 566 ------~~~~~~~~~lV~Ey~~~gsL~~~-----------l---~~~------------------------~~~~~l~~~ 601 (791)
+.........++.+..+...... + +.. .........
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11223445566666665432110 0 000 000001111
Q ss_pred HHHHHHHHHHHHHHHhhc-cCCCCeeecCCCCCcEEEcCCCCeEEeeecccc
Q 003846 602 TRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDTDMKPKISDFGMAR 652 (791)
Q Consensus 602 ~~~~i~~~ia~aL~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFgla~ 652 (791)
.....+..+...+...+. .-+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 122223333333333322 223569999999999999998877899999985
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.86 E-value=0.038 Score=34.34 Aligned_cols=28 Identities=36% Similarity=0.962 Sum_probs=21.4
Q ss_pred cCCC---cCCCCccccCCCC--CcccCCCcccCC
Q 003846 284 TSCV---ACGPFSICNTATG--SCQCLQGFFIGS 312 (791)
Q Consensus 284 ~~C~---~CG~~g~C~~~~~--~C~C~~Gf~~~~ 312 (791)
|+|. .|| +|.|.+-.. .|.|-.||+|.+
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 5675 687 688875544 899999999965
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.19 E-value=0.17 Score=33.00 Aligned_cols=28 Identities=32% Similarity=0.807 Sum_probs=22.0
Q ss_pred cCCC--cCCCCccccCCCC--CcccCCCcccC
Q 003846 284 TSCV--ACGPFSICNTATG--SCQCLQGFFIG 311 (791)
Q Consensus 284 ~~C~--~CG~~g~C~~~~~--~C~C~~Gf~~~ 311 (791)
|+|. .|...|.|..... .|.|++||.-.
T Consensus 1 D~C~~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTTTCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCCCCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4676 7999999976543 89999999653
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.17 E-value=0.17 Score=39.98 Aligned_cols=51 Identities=20% Similarity=0.450 Sum_probs=36.9
Q ss_pred ccceEEeecccCCCCc--cc---ccCCChhHHHHHhhcc----CCccccccc-CCCceeee
Q 003846 335 EDRFLRMHNVKLPSPD--KV---LKLPGIEECKSACLNN----CACTAYAYN-SSGVCSSW 385 (791)
Q Consensus 335 ~~~f~~l~~~~~p~~~--~~---~~~~s~~~C~~~Cl~n----CsC~a~~~~-~~g~C~~w 385 (791)
-++|.+..++.+...+ .. ....+.|+|...|+++ =.|.+|.|+ ..+.|.+-
T Consensus 4 L~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~~~~~C~Ls 64 (91)
T d2qj2a1 4 IHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWF 64 (91)
T ss_dssp GGGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEETTTTEEEEE
T ss_pred hHhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEECCCCeEEEc
Confidence 4678888887765333 11 2234899999999874 469999998 67789874
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.92 E-value=0.28 Score=32.69 Aligned_cols=29 Identities=21% Similarity=0.642 Sum_probs=23.0
Q ss_pred CcCCC--cCCCCccccCCCC--CcccCCCcccC
Q 003846 283 RTSCV--ACGPFSICNTATG--SCQCLQGFFIG 311 (791)
Q Consensus 283 ~~~C~--~CG~~g~C~~~~~--~C~C~~Gf~~~ 311 (791)
.|+|. .|+..+.|.+..+ .|.|++||...
T Consensus 5 idEC~~~~~~~~~~C~Nt~Gsy~C~C~~Gy~~~ 37 (43)
T d1emoa1 5 MDECKEPDVCKHGQCINTDGSYRCECPFGYILA 37 (43)
T ss_dssp CCSSSSTTSCSSSCCCCCSSCCCCCCCTTEEES
T ss_pred eeccCCcCCCCCCEeECCCCCeEeECCCCcccC
Confidence 47886 5777899987654 89999999763
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.83 E-value=0.13 Score=34.22 Aligned_cols=28 Identities=36% Similarity=0.801 Sum_probs=22.1
Q ss_pred CcCCC----cCCCCccccCCCC--CcccCCCccc
Q 003846 283 RTSCV----ACGPFSICNTATG--SCQCLQGFFI 310 (791)
Q Consensus 283 ~~~C~----~CG~~g~C~~~~~--~C~C~~Gf~~ 310 (791)
.++|. .|..+|.|..... .|.|++||.-
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 46675 6999999975543 8999999964
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.41 E-value=0.071 Score=35.54 Aligned_cols=28 Identities=25% Similarity=0.805 Sum_probs=21.1
Q ss_pred cCCC----cCCCCccccCCCC--CcccCCCcccCC
Q 003846 284 TSCV----ACGPFSICNTATG--SCQCLQGFFIGS 312 (791)
Q Consensus 284 ~~C~----~CG~~g~C~~~~~--~C~C~~Gf~~~~ 312 (791)
|+|. .|. +|.|.+..+ .|.|++||....
T Consensus 3 dEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 36 (42)
T d1lmja2 3 DECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLSP 36 (42)
T ss_dssp CHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCCS
T ss_pred cccCCCCCCCC-CCEeECCCCCeEEeCCCCCeECc
Confidence 4564 574 789986655 899999998754
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.61 E-value=0.14 Score=33.42 Aligned_cols=28 Identities=25% Similarity=0.623 Sum_probs=22.0
Q ss_pred cCCC--cCCCCccccCCC-C-CcccCCCcccC
Q 003846 284 TSCV--ACGPFSICNTAT-G-SCQCLQGFFIG 311 (791)
Q Consensus 284 ~~C~--~CG~~g~C~~~~-~-~C~C~~Gf~~~ 311 (791)
|.|. .|...|.|.... + .|.|++||.-.
T Consensus 2 d~C~~~PC~n~g~C~~~~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 2 NECVSNPCQNDATCLDQIGEFQCICMPGYEGV 33 (39)
T ss_dssp CTTTTCCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred cCCcCCCCCCCCEEECCCCCEEEeCCCCCccC
Confidence 5676 799999997543 3 89999999653
|